PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, QH; Gumireddy, K; Schrier, M; Le Sage, C; Nagel, R; Nair, S; Egan, DA; Li, AP; Huang, GH; Klein-Szanto, AJ; Gimotty, PA; Katsaros, D; Coukos, G; Zhang, L; Pure, E; Agami, R				Huang, Qihong; Gumireddy, Kiranmai; Schrier, Mariette; Le Sage, Carlos; Nagel, Remco; Nair, Suresh; Egan, David A.; Li, Anping; Huang, Guanghua; Klein-Szanto, Andres J.; Gimotty, Phyllis A.; Katsaros, Dionyssios; Coukos, George; Zhang, Lin; Pure, Ellen; Agami, Reuven			The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis	NATURE CELL BIOLOGY			English	Article							ADHESION MOLECULES; MESSENGER-RNA; EXPRESSION; CD44; CARCINOMA; CADHERIN; GROWTH; GENES; CELLS	MicroRNAs ( miRNAs) are single-stranded, noncoding RNAs that are important in many biological processes(1,2). Although the oncogenic and tumour-suppressive functions of several miRNAs have been characterized, the role of miRNAs in mediating tumour metastasis was addressed only recently(3) and still remains largely unexplored(4,5). To identify potential metastasis-promoting miRNAs, we set up a genetic screen using a nonmetastatic, human breast tumour cell line that was transduced with a miRNA-expression library and subjected to a trans-well migration assay. We found that human miR-373 and miR-520c stimulated cancer cell migration and invasion in vitro and in vivo, and that certain cancer cell lines depend on endogenous miR-373 activity to migrate efficiently. Mechanistically, the migration phenotype of miR-373 and miR-520c can be explained by suppression of CD44. We found significant upregulation of miR-373 in clinical breast cancer metastasis samples that correlated inversely with CD44 expression. Taken together, our findings indicate that miRNAs are involved in tumour migration and invasion, and implicate miR-373 and miR-520c as metastasis-promoting miRNAs.	[Huang, Qihong; Gumireddy, Kiranmai; Li, Anping; Huang, Guanghua; Pure, Ellen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Schrier, Mariette; Le Sage, Carlos; Nagel, Remco; Nair, Suresh; Agami, Reuven] Netherlands Canc Inst, Div Tumor Biol, Amsterdam, Netherlands; [Egan, David A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Coukos, George; Zhang, Lin] Univ Penn, Ctr Res Early Detect & Cure Ovarian Ctr, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	The Wistar Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Fox Chase Cancer Center; University of Pennsylvania; University of Turin; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Huang, QH (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	qhuang@wistar.org; r.agami@nki.nl	agami, reuven/GOG-8289-2022; Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012; Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Huang, Guanghua/0000-0002-4761-7548; Coukos, George/0000-0001-8813-7367; Agami, Reuven/0000-0002-2848-2473				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berner HS, 2003, HISTOPATHOLOGY, V42, P546, DOI 10.1046/j.1365-2559.2003.01622.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; Cichy J, 2000, J BIOL CHEM, V275, P18061, DOI 10.1074/jbc.M907962199; Cichy J, 2002, J BIOL CHEM, V277, P44440, DOI 10.1074/jbc.M207437200; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Gong Y, 2005, HISTOPATHOLOGY, V46, P24, DOI 10.1111/j.1365-2559.2004.01981.x; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jaeger EB, 2001, CANCER METAST REV, V20, P279, DOI 10.1023/A:1015587411668; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Pereira PA, 2001, ANTICANCER RES, V21, P2713; PLASTERK RHA, 2007, CELL, V449, P682; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ren JL, 2005, WORLD J GASTROENTERO, V11, P2674, DOI 10.3748/wjg.v11.i17.2674; Sasaki M, 2003, LAB INVEST, V83, P1403, DOI 10.1097/01.LAB.0000092230.59485.9E; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037	36	799	871	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					202	U83		10.1038/ncb1681	http://dx.doi.org/10.1038/ncb1681			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193036				2022-12-27	WOS:000252897800016
J	Dent, EW; Kwiatkowski, AV; Mebane, LM; Philippar, U; Barzik, M; Rubinson, DA; Gupton, S; Van Veen, JE; Furman, C; Zhang, JY; Alberts, AS; Mori, S; Gertler, FB				Dent, Erik W.; Kwiatkowski, Adam V.; Mebane, Leslie M.; Philippar, Ulrike; Barzik, Melanie; Rubinson, Douglas A.; Gupton, Stephanie; Van Veen, J. Edward; Furman, Craig; Zhang, Jiangyang; Alberts, Arthur S.; Mori, Susumu; Gertler, Frank B.			Filopodia are required for cortical neurite initiation	NATURE CELL BIOLOGY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ENA/VASP PROTEINS; AXON GUIDANCE; FIBROBLAST MOTILITY; NEURONAL POLARITY; GROWTH CONES; BARBED END; ACTIN; MICROTUBULES; OUTGROWTH	Extension of neurites from a cell body is essential to form a functional nervous system; however, the mechanisms underlying neuritogenesis are poorly understood. Ena/VASP proteins regulate actin dynamics and modulate elaboration of cellular protrusions. We recently reported that cortical axon-tract formation is lost in Ena/VASP-null mice and Ena/VASP-null cortical neurons lack filopodia and fail to elaborate neurites. Here, we report that neuritogenesis in Ena/VASP-null neurons can be rescued by restoring filopodia formation through ectopic expression of the actin nucleating protein mDia2. Conversely, wildtype neurons in which filopodia formation is blocked fail to elaborate neurites. We also report that laminin, which promotes the formation of filopodia-like actin-rich protrusions, rescues neuritogenesis in Ena/VASP-deficient neurons. Therefore, filopodia formation is a key prerequisite for neuritogenesis in cortical neurons. Neurite initiation also requires microtubule extension into filopodia, suggesting that interactions between actin-filament bundles and dynamic microtubules within filopodia are crucial for neuritogenesis.	MIT, Dept Biol, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Div Nucl Magnet Resonance Res, Baltimore, MD 21205 USA; Van Andel Res Inst, Lab Cell Struct & Signal Integrat, Grand Rapids, MI 49503 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Johns Hopkins University; Van Andel Institute; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Gertler, FB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fgertler@mit.edu	Rubinson, Douglas/G-3502-2019; Barzik, Melanie/AAJ-9269-2021; Dent, Erik/L-6208-2019	Rubinson, Douglas/0000-0002-5337-5231; Dent, Erik/0000-0001-8525-7136; Zhang, Jiangyang/0000-0003-0740-2662; van Veen, J. Edward/0000-0003-1798-3210; Zhang, Jiangyang/0000-0003-4146-8163; Barzik, Melanie/0000-0003-3003-1281	NIGMS NIH HHS [GM68678, F32-GM071156] Funding Source: Medline; NINDS NIH HHS [F32-NS45366] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071156, R01GM068678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS045366] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dehmelt L, 2003, J NEUROSCI, V23, P9479; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EDSON K, 1993, DEVELOPMENT, V117, P689; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	50	223	227	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1347	U28		10.1038/ncb1654	http://dx.doi.org/10.1038/ncb1654			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026093				2022-12-27	WOS:000251317300008
J	Liang, JY; Shao, SH; Xu, ZX; Hennessy, B; Ding, ZY; Larrea, M; Kondo, S; Dumont, DJ; Gutterman, JU; Walker, CL; Slingerland, JM; Mills, GB				Liang, Jiyong; Shao, Shan H.; Xu, Zhi-Xiang; Hennessy, Bryan; Ding, Zhiyong; Larrea, Michelle; Kondo, Seiji; Dumont, Dan J.; Gutterman, Jordan U.; Walker, Cheryl L.; Slingerland, Joyce M.; Mills, Gordon B.			The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis	NATURE CELL BIOLOGY			English	Article							KINASE INHIBITOR P27(KIP1); PROTEIN-KINASE; CELL-SURVIVAL; CANCER; GROWTH; LOCALIZATION; DOWNSTREAM; STABILITY; RAPAMYCIN; UPSTREAM	Nutrients and bioenergetics are prerequisites for proliferation and survival of mammalian cells(1,2). We present evidence that the cyclin-dependent kinase inhibitor p27(Kip1), is phosphorylated at Thr 198 downstream of the Peutz-Jeghers syndrome protein-AMP-activated protein kinase (LKB1-AMPK) energy-sensing pathway, thereby increasing p27 stability and directly linking sensing of nutrient concentration and bioenergetics to cell-cycle progression. Ectopic expression of wild-type and phosphomimetic Thr 198 to Asp 198 (T198D), but not unstable Thr 198 to Ala 198 (p27(T198A)) is sufficient to induce autophagy. Under stress conditions that activate the LKB1-AMPK pathway with subsequent induction of autophagy, p27 knockdown results in apoptosis. Thus LKB1-AMPK pathway-dependent phosphorylation of p27 at Thr 198 stabilizes p27 and permits cells to survive growth factor withdrawal and metabolic stress through autophagy. This may contribute to tumour-cell survival under conditions of growth factor deprivation, disrupted nutrient and energy metabolism, or during stress of chemotherapy.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Texas, MD Anderson Hosp & Tumor Inst, Dept Carcinogenesis, Smithville, TX 78957 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Miami	Mills, GB (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gmills@mdanderson.org		Hennessy, Bryan/0000-0002-7871-6477	NCI NIH HHS [P30 CA16672, P01CA099031, P01 CA64602, CA63613, P50-CA83639] Funding Source: Medline; NICHD NIH HHS [HD046282] Funding Source: Medline; NIEHS NIH HHS [ES08263] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046282] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA063613, P50CA083639, P30CA016672, P01CA099031, P01CA064602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008263] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Motti ML, 2004, CELL CYCLE, V3, P1074; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	35	695	723	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					218	U125		10.1038/ncb1537	http://dx.doi.org/10.1038/ncb1537			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237771				2022-12-27	WOS:000243903000015
J	Yang, WH; Kim, JE; Nam, HW; Ju, JW; Kim, HS; Kim, YS; Cho, JW				Yang, Won Ho; Kim, Ji Eun; Nam, Hyung Wook; Ju, Jung Won; Kim, Hoe Suk; Kim, Yu Sam; Cho, Jin Won			Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability	NATURE CELL BIOLOGY			English	Article							ESTROGEN-RECEPTOR-BETA; TUMOR-SUPPRESSOR P53; GLYCOSYLATION/O-PHOSPHORYLATION; POSTTRANSLATIONAL MODIFICATIONS; SIGNAL-TRANSDUCTION; COP9 SIGNALOSOME; MDM2 BINDING; CELL-DEATH; IN-VIVO; GLCNAC	Post-translational addition of O-linked N-acetylglucosamine (O-GlcNAc) to p53 is known to occur, but the site of O-GlcNAcylation and its effects on p53 are not understood. Here, we show that Ser 149 of p53 is O-GlcNAcylated and that this modification is associated with decreased phosphorylation of p53 at Thr 155, which is a site that is targeted by the COP9 signalosome, resulting in decreased p53 ubiquitination. Accordingly, O-GlcNAcylation at Ser 149 stabilizes p53 by blocking ubiquitin-dependent proteolysis. Our results indicate that the dynamic interplay between O-GlcNAc and O-phosphate modifications coordinately regulate p53 stability and activity.	Yonsei Univ, Dept Biol, Seoul 120749, South Korea; Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; ProteomeTech, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University	Cho, JW (corresponding author), Yonsei Univ, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	chojw311@yonsei.ac.kr		Ju, Jung-Won/0000-0001-5248-6995				BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chalkley RJ, 2003, MOL CELL PROTEOMICS, V2, P182, DOI 10.1074/mcp.M300027-MCP200; Chehab NH, 2000, GENE DEV, V14, P278; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Fuchs Serge Y, 2002, Cell, V110, P531, DOI 10.1016/S0092-8674(02)00902-9; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Hsu CH, 1999, BRIT J CANCER, V80, P1080, DOI 10.1038/sj.bjc.6690467; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; Konrad RJ, 2001, BIOCHEM J, V356, P31, DOI 10.1042/0264-6021:3560031; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Licitra L, 2004, J CLIN ONCOL, V22, P4901, DOI 10.1200/JCO.2004.05.071; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Morgan SE, 2000, ONCOGENE, V19, P5010, DOI 10.1038/sj.onc.1203865; Prives C, 1999, J PATHOL, V187, P112; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Ryu J, 2004, MOL CELLS, V17, P353; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shaw P, 1996, ONCOGENE, V12, P921; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Shieh SY, 2000, GENE DEV, V14, P289; Toleman C, 2006, BIOCHEM BIOPH RES CO, V340, P526, DOI 10.1016/j.bbrc.2005.12.041; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	49	322	351	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1074	U53		10.1038/ncb1470	http://dx.doi.org/10.1038/ncb1470			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16964247				2022-12-27	WOS:000241395300011
J	Fallon, L; Belanger, CML; Corera, AT; Kontogiannea, M; Regan-Klapisz, E; Moreau, F; Voortman, J; Haber, M; Rouleau, G; Thorarinsdottir, T; Brice, A; Henegouwen, PMPVBE; Fon, EA				Fallon, Lara; Belanger, Catherine M. L.; Corera, Amadou T.; Kontogiannea, Maria; Regan-Klapisz, Elsa; Moreau, France; Voortman, Jarno; Haber, Michael; Rouleau, Genevieve; Thorarinsdottir, Thorhildur; Brice, Alexis; Henegouwen, Paul M. P. van Bergen en; Fon, Edward A.			A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; RECESSIVE JUVENILE PARKINSONISM; UBIQUITIN-BINDING PROTEINS; ENDOCYTIC PATHWAY; GENE; DISEASE; MOTIF; MONOUBIQUITINATION; ACTIVATION; MUTATIONS	Mutations in the parkin gene are responsible for a common familial form of Parkinson's disease(1,2). As parkin encodes an E3 ubiquitin ligase(3), defects in proteasome-mediated protein degradation are believed to have a central role in the pathogenesis of Parkinson's disease(4). Here, we report a novel role for parkin in a proteasome-independent ubiquitination pathway. We have identified a regulated interaction between parkin and Eps15, an adaptor protein that is involved in epidermal growth factor ( EGF) receptor ( EGFR) endocytosis and trafficking(5). Treatment of cells with EGF stimulates parkin binding to both Eps15 and the EGFR and promotes parkin-mediated ubiquitination of Eps15. Binding of the parkin ubiquitin-like ( Ubl) domain to the Eps15 ubiquitin-interacting motifs ( UIMs) is required for parkin-mediated Eps15 ubiquitination. Furthermore, EGFR endocytosis and degradation are accelerated in parkin-deficient cells, and EGFR signalling via the phosphoinositide 3-kinase ( PI( 3) K)Akt pathway is reduced in parkin knockout mouse brain. We propose that by ubiquitinating Eps15, parkin interferes with the ability of the Eps15 UIMs to bind ubiquitinated EGFR(6-8), thereby delaying EGFR internalization and degradation, and promoting PI( 3)K-Akt signalling. Considering the role of Akt in neuronal survival(9), our results have broad new implications for understanding the pathogenesis of Parkinson's disease.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; INSERM, U679, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75651 Paris 13, France	McGill University; McGill University; Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; van Bergen en Henegouwen, Paul/B-8870-2011	brice, alexis/0000-0002-0941-3990; van Bergen en Henegouwen, Paul/0000-0001-6050-9042				Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; FAUNDEZ V, 1992, J BIOL CHEM, V267, P20363; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Iwakura Y, 2005, J NEUROCHEM, V93, P974, DOI 10.1111/j.1471-4159.2005.03073.x; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	35	297	302	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					834	U87		10.1038/ncb1441	http://dx.doi.org/10.1038/ncb1441			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862145				2022-12-27	WOS:000239423000013
J	Ohta, Y; Hartwig, JH; Stossel, TP				Ohta, Yasutaka; Hartwig, John H.; Stossel, Thomas P.			FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling	NATURE CELL BIOLOGY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESIONS; TARGETS FILAMIN; EXCHANGE FACTOR; CELL; KINASE; CDC42; ALPHA; PHOSPHORYLATION; MIGRATION	FilGAP is a newly recognized filamin A ( FLNa)-binding RhoGTPase-activating protein. The GTPase-activating protein ( GAP) activity of FilGAP is specific for Rac and FLNa binding targets FilGAP to sites of membrane protrusion, where it antagonizes Rac in vivo. Dominant-negative FilGAP constructs lacking GAP activity or knockdown of endogenous FilGAP by small interference RNA ( siRNA) induce spontaneous lamellae formation and stimulate cell spreading on fibronectin. Knockdown of endogenous FilGAP abrogates ROCK-dependent suppression of lamellae. Conversely, forced expression of FilGAP induces numerous blebs around the cell periphery and a ROCK-specific inhibitor suppresses bleb formation. ROCK phosphorylates FilGAP, and this phosphorylation stimulates its RacGAP activity and is a requirement for FilGAP-mediated bleb formation. FilGAP is, therefore, a mediator of the well-established antagonism of Rac by RhoA that suppresses leading edge protrusion and promotes cell retraction to achieve cellular polarity.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Hematol Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ohta, Y (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Hematol Div, Boston, MA 02115 USA.	yohta@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429, R37HL019429] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19429] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aitsebaomo J, 2004, J BIOL CHEM, V279, P17963, DOI 10.1074/jbc.M311721200; Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caron E, 2003, NAT CELL BIOL, V5, P185, DOI 10.1038/ncb0303-185; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Katoh M, 2004, INT J MOL MED, V14, P333; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Puls A, 1999, J CELL SCI, V112, P2983; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roovers K, 2003, MOL CELL BIOL, V23, P4283, DOI 10.1128/MCB.23.12.4283-4294.2003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; Taylor JM, 1998, J BIOL CHEM, V273, P8063, DOI 10.1074/jbc.273.14.8063; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; VALERIUS NH, 1981, CELL, V24, P195, DOI 10.1016/0092-8674(81)90515-8; VIDALI L, IN PRESS MOL BIOL CE; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867	50	280	289	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					803	U35		10.1038/ncb1437	http://dx.doi.org/10.1038/ncb1437			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862148				2022-12-27	WOS:000239423000010
J	Siller, KH; Cabernard, C; Doe, CQ				Siller, Karsten H.; Cabernard, Clemens; Doe, Chris Q.			The NuMA-related Mud protein binds Pins and regulates spindle orientation in Drosophila neuroblasts	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; MUSHROOM-BODY-DEFECT; C-ELEGANS; CORTICAL POLARITY; ALPHA-I; COMPLEX; PARTNER; GENE; DIFFERENTIATION; PROLIFERATION	Asymmetric cell division generates cell diversity during development(1,2) and regulates stem-cell self-renewal in Drosophila and mammals(3,4). In Drosophila, neuroblasts align their spindle with a cortical Partner of Inscuteable (Pins)-Gai crescent to divide asymmetrically, but the link between cortical polarity and the mitotic spindle is poorly understood. Here, we show that Pins directly binds, and coimmunoprecipitates with, the NuMA-related Mushroom body defect (Mud) protein. Pins recruits Mud to the neuroblast apical cortex, and Mud is also strongly localized to centrosome/spindle poles, in a similar way to NuMA. In mud mutants, cortical polarity is normal, but the metaphase spindle frequently fails to align with the cortical polarity axis. When spindle orientation is orthogonal to cell polarity, symmetric division occurs. We propose that Mud is a functional orthologue of mammalian NuMA and Caenorhabditis elegans Lin-5, and that Mud coordinates spindle orientation with cortical polarity to promote asymmetric cell division.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA.	cdoe@uoregon.edu	Cabernard, Clemens/A-9033-2010	Cabernard, Clemens/0000-0003-3706-6401				Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Guan ZH, 2000, P NATL ACAD SCI USA, V97, P8122, DOI 10.1073/pnas.97.14.8122; Haren L, 2002, J CELL SCI, V115, P1815; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; YU JX, GENETICS	29	243	248	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					594	600		10.1038/ncb1412	http://dx.doi.org/10.1038/ncb1412			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16648843				2022-12-27	WOS:000238029000012
J	Muraoka, O; Shimizu, T; Yabe, T; Nojima, H; Bae, YK; Hashimoto, H; Hibi, M				Muraoka, O; Shimizu, T; Yabe, T; Nojima, H; Bae, YK; Hashimoto, H; Hibi, M			Sizzled controls dorso-ventral polarity by repressing cleavage of the Chordin protein	NATURE CELL BIOLOGY			English	Article							FRIZZLED-RELATED PROTEINS; NEGATIVE FEEDBACK REGULATOR; ZEBRAFISH EMBRYO; PATTERN-FORMATION; SPEMANN ORGANIZER; XENOPUS EMBRYOS; TWISTED GASTRULATION; BMP; GENES; NOGGIN	The Bone morphogenetic protein (Bmp) signalling gradient has a major function in the formation of the dorso-ventral axis. The zebrafish ventralized mutant, ogon, encodes Secreted Frizzled ( Sizzled). sizzled is ventrally expressed in a Bmp-dependent manner and is required for the suppression of Bmp signalling on the ventral side of zebrafish embryos. However, it remains unclear how Sizzled inhibits Bmp signalling and controls ventro-lateral cell fate. We found that Sizzled stabilizes Chordin, a Bmp antagonist, by binding and inhibiting the Tolloid-family metalloproteinase, Bmp1a, which cleaves and inactivates Chordin. The cysteine-rich domain of Sizzled is required for inhibition of Bmp1a activity. Loss of both Bmp1a and Tolloid-like1 (Tll1; another Tolloid-family metalloproteinase) function leads to a complete suppression and reversal of the ogon mutant phenotype. These results indicate that Sizzled represses the activities of Tolloid-family proteins, thereby creating the Chordin - Bmp activity gradient along the dorso-ventral axis. Here, we describe a previously unrecognized role for a secreted Frizzled-related protein.	RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuo Ku, Kobe, Hyogo 6500047, Japan; Nagoya Univ, Biosci & Biotechnol Ctr, Aichi 4648601, Japan	RIKEN; Nagoya University	Hibi, M (corresponding author), RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	hibi@cdb.riken.jp	Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444; Yabe, Taijiro/0000-0002-0843-7472				Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bauer H, 2001, DEVELOPMENT, V128, P849; Blader P, 1997, SCIENCE, V278, P1937, DOI 10.1126/science.278.5345.1937; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Connors SA, 1999, DEVELOPMENT, V126, P3119; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dick A, 2000, DEVELOPMENT, V127, P343; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hibi M, 2002, RES PRO CEL, V40, P48; Hild M, 1999, DEVELOPMENT, V126, P2149; Jones CM, 1998, DEV BIOL, V194, P12, DOI 10.1006/dbio.1997.8752; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kramer C, 2002, DEV BIOL, V250, P263, DOI 10.1006/dbio.2002.0805; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nikaido M, 1999, DEVELOPMENT, V126, P181; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Salic AN, 1997, DEVELOPMENT, V124, P4739; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid B, 2000, DEVELOPMENT, V127, P957; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	46	83	86	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					329	U9		10.1038/ncb1379	http://dx.doi.org/10.1038/ncb1379			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16518392				2022-12-27	WOS:000236560000011
J	Zeuschner, D; Geerts, WJC; van Donselaar, E; Humbel, BM; Slot, JW; Koster, AJ; Klumperman, J				Zeuschner, D; Geerts, WJC; van Donselaar, E; Humbel, BM; Slot, JW; Koster, AJ; Klumperman, J			Immuno-electron tomography of ER exit sites reveals the existence of free COPII-coated transport carriers	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; ELECTRON TOMOGRAPHY; GOLGI; LOCALIZATION; PROTEINS; RECONSTITUTION; FIXATION; DYNAMICS; VESICLES; PATHWAY	Transport from the endoplasmic reticulum ( ER) to the Golgi complex requires assembly of the COPII coat complex at ER exit sites. Recent studies have raised the question as to whether in mammalian cells COPII coats give rise to COPII-coated transport vesicles or instead form ER sub-domains that collect proteins for transport via non-coated carriers. To establish whether COPII-coated vesicles do exist in vivo, we developed approaches to combine quantitative immunogold labelling ( to identify COPII) and three-dimensional electron tomography ( to reconstruct entire membrane structures). In tomograms of both chemically fixed and high-pressure-frozen HepG2 cells, immuno-labelled COPII was found on ER-associated buds as well as on free similar to 50-nm diameter vesicles. In addition, we identified a novel type of COPII-coated structure that consists of partially COPII-coated, 150 - 200-nm long, dumb-bell-shaped tubules. Both COPII-coated carriers also contain the SNARE protein Sec22b, which is necessary for downstream fusion events. Our studies unambiguously establish the existence of free, bona fide COPII-coated transport carriers at the ER - Golgi interface, suggesting that assembly of COPII coats in vivo can result in vesicle formation.	UMC Utrecht, Inst Biomembranes, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Klumperman, J (corresponding author), UMC Utrecht, Inst Biomembranes, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	J.Klumperman@lab.azu.nl	Geerts, Willie J.C./B-7640-2011; Koster, Abraham/I-7665-2017	Geerts, Willie J.C./0000-0002-4530-7458; Koster, Abraham/0000-0003-1717-2549				Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; DEGRAAF A, 1991, J HISTOCHEM CYTOCHEM, V39, P1035, DOI 10.1177/39.8.1856453; Fan JY, 2003, HISTOCHEM CELL BIOL, V120, P455, DOI 10.1007/s00418-003-0597-1; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; GEERTS WJC, 2005, ELECT MICROSCOPY TOM; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Klumperman J, 1998, J CELL SCI, V111, P3411; Koster AJ, 2003, NAT REV MOL CELL BIO, pSS6, DOI 10.1038/nrm1194; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Leapman RD, 2004, CURR OPIN NEUROBIOL, V14, P591, DOI 10.1016/j.conb.2004.08.004; LEUNISSEN JL, 1993, IMMUNOGOLD ELECT MIC; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; RABOUILLE C, 1992, J BIOL CHEM, V267, P11573; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; SESSO A, 1994, J CELL SCI, V107, P517; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stephens DJ, 2000, J CELL SCI, V113, P2177; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; WILLINGHAM MC, 1983, J HISTOCHEM CYTOCHEM, V31, P791, DOI 10.1177/31.6.6404984; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Ziese U, 2002, J MICROSC-OXFORD, V205, P187, DOI 10.1046/j.0022-2720.2001.00987.x	38	135	138	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					377	U49		10.1038/ncb1371	http://dx.doi.org/10.1038/ncb1371			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16531996				2022-12-27	WOS:000236560000016
J	Kaji, K; Caballero, IM; MacLeod, R; Nichols, J; Wilson, VA; Hendrich, B				Kaji, K; Caballero, IM; MacLeod, R; Nichols, J; Wilson, VA; Hendrich, B			The NuRD component Mbd3 is required for pluripotency of embryonic stem cells	NATURE CELL BIOLOGY			English	Letter							DNA METHYLATION; BINDING DOMAIN; MESSENGER-RNA; EXPRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; PROTEINS; MESODERM; COMPLEX	Cells of early mammalian embryos have the potential to develop into any adult cell type, and are thus said to be pluripotent. Pluripotency is lost during embryogenesis as cells commit to specific developmental pathways. Although restriction of developmental potential is often associated with repression of inappropriate genetic programmes(1), the role of epigenetic silencing during early lineage commitment remains undefined. Here, we used mouse embryonic stem cells to study the function of epigenetic silencing in pluripotent cells. Embryonic stem cells lacking Mbd3 - a component of the nucleosome remodelling and histone deacetylation (NuRD) complex(2,3) - were viable but failed to completely silence genes that are expressed before implantation of the embryo. Mbd3-deficient embryonic stem cells could be maintained in the absence of leukaemia inhibitory factor (LIF) and could initiate differentiation in embryoid bodies or chimeric embryos, but failed to commit to developmental lineages. Our findings define a role for epigenetic silencing in the cell-fate commitment of pluripotent cells.	Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Hendrich, B (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland.	Brian.Hendrich@ed.ac.uk	Wilson, Valerie A/H-5427-2011; Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Nichols, Jennifer/0000-0002-8650-1388; Kaji, Keisuke/0000-0001-5946-8415; , Val/0000-0003-4182-5159	MRC [G9806702, G0300058] Funding Source: UKRI; Medical Research Council [G0300058, G9806702] Funding Source: Medline; Wellcome Trust [064623, 073621] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Busslinger M, 2000, CURR OPIN IMMUNOL, V12, P151, DOI 10.1016/S0952-7915(99)00065-5; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Huang JQ, 2001, J IMMUNOL, V167, P6073, DOI 10.4049/jimmunol.167.11.6073; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tam PPL, 2003, DEVELOPMENT, V130, P6155, DOI 10.1242/dev.00893; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	34	285	292	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					285	292		10.1038/ncb1372	http://dx.doi.org/10.1038/ncb1372			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16462733				2022-12-27	WOS:000235708000015
J	Villarejo, A; Buren, S; Larsson, S; Dejardin, A; Monne, M; Rudhe, C; Karlsson, J; Jansson, S; Lerouge, P; Rolland, N; von Heijne, G; Grebe, M; Bako, L; Samuelsson, G				Villarejo, A; Buren, S; Larsson, S; Dejardin, A; Monne, M; Rudhe, C; Karlsson, J; Jansson, S; Lerouge, P; Rolland, N; von Heijne, G; Grebe, M; Bako, L; Samuelsson, G			Evidence for a protein transported through the secretory pathway en route to the higher plant chloroplast	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; ARABIDOPSIS; IDENTIFICATION; TRAFFICKING; IMPORT; PREDICTION; MEMBRANE; REVEALS; GLYCANS; AMYLASE	In contrast to animal and fungal cells, green plant cells contain one or multiple chloroplasts, the organelle(s) in which photosynthetic reactions take place. Chloroplasts are believed to have originated from an endosymbiotic event and contain DNA that codes for some of their proteins. Most chloroplast proteins are encoded by the nuclear genome and imported with the help of sorting signals that are intrinsic parts of the polypeptides. Here, we show that a chloroplast-located protein in higher plants takes an alternative route through the secretory pathway, and becomes N-glycosylated before entering the chloroplast.	Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; Stockholm Univ, Arrhenius Lab, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Univ Rouen, UFR Sci, CNRS, UMR 6037,IFRMP 23, F-76821 Mont St Aignan, France; Univ Grenoble 1, CEA Grenoble, INRA, CNRS,UMR 5168,Lab Physiol Cellulaire Vegetale, F-38054 Grenoble, France; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Lab Plant Sci Ctr, S-90183 Umea, Sweden; Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	Umea University; Stockholm University; Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Swedish University of Agricultural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Samuelsson, G (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	goran.samuelsson@plantphys.umu.se	Monné, Magnus/D-5642-2012; Karlsson, Jan/E-7199-2015; Jansson, Stefan/A-1119-2009; ROLLAND, Norbert/B-4405-2012; Burén, Stefan/L-6705-2014; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011; Samuelsson, Goran/E-1824-2015	Monné, Magnus/0000-0003-2344-3878; Karlsson, Jan/0000-0002-6002-929X; Jansson, Stefan/0000-0002-7906-6891; ROLLAND, Norbert/0000-0003-1959-6636; Burén, Stefan/0000-0002-8487-2732; von Heijne, Gunnar/0000-0002-4490-8569; Dejardin, Annabelle/0000-0002-7576-5476; Grebe, Markus/0000-0001-7571-0670				Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Chen MH, 2004, PLANT PHYSIOL, V135, P1367, DOI 10.1104/pp.104.042184; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Gasparian M, 2000, PLANT PHYSIOL, V122, P25, DOI 10.1104/pp.122.1.25; Hermansson M, 2001, J MOL BIOL, V313, P1171, DOI 10.1006/jmbi.2001.5108; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Jarvis P, 2001, BBA-MOL CELL RES, V1541, P64, DOI 10.1016/S0167-4889(01)00147-1; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kunst L, 1998, METH MOL B, V82, P43; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Levitan A, 2005, P NATL ACAD SCI USA, V102, P6225, DOI 10.1073/pnas.0500676102; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Soll J, 2002, CURR OPIN PLANT BIOL, V5, P529, DOI 10.1016/S1369-5266(02)00296-0; SULLI C, 1995, J BIOL CHEM, V270, P13084, DOI 10.1074/jbc.270.22.13084; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	33	236	254	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1224	1231		10.1038/ncb1330	http://dx.doi.org/10.1038/ncb1330			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16284624	Green Published			2022-12-27	WOS:000233748900016
J	Forest, T; Barnard, S; Baines, JD				Forest, T; Barnard, S; Baines, JD			Active intranuclear movement of herpesvirus capsids	NATURE CELL BIOLOGY			English	Article							2,3-BUTANEDIONE MONOXIME; DIFFUSION; CHROMATIN; PROTEINS; DYNAMICS; MYOSIN	Although small molecules diffuse rapidly through the interphase nucleus(1,2), recent reports indicate that nuclear diffusion is limited for particles that are larger than 100 nm in diameter(3). Given the apparent size limits to nuclear diffusion, there is some debate as to whether the movement of large particles should be attributed to diffusion or to active transport(4-6). Here, we show that 125 nm-diameter herpes simplex virus 1 (HSV-1) capsids are actively transported within infected nuclei. Movement is directed, temperature- and energy-dependent, sensitive to the putative myosin inhibitor 2,3-butanedione monoxime (BDM)(7,8) and to actin depolymerization with latrunculin-A, but insensitive to actin depolymerization with cytochalasin-D.	Cornell Univ, Vet Educ Ctr C5132, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	Cornell University; University of Sydney	Baines, JD (corresponding author), Cornell Univ, Vet Educ Ctr C5132, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	jdb11@cornell.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI007227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050740] Funding Source: NIH RePORTER; NIAID NIH HHS [T35 AI07227-19] Funding Source: Medline; NIGMS NIH HHS [R01 GM50740] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Dasgupta A, 1999, J VIROL, V73, P2006, DOI 10.1128/JVI.73.3.2006-2015.1999; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; HERRMANN C, 1992, BIOCHEMISTRY-US, V31, P12227, DOI 10.1021/bi00163a036; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Ward PL, 1996, J VIROL, V70, P4623, DOI 10.1128/JVI.70.7.4623-4631.1996	15	96	99	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					429	U54		10.1038/ncb1243	http://dx.doi.org/10.1038/ncb1243			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15803134				2022-12-27	WOS:000228075500021
J	Ninomiya, H; Winklbauer, R				Ninomiya, Hiromasa; Winklbauer, Rudolf			Epithelial coating controls mesenchymal shape change through tissue-positioning effects and reduction of surface-minimizing tension	NATURE CELL BIOLOGY			English	Article							XENOPUS-LAEVIS; PARAXIAL PROTOCADHERIN; VERTEBRATE DEVELOPMENT; CONVERGENT EXTENSION; SELECTIVE ADHESION; CELL MOVEMENTS; EXPRESSION; MESODERM; GASTRULATION; MORPHOGENESIS	signalling between mesenchymal and epithelial cells has a profound influence on organ morphogenesis. However, less is known about the mechanical function of epithelial mesenchymal interactions. Here, we describe two principal effects by which epithelia can regulate shape changes in mesenchymal cell aggregates. We propose that during formation of the embryonic body axis, the epithelial layer relieves surface minimizing tensions that would force cell aggregates into a spherical shape, and controls the serial arrangement of cell populations along the axis. the combined effects permit the tissue to deviate from a spherical form and to elongate.	[Ninomiya, Hiromasa; Winklbauer, Rudolf] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto	Winklbauer, R (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	winklbauer@zoo.utoronto.ca						Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; ANGRES B, 1991, DEVELOPMENT, V111, P829; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; del Rio OI, 1997, J COLLOID INTERF SCI, V196, P136; Foty RA, 1996, DEVELOPMENT, V122, P1611; GRANER F, 1993, J THEOR BIOL, V164, P455, DOI 10.1006/jtbi.1993.1167; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER RE, 1978, J MORPHOL, V157, P223, DOI 10.1002/jmor.1051570209; Kim SH, 1998, DEVELOPMENT, V125, P4681; Koibuchi N, 1998, DEV GROWTH DIFFER, V40, P355; Kuroda H, 1999, DEV GROWTH DIFFER, V41, P283; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; MOORE SW, 1995, DEVELOPMENT, V121, P3131; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; NARDI JB, 1983, DIFFERENTIATION, V25, P27; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schnabel R, 2006, DEV BIOL, V294, P418, DOI 10.1016/j.ydbio.2006.03.004; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; SHIH J, 1992, DEVELOPMENT, V116, P901; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Steinberg M. S., 1978, SPECIFICITY EMBRYOLO, V4, P99; STEINBERG MS, 1970, J EXP ZOOL, V173, P395, DOI 10.1002/jez.1401730406; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1978, RECEPTORS RECOGNIT B, V4; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435	39	59	60	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					61	U46		10.1038/ncb1669	http://dx.doi.org/10.1038/ncb1669			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084283				2022-12-27	WOS:000252116100013
J	Cheung, N; Chan, LC; Thompson, A; Cleary, ML; So, CWE				Cheung, Ngai; Chan, Li Chong; Thompson, Alex; Cleary, Michael L.; So, Chi Wai Eric			Protein arginine-methyltransferase-dependent oncogenesis	NATURE CELL BIOLOGY			English	Article							MYELOID PROGENITORS; TRANSCRIPTIONAL ACTIVATION; HEMATOPOIETIC PROGENITORS; HISTONE H4; IN-VIVO; METHYLATION; MLL; LEUKEMIA; TRANSFORMATION; GENE	Enzymes that mediate reversible epigenetic modifications have not only been recognized as key in regulating gene expression(1) and oncogenesis(2,3), but also provide potential targets for molecular therapy(4). Although the methylation of arginine 3 of histone 4 ( H4R3) by protein arginine methyltransferase 1 ( PRMT1) is a critical modification for active chromatin(5,6) and prevention of heterochromatin spread(7), there has been no direct evidence of any role of PRMTs in cancer. Here, we show that PRMT1 is an essential component of a novel Mixed Lineage Leukaemia ( MLL) oncogenic transcriptional complex with both histone acetylation and H4R3 methylation activities, which also correlate with the expression of critical MLL downstream targets. Direct fusion of MLL with PRMT1 or Sam68, a bridging molecule in the complex for PRMT1 interaction, could enhance self-renewal of primary haematopoietic cells. Conversely, specific knockdown of PRMT1 or Sam68 expression suppressed MLL-mediated transformation. This study not only functionally dissects the oncogenic transcriptional machinery associated with an MLL fusion complex, but also uncovers-for the first time-an essential function of PRMTs in oncogenesis and reveals their potential as novel therapeutic targets in human cancer.	Inst Canc Res, Hematol Oncol Sect, Sutton SM2 5NG, Surrey, England; Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; Queens Univ Belfast, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	University of London; Institute of Cancer Research - UK; University of Hong Kong; Queens University Belfast; Stanford University	So, CWE (corresponding author), Inst Canc Res, Hematol Oncol Sect, Sutton SM2 5NG, Surrey, England.	eric.so@icr.ac.uk		Thompson, Alex/0000-0002-9315-5321	Worldwide Cancer Research [04-0916] Funding Source: Medline	Worldwide Cancer Research		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cheung N, 2004, BIOCHEM J, V383, P27, DOI 10.1042/BJ20040041; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; So CW, 1997, P NATL ACAD SCI USA, V94, P2563, DOI 10.1073/pnas.94.6.2563; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	35	234	258	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1208	1215		10.1038/ncb1642	http://dx.doi.org/10.1038/ncb1642			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891136				2022-12-27	WOS:000249882300017
J	Wang, GG; Cai, L; Pasillas, MP; Kamps, MP				Wang, Gang G.; Cai, Ling; Pasillas, Martina P.; Kamps, Mark P.			NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis	NATURE CELL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW-CELLS; HISTONE METHYLTRANSFERASE; HOMEOBOX GENES; X-CHROMOSOMES; GERM-LINE; C-ELEGANS; MEIS1; TRANSCRIPTION; MLL	Nuclear receptor-binding SET domain protein 1 (NSD1) prototype is a family of mammalian histone methyltransferases ( NSD1, NSD2/MMSET/WHSC1, NSD3/WHSC1L1) that are essential in development and are mutated in human acute myeloid leukemia ( AML) 1,2, overgrowth syndromes(3), multiple myeloma(4) and lung cancers(5). In AML, the recurring t( 5; 11)( q35; p15.5) translocation fuses NSD1 to nucleoporin-98 ( NUP98)(6). Here, we present the first characterization of the transforming properties and molecular mechanisms of NUP98-NSD1. We demonstrate that NUP98-NSD1 induces AML in vivo, sustains self-renewal of myeloid stem cells in vitro, and enforces expression of the HoxA7, HoxA9, HoxA10 and Meis1 proto-oncogenes. Mechanistically, NUP98-NSD1 binds genomic elements adjacent to HoxA7 and HoxA9, maintains histone H3 Lys 36 (H3K36) methylation and histone acetylation, and prevents EZH2-mediated transcriptional repression of the Hox-A locus during differentiation. Deletion of the NUP98 FG-repeat domain, or mutations in NSD1 that inactivate the H3K36 methyltransferase activity or that prevent binding of NUP98-NSD1 to the Hox-A locus precluded both Hox-A gene activation and myeloid progenitor immortalization. We propose that NUP98-NSD1 prevents EZH2-mediated repression of Hox-A locus genes by colocalizing H3K36 methylation and histone acetylation at regulatory DNA elements. This report is the first to link deregulated H3K36 methylation to tumorigenesis and to link NSD1 to transcriptional regulation of the Hox- A locus.	Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kamps, MP (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mkamps@ucsd.edu	Wang, G Greg/L-6666-2014	Wang, G Greg/0000-0002-7210-9940	NATIONAL CANCER INSTITUTE [R01CA056876] Funding Source: NIH RePORTER; NCI NIH HHS [CA56876] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afonja O, 2000, LEUKEMIA RES, V24, P849, DOI 10.1016/S0145-2126(00)00059-X; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; La Starza R, 2004, GENE CHROMOSOME CANC, V41, P395, DOI 10.1002/gcc.20103; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tompa R, 2007, GENETICS, V175, P585, DOI 10.1534/genetics.106.067751; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	35	288	303	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					804	U134		10.1038/ncb1608	http://dx.doi.org/10.1038/ncb1608			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17589499				2022-12-27	WOS:000247760700016
J	Yuan, JP; Zeng, WZ; Huang, GN; Worley, PF; Muallem, S				Yuan, Joseph P.; Zeng, Weizhong; Huang, Guo N.; Worley, Paul F.; Muallem, Shmuel			STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels	NATURE CELL BIOLOGY			English	Article							CA2+ ENTRY; TRANSIENT RECEPTOR; CATION CHANNELS; CRAC CHANNEL; ORAI1; DEPLETION; RELEASE; ACTIVATION; MECHANISM; TERMINUS	Stromal interacting molecule 1 (STIM1) is a Ca2+ sensor that conveys the Ca2+ load of the endoplasmic reticulum to store-operated channels (SOCs) at the plasma membrane. Here, we report that STIM1 binds TRPC1, TRPC4 and TRPC5 and determines their function as SOCs. Inhibition of STIM1 function inhibits activation of TRPC5 by receptor stimulation, but not by La3+, suggesting that STIM1 is obligatory for activation of TRPC channels by agonists, but STIM1 is not essential for channel function. Through a distinct mechanism, STIM1 also regulates TRPC3 and TRPC6. STIM1 does not bind TRPC3 and TRPC6, and regulates their function indirectly by mediating the heteromultimerization of TRPC3 with TRPC1 and TRPC6 with TRPC4. TRPC7 is not regulated by STIM1. We propose a new definition of SOCs, as channels that are regulated by STIM1 and require the store depletion-mediated clustering of STIM1. By this definition, all TRPC channels, except TRPC7, function as SOCs.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Worley, PF (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu			NIDA NIH HHS [R01 DA010309-08, DA00266, R01 DA010309, R01 DA010309-07, P50 DA000266-310015, R37 DA010309, R01 DA010309-09, P50 DA000266-370017, R01 DA010309-06, R01 DA010309-04, P50 DA000266-360017, P50 DA000266, DA10309, R01 DA010309-05] Funding Source: Medline; NIDCR NIH HHS [R01 DE012309-10, R01 DE012309-03, R01 DE012309-11, DE12309, R01 DE012309-05, R01 DE012309-08, R01 DE012309-06, R01 DE012309-07, R01 DE012309-12, R01 DE012309-09, R01 DE012309, R01 DE012309-04] Funding Source: Medline; NIDDK NIH HHS [R01 DK038938-17, R01 DK038938-23, R01 DK038938-18, R01 DK038938-24, R01 DK038938-21, R01 DK038938, DK38938, R01 DK038938-16, R01 DK038938-15, R01 DK038938-14, R01 DK038938-19, R01 DK038938-22, R01 DK038938-20] Funding Source: Medline; NIMH NIH HHS [P50 MH068830-010002, P50 MH068830-040002, P50 MH068830-030002, P50 MH068830-050002, P50 MH068830, MH068830, P50 MH068830-020002] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010309, R01DA010309, P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2006, PHARMACOL THERAPEUT, V112, P744, DOI 10.1016/j.pharmthera.2006.05.013; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Lievremont JP, 2004, AM J PHYSIOL-CELL PH, V287, pC1709, DOI 10.1152/ajpcell.00350.2004; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; LOESSBERG PA, 1991, J BIOL CHEM, V266, P1363; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Vazquez G, 2006, J BIOL CHEM, V281, P25250, DOI 10.1074/jbc.M604994200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	44	398	408	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					636	U38		10.1038/ncb1590	http://dx.doi.org/10.1038/ncb1590			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486119	Green Accepted			2022-12-27	WOS:000246922700008
J	Ravid, T; Hochstrasser, M				Ravid, Tommer; Hochstrasser, Mark			Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue	NATURE CELL BIOLOGY			English	Article							N-TERMINAL UBIQUITINATION; CONJUGATING ENZYME; IN-VIVO; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; QUALITY-CONTROL; ER MEMBRANE; DEGRADATION; RETICULUM; COMPLEX	Cells have quality-control mechanisms to recognize non-native protein structures and either help the proteins fold or promote their degradation(1,2). Ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) work together to assemble polyubiquitin chains on misfolded or misassembled proteins, which are then degraded by the proteasome(3,4). Here, we find that Ubc7, a yeast E2, can itself undergo degradation when its levels exceed that of its binding partner Cue1, a transmembrane protein that tethers Ubc7 to the endoplasmic reticulum(5-6). Unassembled, and thus mislocalized, Ubc7 is targeted to the proteasome by Ufd4, a homologous to E6-AP C-terminus (HECT)-class E3. Ubc7 is autoubiquitinated by a novel mechanism wherein the catalytic cysteine, instead of a lysine residue, provides the polyubiquitin chain acceptor site, and this cysteine-linked chain functions as a degradation signal. The polyubiquitin chain can also be transferred to a lysine side chain, suggesting a mechanism for polyubiquitin chain assembly that precedes substrate modification.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	NIGMS NIH HHS [GM046904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046904, R01GM046904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821	33	130	134	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					422	U109		10.1038/ncb1558	http://dx.doi.org/10.1038/ncb1558			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17310239				2022-12-27	WOS:000245359400013
J	Turner, BM				Turner, Bryan M.			Defining an epigenetic code	NATURE CELL BIOLOGY			English	Article							HISTONE H3; CHROMATIN-STRUCTURE; METHYLATION; ACETYLATION; EXPRESSION; PROTEINS; NUCLEUS; MEMORY	The nucleosome surface is decorated with an array of enzyme-catalysed modifications on histone tails. These modifications have well-defined roles in a variety of ongoing chromatin functions, often by acting as receptors for non-histone proteins, but their longer-term effects are less clear. Here, an attempt is made to define how histone modifications operate as part of a predictive and heritable epigenetic code that specifies patterns of gene expression through differentiation and development.	Univ Birmingham, Sch Med, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Turner, BM (corresponding author), Univ Birmingham, Sch Med, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England.	b.m.turner@bham.ac.uk			Biotechnology and Biological Sciences Research Council [G18987] Funding Source: Medline; Medical Research Council [G0300332] Funding Source: Medline; MRC [G0300332] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barbieri Marcello, 2003, ORGANIC CODES INTRO; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CRICK FHC, 1963, SCIENCE, V139, P461, DOI 10.1126/science.139.3554.461; CRICK FHC, 1963, PROG NUCLEIC ACID RE, V1, P163, DOI 10.1016/S0079-6603(08)60642-X; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gilbert N, 2005, INT REV CYTOL, V242, P283; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	30	267	282	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					2	6		10.1038/ncb0107-2	http://dx.doi.org/10.1038/ncb0107-2			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17199124				2022-12-27	WOS:000243255100002
J	Tavano, R; Contento, RL; Baranda, SJ; Soligo, M; Tuosto, L; Manes, S; Viola, A				Tavano, Regina; Contento, Rita Lucia; Jimenez Baranda, Sonia; Soligo, Marzia; Tuosto, Loretta; Manes, Santos; Viola, Antonella			CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse	NATURE CELL BIOLOGY			English	Article							ACTIVATION; MEMBRANE; REORGANIZATION; COSTIMULATION; RECRUITMENT; ENGAGEMENT; VAV; LCK	During physiological T-cell stimulation by antigen presenting cells (APCs), a major T-cell membrane rearrangement is known to occur leading to the organization of 'supramolecular activation clusters' at the immunological synapse(1,2). A possible role for the synapse is the generation of membrane compartments where signalling may be organized and propagated(2). Thus, engagement of the costimulatory molecule CD28 at the immunological synapse promotes the organization of a signalling compartment by inducing cytoskeletal changes and lipid raft accumulation(3-5). We identified the actin-binding protein Filamin-A (FLNa) as a novel molecular partner of CD28. We found that, after physiological stimulation, CD28 associated with and recruited FLNa into the immunological synapse, where FLNa organized CD28 signalling. FLNa knockdown by short interfering RNA (siRNA) inhibited CD28-mediated raft accumulation at the immunological synapse and T-cell costimulation. Together, our data indicate that CD28 binding to FLNa is required to induce the T-cell cytoskeletal rearrangements leading to recruitment of lipid microdomains and signalling mediators into the immunological synapse.	Univ Padua, Dept Biomed Sci, Venetian Inst Mol Med, I-35100 Padua, Italy; Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; Ist Clin Humanitas, I-20089 Rozzano, MI, Italy; Univ Roma La Sapienza, Dept Cellular & Dev Biol, I-00185 Rome, Italy	University of Padua; Veneto Institute Molecular Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IRCCS Humanitas Research Hospital; Sapienza University Rome	Viola, A (corresponding author), Univ Padua, Dept Biomed Sci, Venetian Inst Mol Med, I-35100 Padua, Italy.	antonella.viola@unipd.it	Manes, Santos/E-4725-2011; Tuosto, Loretta/F-7017-2011; Soligo, Marzia/AAC-1543-2019; Agatea, Lisa/L-8267-2016; Viola, Antonella/A-4321-2015	Tuosto, Loretta/0000-0001-9056-4077; Manes, Santos/0000-0001-8023-957X; Soligo, Marzia/0000-0002-1420-0914; TAVANO, REGINA/0000-0002-0699-1859; Viola, Antonella/0000-0002-0125-9271				Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hayashi K, 2006, J IMMUNOL, V177, P1721, DOI 10.4049/jimmunol.177.3.1721; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; KARR RW, 1991, J IMMUNOL, V146, P4242; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Pizzo P, 2004, IMMUNOL LETT, V91, P3, DOI 10.1016/j.imlet.2003.09.008; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Viola A, 2001, TRENDS IMMUNOL, V22, P322, DOI 10.1016/S1471-4906(01)01938-X; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang M, 2005, J IMMUNOL, V174, P1479, DOI 10.4049/jimmunol.174.3.1479	32	117	122	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1270	U46		10.1038/ncb1492	http://dx.doi.org/10.1038/ncb1492			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060905				2022-12-27	WOS:000241732400016
J	Hochstrasser, M; Cohen, R				Hochstrasser, M; Cohen, R			Cecile M. Pickart 1954-2006	NATURE CELL BIOLOGY			English	Biographical-Item												mark.hochstrasser@yale.edu; rcohen@jhsph.edu		Hochstrasser, Mark/0000-0002-1131-5484					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					542	543		10.1038/ncb0606-542	http://dx.doi.org/10.1038/ncb0606-542			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16738698	Bronze			2022-12-27	WOS:000238029000003
J	Ogi, T; Lehmann, AR				Ogi, Tomoo; Lehmann, Alan R.			The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair	NATURE CELL BIOLOGY			English	Article							CELLS; RECOMBINATION; REPLICATION; EPSILON; DAMAGE; DELTA; PCNA; ETA	DNA polymerase. (pol kappa) is a member of the Y-family of DNA polymerases that are thought to function in translesion synthesis (TLS) past different types of DNA damage. Here, we show that pol kappa-deficient mouse cells have substantially reduced (but not absent) levels of nucleotide excision repair (NER) of UV damage, as measured by several methods. Our results provide evidence for an unexpected role for pol. in mammalian NER.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Lehmann, AR (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.r.lehmann@sussex.ac.uk		Ogi, Tomoo/0000-0002-5492-9072	Medical Research Council [G0001132] Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish; MRC [G0001132] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; DRESLER SL, 1984, J BIOL CHEM, V259, P3947; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; Godoy VG, 2006, EMBO J, V25, P868, DOI 10.1038/sj.emboj.7600986; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohashi E, 2000, GENE DEV, V14, P1589; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Suzuki N, 2001, BIOCHEMISTRY-US, V40, P15176, DOI 10.1021/bi010702g; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664	15	171	174	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					640	642		10.1038/ncb1417	http://dx.doi.org/10.1038/ncb1417			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16738703				2022-12-27	WOS:000238029000018
J	Bacher, CP; Guggiari, M; Brors, B; Augui, S; Clerc, P; Avner, P; Eils, R; Heard, E				Bacher, CP; Guggiari, M; Brors, B; Augui, S; Clerc, P; Avner, P; Eils, R; Heard, E			Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation	NATURE CELL BIOLOGY			English	Letter							CHROMOSOME INACTIVATION; XIST GENE; TSIX; TRANSCRIPTION; MICE	The initial differential treatment of the two X chromosomes during X-chromosome inactivation is controlled by the X-inactivation centre (Xic). This locus determines how many X chromosomes are present in a cell ('counting') and which X chromosome will be inactivated in female cells ('choice'). Critical control sequences in the Xic include the non-coding RNAs Xist and Tsix, and long-range chromatin elements. However, little is known about the process that ensures that X inactivation is triggered appropriately when more than one Xic is present in a cell. Using three-dimensional fluorescence in situ hybridization (FISH) analysis, we showed that the two Xics transiently colocalize, just before X inactivation, in differentiating female embryonic stem cells. Using Xic transgenes capable of imprinted but not random X inactivation, and Xic deletions that disrupt random X inactivation, we demonstrated that Xic colocalization is linked to Xic function in random X inactivation. Both long-range sequences and the Tsix element, which generates the antisense transcript to Xist, are required for the transient interaction of Xics. We propose that transient colocalization of Xics may be necessary for a cell to determine Xic number and to ensure the correct initiation of X inactivation.	Inst Curie, CNRS, UMR 218, F-75248 Paris 05, France; German Canc Res Ctr, D-69120 Heidelberg, Germany; Inst Pasteur, F-75015 Paris, France; Univ Heidelberg, IPMB, D-69120 Heidelberg, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; German Cancer Research Center (DKFZ); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), Inst Curie, CNRS, UMR 218, 26 Rue Ulm, F-75248 Paris 05, France.	r.eils@dkfz-heidelberg.de; Edith.Heard@curie.fr	Heard, Edith/D-7197-2017; Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009	Heard, Edith/0000-0001-8052-7117; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036				Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Becker R, 1988, COMPUTER SCI SERIES; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Chambeyron S, 2004, CURR OPIN CELL BIOL, V16, P256, DOI 10.1016/j.ceb.2004.03.004; Clerc P, 2003, SEMIN CELL DEV BIOL, V14, P85, DOI 10.1016/S1084-9521(02)00140-4; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COMINGS DE, 1968, AM J HUM GENET; Conover W.J., 1971, PRACTICAL NONPARAMET, P295; Heard E, 1999, MOL CELL BIOL, V19, P3156; HOLLANDER M, 1973, NONPARAMETRIC STAT I; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950	27	273	284	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					293	299		10.1038/ncb1365	http://dx.doi.org/10.1038/ncb1365			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16434960				2022-12-27	WOS:000235708000016
J	Kalantry, S; Mills, KC; Yee, D; Otte, AP; Panning, B; Magnuson, T				Kalantry, S; Mills, KC; Yee, D; Otte, AP; Panning, B; Magnuson, T			The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYOS; XIST RNA; GROUP-COMPLEXES; HISTONE H2A; GIANT-CELLS; GENE; STABILIZATION; ACETYLATION; ASSOCIATION	The Polycomb group (PcG) encodes an evolutionarily conserved set of chromatin-modifying proteins that are thought to maintain cellular transcriptional memory by stably silencing gene expression(1). In mouse embryos that are mutated for the PcG protein Eed, X-chromosome inactivation (XCI) is not stably maintained in extra-embryonic tissues(2). Eed is a component of a histone-methyltransferase complex that is thought to contribute to stable silencing in undifferentiated cells due to its enrichment on the inactive X-chromosome in cells of the early mouse embryo and in stem cells of the extra-embryonic trophectoderm lineage(3-8). Here, we demonstrate that the inactive X-chromosome in Eed(-/-) trophoblast stem cells and in cells of the trophectoderm-derived extra-embryonic ectoderm in Eed(-/-) embryos remain transcriptionally silent, despite lacking the PcG-mediated histone modifications that normally characterize the facultative heterochromatin of the inactive X-chromosome. Whereas undifferentiated Eed(-/-) trophoblast stem cells maintained XCI, reactivation of the inactive X-chromosome occurred when these cells were differentiated. These results indicate that PcG complexes are not necessary to maintain transcriptional silencing of the inactive X-chromosome in undifferentiated stem cells. Instead, PcG proteins seem to propagate cellular memory by preventing transcriptional activation of facultative heterochromatin during differentiation.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; University of California System; University of California San Francisco	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	trm4@med.unc.edu			NICHD NIH HHS [R37 HD024462] Funding Source: Medline; NIGMS NIH HHS [R01 GM063671] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD024462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063671] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Costanzi C, 2000, DEVELOPMENT, V127, P2283; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hattori N, 2000, MOL BIOL CELL, V11, P1037, DOI 10.1091/mbc.11.3.1037; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Plath K, 2004, J CELL BIOL, V167, P1025, DOI 10.1083/jcb.200409026; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sado T, 2001, DEVELOPMENT, V128, P1275; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SIMON J, 1995, MECH DEVELOP, V53, P197, DOI 10.1016/0925-4773(95)00434-3; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574	39	118	124	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					195	U66		10.1038/ncb1351	http://dx.doi.org/10.1038/ncb1351			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16415857	Green Submitted, Green Accepted			2022-12-27	WOS:000235059800015
J	Zhang, HL; Kim, JK; Edwards, CA; Xu, ZH; Taichman, R; Wang, CY				Zhang, HL; Kim, JK; Edwards, CA; Xu, ZH; Taichman, R; Wang, CY			Clusterin inhibits apoptosis by interacting with activated Bax	NATURE CELL BIOLOGY			English	Article							MYC-INDUCED APOPTOSIS; C-MYC; PROSTATE-CANCER; CLUSTERIN/APOLIPOPROTEIN-J; OXIDATIVE STRESS; INDUCE APOPTOSIS; DEATH; CELLS; BCL-2; GENE	Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma(1,2). Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug- mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation- altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c- Myc- mediated apoptosis by interacting with conformation- altered Bax. Clusterin promotes c- Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro- apoptotic activities.	Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Cell & Dev Biol, Microscopy & Image Anal Core, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Periodont Prevent & Geriatr, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, CY (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Ann Arbor, MI 48109 USA.	cunywang@umich.edu		Taichman, Russell S./0000-0002-7890-0020				Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Gleave M, 2003, ANN NY ACAD SCI, V1002, P95, DOI 10.1196/annals.1281.020; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Miyake H, 2003, ONCOL REP, V10, P469; O'Sullivan J, 2003, CELL DEATH DIFFER, V10, P914, DOI 10.1038/sj.cdd.4401254; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Viard I, 1999, J INVEST DERMATOL, V112, P290, DOI 10.1046/j.1523-1747.1999.00531.x; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	27	370	389	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					909	U69		10.1038/ncb1291	http://dx.doi.org/10.1038/ncb1291			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16113678				2022-12-27	WOS:000231601600015
J	Wang, X; Weisleder, N; Collet, C; Zhou, JS; Chu, Y; Hirata, Y; Zhao, XL; Pan, Z; Brotto, M; Cheng, HP; Ma, JJ				Wang, X; Weisleder, N; Collet, C; Zhou, JS; Chu, Y; Hirata, Y; Zhao, XL; Pan, Z; Brotto, M; Cheng, HP; Ma, JJ			Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle	NATURE CELL BIOLOGY			English	Article							CA2+ SPARKS; MDX MOUSE; ELEMENTARY EVENTS; HEART-MUSCLE; 2 MECHANISMS; RELEASE; CONTRACTION; FIBERS; CELLS; MICE	Most excitable cells maintain tight control of intracellular Ca2+ through coordinated interaction between plasma membrane and endoplasmic or sarcoplasmic reticulum. Quiescent sarcoplasmic reticulum Ca2+ release machinery is essential for the survival and normal function of skeletal muscle(1-3). Here we show that subtle membrane deformations induce Ca2+ sparks in intact mammalian skeletal muscle. Spontaneous Ca2+ sparks can be reversibly induced by osmotic shock, and participate in a normal physiological response to exercise. In dystrophic muscle with fragile membrane integrity, stress-induced Ca2+ sparks are essentially irreversible. Moreover, moderate exercise in mdx muscle alters the Ca2+ spark response. Thus, membrane-deformation- induced Ca2+ sparks have an important role in physiological and pathophysiological regulation of Ca2+ signalling, and uncontrolled Ca2+ spark activity in connection with chronic activation of store-operated Ca2+ entry may function as a dystrophic signal in mammalian skeletal muscle.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Rush Univ, Sch Med, Dept Mol Physiol & Biophys, Chicago, IL 60612 USA; Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rush University; Peking University	Ma, JJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019; Weisleder, Noah L/A-7098-2013	Heping, Cheng/0000-0002-9604-6702; Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X	NATIONAL CANCER INSTITUTE [R01CA095739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015556] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA95739] Funding Source: Medline; NHLBI NIH HHS [R01-HL69000] Funding Source: Medline; NIA NIH HHS [R01-AG15556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2004, BIOPHYS J, V87, P268, DOI 10.1529/biophysj.103.039305; Conklin MW, 1999, BIOPHYS J, V77, P1394, DOI 10.1016/S0006-3495(99)76988-2; Crawford GE, 2001, HUM MOL GENET, V10, P2745, DOI 10.1093/hmg/10.24.2745; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Kirsch WG, 2001, J PHYSIOL-LONDON, V537, P379, DOI 10.1111/j.1469-7793.2001.00379.x; Klein MG, 1996, NATURE, V379, P455, DOI 10.1038/379455a0; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Lacampagne A, 2000, P NATL ACAD SCI USA, V97, P7823, DOI 10.1073/pnas.97.14.7823; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee EH, 2004, AM J PHYSIOL-CELL PH, V286, pC179, DOI 10.1152/ajpcell.00176.2003; Leijendekker WJ, 1996, BRIT J PHARMACOL, V118, P611, DOI 10.1111/j.1476-5381.1996.tb15445.x; Lynch GS, 2000, AM J PHYSIOL-CELL PH, V279, pC1290, DOI 10.1152/ajpcell.2000.279.4.C1290; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Porter JD, 1998, J CELL SCI, V111, P1801; Shirokova N, 1998, J PHYSIOL-LONDON, V512, P377, DOI 10.1111/j.1469-7793.1998.377be.x; TAKAGI A, 1992, J NEUROL SCI, V110, P160, DOI 10.1016/0022-510X(92)90023-E; TSUGORKA A, 1995, SCIENCE, V269, P1723, DOI 10.1126/science.7569901; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; Zhou J, 2003, J GEN PHYSIOL, V122, P95, DOI 10.1085/jgp.200308796	29	128	134	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					525	530		10.1038/ncb1254	http://dx.doi.org/10.1038/ncb1254			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15834406				2022-12-27	WOS:000229123500020
J	Flores, MVC; Lam, EYN; Crosier, KE; Crosier, PS				Flores, Maria Vega C.; Lam, Enid Yi Ni; Crosier, Kathryn E.; Crosier, Philip S.			Osteogenic transcription factor Runx2 is a maternal determinant of dorsoventral patterning in zebrafish	NATURE CELL BIOLOGY			English	Article							HOMEOBOX GENES; ORGANIZER FORMATION; AXIS FORMATION; EMBRYO; EXPRESSION; INDUCTION; VENT; WNT8; VOX	The maternal genome greatly influences vertebrate embryogenesis before activation of zygotic transcription. Dorsoventral patterning is initiated by maternal factors(1-3), but the molecular pathways involved are incompletely understood. In frogs and fish, localized zygotic domains are induced whereby cells either express dorsal or ventral genes(1,2). Wnt/beta-catenin signalling promotes expression of the earliest dorsal zygotic genes(4). Among key zygotic ventralizing factors are the bone morphogenetic proteins (Bmps)(5,6) and the Vent homeodomain family(2,7-10); the latter act as repressors of dorsal organizer gene transcription. Here we show that Runx2, a transcription factor essential for bone formation, is an important maternal determinant of ventral zygotic genes in zebrafish. Depletion of maternal Runx2b type2 strongly dorsalizes embryos, due to loss of the earliest zygotic expression of vox, vent and ved, resulting in expansion of dorsal gene expression. To date, Runx2b is the only known regulator of vox, vent and ved at the onset of zygotic transcription; we show that this regulation is direct. Runx2 transcripts are processed in mature mouse oocytes(11) and we show that murine Runx2 type2 can substitute for the zebrafish orthologue in its ventralizing function, suggesting that Runx2 may have an evolutionarily conserved role in axis formation.	[Flores, Maria Vega C.; Lam, Enid Yi Ni; Crosier, Kathryn E.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Auckland 1142, New Zealand	University of Auckland	Crosier, PS (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Sch Med Sci, Private Bag 92019, Auckland 1142, New Zealand.	ps.crosier@auckland.ac.nz		Lam, Enid Yi Ni/0000-0001-5843-7836				Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2005, J Endocrinol Invest, V28, P3; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Imai Y, 2001, DEVELOPMENT, V128, P2407; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kelly C, 2000, DEVELOPMENT, V127, P3899; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Leung TC, 2003, DEVELOPMENT, V130, P3639, DOI 10.1242/dev.00558; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pei W, 2007, DEV BIOL, V308, P368, DOI 10.1016/j.ydbio.2007.05.026; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Sidi S, 2003, P NATL ACAD SCI USA, V100, P3315, DOI 10.1073/pnas.0530115100; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808	31	32	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2008	10	3					346	U80		10.1038/ncb1697	http://dx.doi.org/10.1038/ncb1697			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	271HA	18246063				2022-12-27	WOS:000253778300017
J	Sowinski, S; Jolly, C; Berninghausen, O; Purbhoo, MA; Chauveau, A; Kohler, K; Oddos, S; Eissmann, P; Brodsky, FM; Hopkins, C; Onfelt, B; Sattentau, Q; Davis, DM				Sowinski, Stefanie; Jolly, Clare; Berninghausen, Otto; Purbhoo, Marco A.; Chauveau, Anne; Koehler, Karsten; Oddos, Stephane; Eissmann, Philipp; Brodsky, Frances M.; Hopkins, Colin; Oenfelt, Bjoern; Sattentau, Quentin; Davis, Daniel M.			Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission	NATURE CELL BIOLOGY			English	Article							DENDRITIC CELLS; IMMUNE CELLS; PROTEINS; SYNAPSE; REPLICATION; RETRACTION; FILOPODIA; INFECTION; FISSION; KINASE	Transmission of HIV-1 via intercellular connections has been estimated as 100-1000 times more efficient than a cell-free process, perhaps in part explaining persistent viral spread in the presence of neutralizing antibodies(1,2). Such effective intercellular transfer of HIV-1 could occur through virological synapses(3-5) or target-cell filopodia connected to infected cells(6). Here we report that membrane nanotubes, formed when T cells make contact and subsequently part, provide a new route for HIV-1 transmission. Membrane nanotubes are known to connect various cell types, including neuronal and immune cells(7-13), and allow calcium-mediated signals to spread between connected myeloid cells(9). However, T-cell nanotubes are distinct from open-ended membranous tethers between other cell types(7,12), as a dynamic junction persists within T-cell nanotubes or at their contact with cell bodies. We also report that an extracellular matrix scaffold allows T-cell nanotubes to adopt variably shaped contours. HIV-1 transfers to uninfected T cells through nanotubes in a receptor-dependent manner. These data lead us to propose that HIV-1 can spread using nanotubular connections formed by short-term intercellular unions in which T cells specialize.	[Sowinski, Stefanie; Berninghausen, Otto; Purbhoo, Marco A.; Chauveau, Anne; Koehler, Karsten; Oddos, Stephane; Eissmann, Philipp; Hopkins, Colin; Davis, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Jolly, Clare; Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Brodsky, Frances M.] Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; [Oenfelt, Bjoern] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Imperial College London; University of Oxford; University of California System; University of California San Francisco; Karolinska Institutet	Davis, DM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	d.davis@imperial.ac.uk	Jolly, Clare/A-4501-2013	Davis, Daniel/0000-0002-9182-291X; Brodsky, Frances/0000-0002-1334-9258; Jolly, Clare/0000-0002-4603-2281	Biotechnology and Biological Sciences Research Council [BB/D011663/1] Funding Source: Medline; Medical Research Council [G0500563, G0400453] Funding Source: Medline; NIAID NIH HHS [P01-AI064520] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI064520] Funding Source: NIH RePORTER; BBSRC [BB/D011663/1] Funding Source: UKRI; MRC [G0500563, G0400453] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; Daniels DR, 2007, LANGMUIR, V23, P6667, DOI 10.1021/la0635000; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; La Boissiere S, 2004, J VIROL, V78, P8002, DOI 10.1128/JVI.78.15.8002-8014.2004; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	31	551	564	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					211	219		10.1038/ncb1682	http://dx.doi.org/10.1038/ncb1682			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193035				2022-12-27	WOS:000252897800017
J	Takahashi, Y; Coppola, D; Matsushita, N; Cualing, HD; Sun, M; Sato, Y; Liang, C; Jung, JU; Cheng, JQ; Mule, JJ; Pledger, WJ; Wang, HG				Takahashi, Yoshinori; Coppola, Domenico; Matsushita, Norimasa; Cualing, Hernani D.; Sun, Mei; Sato, Yuya; Liang, Chengyu; Jung, Jae U.; Cheng, Jin Q.; Mule, James J.; Pledger, W. Jack; Wang, Hong-Gang			Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis	NATURE CELL BIOLOGY			English	Article							PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR; MEMBRANE CURVATURE; MAMMALIAN-CELLS; PROTEIN; DOMAIN; GENE; BCL-2; MACROAUTOPHAGY; MECHANISMS	Autophagy is an evolutionarily conserved 'self-eating' process. Although the genes essential for autophagy ( named Atg) have been identified in yeast, the molecular mechanism of how Atg proteins control autophagosome formation in mammalian cells remains to be elucidated. Here, we demonstrate that Bif-1 ( also known as Endophilin B1) interacts with Beclin 1 through ultraviolet irradiation resistance-associated gene ( UVRAG) and functions as a positive mediator of the class III PI( 3) kinase ( PI( 3) KC3). In response to nutrient deprivation, Bif-1 localizes to autophagosomes where it colocalizes with Atg5, as well as microtubule-associated protein light chain 3 (LC3). Furthermore, loss of Bif-1 suppresses autophagosome formation. Although the SH3 domain of Bif-1 is sufficient for binding to UVRAG, both the BAR and SH3 domains are required for Bif-1 to activate PI( 3) KC3 and induce autophagosome formation. We also observed that Bif-1 ablation prolongs cell survival under starvation conditions. Moreover, knockout of Bif-1 significantly enhances the development of spontaneous tumours in mice. These findings suggest that Bif-1 joins the UVRAG-Beclin 1 complex as a potential activator of autophagy and tumour suppressor.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Harvard Univ, Sch Med, Southborough, MA 01772 USA	H Lee Moffitt Cancer Center & Research Institute; Harvard University	Wang, HG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Hong-Gang.Wang@moffitt.org	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817; LIANG, CHENGYU/0000-0001-6082-2143	NCI NIH HHS [R01 CA082197-08, R01 CA082197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082197] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakrishnan A, 2006, GENE CHROMOSOME CANC, V45, P883, DOI 10.1002/gcc.20352; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KISEN GO, 1993, CARCINOGENESIS, V14, P2501, DOI 10.1093/carcin/14.12.2501; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee JW, 2006, PATHOLOGY, V38, P312, DOI 10.1080/00313020600820880; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mathew R, 2007, AUTOPHAGY, V3, P502, DOI 10.4161/auto.4605; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; SCHWARZE PE, 1985, EXP CELL RES, V157, P15, DOI 10.1016/0014-4827(85)90148-X; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Toth S, 2002, CELL TISSUE RES, V309, P409, DOI 10.1007/s00441-001-0506-7; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	46	669	722	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1142	1151		10.1038/ncb1634	http://dx.doi.org/10.1038/ncb1634			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891140	Green Accepted			2022-12-27	WOS:000249882300009
J	Draviam, VM; Stegmeier, F; Nalepa, G; Sowa, ME; Chen, J; Liang, A; Hannon, GJ; Sorger, PK; Harper, JW; Elledge, SJ				Draviam, Viji M.; Stegmeier, Frank; Nalepa, Grzegorz; Sowa, Mathew E.; Chen, Jing; Liang, Anthony; Hannon, Gregory J.; Sorger, Peter K.; Harper, J. Wade; Elledge, Stephen J.			A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling	NATURE CELL BIOLOGY			English	Article							KINETOCHORE LOCALIZATION; CHROMOSOME CONGRESSION; MAMMALIAN-CELLS; PROTEIN-KINASE; CENP-E; MAD2; MITOSIS; BUB1; P38; ACTIVATION	Defects in chromosome-microtubule attachment trigger spindle-checkpoint activation and delay mitotic progression(1,2). How microtubule attachment is sensed and integrated into the steps of checkpoint-signal amplification is poorly understood. In a functional genomic screen targeting human kinases and phosphatases, we identified a microtubule affinity-regulating kinase kinase, TAO1 (also known as MARKK) as an important regulator of mitotic progression, required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 interacts with the checkpoint kinase BubR1 and promotes enrichment of the checkpoint protein Mad2 at sites of defective attachment, providing evidence for a regulatory step that precedes the proposed Mad2-Mad1 dependent checkpoint- signal amplification step(3). We propose that the dual functions of TAO1 in regulating microtubule dynamics and checkpoint signalling may help to coordinate the establishment and monitoring of correct congression of chromosomes, thereby protecting genomic stability in human cells.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Partners Ctr Genet & Genom, Dept Genet,Howard Hughes Med Inst, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Partners Healthcare System; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019	Lab, Nalepa/0000-0002-7560-1906; Harper, Jeffrey/0000-0002-6944-7236; Draviam, Viji/0000-0001-8295-3689; Sorger, Peter/0000-0002-3364-1838; Nalepa, Grzegorz/0000-0002-5779-9103	NCI NIH HHS [CA78048] Funding Source: Medline; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yustein JT, 2003, ONCOGENE, V22, P6129, DOI 10.1038/sj.onc.1206605; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	31	79	83	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					556	U136		10.1038/ncb1569	http://dx.doi.org/10.1038/ncb1569			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417629				2022-12-27	WOS:000246181500014
J	Gareus, R; Huth, M; Breiden, B; Nenci, A; Rosch, N; Haase, I; Bloch, W; Sandhoff, K; Pasparakis, M				Gareus, Ralph; Huth, Marion; Breiden, Bernadette; Nenci, Arianna; Rosch, Nora; Haase, Ingo; Bloch, Wilhelm; Sandhoff, Konrad; Pasparakis, Manolis			Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation	NATURE CELL BIOLOGY			English	Article							KAPPA-B KINASE; MICE LACKING; ALPHA; MORPHOGENESIS; EXPRESSION; MUTANT; MOUSE; LIMB; GENE; PROLIFERATION	The kinase IKK1 (also known as IKK alpha) was previously reported to regulate epidermal development and skeletal morphogenesis by acting in keratinocytes to induce their differentiation in an NF-kappa B independent manner(1-5). Here, we show that mice with epidermal keratinocyte-specific IKK1 ablation (hereafter referred to as IKK1(EKO)) develop a normally differentiated stratified epidermis, demonstrating that the function of IKK1 in inducing epidermal differentiation is not keratinocyte-autonomous. Despite normal epidermal stratification, the IKK1(EKO) mice display impaired epidermal-barrier function and increased transepidermal water loss, due to defects in stratum corneum lipid composition and in epidermal tight junctions. These defects are caused by the deregulation of retinoic acid target genes, encoding key lipid modifying enzymes and tight junction proteins, in the IKK1-deficient epidermis. Furthermore, we show that IKK1-deficient cells display impaired retinoic acid-induced gene transcription, and that IKK1 is recruited to the promoters of retinoic acid-regulated genes, suggesting that one mechanism by which IKK1 controls epidermal-barrier formation is by regulating the expression of retinoic acid receptor target genes in keratinocytes.	Univ Cologne, Inst Genet, Dept Mouse Genet & Inflammat, D-50674 Cologne, Germany; MBL Mouse Biol Unit, I-00016 Monterotondo, Italy; Univ Bonn, LIMES, Membrane Biol & Lipid Biochem Unit, CO Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; German Sport Univ Cologne, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany	University of Cologne; University of Bonn; University of Cologne; German Sport University Cologne	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Inflammat, Zulpicher Str 47, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109; Pasparakis, Manolis/0000-0002-9870-0966				Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Attar PS, 1997, MOL ENDOCRINOL, V11, P792, DOI 10.1210/me.11.6.792; Bouwstra J A, 1998, J Investig Dermatol Symp Proc, V3, P69; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Elias PM, 2001, J CELL BIOL, V153, P243, DOI 10.1083/jcb.153.2.243; Fisher C, 2000, TRENDS GENET, V16, P482, DOI 10.1016/S0168-9525(00)02121-1; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GIGUERE V, 1990, P NATL ACAD SCI USA, V87, P6233, DOI 10.1073/pnas.87.16.6233; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Hughes PJ, 2001, BIOCHEM J, V355, P361, DOI 10.1042/0264-6021:3550361; Humphries JD, 1998, BRIT J DERMATOL, V139, P577; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Reichelt J, 2004, EUR J CELL BIOL, V83, P747, DOI 10.1078/0171-9335-00429; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Weninger W, 1998, J INVEST DERMATOL, V111, P907, DOI 10.1046/j.1523-1747.1998.00393.x; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zettersten E, 1998, J INVEST DERMATOL, V111, P784, DOI 10.1046/j.1523-1747.1998.00386.x	35	69	71	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					461	U185		10.1038/ncb1560	http://dx.doi.org/10.1038/ncb1560			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351639				2022-12-27	WOS:000245359400018
J	Dadke, S; Cotteret, S; Yip, SC; Jaffer, ZM; Haj, F; Ivanov, A; Rauscher, F; Shuai, K; Ng, T; Neel, BG; Chernoff, J				Dadke, Shrikrishna; Cotteret, Sophie; Yip, Shu-Chin; Jaffer, Zahara M.; Haj, Fawaz; Ivanov, Alexey; Rauscher, Frank, III; Shuai, Ke; Ng, Tony; Neel, Benjamin G.; Chernoff, Jonathan			Regulation of protein tyrosine phosphatase 1B by sumoylation	NATURE CELL BIOLOGY			English	Article							E3 LIGASE; SUMO; KINASE; INSULIN; SUBSTRATE; COMPLEX; RANBP2	Protein-tyrosine phosphatase 1B (PTP1B) is an ubiquitously expressed enzyme that negatively regulates growth-factor signalling and cell proliferation by binding to and dephosphorylating key receptor tyrosine kinases, such as the insulin receptor(1). It is unclear how the activity of PTP1B is regulated. Using a yeast two-hybrid assay, a protein inhibitor of activated STAT1 (PIAS1)(2) was isolated as a PTP1B-interacting protein. Here, we show that PIAS1, which functions as a small ubiquitin-like modifier (SUMO) E3 ligase, associates with PTP1B in mammalian fibroblasts and catalyses sumoylation of PTP1B. Sumoylation of PTP1B reduces its catalytic activity and inhibits the negative effect of PTP1B on insulin receptor signalling and on transformation by the oncogene v-crk. Insulin-stimulated sumoylation of endogenous PTP1B results in a transient downregulation of the enzyme; this event does not occur when the endogenous enzyme is replaced with a sumoylation-resistant mutant of PTP1B. These results suggest that sumoylation, which has been implicated primarily in processes in the nucleus and nuclear pore, also modulates a key enzyme-substrate signalling complex that regulates metabolism and cell proliferation.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Beth Israel Deaconess Med Ctr, Canc Biol Program, Boston, MA 02115 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA 90095 USA; Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	Fox Chase Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; The Wistar Institute; University of California System; University of California Los Angeles; University of London; King's College London	Chernoff, J (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	J_Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Ivanov, Alexey/I-9445-2012	Chernoff, Jonathan/0000-0002-4803-7836; Ivanov, Alexey/0000-0002-8617-4604; Ng, Tony/0000-0003-3894-5619	Medical Research Council [G0100152] Funding Source: Medline; MRC [G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Dadke S, 2003, J BIOL CHEM, V278, P40607, DOI 10.1074/jbc.M306772200; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; GOLEMIS EA, 1994, INTERACTION TRAP 2 H; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim YH, 2005, FEBS LETT, V579, P6272, DOI 10.1016/j.febslet.2005.10.010; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh N, 2006, EXP CELL RES, V312, P1418, DOI 10.1016/j.yexcr.2006.01.013; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200	29	90	98	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					80	U102		10.1038/ncb1522	http://dx.doi.org/10.1038/ncb1522			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17159996				2022-12-27	WOS:000243255100015
J	Handa, Y; Suzuki, M; Ohya, K; Iwai, H; Ishijima, N; Koleske, AJ; Fukui, Y; Sasakawa, C				Handa, Yutaka; Suzuki, Masato; Ohya, Kenji; Iwai, Hiroki; Ishijima, Nozomi; Koleske, Anthony J.; Fukui, Yoshinori; Sasakawa, Chihiro			Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASES; EPITHELIAL-CELLS; EFFECTOR PROTEIN; INVASION; RAC1; ACTIVATION; PHAGOCYTOSIS; COOPERATE; CORTACTIN; FLEXNERI	Shigella use a special mechanism to invade epithelial cells called 'the trigger mechanism of entry'(1-3), which allows epithelial cells to trap several bacteria simultaneously. On contact, Shigella deliver effectors into epithelial cells through the type III secretion system(4-6). Here, we show that one of the effectors, IpgB1, has a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. Using pulldown assays, we identified engulfment and cell motility (ELMO) protein as the IpgB1 binding partner. IpgB1 colocalized with ELMO and Dock180 in membrane ruffles induced by Shigella. Shigella invasiveness and IpgB1-induced ruffles were less in ELMO- and Dock180-knockdown cells compared with wild-type cells. Membrane association of ELMO-Dock180 with ruffles were promoted when cells expressed an IpgB1-ELMO chimera, establishing that IpgB1 mimics the role of RhoG in producing membrane ruffles. Taken together, our findings show that IpgB1 mimicry is the key to invasion by Shigella.	Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Minato Ku, Tokyo 1088639, Japan; Int Res Ctr Infect Dis, Dept Infectious Control, Minato Ku, Tokyo 1088639, Japan; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdept Neurosci Program, New Haven, CT 06520 USA; Kyushu Univ, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Div Immunogenet, Fukuoka 8128582, Japan; CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Yale University; Yale University; Kyushu University; Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013	Suzuki, Masato/0000-0001-8975-2193; Fukui, Yoshinori/0000-0003-2335-8745; Ohya, Kenji/0000-0002-8867-3618	NINDS NIH HHS [R01 NS039475] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; BAKER BW, 1992, NUCLEIC ACIDS RES, V20, P5234, DOI 10.1093/nar/20.19.5234; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Mounier J, 1999, J CELL SCI, V112, P2069; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Van Nhieu GT, 2005, CURR OPIN MICROBIOL, V8, P16, DOI 10.1016/j.mib.2004.12.006; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319	30	119	122	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					121	U165		10.1038/ncb1526	http://dx.doi.org/10.1038/ncb1526			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173036				2022-12-27	WOS:000243255100021
J	Yang, JS; Zhang, LL; Lee, SY; Gad, H; Luini, A; Hsu, VW				Yang, Jia-Shu; Zhang, Leiliang; Lee, Stella Y.; Gad, Helge; Luini, Alberto; Hsu, Victor W.			Key components of the fission machinery are interchangeable	NATURE CELL BIOLOGY			English	Article							VESICLE FORMATION; LYSOPHOSPHATIDIC ACID; GOLGI STRUCTURE; TRANSPORT; MEMBRANE; PROTEINS; COAT; CURVATURE; PROMOTES; COMPLEX	Brefeldin- A ADP- ribosylated substrate (BARS) and dynamin function in membrane fission in distinct intracellular transport pathways(1), but whether their functions are mechanistically similar is unclear. Here, we show that ARFGAP1, a GTPase-activating protein (GAP) for ADP- ribosylation factor 1 (ARF1)(2), couples to either BARS or endophilin B for vesicle formation by the coat protein I (COPI) complex- a finding that reveals an unanticipated mechanistic flexibility in mammalian COPI transport. Because dynamin is coupled to endophilin A in vesicle formation by the clathrin- coat complex(3-5), our finding also predicts that dynamin and ARF GAPs are likely to be functional counterparts in membrane fission among different transport pathways that connect intracellular membrane compartments.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Consorzio Mario Negri Sud	Hsu, VW (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	vhsu@rics.bwh.harvard.edu	Gad, Helge/J-2238-2014	Gad, Helge/0000-0001-6530-1443	Telethon [GGP04235] Funding Source: Medline	Telethon(Fondazione Telethon)		Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Emery G, 2000, J CELL SCI, V113, P2507; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015	24	47	51	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1376	U34		10.1038/ncb1503	http://dx.doi.org/10.1038/ncb1503			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17086176				2022-12-27	WOS:000242419800013
J	Aranda, V; Haire, T; Nolan, ME; Calarco, JP; Rosenberg, AZ; Fawcett, JP; Pawson, T; Muthuswamy, SK				Aranda, Victoria; Haire, Teresa; Nolan, Marissa E.; Calarco, Joseph P.; Rosenberg, Avi Z.; Fawcett, James P.; Pawson, Tony; Muthuswamy, Senthil K.			Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CELL POLARITY; TIGHT JUNCTIONS; MAMMARY TUMORIGENESIS; SIGNALING PATHWAYS; CANCER-THERAPY; E-CADHERIN; APKC; RECEPTORS; ONCOGENE	The polarized glandular organization of epithelial cells is frequently lost during development of carcinoma. However, the specific oncogene targets responsible for polarity disruption have not been identified. Here, we demonstrate that activation of ErbB2 disrupts apical-basal polarity by associating with Par6-aPKC, components of the Par polarity complex. Inhibition of interaction between Par6 and aPKC blocked the ability of ErbB2 to disrupt the acinar organization of breast epithelia and to protect cells from apoptosis but was not required for cell proliferation. Therefore, oncogenes target polarity proteins to disrupt glandular organization and protect cells from apoptotic death during development of carcinoma.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Univ Toronto, Program Mol Biol & Canc, Samuel Lunenfeld Res Inst, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Muthuswamy, SK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	muthuswa@cshl.edu	Pawson, Tony J/E-4578-2013; Muthuswamy, Senthil K/AGY-2834-2022	Muthuswamy, Senthil K/0000-0001-6564-9634; Rosenberg, Avi/0000-0003-2356-950X; Fawcett, Jim/0000-0003-0043-2164	NATIONAL CANCER INSTITUTE [R01CA098830, R56CA098830] Funding Source: NIH RePORTER; NCI NIH HHS [CA098830] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Howley P M, 1989, Princess Takamatsu Symp, V20, P199; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Loden M, 2003, ANTICANCER RES, V23, P2053; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Polosukhin VV, 2001, ULTRASTRUCT PATHOL, V25, P119; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; RAGAZ J, 2004, DIS BREAST, P619; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SCHNITT SJ, 2004, DIS BREAST, P77; SCHOENENBERGER CA, 1991, J CELL BIOL, V112, P873, DOI 10.1083/jcb.112.5.873; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	49	195	201	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1235	U20		10.1038/ncb1485	http://dx.doi.org/10.1038/ncb1485			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060907				2022-12-27	WOS:000241732400012
J	Celli, GB; Denchi, EL; de Lange, T				Celli, Giulia B.; Denchi, Eros Lazzerini; de Lange, Titia			Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; IN-VITRO; DNA; REPAIR; DEFICIENT; LENGTH; YEAST; TRF2; KU86	Ku70-Ku80 heterodimers promote the non-homologous endjoining ( NHEJ) of DNA breaks and, as shown here, the fusion of dysfunctional telomeres. Paradoxically, this heterodimer is also located at functional mammalian telomeres and interacts with components of shelterin, the protein complex that protects telomeres(1-6). To determine whether Ku contributes to telomere protection, we analysed Ku70(-/-) mouse cells(7). Telomeres of Ku70(-/-) cells had a normal DNA structure and did not activate a DNA damage signal. However, Ku70 repressed exchanges between sister telomeres - a form of homologous recombination implicated in the alternative lengthening of telomeres ( ALT) pathway(8). Sister telomere exchanges occurred at approximately 15% of the chromosome ends when Ku70 and the telomeric protein TRF2 were absent. Combined deficiency of TRF2 and another NHEJ factor, DNA ligase IV, did not elicit this phenotype. Sister telomere exchanges were not elevated at telomeres with functional TRF2, indicating that TRF2 and Ku70 act in parallel to repress recombination. We conclude that mammalian chromosome ends are highly susceptible to homologous recombination, which can endanger cell viability if an unequal exchange generates a critically shortened telomere. Therefore, Ku- and TRF2-mediated repression of homologous recombination is an important aspect of telomere protection.	Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	lazzerini denchi, eros/F-7913-2010; de Lange, Titia/B-8263-2011; Denchi, Eros Lazzerini/AAD-8208-2020	lazzerini denchi, eros/0000-0001-5378-4644; de Lange, Titia/0000-0002-9267-367X; 	NIGMS NIH HHS [GM49046] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi N, 2001, P NATL ACAD SCI USA, V98, P12109, DOI 10.1073/pnas.201271098; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Bertuch AA, 2003, GENE DEV, V17, P2347, DOI 10.1101/gad.1146603; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; DuBois ML, 2002, GENETICS, V161, P995; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Weinstock DM, 2006, MOL CELL BIOL, V26, P131, DOI 10.1128/MCB.26.1.131-139.2006	35	208	214	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					885	U162		10.1038/ncb1444	http://dx.doi.org/10.1038/ncb1444			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16845382				2022-12-27	WOS:000239423000020
J	Carroll, DK; Carroll, JS; Leong, CO; Cheng, F; Brown, M; Mills, AA; Brugge, JS; Ellisen, LW				Carroll, Danielle K.; Carroll, Jason S.; Leong, Chee-Onn; Cheng, Fang; Brown, Myles; Mills, Alea. A.; Brugge, Joan S.; Ellisen, Leif W.			p63 regulates an adhesion programme and cell survival in epithelial cells	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; P53 HOMOLOG; EPIDERMAL MORPHOGENESIS; EXPRESSION; APOPTOSIS; DELTA-NP63-ALPHA; INTEGRIN; MATRIX; NICHE; SKIN	p63 is critical for epithelial development yet little is known about the transcriptional programmes it regulates. By characterising transcriptional changes and cellular effects following modulation of p63 expression, we have defined a vital role for p63 in cellular adhesion. Knockdown of p63 expression caused downregulation of cell adhesion-associated genes, cell detachment and anoikis in mammary epithelial cells and keratinocytes. Conversely, overexpression of the TAp63 gamma or Delta Np63 alpha isoforms of p63 upregulated cell adhesion molecules, increased cellular adhesion and conferred resistance to anoikis. Apoptosis induced by loss of p63 was rescued by signalling downstream of beta 4 integrin. Our results implicate p63 as a key regulator of cellular adhesion and survival in basal cells of the mammary gland and other stratified epithelial tissues.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; NYU, Courant Inst Math Sci, Bioinformat Grp, New York, NY 10003 USA; NYU, Dept Biol, New York, NY 10003 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; New York University; New York University; Cold Spring Harbor Laboratory	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu	Leong, Chee-Onn/C-9779-2013; Brown, Myles/AAX-5332-2021; Ellisen, Leif W/AAA-6572-2022; Brown, Myles/B-6906-2008	Leong, Chee-Onn/0000-0002-6353-9703; Brown, Myles/0000-0002-8213-1658; Ellisen, Leif W/0000-0003-0444-7910; Carroll, Jason/0000-0003-3643-0080	NCI NIH HHS [CA080111] Funding Source: Medline; NIAMS NIH HHS [AR47898] Funding Source: Medline; NIDCR NIH HHS [DE15945-01, R01 DE015945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dellavalle RP, 2001, J DERMATOL SCI, V27, P82, DOI 10.1016/S0923-1811(01)00105-0; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2002, GENESIS, V32, P138, DOI 10.1002/gene.10067; Nanba D, 2001, DEV GROWTH DIFFER, V43, P535, DOI 10.1046/j.1440-169X.2001.00596.x; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Shimada A, 1999, CANCER RES, V59, P2781; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Westfall MD, 2004, CARCINOGENESIS, V25, P857, DOI 10.1093/carcin/bgh148; Wu GJ, 2003, CANCER RES, V63, P2351; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	42	332	339	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					551	561		10.1038/ncb1420	http://dx.doi.org/10.1038/ncb1420			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16715076				2022-12-27	WOS:000238029000007
J	Rahmouni, S; Cerignoli, F; Alonso, A; Tsutji, T; Henkens, R; Zhu, CJ; Louis-Dit-Sully, C; Moutschen, M; Jiang, W; Mustelin, T				Rahmouni, S; Cerignoli, F; Alonso, A; Tsutji, T; Henkens, R; Zhu, CJ; Louis-Dit-Sully, C; Moutschen, M; Jiang, W; Mustelin, T			Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SIGNAL-REGULATED KINASE; N-TERMINAL-KINASE; MAP KINASE; ACTIVATION; GENE; ERK; RECEPTOR; JNK1; P53	Protein tyrosine phosphatases regulate important processes in eukaryotic cells and have critical functions in many human diseases including diabetes to cancer(1-3). Here, we report that the human Vaccinia H1-related (VHR) dual-specific protein tyrosine phosphatase regulates cell-cycle progression and is itself modulated during the cell cycle. Using RNA interference (RNAi), we demonstrate that cells lacking VHR arrest at the G1-S and G2-M transitions of the cell cycle and show the initial signs of senescence, such as flattening, spreading, appearance of autophagosomes, beta-galactosidase staining and decreased telomerase activity. In agreement with this notion, cells lacking VHR were found to upregulate p21(Cip-Waf1), whereas they downregulated the expression of genes for cell-cycle regulators, DNA replication, transcription and mRNA processing. Loss of VHR also caused a several-fold increase in serum-induced activation of its substrates, the mitogen-activated protein ( MAP) kinases Jnk and Erk. VHR-induced cell-cycle arrest was dependent on this hyperactivation of Jnk and Erk, and was reversed by Jnk and Erk inhibition or knock-down. We conclude that VHR is required for cell-cycle progression as it modulates MAP kinase activation in a cell-cycle phase-dependent manner.	Burnham Inst Med Res, La Jolla, CA 92037 USA; Univ Liege, B-4000 Liege 1, Belgium; Inst Biol & Genet Med, Valladolid 47003, Spain	Sanford Burnham Prebys Medical Discovery Institute; University of Liege	Mustelin, T (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tmustelin@burnham-inst.org	Alonso, Andrés/L-7523-2014	Alonso, Andrés/0000-0001-8674-9378; Moutschen, Michel/0000-0002-6405-1785; Mustelin, Tomas/0000-0001-5912-8840; Jiang, Wei/0000-0002-2309-9571	NIAID NIH HHS [AI35603] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035603] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Alonso A, 2004, TOP CURR GENET, V5, P333; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2004, J BIOL CHEM, V279, P35768, DOI 10.1074/jbc.M403412200; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Chau ASS, 1999, J BIOL CHEM, V274, P32085, DOI 10.1074/jbc.274.45.32085; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorfman K, 1996, ONCOGENE, V13, P925; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Grosch S, 2003, FASEB J, V17, P1316, DOI 10.1096/fj.02-0919fje; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tchou WW, 1999, ONCOGENE, V18, P6974, DOI 10.1038/sj.onc.1203195; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Xue Y, 2003, MOL CARCINOGEN, V36, P38, DOI 10.1002/mc.10096	29	101	105	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					524	U178		10.1038/ncb1398	http://dx.doi.org/10.1038/ncb1398			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16604064				2022-12-27	WOS:000237299400017
J	Kirkpatrick, DS; Denison, C; Gygi, SP				Kirkpatrick, DS; Denison, C; Gygi, SP			Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics	NATURE CELL BIOLOGY			English	Review							PROTEIN SUMOYLATION; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; FUNCTIONAL PROTEOMICS; CELL-CULTURE; AMINO-ACIDS; IDENTIFICATION; DEGRADATION; SUBSTRATE; YEAST	Mass-spectrometry-based proteomics has become an essential tool for the qualitative and quantitative analysis of cellular systems. The biochemical complexity and functional diversity of the ubiquitin system are well suited to proteomic studies. This review summarizes advances involving the identification of ubiquitinated proteins, the elucidation of ubiquitin-modification sites and the determination of polyubiquitin chain linkages, as well as offering a perspective on the application of emerging technologies for mechanistic and functional studies of protein ubiquitination.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirkpatrick, DS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Steven_Gygi@hms.harvard.edu		Kirkpatrick, Donald/0000-0003-3091-2804	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000041, T32HG000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000041, HG 00041, K22 HG000041] Funding Source: Medline; NIGMS NIH HHS [GM 67945, R01 GM067945] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Chang TL, 2004, CELL MOL BIOL, V50, P59; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen WG, 2004, EXPERT REV PROTEOMIC, V1, P343, DOI 10.1586/14789450.1.3.343; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Gururaja T, 2003, J PROTEOME RES, V2, P394, DOI 10.1021/pr034019n; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kirkpatrick DS, 2005, PROTEOMICS, V5, P2104, DOI 10.1002/pmic.200401089; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lee JS, 2004, PROTEOMICS, V4, P3376, DOI 10.1002/pmic.200401000; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; PICKART CM, 2001, NATURE REV MOL CELL, V70, P503; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; TAKADA K, 1995, EUR J BIOCHEM, V233, P42, DOI 10.1111/j.1432-1033.1995.042_1.x; Takada K, 1996, BBA-GEN SUBJECTS, V1290, P282, DOI 10.1016/0304-4165(96)00032-3; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wang DX, 2005, ANAL CHEM, V77, P1458, DOI 10.1021/ac048834d; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Warren MRE, 2005, RAPID COMMUN MASS SP, V19, P429, DOI 10.1002/rcm.1798; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	100	171	178	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					750	757		10.1038/ncb0805-750	http://dx.doi.org/10.1038/ncb0805-750			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056266	Green Accepted			2022-12-27	WOS:000230881500005
J	Le Blanc, I; Luyet, PP; Pons, V; Ferguson, C; Emans, N; Petiot, A; Mayran, N; Demaurex, N; Faure, J; Sadoul, R; Parton, RG; Gruenberg, J				Le Blanc, I; Luyet, PP; Pons, V; Ferguson, C; Emans, N; Petiot, A; Mayran, N; Demaurex, N; Faure, J; Sadoul, R; Parton, RG; Gruenberg, J			Endosome-to-cytosol transport of viral nucleocapsids	NATURE CELL BIOLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; MEMBRANE; RECEPTOR; PROTEIN; BINDING; VESICLES; DOMAINS; PATHWAY; CELLS; LOCALIZATION	During viral infection, fusion of the viral envelope with endosomal membranes and nucleocapsid release were thought to be concomitant events. We show here that for the vesicular stomatitis virus they occur sequentially, at two successive steps of the endocytic pathway. Fusion already occurs in transport intermediates between early and late endosomes, presumably releasing the nucleocapsid within the lumen of intra- endosomal vesicles, where it remains hidden. Transport to late endosomes is then required for the nucleocapsid to be delivered to the cytoplasm. This last step, which initiates infection, depends on the late endosomal lipid lysobisphosphatidic acid ( LBPA) and its putative effector Alix/ AIP1, and is regulated by phosphatidylinositol- 3-phosphate ( PtdIns( 3) P) signalling via the PtdIns( 3) P- binding protein Snx16. We conclude that the nucleocapsid is exported into the cytoplasm after the back- fusion of internal vesicles with the limiting membrane of late endosomes, and that this process is controlled by the phospholipids LBPA and PtdIns( 3) P and their effectors.	Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Queensland, Ctr Microscopy & Microanal, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; Inst Pasteur, Seoul 136791, South Korea; INSERM, U504, F-94807 Villejuif, France; Inst Expt Pathol, CH-1011 Lausanne, Switzerland; Ctr Med Univ Geneva, Dept Physiol, CH-1211 Geneva, Switzerland; Univ Grenoble 1, Hop A Michallon, INSERM, F-38043 Grenoble, France	University of Geneva; University of California System; University of California Berkeley; University of Queensland; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.	jean.gruenberg@biochem.unige.ch	Emans, Neil/H-4299-2011; Fauré, julien/AAJ-1845-2020; Parton, Robert G/C-5673-2009	Fauré, julien/0000-0002-3660-9809; Parton, Robert G/0000-0002-7494-5248; SADOUL, Remy/0000-0002-4763-0320; PETIOT, Anne/0000-0001-8038-470X; PONS, Veronique/0000-0001-5821-8481; Demaurex, Nicolas/0000-0002-9933-6772				Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Galve-de Rochemonteix B, 2000, ARTERIOSCL THROM VAS, V20, P563; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hanson BJ, 2003, J BIOL CHEM, V278, P34617, DOI 10.1074/jbc.M300143200; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, SEMIN CELL DEV BIOL, V9, P517, DOI 10.1006/scdb.1998.0257; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Marsh M, 1997, J CELL SCI, V110, P95; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084952102000605; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; PARTON RG, 1992, J CELL SCI, V103, P335; PESONEN M, 1983, J CELL BIOL, V97, P638, DOI 10.1083/jcb.97.3.638; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Reaves BJ, 1996, J CELL SCI, V109, P749; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Sinclair AM, 1997, GENE THER, V4, P918, DOI 10.1038/sj.gt.3300479; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WHITNEY JA, 1995, CELL, V83, P703	54	235	241	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					653	U25		10.1038/ncb1269	http://dx.doi.org/10.1038/ncb1269			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15951806	Green Accepted, Green Submitted			2022-12-27	WOS:000230190800009
J	Li, J; Lee, WL; Cooper, JA				Li, J; Lee, WL; Cooper, JA			NudEL targets dynein to microtubule ends through LIS1	NATURE CELL BIOLOGY			English	Letter							ASPERGILLUS-NIDULANS; CYTOPLASMIC DYNEIN; SACCHAROMYCES-CEREVISIAE; LISSENCEPHALY GENE; NUCLEAR MIGRATION; PROTEIN; ACETYLHYDROLASE; LOCALIZATION; ACTIVATION; SUBUNIT	Dynein is a minus- end- directed microtubule motor with critical roles in mitosis, membrane transport and intracellular transport. Several proteins regulate dynein activity, including dynactin(1), LIS1 ( refs 2, 3) and NudEL ( NudE- like)(2,4 - 8). Here, we identify a NUDEL homologue in budding yeast and name it Ndl1. The ndl1 Delta. null mutant shows decreased targeting of dynein to microtubule plus ends, an essential element of the model for dynein function. We find that Ndl1 regulates dynein targeting through LIS1, with which it interacts biochemically, but not through CLIP170, another plus- end protein involved in dynein targeting(9). Ndl1 is found at far fewer microtubule ends than are LIS1 and dynein. However, when Ndl1 is present at a plus end, the molar amount of Ndl1 approaches that of LIS1 and dynein. We propose a model in which Ndl1 binds transiently to the plus end to promote targeting of LIS1, which cooperatively recruits dynein.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, POB 8228, St Louis, MO 63110 USA.	jcooper@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047337] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47337, R01 GM047337] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Kaiser C., 1994, METHODS YEAST GENETI; Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sweeney KJ, 2001, MECH DEVELOP, V101, P21, DOI 10.1016/S0925-4773(00)00543-8; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297	24	81	90	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					686	U68		10.1038/ncb1273	http://dx.doi.org/10.1038/ncb1273			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15965467	Green Accepted			2022-12-27	WOS:000230190800012
J	Cao, H; Weller, S; Orth, JD; Chen, J; Huang, B; Chen, JL; Stamnes, M; McNiven, MA				Cao, H; Weller, S; Orth, JD; Chen, J; Huang, B; Chen, JL; Stamnes, M; McNiven, MA			Actin and Arf1-dependent recruitment of a cortactin-dynamin complex to the Golgi regulates post-Golgi transport	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; NETWORK; PROTEIN; CDC42; CYTOSKELETON; INHIBITION; ASSEMBLES; COMPONENT; RECEPTOR	Cortactin is an actin-binding protein that has recently been implicated in endocytosis. It binds directly to dynamin-2 (Dyn2), a large GTPase that mediates the formation of vesicles from the plasma membrane and the Golgi. Here we show that cortactin associates with the Golgi to regulate the actin- and Dyn2-dependent transport of cargo. Cortactin antibodies stain the Golgi apparatus, labelling peripheral buds and vesicles that are associated with the cisternae. Notably, in vitro or intact-cell experiments show that activation of Arf1 mediates the recruitment of actin, cortactin and Dyn2 to Golgi membranes. Furthermore, selective disruption of the cortactin - Dyn2 interaction significantly reduces the levels of Dyn2 at the Golgi and blocks the transit of nascent proteins from the trans-Golgi network, resulting in swollen and distended cisternae. These findings support the idea of an Arf1-activated recruitment of an actin, cortactin and Dyn2 complex that is essential for Golgi function.	Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Mayo Clinic; Mayo Clinic; University of Iowa	McNiven, MA (corresponding author), Mayo Clin, Ctr Basic Res Digest Dis, 1642D Guggenheim Bldg,200 1st St SW, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu	Orth, James/Q-4905-2019; Chen, Ji-Long/AAJ-2134-2021	Chen, Ji-Long/0000-0002-4274-0563; ORTH, JAMES/0000-0002-8559-6186; Stamnes, Mark/0000-0002-5869-7985	NIDDK NIH HHS [DK56647] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056647] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; ANDERSON KL, 1995, EUR J CELL BIOL, V66, P25; Benmerah A, 1999, J CELL SCI, V112, P1303; BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; DE M, 2000, J CELL SCI, V113, P2331; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; di Campli A, 1999, CELL MOTIL CYTOSKEL, V43, P334, DOI 10.1002/(SICI)1097-0169(1999)43:4<334::AID-CM6>3.0.CO;2-3; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; Maier O, 1996, BIOCHEM BIOPH RES CO, V223, P229, DOI 10.1006/bbrc.1996.0876; MATOVCIK LM, 1990, EUR J CELL BIOL, V53, P203; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; SCHWANINGER R, 1992, METHOD ENZYMOL, V219, P110; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Toomre D, 1999, J CELL SCI, V112, P21; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 1998, J CELL SCI, V111, P2433	42	138	143	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					483	U45		10.1038/ncb1246	http://dx.doi.org/10.1038/ncb1246			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15821732				2022-12-27	WOS:000229123500015
J	Kondo, S; Murakami, T; Tatsumi, K; Ogata, M; Kanemoto, S; Otori, K; Iseki, K; Wanaka, A; Imaizumi, K				Kondo, S; Murakami, T; Tatsumi, K; Ogata, M; Kanemoto, S; Otori, K; Iseki, K; Wanaka, A; Imaizumi, K			OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; ER STRESS; MESSENGER-RNA; GRP78; IDENTIFICATION; EXPRESSION; APOPTOSIS; ELEMENT	Endoplasmic reticulum (ER) stress transducers IRE1, PERK and ATF6 are well known to transduce signals from the ER to the cytoplasm and nucleus when unfolded proteins are accumulated in the ER. Here, we identified OASIS as a novel ER stress transducer. OASIS is a basic leucine zipper ( bZIP) transcription factor of the CREB/ATF family with a transmembrane domain that allows it to associate with the ER. The molecule is cleaved at the membrane in response to ER stress, and its cleaved amino-terminal cytoplasmic domain, which contains the bZIP domain, translocates into the nucleus where it activates the transcription of target genes that are mediated by ER stress-responsive and cyclic AMP-responsive elements. Intriguingly, OASIS was induced at the transcriptional level during ER stress in astrocytes of the central nervous system, but not in other cell types examined. Furthermore, overexpression of OASIS resulted in induction of BiP and suppression of ER-stress-induced cell death, whereas knockdown partially reduced BiP levels and led to ER stress in susceptible astrocytes. Our results reveal pivotal roles for OASIS in modulating the unfolded protein response in astrocytes, and the possibility that cell type-specific UPR signalling also exists in other cells.	Miyazaki Univ, Fac Med, Dept Anat, Miyazaki 8891692, Japan; Nara Inst Sci & Technol NAIST, Div Struct Cellular Biol, Nara 6300101, Japan; Nara Med Univ, Dept Anat, Nara 6348522, Japan; Yamagata Univ, Sch Med, Dept Emergency Med, Yamagata 9909585, Japan	University of Miyazaki; Nara Institute of Science & Technology; Nara Medical University; Yamagata University	Imaizumi, K (corresponding author), Miyazaki Univ, Fac Med, Dept Anat, Kihara 5200, Miyazaki 8891692, Japan.	imaizumi@med.miyazaki-u.ac.jp	Wanaka, Akio/GPW-8926-2022; Wanaka, Akio/AAC-9754-2019; Wanaka, Akio/ABE-4671-2020; Longo, Kenneth A/A-5631-2010	Wanaka, Akio/0000-0001-9951-9862; 				Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; ERICKSON AH, 1979, J BIOL CHEM, V254, P1771; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nikaido T, 2002, MOL BRAIN RES, V108, P129, DOI 10.1016/S0169-328X(02)00521-1; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; PECHAN PA, 1992, NEUROREPORT, V3, P469, DOI 10.1097/00001756-199206000-00003; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002	29	228	240	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					186	U112		10.1038/ncb1213	http://dx.doi.org/10.1038/ncb1213			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15665855				2022-12-27	WOS:000226719500016
J	Morishige, M; Hashimoto, S; Ogawa, E; Toda, Y; Kotani, H; Hirose, M; Wei, S; Hashimoto, A; Yamada, A; Yano, H; Mazaki, Y; Kodama, H; Nio, Y; Manabe, T; Wada, H; Kobayashi, H; Sabe, H				Morishige, Masaki; Hashimoto, Shigeru; Ogawa, Eiji; Toda, Yoshinobu; Kotani, Hirokazu; Hirose, Mayumi; Wei, Shumei; Hashimoto, Ari; Yamada, Atsuko; Yano, Hajime; Mazaki, Yuichi; Kodama, Hiroshi; Nio, Yoshinori; Manabe, Toshiaki; Wada, Hiromi; Kobayashi, Hidenori; Sabe, Hisataka			GeP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion	NATURE CELL BIOLOGY			English	Article							CELL-ADHESION; MIGRATION; METASTASIS; EXPRESSION; TUMOR; PROTEINS; IDENTIFICATION; INVASIVENESS; REQUIREMENT; INVADOPODIA	Epidermal growth factor (EGF) receptor ( EGFR) signalling is implicated in tumour invasion and metastasis(1,2). However, whether there are EGFR signalling pathways specifically used for tumour invasion still remains elusive. Overexpression of Arf6 and its effector, AMAP1, correlates with and is crucial for the invasive phenotypes of different breast cancer cells(3-6). Here we identify the mechanism by which Arf6 is activated to induce tumour invasion. We found that GEP100/BRAG2, a guanine nucleotide exchanging factor (GEF) for Arf6, is responsible for the invasive activity of MDA-MB-231 breast cancer cells, whereas the other ArfGEFs are not. GEP100, through its pleckstrin homology domain, bound directly to Tyr1068/1086-phosphorylated EGFR to activate Arf6. Overexpression of GEP100, together with Arf6, caused non-invasive MCF7 cells(7) to become invasive, which was dependent on EGF stimulation. Moreover, GEP100 knockdown blocked tumour metastasis. GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases. Our results indicate that GEP100 links EGFR signalling to Arf6 activation to induce invasive activities of some breast cancer cells, and hence may contribute to their metastasis and malignancy.	[Morishige, Masaki; Hashimoto, Shigeru; Wei, Shumei; Hashimoto, Ari; Yamada, Atsuko; Yano, Hajime; Mazaki, Yuichi; Sabe, Hisataka] Osaka Biosci Inst, Dept Mol Biol, Osaka 5650874, Japan; [Morishige, Masaki; Kobayashi, Hidenori] Oita Univ, Sch Med, Dept Neurosurg, Oita 8795593, Japan; [Ogawa, Eiji; Wada, Hiromi] Kyoto Univ, Dept Thorac Surg, Fac Med, Kyoto 6068507, Japan; [Ogawa, Eiji; Kotani, Hirokazu; Manabe, Toshiaki] Kyoto Univ Hosp, Lab Diagnost Pathol, Kyoto 6068501, Japan; [Toda, Yoshinobu; Kotani, Hirokazu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto 6068507, Japan; [Hirose, Mayumi] Osaka Univ, Lab Supramol Crystallog, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kodama, Hiroshi; Nio, Yoshinori] Kodama Breast Clin, Kyoto 6038325, Japan; [Sabe, Hisataka] Kyoto Univ, Grad Sch Biosci, Kyoto 6068607, Japan	Oita University; Kyoto University; Kyoto University; Kyoto University; Osaka University; Kyoto University	Sabe, H (corresponding author), Osaka Biosci Inst, Dept Mol Biol, Osaka 5650874, Japan.	sabe@obi.or.jp	Sabe, Hisataka/A-4066-2012; まゆみ, 廣瀬/AAK-5735-2020; Sabe, Hisataka/GPF-4385-2022; Hashimoto, Shigeru/D-7138-2012; Hashimoto, Ari/D-7125-2012	Mazaki, Yuichi/0000-0003-4192-0834				Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derrien V, 2002, J CELL SCI, V115, P2867; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FITZPATRICK SL, 1984, CANCER RES, V44, P3442; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Price JT, 1999, CANCER RES, V59, P5475; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; ZAJCHOWSKI D, 1988, CANCER RES, V48, P7041; Zajchowski DA, 2001, CANCER RES, V61, P5168	31	152	159	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					85	U70		10.1038/ncb1672	http://dx.doi.org/10.1038/ncb1672			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084281				2022-12-27	WOS:000252116100016
J	Gong, LW; de Toledo, GA; Lindau, M				Gong, Liang-Wei; Alvarez de Toledo, Guillermo; Lindau, Manfred			Exocytotic catecholamine release is not associated with cation flux through channels in the vesicle membrane but Na+ influx through the fusion pore	NATURE CELL BIOLOGY			English	Article							ADRENAL CHROMAFFIN CELLS; SYNAPTIC VESICLES; TRANSMITTER RELEASE; PATCH AMPEROMETRY; BIOGENIC-AMINES; ION-EXCHANGE; GRANULES; RECORDINGS; RESOLUTION; SECRETION	Release of charged neurotransmitter molecules through a narrow fusion pore requires charge compensation by other ions. It has been proposed that this may occur by ion flow from the cytosol through channels in the vesicle membrane, which would generate a net outward current. This hypothesis was tested in chromaffin cells using cell-attached patch amperometry that simultaneously measured catecholamine release from single vesicles and ionic current across the patch membrane. No detectable current was associated with catecholamine release indicating that < 2% of cations, if any, enter the vesicle through its membrane. Instead, we show that flux of catecholamines through the fusion pore, measured as an amperometric foot signal, decreases when the extracellular cation concentration is reduced. The results reveal that the rate of transmitter release through the fusion pore is coupled to net Na+ influx through the fusion pore, as predicted by electrodiffusion theory applied to fusion-pore permeation, and suggest a prefusion rather than postfusion role for vesicular cation channels.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14850 USA; Univ Seville, Fac Med, Dept Physiol & Biophys, E-41009 Seville, Spain	Cornell University; University of Sevilla	Lindau, M (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14850 USA.	ml95@cornell.edu	Lindau, Manfred/ABD-3449-2021; Alvarez de Toledo, Guillermo/I-2888-2015	Lindau, Manfred/0000-0002-5722-9557; Alvarez de Toledo, Guillermo/0000-0001-7193-2663	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038200] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038200-07, R01-NS38200, R01 NS038200] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ARISPE N, 1992, J MEMBRANE BIOL, V130, P191; BAUR JE, 1988, ANAL CHEM, V60, P1268, DOI 10.1021/ac00164a006; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Burgoyne RD, 1996, BIOCHEM SOC T, V24, P653, DOI 10.1042/bst0240653; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; Dernick G, 2005, NAT METHODS, V2, P699, DOI 10.1038/nmeth0905-699; Dernick G, 2003, NAT CELL BIOL, V5, P358, DOI 10.1038/ncb956; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; GERHARDT G, 1982, ANAL CHEM, V54, P2618, DOI 10.1021/ac00251a054; Gong LW, 2003, J NEUROSCI, V23, P7917; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOLZ RW, 1986, ANNU REV PHYSIOL, V48, P175; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; Montell C, 2006, NEURON, V52, P395, DOI 10.1016/j.neuron.2006.10.012; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; POLLARD HB, 1979, J BIOL CHEM, V254, P1170; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Tabares L, 2003, BIOCHEM SOC T, V31, P837, DOI 10.1042/bst0310837; UVNAS B, 1989, NEWS PHYSIOL SCI, V4, P68; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; WOODBURY DJ, 1995, MOL MEMBR BIOL, V12, P165, DOI 10.3109/09687689509027504; YAKIR N, 1995, J PHYSIOL-LONDON, V485, P683, DOI 10.1113/jphysiol.1995.sp020762; Yin Y, 2002, J PHYSIOL-LONDON, V539, P409, DOI 10.1013/jphysiol.2001.012943; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	39	37	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					915	+		10.1038/ncb1617	http://dx.doi.org/10.1038/ncb1617			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643118	Green Published, Green Accepted			2022-12-27	WOS:000248486700013
J	Wang, XB; Belguise, K; Kersual, N; Kirsch, KH; Mineva, ND; Galtier, F; Chalbos, D; Sonenshein, GE				Wang, Xiaobo; Belguise, Karine; Kersual, Nathalie; Kirsch, Kathrin H.; Mineva, Nora D.; Galtier, Florence; Chalbos, Dany; Sonenshein, Gail E.			Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; BREAST-CANCER CELLS; ACTIVATOR PROTEIN-1 ACTIVITY; PROSTATE-CANCER; MESENCHYMAL TRANSITION; ALPHA EXPRESSION; TRANSGENIC MICE; KINASE CK2; IN-VIVO; RECEPTOR	Aberrant constitutive expression of c-Rel, p65 and p50 NF-kappa B subunits has been reported in over 90% of breast cancers(1,2). Recently, we characterized a de novo RelB NF-kappa B subunit synthesis pathway, induced by the cytomegalovirus (CMV) IE1 protein, in which binding of p50-p65 NF-kappa B and c-Jun-Fra-2 AP-1 complexes to the RELB promoter work in synergy to potently activate transcription(3). Although RelB complexes were observed in mouse mammary tumours induced by either ectopic c-Rel expression(4) or carcinogen exposure(5), little is known about RelB in human breast disease. Here, we demonstrate constitutive de novo RelB synthesis is selectively active in invasive oestrogen receptor alpha (ER alpha)-negative breast cancer cells. ERa signalling reduced levels of functional NF-kappa B and Fra-2 AP-1 and inhibited de novo RelB synthesis, leading to an inverse correlation between RELB and ERa gene expression in human breast cancer tissues and cell lines. Induction of Bcl-2 by RelB promoted the more invasive phenotype of ER alpha-negative cancer cells. Thus, inhibition of de novo RelB synthesis represents a new mechanism whereby ERa controls epithelial to mesenchymal transition (EMT).	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Boston Univ, Sch Med, Lab Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Womens Hlth Interdisciplinary Res Ctr, Boston, MA 02118 USA; INSERM, U540, F-34090 Montpellier, France; Univ Montpellier 1, F-34000 Montpellier, France	Boston University; Boston University; Boston University; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Sonenshein, GE (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	gsonensh@bu.edu	Wang, Xiaobo/A-8604-2011	Kirsch, Kathrin/0000-0003-1532-1715; Wang, Xiaobo/0000-0002-3311-1378; Belguise, Karine/0000-0003-3426-8040	NCI NIH HHS [CA36355, R01 CA036355] Funding Source: Medline; NIEHS NIH HHS [P01 ES011624, ES11624] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; de Moissac D, 1998, J BIOL CHEM, V273, P23946, DOI 10.1074/jbc.273.37.23946; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HORWITZ KB, 1993, BREAST CANCER RES TR, V26, P119, DOI 10.1007/BF00689685; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hyder SM, 1997, CANCER RES, V57, P2547; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Oliveira Cleida A, 2003, Reprod Biol Endocrinol, V1, P75, DOI 10.1186/1477-7827-1-75; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06	35	177	183	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					470	U197		10.1038/ncb1559	http://dx.doi.org/10.1038/ncb1559			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369819	Green Accepted, Green Submitted			2022-12-27	WOS:000245359400019
J	Dellavalle, A; Sampaolesi, M; Tonlorenzi, R; Tagliafico, E; Sacchetti, B; Perani, L; Innocenzi, A; Galvez, BG; Messina, G; Morosetti, R; Li, S; Belicchi, M; Peretti, G; Chamberlain, JS; Wright, WE; Torrente, Y; Ferrari, S; Bianco, P; Cossu, G				Dellavalle, Arianna; Sampaolesi, Maurilio; Tonlorenzi, Rossana; Tagliafico, Enrico; Sacchetti, Benedetto; Perani, Laura; Innocenzi, Anna; Galvez, Beatriz G.; Messina, Graziella; Morosetti, Roberta; Li, Sheng; Belicchi, Marzia; Peretti, Giuseppe; Chamberlain, Jeffrey S.; Wright, Woodring E.; Torrente, Yvan; Ferrari, Stefano; Bianco, Paolo; Cossu, Giulio			Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; DYSTROPHIN EXPRESSION; PROGENITOR CELLS; BONE-MARROW; MULTIPOTENT; POPULATION; DELIVERY; REPAIR; MESOANGIOBLASTS; TRANSPLANTATION	Cells derived from blood vessels of human skeletal muscle can regenerate skeletal muscle, similarly to embryonic mesoangioblasts. However, adult cells do not express endothelial markers, but instead express markers of pericytes, such as NG2 proteoglycan and alkaline phosphatase ( ALP), and can be prospectively isolated from freshly dissociated ALP(+) cells. Unlike canonical myogenic precursors ( satellite cells), pericyte-derived cells express myogenic markers only in differentiated myotubes, which they form spontaneously with high efficiency. When transplanted into severe combined immune deficient-X-linked, mouse muscular dystrophy (scid-mdx) mice, pericyte-derived cells colonize host muscle and generate numerous fibres expressing human dystrophin. Similar cells isolated from Duchenne patients, and engineered to express human mini-dystrophin, also give rise to many dystrophin-positive fibres in vivo. These data show that myogenic precursors, distinct from satellite cells, are associated with microvascular walls in the human skeletal muscle, may represent a correlate of embryonic 'mesoangioblasts' present after birth and may be a promising candidate for future cell-therapy protocols in patients.	Ist Sci San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy; Univ Roma La Sapienza, Dept Cellular & Dev Biol, I-00161 Rome, Italy; Catholic Univ, Dept Neurol, I-00168 Rome, Italy; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Milan, Osped Maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Roma La Sapienza, Dept Expt Pathol, I-00161 Rome, Italy; Univ Milan, Dept Biol, I-20130 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; Universita di Modena e Reggio Emilia; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Washington; University of Washington Seattle; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome; University of Milan	Bianco, P (corresponding author), Ist Sci San Raffaele, Stem Cell Res Inst, 58 Via Olgettina, I-20132 Milan, Italy.	p.bianco@flashnet.it; cossu.giulio@hsr.it	MOROSETTI, ROBERTA/ABE-1045-2021; Tonlorenzi, Rossana/AAN-2241-2020; sacchetti, benedetto/A-3314-2009; Peretti, Giuseppe/K-6358-2016; Sampaolesi, Maurilio/H-6509-2013; Tagliafico, Enrico/C-9079-2009; Perani, Laura/AAN-2838-2020; Gálvez, Beatriz G./H-1644-2015; Messina, Graziella/A-1469-2014; TORRENTE, YVAN/A-2964-2015	MOROSETTI, ROBERTA/0000-0001-5017-4904; Peretti, Giuseppe/0000-0001-9341-7187; Sampaolesi, Maurilio/0000-0002-2422-3757; Tagliafico, Enrico/0000-0003-0981-2542; Perani, Laura/0000-0001-8616-3377; Gálvez, Beatriz G./0000-0002-8082-9323; Messina, Graziella/0000-0001-8189-0727; Tonlorenzi, Rossana/0000-0002-6060-8208; TORRENTE, YVAN/0000-0002-2705-3984; Chamberlain, Jeffrey/0000-0001-5299-0059	Telethon [GSP030543] Funding Source: Medline	Telethon(Fondazione Telethon)		Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li S, 2005, GENE THER, V12, P1099, DOI 10.1038/sj.gt.3302505; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; NEUMEYER AM, 1992, NEUROLOGY, V42, P2258, DOI 10.1212/WNL.42.12.2258; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; SAFADI A, 1991, J HISTOCHEM CYTOCHEM, V39, P199, DOI 10.1177/39.2.1987264; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794	38	733	763	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					255	U30		10.1038/ncb1542	http://dx.doi.org/10.1038/ncb1542			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293855				2022-12-27	WOS:000244558600010
J	Zhao, WN; Malinin, N; Yang, FC; Staknis, D; Gekakis, N; Maier, B; Reischl, S; Kramer, A; Weitz, CJ				Zhao, Wen-Ning; Malinin, Nikolay; Yang, Fu-Chia; Staknis, David; Gekakis, Nicholas; Maier, Bert; Reischl, Silke; Kramer, Achim; Weitz, Charles J.			CIPC is a mammalian circadian clock protein without invertebrate homologues	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; FEEDBACK LOOPS; NUCLEAR ENTRY; NEGATIVE LIMB; MOUSE; MPER1; TIME; TRANSCRIPTION; OSCILLATORS; MECHANISMS	At the core of the mammalian circadian clock is a feedback loop in which the heterodimeric transcription factor CLOCK-Brain, Muscle Arnt-like-1 (BMAL1) drives expression of its negative regulators, periods (PERs) and cryptochromes (CRYs). Here, we provide evidence that CLOCK-Interacting Protein, Circadian ( CIPC) is an additional negative-feedback regulator of the circadian clock. CIPC exhibits circadian regulation in multiple tissues, and it is a potent and specific inhibitor of CLOCK-BMAL1 activity that functions independently of CRYs. CIPC-CLOCK protein complexes are present in vivo, and depletion of endogenous CIPC shortens the circadian period length. CIPC is unrelated to known proteins and has no recognizable homologues outside vertebrates. Our results suggest that negative feedback in the mammalian circadian clock is divided into distinct pathways, and that the addition of new genes has contributed to the complexity of vertebrate clocks.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Charite Univ Med Berlin, Lab Chronobiol, Inst Med Immunol, D-10098 Berlin, Germany	Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Malinin, Nikolay/Z-5308-2019; Malinin, Nikolay/J-4271-2012; Maier, Bert/B-2501-2009	Malinin, Nikolay/0000-0002-2654-1783; Kramer, Achim/0000-0001-9671-6078	NIMH NIH HHS [R01-MH59943] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059943] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	38	58	64	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					268	U53		10.1038/ncb1539	http://dx.doi.org/10.1038/ncb1539			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310242				2022-12-27	WOS:000244558600011
J	Nakamura, T; Arai, Y; Umehara, H; Masuhara, M; Kimura, T; Taniguchi, H; Sekimoto, T; Ikawa, M; Yoneda, Y; Okabe, M; Tanaka, S; Shiota, K; Nakano, T				Nakamura, Toshinobu; Arai, Yoshikazu; Umehara, Hiroki; Masuhara, Masaaki; Kimura, Tohru; Taniguchi, Hisaaki; Sekimoto, Toshihiro; Ikawa, Masahito; Yoneda, Yoshihiro; Okabe, Masaru; Tanaka, Satoshi; Shiota, Kunio; Nakano, Toru			PGC7/Stella protects against DNA demethylation in early embryogenesis	NATURE CELL BIOLOGY			English	Article							CYTOSINE METHYLATION; BINDING; GENOME	DNA methylation is an important means of epigenetic gene regulation(1,2) and must be carefully controlled as a prerequisite for normal early embryogenesis. Although global demethylation occurs soon after fertilization, it is not evenly distributed throughout the genome. Genomic imprinting and epigenetic asymmetry between parental genomes, that is, delayed demethylation of the maternal genome after fertilization(3-6), are clear examples of the functional importance of DNA methylation. Here, we show that PGC7/Stella, a maternal factor essential for early development, protects the DNA methylation state of several imprinted loci and epigenetic asymmetry. After determining that PGC7/Stella binds to Ran binding protein 5 (RanBP5; a nuclear transport shuttle protein), mutant versions of the two proteins were used to examine exactly when and where PGC7/Stella functions within the cell. It is likely that PGC7/Stella protects the maternal genome from demethylation only after localizing to the nucleus, where it maintains the methylation of several imprinted genes. These results demonstrate that PGC7/Stella is indispensable for the maintenance of methylation involved in epigenetic reprogramming after fertilization.	Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Pathol, Suita, Osaka 5650871, Japan; Univ Tokyo, Dept Anim Resources Sci Vet Med Sci, Tokyo 1138657, Japan; Meikai Univ, Sch Dent, Dept Oral Anat, Kawagoe, Saitama 3500283, Japan; Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; University of Tokyo; Meikai University; Tokushima University; Osaka University; Osaka University; Osaka University; Osaka University	Nakano, T (corresponding author), Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Pathol, Suita, Osaka 5650871, Japan.	tnakano@patho.med.osaka-u.ac.jp	Nakamura, Toshinobu/ABD-5906-2020; Taniguchi, Hisaaki/I-9171-2012; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Nakamura, Toshinobu/0000-0003-3881-3368; Okabe, Masaru/0000-0002-0803-9044; Kimura, Tohru/0000-0001-9227-0996; Tanaka, Satoshi/0000-0002-4745-550X				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bortvin Alex, 2004, BMC Developmental Biology, V4; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; YE Q, 1994, J BIOL CHEM, V269, P11306	28	419	442	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					64	U81		10.1038/ncb1519	http://dx.doi.org/10.1038/ncb1519			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17143267				2022-12-27	WOS:000243255100013
J	Scheckhuber, CQ; Erjavec, N; Tinazli, A; Hamann, A; Nystrom, T; Osiewacz, HD				Scheckhuber, C. Q.; Erjavec, N.; Tinazli, A.; Hamann, A.; Nystrom, T.; Osiewacz, H. D.			Reducing mitochondrial fission results in increased life span and fitness of two fungal ageing models	NATURE CELL BIOLOGY			English	Article							DYNAMIN-RELATED GTPASE; PODOSPORA-ANSERINA; FUSION; DNA; EXPRESSION; MORPHOLOGY; PLASMID; GENES; DEATH; YEAST	Ageing of biological systems is accompanied by alterations in mitochondrial morphology, including a transformation from networks and filaments to punctuate units(1). The significance of these alterations with regard to ageing is not known. Here, we demonstrate that the dynamin-related protein 1 (Dnm1p), a mitochondrial fission protein conserved from yeast to humans(2), affects ageing in the two model systems we studied, Podospora anserina and Saccharomyces cerevisiae. Deletion of the Dnm1 gene delays the transformation of filamentous to punctuate mitochondria and retards ageing without impairing fitness and fertility typically observed in long-lived mutants. Our data further suggest that reduced mitochondrial fission extends life span by increasing cellular resistance to the induction of apoptosis and links mitochondrial dynamics, apoptosis and life-span control.	Goethe Univ Frankfurt, Inst Mol Biosci, D-90438 Frankfurt, Germany; Gothenburg Univ, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden	Goethe University Frankfurt; University of Gothenburg	Osiewacz, HD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-90438 Frankfurt, Germany.	osiewacz@bio.uni-frankfurt.de	Osiewacz, Heinz D./D-3454-2011; Scheckhuber, Christian Q./A-6462-2012	Scheckhuber, Christian Q./0000-0002-2924-7547; Hamann, Andrea/0000-0001-9821-7491				BELCOUR L, 1981, CURR GENET, V3, P13, DOI 10.1007/BF00419575; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Borghouts C, 2000, CURR GENET, V37, P268, DOI 10.1007/s002940050528; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Hamann A, 2005, CURR GENET, V48, P270, DOI 10.1007/s00294-005-0018-1; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728; Osiewacz HD, 2002, MYCOLOGY S, V15, P87; OSIEWACZ HD, 2002, AGEING RES REV, V28, P1; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; PRILLINGER H, 1977, MOL GEN GENET, V156, P333, DOI 10.1007/BF00267190; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026	29	256	265	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					99	U129		10.1038/ncb1524	http://dx.doi.org/10.1038/ncb1524			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173038				2022-12-27	WOS:000243255100018
J	Feng, QY; Baird, D; Peng, X; Wang, JB; Ly, T; Guan, JL; Cerione, RA				Feng, Qiyu; Baird, Dan; Peng, Xu; Wang, Jianbin; Ly, Thi; Guan, Jun-Lin; Cerione, Richard A.			Cool-1 functions as an essential regulatory node for EGF receptor-and Src-mediated cell growth	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; C-CBL; P21-ACTIVATED KINASES; BINDING PARTNERS; DOWN-REGULATION; FOCAL ADHESION; RING FINGER; DBL FAMILY; BETA-PIX; PROTEIN	Cool-1 (cloned-out of library 1) has a key role in regulating epidermal growth factor receptor (EGFR) degradation. Here, we show that Cool-1 performs this function by functioning as both an upstream activator and downstream target for Cdc42. EGF-dependent phosphorylation of Cool-1 enables it to act as a nucleotide exchange factor for Cdc42 and to form a complex with the E3 ligase Cbl, thus regulating Cbl-catalysed EGFR degradation. The EGF-dependent phosphorylation is normally transient; however, Cool-1 phosphorylation is sustained in cells expressing v-Src and is essential for cellular transformation, as well as for v-Src-induced tumour formation in mice. These findings demonstrate that the regulated phosphorylation of Cool-1 is necessary to maintain the balance between normal signalling by EGFR and Src versus aberrant growth and transformation.	Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu						Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Flanders JA, 2003, FEBS LETT, V550, P119, DOI 10.1016/S0014-5793(03)00853-6; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHNSON PL, 1983, MOL CELL BIOL, V5, P1073; Jozic D, 2005, NAT STRUCT MOL BIOL, V12, P972, DOI 10.1038/nsmb1000; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; PAVELIC K, 1993, ANTICANCER RES, V13, P1133; Schmidt MHH, 2006, ONCOGENE, V25, P3071, DOI 10.1038/sj.onc.1209329; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; WHITEHEAD IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, pR1; WILSON LK, 1990, ONCOGENE, V5, P1471; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3	29	86	88	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					945	U55		10.1038/ncb1453	http://dx.doi.org/10.1038/ncb1453			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16892055				2022-12-27	WOS:000240241700010
J	Varga, V; Helenius, J; Tanaka, K; Hyman, AA; Tanaka, TU; Howard, J				Varga, Vladimir; Helenius, Jonne; Tanaka, Kozo; Hyman, Anthony A.; Tanaka, Tomoyuki U.; Howard, Jonathon			Yeast kinesin-8 depolymerizes microtubules in a length-dependent manner	NATURE CELL BIOLOGY			English	Article							PLUS-END; PROTEINS; DYNAMICS; MITOSIS; MECHANISMS; MEIOSIS; ROLES	The microtubule cytoskeleton and the mitotic spindle are highly dynamic structures(1), yet their sizes are remarkably constant, thus indicating that the growth and shrinkage of their constituent microtubules are finely balanced(2,3). This balance is achieved, in part, through kinesin-8 proteins (such as Kip3p in budding yeast and KLP67A in Drosophila) that destabilize microtubules(3.-8). Here, we directly demonstrate that Kip3p destabilizes microtubules by depolymerizing them - accounting for the effects of kinesin-8 perturbations on microtubule and spindle length observed in fungi and metazoan cells. Furthermore, using single- molecule microscopy assays(9), we show that Kip3p has several properties that distinguish it from other depolymerizing kinesins, such as the kinesin-13 MCAK(10,11). First, Kip3p disassembles microtubules exclusively at the plus end and second, remarkably, Kip3p depolymerizes longer microtubules faster than shorter ones. These properties are consequences of Kip3p being a highly processive, plus-end-directed motor(12), both in vitro and in vivo. Length- dependent depolymerization provides a new mechanism for controlling the lengths of subcellular structures(13).	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Max Planck Society; University of Dundee	Howard, J (corresponding author), Max Planck Inst Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Tanaka, Tomoyuki U/A-4775-2008; Howard, Jonathon/D-4229-2011; Tanaka, Kozo/Y-6566-2018	Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X; Howard, Jonathon/0000-0003-0086-1196; Varga, Vladimir/0000-0002-0384-1281; Tanaka, Tomoyuki/0000-0002-9886-5947; Tanaka, Kozo/0000-0001-6086-2858	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HOWARD J, 2001, MECH MOTOR PROTEINS, V367; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Kalaidzidis YL, 1997, PROGRAM COMPUT SOFT+, V23, P206; Lawrence CJ, 2002, J MOL EVOL, V54, P42, DOI 10.1007/s00239-001-0016-y; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Marshall WF, 2004, ANNU REV CELL DEV BI, V20, P677, DOI 10.1146/annurev.cellbio.20.012103.094437; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Rischitor PE, 2004, EUKARYOT CELL, V3, P632, DOI 10.1128/EC.3.3.632-645.2004; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Savoian MS, 2004, J CELL SCI, V117, P3669, DOI 10.1242/jcs.01213; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919	31	323	325	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					957	U60		10.1038/ncb1462	http://dx.doi.org/10.1038/ncb1462			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906145				2022-12-27	WOS:000240241700011
J	Ross, JL; Wallace, K; Shuman, H; Goldman, YE; Holzbaur, ELF				Ross, Jennifer L.; Wallace, Karen; Shuman, Henry; Goldman, Yale E.; Holzbaur, Erika L. F.			Processive bidirectional motion of dynein-dynactin complexes in vitro	NATURE CELL BIOLOGY			English	Article							ACTIN-RELATED PROTEIN; MOTOR-NEURON DISEASE; CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; MOLECULAR MOTORS; ATP HYDROLYSIS; MICROTUBULES; KINESIN; INCREASES; BINDING	Cytoplasmic dynein is the primary molecular motor responsible for transport of vesicles, organelles, proteins and RNA cargoes from the periphery of the cell towards the nucleus along the microtubule cytoskeleton of eukaryotic cells. Dynactin, a large multi-subunit activator of dynein, docks cargo to the motor and may enhance dynein processivity. Here, we show that individual fluorescently labelled dynein-dynactin complexes exhibit bidirectional and processive motility towards both the plus and minus ends of microtubules. The dependence of this activity on substrate ATP concentration, nucleotide analogues and inhibitors suggests that bidirectional motility is an active energy-transduction property of dynein-dynactin motor mechano-chemistry. The unique motility characteristics observed may reflect the flexibility of the dynein structure that leads to an enhanced ability to navigate around obstacles in the cell.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu	Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075754] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR-051174] Funding Source: Medline; NIGMS NIH HHS [1F32GM075754-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; EUTENEUER U, 1988, NATURE, V332, P176, DOI 10.1038/332176a0; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P7010, DOI 10.1021/bi00443a034; Ishii Y, 2004, CURR PROTEIN PEPT SC, V5, P81, DOI 10.2174/1389203043486838; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; Nan XL, 2005, J PHYS CHEM B, V109, P24220, DOI 10.1021/jp056360w; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; SHIMIZU T, 1995, BIOCHEMISTRY-US, V34, P1575, DOI 10.1021/bi00005a013; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	40	227	231	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					562	570		10.1038/ncb1421	http://dx.doi.org/10.1038/ncb1421			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16715075				2022-12-27	WOS:000238029000008
J	Reis, A; Chang, HY; Levasseur, M; Jones, KT				Reis, A; Chang, HY; Levasseur, M; Jones, KT			APC(cdh1) activity in mouse oocytes prevents entry into the first meiotic division	NATURE CELL BIOLOGY			English	Article							DEGRADATION; MATURATION; ARREST; EGGS	Fully grown mammalian oocytes maintain a prophase I germinal-vesicle stage arrest in the ovary for extended periods before a luteinizing hormone surge induces entry into the first meiotic division. Cdh1 is an activator of the anaphase-promoting complex (APC) and APC(cdh1) is normally restricted to late M to early G1 phases of the cell cycle. Here, we find that APC(cdh1) is active in mouse oocytes and is necessary to maintain prophase arrest.	Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Jones, KT (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	k.t.jones@newcastle.ac.uk	Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851	Wellcome Trust [075744, 065354] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Madgwick S, 2004, DEV BIOL, V275, P68, DOI 10.1016/j.ydbio.2004.07.024; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	11	123	124	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					539	540		10.1038/ncb1406	http://dx.doi.org/10.1038/ncb1406			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16715549	Green Accepted			2022-12-27	WOS:000237299400019
J	Sirbu, IO; Duester, G				Sirbu, IO; Duester, G			Retinoic-acid signalling in node ectoderm and posterior neural plate directs left-right patterning of somitic mesoderm	NATURE CELL BIOLOGY			English	Article							SEGMENTATION CLOCK; BINDING-PROTEINS; MOUSE; SOMITOGENESIS; TRANSCRIPTION; EXPRESSION; RALDH2; FGF; MORPHOGENESIS; ACTIVATION	Somitogenesis requires bilateral rhythmic segmentation of paraxial mesoderm along the antero-posterior axis(1). The location of somite segmentation depends on opposing signalling gradients of retinoic acid (generated by retinaldehyde dehydrogenase-2; Raldh2) anteriorly and fibroblast growth factor (FGF; generated by Fgf8) posteriorly(2,3). Retinoic-acid-deficient embryos exhibit somite left-right asymmetry(4-6), but it remains unclear how retinoic acid mediates left-right patterning. Here, we demonstrate that retinoic-acid signalling is uniform across the left-right axis and occurs in node ectoderm but not node mesoderm. In Raldh2(-/-) mouse embryos, ectodermal Fgf8 expression encroaches anteriorly into node ectoderm and neural plate, but its expression in presomitic mesoderm is initially unchanged. The late stages of somitogenesis were rescued in Raldh2(-/-) mouse embryos when the maternal diet was supplemented with retinoic acid until only the 6-somite stage, demonstrating that retinoic acid is only needed during node stages. A retinoic-acid-reporter transgene marking the action of maternal retinoic acid in rescued Raldh2(-/-) embryos revealed that the targets of retinoic-acid signalling during somitogenesis are the node ectoderm and the posterior neural plate, not the presomitic mesoderm. Our findings suggest that antagonism of Fgf8 expression by retinoic acid occurs in the ectoderm and that failure of this mechanism generates excessive FGF8 signalling to adjacent mesoderm, resulting initially in smaller somites and then left-right asymmetry.	Burnham Inst Med Res, OncoDev Biol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Duester, G (corresponding author), Burnham Inst Med Res, OncoDev Biol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	duester@burnham.org	Sirbu, Ioan Ovidiu/AAP-1290-2021; Sirbu, Ioan Ovidiu/F-1841-2010	Sirbu, Ioan Ovidiu/0000-0003-1618-9656; Sirbu, Ioan Ovidiu/0000-0003-1618-9656; Duester, Gregg/0000-0003-4335-3650	NIGMS NIH HHS [R01 GM062848, GM62848, R01 GM062848-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kim SH, 1998, DEVELOPMENT, V125, P4681; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; QIU YH, 1994, TRENDS ENDOCRIN MET, V5, P234, DOI 10.1016/1043-2760(94)P3081-H; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488	28	126	132	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					271	277		10.1038/ncb1374	http://dx.doi.org/10.1038/ncb1374			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16489341	Green Accepted			2022-12-27	WOS:000235708000013
J	Luders, J; Patel, UK; Stearns, T				Luders, J; Patel, UK; Stearns, T			GCP-WD is a gamma-tubulin targeting factor required for centrosomal and chromatin-mediated microtubule nucleation	NATURE CELL BIOLOGY			English	Article							SMALL GTPASE RAN; RING COMPLEX; MINUS-END; KINETOCHORE MICROTUBULES; CAENORHABDITIS-ELEGANS; SPINDLE MICROTUBULES; ORGANIZING CENTERS; MITOTIC SPINDLE; CELL-CYCLE; PROTEIN	The gamma-tubulin ring complex (gamma TuRC) is a large multi-protein complex that is required for microtubule nucleation from the centrosome. Here, we show that the GCP-WD protein ( originally named NEDD1) is the orthologue of the Drosophila Dgrip71WD protein, and is a subunit of the human gamma TuRC. GCP- WD has the properties of an attachment factor for the gamma TuRC: depletion or inhibition of GCP-WD results in loss of the gamma TuRC from the centrosome, abolishing centrosomal microtubule nucleation, although the gamma TuRC is intact and able to bind to microtubules. GCP-WD depletion also blocks mitotic chromatin-mediated microtubule nucleation, resulting in failure of spindle assembly. Mitotic phosphorylation of GCP-WD is required for association of gamma-tubulin with the spindle, separately from association with the centrosome. Our results indicate that GCP-WD broadly mediates targeting of the gamma TuRC to sites of microtubule nucleation and to the mitotic spindle, which is essential for spindle formation.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	stearns@stanford.edu	Lüders, Jens/H-2812-2015	Lüders, Jens/0000-0002-9018-7977; Stearns, Tim/0000-0002-0671-6582	NIGMS NIH HHS [GM52022] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Buster D, 2002, J CELL SCI, V115, P1083; CZABAN BB, 1985, J CELL SCI, V79, P1; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; DEBRABANDER M, 1981, CELL MOTIL CYTOSKEL, V1, P469, DOI 10.1002/cm.970010407; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Gunawardane RN, 2003, MOL BIOL CELL, V14, P1017, DOI 10.1091/mbc.E02-01-0034; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Jeng R, 1999, TRENDS CELL BIOL, V9, P339, DOI 10.1016/S0962-8924(99)01621-9; Jorde W, 2001, ALLERGOLOGIE, V24, P596; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KUMAR S, 1994, J BIOL CHEM, V269, P11318; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LI QQ, 1995, J CELL BIOL, V131, P207, DOI 10.1083/jcb.131.1.207; LIU B, 1993, J CELL SCI, V104, P1217; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; TAKAI S, 1995, HUM GENET, V95, P96; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Vaughn KC, 1998, INT REV CYTOL, V181, P75, DOI 10.1016/S0074-7696(08)60417-9; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; WITT PL, 1980, CHROMOSOMA, V81, P483, DOI 10.1007/BF00368158; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	42	247	249	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					137	U10		10.1038/ncb1349	http://dx.doi.org/10.1038/ncb1349			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16378099				2022-12-27	WOS:000235059800008
J	del Pozo, MA; Balasubramanian, N; Alderson, NB; Kiosses, WB; Grande-Garcia, A; Anderson, RGW; Schwartz, MA				del Pozo, MA; Balasubramanian, N; Alderson, NB; Kiosses, WB; Grande-Garcia, A; Anderson, RGW; Schwartz, MA			Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization	NATURE CELL BIOLOGY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; CAVEOLIN-1-NULL MICE; BREAST-CANCER; IN-VIVO; CELLS; RAC; PHOSPHORYLATION; INVASIVENESS; TRAFFICKING; HYPERPLASIA	Growth of normal cells is anchorage dependent because signalling through multiple pathways including Erk, phosphatidylinositol- 3- OH kinase ( PI( 3) K) and Rac requires integrin- mediated cell adhesion(1). Components of these pathways localize to low- density, cholesterol- rich domains in the plasma membrane named ' lipid rafts'(2,3) or 'cholesterol-enriched membrane microdomains' ( CEMM)(4). We previously reported that integrin- mediated adhesion regulates CEMM transport such that cell detachment from the extracellular matrix triggers CEMM internalization and clearance from the plasma membrane(5). We now report that this internalization is mediated by dynamin- 2 and caveolin- 1. Internalization requires phosphorylation of caveolin- 1 on Tyr 14. A shift in localization of phospho- caveolin- 1 from focal adhesions to caveolae induces CEMM internalization upon cell detachment, which mediates inhibition of Erk, PI( 3) K and Rac. These data define a novel molecular mechanism for growth and tumour suppression by caveolin- 1.	CNIC, Madrid 28029, Spain; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Microbiol & Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Scripps Res Inst, Microscopy Facil, La Jolla, CA 92037 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Virginia; University of Virginia; Scripps Research Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	del Pozo, MA (corresponding author), CNIC, Madrid 28029, Spain.	madelpozo@cnic.es	Grande-García, Araceli/ABH-3169-2020; del Pozo, Miguel Angel/L-2861-2014	Grande-García, Araceli/0000-0003-2619-5013; del Pozo, Miguel Angel/0000-0001-9077-391X; Balasubramanian, Nagaraj/0000-0002-8219-8844; schwartz, martin/0000-0002-2071-1243	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM47214, R01 GM047214] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Boyd ND, 2003, BIOCHEM CELL BIOL, V81, P335, DOI 10.1139/O03-063; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Fielding CJ, 2001, ADV DRUG DELIVER REV, V49, P251, DOI 10.1016/S0169-409X(01)00140-5; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Grande-Garcia A, 2005, BIOCHEM SOC T, V33, P609, DOI 10.1042/BST0330609; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Razani B, 2001, J BIOL CHEM, V276, P38121; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200	30	327	332	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					901	U57		10.1038/ncb1293	http://dx.doi.org/10.1038/ncb1293			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16113676	Green Accepted			2022-12-27	WOS:000231601600014
J	Sen, GL; Blau, HM				Sen, GL; Blau, HM			Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies	NATURE CELL BIOLOGY			English	Article							INTERFERENCE; MICRORNA; CLEAVAGE	RNA interference (RNAi) is an important means of eliminating mRNAs, but the intracellular location of RNA-induced silencing complex (RISC) remains unknown. We show here that Argonaute 2, a key component of RISC, is not randomly distributed but concentrates in mRNA decay centres that are known as cytoplasmic bodies. The localization of Argonaute 2 in decay centres is not altered by the presence or absence of small interfering RNAs or their targeted mRNAs. However, RNA is required for the integrity of cytoplasmic bodies because RNase eliminates Argonaute 2 localization. In addition, Argonaute 1, another Argonaute family member, is concentrated in cytoplasmic bodies. These results provide new insight into the mechanism of RNAi function.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 Campus Dr,CCSR 4225A, Stanford, CA 94305 USA.	hblau@stanford.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL65572] Funding Source: Medline; NIA NIH HHS [AG09521, AG20961] Funding Source: Medline; NICHD NIH HHS [HD18179] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	18	471	502	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					633	U28		10.1038/ncb1265	http://dx.doi.org/10.1038/ncb1265			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15908945				2022-12-27	WOS:000229562100018
J	Maroto, R; Raso, A; Wood, TG; Kurosky, A; Martinac, B; Hamill, OP				Maroto, R; Raso, A; Wood, TG; Kurosky, A; Martinac, B; Hamill, OP			TRPC1 forms the stretch-activated cation channel in vertebrate cells	NATURE CELL BIOLOGY			English	Article							XENOPUS-LAEVIS OOCYTES; MECHANOSENSITIVE CHANNELS; FUNCTIONAL EXPRESSION; HUMAN HOMOLOG; ION CHANNELS; LIVING CELLS; CALCIUM; MEMBRANE; PROTEINS; CLONING	The mechanosensitive cation channel (MscCa) transduces membrane stretch into cation (Na+, K+, Ca2+ and Mg2+) flux across the cell membrane, and is implicated in cell-volume regulation(1), cell locomotion(2), muscle dystrophy(3) and cardiac arrhythmias(4). However, the membrane protein(s) that form the MscCa in vertebrates remain unknown. Here, we use an identification strategy that is based on detergent solubilization of frog oocyte membrane proteins, followed by liposome reconstitution and evaluation by patch-clamp(5). The oocyte was chosen because it expresses the prototypical MscCa (greater than or equal to 10(7) MscCa/oocyte)(6) that is preserved in cytoskeleton-deficient membrane vesicles(7). We identified a membrane-protein fraction that reconstituted high MscCa activity and showed an abundance of a protein that had a relative molecular mass of 80,000 (M-r 80K). This protein was identified, by immunological techniques, as the canonical transient receptor potential channel 1 (TRPC1)(8-10). Heterologous expression of the human TRPC1 resulted in a > 1,000% increase in MscCa patch density, whereas injection of a TRPC1-specific antisense RNA abolished endogenous MscCa activity. Transfection of human TRPC1 into CHO-K1 cells also significantly increased MscCa expression. These observations indicate that TRPC1 is a component of the vertebrate MscCa, which is gated by tension developed in the lipid bilayer, as is the case in various prokaryotic mechanosensitive (Ms) channels(11).	Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Western Australia; University of Texas System; University of Texas Medical Branch Galveston	Hamill, OP (corresponding author), Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	ohamill@utmb.edu	Wood, Thomas/B-6172-2012; Wood, Thomas/GWZ-2481-2022; Martinac, Boris/A-7178-2018	Wood, Thomas/0000-0001-8962-8571; Martinac, Boris/0000-0001-8422-7082				Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Brereton HM, 2001, BBA-MOL CELL RES, V1540, P107, DOI 10.1016/S0167-4889(01)00124-0; CHRISTENSEN O, 1987, NATURE, V330, P66, DOI 10.1038/330066a0; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Martinac B, 2003, PROG BIOPHYS MOL BIO, V82, P11, DOI 10.1016/S0079-6107(03)00002-6; MCBRIDE DW, 1992, PFLUG ARCH EUR J PHY, V421, P606, DOI 10.1007/BF00375058; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; OBREGONFRANCO A, 2002, J PHYSL, V539, P391; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Sinkins WG, 1998, BIOCHEM J, V331, P331, DOI 10.1042/bj3310331; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; TAGLIETTI V, 1988, J PHYSIOL-LONDON, V407, P311, DOI 10.1113/jphysiol.1988.sp017417; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; WALL DA, 1989, J MEMBRANE BIOL, V107, P189, DOI 10.1007/BF01871724; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wilkinson NC, 1998, J MEMBRANE BIOL, V165, P161, DOI 10.1007/s002329900430; Wu G, 1998, PFLUG ARCH EUR J PHY, V435, P572, DOI 10.1007/s004240050554; YANG XC, 1990, J PHYSIOL-LONDON, V431, P103, DOI 10.1113/jphysiol.1990.sp018322; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P83, DOI 10.1111/j.1469-7793.2000.t01-2-00083.x; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	30	475	520	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					179	U99		10.1038/ncb1218	http://dx.doi.org/10.1038/ncb1218			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15665854				2022-12-27	WOS:000226719500015
J	Balasubramanian, N; Scott, DW; Castle, JD; Casanova, JE; Schwartz, MA				Balasubramanian, Nagaraj; Scott, David W.; Castle, J. David; Casanova, James E.; Schwartz, Martin Alexander			Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CELL-MIGRATION; DOWNSTREAM ACTIVATION; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; ENDOGENOUS ARF6; RHO-GTPASES; RAC; INTERNALIZATION; MACROPHAGES	Integrin-mediated adhesion regulates membrane binding sites for Rac1 within lipid rafts. Detachment of cells from the substratum triggers the clearance of rafts from the plasma membrane through caveolin-dependent internalization. The small GTPase Arf6 and microtubules also regulate Rac-dependent cell spreading and migration, but the mechanisms are poorly understood. Here we show that endocytosis of rafts after detachment requires F-actin, followed by microtubule-dependent trafficking to recycling endosomes. When cells are replated on fibronectin, rafts exit from recycling endosomes in an Arf6-dependent manner and return to the plasma membrane along microtubules. Both of these steps are required for the plasma membrane targeting of Rac1 and for its activation. These data therefore define a new membrane raft trafficking pathway that is crucial for anchorage-dependent signalling.	Univ Virginia, Mellon Prostate Canc Res Inst, Robert M Beirne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Mellon Prostate Canc Res Inst, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Mellon Prostate Canc Res Inst, Robert M Beirne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu		Balasubramanian, Nagaraj/0000-0002-8219-8844; schwartz, martin/0000-0002-2071-1243	NIGMS NIH HHS [R01 GM047214, R01 GM047214-17, R01 GM47214] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; CHEUNG HT, 1980, CELL BIOL INT REP, V4, P1125, DOI 10.1016/0309-1651(80)90050-8; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DDOUZASCHOREY C, 2006, NATURE REV MOL CELL, V7, P347; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Golub T, 2005, BIOCHEM SOC SYMP, V72, P119, DOI 10.1042/bss0720119; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rosania GR, 1996, CELL MOTIL CYTOSKEL, V34, P230, DOI 10.1002/(SICI)1097-0169(1996)34:3<230::AID-CM6>3.0.CO;2-D; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song J, 1998, J CELL SCI, V111, P2257; Torgersen ML, 2001, J CELL SCI, V114, P3737; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	49	156	158	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1381	U73		10.1038/ncb1657	http://dx.doi.org/10.1038/ncb1657			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026091	Green Accepted			2022-12-27	WOS:000251317300011
J	Petersen, J; Nurse, P				Petersen, Janni; Nurse, Paul			TOR signalling regulates mitotic commitment through the stress MAP kinase pathway and the Polo and Cdc2 kinases	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE CONTROL; FISSION YEAST; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; ACTIVATED KINASE; RAPAMYCIN TOR; EIF2 KINASES; GROWTH; GENE; DIVISION	The coupling of growth to cell cycle progression allows eukaryotic cells to divide at particular sizes depending on nutrient availability. In fission yeast, this coupling involves the Spc1/Sty1 mitogen-activated protein kinase ( MAPK) pathway working through Polo kinase recruitment to the spindle pole bodies ( SPBs). Here we report that changes in nutrients influence TOR signalling, which modulates Spc1/Sty1 activity. Rapamycin-induced inhibition of TOR signalling advanced mitotic onset, mimicking the reduction in cell size at division seen after shifts to poor nitrogen sources. Gcn2, an effector of TOR signalling and modulator of translation, regulates the Pyp2 phosphatase that in turn modulates Spc1/Sty1 activity. Rapamycin-or nutrient-induced stimulation of Spc1/Sty1 activity promotes Polo kinase SPB recruitment and Cdc2 activation to advance mitotic onset. This advanced mitotic onset is abolished in cells depleted of Gcn2, Pyp2, or Spc1/Sty1 or on blockage of Spc1/Sty1-dependent Polo SPB recruitment. Therefore, TOR signalling modulates mitotic onset through the stress MAPK pathway via the Pyp2 phosphatase.	Rockefeller Univ, New York, NY 10021 USA; Univ Manchester, Manchester M13 9PT, Lancs, England	Rockefeller University; University of Manchester	Petersen, J (corresponding author), Rockefeller Univ, Box 5,1230 York Ave, New York, NY 10021 USA.	Janni.Petersen@manchester.ac.uk		Petersen, Janni/0000-0003-0729-9335				Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BOOHER R, 1987, EMBO J, V6, P3441, DOI 10.1002/j.1460-2075.1987.tb02667.x; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; DAVEY J, 1994, CURR GENET, V26, P105, DOI 10.1007/BF00313796; Degols G, 1996, MOL CELL BIOL, V16, P2870; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kawai M, 2001, CURR GENET, V39, P166; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacIver FH, 2003, GENE DEV, V17, P1507, DOI 10.1101/gad.256003; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pardo M, 2005, J CELL SCI, V118, P1705, DOI 10.1242/jcs.02305; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petersen J, 2001, J CELL SCI, V114, P4371; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Toone WM, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P57; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443	52	142	142	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1263	U97		10.1038/ncb1646	http://dx.doi.org/10.1038/ncb1646			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952063				2022-12-27	WOS:000250659600012
J	van der Laan, M; Meinecke, M; Dudek, J; Hutu, DP; Lind, M; Perschil, I; Guiard, B; Wagner, R; Pfanner, N; Rehling, P				van der Laan, Martin; Meinecke, Michael; Dudek, Jan; Hutu, Dana P.; Lind, Maria; Perschil, Inge; Guiard, Bernard; Wagner, Richard; Pfanner, Nikolaus; Rehling, Peter			Motor-free mitochondrial presequence translocase drives membrane integration of preproteins	NATURE CELL BIOLOGY			English	Article							PROTEIN IMPORT CHANNEL; CONTACT SITES; INTERMEMBRANE SPACE; PRECURSOR PROTEINS; OUTER-MEMBRANE; TIM21; IDENTIFICATION; COMPLEX; ABSENCE; MATRIX	The mitochondrial inner membrane is the central energy-converting membrane of eukaryotic cells. the electrochemical proton gradient generated by the respiratory chain drives the ATP synthase. to maintain this proton-motive force, the inner membrane forms a tight barrier and strictly controls the translocation of ions(1). However, the major preprotein transport machinery of the inner membrane, termed the presequence translocase, translocates polypeptide chains into or across the membrane(2-9). Different views exist of the molecular mechanism of the translocase, in particular of the coupling with the import motor of the matrix(8,10,11). Wehave reconstituted preprotein transport into the mitochondrial inner membrane by incorporating the purified presequence translocase into cardiolipin-containing liposomes. We show that the motor-free form of the presequence translocase integrates preproteins into the membrane. the reconstituted presequence translocase responds to targeting peptides and mediates voltage-driven preprotein translocation, lateral release and insertion into the lipid phase. thus, the minimal system for preprotein integration into the mitochondrial inner membrane is the presequence translocase, a cardiolipin-rich membrane and a membrane potential.	Univ Freiburg, Inst Biochem & Molekularbiol, Zent Biochem & Mol Zellforschung, D-79104 Freiburg, Germany; Univ Osnabruck, D-49034 Osnabruck, Germany; Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; Uppsala Univ, Evolut Biol Ctr, Dept Comparat Physiol, S-75236 Uppsala, Sweden; CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University Osnabruck; University of Freiburg; Uppsala University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Molekularbiol, Zent Biochem & Mol Zellforschung, Hermann-Herder Str 7, D-79104 Freiburg, Germany.	wagner@uos.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; van der Laan, Martin/0000-0003-0789-9912				Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; PFANNER N, 1987, EUR J BIOCHEM, V169, P289, DOI 10.1111/j.1432-1033.1987.tb13610.x; Rapaport D, 2001, MOL BIOL CELL, V12, P1189, DOI 10.1091/mbc.12.5.1189; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; ZWIZINSKI C, 1983, J BIOL CHEM, V258, P3340	30	138	137	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1152	1159		10.1038/ncb1635	http://dx.doi.org/10.1038/ncb1635			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828250				2022-12-27	WOS:000249882300010
J	St John, J; Lovell-Badge, R				St John, Justin; Lovell-Badge, Robin			Human-animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate	NATURE CELL BIOLOGY			English	Article							NUCLEAR TRANSFER; GENE-EXPRESSION; STEM-CELLS; DNA-REPLICATION; MOUSE; OOCYTES; MTDNA; FIBROBLASTS; TRANSPLANTATION; TRANSCRIPTION	Scientists are seeking permission to generate human embryonic stem cells to study disease by introducing human genetic material into an animal oocyte. this has raised ethical questions that centre on whether the entities being generated are actually human. the answer to these questions will determine how this area of research will be regulated and whether such work will be legal. the function of the extra-nuclear mitochondrial genome lies at the heart of these issues and forms the focus of this commentary.	Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; Univ Warwick, Warwick Med Sch, Reprod Genet Grp, Coventry CV2 2DX, W Midlands, England	MRC National Institute for Medical Research; University of Warwick	St John, J (corresponding author), Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, Ridgeway Mill Hill, London NW7 1AA, England.	j.c.st-john@warwick.ac.uk; rlovell@nimr.mrc.ac.uk	St. John, Justin C/A-2942-2010	St. John, Jus/0000-0002-3993-1449; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; Bowles EJ, 2007, GENETICS, V176, P1511, DOI 10.1534/genetics.106.070177; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Chang KH, 2003, FERTIL STERIL, V80, P1380, DOI 10.1016/j.fertnstert.2003.07.006; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; *DEP HLTH COMM, 2006, 698 DEP HLTH COMM; *EDIT, 2007, NATURE, V447, P353; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Holden C, 2005, SCIENCE, V310, P1402, DOI 10.1126/science.310.5753.1402; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; JOHN JC, 2004, REPRODUCTION, V127, P631; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; Moyes CD, 1998, J EXP BIOL, V201, P299; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pacheco-Trigon S, 2002, BIOL REPROD, V67, P1907, DOI 10.1095/biolreprod67.6.1907; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; SPOLSKY CM, 1972, FEBS LETT, V25, P319, DOI 10.1016/0014-5793(72)80514-3; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Blerkom J, 2000, HUM REPROD, V15, P2621, DOI 10.1093/humrep/15.12.2621; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 2005, SCIENCE, V310, P1903; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang CX, 2003, MOL REPROD DEV, V65, P396, DOI 10.1002/mrd.10320	45	18	18	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					988	992		10.1038/ncb436	http://dx.doi.org/10.1038/ncb436			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762888				2022-12-27	WOS:000249256500002
J	Iioka, H; Iemura, S; Natsume, T; Kinoshita, N				Iioka, Hidekazu; Iemura, Shun-ichiro; Natsume, Tohru; Kinoshita, Noriyuki			Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility	NATURE CELL BIOLOGY			English	Article							RING FINGER PROTEIN; CONVERGENT EXTENSION; GASTRULATION MOVEMENTS; ACTIN DYNAMICS; FOCAL ADHESION; PROTEASOME; POLARITY; XWNT11; TALIN; PKC	Gastrulation movements are critical for establishing the three germ layers and the architecture of vertebrate embryos. During Xenopus laevis gastrulation, mesodermal tissue migrates on the blastocoel roof and elongates along the antero-posterior axis(1),(2). During this process, cells in the dorsal mesoderm are polarized and intercalate with each other, which is defined as convergent extension and is known to be regulated by the non-canonical Wnt pathway(3-5). Here, we show that paxillin plays an essential role in this process. Paxillin is a focal-adhesion associated protein implicated in the regulation of actin cytoskeletal organization and cell motility(6),7, but its role in Xenopus embryogenesis has not yet been clarified. We demonstrate that the Wnt pathway controls the ubiquitination and stability of paxillin, and that this regulatory mechanism is essential for convergent extension movements. We identified a RING finger protein XRNF185, which physically binds to paxillin and the proteasome. XRNF185 destabilizes paxillin at focal adhesions and promotes mesodermal cell migration during convergent extension. We propose a mechanism to regulate gastrulation movements that involves paxillin ubiquitination and stability controlled by Wnt signalling.	Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan; Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; Biol Informat Res Ctr, Tokyo 1350064, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institute of Advanced Industrial Science & Technology (AIST); Graduate University for Advanced Studies - Japan	Kinoshita, N (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 4448585, Japan.	nkinoshi@nibb.ac.jp	Iioka, Hidekazu/AAB-1424-2021; Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Kinoshita, Noriyuki/0000-0002-1362-4045; Iioka, Hidekazu/0000-0002-2639-8315				Broday L, 2004, J CELL BIOL, V165, P857, DOI 10.1083/jcb.200401133; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; Li M, 2004, DEV BIOL, V275, P202, DOI 10.1016/j.ydbio.2004.08.005; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Tada M, 2000, DEVELOPMENT, V127, P2227; TOKUMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P1106, DOI 10.1006/bbrc.1993.1531; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	32	47	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					813	U150		10.1038/ncb1607	http://dx.doi.org/10.1038/ncb1607			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558393				2022-12-27	WOS:000247760700017
J	Buffin, E; Emre, D; Karess, RE				Buffin, Eulalie; Emre, Doruk; Karess, Roger E.			Flies without a spindle checkpoint	NATURE CELL BIOLOGY			English	Article							MITOTIC CHECKPOINT; CHROMOSOME MISSEGREGATION; ROUGH DEAL; CYCLIN-B; DROSOPHILA; MAD2; MITOSIS; CDC20; KINETOCHORE; REVEALS	Mad2 has a key role in the spindle- assembly checkpoint (SAC) - the mechanism delaying anaphase onset until all chromosomes correctly attach to the spindle. Here, we show that unlike every other reported case of SAC inactivation in metazoans, mad2-null Drosophila are viable and fertile, and their cells almost always divide correctly despite having no SAC and an accelerated 'clock', which is caused by premature degradation of cyclin B. Mitosis in Drosophila does not need the SAC because correct chromosome attachment is achieved very rapidly, before even the cell lacking Mad2 can initiate anaphase. Experimentally reducing spindle-assembly efficiency renders the cells Mad2-dependent. In fact, the robustness of the SAC may generally mask minor mitotic defects of mutations affecting spindle function. The reported lethality of other Drosophila SAC mutations may be explained by their multifunctionality, and thus the 'checkpoint' phenotypes previously ascribed to these mutations should be considered the consequence of eliminating both the checkpoint and a second mitotic function.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Karess, RE (corresponding author), CNRS, Ctr Genet Mol, Ave Terrasse, F-91198 Gif Sur Yvette, France.	karess@cgm.cnrs-gif.fr		Karess, Roger/0000-0002-7299-0600; Buffin, Eulalie/0000-0002-0471-7258				Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; KARESS RE, 1989, J CELL BIOL, V109, P2951, DOI 10.1083/jcb.109.6.2951; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Lopes CS, 2005, J CELL SCI, V118, P187, DOI 10.1242/jcs.01602; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Savoian MS, 2002, J CELL SCI, V115, P3061; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759	32	97	99	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					565	U150		10.1038/ncb1570	http://dx.doi.org/10.1038/ncb1570			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417628				2022-12-27	WOS:000246181500015
J	Even-Ram, S; Doyle, AD; Conti, MA; Matsumoto, K; Adelstein, RS; Yamada, KM				Even-Ram, Sharona; Doyle, Andrew D.; Conti, Mary Anne; Matsumoto, Kazue; Adelstein, Robert S.; Yamada, Kenneth M.			Myosin IIA regulates cell motility and actomyosin microtubule crosstalk	NATURE CELL BIOLOGY			English	Article							MITOTIC KINESIN EG5; MIGRATING CELLS; INHIBITORS; DYNAMICS; ADHESION; RAC; CONTRACTILITY; TRANSLOCATION; ORGANIZATION; CYTOSKELETON	Non-muscle myosin II has diverse functions in cell contractility, cytokinesis and locomotion, but the specific contributions of its different isoforms have yet to be clarified. Here, we report that ablation of the myosin IIA isoform results in pronounced defects in cellular contractility, focal adhesions, actin stress fibre organization and tail retraction. Nevertheless, myosin IIA-deficient cells display substantially increased cell migration and exaggerated membrane ruffling, which was dependent on the small G-protein Rac1, its activator Tiam1 and the microtubule moter kinesin Eg5. Myosin IIA deficiency stabilized microtubules, shifting the balance between actomyosin and microtubules with increased microtubules in active membrane ruffles. When microtubule polymerization was suppressed, myosin IIB could partially compensate for the absence of the IIA isoform in cellular contractility, but not in cell migration. We conclude that myosin IIA negatively regulates cell migration and suggest that it maintains a balance between the actomyosin and microtubule systems by regulating microtubule dynamics.	NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yamada, KM (corresponding author), NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.	ky4w@nih.gov		Yamada, Kenneth/0000-0003-1512-6805; Even-Ram, Sharona/0000-0002-5540-3822; Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004218, ZIAHL004218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; CONLEY BJ, 2005, CURR PROTOCOLS CELL, V23, P22; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; GORDON SR, 1990, CELL MOTIL CYTOSKEL, V16, P47, DOI 10.1002/cm.970160107; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; HONER B, 1988, J CELL BIOL, V107, P2181, DOI 10.1083/jcb.107.6.2181; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kaverina I, 2002, J CELL SCI, V115, P2283; Koivisto L, 2004, EXP CELL RES, V293, P68, DOI 10.1016/j.yexcr.2003.09.026; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; Thompson RF, 2002, ANAT RECORD, V268, P276, DOI 10.1002/ar.10160; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; WATERMANSTORER CM, 1995, J CELL BIOL, V130, P1161, DOI 10.1083/jcb.130.5.1161; WELCH MP, 1990, J CELL BIOL, V110, P133, DOI 10.1083/jcb.110.1.133; Yoon SY, 2005, CELL MOTIL CYTOSKEL, V60, P181, DOI 10.1002/cm.20057	37	380	388	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					299	U104		10.1038/ncb1540	http://dx.doi.org/10.1038/ncb1540			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310241				2022-12-27	WOS:000244558600014
J	Publicover, S; Harper, CV; Barratt, C				Publicover, Stephen; Harper, Claire V.; Barratt, Christopher			[Ca2+](i) signalling in sperm - making the most of what you've got	NATURE CELL BIOLOGY			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTOR; SECRETORY PATHWAY CA2+-ATPASE; MEMBRANE PROGESTIN RECEPTOR; ACROSOME REACTION; INTRACELLULAR CALCIUM; HUMAN SPERMATOZOA; MOUSE SPERM; ZONA-PELLUCIDA; BINDING CHARACTERISTICS; OLFACTORY RECEPTOR	Thanks to a worrying decrease in male fertility, understanding how sperm ;'work' is a matter both of interest and great importance. Sperm of all animals detect various environmental cues. The 'behavioural' and physiological responses of sperm must be specific, appropriate and correctly timed. Strangely, in a cell with few organelles and minimal cytoplasmic volume, internal Ca2+ concentration, [Ca2+](i), regulates almost all these activities. How does such a simple cell achieve this - and is it as simple as it seems?.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, Ctr Human Reprod Sci, Birmingham B15 2TG, W Midlands, England; Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Birmingham, Sch Med, Reprod Biol & Genet Res Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham; Birmingham Women's Hospital; University of Liverpool; University of Birmingham	Publicover, S (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	s.j.publicover@bham.ac.uk	Publicover, Steve J/E-7970-2018	Barratt, christopher/0000-0003-0062-9979; harper, claire/0000-0001-6228-4078	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ainsworth C, 2005, NATURE, V436, P770, DOI 10.1038/436770a; ANDERSEN AN, 2005, HUM REPROD, V15, P366; Baker MA, 2005, PROTEOMICS, V5, P1003, DOI 10.1002/pmic.200401100; Barratt CLR, 2001, LANCET, V358, P1660, DOI 10.1016/S0140-6736(01)06727-7; Bedu-Addo K, 2007, DEV BIOL, V302, P324, DOI 10.1016/j.ydbio.2006.09.040; Bohmer M, 2005, EMBO J, V24, P2741, DOI 10.1038/sj.emboj.7600744; Bray C, 2005, MOL HUM REPROD, V11, P881, DOI 10.1093/molehr/gah245; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; CONNER SJ, 2007, REPRODUCTION, V63, P237; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; DOMINO SE, 1988, J BIOL CHEM, V263, P690; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Forti G, 1999, ANN ENDOCRINOL-PARIS, V60, P107; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gonzalez-Martinez MT, 2001, DEV BIOL, V236, P220, DOI 10.1006/dbio.2001.0323; Gunaratne HJ, 2006, FEBS LETT, V580, P3900, DOI 10.1016/j.febslet.2006.06.019; Gunaratne HJ, 2006, J CELL PHYSIOL, V207, P413, DOI 10.1002/jcp.20575; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Hirohashi N, 2003, BIOCHEM BIOPH RES CO, V304, P285, DOI 10.1016/S0006-291X(03)00587-4; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Holden CA, 2005, HUM REPROD, V20, P3429, DOI 10.1093/humrep/dei307; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Jaiswal BS, 1999, BIOL REPROD, V60, P1314, DOI 10.1095/biolreprod60.6.1314; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Johnston DS, 2005, ANN NY ACAD SCI, V1061, P190, DOI 10.1196/annals.1336.021; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kampa M, 2006, MOL CELL ENDOCRINOL, V246, P76, DOI 10.1016/j.mce.2005.11.018; Kaupp UB, 2006, J CELL PHYSIOL, V208, P487, DOI 10.1002/jcp.20669; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; Kuroda Y, 1999, LIFE SCI, V65, P135, DOI 10.1016/S0024-3205(99)00230-1; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liu DY, 2003, FERTIL STERIL, V79, P74, DOI 10.1016/S0015-0282(02)04555-7; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; MARQUEZ B, 2006, DEV BIOL, DOI DOI 10.1016/J.YDBIO.006.11; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meizel S, 2004, BIOL REV, V79, P713, DOI 10.1017/S1464793103006407; Minelli A, 2000, MOL REPROD DEV, V56, P527, DOI 10.1002/1098-2795(200008)56:4&lt;527::AID-MRD11&gt;3.0.CO;2-R; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Naaby-Hansen S, 2001, MOL HUM REPROD, V7, P923, DOI 10.1093/molehr/7.10.923; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Nipper RW, 2006, BIOL REPROD, V75, P189, DOI 10.1095/biolreprod.106.050963; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Patrat C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-59; Pixton KL, 2004, HUM REPROD, V19, P1438, DOI 10.1093/humrep/deh224; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Sharpe RM, 2004, BMJ-BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447; Sitruk-Ware R, 2006, HUM REPROD UPDATE, V12, P169, DOI 10.1093/humupd/dmi046; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strauss JF, 2004, NATURE, V432, P43, DOI 10.1038/432043a; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; SUAREZ SS, 1995, MOL REPROD DEV, V42, P325, DOI 10.1002/mrd.1080420310; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Thomas P, 2005, STEROIDS, V70, P427, DOI 10.1016/j.steroids.2005.02.010; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Wood CD, 2003, J CELL BIOL, V161, P89, DOI 10.1083/jcb.200212053; YAMAGIMACHI R, 1994, PHYSL REPROD; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	87	214	224	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					235	242		10.1038/ncb0307-235	http://dx.doi.org/10.1038/ncb0307-235			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17330112				2022-12-27	WOS:000244558600003
J	Kang, TH; Kim, KT				Kang, Tae-Hong; Kim, Kyong-Tai			Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; VACCINIA-RELATED KINASE-1; MAP KINASE; CATALYTIC ACTIVATION; NEURITE OUTGROWTH; GENE FAMILY; IN-VIVO; PHOSPHORYLATION; BINDING; JNK	Extracellular signal regulated kinases ( ERKs) represent a signalling hub in many physiological responses and have pivotal functions in cell proliferation, differentiation, development and death, as well as in synaptic plasticity(1,2). Mitogen-activated protein kinase phosphatases ( MKPs) selectively inactivate ERKs by dephosphorylating critical phosphothreonine and phosphotyrosine residues(3,4). Transcriptional induction of MKP expression(5,6) and posttranscriptional stabilization of MKP mRNA7 are well-documented as negative-feedback mechanisms for ERK signalling. Vaccinia-related kinase 3 ( VRK3) is a member of the novel VRK family(8,9), but its function has not been defined. Here, we show that VRK3 suppresses ERK activity through direct binding to one of the MKPs, vaccinia H1-related ( VHR)(10), which specifically dephosphorylates and inactivates ERK in the nucleus(11). Notably, VRK3 enhances the phosphatase activity of VHR by a mechanism independent of its kinase activity. VRK3 is therefore a member of a new class of phosphatase-activating kinases that regulate the activity of ERK. Our findings show that direct interaction of VHR with VRK3 posttranslationally regulates ERK signalling.	Pohang Univ Sci & Technol, Dept Life Sci, Biotechnol Res Ctr, Div Mol & Life Sci, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Biotechnol Res Ctr, Div Mol & Life Sci, San 31,Hyoja Dong, Pohang 790784, South Korea.	ktk@postech.ac.kr	Kang, Tae-Hong/Y-8294-2019	Kang, Tae-Hong/0000-0002-6013-900X; KIM, KYONG-TAI/0000-0001-7292-2627				Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Gwag BJ, 1998, MOL BRAIN RES, V63, P53, DOI 10.1016/S0169-328X(98)00251-4; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Olsson AK, 2001, EXP CELL RES, V265, P21, DOI 10.1006/excr.2001.5163; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Sugiura R, 2003, NATURE, V424, P961, DOI 10.1038/nature01907; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Volmat V, 2001, J CELL SCI, V114, P3433; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	30	64	68	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					863	U126		10.1038/ncb1447	http://dx.doi.org/10.1038/ncb1447			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16845380				2022-12-27	WOS:000239423000017
J	Guccione, E; Martinato, F; Finocchiaro, G; Luzi, L; Tizzoni, L; Dall'Olio, V; Zardo, G; Nervi, C; Bernard, L; Amati, B				Guccione, Ernesto; Martinato, Francesca; Finocchiaro, Giacomo; Luzi, Lucilla; Tizzoni, Laura; Dall'Olio, Valentina; Zardo, Giuseppe; Nervi, Clara; Bernard, Loris; Amati, Bruno			Myc-binding-site recognition in the human genome is determined by chromatin context	NATURE CELL BIOLOGY			English	Article							HISTONE MODIFICATIONS; C-MYC; ACTIVE GENES; METHYLATION; ACETYLATION; H3; PATTERNS; PROMOTER; NETWORK; PROTEIN	Large-scale chromatin immunoprecipitation ( ChIP) studies have been effective in unravelling the distribution of DNA-binding transcription factors along eukaryotic genomes(1), but specificity determinants remain elusive. Gene-regulatory regions display distinct histone variants and modifications ( or marks)(2-15). An attractive hypothesis is that these marks modulate protein recognition(16-18), but whether or not this applies to transcription factors remains unknown. Based on large-scale datasets(2,19-21) and quantitative ChIP, we dissect the correlations between 35 histone marks and genomic binding by the transcription factor Myc. Our data reveal a relatively simple combinatorial organization of histone marks in human cells, with a few main groups of marks clustering on distinct promoter populations. A stretch of chromatin bearing high H3 K4/K79 methylation and H3 acetylation ( or 'euchromatic island'), which is generally associated with a pre-engaged basal transcription machinery(12,13), is a strict prerequisite for recognition of any target site by Myc ( whether the consensus CACGTG or an alternative sequence)(22). These data imply that tethering of a transcription factor to restricted chromatin domains is rate-limiting for sequence-specific DNA binding in vivo.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; IFOM, FIRC, Inst Mol Oncol, I-20139 Milan, Italy; Real Time PCR Facil, I-20139 Milan, Italy; Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00128 Rome, Italy; San Raffaele BioMed Pk Fdn, I-00128 Rome, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; Sapienza University Rome; Sapienza University Rome	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM-IEO Campus, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Luzi, Lucilla/K-4350-2018; guccione, ernesto/G-9874-2011; Amati, Bruno/AAM-3418-2020	Luzi, Lucilla/0000-0002-8746-4179; Amati, Bruno/0000-0002-2958-1799; NERVI, Clara/0000-0001-9341-0188				Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705	31	295	298	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					764	U225		10.1038/ncb1434	http://dx.doi.org/10.1038/ncb1434			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767079				2022-12-27	WOS:000238837800020
J	Shinin, V; Gayraud-Morel, B; Gomes, D; Tajbakhsh, S				Shinin, Vasily; Gayraud-Morel, Barbara; Gomes, Danielle; Tajbakhsh, Shahragim			Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; SKELETAL-MUSCLE; NEUROEPITHELIAL CELLS; PROGENITOR CELLS; BONE-MARROW; NUMB; DROSOPHILA; SEGREGATION; FATE; SPECIFICATION	Satellite cells assure postnatal skeletal muscle growth and repair. Despite extensive studies, their stem cell character remains largely undefined. Using pulse-chase labelling with BrdU to mark the putative stem cell niche, we identify a subpopulation of label-retaining satellite cells during growth and after injury. Strikingly, some of these cells display selective template-DNA strand segregation during mitosis in the muscle fibre in vivo, as well as in culture independent of their niche, indicating that genomic DNA strands are nonequivalent. Furthermore, we demonstrate that the asymmetric cell-fate determinant Numb segregates selectively to one daughter cell during mitosis and before differentiation, suggesting that Numb is associated with self-renewal. Finally, we show that template DNA cosegregates with Numb in label-retaining cells that express the self-renewal marker Pax7. The cosegregation of 'immortal' template DNA strands and their link with the asymmetry apparatus has important implications for stem cell biology and cancer.	Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tajbakhsh, S (corresponding author), Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, 25 Rue Dr Roux, F-75724 Paris 15, France.	shaht@pasteur.fr		Shinin, Vasily/0000-0002-4285-6515				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; BISCHOFF R, 1970, J CELL BIOL, V44, P134, DOI 10.1083/jcb.44.1.134; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; KUROKI T, 1989, JPN J CANCER RES, V80, P637, DOI 10.1111/j.1349-7006.1989.tb01690.x; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Merok JR, 2002, CANCER RES, V62, P6791; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Ogino H, 2002, J BIOCHEM, V132, P953, DOI 10.1093/oxfordjournals.jbchem.a003309; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Tajbakhsh S, 2005, EXP CELL RES, V306, P364, DOI 10.1016/j.yexcr.2005.03.033; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	51	358	376	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					677	U69		10.1038/ncb1425	http://dx.doi.org/10.1038/ncb1425			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16799552				2022-12-27	WOS:000238837800010
J	Goto, H; Kiyono, T; Tomono, Y; Kawajiri, A; Urano, T; Furukawa, K; Nigg, EA; Inagaki, M				Goto, H; Kiyono, T; Tomono, Y; Kawajiri, A; Urano, T; Furukawa, K; Nigg, EA; Inagaki, M			Complex formation of Plk1 and INCENP required for metaphase-anaphase transition	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE-1; SPINDLE-CHECKPOINT PROTEINS; AURORA-B; CELL-DIVISION; CYTOKINESIS; KINETOCHORES; ACTIVATION; PHOSPHORYLATION; ASSOCIATION; REGULATORS	Mitotic chromosomal dynamics is regulated by the coordinated activities of many mitotic kinases(1), such as cyclin-dependent kinase 1 (Cdk1)(2,3), Aurora-B-4 or Polo-like kinase 1 (Plk1)(5), but the mechanisms of their coordination remain unknown. Here, we report that Cdk1 phosphorylates Thr 59 and Thr 388 on inner centromere protein (INCENP), which regulates the localization(4) and kinase activity(6-8) of Aurora-B from prophase to metaphase. INCENP depletion disrupts Plk1 localization specifically at the kinetochore. This phenotype is rescued by the exogenous expression of INCENP wild type and INCENP mutated at Thr 59 to Ala (T59A), but not at Thr 388 to Ala (T388A). The replacement of endogenous INCENP with T388A resulted in the delay of progression from metaphase to anaphase. We propose that INCENP phosphorylation by Cdk1 is necessary for the recruitment of Plk1 to the kinetochore, and that the complex formation of Plk1 and Aurora-B on INCENP may play crucial roles in the regulation of chromosomal dynamics.	Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan; Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan; Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7010202, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem 2, Aichi 4668550, Japan; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Aichi Cancer Center; National Cancer Center - Japan; Nagoya University; Max Planck Society	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan.	minagaki@aichi-cc.jp	Kiyono, Tohru/H-5834-2011; Inagaki, Masaki/B-9920-2016	Urano, Takeshi/0000-0003-3383-3554; Goto, Hidemasa/0000-0002-6796-4467; nigg, erich/0000-0003-4835-5719				Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Doree M, 2002, J CELL SCI, V115, P2461; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; YANO T, 1991, BIOCHEM BIOPH RES CO, V175, P1144, DOI 10.1016/0006-291X(91)91685-6; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	30	143	147	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					180	U52		10.1038/ncb1350	http://dx.doi.org/10.1038/ncb1350			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16378098				2022-12-27	WOS:000235059800013
J	Lee, HS; Bong, YS; Moore, KB; Soria, K; Moody, SA; Daar, IO				Lee, HS; Bong, YS; Moore, KB; Soria, K; Moody, SA; Daar, IO			Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway	NATURE CELL BIOLOGY			English	Article							FORMATION REQUIRE; XENOPUS; RECEPTOR; GENE; MORPHOGENESIS; GASTRULATION; PROGENITORS; ACTIVATION; EXPRESSION; MOVEMENTS	An important step in retinal development is the positioning of progenitors within the eye field where they receive the local environmental signals that will direct their ultimate fate(1). Recent evidence indicates that ephrinB1 functions in retinal progenitor movement, but the signalling pathway is unclear. We present evidence that ephrinB1 signals through its intracellular domain to control retinal progenitor movement into the eye field by interacting with Xenopus Dishevelled ( Xdsh), and by using the planar cell polarity ( PCP) pathway. Blocking Xdsh translation prevents retinal progeny from entering the eye field, similarly to the morpholino- mediated loss of ephrinB1 ( ref. 2). Overexpression of Xdsh can rescue the phenotype induced by loss of ephrinB1, and this rescue ( as well as a physical association between Xdsh and ephrinB1) is completely dependent on the DEP ( Dishevelled, Egl- 10, Pleckstrin) domain of Xdsh. Similar gain- and loss- of- function experiments suggest that Xdsh associates with ephrinB1 and mediates ephrinB1 signalling through downstream members of the PCP pathway during eye field formation.	NCI, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA; Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; George Washington Univ, Med Ctr, Dept Anat & Cell Biol, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; George Washington University	Daar, IO (corresponding author), NCI, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov	Moody, Sally A./AAI-3660-2020; Lee, Hyun-Shik/G-3555-2011	Moody, Sally A./0000-0003-4192-1087; Moore, Kathryn/0000-0002-6993-152X; Daar, Ira/0000-0003-2657-526X	NATIONAL CANCER INSTITUTE [Z01BC010006] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010096] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NEI NIH HHS [EY10096] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Heller N, 1999, DEV GENET, V24, P208, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<208::AID-DVG4>3.0.CO;2-J; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HUANG S, 1993, J NEUROSCI, V13, P3193; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Kenyon KL, 2001, DEV BIOL, V240, P77, DOI 10.1006/dbio.2001.0464; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; MOODY SA, 1999, METHODS MOL BIOL DEV, P331; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Murakami MS, 2004, DEVELOPMENT, V131, P571, DOI 10.1242/dev.00971; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; SAHA MS, 1992, NEURON, V8, P1003, DOI 10.1016/0896-6273(92)90123-U; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Small EM, 2000, MECH DEVELOP, V96, P259, DOI 10.1016/S0925-4773(00)00400-7; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zygar CA, 1998, DEVELOPMENT, V125, P3509	34	89	92	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					55	U21		10.1038/ncb1344	http://dx.doi.org/10.1038/ncb1344			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16362052				2022-12-27	WOS:000234651500012
J	Habedanck, R; Stierhof, YD; Wilkinson, CJ; Nigg, EA				Habedanck, R; Stierhof, YD; Wilkinson, CJ; Nigg, EA			The Polo kinase Plk4 functions in centriole duplication	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; XENOPUS EGG EXTRACTS; CENTROSOME DUPLICATION; MAMMALIAN-CELLS; C-ELEGANS; SAK; PROLIFERATION; REQUIREMENT; CDK2-CYCLIN; EXPRESSION	The human Polo-like kinase 1 (PLK1) and its functional homologues that are present in other eukaryotes have multiple, crucial roles in meiotic and mitotic cell division(1,2). By contrast, the functions of other mammalian Polo family members remain largely unknown. Plk4 is the most structurally divergent Polo family member; it is maximally expressed in actively dividing tissues and is essential for mouse embryonic development(3). Here, we identify Plk4 as a key regulator of centriole duplication. Both gain- and loss-of-function experiments demonstrate that Plk4 is required - in cooperation with Cdk2, CP110 and Hs-SAS6 - for the precise reproduction of centrosomes during the cell cycle. These findings provide an attractive explanation for the crucial function of Plk4 in cell proliferation and have implications for the role of Polo kinases in tumorigenesis.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Univ Tubingen, Ctr Plant Mol Biol, Electron Microscopy Unit, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	nigg@biochem.mpg.de		Wilkinson, Christopher/0000-0002-7448-0938; nigg, erich/0000-0003-4835-5719				BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fode C, 1996, MOL CELL BIOL, V16, P4665; Glover DM, 2005, ONCOGENE, V24, P230, DOI 10.1038/sj.onc.1208279; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Karn T, 1997, ONCOL REP, V4, P505; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SLUDER G, 2004, CENTROSOMES DEV DIS, P167, DOI DOI 10.1002/3527603808.CH9; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; VANKREEVELD S, 2004, CENTROSOMES DEV DIS, P43; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059	32	602	619	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1140	1146		10.1038/ncb1320	http://dx.doi.org/10.1038/ncb1320			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16244668				2022-12-27	WOS:000232930400019
J	MacKeigan, JP; Murphy, LO; Blenis, J				MacKeigan, JP; Murphy, LO; Blenis, J			Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance	NATURE CELL BIOLOGY			English	Article							DRUG-INDUCED APOPTOSIS; TUMOR-SUPPRESSOR PTEN; GROWTH-FACTOR-BETA; HUMAN GENOME; CANCER; MUTATIONS; SURVIVAL; PATHWAY; GENE; CHEMOTHERAPY	Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome. In addition to known kinases, we identified several new survival kinases. Interestingly, numerous phosphatases and associated regulatory subunits contribute to cell survival, revealing a previously unrecognized general role for phosphatases as negative regulators of apoptosis. We also identified a subset of phosphatases with tumour-suppressor-like activity. Finally, RNAi targeting of specific protein kinases sensitizes resistant cells to chemotherapeutic agents. The development of inhibitors that target these kinases or phosphatases may lead to new anti-cancer strategies.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu		MacKeigan, Jeffrey/0000-0002-0198-5679	NATIONAL CANCER INSTITUTE [R01CA046595] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA46595] Funding Source: Medline; NIGMS NIH HHS [GM51405] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Huang Shile, 2002, Curr Opin Investig Drugs, V3, P295; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; MacKeigan JP, 2003, CANCER RES, V63, P6928; MacKeigan JP, 2002, CLIN CANCER RES, V8, P2091; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Makin G, 2001, BREAST CANCER RES, V3, P150, DOI 10.1186/bcr289; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Narayan G, 2003, ONCOGENE, V22, P3489, DOI 10.1038/sj.onc.1206432; PASLEAU F, 1993, ONCOGENE, V8, P849; Pietras K, 2002, CANCER RES, V62, P5476; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; VANMAANEN JMS, 1988, J NATL CANCER I, V80, P1526, DOI 10.1093/jnci/80.19.1526; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200	43	448	482	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					591	U19		10.1038/ncb1258	http://dx.doi.org/10.1038/ncb1258			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15864305				2022-12-27	WOS:000229562100013
J	Fontana, L; Pelosi, E; Greco, P; Racanicchi, S; Testa, U; Liuzzi, F; Croce, CM; Brunetti, E; Grignani, F; Peschle, C				Fontana, Laura; Pelosi, Elvira; Greco, Paolo; Racanicchi, Serena; Testa, Ugo; Liuzzi, Francesca; Croce, Carlo M.; Brunetti, Ercole; Grignani, Francesco; Peschle, Cesare			MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation	NATURE CELL BIOLOGY			English	Article							COLONY-STIMULATING FACTOR; DIFFERENTIATION; GENE; ERYTHROPOIESIS; IDENTIFICATION; HEMATOPOIESIS; EXPRESSION; PROMOTES; LEUKEMIA; GROWTH	We investigated the role of microRNAs (miRNA) 17-5p, 20a and 106a in monocytic differentiation and maturation. In unilineage monocytic culture generated by haematopoietic progenitor cells these miRNAs are downregulated, whereas the transcription factor acute myeloid leukaemia-1 (AML1; also known as Runt-related transcription factor 1, Runx1) is upregulated at protein but not mRNA level. As miRNAs 17-5p, 20a and 106a bind the AML1 mRNA 3'UTR, their decline may unblock AML1 translation. Accordingly, transfection with miRNA 17-5p-20a-106a suppresses AML1 protein expression, leading to M- CSF receptor (M-CSFR) downregulation, enhanced blast proliferation and inhibition of monocytic differentiation and maturation. Treatment with anti-miRNA 17-5p, 20a and 106a causes opposite effects. Knockdown of AML1 or M-CSFR by short interfering RNA (siRNA) mimics the action of the miRNA 17-5p-20a-106a, confirming that these miRNAs target AML1, which promotes M-CSFR transcription. In addition, AML1 binds the miRNA 17-5p-92 and 106a-92 cluster promoters and transcriptionally inhibits the expression of miRNA 17-5p 20a -106a. These studies indicate that monocytopoiesis is controlled by a circuitry involving sequentially miRNA 17-5p-20a-106a, AML1 and M-CSFR, whereby miRNA 17-5p-20a-106a function as a master gene complex interlinked with AML1 in a mutual negative feedback loop.	Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; Univ Perugia, Dept Gen Pathol, I-06100 Perugia, Italy; Ohio State Univ, Columbus, OH 43210 USA; San Pietro FBF, Ctr Ric AFaR, I-00189 Rome, Italy	Istituto Superiore di Sanita (ISS); University of Perugia; University System of Ohio; Ohio State University	Fontana, L (corresponding author), Ist Super Sanita, Dept Haematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lfontana@iss.it; c.peschle@iss.it	Testa, Ugo/J-6472-2016; Young, Richard A/F-6495-2012; pelosi, elvira/J-7298-2016; Grignani, Francesco/AAC-2565-2022	Testa, Ugo/0000-0001-7900-8942; Young, Richard A/0000-0001-8855-8647; pelosi, elvira/0000-0002-3043-6249; 	NHLBI NIH HHS [1R01HL63168] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063168] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Frank R, 1995, ONCOGENE, V11, P2667; Gordon AT, 2000, GENE CHROMOSOME CANC, V28, P220, DOI 10.1002/(SICI)1098-2264(200006)28:2<220::AID-GCC11>3.3.CO;2-K; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuchenbauer F, 2005, CELL CYCLE, V4, P1716, DOI 10.4161/cc.4.12.2256; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rhoades KL, 2000, BLOOD, V96, P2108; Schmidt H, 2005, MODERN PATHOL, V18, P638, DOI 10.1038/modpathol.3800326; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; STANLEY ER, 1986, CIBA F SYMP, V118, P29, DOI 10.1002/9780470720998.ch3; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Testa U, 1996, BLOOD, V88, P3391, DOI 10.1182/blood.V88.9.3391.bloodjournal8893391; Uchida H, 1997, J IMMUNOL, V158, P2251; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Zeuner A, 2006, BLOOD, V107, P3495, DOI 10.1182/blood-2005-07-3037; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Ziegler B, 1998, Stem Cells, V16 Suppl 1, P51	50	363	401	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					775	U90		10.1038/ncb1613	http://dx.doi.org/10.1038/ncb1613			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17589498				2022-12-27	WOS:000247760700013
J	Qi, ML; Tagawa, K; Enokido, Y; Yoshimura, N; Wada, Y; Watase, K; Ishiura, S; Kanazawa, I; Botas, J; Saitoe, M; Wanker, EE; Okazawa, H				Qi, Mei-Ling; Tagawa, Kazuhiko; Enokido, Yasushi; Yoshimura, Natsue; Wada, Yo-ichi; Watase, Kei; Ishiura, Sho-ichi; Kanazawa, Ichiro; Botas, Juan; Saitoe, Minoru; Wanker, Erich E.; Okazawa, Hitoshi			Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases	NATURE CELL BIOLOGY			English	Article							HUNTINGTONS-DISEASE; TRANSCRIPTIONAL REPRESSION; MUTANT HUNTINGTIN; NEURODEGENERATIVE DISEASE; NEURONAL DEATH; MOUSE MODEL; DNA-REPAIR; CELL-DEATH; IN-VITRO; DROSOPHILA	Nuclear dysfunction is a key feature of the pathology of polyglutamine (polyQ) diseases. It has been suggested that mutant polyQ proteins impair functions of nuclear factors by interacting with them directly in the nucleus. However, a systematic analysis of quantitative changes in soluble nuclear proteins in neurons expressing mutant polyQ proteins has not been performed. Here, we perform a proteome analysis of soluble nuclear proteins prepared from neurons expressing huntingtin (Htt) or ataxin-1 (AT1) protein, and show that mutant AT1 and Htt similarly reduce the concentration of soluble high mobility group B1/2 (HMGB1/2) proteins. Immunoprecipitation and pulldown assays indicate that HMGBs interact with mutant AT1 and Htt. Immunohistochemistry showed that these proteins were reduced in the nuclear region outside of inclusion bodies in affected neurons. Compensatory expression of HMGBs ameliorated polyQ-induced pathology in primary neurons and in Drosophila polyQ models. Furthermore, HMGBs repressed genotoxic stress signals induced by mutant Htt or transcriptional repression. Thus, HMGBs may be critical regulators of polyQ disease pathology and could be targets for therapy development.	Tokyo Med & Dent Univ, Dept Neuropathol, Inst Med Res, Tokyo 113, Japan; Tokyo Med & Dent Univ, Century COE Program Brain Integrat & Its Dysfinct, Tokyo 113, Japan; Univ Tokyo, Fac Culture & Sci, Tokyo 106, Japan; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Baylor College of Medicine; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Okazawa, H (corresponding author), Tokyo Med & Dent Univ, Dept Neuropathol, Inst Med Res, Tokyo 113, Japan.	okazawa-tky@umin.ac.jp	; Yoshimura, Natsue/E-7087-2014	Saitoe, Minoru/0000-0001-9731-4214; Yoshimura, Natsue/0000-0002-7495-9113; Enokido, Yasushi/0000-0003-3252-504X; Wanker, Erich/0000-0001-8072-1630				Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; Hoshino M, 2004, BIOCHEM BIOPH RES CO, V313, P110, DOI 10.1016/j.bbrc.2003.11.086; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tagawa K, 2004, J NEUROCHEM, V89, P974, DOI 10.1111/j.1471-4159.2004.02372.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	84	90	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					402	414		10.1038/ncb1553	http://dx.doi.org/10.1038/ncb1553			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17384639				2022-12-27	WOS:000245359400011
J	Sherer, NM; Lehmann, MJ; Jimenez-Soto, LF; Horensavitz, C; Pypaert, M; Mothes, W				Sherer, Nathan M.; Lehmann, Maik J.; Jimenez-Soto, Luisa F.; Horensavitz, Christina; Pypaert, Marc; Mothes, Walther			Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission	NATURE CELL BIOLOGY			English	Article							ACTIN CYTOSKELETON; ENVELOPE PROTEIN; VIRUS; RECEPTOR; DROSOPHILA; SYNAPSE; ENTRY; LYMPHOCYTES; MACROPHAGES; HEMIFUSION	The spread of retroviruses between cells is estimated to be 2-3 orders of magnitude more efficient when cells can physically interact with each other(1,2). The underlying mechanism is largely unknown, but transfer is believed to occur through large-surface interfaces, called virological or infectious synapses(3-6). Here, we report the direct visualization of cell-to-cell transmission of retroviruses in living cells. Our results reveal a mechanism of virus transport from infected to non-infected cells, involving thin filopodial bridges. These filopodia originate from noninfected cells and interact, through their tips, with infected cells. A strong association of the viral envelope glycoprotein (Env) in an infected cell with the receptor molecules in a target cell generates a stable bridge. Viruses then move along the outer surface of the filopodial bridge toward the target cell. Our data suggest that retroviruses spread by exploiting an inherent ability of filopodia to transport ligands from cell to cell.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University	Mothes, W (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	walther.mothes@yale.edu		Jimenez Soto, Luisa Fernanda/0000-0001-8551-5019	NATIONAL CANCER INSTITUTE [R01CA098727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065284] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098727-05, R01CA098727, R01 CA098727] Funding Source: Medline; NIAID NIH HHS [R21 AI065284] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Chen CP, 2004, J VIROL, V78, P882, DOI 10.1128/JVI.78.2.882-891.2004; Davey RA, 1999, J VIROL, V73, P3758, DOI 10.1128/JVI.73.5.3758-3763.1999; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KLEMENT V, 1969, P NATL ACAD SCI USA, V63, P753, DOI 10.1073/pnas.63.3.753; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zavorotinskaya T, 2004, J VIROL, V78, P473, DOI 10.1128/JVI.78.1.473-481.2004; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	26	333	342	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					310	U106		10.1038/ncb1544	http://dx.doi.org/10.1038/ncb1544			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293854	Green Accepted			2022-12-27	WOS:000244558600015
J	Zhu, XJ; Wang, CZ; Dai, PG; Xie, Y; Song, NN; Liu, Y; Du, QS; Mei, L; Ding, YQ; Xiong, WC				Zhu, Xiao-Juan; Wang, Cheng-Zhong; Dai, Peng-Gao; Xie, Yi; Song, Ning-Ning; Liu, Yu; Du, Quan-Sheng; Mei, Lin; Ding, Yu-Qiang; Xiong, Wen-Cheng			Myosin X regulates netrin receptors and functions in axonal path-finding	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; PLECKSTRIN HOMOLOGY; NEURITE OUTGROWTH; DCC; PROTEIN; CELLS; MOTOR; SRC	Netrins regulate axon path-finding during development, but the underlying mechanisms are not well understood. Here, we provide evidence for the involvement of the unconventional myosin X (Myo X) in netrin-1 function. We find that Myo X interacts with the netrin receptor deleted in colorectal cancer (DCC) and neogenin, a DCC-related protein. Expression of Myo X redistributes DCC to the cell periphery or to the tips of neurites, whereas its silencing prevents DCC distribution in neurites. Moreover, expression of DCC, but not neogenin, stimulates Myo X-mediated formation and elongation of filopodia, suggesting that Myo X function may be differentially regulated by DCC and neogenin. The involvement of Myo X in netrin-1 function was further supported by the effects of inhibiting Myo X function in neurons. Cortical explants derived from mouse embryos expressing a motor-less Myo X exhibit reduced neurite outgrowth in response to netrin-1 and chick commissural neurons expressing the motor-less Myo X, or in which Myo X is silenced using microRNA (miRNA), show impaired axon projection in vivo. Taken together, these results identify a novel role for Myo X in regulating netrin-1 function.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Coll Georgia, Program Dev Neurobiol, IMMAG, Augusta, GA 30912 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham	Ding, YQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	dingyq@ion.ac.cn; wxiong@mcg.edu	Mei, Lin/G-8755-2012; Wang, Chengzhong/A-6039-2015	Ding, Yu-Qiang/0000-0003-1202-4635; Song, Ning-Ning/0000-0001-5206-1911; Du, Quansheng/0000-0003-4079-8662	NINDS NIH HHS [R01 NS060648] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huang X, 2002, NEURON, V34, P563, DOI 10.1016/S0896-6273(02)00672-4; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richards LJ, 1997, J NEUROSCI, V17, P2445; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Xie Y, 2005, NAT CELL BIOL, V7, P1124, DOI 10.1038/ncb1321; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	32	110	123	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					184	U79		10.1038/ncb1535	http://dx.doi.org/10.1038/ncb1535			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237772				2022-12-27	WOS:000243903000011
J	Nieminen, M; Henttinen, T; Merinen, M; Marttila-Ichihara, F; Eriksson, JE; Jalkanen, S				Nieminen, M; Henttinen, T; Merinen, M; Marttila-Ichihara, F; Eriksson, JE; Jalkanen, S			Vimentin function in lymphocyte adhesion and transcellular migration	NATURE CELL BIOLOGY			English	Article							INTERMEDIATE-FILAMENTS; ENDOTHELIAL-CELLS; VENULES	Although the adhesive interactions of leukocytes with endothelial cells are well understood, little is known about the detailed mechanisms underlying the actual migration of leukocytes across the endothelium ( diapedesis). Leukocytes have been shown to use both paracellular and transcellular routes for transendothelial migration. Here we show that peripheral blood mononuclear cells (PBMCs; T- and B-lymphocytes) preferentially use the transcellular route. The intermediate filaments of both endothelial cells and lymphocytes formed a highly dynamic anchoring structure at the site of contact between these two cell types. The initiation of this process was markedly reduced in vimentin-deficient (vim(-/-)) PBMCs and endothelial cells. When compared with wild-type PBMCs, vim(-/-) PBMCs showed a markedly reduced capacity to home to mesenteric lymph nodes and spleen. Furthermore, endothelial integrity was compromised in vim(-/-) mice, demonstrating that intermediate filaments also regulate the barrier that governs leukocyte extravasation. Absence of vimentin resulted in highly aberrant expression and distribution of surface molecules critical for homing (ICAM-1 and VCAM-1 on endothelial cells and integrin-beta 1 on PBMCs). These data show that intermediate filaments are active in lymphocyte adhesion and transmigration.	Univ Turku, Ctr Biotechnol, FIN-20521 Turku, Finland; Abo Akad Univ, FIN-20521 Turku, Finland; Univ Turku, Dept Biol, FIN-20014 Turku, Finland; Univ Turku, Med Res Lab, FIN-20520 Turku, Finland; Univ Turku, Dept Med Microbiol, FIN-20520 Turku, Finland; Natl Publ Hlth Inst, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku; Finland National Institute for Health & Welfare	Eriksson, JE (corresponding author), Univ Turku, Ctr Biotechnol, POB 123, FIN-20521 Turku, Finland.	john.eriksson@btk.utu.fi		Karikoski, Marika/0000-0001-6512-6331				Ager A, 2003, NATURE, V421, P703, DOI 10.1038/421703a; Ameen NA, 2001, J CELL SCI, V114, P563; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; COOKE BM, 1993, PARASITOLOGY, V107, P359, DOI 10.1017/S0031182000067706; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; HOGG N, 1995, IMMUNOL TODAY, V16, P327, DOI 10.1016/0167-5699(95)80147-2; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Runembert I, 2004, AM J PHYSIOL-RENAL, V287, pF960, DOI 10.1152/ajprenal.00064.2004; Runembert I, 2002, J CELL SCI, V115, P713; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; VONANDRIAN UH, 1992, AM J PHYSIOL, V263, pH1034, DOI 10.1152/ajpheart.1992.263.4.H1034; WANHONG S, 2002, BLOOD, V100, P3597; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	26	333	354	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					156	U41		10.1038/ncb1355	http://dx.doi.org/10.1038/ncb1355			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16429129				2022-12-27	WOS:000235059800010
J	Adereth, Y; Dammai, V; Kose, N; Li, RZ; Hsu, T				Adereth, Y; Dammai, V; Kose, N; Li, RZ; Hsu, T			RNA-dependent integrin alpha(3) protein localization regulated by the Muscleblind-like protein MLP1	NATURE CELL BIOLOGY			English	Article							ACTIN MESSENGER-RNA; EXPANDED-REPEAT TRANSCRIPTS; IN-VIVO; DROSOPHILA; CELLS; ORGANIZATION; LAMININ-5; MIGRATION; MBNL	We show that localized expression of the integrin alpha(3) protein is regulated at the level of RNA localization by the human homologue of Drosophila Muscleblind, MLP1/MBLL/MBNL2, a unique Cys(3)His zinc-finger protein. This is supported by the following observations: MLP1 knockdown abolishes localization of integrin alpha(3) to the adhesion complexes; MLP1 is localized in adhesion plaques that contain phospho-focal adhesion kinase; this localization is microtubule-dependent; integrin alpha(3) transcripts colocalize with MLP1 in distinct cytoplasmic loci; integrin alpha(3) transcripts are physically associated with MLP1 in cells and MLP1 binds to a specific ACACCC motif in the integrin alpha(3) 3' untranslated region (UTR) in vitro; and a green fluorescent protein (GFP) open reading frame-integrin alpha(3) 3' UTR chimeric gene directs GFP protein localization to distinct cytoplasmic loci near the cell periphery, which is dependent on MLP1 and is mediated by the ACACCC motif but is independent of the integrin alpha(3) signal peptide.	Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Hsu, T (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, 86 Jonathan Lucas St,Room 330, Charleston, SC 29425 USA.	hsut@musc.edu		Hsu, Tien/0000-0003-2308-4297	NCI NIH HHS [K22CA109577, R01CA109860, P01 CA078582, R01 CA109860, P01 CA078582-070005, K22 CA109577, R01 CA109860-03, P01CA78582] Funding Source: Medline; NIGMS NIH HHS [R01 GM057843-06, R01 GM057843] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA109577, R01CA109860, P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057843] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Bassell GJ, 1998, J NEUROSCI, V18, P251; Begemann G, 1997, DEVELOPMENT, V124, P4321; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; FULTON AB, 1993, J CELL BIOCHEM, V52, P148, DOI 10.1002/jcb.240520206; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kislauskis Edward H., 1992, Current Opinion in Cell Biology, V4, P975, DOI 10.1016/0955-0674(92)90128-Y; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; Micklem DR, 1995, DEV BIOL, V172, P377, DOI 10.1006/dbio.1995.8048; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; SINGER R H, 1992, Current Opinion in Cell Biology, V4, P15, DOI 10.1016/0955-0674(92)90053-F; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5	22	109	111	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1240	1247		10.1038/ncb1335	http://dx.doi.org/10.1038/ncb1335			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16273094	Green Accepted			2022-12-27	WOS:000233748900018
J	Song, S; Ewald, AJ; Stallcup, W; Werb, Z; Bergers, G				Song, S; Ewald, AJ; Stallcup, W; Werb, Z; Bergers, G			PDGFR beta(+) perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival	NATURE CELL BIOLOGY			English	Article							BLOOD-VESSEL FORMATION; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; ENDOTHELIAL-CELL; PDGF-B; NG2 PROTEOGLYCAN; TGF-BETA; TUMORIGENESIS; ANGIOGENESIS; RECRUITMENT	The microvasculature consists of endothelial cells and their surrounding pericytes. Few studies on the regulatory mechanisms of tumour angiogenesis have focused on pericytes. Here we report the identification of tumour- derived PDGFR beta(+) ( platelet- derived growth factor receptor beta) progenitor perivascular cells ( PPCs) that have the ability to differentiate into pericytes and regulate vessel stability and vascular survival in tumours. A subset of PDGFR beta(+) PPCs is recruited from bone marrow to perivascular sites in tumours. Specific inhibition of PDGFR beta signalling eliminates PDGFR beta(+) PPCs and mature pericytes around tumour vessels, leading to vascular hyperdilation and endothelial cell apoptosis in pancreatic islet tumours of transgenic Rip1Tag2 mice.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Sanford Burnham Prebys Medical Discovery Institute	Bergers, G (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	bergers@itsa.ucsf.edu	Bergers, Gabriele/AAJ-5535-2020		NCI NIH HHS [P01 CA072006-07, R01 CA95287, R01 CA109390-01, R01 CA095287-05, P01 CA72006, R01 CA099948, P01 CA072006, R01 CA095287, R01 CA109390, R01 CA99948] Funding Source: Medline; NHLBI NIH HHS [T32 HL007731, 5T32HL007731] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109390, P01CA072006, R01CA099948, R01CA095287] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Betsholtz C, 2005, EXP SUPPL, V94, P115; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4; Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/1547328042417336; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Kanamori M, 2004, CANCER RES, V64, P2751, DOI 10.1158/0008-5472.CAN-03-3354; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V126, P3047; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Parangi S, 1996, P NATL ACAD SCI USA, V93, P2002, DOI 10.1073/pnas.93.5.2002; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Reinmuth N, 2001, FASEB J, V15, P1239, DOI 10.1096/fj.00-0693fje; Shaheen RM, 2001, CANCER RES, V61, P1464; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	43	422	434	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					870	U16		10.1038/ncb1288	http://dx.doi.org/10.1038/ncb1288			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16113679	Green Accepted			2022-12-27	WOS:000231601600010
J	Papoulas, O; Hays, TS; Sisson, JC				Papoulas, O; Hays, TS; Sisson, JC			The golgin Lava lamp mediates dynein-based Golgi movements during Drosophila cellularization	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC DYNEIN; OOCYTE DIFFERENTIATION; DYNACTIN COMPLEX; MOTOR; PROTEIN; TRANSPORT; MICROTUBULES; BINDING; EMBRYOS; PHOSPHORYLATION	Drosophila melanogaster cellularization is a dramatic form of cytokinesis in which a membrane furrow simultaneously encapsulates thousands of cortical nuclei of the syncytial embryo to generate a polarized cell layer. Formation of this cleavage furrow depends on Golgi-based secretion and microtubules(1-3). During cellularization, specific Golgi move along microtubules, first to sites of furrow formation and later to accumulate within the apical cytoplasm of the newly forming cells(3). Here we show that Golgi movements and furrow formation depend on cytoplasmic dynein. Furthermore, we demonstrate that Lava lamp (Lva), a golgin protein that is required for cellularization, specifically associates with dynein, dynactin, cytoplasmic linker protein-190 (CLIP-190) and Golgi spectrin, and is required for the dynein-dependent targeting of the secretory machinery. The Lva domains that bind these microtubule-dependent motility factors inhibit Golgi movement and cellularization in a live embryo injection assay. Our results provide new evidence that golgins promote dynein-based motility of Golgi membranes.	Univ Texas, Sect MCD Biol, Austin, TX 78712 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Minnesota System; University of Minnesota Twin Cities	Sisson, JC (corresponding author), Univ Texas, Sect MCD Biol, Austin, TX 78712 USA.	sisson@icmb.utexas.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067013, R01GM053695] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM067013, R01 GM067013, GM053695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; Fan SS, 1997, DEVELOPMENT, V124, P1497; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Foe Victoria E., 1993, P149; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kumar S, 2000, J BIOL CHEM, V275, P31798, DOI 10.1074/jbc.M000449200; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; McGrail M, 1997, DEVELOPMENT, V124, P2409; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; TURNER FR, 1976, DEV BIOL, V50, P95, DOI 10.1016/0012-1606(76)90070-1; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153	29	80	82	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					612	U23		10.1038/ncb1264	http://dx.doi.org/10.1038/ncb1264			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15908943				2022-12-27	WOS:000229562100015
J	Gonzalo, S; Garcia-Cao, M; Fraga, MF; Schotta, G; Peters, AHFM; Cotter, SE; Eguia, R; Dean, DC; Esteller, M; Jenuwein, T; Blasco, MA				Gonzalo, S; Garcia-Cao, M; Fraga, MF; Schotta, G; Peters, AHFM; Cotter, SE; Eguia, R; Dean, DC; Esteller, M; Jenuwein, T; Blasco, MA			Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin	NATURE CELL BIOLOGY			English	Article							TELOMERE LENGTH; G(1) CONTROL; P53; REREPLICATION; INHIBITORS; PROTEINS; PATHWAY; TARGETS; GENES; CELLS	Here, we show a role for the RB1 family proteins in directing full heterochromatin formation. Mouse embryonic fibroblasts that are triply deficient for RB1 (retinoblastoma 1), RBL1 (retinoblastoma-like 1) and RBL2 (retinoblastoma-like 2) - known as TKO cells - show a marked genomic instability, which is coincidental with decreased DNA methylation, increased acetylation of histone H3 and decreased tri-methylation of histone H4 at lysine 20 (H4K20). Chromatin immunoprecipitation showed that H4K20 tri-methylation was specifically decreased at pericentric and telomeric chromatin. These defects are independent of E2F family function. Indeed, we show a direct interaction between the RB1 proteins and the H4K20 tri-methylating enzymes Suv4-20h1 and Suv4-20h2, indicating that the RB1 family has a role in controlling H4K20 tri-methylation by these histone methyltransferases. These observations indicate that the RB1 family is involved in maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin, linking tumour suppression and the epigenetic definition of chromatin.	Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; Spanish Natl Canc Ctr CNIO, Mol Pathol Program, Epigenet Grp, E-28029 Madrid, Spain; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Washington Univ, Sch Med, Div Mol Oncol, St Louis, MO 63110 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Washington University (WUSTL)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain.	mblasco@cnio.es	Esteller, Manel/L-5956-2014; Gonzalo, Susana/T-8275-2019; Fraga, Mario F/H-7824-2017; Blasco, Maria A./M-1694-2014	Esteller, Manel/0000-0003-4490-6093; Fraga, Mario F/0000-0001-8450-2603; Blasco, Maria A./0000-0002-4211-233X; Gonzalo, Susana/0000-0001-9631-1206; Peters, Antoine/0000-0002-0311-1887; Schotta, Gunnar/0000-0003-4940-6135				Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Bernard P, 2002, TRENDS CELL BIOL, V12, P419, DOI 10.1016/S0962-8924(02)02344-9; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Di Leonardo A, 1997, CANCER RES, V57, P1013; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; GOODWIN GH, 1977, BIOCHEM J, V167, P485, DOI 10.1042/bj1670485; GURLEY LR, 1983, ANAL BIOCHEM, V131, P465, DOI 10.1016/0003-2697(83)90200-2; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Khan SH, 1998, CANCER RES, V58, P396; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LINDNER H, 1992, J CHROMATOGR, V608, P211, DOI 10.1016/0021-9673(92)87126-S; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Pantoja C, 2001, EXP GERONTOL, V36, P1289, DOI 10.1016/S0531-5565(01)00104-8; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6	31	266	280	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					420	U52		10.1038/ncb1235	http://dx.doi.org/10.1038/ncb1235			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15750587				2022-12-27	WOS:000228075500020
J	Wee, S; Geyer, RK; Toda, T; Wolf, DA				Wee, S; Geyer, RK; Toda, T; Wolf, DA			CSN facilitates Cullin-RING ubiquitin ligase function by counteracting autocatalytic adapter instability	NATURE CELL BIOLOGY			English	Article							BOX PROTEIN SKP2; COP9 SIGNALOSOME; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DNA-DAMAGE; DEGRADATION; SCF; COMPLEX; SUBUNITS; CLEAVAGE	The COP9 signalosome (CSN) is known to bind cullin-RING ubiquitin ligases (CRLs) and to promote their activity in vivo(1-3). The mechanism of this stimulation has remained enigmatic because CSN's intrinsic and associated enzymatic activities paradoxically inhibit CRL activity in vitro(4,5). Reconciling this paradox, we show here that Csn5-catalysed cullin (Cul) deneddylation and Ubp12-mediated deubiquitination cooperate in maintaining the stability of labile substrate adapters, thus facilitating CRL function. Various fission-yeast csn and ubp12 deletion mutants have lower levels of the Cul3p adapter Btb3p. This decrease is due to increased autocatalytic, Cul3p dependent, ubiquitination and the subsequent degradation of Btb3p. The CSN-Ubp12p pathway also maintains the stability of the Cul1p adapter Pop1p, a mechanism required for the efficient destruction of its cognate substrate Rum1p. Emphasizing the physiological importance of this mechanism, we found that the dispensable csn5 and ubp12 genes become essential for viability when adapter recruitment to Cul1p is compromised. Our data suggest that maintenance of adapter stability is a general mechanism of CRL control by the CSN.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Canc Res UK, Lab Cell Regulat, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England	Harvard University; Harvard T.H. Chan School of Public Health; Cancer Research UK	Wolf, DA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	dwolf@hsph.harvard.edu	Wolf, Dieter/AAE-5890-2021	Wolf, Dieter/0000-0002-3761-1070	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, T32ES007155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059780] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00002, ES07155] Funding Source: Medline; NIGMS NIH HHS [R01 GM059780, GM59780] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Lu LF, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-22; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; XU L, NATURE, V425, P316; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	27	144	148	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					387	U39		10.1038/ncb1241	http://dx.doi.org/10.1038/ncb1241			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793566				2022-12-27	WOS:000228075500015
J	Toshima, J; Toshima, JY; Martin, AC; Drubin, DG				Toshima, J; Toshima, JY; Martin, AC; Drubin, DG			Phosphoregulation of Arp2/3-dependent actin assembly during receptor-mediated endocytosis	NATURE CELL BIOLOGY			English	Article							REGULATING KINASE PRK1P; ARP2/3 COMPLEX; CYTOSKELETON ORGANIZATION; BUDDING YEAST; MYOSIN-I; PROTEIN; DOMAIN; PAN1P; DYNAMICS; CLATHRIN	In both yeast and mammals, endocytic internalization is accompanied by a transient burst of actin polymerization(1,2). The yeast protein kinases Prk1p and Ark1p, which are related to the mammalian proteins GAK and AAK1, are key regulators of this process(3-6). However, the molecular mechanism(s) by which they regulate actin assembly at endocytic sites have not yet been determined. The Eps15-like yeast protein Pan1p is a Prk1p substrate that is essential for endocytic internalization and for proper actin organization(7-9). Pan1p is an Arp2/3 activator and here we show that this activity is dependent on F-actin binding. Mutation of all 15 Prk1p-targeted threonines in Pan1p to alanines mimicked the ark1Delta. prk1Delta. phenotype, demonstrating that Pan1p is a key Prk1p target in vivo. Moreover, phosphorylation by Prk1p inhibited the ability of Pan1p to bind to F-actin and to activate the Arp2/3 complex, thereby identifying the endocytic phosphoregulation mechanism of Prk1p. We conclude that Prk1p phosphorylation of Pan1p shuts off Arp2/3-mediated actin polymerization on endocytic vesicles, allowing them to fuse with endosomes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.	drubin@socrates.berkeley.edu	純子, 十島 Y/GRS-7321-2022					Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gourlay CW, 2003, J CELL SCI, V116, P2551, DOI 10.1242/jcs.00454; Henry KR, 2003, CURR BIOL, V13, P1564, DOI 10.1016/S0960-9822(03)00579-7; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Huang B, 2003, MOL BIOL CELL, V14, P4871, DOI 10.1091/mbc.E03-06-0362; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miliaras NB, 2004, TRAFFIC, V5, P963, DOI 10.1111/j.1600-0854.2004.00238.x; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Tang HY, 1997, MOL CELL BIOL, V17, P4294, DOI 10.1128/MCB.17.8.4294; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Watson HA, 2001, MOL BIOL CELL, V12, P3668, DOI 10.1091/mbc.12.11.3668; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759; Zeng GS, 1999, J CELL BIOL, V144, P71, DOI 10.1083/jcb.144.1.71	31	84	86	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					246	U44		10.1038/ncb1229	http://dx.doi.org/10.1038/ncb1229			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15711538				2022-12-27	WOS:000227329800012
J	Walkley, CR; Fero, ML; Chien, WM; Purton, LE; McArthur, GA				Walkley, CR; Fero, ML; Chien, WM; Purton, LE; McArthur, GA			Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells	NATURE CELL BIOLOGY			English	Article							COMPETITIVE REPOPULATION; CD34(+) CELLS; EXPRESSION; IDENTIFICATION; REQUIREMENTS; QUIESCENCE; SURVIVAL; ASSAY; MAD1	Haematopoietic stem cells (HSCs) are capable of shifting from a state of relative quiescence under homeostatic conditions to rapid proliferation under conditions of stress. The mechanisms that regulate the relative quiescence of stem cells and its association with self-renewal are unclear, as is the contribution of molecular regulators of the cell cycle to these decisions. Understanding the mechanisms that govern these transitions will provide important insights into cell-cycle regulation of HSCs and possible therapeutic approaches to expand HSCs. We have investigated the role of two negative regulators of the cell cycle, p27(Kip1) and MAD1, in controlling this transition. Here we show that Mad1(-/-) p27(Kip1-/-) bone marrow has a 5.7-fold increase in the frequency of stem cells, and surprisingly, an expanded pool of quiescent HSCs. However, Mad1(-/-) p27(Kip1-/-) stem cells exhibit an enhanced proliferative response under conditions of stress, such as cytokine stimulation in vitro and regeneration of the haematopoietic system after ablation in vivo. Together these data demonstrate that the MYC-antagonist MAD1 and cyclin-dependent kinase inhibitor p27(Kip1) cooperate to regulate the self-renewal and differentiation of HSCs in a context-dependent manner.	Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Vic 3002, Australia; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Fred Hutchinson Cancer Center	Purton, LE (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02129 USA.	lpurton@partners.org; grant.mcarthur@petermac.org	Purton, Louise/AAI-8956-2021; Walkley, Carl/AAO-6021-2020	Purton, Louise/0000-0001-6593-3168; Walkley, Carl/0000-0002-4784-9031; Fero, Matthew/0000-0002-9967-4659; McArthur, Grant/0000-0001-8908-6071	NCI NIH HHS [K22 CA087731] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bradford GB, 1997, EXP HEMATOL, V25, P445; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HODGSON GS, 1982, EXP HEMATOL, V10, P26; Holzel M, 2001, EMBO REP, V2, P1125, DOI 10.1093/embo-reports/kve251; Jordan CT, 1996, EXP HEMATOL, V24, P1347; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LEARY AG, 1992, P NATL ACAD SCI USA, V89, P4013, DOI 10.1073/pnas.89.9.4013; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LERNER C, 1990, EXP HEMATOL, V18, P114; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; McArthur GA, 2002, MOL CELL BIOL, V22, P3014, DOI 10.1128/MCB.22.9.3014-3023.2002; OKADA S, 1992, BLOOD, V80, P3044; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tajima F, 2000, BLOOD, V96, P1989, DOI 10.1182/blood.V96.5.1989.h8001989_1989_1993; TASWELL C, 1981, J IMMUNOL, V126, P1614; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Walkley CR, 2004, BLOOD, V103, P1286, DOI 10.1182/blood-2003-07-2391; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008	30	92	99	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					172	U90		10.1038/ncb1214	http://dx.doi.org/10.1038/ncb1214			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15654333				2022-12-27	WOS:000226719500014
J	Aulehla, A; Wiegraebe, W; Baubet, V; Wahl, MB; Deng, CX; Taketo, M; Lewandoski, M; Pourquie, O				Aulehla, Alexander; Wiegraebe, Winfried; Baubet, Valerie; Wahl, Matthias B.; Deng, Chuxia; Taketo, Makoto; Lewandoski, Mark; Pourquie, Olivier			A beta-catenin gradient links the clock and wavefront systems in mouse embryo segmentation	NATURE CELL BIOLOGY			English	Article							ANTEROPOSTERIOR AXIS ELONGATION; PRESOMITIC MESODERM; SOMITE SEGMENTATION; GENE-EXPRESSION; LUNATIC-FRINGE; TRANSCRIPTION FACTORS; FLUORESCENT PROTEIN; IN-VIVO; NOTCH; WNT	Rhythmic production of vertebral precursors, the somites, causes bilateral columns of embryonic segments to form. This process involves a molecular oscillator - the segmentation clock - whose signal is translated into a spatial, periodic pattern by a complex signalling gradient system within the presomitic mesoderm (PSM). In mouse embryos, Wnt signalling has been implicated in both the clock and gradient mechanisms, but how the Wnt pathway can perform these two functions simultaneously remains unclear. Here, we use a yellow fluorescent protein (YFP)-based, real-time imaging system in mouse embryos to demonstrate that clock oscillations are independent of beta-catenin protein levels. In contrast, we show that the Wnt-signalling gradient is established through a nuclear beta-catenin protein gradient in the posterior PSM. This gradient of nuclear beta-catenin defines the size of the oscillatory field and controls key aspects of PSM maturation and segment formation, emphasizing the central role of Wnt signalling in this process.	[Aulehla, Alexander; Wiegraebe, Winfried; Wahl, Matthias B.; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Baubet, Valerie] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Deng, Chuxia] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Taketo, Makoto] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Lewandoski, Mark] NCI, Lab Canc & Dev Biol, NIH, Frederick, MD 21702 USA; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Pourquie, O (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; deng, chuxia/N-6713-2016	Pourquié, Olivier/0000-0001-5189-1227; Lewandoski, Mark/0000-0002-1066-3735; Aulehla, Alexander/0000-0003-3487-9239	Intramural NIH HHS [Z01 BC010338] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010338, Z01BC010338] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brault V, 2001, DEVELOPMENT, V128, P1253; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DEANGELIS H, 1997, NATURE, V386, P717; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; GONZELEZ RC, 2007, DIGITAL IMAGE PROCES; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones EAV, 2002, GENESIS, V34, P228, DOI 10.1002/gene.10162; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maruhashi M, 2005, DEV DYNAM, V234, P332, DOI 10.1002/dvdy.20546; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakajima Y, 2006, DEVELOPMENT, V133, P2517, DOI 10.1242/dev.02422; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Sawada A, 2001, DEVELOPMENT, V128, P4873; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; Yoon JK, 2000, DEV BIOL, V222, P376, DOI 10.1006/dbio.2000.9717	50	224	226	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					186	U56		10.1038/ncb1679	http://dx.doi.org/10.1038/ncb1679			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18157121	Green Accepted			2022-12-27	WOS:000252897800014
J	Behr, M; Wingen, C; Wolf, C; Schuh, R; Hoch, M				Behr, Matthias; Wingen, Christian; Wolf, Christian; Schuh, Reinhard; Hoch, Michael			Wurst is essential for airway clearance and respiratory-tube size control	NATURE CELL BIOLOGY			English	Article							GENETIC-CONTROL; J-DOMAIN; MECHANISMS; BIOSYNTHESIS; REQUIREMENT; ENDOCYTOSIS; AUXILIN; DYNAMIN; MATRIX; HSC70	The Drosophila melanogaster tracheal system and the mammalian lung are branching networks of tubular epithelia that convert during late embryogenesis from liquid- to air-filling(1-3). Little is known about how respiratory-tube size and physiology are coordinated. Here, we show that the Drosophila wurst gene encodes a unique J-domain transmembrane protein highly conserved in metazoa. In wurst mutants, respiratory-tube length is increased and lumen clearance is abolished, preventing gas filling of the airways. Wurst is essential for clathrin-mediated endocytosis(4), which is required for size determination and lumen clearance of the airways. wurst recruits heat shock cognate protein 70-4 and clathrin to the apical membrane of epithelial cells. The sequence conservation of the single Wurst orthologues in mice and humans offer new opportunities for genetic studies of clinically relevant lung syndromes caused by the failure of liquid clearance and respiratory-tube size control.	Univ Bonn, LIMES Inst, Lab Mol Dev Biol, Program Unit Dev & Genet, D-53115 Bonn, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Bonn; Max Planck Society	Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Lab Mol Dev Biol, Program Unit Dev & Genet, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Behr, Matthias/K-6505-2019	Behr, Matthias/0000-0001-9869-1257				Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Arias A.M., 1993, DEV DROSOPHILA, P609; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; OBrodovich HM, 1996, P ASSOC AM PHYSICIAN, V108, P345; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	29	48	49	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					847	U211		10.1038/ncb1611	http://dx.doi.org/10.1038/ncb1611			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558392	Green Published			2022-12-27	WOS:000247760700021
J	Kondo, T; Hashimoto, Y; Kato, K; Inagaki, S; Hayashi, S; Kageyama, Y				Kondo, Takefumi; Hashimoto, Yoshiko; Kato, Kagayaki; Inagaki, Sachi; Hayashi, Shigeo; Kageyama, Yuji			Small peptide regulators of actin-based cell morphogenesis encoded by a polycistronic mRNA	NATURE CELL BIOLOGY			English	Article							DROSOPHILA-MELANOGASTER; DIFFERENTIATION; PROTEIN; IDENTIFICATION; ORGANIZATION; WINGLESS; DENTICLE; PATTERN; SYSTEM; GENOME	Transcriptome analyses in eukaryotes, including mice and humans, have identified polyA- containing transcripts that lack long open reading frames (ORFs; > 100 amino acids) 1,2. These transcripts are believed most likely to function as non-coding RNAs, but their translational capacities and biological activities have not been characterized in detail. Here, we report that polished rice (pri), which was previously identified as a gene for a non-coding RNA in Drosophila3,4, is in fact transcribed into a polycistronic mRNA that contains evolutionarily conserved short ORFs that encode 11 or 32 amino acid-long peptides. pri was expressed in all epithelial tissues during embryogenesis. The loss of pri function completely eliminated apical cuticular structures, including the epidermal denticles and tracheal taenidia, and also caused defective tracheal-tube expansion. We found that pri is essential for the formation of specific F-actin bundles that prefigures the formation of the denticles and taenidium. We provide evidences that pri acts non-cell autonomously and that four of the conserved pri ORFs are functionally redundant. These results demonstrate that pri has essential roles in epithelial morphogenesis by regulating F-actin organization.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Sci & Technol, Dept Life Sci, Kobe, Hyogo 657, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	RIKEN; Kobe University; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Kageyama, Y (corresponding author), Okazaki Inst Integrated Biosci, 5-1 Myoudaiji Higashiyama, Okazaki, Aichi 4448787, Japan.	kageyama@nibb.ac.jp	Hayashi, Shigeo/N-5128-2015; Hayashi, Shigeo/J-9628-2019; Inagaki, Sachi/P-8036-2019	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Inagaki, Sachi/0000-0002-2365-9938; Kondo, Takefumi/0000-0001-8127-1141; Kato, Kagayaki/0000-0003-4757-3773				BARTOSZEWSKI S, 1994, DROSOPHILA INFORMATI, V14; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, DEV DYNAM, V233, P1056, DOI 10.1002/dvdy.20389; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Ohtake H, 2004, DNA RES, V11, P305, DOI 10.1093/dnares/11.4.305; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PATEL N, 1995, DROSOPHILA MELANOGAS, P445; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454	28	181	192	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					660	U87		10.1038/ncb1595	http://dx.doi.org/10.1038/ncb1595			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486114				2022-12-27	WOS:000246922700011
J	van der Horst, A; de Vries-Smits, AMM; Brenkman, AB; van Triest, MH; van den Broek, N; Colland, F; Maurice, MM; Burgering, BMT				van der Horst, Armando; de Vries-Smits, Alida M. M.; Brenkman, Arjan B.; van Triest, Miranda H.; van den Broek, Niels; Colland, Frederic; Maurice, Madelon M.; Burgering, Boudewijn M. T.			FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-B; PROMOTES CELL-SURVIVAL; OXIDATIVE STRESS; FACTOR AFX; PROTEASOMAL DEGRADATION; CAENORHABDITIS-ELEGANS; TUMOR SUPPRESSION; LIFE-SPAN; FORKHEAD; PATHWAY	FOXO (Forkhead box O) transcription factors are important regulators of cellular metabolism, cell-cycle progression and cell death. FOXO activity is regulated by multiple post-translational modifications, including phosphorylation, acetylation and polyubiquitination. Here, we show that FOXO becomes monoubiquitinated in response to increased cellular oxidative stress, resulting in its re-localization to the nucleus and an increase in its transcriptional activity. Deubiquitination of FOXO requires the deubiquitinating enzyme USP7/HAUSP (herpesvirus-associated ubiquitin-specific protease), which interacts with and deubiquitinates FOXO in response to oxidative stress. Oxidative stress-induced ubiquitination and deubiquitination by USP7 do not influence FOXO protein half-life. However, USP7 does negatively regulate FOXO transcriptional activity towards endogenous promoters. Our results demonstrate a novel mechanism of FOXO regulation and indicate that USP7 has an important role in regulating FOXO-mediated stress responses.	Univ Utrecht, Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Hybrigen SA, F-75014 Paris, France; Univ Utrecht, Dept Cell Biol, Med Ctr, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University	Burgering, BMT (corresponding author), Univ Utrecht, Med Ctr, Dept Physiol Chem, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands.	B.M.T.Burgering@med.uu.nl		Maurice, Madelon/0000-0001-6885-5361				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cao C, 2005, ONCOGENE, V24, P2433, DOI 10.1038/sj.onc.1208454; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; De Ruiter ND, 2001, MOL CELL BIOL, V21, P8225, DOI 10.1128/MCB.21.23.8225-8235.2001; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fukuoka M, 2003, INT J MOL MED, V12, P503; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Katoh M, 2004, INT J ONCOL, V25, P1495; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahmud DL, 2002, ONCOGENE, V21, P1556, DOI 10.1038/sj.onc.1205230; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nanji M, 2005, AGING CELL, V4, P235, DOI 10.1111/j.1474-9726.2005.00166.x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Onishi Y, 2005, BIOCHEM BIOPH RES CO, V336, P799, DOI 10.1016/j.bbrc.2005.08.175; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019	47	371	397	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1064	U40		10.1038/ncb1469	http://dx.doi.org/10.1038/ncb1469			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16964248				2022-12-27	WOS:000241395300010
J	Gao, MG; Kaiser, CA				Gao, Minggeng; Kaiser, Chris A.			A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; LATE-GOLGI; ACTIN CYTOSKELETON; SECRETORY PATHWAY; PROTEIN COMPLEXES; BINDING PROTEINS; CONTROLS ENTRY; ENDOSOME; VACUOLAR	The Saccharomyces cerevisiae general amino-acid permease, Gap1p, is a model for membrane proteins that are regulated by intracellular sorting according to physiological cues set by the availability of amino acids. Here, we report the identification of a conserved sorting complex for Gap1p, named the GTPase-containing complex for Gap1p sorting in the endosomes ( GSE complex), which is required for proper sorting of Gap1p from the late endosome for eventual delivery to the plasma membrane. The complex contains two small GTPases ( Gtr1p and Gtr2p) and three other proteins ( Ybr077c, Ykr007w and Ltv1p) that are located in the late endosomal membrane. Importantly, Gtr2p interacts with the carboxy ( C)-terminal cytosolic domain of Gap1p and a tyrosine-containing motif in this domain is necessary both to bind Gtr2p and to direct sorting of Gap1p to the plasma membrane. Together, these studies provide evidence that the GSE complex has a key role in trafficking Gap1p out of the endosome and may serve as coat proteins in this process.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kaiser, CA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckaiser@mit.edu			NIGMS NIH HHS [GM56933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM PR, 1992, YEAST, V8, P227, DOI 10.1002/yea.320080309; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Ashrafi K, 1998, J BIOL CHEM, V273, P25864, DOI 10.1074/jbc.273.40.25864; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kaiser CA, 2002, METHOD ENZYMOL, V351, P325; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Nakashima N, 1999, GENETICS, V152, P853; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Redding K, 1996, MOL CELL BIOL, V16, P6208; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397	48	142	149	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					657	U14		10.1038/ncb1419	http://dx.doi.org/10.1038/ncb1419			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16732272				2022-12-27	WOS:000238837800008
J	Puthenveedu, MA; Bachert, C; Puri, S; Lanni, F; Linstedt, AD				Puthenveedu, MA; Bachert, C; Puri, S; Lanni, F; Linstedt, AD			GM130 and GRASP65-dependent lateral cisternal fusion allows uniform Golgi-enzyme distribution	NATURE CELL BIOLOGY			English	Article							CELL-FREE SYSTEM; ENDOPLASMIC-RETICULUM; RIBBON FORMATION; MATRIX PROTEIN; HELA-CELLS; COMPLEX; APPARATUS; STACKING; DISRUPTION; DROSOPHILA	The mammalian Golgi apparatus exists as stacks of cisternae that are laterally linked to form a continuous membrane ribbon, but neither the molecular requirements for, nor the purpose of, Golgi ribbon formation are known. Here, we demonstrate that ribbon formation is mediated by specific membrane-fusion events that occur during Golgi assembly, and require the Golgi proteins GM130 and GRASP65. Furthermore, these GM130 and GRASP65-dependent lateral cisternal-fusion reactions are necessary to achieve uniform distribution of enzymes in the Golgi ribbon. The membrane continuity created by ribbon formation facilitates optimal processing conditions in the biosynthetic pathway.	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.	linstedt@andrew.cmu.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231	NIGMS NIH HHS [GM-56779-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Linstedt AD, 1999, CURR BIOL, V9, pR893, DOI 10.1016/S0960-9822(00)80077-9; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Natarajan R, 2004, MOL BIOL CELL, V15, P4798, DOI 10.1091/mbc.E04-05-0366; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puri S, 2003, MOL BIOL CELL, V14, P5011, DOI 10.1091/mbc.E03-06-0437; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, EXP CELL RES, V271, P22, DOI 10.1006/excr.2001.5367; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; Rios RM, 2004, CELL, V118, P323; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Vasile E, 2003, TRAFFIC, V4, P254, DOI 10.1034/j.1600-0854.2003.00080.x; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	42	246	264	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					238	248		10.1038/ncb1366	http://dx.doi.org/10.1038/ncb1366			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16489344				2022-12-27	WOS:000235708000009
J	Feldman, N; Gerson, A; Fang, J; Li, E; Zhang, Y; Shinkai, Y; Cedar, H; Bergman, Y				Feldman, N; Gerson, A; Fang, J; Li, E; Zhang, Y; Shinkai, Y; Cedar, H; Bergman, Y			G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis	NATURE CELL BIOLOGY			English	Article							DE-NOVO METHYLATION; HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR; LYSINE-9 METHYLATION; GENE-EXPRESSION; DNA METHYLATION; STEM-CELLS; GERMLINE; BINDING; NUCLEI	Oct-3/4 is a POU domain homeobox gene that is expressed during gametogenesis and in early embryonic cells(1,2), where it has been shown to be important for maintaining pluripotency(3). Following implantation, this gene undergoes a novel multi-step programme of inactivation. Transcriptional repression is followed by a pronounced increase in histone H3 methylation on Lys 9 that is mediated by the SET-containing protein, G9a. This step sets the stage for local heterochromatinization via the binding of HP1 and is required for subsequent de novo methylation at the promoter by the enzymes Dnmt3a/3b. Genetic studies show that these epigenetic changes actually have an important role in the inhibition of Oct-3/4 reexpression, thereby preventing reprogramming.	Hebrew Univ Jerusalem, Sch Med, Dept Expt Med, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Cellular Biochem, IL-91120 Jerusalem, Israel; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 6068507, Japan	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Kyoto University	Bergman, Y (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Expt Med, IL-91120 Jerusalem, Israel.	yberg@md.huji.ac.il	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484; Zhang, Yi/0000-0002-2789-0811; Fang, Jia/0000-0001-8583-1652				Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brehm A, 1998, APMIS, V106, P114, DOI 10.1111/j.1699-0463.1998.tb01326.x; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Ji YH, 2003, P NATL ACAD SCI USA, V100, P7557, DOI 10.1073/pnas.0932635100; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200	30	498	524	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					188	U55		10.1038/ncb1353	http://dx.doi.org/10.1038/ncb1353			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16415856				2022-12-27	WOS:000235059800014
J	Tu, S; McStay, GP; Boucher, LM; Mak, T; Beere, HM; Green, DR				Tu, S; McStay, GP; Boucher, LM; Mak, T; Beere, HM; Green, DR			In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis	NATURE CELL BIOLOGY			English	Article							CELL-DEATH; INDEPENDENT MECHANISMS; CYTOCHROME-C; FAS LIGAND; MITOCHONDRIA; EXPRESSION; UPSTREAM; RELEASE; PROTEIN	Activation of 'initiator' ( or 'apical') caspases- 2, - 8 or - 9 ( refs 1 - 3) is crucial for induction of apoptosis. These caspases function to activate executioner caspapses that, in turn, orchestrate apoptotic cell death. Here, we show that a cell-permeable, biotinylated pan- caspase inhibitor ( bVAD - fmk) both inhibited and ' trapped' the apical caspase activated when apoptosis was triggered. As expected, only caspase- 8 was trapped in response to ligation of death receptors, whereas only caspase- 9 was trapped in response to a variety of other apoptosis- inducing agents. Caspase- 2 was exclusively activated in heat shock- induced apoptosis. This activation of caspase- 2 was also observed in cells protected from heat- shock- induced apoptosis by Bcl- 2 or Bcl- xL. Reduced sensitivity to heat-shock-induced death was observed in caspase- 2(-/-) cells. Furthermore, cells lacking the adapter molecule RAIDD failed to activate caspase- 2 after heat shock treatment and showed resistance to apoptosis in this setting. This approach unambiguously identifies the apical caspase activated in response to apoptotic stimuli, and establishes caspase- 2 as a proximal mediator of heat shock- induced apoptosis.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	La Jolla Institute for Immunology; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,332 N Lauderdale St, Memphis, TN 38105 USA.	helen.beere@stjude.org; douglas.green@stjude.org	Green, Douglas R/N-8083-2018; McStay, Gavin/K-9574-2013	Green, Douglas R/0000-0002-7332-1417; McStay, Gavin/0000-0003-1363-8719; Tu, S. Sean/0000-0003-0391-8186; Boucher, Louis-Martin/0000-0003-2802-2124	NIAID NIH HHS [AI58422, AI47891, AI44828, AI40646] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646, R37AI044828, R01AI044828, R01AI047891, F32AI058422] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brunner T, 2000, J BIOL CHEM, V275, P9767, DOI 10.1074/jbc.275.13.9767; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cippitelli M, 2005, J IMMUNOL, V174, P223, DOI 10.4049/jimmunol.174.1.223; CUENDE E, 1993, EMBO J, V12, P1555, DOI 10.1002/j.1460-2075.1993.tb05799.x; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lassus P, 2004, SCIENCE, V306, P1683; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lin CF, 2005, J BIOL CHEM, V280, P23758, DOI 10.1074/jbc.M412292200; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Petak I, 2000, CANCER RES, V60, P2643; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; Troy CM, 1997, J NEUROSCI, V17, P1911; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	32	164	169	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					72	U24		10.1038/ncb1340	http://dx.doi.org/10.1038/ncb1340			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16362053				2022-12-27	WOS:000234651500014
J	Platta, HW; Grunau, S; Rosenkranz, K; Girzalsky, W; Erdmann, R				Platta, HW; Grunau, S; Rosenkranz, K; Girzalsky, W; Erdmann, R			Functional role of the AAA peroxins in dislocation of the cycling PTS1 receptor back to the cytosol	NATURE CELL BIOLOGY			English	Letter							MATRIX PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; PEROXISOMAL MATRIX; PEX5P; YEAST; BIOGENESIS; PEX6P; FRUCTOSE-1,6-BISPHOSPHATASE; UBIQUITINATION; TRANSLOCATION	Peroxisomal import receptors bind their cargo proteins in the cytosol and target them to docking and translocation machinery at the peroxisomal membrane (reviewed in ref. 1). The receptors release the cargo proteins into the peroxisomal lumen and, according to the model of cycling receptors, they are supposed to shuttle back to the cytosol. This shuttling of the receptors has been assigned to peroxins including the AAA peroxins Pex1p and Pex6p, as well as the ubiquitin-conjugating enzyme Pex4p (reviewed in ref. 2). One possible target for Pex4p is the PTS1 receptor Pex5p, which has recently been shown to be ubiquitinated(3-5). Pex1p and Pex6p are both cytosolic and membrane-associated AAA ATPases of the peroxisomal protein import machinery, the exact function of which is still unknown. Here we demonstrate that the AAA peroxins mediate the ATP-dependent dislocation of the peroxisomal targeting signal-1 (PTS1) receptor from the peroxisomal membrane to the cytosol.	Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Brown KA, 2000, J NUCL CARDIOL, V7, P388, DOI 10.1067/mnc.2000.108031; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Gouveia AM, 2003, ADV EXP MED BIOL, V544, P219; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399	30	175	180	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					817	U83		10.1038/ncb1281	http://dx.doi.org/10.1038/ncb1281			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16007078				2022-12-27	WOS:000230881500016
J	Dentice, M; Bandyopadhyay, A; Gereben, B; Callebaut, I; Christoffolete, MA; Kim, BW; Nissim, S; Mornon, JP; Zavacki, AM; Zeold, A; Capelo, LP; Curcio-Morelli, C; Ribeiro, R; Harney, JW; Tabin, CJ; Bianco, AC				Dentice, M; Bandyopadhyay, A; Gereben, B; Callebaut, I; Christoffolete, MA; Kim, BW; Nissim, S; Mornon, JP; Zavacki, AM; Zeold, A; Capelo, LP; Curcio-Morelli, C; Ribeiro, R; Harney, JW; Tabin, CJ; Bianco, AC			The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate	NATURE CELL BIOLOGY			English	Letter							RETICULUM-ASSOCIATED DEGRADATION; TYPE-2 IODOTHYRONINE DEIODINASE; INDIAN HEDGEHOG; PROTEIN; COMPLEX; DIFFERENTIATION; SOCS; CHONDROCYTES; REPEAT; CELLS	WSB- 1 is a SOCS- box- containing WD- 40 protein of unknown function that is induced by Hedgehog signalling in embryonic structures during chicken development. Here we show that WSB- 1 is part of an E3 ubiquitin ligase for the thyroid- hormone-activating type 2 iodothyronine deiodinase ( D2). The WD- 40 propeller of WSB- 1 recognizes an 18- amino- acid loop in D2 that confers metabolic instability, whereas the SOCS- box domain mediates its interaction with a ubiquitinating catalytic core complex, modelled as Elongin BC - Cul5 - Rbx1 ( ECSWSB- 1). In the developing tibial growth plate, Hedgehog- stimulated D2 ubiquitination via ECSWSB- 1 induces parathyroid hormone- related peptide ( PTHrP), thereby regulating chondrocyte differentiation. Thus, ECSWSB- 1 mediates a mechanism by which ' systemic' thyroid hormone can effect local control of the Hedgehog PTHrP negative feedback loop and thus skeletogenesis.	Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, H-1083 Budapest, Hungary; Univ Paris 06, Dept Biol Struct, LMCP, CNRS,UMR7590, F-75252 Paris, France; Univ Paris 07, Dept Biol Struct, LMCP, CNRS,UMR7590, F-75252 Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite	Bianco, AC (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, 75 Francis St, Boston, MA 02115 USA.	abianco@partners.org	Bandyopadhyay, Amitabha/B-9735-2008; Capelo, Luciane/AAV-2593-2020; Capelo, Luciane/AFW-4604-2022; Bianco, Antonio C/A-4965-2008; Bianco, Antonio/AAK-6336-2020	Capelo, Luciane/0000-0002-3004-1220; Bianco, Antonio C/0000-0001-7737-6813; Bianco, Antonio/0000-0001-7737-6813; Bandyopadhyay, Amitabha/0000-0002-0429-438X; Christoffolete, Marcelo/0000-0003-0374-0795; Nissim, Sahar/0000-0002-2303-6415	FOGARTY INTERNATIONAL CENTER [R03TW006467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246, R01DK058538] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW006467, TW006467] Funding Source: Medline; NIDDK NIH HHS [R01 DK058538, DK56246, P01 DK056246, DK058538] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Callebaut I, 2003, J BIOL CHEM, V278, P36887, DOI 10.1074/jbc.M305725200; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Cook WJ, 1997, BIOCHEMISTRY-US, V36, P1621, DOI 10.1021/bi962639e; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Curcio-Morelli C, 2003, ENDOCRINOLOGY, V144, P937, DOI 10.1210/en.2002-220960; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Hamilton KS, 2000, J BIOMOL NMR, V18, P319, DOI 10.1023/A:1026773008237; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kim BW, 2003, MOL ENDOCRINOL, V17, P2603, DOI 10.1210/me.2003-0082; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Long FX, 2001, DEVELOPMENT, V128, P5099; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Robson H, 2000, ENDOCRINOLOGY, V141, P3887, DOI 10.1210/en.141.10.3887; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Solomon V, 1998, J BIOL CHEM, V273, P25216, DOI 10.1074/jbc.273.39.25216; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Steinsapir J, 1998, J CLIN INVEST, V102, P1895, DOI 10.1172/JCI4672; Stevens DA, 2000, J BONE MINER RES, V15, P2431, DOI 10.1359/jbmr.2000.15.12.2431; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	35	176	182	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					698	U87		10.1038/ncb1272	http://dx.doi.org/10.1038/ncb1272			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15965468	Green Accepted			2022-12-27	WOS:000230190800014
J	van Es, JH; Jay, P; Gregorieff, A; van Gijn, ME; Jonkheer, S; Hatzis, P; Thiele, A; van den Born, M; Begthel, H; Brabletz, T; Taketo, MM; Clevers, H				van Es, JH; Jay, P; Gregorieff, A; van Gijn, ME; Jonkheer, S; Hatzis, P; Thiele, A; van den Born, M; Begthel, H; Brabletz, T; Taketo, MM; Clevers, H			Wnt signalling induces maturation of Paneth cells in intestinal crypts	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; METALLOPROTEINASE MATRILYSIN; FUNCTIONAL INTERACTION; COLORECTAL-CANCER; ALPHA-DEFENSINS; ACTIVATION; COMPLEX; MICE; AXIN	Wnt signalling, which is transduced through beta-catenin/TCF4, maintains the undifferentiated state of intestinal crypt progenitor cells(1,2). Mutational activation of the pathway initiates the adenomacarcinoma sequence(3,4). Whereas all other differentiated epithelial cells migrate from the crypt onto the villus, Paneth cells home towards the source of Wnt signals - that is, the crypt bottom. Here, we show that expression of a Paneth gene programme is critically dependent on TCF4 in embryonic intestine. Moreover, conditional deletion of the Wnt receptor Frizzled-5 abrogates expression of these genes in Paneth cells in the adult intestine. Conversely, adenomas in Apc-mutant mice and colorectal cancers in humans inappropriately express these Paneth-cell genes. These observations imply that Wnt signals in the crypt can separately drive a stem-cell/progenitor gene programme and a Paneth-cell maturation programme. In intestinal cancer, both gene programmes are activated simultaneously.	Netherlands Inst Dev Biol, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; CNRS, UPR 1142, Inst Genet Humaine, F-34396 Montpellier, France; Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Erlangen Nuremberg; Kyoto University	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Jay, Philippe/ABD-9223-2020; Eckhardt, Erik/G-1567-2010; van+Es, Johan/ABD-5411-2021; Jay, Philippe/I-7116-2016	Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700				Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; BANCROFT JD, 1996, THEORY PRACTICE HIST, P304; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Krause R, 1998, DIFFERENTIATION, V63, P285, DOI 10.1046/j.1432-0436.1998.6350285.x; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moller P, 1996, AM J PATHOL, V149, P9; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; van Beest M, 2000, J BIOL CHEM, V275, P27266; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	30	467	477	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					381	U37		10.1038/ncb1240	http://dx.doi.org/10.1038/ncb1240			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15778706				2022-12-27	WOS:000228075500014
J	Benanti, JA; Cheung, SK; Brady, MC; Toczyski, DP				Benanti, Jennifer A.; Cheung, Stephanie K.; Brady, Mariska C.; Toczyski, David P.			A proteomic screen reveals sCFGrr1 targets that regulate the glycolytic-gluconeogenic switch	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASES; GLOBAL ANALYSIS; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAYS; KINASE-I; YEAST; PROTEIN; GLUCOSE; DEGRADATION	Entry into the cell cycle is regulated by nutrient availability such that cells do not divide when resources are limited. The Skp1-Cul1-F-box(SCF) ubiquitin ligase with the F-box protein Grr1 ( SCFGrr1) controls the proteolytic turnover of regulators of cell-cycle entry and a glucose sensor, suggesting that it links the cell cycle with nutrient availability. Here, we show that SCFGrr1 broadly regulates cellular metabolism. We have developed a proteomic screening method that uses high-throughput quantitative microscopy to comprehensively screen for ubiquitin-ligase substrates. Seven new metabolic targets of SCFGrr1 were identified, including two regulators of glycolysis-the transcription factor Tye7 and Pfk27. The latter produces the second messenger fructose-2,6- bisphosphate that activates glycolysis and inhibits gluconeogenesis. We show that SCFGrr1 targets Pfk27 and Tye7 in response to glucose removal. Moreover, Pfk27 is phosphorylated by the kinase Snf1, and unphosphorylatable Pfk27 is stable and inhibits growth in the absence of glucose. These results demonstrate a role for SCFGrr1 in regulating the glycolytic-gluconeogenic switch.	Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Toczyski, DP (corresponding author), Univ Calif San Francisco, Canc Res Inst, Dept Biochem & Biophys, 2340 Sutter St, San Francisco, CA 94115 USA.	toczyski@cc.ucsf.edu		Benanti, Jennifer/0000-0003-2484-5721				Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Eckert-Boulet N, 2005, CURR GENET, V47, P139, DOI 10.1007/s00294-004-0553-1; Espinoza FH, 1998, MOL CELL BIOL, V18, P6365, DOI 10.1128/MCB.18.11.6365; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goncalves PM, 1997, MOL MICROBIOL, V25, P483, DOI 10.1046/j.1365-2958.1997.4811847.x; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kishi T, 1998, J CELL SCI, V111, P3655; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; NISHI K, 1995, MOL CELL BIOL, V15, P2646; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Purnapatre K, 2005, MOL CELL BIOL, V25, P440, DOI 10.1128/MCB.25.1.440-450.2005; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	27	71	71	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1184	1191		10.1038/ncb1639	http://dx.doi.org/10.1038/ncb1639			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828247				2022-12-27	WOS:000249882300014
J	Stroissnigg, H; Trancikova, A; Descovich, L; Fuhrmann, J; Kutschera, W; Kostan, J; Meixner, A; Nothias, F; Propst, F				Stroissnigg, Heike; Trancikova, Alzbeta; Descovich, Luise; Fuhrmann, Jakob; Kutschera, Waltraud; Kostan, Julius; Meixner, Arabella; Nothias, Fatiha; Propst, Friedrich			S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction	NATURE CELL BIOLOGY			English	Article							TRANSIENT RETINOTECTAL PROJECTION; GROWTH CONE COLLAPSE; LIGHT-CHAIN; NEURONAL MIGRATION; NERVOUS-SYSTEM; MOTOR PROTEINS; IN-VITRO; MAP1B; TRANSPORT; BINDING	Treatment of cultured vertebrate neurons with nitric oxide leads to growth-cone collapse, axon retraction and the reconfiguration of axonal microtubules. We show that the light chain of microtubule-associated protein ( MAP) 1B is a substrate for S-nitrosylation in vivo, in cultured cells and in vitro. S-nitrosylation occurs at Cys 2457 in the COOH terminus. Nitrosylation of MAP1B leads to enhanced interaction with microtubules and correlates with the inhibition of neuroblastoma cell differentiation. We further show, in dorsal root ganglion neurons, that MAP1B is necessary for neuronal nitric oxide synthase control of growth-cone size, growth-cone collapse and axon retraction. These results reveal an S-nitrosylation-dependent signal-transduction pathway that is involved in regulation of the axonal cytoskeleton and identify MAP1B as a major component of this pathway. We propose that MAP1B acts by inhibiting a microtubule- and dynein-based mechanism that normally prevents axon retraction.	Austrian Acad Sci, Inst Mol Biotechnol GmbH, A-1030 Vienna, Austria; Univ Vienna, Dept Mol & Cell Biol, A-1030 Vienna, Austria; Univ Paris 06, UMR7101 NSI, F-75005 Paris, France; CNRS, UMR7101, IFR83, F-75005 Paris, France	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Vienna; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Propst, F (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol GmbH, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	friedrich.propst@univie.ac.at	Trancikova, Alzbeta Kralova/X-7402-2018	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Kostan, Julius/0000-0002-8347-111X; Nothias-Chahir, Fatiha/0000-0002-2497-2096				Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Cramer KS, 1996, J NEUROSCI, V16, P7995; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ernst AF, 2000, J NEUROSCI, V20, P1458; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; FAWCETT JW, 1994, NEUROSCIENCE, V61, P789, DOI 10.1016/0306-4522(94)90402-2; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; He Y, 2002, J NEUROSCI, V22, P5982; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kaytor MD, 2001, CELL, V107, P555, DOI 10.1016/S0092-8674(01)00590-6; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Ma D, 1997, J NEUROSCI RES, V49, P319, DOI 10.1002/(SICI)1097-4547(19970801)49:3<319::AID-JNR7>3.0.CO;2-F; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mize RR, 1998, PROG BRAIN RES, V118, P133; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pigino G, 1997, J CELL SCI, V110, P257; Renteria RC, 1996, J NEUROBIOL, V29, P415; Sambrook J., 2002, MOL CLONING LAB MANU; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Soares S, 2002, EUR J NEUROSCI, V16, P593, DOI 10.1046/j.1460-9568.2002.02126.x; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885	49	60	62	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1035	U8		10.1038/ncb1625	http://dx.doi.org/10.1038/ncb1625			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704770				2022-12-27	WOS:000249256500011
J	Mougous, JD; Gifford, CA; Ramsdell, TL; Mekalanos, JJ				Mougous, Joseph D.; Gifford, Casey A.; Ramsdell, Talia L.; Mekalanos, John J.			Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa	NATURE CELL BIOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; FHA DOMAINS; ACUTE INFECTION; III SECRETION; VIRULENCE; KINASE; GENES; IDENTIFICATION; EXPRESSION; STRAIN	Secreted proteins are crucial to the arsenal of bacterial pathogens. Although optimal activity of these proteins is likely to require precise regulation of release, the signalling events that trigger secretion are poorly understood. Here, we identify a threonine phosphorylation event that post-translationally regulates the Hcp secretion island-I-encoded type VI secretion system of Pseudomonas aeruginosa (H-T6SS). We show that a serine-threonine kinase, PpkA, is required for assembly of the H-T6SS and for secretion of Hcp1. PpkA activity is antagonized by PppA, a Ser-Thr phosphatase. These proteins exhibit reciprocal effects on the H-T6SS by acting on an FHA domain-containing protein, termed Fha1. Colocalization experiments with the T6S AAA+ family protein, ClpV1, indicate that Fha1 is a core scaffolding protein of the H-T6SS. Mutations affecting this H- T6S regulatory pathway provide a molecular explanation for the variation in Hcp1 secretion among clinical P. aeruginosa isolates. This mechanism of triggering secretion may be general, as many T6SSs contain orthologues of these proteins. Post-translational regulation of protein secretion by Thr phosphorylation is unprecedented in bacteria, and is likely to reflect the requirement for T6S to respond rapidly and reversibly to its environment.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu		Gifford, Casey/0000-0002-7757-573X	NIAID NIH HHS [AI26289, R01 AI026289] Funding Source: Medline; NIGMS NIH HHS [U54 GM074942] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Yahr TL, 2006, NEW ENGL J MED, V355, P1171, DOI 10.1056/NEJMcibr063931; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009	31	221	235	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					797	U121		10.1038/ncb1605	http://dx.doi.org/10.1038/ncb1605			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558395				2022-12-27	WOS:000247760700015
J	Stelter, P; Kunze, R; Flemming, D; Hopfner, D; Diepholz, M; Philippsen, P; Bottcher, B; Hurt, E				Stelter, Philipp; Kunze, Ruth; Flemming, Dirk; Hoepfner, Dominic; Diepholz, Meikel; Philippsen, Peter; Boettcher, Bettina; Hurt, Ed			Molecular basis for the functional interaction of dynein light chain with the nuclear-pore complex	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; NUCLEOPORIN COMPLEX; TERMINAL DOMAIN; PROTEIN IMPORT; TRANSPORT; YEAST; MECHANISM; NSP1P; RAT7P/NUP159P	Nucleocytoplasmic transport occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope(1). Here, we discovered an unexpected role for yeast dynein light chain (Dyn2) 2 in the NPC. Dyn2 is a previously undescribed nucleoporin that functions as molecular glue to dimerize and stabilize the Nup82-Nsp1-Nup159 complex, a module of the cytoplasmic pore filaments(3). Biochemical analyses showed that Dyn2 binds to a linear motif ( termed DIDNup159) inserted between the Phe-Gly repeat and coiled-coil domain of Nup159. Electron microscopy revealed that the reconstituted Dyn2 DIDNup159 complex forms a rigid rod-like structure, in which five Dyn2 homodimers align like 'pearls on a string' between two extented DIDNup159 strands. These findings imply that the rigid 20 nm long Dyn2-DIDNup159 filament projects the Nup159 Phe-Gly repeats from the Nup82 module. Thus, it is possible that dynein light chain plays a role in organizing natively unfolded Phe-Gly repeats within the NPC scaffold to facilitate nucleocytoplasmic transport.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; EMBL, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Basel; European Molecular Biology Laboratory (EMBL)	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Bottcher, Bettina/E-9397-2010; Flemming, Dirk/AAP-3274-2021; Ed Hurt, Dr./AAE-8874-2019	Bottcher, Bettina/0000-0002-7962-4849; Ed Hurt, Dr./0000-0002-4535-8255				BABLER J, 2001, MOL CELL, V8, P517; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Del Priore V, 1997, J CELL SCI, V110, P2987; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dick T, 1996, MOL GEN GENET, V251, P38; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig O, 1998, YEAST, V14, P1139; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032	40	75	77	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					788	U108		10.1038/ncb1604	http://dx.doi.org/10.1038/ncb1604			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17546040				2022-12-27	WOS:000247760700014
J	Wang, XC; Wang, J; Gengyo-Ando, K; Gu, LC; Sun, CL; Yang, CL; Shi, Y; Kobayashi, T; Shi, YG; Mitani, SH; Xie, XS; Xue, D				Wang, Xiaochen; Wang, Jin; Gengyo-Ando, Keiko; Gu, Lichuan; Sun, Chun-Ling; Yang, Chonglin; Shi, Yong; Kobayashi, Tetsuo; Shi, Yigong; Mitani, Shohei; Xie, Xiao-Song; Xue, Ding			C-elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1	NATURE CELL BIOLOGY			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CORPSE ENGULFMENT; MEMBRANE PHOSPHOLIPIDS; TRANSBILAYER MOVEMENT; DEATH; PROTEIN; DNA; RECEPTOR; RECOGNITION; LYMPHOCYTES	Externalization of phosphatidylserine, which is normally restricted to the inner leaflet of plasma membrane, is a hallmark of mammalian apoptosis1-4. It is not known what activates and mediates the phosphatidylserine externalization process in apoptotic cells. Here, we report the development of an annexin V-based phosphatidylserine labelling method and show that a majority of apoptotic germ cells in Caenorhabditis elegans have surface-exposed phosphatidylserine, indicating that phosphatidylserine externalization is a conserved apoptotic event in worms. Importantly, inactivation of the gene encoding either the C. elegans apoptosis- inducing factor (AIF) homologue (WAH-1) 5, a mitochondrial apoptogenic factor, or the C. elegans phospholipid scramblase 1 (SCRM-1), a plasma membrane protein, reduces phosphatidylserine exposure on the surface of apoptotic germ cells and compromises cell-corpse engulfment. WAH-1 associates with SCRM-1 and activates its phospholipid scrambling activity in vitro. Thus WAH-1, after its release from mitochondria during apoptosis, promotes plasma membrane phosphatidylserine externalization through its downstream effector, SCRM-1.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Univ Texas, Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan; JST, CREST, Tokyo 1628666, Japan; Princeton Univ, Dept Mol biol, Princeton, NJ 08544 USA	University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Princeton University	Xue, D (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	ding.xue@colorado.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Gengyo-Ando, Keiko/B-2753-2012	XUE, DING/0000-0002-8429-8136; Shi, Yigong/0000-0003-2030-168X				Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; BRENNER S, 1974, GENETICS, V77, P71; ELLIS RE, 1991, GENETICS, V129, P79; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, CELL DEATH DIFFER, V8, P582, DOI 10.1038/sj.cdd.4400856; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; MARTIN SJ, 1995, ABL J EXP MED, V182, P1545; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Riddle DL, 1997, C ELEGANS; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Vahsen N, 2006, ONCOGENE, V25, P1763, DOI 10.1038/sj.onc.1209206; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; WOODLE MC, 1989, METHOD ENZYMOL, V171, P193; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Zhou QS, 1998, BIOCHEMISTRY-US, V37, P2356, DOI 10.1021/bi972625o; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	92	112	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					541	U111		10.1038/ncb1574	http://dx.doi.org/10.1038/ncb1574			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17401362				2022-12-27	WOS:000246181500012
J	Binne, UK; Classon, MK; Dick, FA; Wei, W; Rape, M; Kaelin, WG; Naar, AM; Dyson, NJ				Binne, Ulrich K.; Classon, Marie K.; Dick, Frederick A.; Wei, Wenyi; Rape, Michael; Kaelin, William G., Jr.; Naar, Anders M.; Dyson, Nicholas J.			Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; DEGRADATION; BINDING; SKP2; PRB; DOMAIN; DIFFERENTIATION; TRANSCRIPTION; INHIBITOR; P27(KIP1)	The retinoblastoma protein (pRB) negatively regulates the progression from G1 to S phase of the cell cycle, in part, by repressing E2F-dependent transcription(1). pRB also possesses E2F-independent functions that contribute to cell-cycle control - for example, during pRB-mediated cell-cycle arrest pRB associates with Skp2, the F-box protein of the Skp1-Cullin-F-box protein (SCF) E3 ubiquitin ligase complex, and promotes the stability of the cyclin-dependent kinase-inhibitor p27(Kip1) through an unknown mechanism(2,3). Degradation of p27(Kip1) is mediated by ubiquitin-dependent targeting of p27(Kip1) by SCF-Skp2 (ref. 4). Here, we report a novel interaction between pRB and the anaphase-promoting complex/cyclosome (APC/C) that controls p27(Kip1) stability by targeting Skp2 for ubiquitin-mediated degradation. Cdh1, an activator of APC/C, not only interacts with pRB but is also required for a pRB-induced cell-cycle arrest. The results reveal an unexpected physical convergence between the pRB tumour-suppressor protein and E3 ligase complexes, and raise the possibility that pRB may direct APC/C to additional targets during pRB-mediated cell-cycle exit.	Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Schulich Sch Med, Dept Biochem, London, ON N6A 4L6, Canada; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Dyson, NJ (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	Naar@helix.mgh.harvard.edu; Dyson@helix.mgh.harvard.edu		Rape, Michael/0000-0003-4849-6343	NCI NIH HHS [CA64402] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064402] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; ANG XL, 2004, SCI STKE E, V31; ANG XL, 2004, SCI STKE, pE31; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dick FA, 2002, J VIROL, V76, P6224, DOI 10.1128/JVI.76.12.6224-6234.2002; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Imaki H, 2003, CANCER RES, V63, P4607; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Miyake S, 2000, MOL CELL BIOL, V20, P8889, DOI 10.1128/MCB.20.23.8889-8902.2000; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stroschein SL, 2001, GENE DEV, V15, P2822; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	33	131	133	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					225	U140		10.1038/ncb1532	http://dx.doi.org/10.1038/ncb1532			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17187060				2022-12-27	WOS:000243903000016
J	Kametani, Y; Takeichi, M				Kametani, Yoshiko; Takeichi, Masatoshi			Basal-to-apical cadherin flow at cell junctions	NATURE CELL BIOLOGY			English	Article							RETROGRADE ACTIN FLOW; ADHERENS JUNCTIONS; ALPHA-CATENIN; GROWTH CONE; F-ACTIN; ADHESION; DYNAMICS; MORPHOGENESIS; PROTRUSION; MOTILITY	Stable cell-cell adhesion is essential for maintaining tissue integrity, but cells are also able to relocate, implying the existence of mechanisms for coordinating cell adhesion and movement. Here, we show that, in some transformed lines, cadherin adhesion molecules exhibit a flow-like movement in a basal-apical direction at the cell junction and that this flow is associated with reorganizing actin filaments. Such flow also occurs in normal epithelial sheets, but solely at the junctions formed by moving cells. We propose that cadherin flow may provide a mechanism for facilitating the sliding of the two contacting cell membranes in morphogenetically active cell sheets.	Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	23	165	168	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					92	U118		10.1038/ncb1520	http://dx.doi.org/10.1038/ncb1520			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17159998				2022-12-27	WOS:000243255100017
J	Karsenti, E; Nedelec, F; Surrey, T				Karsenti, Eric; Nedelec, Francois; Surrey, Thomas			Modelling microtubule patterns	NATURE CELL BIOLOGY			English	Review							SELF-ORGANIZATION; DYNAMIC INSTABILITY; MOLECULAR MOTORS; DIRECTIONAL INSTABILITY; COMPUTER-SIMULATIONS; MECHANISTIC MODEL; FORCE GENERATION; KINESIN; MOTILITY; TRANSPORT	The cellular cytoskeleton is well studied in terms of its biological and physical properties, making it an attractive subject for systems approaches. Here, we describe the experimental and theoretical strategies used to study the collective behaviour of microtubules and motors. We illustrate how this led to the beginning of an understanding of dynamic cellular patterns that have precise functions.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	karsenti@embl.de; nedelec@embl.de; surrey@embl.de	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Surrey, Thomas/AAC-4608-2021	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Surrey, Thomas/0000-0001-9082-1870				Ahmadi A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.060901; Aranson IS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.050901; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Astumian RD, 2000, PHILOS T R SOC B, V355, P511, DOI 10.1098/rstb.2000.0592; Badoual M, 2002, P NATL ACAD SCI USA, V99, P6696, DOI 10.1073/pnas.102692399; Bassetti B, 2000, EUR PHYS J B, V15, P483, DOI 10.1007/s100510051150; BOURDIEU L, 1995, PHYS REV LETT, V75, P176, DOI 10.1103/PhysRevLett.75.176; Brust-Mascher I, 2004, P NATL ACAD SCI USA, V101, P15938, DOI 10.1073/pnas.0407044101; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Cytrynbaum EN, 2004, J CELL SCI, V117, P1381, DOI 10.1242/jcs.00919; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Dogterom M, 1998, PHYS REV LETT, V81, P485, DOI 10.1103/PhysRevLett.81.485; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Gibbons F, 2001, BIOPHYS J, V80, P2515, DOI 10.1016/S0006-3495(01)76223-6; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Glade N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-23; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HILL TL, 1987, LINEAR AGGREGATION T, P305; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Janson ME, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.248101; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Janulevicius A, 2006, BIOPHYS J, V90, P788, DOI 10.1529/biophysj.105.059410; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; KAUFFMAN S, 1995, AT HOME UNIVERSE; Khodjakov A, 1999, CELL MOTIL CYTOSKEL, V43, P179, DOI 10.1002/(SICI)1097-0169(1999)43:3<179::AID-CM1>3.3.CO;2-W; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Klumpp S, 2005, BIOPHYS J, V88, P3118, DOI 10.1529/biophysj.104.056127; Kruse K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.138101; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Lee HY, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056113; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; Malikov V, 2005, NAT CELL BIOL, V7, P1213, DOI 10.1038/ncb1332; Maly IV, 2002, TRENDS CELL BIOL, V12, P462, DOI 10.1016/S0962-8924(02)02369-3; Mandelkow E, 1999, CURR OPIN CELL BIOL, V11, P34, DOI 10.1016/S0955-0674(99)80005-2; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004; Mogilner M, 2006, TRENDS CELL BIOL, V16, P88, DOI 10.1016/j.tcb.2005.12.007; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Papaseit C, 2000, P NATL ACAD SCI USA, V97, P8364, DOI 10.1073/pnas.140029597; Parmeggiani A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086601; PESKIN CS, 1995, BIOPHYS J, V68, pS202; Raj A, 2006, P NATL ACAD SCI USA, V103, P5349, DOI 10.1073/pnas.0601215103; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Sankararaman S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031905; Schaffner SC, 2006, P NATL ACAD SCI USA, V103, P11166, DOI 10.1073/pnas.0604721103; Schief WR, 2004, P NATL ACAD SCI USA, V101, P1183, DOI 10.1073/pnas.0304369101; Shao Q, 2006, P NATL ACAD SCI USA, V103, P8072, DOI 10.1073/pnas.0602828103; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thomas N, 2002, P ROY SOC B-BIOL SCI, V269, P2363, DOI 10.1098/rspb.2002.2117; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; URRUTIA R, 1991, P NATL ACAD SCI USA, V88, P6701, DOI 10.1073/pnas.88.15.6701; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; Vilfan A, 1998, EUR PHYS J B, V3, P535, DOI 10.1007/s100510050343; Vilfan A, 2001, J MOL BIOL, V312, P1011, DOI 10.1006/jmbi.2001.5020; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zumdieck A, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.258103, 10.1103/PhysREvLett.95.258103]	93	73	74	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1204	1211		10.1038/ncb1498	http://dx.doi.org/10.1038/ncb1498			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060901				2022-12-27	WOS:000241732400005
J	Martin, AC; Welch, MD; Drubin, DG				Martin, Adam C.; Welch, Matthew D.; Drubin, David G.			Arp2/3 ATP hydrolysis-catalysed branch dissociation is critical for endocytic force generation	NATURE CELL BIOLOGY			English	Article							ACTIN-BASED MOTILITY; SACCHAROMYCES-CEREVISIAE; MEDIATED ENDOCYTOSIS; BUDDING YEAST; IN-VIVO; COMPLEX; PROTEIN; FILAMENT; MECHANISM; INTERNALIZATION	The Arp2/3 complex, which is crucial for actin-based motility, nucleates actin filaments and organizes them into y-branched networks. The Arp2 subunit has been shown to hydrolyse ATP, but the functional importance of Arp2/3 ATP hydrolysis is not known. Here, we analysed an Arp2 mutant in Saccharomyces cerevisiae that is defective in ATP hydrolysis. Arp2 ATP hydrolysis and Arp2/3-dependent actin nucleation occur almost simultaneously. However, ATP hydrolysis is not required for nucleation. In addition, Arp2 ATP hydrolysis is not required for the release of a WASP-like activator from y-branches. ATP hydrolysis by Arp2, and possibly Arp3, is essential for efficient y-branch dissociation in vitro. In living cells, both Arp2 and Arp3 ATP-hydrolysis mutants exhibit defects in endocytic internalization and actin-network disassembly. Our results suggest a critical feature of dendritic nucleation in which debranching and subsequent actin-filament remodelling and/or depolymerization are important for endocytic vesicle morphogenesis.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.	drubin@socrates.berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042759, R01GM059609, R01GM042759, R01GM050399] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59609, R01 GM059609-07, GM50399, GM42759, R01 GM059609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Martin AC, 2005, J CELL BIOL, V168, P315, DOI 10.1083/jcb.200408177; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5	30	63	63	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					826	U71		10.1038/ncb1443	http://dx.doi.org/10.1038/ncb1443			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862144				2022-12-27	WOS:000239423000012
J	Valentine, MT; Fordyce, PM; Krzysiak, TC; Gilbert, SP; Block, SM				Valentine, MT; Fordyce, PM; Krzysiak, TC; Gilbert, SP; Block, SM			Individual dimers of the mitotic kinesin motor Eg5 step processively and support substantial loads in vitro	NATURE CELL BIOLOGY			English	Article							OPTICAL FORCE CLAMP; STATISTICAL KINETICS; MICROTUBULE MOTOR; SINGLE MOLECULES; CROSS-LINKS; MOVEMENT; SPINDLES; VELOCITY; ATP; NCD	Eg5, a member of the kinesin superfamily of microtubule-based motors, is essential for bipolar spindle assembly and maintenance during mitosis, yet little is known about the mechanisms by which it accomplishes these tasks. Here, we used an automated optical trapping apparatus in conjunction with a novel motility assay that employed chemically modified surfaces to probe the mechanochemistry of Eg5. Individual dimers, formed by a recombinant human construct Eg5 513-5His, stepped processively along microtubules in 8-nm increments, with short run lengths averaging approximately eight steps. By varying the applied load ( with a force clamp) and the ATP concentration, we found that the velocity of Eg5 was slower and less sensitive to external load than that of conventional kinesin, possibly reflecting the distinct demands of spindle assembly as compared with vesicle transport. The Eg5-513-5His velocity data were described by a minimal, three-state model where a force-dependent transition follows nucleotide binding.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sblock@stanford.edu	Fordyce, Polly/AAY-6365-2020	Fordyce, Polly/0000-0002-9505-0638; Valentine, Megan/0000-0003-4781-8478	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051453] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOCK SM, 1995, TRENDS CELL BIOL, V5, P169; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Kamei T, 2005, BIOPHYS J, V88, P2068, DOI 10.1529/biophysj.104.049759; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Shaevitz JW, 2005, BIOPHYS J, V89, P2277, DOI 10.1529/biophysj.105.064295; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146	34	192	197	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					470	U89		10.1038/ncb1394	http://dx.doi.org/10.1038/ncb1394			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16604065	Green Accepted			2022-12-27	WOS:000237299400010
J	Hoeller, D; Crosetto, N; Blagoev, B; Raiborg, C; Tikkanen, R; Wagner, S; Kowanetz, K; Breitling, R; Mann, M; Stenmark, H; Dikic, I				Hoeller, D; Crosetto, N; Blagoev, B; Raiborg, C; Tikkanen, R; Wagner, S; Kowanetz, K; Breitling, R; Mann, M; Stenmark, H; Dikic, I			Regulation of ubiquitin-binding proteins by monoubiquitination	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; C-CBL; INTERACTING MOTIF; ENDOCYTIC PATHWAY; CLATHRIN; UBIQUITYLATION; DEGRADATION; RECRUITMENT; PROTEOMICS	Proteins containing ubiquitin-binding domains (UBDs) interact with ubiquitinated targets and regulate diverse biological processes, including endocytosis, signal transduction, transcription and DNA repair(1-3). Many of the UBD-containing proteins are also themselves monoubiquitinated, but the functional role and the mechanisms that underlie this modification are less well understood. Here, we demonstrate that monoubiquitination of the endocytic proteins Sts1, Sts2, Eps15 and Hrs results in intramolecular interactions between ubiquitin and their UBDs, thereby preventing them from binding in trans to ubiquitinated targets. Permanent monoubiquitination of these proteins, mimicked by the fusion of ubiquitin to their carboxyl termini, impairs their ability to regulate trafficking of ubiquitinated receptors. Moreover, we mapped the in vivo monoubiquitination site in Sts2 and demonstrated that its mutation enhances the Sts2-mediated effects of epidermal-growth-factor-receptor downregulation. We propose that monoubiquitination of ubiquitin-binding proteins inhibits their capacity to bind to and control the functions of ubiquitinated targets in vivo.	Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; Univ So Denmark Odense, Ctr Expt Bioinformat, DK-5230 Odense, Denmark; Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway; Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; Univ Groningen, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands; MPI, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	Goethe University Frankfurt; University of Southern Denmark; University of Oslo; Ludwig Institute for Cancer Research; University of Groningen; Max Planck Society	Dikic, I (corresponding author), Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Mann, Matthias/A-3454-2013; Stenmark, Harald/B-8868-2008; Wagner, Sebastian/B-9056-2012; Hoeller, Daniela/GVT-8953-2022; Dikic, Ivan/O-4650-2015	Mann, Matthias/0000-0003-1292-4799; Dikic, Ivan/0000-0001-8156-9511; Breitling, Rainer/0000-0001-7173-0922; Tikkanen, Ritva/0000-0002-8393-1825; Blagoev, Blagoy/0000-0002-3596-0066				Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Clague MJ, 2002, CURR BIOL, V12, pR529, DOI 10.1016/S0960-9822(02)01030-8; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Honda A, 2005, FRONT BIOSCI-LANDMRK, V10, P1290, DOI 10.2741/1619; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723	25	250	253	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					163	U45		10.1038/ncb1354	http://dx.doi.org/10.1038/ncb1354			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16429130	Green Published			2022-12-27	WOS:000235059800011
J	Hurtado-Lorenzo, A; Skinner, M; El Annan, J; Futai, M; Sun-Wada, GH; Bourgoin, S; Casanova, J; Wildeman, A; Bechoua, S; Ausiello, DA; Brown, D; Marshansky, V				Hurtado-Lorenzo, A; Skinner, M; El Annan, J; Futai, M; Sun-Wada, GH; Bourgoin, S; Casanova, J; Wildeman, A; Bechoua, S; Ausiello, DA; Brown, D; Marshansky, V			V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR; VACUOLAR H+-ATPASE; PROTON PUMP ATPASE; NUCLEOTIDE EXCHANGE; PROXIMAL TUBULES; PLASMA-MEMBRANE; A3 ISOFORM; KIDNEY; ACIDIFICATION; SUBUNIT	The recruitment of the small GTPase Arf6 and ARNO from cytosol to endosomal membranes is driven by V-ATPase-dependent intra-endosomal acidification. The molecular mechanism that mediates this pH-sensitive recruitment and its role are unknown. Here, we demonstrate that Arf6 interacts with the c-subunit, and ARNO with the a2-isoform of V-ATPase. The a2-isoform is targeted to early endosomes, interacts with ARNO in an intra-endosomal acidification-dependent manner, and disruption of this interaction results in reversible inhibition of endocytosis. Inhibition of endosomal acidification abrogates protein trafficking between early and late endosomal compartments. These data demonstrate the crucial role of early endosomal acidification and V-ATPase/ARNO/Arf6 interactions in the regulation of the endocytic degradative pathway. They also indicate that V-ATPase could modulate membrane trafficking by recruiting and interacting with ARNO and Arf6; characteristics that are consistent with the role of V-ATPase as an essential component of the endosomal pH-sensing machinery.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Richard Simches Res Ctr,Program Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Richard Simches Res Ctr,Nephrol Div, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; Microbial Chem Res Ctr, Futai Special Lab, Tokyo 1410021, Japan; Doshisha Womens Coll, Dept Biochem, Kyoto 6100395, Japan; Univ Laval, CHUL, Quebec City, PQ G1V 4G2, Canada; Univ Virginia, Hlth Sci Ctr, Dept Cell Biol, Charlottesville, VA 22908 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Guelph; Laval University; University of Virginia	Marshansky, V (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Richard Simches Res Ctr,Program Membrane Biol, Boston, MA 02114 USA.	Vladimir_Marshansky@hms.harvard.edu	Marshansky, Vladimir/AAZ-7890-2020; Hurtado-Lorenzo, Ph.D., Andres/A-8331-2009	Bourgoin, Sylvain/0000-0001-9779-0368	NIDDK NIH HHS [DK43341, DK57521, DK42956, DK38452] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043341, R01DK042956, R37DK042956, P01DK038452, P30DK057521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brown D., 2004, HDB ATPASES BIOCH CE, P413; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; D'SOUZA-SCHOREY C, 1995, EXP CELL RES, V221, P153, DOI 10.1006/excr.1995.1362; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; El Annan J, 2004, AM J PHYSIOL-CELL PH, V286, pC768, DOI 10.1152/ajpcell.00250.2003; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Gu F, 1999, FEBS LETT, V452, P61, DOI 10.1016/S0014-5793(99)00561-X; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Marshansky V, 1997, ELECTROPHORESIS, V18, P538, DOI 10.1002/elps.1150180334; Marshansky V, 1996, BBA-BIOMEMBRANES, V1284, P171, DOI 10.1016/S0005-2736(96)00123-X; Marshansky V, 1997, ELECTROPHORESIS, V18, P2661, DOI 10.1002/elps.1150181423; Marshansky V, 2002, CURR OPIN NEPHROL HY, V11, P527, DOI 10.1097/00041552-200209000-00009; Marshansky V, 1996, J MEMBRANE BIOL, V153, P59, DOI 10.1007/s002329900110; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Peters PJ, 2001, TRAFFIC, V2, P885, DOI 10.1034/j.1600-0854.2001.21204.x; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Skinner MA, 2001, J BIOL CHEM, V276, P48451, DOI 10.1074/jbc.M103569200; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sun-Wada GH, 2003, J BIOL CHEM, V278, P44843, DOI 10.1074/jbc.M307197200; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619; ZEUZEM S, 1992, J MEMBRANE BIOL, V125, P231; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	49	360	367	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					124	U8		10.1038/ncb1348	http://dx.doi.org/10.1038/ncb1348			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16415858				2022-12-27	WOS:000235059800007
J	Muthumani, K; Choo, AY; Zong, WX; Madesh, M; Hwang, DS; Premkumar, A; Thieu, KP; Emmanuel, J; Kumar, S; Thompson, CB; Weiner, DB				Muthumani, K; Choo, AY; Zong, WX; Madesh, M; Hwang, DS; Premkumar, A; Thieu, KP; Emmanuel, J; Kumar, S; Thompson, CB; Weiner, DB			The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1	NATURE CELL BIOLOGY			English	Article							VIRAL PROTEIN-R; NF-KAPPA-B; CELL-CYCLE; DNA-BINDING; T-CELLS; VIRUS; TRANSCRIPTION; ACTIVATION; EXPRESSION; MECHANISM	The Vpr protein of HIV-1 functions as a vital accessory gene by regulating various cellular functions, including cell differentiation, apoptosis, nuclear factor of kappa B (NF-kappa B) suppression and cell-cycle arrest of the host cell. Several reports have indicated that Vpr complexes with the glucocorticoid receptor (GR), but it remains unclear whether the GR pathway is required for Vpr to function(1). Here, we report that Vpr uses the GR pathway as a recruitment vehicle for the NF-kappa B co-activating protein, poly(ADP-ribose) polymerase(1) (PARP-1). The GR interaction with Vpr is both necessary and sufficient to facilitate this interaction by potentiating the formation of a Vpr-GR-PARP-1 complex. The recruitment of PARP-1 by the Vpr-GR complex prevents its nuclear localization, which is necessary for Vpr to suppress NF-kappa B. The association of GR with PARP-1 is not observed with steroid (glucocorticoid) treatment, indicating that the GR association with PARP-1 is a gain of function that is solely attributed to HIV-1 Vpr. These data provide important insights into Vpr biology and its role in HIV pathogenesis.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Lab Mol Neuropharmacol, New York, NY 10021 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Weiner, DB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Muthumani, Kar/AAQ-4939-2020; Muthumani, Kar/C-8252-2017; Muthumani, Karuppiah/D-1092-2009; Weiner, David B/H-8579-2014	Muthumani, Kar/0000-0002-6807-2065; Muthumani, Kar/0000-0002-6807-2065; 	NCI NIH HHS [K01 CA098092-01A2, K01 CA098092, K01 CA098092-04, K01 CA098092-03, K01 CA098092-06, K01 CA098092-05, K01 CA098092-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA098092] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Doppler W, 2001, MOL CELL BIOL, V21, P3266, DOI 10.1128/MCB.21.9.3266-3279.2001; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kashanchi F, 2000, J VIROL, V74, P652, DOI 10.1128/JVI.74.2.652-660.2000; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kino T, 1999, J EXP MED, V189, P51, DOI 10.1084/jem.189.1.51; Letvin NL, 1998, SCIENCE, V280, P1875, DOI 10.1126/science.280.5371.1875; LEVY DN, 1995, J VIROL, V69, P1243, DOI 10.1128/JVI.69.2.1243-1252.1995; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Mahalingam S, 1997, J VIROL, V71, P6339, DOI 10.1128/JVI.71.9.6339-6347.1997; Muthumani K, 2005, MOL THER, V12, P910, DOI 10.1016/j.ymthe.2005.05.009; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Ramanathan MP, 2002, J BIOL CHEM, V277, P47854, DOI 10.1074/jbc.M203905200; REFAELI Y, 1995, P NATL ACAD SCI USA, V92, P3621, DOI 10.1073/pnas.92.8.3621; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	34	57	62	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					170	U48		10.1038/ncb1352	http://dx.doi.org/10.1038/ncb1352			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16429131	Green Published, Green Accepted			2022-12-27	WOS:000235059800012
J	Yoshida, K; Yamaguchi, T; Natsume, T; Kufe, D; Miki, Y				Yoshida, K; Yamaguchi, T; Natsume, T; Kufe, D; Miki, Y			JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; 14-3-3 PROTEINS; SUBCELLULAR-LOCALIZATION; STRESS; CELLS; BCR; SPECIFICITY; BINDING; DEATH; DELTA	The ubiquitously expressed c-Abl tyrosine kinase localizes to the cytoplasm and nucleus(1,2). Nuclear c-Abl is activated by diverse genotoxic agents and induces apoptosis(3,4); however, the mechanisms that are responsible for nuclear targeting of c-Abl remain unclear. Here, we show that cytoplasmic c-Abl is targeted to the nucleus in the DNA damage response. The results show that c-Abl is sequestered into the cytoplasm by binding to 14-3-3 proteins. Phosphorylation of c-Abl on Thr 735 functions as a site for direct binding to 14-3-3 proteins. We also show that, in response to DNA damage, activation of the c-Jun N-terminal kinase (Jnk) induces phosphorylation of 14-3-3 proteins and their release from c-Abl. Together with these results, expression of an unphosphorylated 14-3-3 mutant attenuates DNA-damage-induced nuclear import of c-Abl and apoptosis. These findings indicate that 14-3-3 proteins are pivotal regulators of intracellular c-Abl localization and of the apoptotic response to genotoxic stress.	Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Tokyo 1138510, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Kohtoh Ku, Tokyo 1350064, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yoshida, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Tokyo 1138510, Japan.	yos.mgen@mri.tmd.ac.jp; miki.mgen@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	NCI NIH HHS [CA98628, CA29431] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098628, R01CA029431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Gong JG, 1999, NATURE, V399, P806; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Won J, 2003, J BIOL CHEM, V278, P19347, DOI 10.1074/jbc.M213098200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	28	191	202	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					278	U97		10.1038/ncb1228	http://dx.doi.org/10.1038/ncb1228			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15696159				2022-12-27	WOS:000227329800016
J	Men, SZ; Boutte, Y; Ikeda, Y; Li, XG; Palme, K; Stierhof, YD; Hartmann, MA; Moritz, T; Grebe, M				Men, Shuzhen; Boutte, Yohann; Ikeda, Yoshihisa; Li, Xugang; Palme, Klaus; Stierhof, York-Dieter; Hartmann, Marie-Andree; Moritz, Thomas; Grebe, Markus			Sterol-dependent endocytosis mediates post-cytokinetic acquisition of PIN2 auxin efflux carrier polarity	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; TRANSPORT; PROTEIN; GRAVITROPISM; TRAFFICKING; IDENTIFICATION; PURIFICATION; MICRODOMAINS	The polarization of yeast and animal cells relies on membrane sterols for polar targeting of proteins to the plasma membrane, their polar endocytic recycling and restricted lateral diffusion(1-4). However, little is known about sterol function in plant-cell polarity(5). Directional root growth along the gravity vector requires polar transport of the plant hormone auxin. In Arabidopsis, asymmetric plasma membrane localization of the PIN-FORMED2 (PIN2) auxin transporter directs root gravitropism(6-10). Although the composition of membrane sterols influences gravitropism and localization of two other PIN proteins(11), it remains unknown how sterols contribute mechanistically to PIN polarity. Here, we show that correct membrane sterol composition is essential for the acquisition of PIN2 polarity. Polar PIN2 localization is defective in the sterol-biosynthesis mutant cyclopropylsterol isomerase1-1 (cpi1-1) which displays altered sterol composition, PIN2 endocytosis, and root gravitropism. At the end of cytokinesis, PIN2 localizes initially to both newly formed membranes but subsequently disappears from one. By contrast, PIN2 frequently remains at both daughter membranes in endocytosis-defective cpi1-1 cells. Hence, sterol composition affects post-cytokinetic acquisition of PIN2 polarity by endocytosis, suggesting a mechanism for sterol action on establishment of asymmetric protein localization.	[Men, Shuzhen; Boutte, Yohann; Ikeda, Yoshihisa; Moritz, Thomas; Grebe, Markus] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden; [Li, Xugang; Palme, Klaus] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Hartmann, Marie-Andree] Univ Strasbourg, CNRS, UPR 2357, IBMP,Inst Plant Mol Biol, F-67083 Strasbourg, France	Swedish University of Agricultural Sciences; University of Freiburg; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grebe, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, UPSC, SE-90183 Umea, Sweden.	markus.grebe@plantphys.umu.e	Ikeda, Yoshihisa/B-4614-2013; BOUTTE, Yohann/GVC-8653-2022; BOUTTE, Yohann/AAY-5188-2021; Palme, Klaus/A-9524-2013	BOUTTE, Yohann/0000-0002-7555-074X; Palme, Klaus/0000-0002-2728-3835; Grebe, Markus/0000-0001-7571-0670; Men, Shuzhen/0000-0001-6472-6829; Moritz, Thomas/0000-0002-4258-3190				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Betts H, 2003, CURR BIOL, V13, pR781, DOI 10.1016/j.cub.2003.09.023; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Brandizzi F, 2002, PLANT CELL, V14, P1293, DOI 10.1105/tpc.001586; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; GU J, 1994, BIOTECHNIQUES, V17, P257; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; HARTMANN MA, 1987, METHOD ENZYMOL, V148, P632; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jang JC, 2000, GENE DEV, V14, P1485; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kleine-Vehn J, 2006, PLANT CELL, V18, P3171, DOI 10.1105/tpc.106.042770; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lovato MA, 2000, J BIOL CHEM, V275, P13394, DOI 10.1074/jbc.275.18.13394; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Muller I, 2003, NAT CELL BIOL, V5, P531, DOI 10.1038/ncb991; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pichler H, 2004, BBA-BIOMEMBRANES, V1666, P51, DOI 10.1016/j.bbamem.2004.05.011; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	56	254	266	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					237	U124		10.1038/ncb1686	http://dx.doi.org/10.1038/ncb1686			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18223643				2022-12-27	WOS:000252897800020
J	Schoeftner, S; Blasco, MA				Schoeftner, Stefan; Blasco, Maria A.			Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II	NATURE CELL BIOLOGY			English	Article							EPIGENETIC REGULATION; DOSAGE COMPENSATION; POSITION; LENGTH; PROTEINS; METHYLATION; ACTIVATION; EXPRESSION; COMPLEX; GENOME	Mammalian telomeres consist of non-coding TTAGGG repeats that are bound by the multi-protein complex 'shelterin', thus protecting chromosome ends from DNA repair mechanisms and degradation(1). Mammalian telomeric chromatin is enriched for the constitutive heterochromatin marks H3K9me3, H4K20me3 and HP1 (refs 2-7). Similar to pericentric heterochromatin, telomeric heterochromatin is thought to be fundamental for the maintenance of chromosomal integrity(8). Here, we report that telomeric repeats are transcribed by DNA-dependent RNA polymerase II, which, in turn, interacts with the TRF1 shelterin protein. Telomeric RNAs (TelRNAs) contain UUAGGG repeats, are polyadenylated and are transcribed from the telomeric C-rich strand. Transcription of mammalian telomeres is regulated by several mechanisms, including developmental status, telomere length, cellular stress, tumour stage and chromatin structure. Using RNA-flourescent in situ hybridization ( FISH), we show that TelRNAs are novel structural components of telomeric chromatin. Importantly, we provide evidence that TelRNAs block the activity of telomerase in vitro, suggesting that TelRNAs may regulate telomerase activity at chromosome ends. Our results indicate that TelRNAs are novel components of mammalian telomeres, which are anticipated to be fundamental for understanding telomere biology and telomere-related diseases, such as cancer and ageing.	[Schoeftner, Stefan; Blasco, Maria A.] CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; SCHOEFTNER, Stefan/0000-0002-8918-6627				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Cohen HR, 2007, CHROMOSOMA, V116, P373, DOI 10.1007/s00412-007-0100-1; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	33	560	580	1	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					228	U106		10.1038/ncb1685	http://dx.doi.org/10.1038/ncb1685			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18157120				2022-12-27	WOS:000252897800019
J	Ahmad, R; Raina, D; Trivedi, V; Ren, J; Rajabi, H; Kharbanda, S; Kufe, D				Ahmad, Rehan; Raina, Deepak; Trivedi, Vishal; Ren, Jian; Rajabi, Hasan; Kharbanda, Surender; Kufe, Donald			MUC1 oncoprotein activates the I kappa B kinase beta complex and constitutive NF-kappa B signalling	NATURE CELL BIOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; MAMMARY EPITHELIAL-CELLS; FACTOR-ALPHA; TNF; CANCER; IKK; MORPHOGENESIS; RECEPTOR-1; PATHWAY; GROWTH	Nuclear factor-kappa B ( NF-kappa B) is constitutively activated in diverse human malignancies by mechanisms that are not understood(1,2). The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas and, similarly to NF-kappa B, blocks apoptosis and induces transformation(3-6). This study demonstrates that overexpression of MUC1 in human carcinoma cells is associated with constitutive activation of NF-kappa B p65. We show that MUC1 interacts with the high-molecular-weight I kappa B kinase (IKK) complex in vivo and that the MUC1 cytoplasmic domain binds directly to IKK beta and IKK gamma. Interaction of MUC1 with both IKK beta and IKK gamma is necessary for IKK beta activation, resulting in phosphorylation and degradation of I kappa B alpha. Studies in non-malignant epithelial cells show that MUC1 is recruited to the TNF-R1 complex and interacts with IKK eta-IKK gamma in response to TNF alpha stimulation. TNF alpha-induced recruitment of MUC1 is dependent on TRADD and TRAF2, but not the death-domain kinase RIP1. In addition, MUC1-mediated activation of IKK beta is dependent on TAK1 and TAB2. These findings indicate that MUC1 is important for physiological activation of IKK beta and that overexpression of MUC1, as found in human cancers, confers sustained induction of the IKK beta-NF kappa B p65 pathway.	Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Kufe, D (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		NATIONAL CANCER INSTITUTE [R01CA042802, R01CA097098, P50CA100707] Funding Source: NIH RePORTER; NCI NIH HHS [CA42802, R01 CA042802, R01 CA097098, P50 CA100707, CA97098, CA100707] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Brantley DM, 2000, MECH DEVELOP, V97, P149, DOI 10.1016/S0925-4773(00)00405-6; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dyomin VG, 2000, BLOOD, V95, P2666; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lee PPH, 2000, ENDOCRINOLOGY, V141, P3764, DOI 10.1210/en.141.10.3764; Li Q, 2004, BIOCHEM BIOPH RES CO, V315, P471, DOI 10.1016/j.bbrc.2004.01.075; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P2558, DOI 10.1210/en.142.6.2558; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; SOULE HD, 1990, CANCER RES, V50, P6075; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varela LM, 1996, ENDOCRINOLOGY, V137, P4915, DOI 10.1210/en.137.11.4915; Varela LM, 1997, ENDOCRINOLOGY, V138, P3891, DOI 10.1210/en.138.9.3891; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	35	154	164	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1419	U146		10.1038/ncb1661	http://dx.doi.org/10.1038/ncb1661			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037881	Green Accepted			2022-12-27	WOS:000251317300015
J	Tang, XL; Jang, SW; Wang, XR; Liu, ZX; Bahr, SM; Sun, SY; Brat, D; Gutmann, DH; Ye, KQ				Tang, Xiaoling; Jang, Sung-Wuk; Wang, Xuerong; Liu, Zhixue; Bahr, Scott M.; Sun, Shi-Yong; Brat, Daniel; Gutmann, David H.; Ye, Keqiang			Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation	NATURE CELL BIOLOGY			English	Article							GENE-PRODUCT; BINDING; PROTEIN; GROWTH; INHIBITION; SPECTRIN; REVEALS; RICTOR; ASSOCIATION; INTERACTS	The neurofibromatosis-2 (NF2) tumour-suppressor gene encodes an intracellular membrane-associated protein, called merlin, whose growth-suppressive function is dependent on its ability to form interactions through its intramolecular amino-terminal domain ( NTD) and carboxy-terminal domain (CTD)(1-3). Merlin phosphorylation plays a critical part in dictating merlin NTD/ CTD interactions as well as in controlling binding to its effector proteins4-7. Merlin is partially regulated by phosphorylation of Ser 518, such that hyperphosphorylated merlin is inactive and fails to form productive intramolecular and intermolecular interactions(8,9).Here, we show that the protein kinase Akt directly binds to and phosphorylates merlin on residues Thr 230 and Ser 315, which abolishes merlin NTD/ CTD interactions and binding to merlin's effector protein PIKE-L and other binding partners. Furthermore, Akt-mediated phosphorylation leads to merlin degradation by ubiquitination. These studies demonstrate that Akt-mediated merlin phosphorylation regulates the function of merlin in the absence of an inactivating mutation.	Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Emory University; Emory University; Washington University (WUSTL)	Ye, KQ (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu		Gutmann, David/0000-0002-3127-5045	NATIONAL CANCER INSTITUTE [R01CA117872] Funding Source: NIH RePORTER; NCI NIH HHS [R01 (CA117872)] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; ALFTHAN K, 2004, J BIOL CHEM; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen YW, 2001, J MOL NEUROSCI, V17, P59, DOI 10.1385/JMN:17:1:59; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Gautreau A, 2002, J BIOL CHEM, V277, P31279, DOI 10.1074/jbc.C200125200; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gutmann DH, 1999, J NEUROSCI RES, V58, P706, DOI 10.1002/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.3.CO;2-Q; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kakhniashvili DG, 2001, BIOCHEMISTRY-US, V40, P11630, DOI 10.1021/bi010176t; Kim H, 2004, J BIOL CHEM, V279, P7812, DOI 10.1074/jbc.M305526200; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lee JY, 2006, ONCOGENE, V25, P1143, DOI 10.1038/sj.onc.1209150; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Neill GW, 2001, BIOCHEM J, V358, P727, DOI 10.1042/0264-6021:3580727; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	28	62	65	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1199	1207		10.1038/ncb1641	http://dx.doi.org/10.1038/ncb1641			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891137				2022-12-27	WOS:000249882300016
J	Berkovich, E; Monnat, RJ; Kastan, MB				Berkovich, Elijahu; Monnat, Raymond J., Jr.; Kastan, Michael B.			Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; S-PHASE; DAMAGE; ACTIVATION; AUTOPHOSPHORYLATION; IDENTIFICATION; ENDONUCLEASE; RECRUITMENT; CHECKPOINT	We developed a novel system to create DNA double-strand breaks (DSBs) at defined endogenous sites in the human genome, and used this system to detect protein recruitment and loss at and around these breaks by chromatin immunoprecipitation (ChIP). The detection of human ATM protein at site-specific DSBs required functional NBS1 protein, ATM kinase activity and ATM autophosphorylation on Ser 1981. DSB formation led to the localized disruption of nucleosomes, a process that depended on both functional NBS1 and ATM. These two proteins were also required for efficient recruitment of the repair cofactor XRCC4 to DSBs, and for efficient DSB repair. These results demonstrate the functional importance of ATM kinase activity and phosphorylation in the response to DSBs, and support a model in which ordered chromatin structure changes that occur after DNA breakage depend on functional NBS1 and ATM, and facilitate DNA DSB repair.	St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kastan, MB (corresponding author), St Jude Childrens Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org			NATIONAL CANCER INSTITUTE [R01CA071387, R01CA048022, P30CA021765, R29CA048022] Funding Source: NIH RePORTER; NCI NIH HHS [CA71387, CA21765, CA48022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; Berkovich E, 2003, CELL CYCLE, V2, P127, DOI 10.4161/cc.2.2.293; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Monnat RJ, 1999, BIOCHEM BIOPH RES CO, V255, P88, DOI 10.1006/bbrc.1999.0152; MUSCARELLA DE, 1990, MOL CELL BIOL, V10, P3386, DOI 10.1128/MCB.10.7.3386; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200	27	364	370	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					683	U137		10.1038/ncb1599	http://dx.doi.org/10.1038/ncb1599			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486112				2022-12-27	WOS:000246922700014
J	Baines, CP; Kaiser, RA; Sheiko, T; Craigen, WJ; Molkentin, JD				Baines, Christopher P.; Kaiser, Robert A.; Sheiko, Tatiana; Craigen, William J.; Molkentin, Jeffery D.			Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death	NATURE CELL BIOLOGY			English	Article							PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; CYCLOPHILIN-D; CYTOCHROME-C; VDAC CHANNELS; BCL-2 FAMILY; BAX; RESPIRATION; APOPTOSIS; RELEASE	Mitochondria are critically involved in necrotic cell death induced by Ca2+ overload, hypoxia and oxidative damage. The mitochondrial permeability transition (MPT) pore-a protein complex that spans both the outer and inner mitochondrial membranes - is considered the mediator of this event and has been hypothesized to minimally consist of the voltage-dependent anion channel (Vdac) in the outer membrane, the adenine-nucleotide translocase (Ant) in the inner membrane and cyclophilin-D in the matrix(1-3). Here, we report the effects of deletion of the three mammalian Vdac genes on mitochondrial-dependent cell death. Mitochondria from Vdac1-, Vdac3-, and Vdac1-Vdac3-null mice exhibited a Ca2+- and oxidative stress- induced MPT that was indistinguishable from wild- type mitochondria. Similarly, Ca2+- and oxidative- stress- induced MPT and cell death was unaltered, or even exacerbated, in fibroblasts lacking Vdac1, Vdac2, Vdac3, Vdac1-Vdac3 and Vdac1-Vdac2-Vdac3. Wildtype and Vdac-deficient mitochondria and cells also exhibited equivalent cytochrome c release, caspase cleavage and cell death in response to the pro- death Bcl-2 family members Bax and Bid. These results indicate that Vdacs are dispensable for both MPT and Bcl-2 family member-driven cell death.	Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	jeff.molkentin@cchmc.org		Baines, Christopher/0000-0002-4473-3869; Molkentin, Jeffery/0000-0002-3558-6529	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081104, P01HL069779, R01HL060562, P50HL077101, R01HL062927] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL060562, P01 HL069779-06A10003, R01 HL062927, R01 HL081104, R01 HL060562-11, R01 HL062927-10A1, P50 HL077101-050004, P01 HL069779, P50 HL077101, R01 HL081104-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Kagawa S, 2000, GENE THER, V7, P75, DOI 10.1038/sj.gt.3301048; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Polcic P, 2003, BIOCHEM J, V374, P393, DOI 10.1042/BJ20030690; Priault M, 1999, EUR J BIOCHEM, V260, P684, DOI 10.1046/j.1432-1327.1999.00198.x; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	33	734	760	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					550	U122		10.1038/ncb1575	http://dx.doi.org/10.1038/ncb1575			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417626	Green Accepted			2022-12-27	WOS:000246181500013
J	Sarkisian, CJ; Keister, BA; Stairs, DB; Boxer, RB; Moody, SE; Chodosh, LA				Sarkisian, Christopher J.; Keister, Blaine A.; Stairs, Douglas B.; Boxer, Robert B.; Moody, Susan E.; Chodosh, Lewis A.			Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE ARREST; K-RAS ONCOGENE; CONDITIONAL EXPRESSION; PREMATURE SENESCENCE; TUMOR INITIATION; PROLIFERATION; ACTIVATION; GLAND; MICE; P53	Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline- inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation - similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 - stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation - similar to those found in tumours bearing endogenous Kras2 mutations - induce cellular senescence that is Ink4a-Arf-dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53-Ink4a-Arf-dependent senescence checkpoints.	Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Chodosh, LA (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.	chodosh@mail.med.upenn.edu			NATIONAL CANCER INSTITUTE [U01CA105490, R01CA093719, R01CA098371] Funding Source: NIH RePORTER; NCI NIH HHS [CA98371, CA93719, CA92910, CA105490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Algarra Ignacio, 1998, Invasion and Metastasis, V18, P261, DOI 10.1159/000024519; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; Fujita M, 1996, J BIOL CHEM, V271, P4349; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; IMAGAWA W, 1994, PHYSL REPRODUCTION; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; NARARITA M, 2003, CELL, V113, P703; Okamura M, 2006, TOXICOLOGY, V217, P129, DOI 10.1016/j.tox.2005.09.021; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sarkisian CJ, 2001, J BIOL CHEM, V276, P37640, DOI 10.1074/jbc.M106281200; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stairs DB, 2005, TRANSGENIC RES, V14, P919, DOI 10.1007/s11248-005-1806-6; Stoeber K, 2001, J CELL SCI, V114, P2027; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wolf JS, 2001, CLIN CANCER RES, V7, P1812	51	332	344	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					493	U25		10.1038/ncb1567	http://dx.doi.org/10.1038/ncb1567			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450133				2022-12-27	WOS:000246181500007
J	Mikule, K; Delaval, B; Kaldis, P; Jurcyzk, A; Hergert, P; Doxsey, S				Mikule, Keith; Delaval, Benedicte; Kaldis, Philipp; Jurcyzk, Agata; Hergert, Polla; Doxsey, Stephen			Loss of centrosome integrity induces p38-p53-p21dependent G1-S arrest	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; CENTRIOLE DUPLICATION; C-ELEGANS; S-PHASE; MICROTUBULE NUCLEATION; CANCER PROGRESSION; TUMOR SUPPRESSION; MAMMALIAN-CELLS; DNA-DAMAGE; PROTEIN	Centrosomes organize the microtubule cytoskeleton for both interphase and mitotic functions. They are implicated in cell-cycle progression but the mechanism is unknown. Here, we show that depletion of 14 out of 15 centrosome proteins arrests human diploid cells in G1 with reduced Cdk2-cyclin A activity and that expression of a centrosome-disrupting dominant-negative construct gives similar results. Cell-cycle arrest is always accompanied by defects in centrosome structure and function (for example, duplication and primary cilia assembly). The arrest occurs from within G1, excluding contributions from mitosis and cytokinesis. The arrest requires p38, p53 and p21, and is preceded by p38-dependent activation and centrosomal recruitment of p53. p53-deficient cells fail to arrest, leading to centrosome and spindle dysfunction and aneuploidy. We propose that loss of centrosome integrity activates a checkpoint that inhibits G1-S progression. This model satisfies the definition of a checkpoint in having three elements: a perturbation that is sensed, a transducer (p53) and a receiver (p21).	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; NCI, Frederick, MD 21702 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doxsey, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	Stephen.Doxsey@umassmed.edu	Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM51994] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051994, R01GM051994] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balczon R, 2002, CELL MOTIL CYTOSKEL, V52, P183, DOI 10.1002/cm.10043; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GERDES J, 1984, J IMMUNOL, V133, P1710; Gillingham AK, 2000, EMBO REP, V1, P524; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; HARPER JW, 1993, CELL, V75, P805; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Jouvenet N, 2005, J GEN VIROL, V86, P589, DOI 10.1099/vir.0.80623-0; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; LACEYKR, 1999, P NATL ACAD SCI USA, V96, P2817; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; TUFFANELLI DL, 1983, ARCH DERMATOL, V119, P560, DOI 10.1001/archderm.119.7.560; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	49	233	238	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					160	U49		10.1038/ncb1529	http://dx.doi.org/10.1038/ncb1529			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17330329				2022-12-27	WOS:000243903000008
J	Yu, HYE; Bement, WM				Yu, Hoi-Ying E.; Bement, William M.			Control of local actin assembly by membrane fusion-dependent compartment mixing	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; CORTICAL GRANULE EXOCYTOSIS; XENOPUS EGGS; N-WASP; PHOSPHOLIPASE-D; PHORBOL ESTER; DIACYLGLYCEROL; ACTIVATION; BINDING; CALCIUM	Local actin assembly is associated with sites of exocytosis in processes ranging from phagocytosis to compensatory endocytosis. Here, we examine whether the trigger for actin-coat assembly around exocytosing Xenopus egg cortical granules is 'compartment mixing' - the union of the contents of the plasma membrane with that of the secretory granule membrane. Consistent with this model, compartment mixing occurs on cortical granule - plasma membrane fusion and is required for actin assembly. Compartment mixing triggers actin assembly, at least in part, through diacylglycerol (DAG), which incorporates into the cortical granule membranes from the plasma membrane after cortical granule - plasma membrane fusion. DAG, in turn, directs long-term recruitment of protein kinase C beta (PKC beta) to exocytosing cortical granules, where it is required for activation of Cdc42 localized on the cortical granules. The results demonstrate that mixing of two membrane compartments can direct local actin assembly and indicate that this process is harnessed during Xenopus egg cortical granule exocytosis to drive compensatory endocytosis.	Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, HYE (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	heyu@uwalumni.com	Bement, William/AAA-5444-2021		NIGMS NIH HHS [R01 GM052932, R01 GM052932-09, GM52932] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052932] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abousalham A, 1997, J BIOL CHEM, V272, P1069, DOI 10.1074/jbc.272.2.1069; Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; Becker KA, 1999, J CELL SCI, V112, P97; BEMENT WM, 1989, J CELL BIOL, V108, P885, DOI 10.1083/jcb.108.3.885; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chen K H, 1988, Second Messengers Phosphoproteins, V12, P251; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; GRANDIN N, 1991, DEVELOPMENT, V112, P461; Gundersen CB, 2002, J CELL SCI, V115, P1313; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Larabell CA, 2004, DIFFERENTIATION, V72, P41, DOI 10.1111/j.1432-0436.2004.07201005.x; Li WQ, 1996, ONCOGENE, V13, P731; LIAO L, 1994, CELL GROWTH DIFFER, V5, P1185; May RC, 2001, J CELL SCI, V114, P1061; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; OHNO S, 1990, J BIOL CHEM, V265, P6296; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Stith BJ, 1997, MOL BIOL CELL, V8, P755, DOI 10.1091/mbc.8.4.755; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	36	56	56	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					149	U31		10.1038/ncb1527	http://dx.doi.org/10.1038/ncb1527			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17237773	Green Accepted			2022-12-27	WOS:000243903000007
J	Driskell, OJ; Mironov, A; Allan, VJ; Woodman, PG				Driskell, Owen J.; Mironov, Aleksandr; Allan, Victoria J.; Woodman, Philip G.			Dynein is required for receptor sorting and the morphogenesis of early endosomes	NATURE CELL BIOLOGY			English	Article							CARCINOMA A431 CELLS; RECYCLING PATHWAY; DISTINCT POPULATIONS; EGF RECEPTOR; IN-VITRO; DYNACTIN; MEMBRANE; TRANSFERRIN; TRANSPORT; MOTILITY	The early endosome is organised into domains to ensure the separation of cargo(1,2). Activated mitogenic receptors, such as epidermal growth factor (EGF) receptor, are concentrated into vacuoles enriched for the small GTPase Rab5(3,4), which progressively exclude nutrient receptors, such as transferrin receptor, into neighbouring tubules(4-7). These vacuoles become enlarged, increase their content of intralumenal vesicles as EGF receptor is sorted from the limiting membrane, and eventually mature to late endosomes(8). Maturation is governed by the loss of Rab5 and is accompanied by the movement of endosomes along microtubules towards the cell centre(9). Here, we show that EGF relocates to the cell centre in a dynein-dependent fashion, concomitant with the sorting away of transferrin receptor, although it remains in Rab5-positive early endosomes. When dynein function is acutely disrupted, efficient recycling of transferrin from EGF-containing endosomes is retarded, loss of Rab5 is slowed and endosome enlargement is reduced.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Allan, VJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	philip.woodman@manchester.ac.uk		Mironov, Aleksandr/0000-0002-1497-328X; Allan, Victoria/0000-0003-4583-0836	Biotechnology and Biological Sciences Research Council [BB/C512929/1] Funding Source: Medline; Medical Research Council [G0501725, G0001128, G9722026] Funding Source: Medline; MRC [G0501725, G9722026, G0001128] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bananis E, 2003, J CELL SCI, V116, P2749, DOI 10.1242/jcs.00478; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Mayhew TM, 2002, J MICROSC-OXFORD, V205, P153, DOI 10.1046/j.0022-2720.2001.00977.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	137	138	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					113	U152		10.1038/ncb1525	http://dx.doi.org/10.1038/ncb1525			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173037				2022-12-27	WOS:000243255100020
J	Oshimori, N; Ohsugi, M; Yamamoto, T				Oshimori, Naoki; Ohsugi, Miho; Yamamoto, Tadashi			The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE; CELL-DIVISION; CHROMOKINESIN KID; TUBULIN; PHOSPHORYLATION; CENTRIOLES; COMPLEX; MITOSIS; ORGANIZATION; CHROMOSOMES	Formation of a bipolar spindle is essential for faithful chromosome segregation at mitosis. Because centrosomes define spindle poles, defects in centrosome number and structural organization can lead to a loss of bipolarity(1). In addition, microtubule-mediated pulling and pushing forces acting on centrosomes and chromosomes are also important for bipolar spindle formation(2). Polo-like kinase 1 (Plk1) is a highly conserved Ser/Thr kinase that has essential roles in the formation of a bipolar spindle with focused poles(3-5). However, the mechanism by which Plk1 regulates spindle-pole formation is poorly understood. Here, we identify a novel centrosomal substrate of Plk1, Kizuna (Kiz), depletion of which causes fragmentation and dissociation of the pericentriolar material from centrioles at prometaphase, resulting in multipolar spindles. We demonstrate that Kiz is critical for establishing a robust mitotic centrosome architecture that can endure the forces that converge on the centrosomes during spindle formation, and suggest that Plk1 maintains the integrity of the spindle poles by phosphorylating Kiz.	Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp	Ohsugi, Miho/AAY-9339-2020	Ohsugi, Miho/0000-0003-0288-3428				Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chang P, 2003, NAT CELL BIOL, V5, P71, DOI 10.1038/ncb900; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fry AM, 2000, CURR TOP DEV BIOL, V49, P291; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mogensen MM, 2000, J CELL SCI, V113, P3013; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Paoletti A, 1996, J CELL SCI, V109, P3089; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	34	112	121	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1095	U86		10.1038/ncb1474	http://dx.doi.org/10.1038/ncb1474			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16980960				2022-12-27	WOS:000241395300013
J	Gaetz, J; Gueroui, Z; Libchaber, A; Kapoor, TM				Gaetz, Jedidiah; Gueroui, Zoher; Libchaber, Albert; Kapoor, Tarun M.			Examining how the spatial organization of chromatin signals influences metaphase spindle assembly	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; SMALL-MOLECULE INHIBITOR; GTP-BOUND RAN; MITOTIC SPINDLE; SELF-ORGANIZATION; CYTOPLASMIC DYNEIN; MICROTUBULE STABILIZATION; MOTOR PROTEINS; CELL-CYCLE; IN-VITRO	During cell division, the proper assembly of a microtubule-based bipolar spindle depends on signals from chromatin. However, it is unknown how the spatial organization of chromatin signals affects spindle morphology. Here, we use paramagnetic chromatin beads, and magnetic fields for their alignment in cell-free extracts, to examine the spatial components of signals that regulate spindle assembly. We find that for linear chromatin-bead arrays that vary by eightfold in length, metaphase spindle size and shape are constant. Our findings indicate that, although chromatin provides cues for microtubule formation, metaphase spindle organization, which is controlled by microtubule-based motors, is robust to changes in the shape of chromatin signals.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Libchaber, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	libchbr@rockefeller.edu; kapoor@rockefeller.edu		Gaetz, Jedidiah/0000-0002-7103-6241	NIGMS NIH HHS [GM 65933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Durand D, 2003, TRENDS GENET, V19, P2, DOI 10.1016/S0168-9525(02)00008-2; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heald R, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P326; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Houchmandzadeh B, 1997, J CELL BIOL, V139, P1, DOI 10.1083/jcb.139.1.1; Houchmandzadeh B, 1999, J CELL BIOL, V145, P215, DOI 10.1083/jcb.145.2.215; HYMAN AA, 1991, J CELL SCI, P125; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; NICKLAS RB, 1965, J CELL BIOL, V25, P119, DOI 10.1083/jcb.25.1.119; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Pitaevskii L.P., 1986, THEORY ELASTICITY; Poirier MG, 2002, MOL BIOL CELL, V13, P2170, DOI 10.1091/mbc.01-08-0401; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 1999, METHOD CELL BIOL, V61, P137	58	30	30	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					924	U41		10.1038/ncb1455	http://dx.doi.org/10.1038/ncb1455			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16892054				2022-12-27	WOS:000240241700008
J	Larrivee, M; Wellinger, RJ				Larrivee, Michel; Wellinger, Raymund J.			Telomerase- and capping-independent yeast survivors with alternate telomere states	NATURE CELL BIOLOGY			English	Article							DNA; RECOMBINATION; MAINTENANCE; REPLICATION; CHROMOSOMES; ADAPTATION; ELONGATION; GENERATION; PROTEINS; PATHWAY	Maintaining telomeric DNA at chromosome ends is essential for genome stability(1,2). In virtually all organisms the telomerase enzyme provides this function; however, telomerase-independent mechanisms also exist(3,4). These latter mechanisms rely on recombination pathways to replenish telomeric DNA(4,5) and extrachromosomal DNA may also be implicated(6). Here, we report that in Saccharomyces cerevisiae cells, extrachromosomal circular DNA occurs for both subtypes of telomerase- independent telomere-maintenance mechanisms. This DNA consists of circular molecules of full-length subtelomeric repeat elements in type I cells, and very heterogeneously sized circles of telomeric repeat DNA in type II cells that are at least partially single stranded. Surprisingly, both type I and type II cells can adapt to a loss of the normally essential telomere-capping protein Cdc13p by inducing an alternate and reversible state of chromosome ends. Chromosome capping, therefore, is not strictly dependent on canonical capping proteins, such as Cdc13p, but can be achieved by alternate mechanisms.	Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Wellinger, RJ (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada.	Raymund.Wellinger@Usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759				BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Chakhparonian M, 2003, TRENDS GENET, V19, P439, DOI 10.1016/S0168-9525(03)00135-5; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Groff-Vindman C, 2005, MOL CELL BIOL, V25, P4406, DOI 10.1128/MCB.25.11.4406-4412.2005; HOROWITZ H, 1985, MOL CELL BIOL, V5, P2369, DOI 10.1128/MCB.5.9.2369; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Le S, 1999, GENETICS, V152, P143; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lundblad V, 2003, NATURE, V423, P926, DOI 10.1038/423926a; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tomaska L, 2004, FEBS LETT, V567, P142, DOI 10.1016/j.febslet.2004.04.058; Vega LR, 2003, NAT REV MOL CELL BIO, V4, P948, DOI 10.1038/nrm1256; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V	30	58	58	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					741	U187		10.1038/ncb1429	http://dx.doi.org/10.1038/ncb1429			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767083				2022-12-27	WOS:000238837800017
J	Li, XG; Luo, Y; Starremans, PG; McNamara, CA; Pei, Y; Zhou, J				Li, XG; Luo, Y; Starremans, PG; McNamara, CA; Pei, Y; Zhou, J			Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor ld2	NATURE CELL BIOLOGY			English	Article							KIDNEY-DISEASE; C-MYC; CATION CHANNEL; ID2; PROTEIN; PKD1; GENE; ACTIVATION; KINASE; TARGET	Autosomal-dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is characterized by progressive cyst formation and ultimate loss of renal function. Increased cell proliferation is a key feature of the disease. Here, we show that the ADPKD protein polycystin-2 (PC2) regulates the cell cycle through direct interaction with Id2, a member of the helix-loop-helix (HLH) protein family that is known to regulate cell proliferation and differentiation. Id2 expression suppresses the induction of a cyclin-dependent kinase inhibitor, p21, by either polycystin-1 (PC1) or PC2. The PC2-Id2 interaction is regulated by PC1-dependent phosphorylation of PC2. Enhanced Id2 nuclear localization is seen in human and mouse cystic kidneys. Inhibition of Id2 expression by RNA interference corrects the hyperproliferative phenotype of PC1 mutant cells. We propose that Id2 has a crucial role in cell-cycle regulation that is mediated by PC1 and PC2.	Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Virginia, Hlth Sci Ctr, Dept Internal Med, Div Cardiovasc, Charlottesville, VA 22908 USA; Toronto Hosp, Dept Med, Div Nephrol, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Virginia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Zhou, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA.	zhou@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051050, R01DK053357, R01DK051050, R01DK040703] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53357, DK51050, DK40703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Calvet J P, 1994, Curr Opin Nephrol Hypertens, V3, P340, DOI 10.1097/00041552-199405000-00017; Deed RW, 1996, FEBS LETT, V393, P113, DOI 10.1016/0014-5793(96)00868-X; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GABOW PA, 1993, AM J KIDNEY DIS, V22, P511, DOI 10.1016/S0272-6386(12)80921-8; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GRANTHAM JJ, 1993, J AM SOC NEPHROL, V3, P1843; Grantham JJ, 2001, CURR OPIN NEPHROL HY, V10, P533, DOI 10.1097/00041552-200107000-00008; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lakkis M, 2003, NEPHRON EXP NEPHROL, V93, pE3, DOI 10.1159/000066648; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Matsumura ME, 2002, J BIOL CHEM, V277, P7293, DOI 10.1074/jbc.M108986200; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pagliuca A, 2000, CANCER RES, V60, P1376; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Stayner C, 2001, TRENDS PHARMACOL SCI, V22, P543, DOI 10.1016/S0165-6147(00)01832-0; Trudel M, 1997, J EXP MED, V186, P1873, DOI 10.1084/jem.186.11.1873; Trudel M, 1998, AM J PATHOL, V152, P219; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Wilson PD, 1997, AM J PHYSIOL-RENAL, V272, pF434, DOI 10.1152/ajprenal.1997.272.4.F434; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	45	153	160	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1202	1212		10.1038/ncb1326	http://dx.doi.org/10.1038/ncb1326			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16311606				2022-12-27	WOS:000233748900013
J	Monen, J; Maddox, PS; Hyndman, F; Oegema, K; Desai, A				Monen, J; Maddox, PS; Hyndman, F; Oegema, K; Desai, A			Differential role of CENP-A in the segregation of holocentric C-elegans chromosomes during meiosis and mitosis	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; MEIOTIC PROPHASE; CROSSING-OVER; KINETOCHORE; PROTEIN; CENTROMERE; CELL; ORGANIZATION; COHESION; BIOLOGY	Two distinct chromosome architectures are prevalent among eukaryotes: monocentric, in which localized centromeres restrict kinetochore assembly to a single chromosomal site, and holocentric, in which diffuse kinetochores form along the entire chromosome length. During mitosis, both chromosome types use specialized chromatin, containing the histone H3 variant CENP-A(1-3), to direct kinetochore assembly(4-7). For the segregation of recombined homologous chromosomes during meiosis(8,9), monocentricity is thought to be crucial for limiting spindle-based forces to one side of a crossover and to prevent recombined chromatids from being simultaneously pulled towards both spindle poles. The mechanisms that allow holocentric chromosomes to avert this fate remain uncharacterized. Here, we show that markedly different mechanisms segregate holocentric chromosomes during meiosis and mitosis in the nematode Caenorhabditis elegans. Immediately prior to oocyte meiotic segregation, outer-kinetochore proteins were recruited to cup-like structures on the chromosome surface via a mechanism that is independent of CENP-A. In striking contrast to mitosis, both oocyte meiotic divisions proceeded normally following depletion of either CENP-A or the closely associated centromeric protein CENP-C. These findings highlight a pronounced difference between the segregation of holocentric chromosomes during meiosis and mitosis and demonstrate the potential to uncouple assembly of outer-kinetochore proteins from CENP-A chromatin.	Univ Calif San Diego, Biomed Sci Grad Program, Dept Cellular & Mol Med, Ludwig Inst Canc Res,UCSD CMM E, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, Dept Cellular & Mol Med, Ludwig Inst Canc Res,UCSD CMM E, Room 3052,9500 Gilman Dr, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Barron, Francie/E-5870-2010	Barron, Francie/0000-0001-6568-7358	NIGMS NIH HHS [R01GM074215-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; COMINGS DE, 1972, CHROMOSOMA, V37, P177; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hubbard EJA, 2000, DEV DYNAM, V218, P2, DOI 10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LAIKEN SL, 1972, J MOL BIOL, V66, P143, DOI 10.1016/S0022-2836(72)80012-3; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Mellone BG, 2003, CURR OPIN GENET DEV, V13, P191, DOI 10.1016/S0959-437X(03)00019-4; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Moore LL, 1999, J CELL BIOL, V147, P471, DOI 10.1083/jcb.147.3.471; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OEGEMA K, 2005, WORMBOOK; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045	33	138	155	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1248	1255		10.1038/ncb1331	http://dx.doi.org/10.1038/ncb1331			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16273096				2022-12-27	WOS:000233748900019
J	Pinner, S; Sahai, E				Pinner, Sophie; Sahai, Erik			PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE	NATURE CELL BIOLOGY			English	Article							SIGNALING PATHWAYS; KINASE; MIGRATION; INVASION; ACTIN; PHOSPHORYLATION; EXPRESSION; FAMILY; MEMBER; TRANSFORMATION	In three-dimensional matrices cancer cells move with a rounded, amoeboid morphology that is controlled by ROCK-dependent contraction of acto-myosin. In this study, we show that PDK1 is required for phosphorylation of myosin light chain and cell motility, both on deformable gels and in vivo. Depletion of PDK1 alters the localization of ROCK1 and reduces its ability to drive cortical acto-myosin contraction. This form of ROCK1 regulation does not require PDK1 kinase activity, but instead involves direct binding of PDK1 to ROCK1 at the plasma membrane; PDK1 competes directly with RhoE for binding to ROCK1. In the absence of PDK1, negative regulation by RhoE predominates, causing reduced acto-myosin contractility and motility. This work uncovers a novel non-catalytic role for PDK1 in regulating cortical acto-myosin and cell motility.	[Pinner, Sophie; Sahai, Erik] Canc Res UK, London Res Inst, Tumor Cell Biol Lab, London WC2A 3PX, England	Cancer Research UK	Sahai, E (corresponding author), Canc Res UK, London Res Inst, Tumor Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Erik.Sahai@cancer.org.uk	Acton, Sophie/G-9784-2012	Acton, Sophie/0000-0003-2704-716X; Sahai, Erik/0000-0002-3932-5086				Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Friedl P, 2003, BIOCHEM SOC SYMP, V70, P277, DOI 10.1042/bss0700277; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Miyazaki K, 2006, CELL BIOCHEM BIOPHYS, V45, P243, DOI 10.1385/CBB:45:3:243; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	44	201	211	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					127	U16		10.1038/ncb1675	http://dx.doi.org/10.1038/ncb1675			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18204440				2022-12-27	WOS:000252897800008
J	Plun-Favreau, H; Klupsch, K; Moisoi, N; Gandhi, S; Kjaer, S; Frith, D; Harvey, K; Deas, E; Harvey, RJ; McDonald, N; Wood, NW; Martins, LM; Downward, J				Plun-Favreau, Helene; Klupsch, Kristina; Moisoi, Nicoleta; Gandhi, Sonia; Kjaer, Svend; Frith, David; Harvey, Kirsten; Deas, Emma; Harvey, Robert J.; McDonald, Neil; Wood, Nicholas W.; Martins, L. Miguel; Downward, Julian			The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1	NATURE CELL BIOLOGY			English	Article							EARLY-ONSET PARKINSONISM; SERINE-PROTEASE; CELL-DEATH; RECESSIVE PARKINSONISM; STRESS-RESPONSE; PDZ DOMAIN; MUTATIONS; OMI/HTRA2; APOPTOSIS; INHIBITOR	In mice, targeted deletion of the serine protease HtrA2 ( also known as Omi) causes mitochondrial dysfunction leading to a neurodegenerative disorder with parkinsonian features. In humans, point mutations in HtrA2 are a susceptibility factor for Parkinson's disease ( PARK13 locus). Mutations in PINK1, a putative mitochondrial protein kinase, are associated with the PARK6 autosomal recessive locus for susceptibility to early-onset Parkinson's disease. Here we determine that HtrA2 interacts with PINK1 and that both are components of the same stress-sensing pathway. HtrA2 is phosphorylated on activation of the p38 pathway, occurring in a PINK1-dependent manner at a residue adjacent to a position found mutated in patients with Parkinson's disease. HtrA2 phosphorylation is decreased in brains of patients with Parkinson's disease carrying mutations in PINK1. We suggest that PINK1-dependent phosphorylation of HtrA2 might modulate its proteolytic activity, thereby contributing to an increased resistance of cells to mitochondrial stress.	MRC Toxicol Unit, Cell Death Regulat Lab, Leicester LE1 9HN, Leics, England; Canc Res UK London Res Inst, Prot Anal Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Struct Biol Lab, London WC2A 3PX, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of Leicester; Cancer Research UK; Cancer Research UK; Cancer Research UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London School of Pharmacy	Martins, LM (corresponding author), MRC Toxicol Unit, Cell Death Regulat Lab, Lancaster Rd, Leicester LE1 9HN, Leics, England.	lmm24@leicester.ac.uk; julian.downward@cancer.org.uk	Plun-Favreau, Helene/Q-4111-2016; Martins, Miguel/AAH-3971-2019; Downward, Julian/A-3251-2012; Deas, Emma/A-6755-2010; Harvey, Robert/D-3994-2016; Wood, Nicholas W/C-2505-2009; PLUN-FAVREAU, Helene/C-8513-2009	Plun-Favreau, Helene/0000-0002-1401-9656; Martins, Miguel/0000-0002-3019-4809; Harvey, Robert/0000-0001-5956-6664; Wood, Nicholas W/0000-0002-9500-3348; Downward, Julian/0000-0002-2331-4729; Moisoi, Nicoleta/0000-0002-0400-9227; Kjaer, Susanne/0000-0002-8347-1398	MRC [G0400000, G0700183, MC_U132674518] Funding Source: UKRI; Medical Research Council [G0700183, G0400000, MC_U132674518] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; GAMER AP, 2002, ONCOGENE, V21, P8089; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/14728222.7.2.187; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Li Y, 2005, NEUROLOGY, V64, P1955, DOI 10.1212/01.WNL.0000164009.36740.4E; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rohe CF, 2004, ANN NEUROL, V56, P427, DOI 10.1002/ana.20247; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vyas S, 2004, J BIOL CHEM, V279, P30983, DOI 10.1074/jbc.M400692200; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	42	364	372	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1243	U63		10.1038/ncb1644	http://dx.doi.org/10.1038/ncb1644			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17906618				2022-12-27	WOS:000250659600010
J	Derynck, R; Akhurst, RJ				Derynck, Rik; Akhurst, Rosemary J.			Differentiation plasticity regulated by TGF-beta family proteins in development and disease	NATURE CELL BIOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN; EPITHELIAL-MESENCHYMAL TRANSFORMATION; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INTERSTITIAL FLUID PRESSURE; CARDIAC-VALVE FORMATION; HUMAN BREAST-CANCER; GROWTH-FACTOR-BETA; STEM-CELLS; PULMONARY-FIBROSIS; CALVARIAL DEFECTS	During development, stem and progenitor cells gradually commit to differentiation pathways. Cell fate decisions are regulated by differentiation factors, which activate transcription programmes that specify lineage and differentiation status. Among these factors, the transforming growth factor (TGF)-beta family is important in both lineage selection and progression of differentiation of most, if not all, cell and tissue types. There is now increasing evidence that TGF-beta family proteins have the ability to redirect the differentiation of cells that either have fully differentiated or have engaged in differentiation along a particular lineage, and can thereby elicit 'transdifferentiation'. This capacity for cellular plasticity is critical for normal embryonic development, but when recapitulated in the adult it can give rise to, or contribute to, a variety of diseases. This is illustrated by the ability of TGF-beta family members to redirect epithelial cells into mesenchymal differentiation and to cause switching of mesenchymal cells from one lineage to another. Hence, various pathologies in adults may be considered diseases of abnormal development and differentiation.	Univ Calif San Francisco, Program Cell & Dev Biol, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Program Cell & Dev Biol, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu; rakhurst@cc.ucsf.edu		AKHURST, ROSEMARY/0000-0002-4474-9668				Aker FV, 2004, ENDOCR J, V51, P457, DOI 10.1507/endocrj.51.457; AKHURST RJ, 2007, TGF BETA FAMILY; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Carnac G, 2006, MINI-REV MED CHEM, V6, P765, DOI 10.2174/138955706777698642; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Dandachi N, 2001, J PATHOL, V193, P181, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V; DERYNCK R, 2006, SMAD SIGNAL TRANSDUC, P93; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hjelmeland AB, 2005, MOL CELL BIOL, V25, P9460, DOI 10.1128/MCB.25.21.9460-9468.2005; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kane CL, 2004, SEMIN CUTAN MED SURG, V23, P54, DOI 10.1016/S1085-5629(03)00088-9; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398	52	284	306	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1000	1004		10.1038/ncb434	http://dx.doi.org/10.1038/ncb434			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762890				2022-12-27	WOS:000249256500004
J	Rolls, A; Shechter, R; London, A; Ziv, Y; Ronen, A; Levy, R; Schwartz, M				Rolls, Asya; Shechter, Ravid; London, Anat; Ziv, Yaniv; Ronen, Ayal; Levy, Rinat; Schwartz, Michal			Toll-like receptors modulate adult hippocampal neurogenesis	NATURE CELL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; INNATE IMMUNITY; DENTATE GYRUS; CELLS; ACTIVATION; INFLAMMATION; RECOGNITION; EXPRESSION; RESPONSES	Neurogenesis-the formation of new neurons in the adult brain - is considered to be one of the mechanisms by which the brain maintains its lifelong plasticity in response to extrinsic and intrinsic changes(1). The mechanisms underlying the regulation of neurogenesis are largely unknown. Here, we show that Toll-like receptors (TLRs), a family of highly conserved pattern-recognizing receptors involved in neural system development in Drosophila(2) and innate immune activity in mammals(3,4), regulate adult hippocampal neurogenesis. We show that TLR2 and TLR4 are found on adult neural stem/progenitor cells (NPCs) and have distinct and opposing functions in NPC proliferation and differentiation both in vitro and in vivo. TLR2 deficiency in mice impaired hippocampal neurogenesis, whereas the absence of TLR4 resulted in enhanced proliferation and neuronal differentiation. In vitro studies further indicated that TLR2 and TLR4 directly modulated self-renewal and the cell-fate decision of NPCs. The activation of TLRs on the NPCs was mediated via MyD88 and induced PKC alpha/beta-dependent activation of the NF-kappa B signalling pathway. Thus, our study identified TLRs as players in adult neurogenesis and emphasizes their specified and diverse role in cell renewal.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	michal.schwartz@weizmann.ac.il	Shechter, Ravid/GYA-5446-2022	Shechter, Ravid/0000-0002-5956-413X; Rolls, Asya/0000-0001-5862-4287				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Reome JB, 2000, J IMMUNOL, V165, P4226, DOI 10.4049/jimmunol.165.8.4226; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Spitzer JH, 2002, EUR J IMMUNOL, V32, P1182, DOI 10.1002/1521-4141(200204)32:4<1182::AID-IMMU1182>3.0.CO;2-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	32	438	459	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1081	U61		10.1038/ncb1629	http://dx.doi.org/10.1038/ncb1629			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704767				2022-12-27	WOS:000249256500016
J	Franck, AD; Powers, AF; Gestaut, DR; Gonen, T; Davis, TN; Asbury, CL				Franck, Andrew D.; Powers, Andrew F.; Gestaut, Daniel R.; Gonen, Tamir; Davis, Trisha N.; Asbury, Charles L.			Tension applied through the Dam1 complex promotes microtubule elongation providing a direct mechanism for length control in mitosis	NATURE CELL BIOLOGY			English	Article							KINETOCHORE MOTILITY; DYNAMIC INSTABILITY; RING COMPLEX; FORCE; CHROMOSOME; SPINDLE; CENTROMERE; MOVEMENTS; METAPHASE; YEAST	In dividing cells, kinetochores couple chromosomes to the tips of growing and shortening microtubule fibres(1,2) and tension at the kinetochore-microtubule interface promotes fibre elongation(3-6). Tension-dependent microtubule fibre elongation is thought to be essential for coordinating chromosome alignment and separation(1,3,7-10), but the mechanism underlying this effect is unknown. Using optical tweezers, we applied tension to a model of the kinetochore-microtubule interface composed of the yeast Dam1 complex(11-13) bound to individual dynamic microtubule tips(14). Higher tension decreased the likelihood that growing tips would begin to shorten, slowed shortening, and increased the likelihood that shortening tips would resume growth. These effects are similar to the effects of tension on kinetochore-attached microtubule fibres in many cell types, suggesting that we have reconstituted a direct mechanism for microtubule-length control in mitosis.	Univ Washington, Dept Physiol, Seattle, WA 98195 USA; Univ Washington, Dept Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Asbury, CL (corresponding author), Univ Washington, Dept Physiol, Seattle, WA 98195 USA.	casbury@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, T32GM007270] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079373, T32 GM07270, R01 GM079373-01, T32 GM007270, R01 GM079373-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Inoue S, 1975, Soc Gen Physiol Ser, V30, P3; Janson ME, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.248101; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Skibbens RV, 1997, EXP CELL RES, V235, P314, DOI 10.1006/excr.1997.3691; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Waters JC, 1996, J CELL SCI, V109, P2823; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	34	119	123	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					832	U171		10.1038/ncb1609	http://dx.doi.org/10.1038/ncb1609			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17572669	Green Accepted			2022-12-27	WOS:000247760700019
J	Chen, T; Muratore, TL; Schaner-Tooley, CE; Shabanowitz, J; Hunt, DF; Macara, IG				Chen, Ting; Muratore, Tara L.; Schaner-Tooley, Christine E.; Shabanowitz, Jeffrey; Hunt, Donald F.; Macara, Ian G.			N-terminal alpha-methylation of RCC1 is necessary for stable chromatin association and normal mitosis	NATURE CELL BIOLOGY			English	Article							NUCLEAR IMPORT; CHROMOSOME CONDENSATION; SEQUENCE-ANALYSIS; PROTEIN; EXCHANGE; PHOSPHORYLATION; PEPTIDE; H2A; RAN	Regulator of chromatin condensation 1 (RCC1) is the only known guanine nucleotide-exchange factor for the Ran GTPase and has pivotal roles in nucleo-cytoplasmic transport, mitosis, and nuclear-envelope assembly(1). RCC1 associates dynamically with chromatin through binding to histones H2A and/ or H2B in a Ran-regulated manner(2,3). Here, we report that, unexpectedly, the amino-terminal serine or proline residue of RCC1 is uniquely methylated on its alpha-amino group. Methylation requires removal of the initiating methionine, and the presence of proline and lysine at positions 3 and 4, respectively. Methylation-defective mutants of RCC1 bind less effectively than wild-type protein to chromatin during mitosis, which causes spindle-pole defects. We propose a bimodal attachment mechanism for RCC1 in which the tail promotes stable RCC1 association with chromatin through DNA binding in an alpha-N-methylation-dependent manner. These data provide the first known function for N-terminal protein methylation.	Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Chem, Charlottetown, PE 22904, Canada; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Macara, IG (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Dept Microbiol, Charlottesville, VA 22908 USA.	igm9c@virginia.edu	Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368	NCI NIH HHS [CA040042, P01 CA040042] Funding Source: Medline; NIGMS NIH HHS [R01 GM070902, R01 GM050526, GM070902, GM37537, R01 GM037537] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902, R01GM037537, R01GM050526] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAI R, 1986, MOL CELL BIOL, V6, P2027, DOI 10.1128/MCB.6.6.2027; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Li HN, 2003, J CELL BIOL, V160, P635, DOI 10.1083/jcb.200211004; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Sluder G, 1997, J CELL SCI, V110, P421; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099	23	104	108	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					596	U203		10.1038/ncb1572	http://dx.doi.org/10.1038/ncb1572			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435751	Green Accepted			2022-12-27	WOS:000246181500019
J	Carter, S; Bischof, O; Dejean, A; Vousden, KH				Carter, Stephanie; Bischof, Oliver; Dejean, Anne; Vousden, Karen H.			C-terminal modifications regulate MDM2 dissociation and nuclear export of p53	NATURE CELL BIOLOGY			English	Article							RING-FINGER DOMAIN; SUMO-1 MODIFICATION; WILD-TYPE; IN-VIVO; UBIQUITIN; PROTEIN; PHOSPHORYLATION; LOCALIZATION; BINDING; SIGNAL	p53 functions to prevent malignant progression, in part by inhibiting proliferation or inducing the death of potential tumour cells(1). One of the most important regulators of p53 is MDM2, a RING domain E3 ligase that ubiquitinates p53, leading to both proteasomal degradation and relocation of p53 from the nucleus to the cytoplasm(1). Previous studies have suggested that although polyubiquitination is required for degradation, monoubiquitination of p53 is sufficient for nuclear export(2). Using a p53-ubiquitin fusion protein we show that ubiquitination contributes to two steps before export: exposure of a carboxy-terminal nuclear export sequence (NES), and dissociation of MDM2. Monoubiquitination can directly promote further modifications of p53 with ubiquitin-like proteins and MDM2 promotes the interaction of the SUMO E3 ligase PIASy with p53, enhancing both sumoylation and nuclear export. Our results suggest that modifications such as sumoylation can regulate the strength of the p53-MDM2 interaction and participate in driving the export of p53.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Inst Pasteur, INSERM, U579, F-75724 Paris 15, France	Beatson Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vousden, KH (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Dejean, Anne/L-5145-2018; Bischof, Oliver/K-1548-2019					Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lee JC, 2005, APOPTOSIS, V10, P1483, DOI 10.1007/s10495-005-1833-z; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; MARSTON NJ, 1995, ONCOGENE, V10, P1709; MARSTON NJ, 1994, ONCOGENE, V9, P2707; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; ZERRAHN J, 1992, ONCOGENE, V7, P1371; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	35	184	191	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					428	U111		10.1038/ncb1562	http://dx.doi.org/10.1038/ncb1562			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369817				2022-12-27	WOS:000245359400014
J	Spudich, G; Chibalina, MV; Au, JSY; Arden, SD; Buss, F; Kendrick-Jones, J				Spudich, Giulietta; Chibalina, Margarita V.; Au, Josephine Sui-Yan; Arden, Susan D.; Buss, Folma; Kendrick-Jones, John			Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to disabled-2 and PtdIns(4,5)P-2	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PROTEIN INTERACTIONS; GOLGI-COMPLEX; ORGANIZATION; ENDOCYTOSIS; FIBROBLASTS; RECRUITMENT; TRANSPORT; VESICLES; KINESIN	Vesicle transport is essential for the movement of proteins, lipids and other molecules between membrane compartments within the cell. The role of the class VI myosins in vesicular transport is particularly intriguing because they are the only class that has been shown to move 'backwards' towards the minus end of actin filaments(1). Myosin VI is found in distinct intracellular locations and implicated in processes such as endocytosis(2,3), exocytosis, maintenance of Golgi morphology(4,5) and cell movement(6). We have shown that the carboxy-terminal tail is the key targeting region and have identified three binding sites: a WWY motif for Disabled-2 (Dab2) binding, a RRL motif for glucose-transporter binding protein (GIPC) and optineurin binding and a site that binds specifically and with high affinity (K-d = 0.3 mu M) to PtdIns(4,5)P-2-containing liposomes. This is the first demonstration that myosin VI binds lipid membranes. Lipid binding induces a large structural change in the myosin VI tail (31% increase in helicity) and when associated with lipid vesicles, it can dimerize. In vivo targeting and recruitment of myosin VI to clathrin-coated structures (CCSs) at the plasma membrane is mediated by Dab2 and PtdIns(4,5) P-2 binding.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; University of Cambridge	Kendrick-Jones, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jkj@mrc-lmb.cam.ac.uk		Buss, Folma/0000-0003-4457-3479	Wellcome Trust [071162] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cremona O, 2001, J CELL SCI, V114, P1041; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Itoh T, 2004, CURR TOP MICROBIOL, V282, P31; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Janmey PA, 1999, CHEM PHYS LIPIDS, V101, P93, DOI 10.1016/S0009-3084(99)00058-4; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Lou XJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134918; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	32	157	159	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					176	U67		10.1038/ncb1531	http://dx.doi.org/10.1038/ncb1531			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17187061	Green Accepted			2022-12-27	WOS:000243903000010
J	Choi, JH; Kim, HS; Kim, SH; Yang, YR; Bae, YS; Chang, JS; Kwon, HM; Ryu, SH; Suh, PG				Choi, Jang Hyun; Kim, Hyeon Soo; Kim, Sun-Hee; Yang, Yong Ryoul; Bae, Yun Soo; Chang, Jong-Soo; Kwon, H. Moo; Ryu, Sung Ho; Suh, Pann-Ghill			Phospholipase C gamma 1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; FACTOR-RECEPTOR; INSULIN SENSITIVITY; C-FOS; MICE; 1B; KINASE; ENDOCYTOSIS; ACTIVATION; FAILURE	Growth hormone binds to its membrane receptor (GHR), whereby it regulates many cellular functions, including proliferation, differentiation and chemotaxis. However, although the activation of growth hormone-mediated signalling is well understood, the precise mechanism responsible for its regulation has not been elucidated. Here, we demonstrate that phospholipase C gamma 1 (PLC gamma 1) modulates the action of growth hormone-mediated signalling by interacting with tyrosine kinase Jak2 (janus kinase 2) in a growth hormone-dependent manner. In the absence of PLC gamma 1 (PLC gamma 1(-/-)), growth hormone-induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts (MEFs). Furthermore, the re-expression of PLC gamma 1 reduced growth hormone-induced Jak2 activation. Growth hormone-induced Jak2 phosphorylation was enhanced by siRNA-specific knockdown of PLC gamma 1. Interestingly, PLC gamma 1 physically linked Jak2 and protein tyrosine phosphatase-1B (PTP-1B) by binding to both using different domains, and this process was implicated in the modulation of cytokine signalling through Jak2. In addition, in PLC gamma 1(-/-) MEFs, growth hormone-dependent c-Fos activation was upregulated and growth hormone-induced proliferation was potentiated. These results suggest that PLC gamma 1 has a key function in the regulation of growth hormone-mediated signalling by negatively regulating Jak2 activation.	Pohang Univ Sci & Technol, Dept Life Sci, Natl Res Lab Signaling Network, Pohang 790784, Kyungbuk, South Korea; Ewha Womans Univ, Div Mol Life Sci, Ctr Cell Signalling Res, Seoul 120750, South Korea; Daejin Univ, Coll Nat Sci, Dept Life Sci, Kyonggi Do 487711, South Korea; Univ Maryland, Div Nephrol, Baltimore, MD 21201 USA	Pohang University of Science & Technology (POSTECH); Ewha Womans University; Daejin University; University System of Maryland; University of Maryland Baltimore	Suh, PG (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Natl Res Lab Signaling Network, Pohang 790784, Kyungbuk, South Korea.	pgs@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Choi, Jang Hyun/B-3055-2012; Lee-Kwon, Whaseon/D-6021-2011	Ryu, Sung Ho/0000-0003-0913-3048				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DOGLIO A, 1989, P NATL ACAD SCI USA, V86, P1148, DOI 10.1073/pnas.86.4.1148; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FAIN JN, 1990, BIOCHIM BIOPHYS ACTA, V1053, P81, DOI 10.1016/0167-4889(90)90029-D; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROGERS SA, 1989, P NATL ACAD SCI USA, V86, P6363, DOI 10.1073/pnas.86.16.6363; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Sjoholm A, 2000, J BIOL CHEM, V275, P21033, DOI 10.1074/jbc.M001212200; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a	30	27	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1389	U53		10.1038/ncb1509	http://dx.doi.org/10.1038/ncb1509			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17128263				2022-12-27	WOS:000242419800015
J	Tam, S; Geller, R; Spiess, C; Frydman, J				Tam, Stephen; Geller, Ron; Spiess, Christoph; Frydman, Judith			The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions	NATURE CELL BIOLOGY			English	Article							INCLUSION-BODY FORMATION; UBIQUITIN-PROTEASOME SYSTEM; AMYLOID-LIKE FIBRILS; MOLECULAR CHAPERONES; IN-VIVO; MUTANT HUNTINGTIN; PROTEIN; HSP70; YEAST; HSP40	Misfolding and aggregation of proteins containing expanded polyglutamine repeats underlie Huntington's disease and other neurodegenerative disorders(1). Here, we show that the hetero-oligomeric chaperonin TRiC (also known as CCT) physically interacts with polyglutamine-expanded variants of huntingtin (Htt) and effectively inhibits their aggregation. Depletion of TRiC enhances polyglutamine aggregation in yeast and mammalian cells. Conversely, overexpression of a single TRiC subunit, CCT1, is sufficient to remodel Htt-aggregate morphology in vivo and in vitro, and reduces Htt-induced toxicity in neuronal cells. Because TRiC acts during de novo protein biogenesis(2), this chaperonin may have an early role preventing Htt access to pathogenic conformations. Based on the specificity of the Htt - CCT1 interaction, the CCT1 substrate-binding domain may provide a versatile scaffold for therapeutic inhibitors of neurodegenerative disease.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Geophys Grad Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Geller, Ron/D-2919-2017	Geller, Ron/0000-0002-7612-4611; Spiess, Christoph/0000-0002-0570-9700; , judith/0000-0003-2302-6943	NIGMS NIH HHS [R01 GM056433-07, R01 GM074074-03, R01 GM056433, R01 GM056433-06, R01 GM074074-04, R01 GM056433-10S1, R01 GM056433-10, R01 GM074074-01S1, R01 GM056433-12, R01 GM074074-02, GM74074, R01 GM056433-09, R37 GM056433, R01 GM056433-08, R01 GM074074-01, R01 GM056433-03, R01 GM056433-04, R01 GM056433-05, R01 GM074074, R01 GM056433-11, GM56433] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433, R01GM074074] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS A, 1997, METHODS YEASTS GENET; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Ferreyra RG, 2000, METH MOL B, V140, P153; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kabir MA, 2005, YEAST, V22, P219, DOI 10.1002/yea.1210; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Parran DK, 2005, TOXICOL SCI, V86, P132, DOI 10.1093/toxsci/kfi175; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	30	220	229	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1155	U211		10.1038/ncb1477	http://dx.doi.org/10.1038/ncb1477			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16980959	Green Accepted			2022-12-27	WOS:000241395300021
J	Wang, CG; Chen, LH; Hou, XH; Li, ZY; Kabra, N; Ma, YH; Nemoto, S; Finkel, T; Gu, W; Cress, WD; Chen, JD				Wang, Chuangui; Chen, Lihong; Hou, Xinghua; Li, Zhenyu; Kabra, Neha; Ma, Yihong; Nemoto, Shino; Finkel, Toren; Gu, Wei; Cress, W. Douglas; Chen, Jiandong			Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN EXTENSION; CELL-SURVIVAL; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; P53; TRANSCRIPTION; DEACETYLASE; EXPRESSION; INDUCTION; CYCLE	The nicotinamide adenine dinucleotide (NAD)-dependent deacetylase Sir2 (silent information regulator 2) regulates gene silencing in yeast and promotes lifespan extension during caloric restriction. The mammalian homologue of Sir2 (SirT1) regulates p53, NF-kappa B and Forkhead transcription factors, and is implicated in stress response. This report shows that the cell-cycle and apoptosis regulator E2F1 induces SirT1 expression at the transcriptional level. Furthermore, SirT1 binds to E2F1 and inhibits E2F1 activities, forming a negative feedback loop. Knockdown of SirT1 by small interference RNA (siRNA) increases E2F1 transcriptional and apoptotic functions. DNA damage by etoposide causes E2F1-dependent induction of SirT1 expression and knockdown of SirT1 increases sensitivity to etoposide. These results reveal a mutual regulation between E2F1 and SirT1 that affects cellular sensitivity to DNA damage.	H Lee Moffit Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA	Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chen, JD (corresponding author), H Lee Moffit Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jchen@moffitt.usf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, Z01HL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Guarante LP, 2005, ANN NY ACAD SCI, V1055, P222; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin WC, 2001, GENE DEV, V15, P1833; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Ma YH, 2004, CANCER BIOL THER, V3, P1262, DOI 10.4161/cbt.3.12.1239; Ma YH, 2003, J BIOL CHEM, V278, P16770, DOI 10.1074/jbc.M212702200; Ma YH, 2003, MOL CANCER THER, V2, P73; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Pruschy M, 1999, CELL GROWTH DIFFER, V10, P141; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	30	343	368	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1025	U109		10.1038/ncb1468	http://dx.doi.org/10.1038/ncb1468			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16892051				2022-12-27	WOS:000240241700020
J	Tang, J; Qu, LK; Zhang, J; Wang, W; Michaelson, JS; Degenhardt, YY; El-Deiry, WS; Yang, XO				Tang, Jun; Qu, Li-Ke; Zhang, Jianke; Wang, Wenge; Michaelson, Jennifer S.; Degenhardt, Yan Y.; El-Deiry, Wafik S.; Yang, Xiaolu			Critical role for Daxx in regulating Mdm2	NATURE CELL BIOLOGY			English	Article							UBIQUITIN LIGASE; P53; PROTEIN; APOPTOSIS; DOMAIN; HAUSP; DEUBIQUITINATION; DEGRADATION; ACTIVATION; PATHWAY	The tumour suppressor p53 induces apoptosis or cell-cycle arrest in response to genotoxic and other stresses(1,2). In unstressed cells, the anti-proliferative effects of p53 are restrained by mouse double minute 2 ( Mdm2), a ubiquitin ligase ( E3) that promotes p53 ubiquitination and degradation(3). Mdm2 also mediates its own degradation through auto-ubiquitination. It is unclear how the cis- and trans-E3 activities of Mdm2, which have opposing effects on cell fate, are differentially regulated. Here, we show that death domain-associated protein ( Daxx) 4 is required for Mdm2 stability. Downregulation of Daxx decreases Mdm2 levels, whereas overexpression of Daxx strongly stabilizes Mdm2. Daxx simultaneously binds to Mdm2 and the deubiquitinase Hausp, and it mediates the stabilizing effect of Hausp on Mdm2. In addition, Daxx enhances the intrinsic E3 activity of Mdm2 towards p53. On DNA damage, Daxx dissociates from Mdm2, which correlates with Mdm2 self-degradation. These findings reveal that Daxx modulates the function of Mdm2 at multiple levels and suggest that the disruption of the Mdm2-Daxx interaction may be important for p53 activation in response to DNA damage.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet & Pharmacol, Philadelphia, PA 19104 USA; Biogen Idec Inc, Dept Exploratory Sci, Cambridge, MA 02142 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Jefferson University; University of Pennsylvania; University of Pennsylvania; Biogen	Yang, XO (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Zhang, Jianke/0000-0002-5822-2226; Wang, Edward/0000-0001-9509-6735	NATIONAL CANCER INSTITUTE [T32CA009140, R01CA088868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060911] Funding Source: NIH RePORTER; NCI NIH HHS [CA88868, T32CA09140] Funding Source: Medline; NIGMS NIH HHS [GM60911] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	29	176	188	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					855	U115		10.1038/ncb1442	http://dx.doi.org/10.1038/ncb1442			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16845383				2022-12-27	WOS:000239423000016
J	Natarajan, M; Lin, KM; Hsueh, RC; Sternweis, PC; Ranganathan, R				Natarajan, Madhusudan; Lin, Keng-Mean; Hsueh, Robert C.; Sternweis, Paul C.; Ranganathan, Rama			A global analysis of cross-talk in a mammalian cellular signalling network	NATURE CELL BIOLOGY			English	Article							TOLL-LIKE RECEPTOR; SOCS PROTEINS; CUTTING EDGE; TNF-ALPHA; LIPOPOLYSACCHARIDE; CYTOKINE; MACROPHAGES; INTERFERON; TLR; ACTIVATION	Cellular information processing requires the coordinated activity of a large network of intracellular signalling pathways. Crosstalk between pathways provides for complex non-linear responses to combinations of stimuli, but little is known about the density of these interactions in any specific cell. Here, we have analysed a large-scale survey of pathway interactions carried out by the Alliance for Cellular Signalling (AfCS) in RAW 264.7 macrophages. Twenty-two receptor-specific ligands were studied, both alone and in all pairwise combinations, for Ca2+ mobilization, cAMP synthesis, phosphorylation of many signalling proteins and for cytokine production. A large number of non-additive interactions are evident that are consistent with known mechanisms of cross-talk between pathways, but many novel interactions are also revealed. A global analysis of cross-talk suggests that many external stimuli converge on a relatively small number of interaction mechanisms to provide for context-dependent signalling.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Alliance Cellular Signalling, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		Natarajan, Madhusudan/0000-0003-1607-2917	NIGMS NIH HHS [U54 GM062114] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062114] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADERKA D, 1989, J IMMUNOL, V143, P3517; Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Chen LW, 2005, J BIOMED SCI, V12, P311, DOI 10.1007/s11373-005-1704-1; CHEN ZP, 1995, J NEUROENDOCRINOL, V7, P83, DOI 10.1111/j.1365-2826.1995.tb00671.x; Dalpke AH, 2003, J ENDOTOXIN RES, V9, P51, DOI 10.1179/096805103125001342; Durbin J, 2003, J ENDOTOXIN RES, V9, P313, DOI 10.1179/096805103225002575; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; GESSANI S, 1989, J VIROL, V63, P2785, DOI 10.1128/JVI.63.6.2785-2789.1989; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Harada K, 2006, J CLIN PATHOL, V59, P184, DOI 10.1136/jcp.2004.023507; Hareng L, 2003, EUR J IMMUNOL, V33, P2287, DOI 10.1002/eji.200323923; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Heeg K, 2003, VACCINE, V21, pS61, DOI 10.1016/S0264-410X(03)00202-0; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Nansen A, 2001, J IMMUNOL, V166, P982, DOI 10.4049/jimmunol.166.2.982; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; O'Donnell PM, 2002, J INTERF CYTOK RES, V22, P539, DOI 10.1089/10799900252982016; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Tilg H, 2004, EXPERT OPIN BIOL TH, V4, P469, DOI 10.1517/eobt.4.4.469.29791; VanDeusen JB, 2006, EUR J IMMUNOL, V36, P623, DOI 10.1002/eji.200535241; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang HB, 1999, AM J RESP CRIT CARE, V160, P1703, DOI 10.1164/ajrccm.160.5.9903068; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	31	180	186	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					571	580		10.1038/ncb1418	http://dx.doi.org/10.1038/ncb1418			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16699502				2022-12-27	WOS:000238029000009
J	Kamasaki, T; Arai, R; Osumi, M; Mabuchi, I				Kamasaki, T; Arai, R; Osumi, M; Mabuchi, I			Directionality of F-actin cables changes during the fission yeast cell cycle	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; V MYOSINS; GROWTH; LOCALIZATION; DIVISION; POLARITY; RING	Longitudinal F- actin cables are thought to be important for transporting materials for polarized cell growth in fission yeast. We show that most F- actin in the cables is oriented such that the barbed end faces the nearest cell tip during interphase; however, this directionality is reversed during mitosis. These orientations of F- actin ensure proper transport of materials to growing sites during these cell- cycle stages.	Univ Tokyo, Grad Sch Arts & Sci, Div Biol, Tokyo 1538902, Japan; Japan Womens Univ, Grad Sch Sci, Div Mat & Biol Funct Sci, Tokyo 1128681, Japan; Teikyo Univ, Inst Med Mycol, Tokyo 1920395, Japan	University of Tokyo; Japan Womens University; Teikyo University	Mabuchi, I (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Div Biol, Tokyo 1538902, Japan.	mabuchi@ims.u-tokyo.ac.jp						Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; ISHIKAWA H, 1969, J CELL BIOL, V43, P312; LOWEY S, 1969, J MOL BIOL, V42, P1, DOI 10.1016/0022-2836(69)90483-5; MARKS J, 1985, EUR J CELL BIOL, V39, P27; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Win TZ, 2001, J CELL SCI, V114, P69	14	45	45	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					916	U74		10.1038/ncb1295	http://dx.doi.org/10.1038/ncb1295			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16136186				2022-12-27	WOS:000231601600016
J	Veiga, E; Cossart, P				Veiga, E; Cossart, P			Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; MEDIATED ENDOCYTOSIS; DOWN-REGULATION; PROTEIN; MET; MONOCYTOGENES; INVASION; CBL; DEGRADATION; SUFFICIENT	The bacterial pathogen Listeria monocytogenes uses the surface protein InlB to invade a variety of cell types(1-3). The interaction of InlB with the hepatocyte growth- factor receptor, Met, is crucial for infection to occur(3). Remarkably, the ubiquitin ligase Cbl is rapidly recruited to InlB- activated Met(4). Recent studies have shown that ligand- dependent endocytosis of Met and other receptor tyrosine kinases is triggered by monoubiquitination of the receptor, a process that is mediated by Cbl(5-8). Here, we show that purified InlB induces the Cbl-dependent monoubiquitination and endocytosis of Met. We then demonstrate that the bacterium exploits the ubiquitin-dependent endocytosis machinery to invade mammalian cells. First, we show that L. monocytogenes colocalizes with Met, EEA1, Cbl, clathrin and dynamin during entry. Then, we assess the role of different proteins of the endocytic machinery during L. monocytogenes infection. Over- expression or down-regulation of Cbl, respectively, increases or decreases bacterial invasion. Furthermore, RNA interference- mediated knock- down of major components of the endocytic machinery ( for example, clathrin, dynamin, eps15, Grb2, CIN85, CD2AP, cortactin and Hrs), inhibit bacterial entry, establishing that the endocytic machinery is key to the bacterial internalization process.	Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; INRA, USC2020, INSERM, U604, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, 28 Rue Dr Roux, F-75015 Paris, France.	pcossart@pasteur.fr	veiga, esteban/C-2129-2011	veiga, esteban/0000-0002-7333-2466				AGGELER J, 1982, J CELL BIOL, V94, P613, DOI 10.1083/jcb.94.3.613; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dikic I, 2003, CELL MOL LIFE SCI, V60, P1805, DOI 10.1007/s00018-003-3029-4; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Harvey HA, 2001, MOL MICROBIOL, V42, P659, DOI 10.1046/j.1365-2958.2001.02666.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Owen DJ, 2004, BIOCHEM SOC T, V32, P1, DOI 10.1042/BST0320001; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	33	240	249	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					894	U46		10.1038/ncb1292	http://dx.doi.org/10.1038/ncb1292			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16113677				2022-12-27	WOS:000231601600013
J	Wang, XH; Zeng, WZ; Soyombo, AA; Tang, W; Ross, EM; Barnes, AP; Milgram, SL; Penninger, JM; Allen, PB; Greengard, P; Muallem, S				Wang, XH; Zeng, WZ; Soyombo, AA; Tang, W; Ross, EM; Barnes, AP; Milgram, SL; Penninger, JM; Allen, PB; Greengard, P; Muallem, S			Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors	NATURE CELL BIOLOGY			English	Article							ACINAR	Signalling by G proteins is controlled by the regulator of G-protein signalling (RGS) proteins that accelerate the GTPase activity of G alpha subunits and act in a G-protein-coupled receptor (GPCR)-specific manner(1-4). The conserved RGS domain accelerates the Ga subunit GTPase activity(5), whereas the variable amino-terminal domain participates in GPCR recognition(6). How receptor recognition is achieved is not known. Here, we show that the scaffold protein spinophilin (SPL)(7), which binds the third intracellualar loop (3iL) of several GPCRs(8-10), binds the N-terminal domain of RGS2. SPL also binds RGS1, RGS4, RGS16 and GAIP. When expressed in Xenopus laevis oocytes, SPL markedly increased inhibition of alpha-adrenergic receptor (alpha AR) Ca2+ signalling by RGS2. Notably, the constitutively active mutant alpha AR(A293E) (the mutation being in the 3iL) did not bind SPL and was relatively resistant to inhibition by RGS2. Use of beta AR-alpha AR chimaeras identified the (288)REKKAA(293) sequence as essential for the binding of SPL and inhibition of Ca2+ signalling by RGS2. Furthermore, alpha AR-evoked Ca2+ signalling is less sensitive to inhibition by SPL in rgs2(-/-) cells and less sensitive to inhibition by RGS2 in spl(-/-) cells. These findings provide a general mechanism by which RGS proteins recognize GPCRs to confer signalling specificity.	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yale University; Rockefeller University	Muallem, S (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	SHMUEL.MUALLEM@utsouthwestern.edu	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Soyombo, Abigail/0000-0003-0850-2593; Barnes, Anthony/0000-0002-4598-9591	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK38938] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen PB, 1999, BIOCHEM SOC T, V27, P543, DOI 10.1042/bst0270543; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; DELAPENA P, 1995, J BIOL CHEM, V270, P3554, DOI 10.1074/jbc.270.8.3554; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; GILCHRIST A, 2002, SCI STKE, V5, pPL1; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Scheer A, 1997, J RECEPT SIGNAL TR R, V17, P57, DOI 10.3109/10799899709036594; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Xu X, 1996, J PHYSIOL-LONDON, V491, P647, DOI 10.1113/jphysiol.1996.sp021246; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zeng WZ, 1996, J BIOL CHEM, V271, P18520, DOI 10.1074/jbc.271.31.18520; Zeng WZ, 1997, J BIOL CHEM, V272, P32956, DOI 10.1074/jbc.272.52.32956; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7	22	119	123	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					405	411		10.1038/ncb1237	http://dx.doi.org/10.1038/ncb1237			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793568				2022-12-27	WOS:000228075500018
J	Tanentzapf, G; Devenport, D; Godt, D; Brown, NH				Tanentzapf, Guy; Devenport, Danelle; Godt, Dorothea; Brown, Nicholas H.			Integrin-dependent anchoring of a stem-cell niche	NATURE CELL BIOLOGY			English	Article							DROSOPHILA; CADHERIN; MORPHOGENESIS; PROLIFERATION; NEIGHBORS; ADHESION; OOCYTE	Interactions between stem cells and their surrounding microenvironment, or niche, are critical for the establishment and maintenance of stem-cell properties(1). the adult Drosophila testis contains a morphologically discrete stem-cell niche, the 'hub'(2-4). the small cluster of non-dividing, somatic hub cells at the anterior tip of the fly testis is contacted by the germline stem cells (GsCs)(5), which retain their stem-cell character through the direct association with the hub(6). Here we show that integrin-mediated adhesion is important for maintaining the correct position of embryonic hub cells during gonad morphogenesis. the misplaced hub in integrin-deficient embryos directs the orientation of cell divisions in the presumptive GsCs, a hallmark of the active germline stem-cell niche. A decrease in integrin-mediated adhesion in adult testes, which resulted in a loss of the hub and the stem-cell population, revealed the importance of hub-cell anchoring. Finally, we show that an extracellular matrix (ECM) is present around the gonad during late embryogenesis and that this ECM is defective in integrin-deficient gonads. On the basis of our data, we propose that integrins are required for the attachment of the hub cells to the ECM, which is essential for maintaining the stem-cell niche.	Univ Cambridge, Gurdon Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England; Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; Univ British Columbia, Life Sci Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Rockefeller Univ, Lab Mammalian Genet & Dev, New York, NY 10021 USA	University of Cambridge; University of Toronto; University of British Columbia; Rockefeller University	Tanentzapf, G (corresponding author), Univ Cambridge, Gurdon Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England.	guy.tanentzapf@ubc.ca	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; Devenport, Danelle/0000-0002-5464-259X; Brown, Nicholas/0000-0002-8958-7017	Wellcome Trust [069943, 69943, 72817] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Chou TB, 1996, GENETICS, V144, P1673; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	31	163	170	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1413	U127		10.1038/ncb1660	http://dx.doi.org/10.1038/ncb1660			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17982446	Green Accepted			2022-12-27	WOS:000251317300014
J	You, ZS; Bailis, JM; Johnson, SA; Dilworth, SM; Hunter, T				You, Zhongsheng; Bailis, Julie M.; Johnson, Sam A.; Dilworth, Stephen M.; Hunter, Tony			Rapid activation of ATM on DNA flanking double-strand breaks	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; IN-VIVO; MRE11-RAD50-NBS1 COMPLEX; REPLICATION CHECKPOINT; DAMAGE-RESPONSE; PHOSPHATASE 2A; REQUIRES ATM; AUTOPHOSPHORYLATION; MDC1; NBS1	The tumour-suppressor gene ATM, mutations in which cause the human genetic disease ataxia telangiectasia ( A-T), encodes a key protein kinase that controls the cellular response to DNA double-strand breaks ( DSBs)(1,2). DNA DSBs caused by ionizing radiation or chemicals result in rapid ATM autophosphorylation, leading to checkpoint activation and phosphorylation of substrates that regulate cell-cycle progression, DNA repair, transcription and cell death(3). However, the precise mechanism by which damaged DNA induces ATM and checkpoint activation remains unclear. Here, we demonstrate that linear DNA fragments added to Xenopus egg extracts mimic DSBs in genomic DNA and provide a platform for ATM autophosphorylation and activation. ATM autophosphorylation and phosphorylation of its substrate NBS1 are dependent on DNA fragment length and the concentration of DNA ends. The minimal DNA length required for efficient ATM autophosphorylation is similar to 200 base pairs, with cooperative autophosphorylation induced by DNA fragments of at least 400 base pairs. Importantly, full ATM activation requires it to bind to DNA regions flanking DSB ends. These findings reveal a direct role for DNA flanking DSB ends in ATM activation.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Metab Med, London W12 0NN, England	Salk Institute; Imperial College London	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu	You, Zhongsheng/F-5404-2012	You, Zhongsheng/0000-0002-9719-8791	Biotechnology and Biological Sciences Research Council [C19979, BBS/B/06962] Funding Source: Medline; NCI NIH HHS [CA80100, CA14195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080100, P30CA014195] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; ALMOUZNI G, 1988, EMBO J, V7, P4355, DOI 10.1002/j.1460-2075.1988.tb03334.x; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Costanzo Vincenzo, 2004, Methods Mol Biol, V280, P213; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson SA, 2007, DNA REPAIR, V6, P1277, DOI 10.1016/j.dnarep.2007.02.025; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; McSherry TD, 2004, MOL CELL BIOL, V24, P9968, DOI 10.1128/MCB.24.22.9968-9985.2004; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Robertson K, 1999, ONCOGENE, V18, P7070, DOI 10.1038/sj.onc.1203194; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200	40	71	75	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					311	U193		10.1038/ncb1651	http://dx.doi.org/10.1038/ncb1651			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952060				2022-12-27	WOS:000250659600017
J	Green, JBA; Davidson, LA				Green, Jeremy B. A.; Davidson, Lance A.			Convergent extension and the hexahedral cell	NATURE CELL BIOLOGY			English	Article							GASTRULATION MOVEMENTS; XENOPUS-LAEVIS; VERTEBRATE GASTRULATION; ZEBRAFISH GASTRULATION; CARTILAGE DEVELOPMENT; EXTRACELLULAR-MATRIX; SELF-ORGANIZATION; PLANAR POLARITY; MESODERM; FIBRONECTIN	During development, embryonic cells sculpt three-dimensional tissues. Although cell polarity is commonly analysed along one, and sometimes two, dimensions, this perspective illustrates how higher-order cell polarity regulates convergent extension-the coordinated cell rearrangement that produces solid tissue elongation.	Kings Coll Med, Dept Craniofac Dev, London SE1 9RT, England; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA	University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Green, JBA (corresponding author), Kings Coll Med, Dept Craniofac Dev, London SE1 9RT, England.	jeremy.green@kcl.ac.uk	Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620	Medical Research Council [G0601131] Funding Source: Medline; NICHD NIH HHS [R01 HD044750, R01 HD044750-03, HD044750] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Axelrod JD, 2001, GENE DEV, V15, P1182; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Chung HA, 2005, DEV BIOL, V282, P95, DOI 10.1016/j.ydbio.2005.02.030; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dabdoub A, 2005, J NEUROBIOL, V64, P446, DOI 10.1002/neu.20171; Davidson LA, 2004, DEV DYNAM, V231, P888, DOI 10.1002/dvdy.20217; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; ELSDALE T, 1972, NATURE, V236, P152, DOI 10.1038/236152a0; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Green JBA, 2004, DEV DYNAM, V231, P576, DOI 10.1002/dvdy.20163; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hannus M, 2002, DEVELOPMENT, V129, P3493; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLER R, 2003, GASTRULATION CELLS E, P171; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; SHIH J, 1992, DEVELOPMENT, V116, P915; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Stern C.D., 2004, GASTRULATION CELLS E; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; SYMES K, 1987, DEVELOPMENT, V101, P339; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Trinkaus J. P., 1984, CELLS ORGANS FORCES; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	56	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1010	1015		10.1038/ncb438	http://dx.doi.org/10.1038/ncb438			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762892				2022-12-27	WOS:000249256500006
J	Serrels, B; Serrels, A; Brunton, VG; Holt, M; McLean, GW; Gray, CH; Jones, GE; Frame, MC				Serrels, Bryan; Serrels, Alan; Brunton, Valerie G.; Holt, Mark; McLean, Gordon W.; Gray, Christopher H.; Jones, Gareth E.; Frame, Margaret C.			Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex	NATURE CELL BIOLOGY			English	Article							N-WASP; DOMAIN; VINCULIN; FAK; LOCALIZATION; PROTEINS; SRC	Networks of actin filaments, controlled by the Arp2/3 complex, drive membrane protrusion during cell migration. How integrins signal to the Arp2/3 complex is not well understood. Here, we show that focal adhesion kinase (FAK) and the Arp2/ 3 complex associate and colocalize at transient structures formed early after adhesion. Nascent lamellipodia, which originate at these structures, do not form in FAK-deficient cells, or in cells in which FAK mutants cannot be autophosphorylated after integrin engagement. The FERM domain of FAK binds directly to Arp3 and can enhance Arp2/3-dependent actin polymerization. Critically, Arp2/ 3 is not bound when FAK is phosphorylated on Tyr 397. Interfering peptides and FERM-domain point mutants show that FAK binding to Arp2/ 3 controls protrusive lamellipodia formation and cell spreading. This establishes a new function for the FAK FERM domain in forming a phosphorylation-regulated complex with Arp2/ 3, linking integrin signalling directly with the actin polymerization machinery.	Univ Edinburgh, Queens Med Res Inst, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh	Frame, MC (corresponding author), Univ Edinburgh, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland.	m.frame@beatson.gla.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048; Holt, Mark/0000-0001-7775-8539; Frame, Margaret/0000-0001-5882-1942	Medical Research Council [G0100152] Funding Source: Medline; MRC [G0100152] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Butler B, 2006, CURR BIOL, V16, P242, DOI 10.1016/j.cub.2005.12.033; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; ILLC D, 1995, NATURE, V377, P539; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Xu WM, 1998, DEVELOPMENT, V125, P327; Yarrow JC, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-5	28	200	203	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1046	U15		10.1038/ncb1626	http://dx.doi.org/10.1038/ncb1626			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721515				2022-12-27	WOS:000249256500012
J	Collis, SJ; Barber, LJ; Clark, AJ; Martin, JS; Ward, JD; Boulton, SJ				Collis, Spencer J.; Barber, Louise J.; Clark, Allison J.; Martin, Julie S.; Ward, Jordan D.; Boulton, Simon J.			HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE-RESPONSE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPLICATION STRESS; STRAND BREAKS; CAENORHABDITIS-ELEGANS; TUMOR SUPPRESSION; GENOME INTEGRITY; GENOTOXIC STRESS; CLOCK GENES	Here, we show that the human homologue of the Caenorhabditis elegans biological clock protein CLK-2 (HCLK2) associates with the S-phase checkpoint components ATR, ATRIP, claspin and Chk1. Consistent with a critical role in the S-phase checkpoint, HCLK2-depleted cells accumulate spontaneous DNA damage in S-phase, exhibit radio-resistant DNA synthesis, are impaired for damage-induced monoubiquitination of FANCD2 and fail to recruit FANCD2 and Rad51 (critical components of the Fanconi anaemia and homologous recombination pathways, respectively) to sites of replication stress. Although Thr 68 phosphorylation of the checkpoint effector kinase Chk2 remains intact in the absence of HCLK2, claspin phosphorylation and degradation of the checkpoint phosphatase Cdc25A are compromised following replication stress as a result of accelerated Chk1 degradation. ATR phosphorylation is known to both activate Chk1 and target it for proteolytic degradation, and depleting ATR or mutation of Chk1 at Ser 345 restored Chk1 protein levels in HCLK2-depleted cells. We conclude that HCLK2 promotes activation of the S-phase checkpoint and downstream repair responses by preventing unscheduled Chk1 degradation by the proteasome.	London Res Inst, DNA Damage Res Lab, Potters Bar EN6 3LD, Herts, England		Boulton, SJ (corresponding author), London Res Inst, DNA Damage Res Lab, Potters Bar EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Ward, Jordan/H-3444-2019; Barber, Louise J./L-8579-2019	Ward, Jordan/0000-0001-9870-8936; Barber, Louise J./0000-0001-9265-3516; Collis, Spencer/0000-0002-7874-1891	Breast Cancer Now [2003:569] Funding Source: Medline	Breast Cancer Now		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Jaspers Nicolaas G J, 2006, Methods Mol Biol, V314, P51; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Liu QH, 2000, GENE DEV, V14, P1448; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; WANG X, 2007, MOL CELL BIOL; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	103	103	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					391	U62		10.1038/ncb1555	http://dx.doi.org/10.1038/ncb1555			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17384638	Green Published			2022-12-27	WOS:000245359400010
J	Jancic, C; Savina, A; Wasmeier, C; Tolmachova, T; El-Benna, J; Dang, PMC; Pascolo, S; Gougerot-Pocidalo, MA; Raposo, G; Seabra, MC; Amigorena, S				Jancic, Carolina; Savina, Ariel; Wasmeier, Christina; Tolmachova, Tanya; El-Benna, Jamel; Dang, Pham My-Chan; Pascolo, Steve; Gougerot-Pocidalo, Maire-Anne; Raposo, Graca; Seabra, Miguel C.; Amigorena, Sebastian			Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes	NATURE CELL BIOLOGY			English	Article							CROSS-PRESENTATION; ANTIGEN; COMPARTMENT; MELANOSOMES; LYSOSOMES; EFFECTOR; IMMUNITY; BURST	To prevent excessive degradation of internalized antigens, which could destroy the peptides recognized by T lymphocytes, dendritic cells have developed several strategies that limit proteolytic activity in phagosomes. The recruitment of the NADPH oxidase NOX2 prevents acidification of phagosomes, limiting antigen degradation. Here, we show that dendritic cells derived from Rab27a-deficient ashen mice show increased phagosome acidification and antigen degradation, causing a defect in antigen cross-presentation. Enhanced acidification results from a delay in the recruitment to phagosomes of a subset of lysosome-related organelles containing the membrane subunits of NOX2. The Rab27a-dependent recruitment of these "inhibitory lysosome-related organelles" to phagosomes continuously limits acidification and degradation of ingested particles in dendritic cells, thus promoting antigen cross-presentation.	INSERM, U653, Inst Curie, Paris 05, France; Univ London Imperial Coll Sci Technol & Med, NHLI, London SW7 2AZ, England; Univ Paris 07, INSERM, U773, CRB3,UMRS 773, F-75018 Paris, France; Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany; CNRS, Inst Curie, UMR144, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Amigorena, S (corresponding author), INSERM, U653, Inst Curie, 26 Rue Ulm, Paris 05, France.	sebastian.amigorena@curie.fr	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019	Seabra, Miguel C/0000-0002-6404-4892; Amigorena, Sebastian/0000-0001-8583-8416; Tolmachova, Tanya/0000-0002-8841-0797; Raposo, graca/0000-0001-9590-1298	MRC [G9805886] Funding Source: UKRI; Medical Research Council [G9805886] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; CALAFAT J, 1993, BLOOD, V81, P3122; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hume AN, 2002, TRAFFIC, V3, P193, DOI 10.1034/j.1600-0854.2002.030305.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; RAPOSO G, 1997, HDB EXP IMMUNOL, V208, P1; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	27	178	181	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					367	U29		10.1038/ncb1552	http://dx.doi.org/10.1038/ncb1552			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351642				2022-12-27	WOS:000245359400008
J	Linares, LK; Kiernan, R; Triboulet, R; Chable-Bessia, C; Latreille, D; Cuvier, O; Lacroix, M; Le Cam, L; Coux, O; Benkirane, M				Linares, Laetitia K.; Kiernan, Rosemary; Triboulet, Robinson; Chable-Bessia, Christine; Latreille, Daniel; Cuvier, Olivier; Lacroix, Matthieu; Le Cam, Laurent; Coux, Olivier; Benkirane, Monsef			Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; P53 ACTIVATION; MDM2; DEGRADATION; ACETYLATION; LIGASE; DOMAINS; SYSTEM; CELLS; P300	The p300-CBP-associated factor ( PCAF) is a histone acetyltransferase ( HAT) involved in the reversible acetylation of various transcriptional regulators(1), including the tumour suppressor p53. It is implicated in many cellular processes, such as transcription, differentiation, proliferation and apoptosis. We observed that knockdown of PCAF expression in HeLa or U2OS cell lines induces stabilization of the oncoprotein Hdm2, a RING finger E3 ligase primarily known for its role in controlling p53 stability(2,3). To investigate the molecular basis of this effect, we examined whether PCAF is involved in Hdm2 ubiquitination. Here, we show that PCAF, in addition to its acetyltransferase activity, possesses an intrinsic ubiquitination activity that is critical for controlling Hdm2 expression levels, and thus p53 functions. Our data highlight a regulatory crosstalk between PCAF and Hdm2 activities, which is likely to have a central role in the subtle control of p53 activity after DNA damage.	UNII, Ctr Rech Biochim Macromol, CNRS, UMR5237, Montpellier, France; CNRS, UPR1142, Mol Virol Lab, Inst Genet Humaine, Montpellier, France; CNRS, UPR1142, Lab Dynam Genome & Dev, Inst Genet Humaine, Montpellier, France; UNII, Inst Genet Mol Montpellier, CNRS, UMR5535, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Coux, O (corresponding author), UNII, Ctr Rech Biochim Macromol, CNRS, UMR5237, Montpellier, France.	olivier.coux@crbm.cnrs.fr; monsef.benkirane@igh.cnrs.fr	Linares, Laetitia LKL/F-9901-2018; Kiernan, Rosemary/GXV-8695-2022; Coux, Olivier/P-6847-2019; Coux, Olivier/B-3406-2010; Cuvier, Olivier/ADO-0657-2022; CUVIER, Olivier/AAC-4693-2019; Le Cam, Laurent/O-1408-2016; Lacroix, Matthieu/O-1928-2018	Linares, Laetitia LKL/0000-0003-1661-2119; Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849; CUVIER, Olivier/0000-0003-0644-2734; Lacroix, Matthieu/0000-0002-1268-9058; Kiernan, Rosemary/0000-0001-6645-0686; LE CAM, Laurent/0000-0003-0325-878X				Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bres V, 2002, EMBO J, V21, P6811, DOI 10.1093/emboj/cdf669; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jin YT, 2002, J BIOL CHEM, V277, P30838, DOI 10.1074/jbc.M204078200; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Robinson PA, 2004, J CELL SCI, V117, P5191, DOI 10.1242/jcs.01539; SCHILTZ RL, 2000, BIOCHIM BIOPHYS ACTA, V1470, P37; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun Xiu Zhu, 2003, Methods Mol Biol, V234, P17; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103	31	137	146	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					331	U153		10.1038/ncb1545	http://dx.doi.org/10.1038/ncb1545			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293853				2022-12-27	WOS:000244558600018
J	Daga, RR; Lee, KG; Bratman, S; Salas-Pino, S; Chang, F				Daga, Rafael R.; Lee, Kyeng-Gea; Bratman, Scott; Salas-Pino, Silvia; Chang, Fred			Self-organization of microtubule bundles in anucleate fission yeast cells	NATURE CELL BIOLOGY			English	Article							ORGANIZING CENTERS; NUCLEAR; DIVISION; COMPLEX; INTERPHASE; PROTEINS; POLARITY; ROLES	Self-organization of cellular structures is an emerging principle underlying cellular architecture. Properties of dynamic microtubules and microtubule-binding proteins contribute to the self-assembly of structures such as microtubule asters(1,2). In the fission yeast Schizosaccharomyces pombe, longitudinal arrays of cytoplasmic microtubule bundles regulate cell polarity and nuclear positioning(3-5). These bundles are thought to be organized from the nucleus at multiple interphase microtubule organizing centres (iMTOCs)(3). Here, we find that microtubule bundles assemble even in cells that lack a nucleus. These bundles have normal organization, dynamics and orientation, and exhibit anti-parallel overlaps in the middle of the cell. The mechanisms that are responsible for formation of these microtubule bundles include cytoplasmic microtubule nucleation, microtubule release from the equatorial MTOC (eMTOC), and the dynamic fusion and splitting of microtubule bundles. Bundle formation and organization are dependent on mto1p (gamma-TUC associated protein), ase1p (PRC1), klp2p (kinesin-14) and tip1p (CLIP-170). Positioning of nuclear fragments and polarity factors by these microtubules illustrates how self- organization of these bundles contributes to establishing global spatial order.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Chang, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 168th St, New York, NY 10032 USA.	fc99@columbia.edu	salas-pino, silvia/T-7800-2017; Daga, Rafael/P-8340-2014	salas-pino, silvia/0000-0003-2713-0123; Daga, Rafael/0000-0001-5726-761X; Bratman, Scott/0000-0001-8610-4908	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069670] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069670, R01 GM069670] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Daga RR, 2006, CURR BIOL, V16, P1544, DOI 10.1016/j.cub.2006.06.026; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Ding DQ, 1998, J CELL SCI, V111, P701; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Hagan IM, 2000, PRACT APPROACH SER, V218, P179; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Heitz MJ, 2001, J CELL SCI, V114, P4521; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Sacconi L, 2005, APPL OPTICS, V44, P2001, DOI 10.1364/AO.44.002001; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Tolic-Norrelykke IM, 2005, CURR BIOL, V15, P1212, DOI 10.1016/j.cub.2005.05.052; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676; Zimmerman S, 2004, DEV CELL, V6, P497, DOI 10.1016/S1534-5807(04)00096-6	26	50	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1108	U98		10.1038/ncb1480	http://dx.doi.org/10.1038/ncb1480			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998476				2022-12-27	WOS:000241395300015
J	Di, A; Brown, ME; Deriy, LV; Li, CY; Szeto, FL; Chen, YM; Huang, P; Tong, JK; Naren, AP; Bindokas, V; Palfrey, HC; Nelson, DJ				Di, Anke; Brown, Mary E.; Deriy, Ludmila V.; Li, Chunying; Szeto, Frances L.; Chen, Yimei; Huang, Ping; Tong, Jiankun; Naren, Anjaparavanda P.; Bindokas, Vytautas; Palfrey, H. Clive; Nelson, Deborah J.			CFTR regulates phagosome acidification in macrophages and alters bactericidal activity	NATURE CELL BIOLOGY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNELS; INTRACELLULAR ORGANELLES; HUMAN NEUTROPHILS; PH; PHAGOCYTOSIS; CELLS; ACTIVATION; MATURATION	Acidification of phagosomes has been proposed to have a key role in the microbicidal function of phagocytes. Here, we show that in alveolar macrophages the cystic fibrosis transmembrane conductance regulator Cl- channel (CFTR) participates in phagosomal pH control and has bacterial killing capacity. Alveolar macrophages from Cftr(-/-) mice retained the ability to phagocytose and generate an oxidative burst, but exhibited defective killing of internalized bacteria. Lysosomes from CFTR-null macrophages failed to acidify, although they retained normal fusogenic capacity with nascent phagosomes. We hypothesize that CFTR contributes to lysosomal acidification and that in its absence phagolysosomes acidify poorly, thus providing an environment conducive to bacterial replication.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Tennessee, Dept Physiol, Memphis, TN 38163 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago; University of Chicago	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	nelson@uchicago.edu			NIDDK NIH HHS [DK42086] Funding Source: Medline; NIGMS NIH HHS [R01 GM36823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; ALAWQATI Q, 1992, J EXP BIOL, V172, P245; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BARASCH J, 1993, J CELL SCI, P229; Barg S, 2001, J CELL SCI, V114, P2145; Belhoussine R, 1999, INT J CANCER, V81, P81, DOI 10.1002/(SICI)1097-0215(19990331)81:1<81::AID-IJC15>3.0.CO;2-P; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bradbury NA, 1999, PHYSL REV S, V79, P175, DOI DOI 10.1152/physrev.1999.79.1.S175; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; DECOURSEY TE, 2004, SCI STKE; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; Gibson GA, 2000, AM J PHYSIOL-CELL PH, V279, pC1088, DOI 10.1152/ajpcell.2000.279.4.C1088; GRISHAM MB, 1985, J IMMUNOL METHODS, V82, P315, DOI 10.1016/0022-1759(85)90363-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamrick TS, 2000, INFECT IMMUN, V68, P125, DOI 10.1128/IAI.68.1.125-132.2000; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Harrison RE, 2002, CURR BIOL, V12, pR357, DOI 10.1016/S0960-9822(02)00859-X; JENSEN MS, 1973, J CELL BIOL, V56, P379, DOI 10.1083/jcb.56.2.379; JOVOV B, 1995, J BIOL CHEM, V270, P29194, DOI 10.1074/jbc.270.49.29194; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kobayashi T, 2000, HISTOCHEM CELL BIOL, V113, P251, DOI 10.1007/s004180000132; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Luckie DB, 2001, J MEMBRANE BIOL, V179, P275, DOI 10.1007/s002320010052; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Makranz C, 2006, GLIA, V53, P441, DOI 10.1002/glia.20303; McCarty NA, 2000, J EXP BIOL, V203, P1947; Moraes TJ, 2006, AM J RESP CELL MOL, V34, P364, DOI 10.1165/rcmb.2005-0146OC; Morris MR, 2005, CLIN EXP IMMUNOL, V142, P68, DOI [10.1111/j.1365-2249.2005.02893.x, 10.1111/j.1365-2249.2005.02893.X]; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; Poschet J, 2002, TRENDS MOL MED, V8, P512, DOI 10.1016/S1471-4914(02)02414-0; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; SCHWIEBERT EM, 1999, PHYSL REV S, V79, P145; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Sonawane ND, 2003, J CELL BIOL, V160, P1129, DOI 10.1083/jcb.200211098; Sonawane ND, 2002, J BIOL CHEM, V277, P5506, DOI 10.1074/jbc.M110818200; STYRT B, 1982, FEBS LETT, V149, P113, DOI 10.1016/0014-5793(82)81083-1; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Ydrenius L, 2000, J LEUKOCYTE BIOL, V67, P520, DOI 10.1002/jlb.67.4.520	49	366	375	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					933	U52		10.1038/ncb1456	http://dx.doi.org/10.1038/ncb1456			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16921366				2022-12-27	WOS:000240241700009
J	Kortlever, RM; Higgins, PJ; Bernards, R				Kortlever, Roderik M.; Higgins, Paul J.; Bernards, Rene			Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence	NATURE CELL BIOLOGY			English	Article							CELLULAR SENESCENCE; CANCER PROGRESSION; HUMAN FIBROBLASTS; ONCOGENIC RAS; G(1) CONTROL; HUMAN-CELLS; CYCLIN D1; EXPRESSION; GROWTH; GENE	p53 limits the proliferation of primary diploid fibroblasts by inducing a state of growth arrest named replicative senescence - a process which protects against oncogenic transformation and requires integrity of the p53 tumour suppressor pathway(1-3). However, little is known about the downstream target genes of p53 in this growth-limiting response. Here, we report that suppression of the p53 target gene encoding plasminogen activator inhibitor-1 ( PAI-1) by RNA interference ( RNAi) leads to escape from replicative senescence both in primary mouse embryo fibroblasts and primary human BJ fibroblasts. PAI-1 knockdown results in sustained activation of the PI( 3) K-PKB-GSK3 beta pathway and nuclear retention of cyclin D1, consistent with a role for PAI-1 in regulating growth factor signalling. In agreement with this, we find that the PI( 3) K-PKB-GSK3 beta-cyclin D1 pathway is also causally involved in cellular senescence. Conversely, ectopic expression of PAI-1 in proliferating p53-deficient murine or human fibroblasts induces a phenotype displaying all the hallmarks of replicative senescence. Our data indicate that PAI-1 is not merely a marker of senescence, but is both necessary and sufficient for the induction of replicative senescence downstream of p53.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Albany Medical College	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Kortlever, Roderik/AAY-9220-2020	Bernards, Rene/0000-0001-8677-3423; Kortlever, Roderik/0000-0001-5558-2851	NIGMS NIH HHS [R01 GM057242-10, R01 GM057242, GM57242] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bissell MJ, 1999, CANCER RES, V59, p1757S; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DEPETRO G, 1994, EXP CELL RES, V213, P286, DOI 10.1006/excr.1994.1200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Frandsen TL, 2001, CANCER RES, V61, P532; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Martens JWM, 2003, THROMB HAEMOSTASIS, V89, P393; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Parfyonova YV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P119, DOI 10.1023/A:1013964517211; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; PRENDERGAST GC, 1990, MOL CELL BIOL, V10, P1265, DOI 10.1128/MCB.10.3.1265; QUELLE DE, 1995, ONCOGENE, V11, P635; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; Usher PA, 2005, INT J CANCER, V113, P870, DOI 10.1002/ijc.20665; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; West MD, 1996, EXP GERONTOL, V31, P175, DOI 10.1016/0531-5565(95)02013-6; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zhao RB, 2000, GENE DEV, V14, P981	41	411	420	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					877	U155		10.1038/ncb1448	http://dx.doi.org/10.1038/ncb1448			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862142	Green Published, Green Accepted			2022-12-27	WOS:000239423000019
J	Okada, M; Cheeseman, IM; Hori, T; Okawa, K; McLeod, IX; Yates, JR; Desai, A; Fukagawa, T				Okada, M; Cheeseman, IM; Hori, T; Okawa, K; McLeod, IX; Yates, JR; Desai, A; Fukagawa, T			The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST KINETOCHORE; VERTEBRATE CELLS; SACCHAROMYCES-CEREVISIAE; OUTER KINETOCHORE; FISSION YEAST; PROTEIN; COMPONENT; CORE; ARCHITECTURE; SEGREGATION	In vertebrates, centromeres lack defined sequences and are thought to be propagated by epigenetic mechanisms involving the incorporation of specialized nucleosomes containing the histone H3 variant centromere protein (CENP)-A. However, the precise mechanisms that target CENP-A to centromeres remain poorly understood. Here, we isolated a multi-subunit complex, which includes the established inner kinetochore components CENP-H and CENP-I, and nine other proteins, from both human and chicken cells. Our analysis of these proteins demonstrates that the CENP-H-I complex can be divided into three functional sub-complexes, each of which is required for faithful chromosome segregation. Interestingly, newly expressed CENP-A is not efficiently incorporated into centromeres in knockout mutants of a subclass of CENP-H-I complex proteins, indicating that the CENP-H-I complex may function, in part, as a marker directing CENP-A deposition to centromeres.	Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan; Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Kyoto Univ, HMRO, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Ludwig Institute for Cancer Research; Kyoto University; Scripps Research Institute	Fukagawa, T (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Fukagawa, Tatsuo/AAK-3922-2021	Cheeseman, Iain/0000-0002-3829-5612	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM074215-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Bierie B, 2004, GENE EXPR PATTERNS, V4, P389, DOI 10.1016/j.modgep.2004.01.008; Cheeseman I. M., 2005, SCI STKE, V266, ppl1; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Fukagawa T, 2004, EXP CELL RES, V296, P21, DOI 10.1016/j.yexcr.2004.03.004; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Yamashita A, 2000, FEBS LETT, V481, P147, DOI 10.1016/S0014-5793(00)01987-6	32	376	407	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					446	U61		10.1038/ncb1396	http://dx.doi.org/10.1038/ncb1396			41	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622420				2022-12-27	WOS:000237299400008
J	Malikov, V; Cytrynbaum, EN; Kashina, A; Mogilner, A; Rodionov, V				Malikov, V; Cytrynbaum, EN; Kashina, A; Mogilner, A; Rodionov, V			Centering of a radial microtubule array by translocation along microtubules spontaneously nucleated in the cytoplasm	NATURE CELL BIOLOGY			English	Article							DYNAMICS; MICROSCOPY	Positioning of a radial array of microtubules (MTs) in the cell centre is crucial for cytoplasmic organization, but the mechanisms of such centering are difficult to study in intact cells that have pre-formed radial arrays. Here, we use cytoplasmic fragments of melanophores, and cytoplasts of BS-C-1 cells to study MT centering mechanisms. Using live imaging and computer modelling, we show that the MT aster finds a central location in the cytoplasm by moving along spontaneously nucleated non-astral MTs towards a point at which MT nucleation events occur equally on all sides. We hypothesize that similar mechanisms, in the presence of the centrosome, contribute to this centering mechanism and ensure the robustness of cytoplasmic organization.	Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA; Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06032 USA; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Calif Davis, Dept Math, Lab Cell & Computat Biol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA	University of Connecticut; University of Connecticut; University of British Columbia; University of Pennsylvania; University of California System; University of California Davis; University of California System; University of California Davis	Rodionov, V (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06032 USA.	rodionov@nso.uchc.edu	Mogilner, Alex/A-3135-2008	Cytrynbaum, Eric/0000-0001-8789-1667	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68952] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Malikov V, 2004, MOL BIOL CELL, V15, P2742, DOI 10.1091/mbc.E03-10-0770; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rios RM, 2004, CELL, V118, P323; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov V, 2001, METHOD CELL BIOL, V67, P43; Rodionov VI, 1997, NATURE, V386, P170, DOI 10.1038/386170a0; RODIONOV VI, 1994, J CELL BIOL, V126, P1455, DOI 10.1083/jcb.126.6.1455; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Vallee RB, 2005, TRENDS CELL BIOL, V15, P288, DOI 10.1016/j.tcb.2005.04.005; Vorobiev I, 2001, P NATL ACAD SCI USA, V98, P10160, DOI 10.1073/pnas.181354198; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Yvon AMC, 1997, J CELL SCI, V110, P2391	17	33	38	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1213	1218		10.1038/ncb1332	http://dx.doi.org/10.1038/ncb1332			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16273095				2022-12-27	WOS:000233748900014
J	Parekh, SH; Chaudhuri, O; Theriot, JA; Fletcher, DA				Parekh, SH; Chaudhuri, O; Theriot, JA; Fletcher, DA			Loading history determines the velocity of actin-network growth	NATURE CELL BIOLOGY			English	Article							LISTERIA-MONOCYTOGENES; MOTILITY; FORCE; POLYMERIZATION; MICROTUBULES; PROPULSION; FILAMENTS; VESICLES; MYOSIN; DRIVEN	Directional polymerization of actin filaments in branched networks is one of the most powerful force-generating systems in eukaryotic cells(1). Growth of densely cross-linked actin networks drives cell crawling(2), intracellular transport of vesicles and organelles(3,4) and movement of intracellular pathogens such as Listeria monocytogenes'. Using a modified atomic force microscope (AFM), we obtained force-velocity (Fv) measurements of growing actin networks in vitro until network elongation ceased at the stall force. We found that the growth velocity of a branched actin network against increasing forces is load-independent over a wide range of forces before a convex decline to stall. Surprisingly, when force was decreased on a growing network, the velocity increased to a value greater than the previous velocity, such that two or more stable growth velocities can exist at a single load. These results demonstrate that a single Fv relationship does not capture the complete behaviour of this system, unlike other molecular motors in cells, because the growth velocity depends on loading history rather than solely on the instantaneous load.	Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California Berkeley; Stanford University	Fletcher, DA (corresponding author), Univ Calif Berkeley, UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA 94720 USA.	fletch@berkeley.edu	Theriot, Julie/HHN-2034-2022	Chaudhuri, Ovijit/0000-0002-9287-3401; Theriot, Julie/0000-0002-2334-2535	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036929] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI036929] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Carlsson AE, 2003, BIOPHYS J, V84, P2907, DOI 10.1016/S0006-3495(03)70018-6; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; McGrath JL, 2003, CURR BIOL, V13, P329, DOI 10.1016/S0960-9822(03)00051-4; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Schwartz IM, 2004, CURR BIOL, V14, P1094, DOI 10.1016/j.cub.2004.06.023; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148	27	154	158	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1219	1223		10.1038/ncb1336	http://dx.doi.org/10.1038/ncb1336			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16299496				2022-12-27	WOS:000233748900015
J	Prasad, SVN; Jayatilleke, A; Madamanchi, A; Rockman, HA				Prasad, SVN; Jayatilleke, A; Madamanchi, A; Rockman, HA			Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis	NATURE CELL BIOLOGY			English	Article							MEDIATED ENDOCYTOSIS; COUPLED RECEPTORS; ACTIN; RECRUITMENT; TROPOMYOSIN; MEMBRANE; AUTOPHOSPHORYLATION; PHOSPHORYLATION; SPECIFICITY; ACTIVATION	Phosphoinositide 3-kinase (PI(3)K) is a unique enzyme characterized by both lipid and protein kinase activities. Here, we demonstrate a requirement for the protein kinase activity of PI(3)K in agonist-dependent beta-adrenergic receptor (beta AR) internalization. Using PI(3)K mutants with either protein or lipid phosphorylation activity, we identify the cytoskeletal protein non-muscle tropomyosin as a substrate of PI(3)K, which is phosphorylated in a wortmannin-sensitive manner on residue Ser 61. A constitutively dephosphorylated (S61A) tropomyosin mutant blocks agonist-dependent beta AR internalization, whereas a tropomyosin mutant that mimics constitutive phosphorylation (S61D) compliments the PI(3)K mutant, with only lipid phosphorylation activity reversing the defective beta AR internalization. Notably, knocking down endogenous tropomyosin expression using siRNAs that target different regions of tropomyosin resulted in complete inhibition of beta AR endocytosis, showing that non-muscle tropomyosin is essential for agonist-mediated receptor internalization. These studies demonstrate a previously unknown role for the protein phosphorylation activity of PI(3)K in beta AR internalization and identify non-muscle tropomyosin as a cellular substrate for protein kinase activity of PI(3)K.	Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA	Duke University	Rockman, HA (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA.	h.rockman@duke.edu	, Proteomics Core UNC/AFQ-7201-2022	Madamanchi, Aasakiran/0000-0003-1047-6646; Jayatilleke, Arundathi/0000-0003-0875-4280	NHLBI NIH HHS [P01 HL 075443] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Czupalla C, 2003, J BIOL CHEM, V278, P11536, DOI 10.1074/jbc.M210351200; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; GOTTLIEB TA, 1993, J CELL BIOL, V120, P695, DOI 10.1083/jcb.120.3.695; Horne J, 2002, PROTEIN SCI, V11, P2041, DOI 10.1110/ps.4560102; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; PITTENGER MF, 1994, CURR OPIN CELL BIOL, V6, P96, DOI 10.1016/0955-0674(94)90122-8; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sano K, 2000, J BIOCHEM-TOKYO, V127, P1095; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1999, EMBO J, V18, P1292, DOI 10.1093/emboj/18.5.1292; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319	36	103	106	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					785	U48		10.1038/ncb1278	http://dx.doi.org/10.1038/ncb1278			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16094730				2022-12-27	WOS:000230881500013
J	Reilein, A; Nelson, WJ				Reilein, A; Nelson, WJ			APC is a component of an organizing template for cortical microtubule networks	NATURE CELL BIOLOGY			English	Article							ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; CYTOPLASMIC DYNEIN; GENE-PRODUCT; PLUS ENDS; EB1; BINDING; P150(GLUED); DYNAMICS; CDC42	A microtubule network on the basal cortex of polarized epithelial cells consists of non-centrosomal microtubules of mixed polarity. Here, we investigate the proteins that are involved in organizing this network, and we show that end-binding protein 1 (EB1), adenomatous polyposis coli protein (APC) and p150(Glued) - although considered to be microtubule plus-end-binding proteins - are localized along the entire length of microtubules within the network, and at T-junctions between microtubules. The network shows microtubule behaviours that arise from physical interactions between microtubules, including microtubule plus-end stabilization on the sides of other microtubules, and sliding of microtubule ends along other microtubules. APC also localizes to the basal cortex. Microtubules grew over and paused at APC puncta; an in vitro reconstituted microtubule network overlaid APC puncta; and microtubule network reconstitution was inhibited by function-blocking APC antibodies. Thus, APC is a component of a cortical template that guides microtubule network formation.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med B121, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med B121, Dept Cellular & Mol Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	wjnelson@stanford.edu			NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042735] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09151, T32 CA009151] Funding Source: Medline; NIGMS NIH HHS [R01 GM035527] Funding Source: Medline; NINDS NIH HHS [NS 42735, R01 NS042735] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Barth AIM, 2002, J CELL SCI, V115, P1583; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Drees Frauke, 2004, V294, P303; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; HOWARD WD, 1988, J BIOL CHEM, V263, P1342; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Mariadason JM, 2001, CANCER RES, V61, P3465; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; Shimizu K, 1996, J BIOL CHEM, V271, P27013, DOI 10.1074/jbc.271.43.27013; SU LK, 1995, CANCER RES, V55, P2972; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vaughan KT, 2004, TRENDS CELL BIOL, V14, P491, DOI 10.1016/j.tcb.2004.07.011; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	47	85	88	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					463	U20		10.1038/ncb1248	http://dx.doi.org/10.1038/ncb1248			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15892196	Green Accepted			2022-12-27	WOS:000229123500013
J	Wodarz, A; Nathke, I				Wodarz, Andreas; Naethke, Inke			Cell polarity in development and cancer	NATURE CELL BIOLOGY			English	Review							TUMOR-SUPPRESSOR PROTEIN; LETHAL-GIANT-LARVAE; KINASE-C-IOTA; REGULATES SPINDLE ORIENTATION; NEUROBLAST SELF-RENEWAL; DISCS LARGE; E-CADHERIN; TGF-BETA; INTERCELLULAR-JUNCTIONS; HUMAN HOMOLOG	The development of cancer is a multistep process in which the DNA of a single cell accumulates mutations in genes that control essential cellular processes. Loss of cell-cell adhesion and cell polarity is commonly observed in advanced tumours and correlates well with their invasion into adjacent tissues and the formation of metastases. Growing evidence indicates that loss of cell-cell adhesion and cell polarity may also be important in early stages of cancer. The strongest hints in this direction come from studies on tumour suppressor genes in the fruitfly Drosophila melanogaster, which have revealed their importance in the control of apical-basal cell polarity.	Univ Gottingen, CMPB, DFG, Dept Stem Cell Biol, D-37077 Gottingen, Germany; Univ Dundee, Inke Nathke Cell Dev Biol, Dundee DD1 5EH, Scotland	German Research Foundation (DFG); University of Gottingen; University of Dundee	Wodarz, A (corresponding author), Univ Gottingen, CMPB, DFG, Dept Stem Cell Biol, Justus Von Liebig Weg 11, D-37077 Gottingen, Germany.	awodarz@gwdg.de; inke@lifesci.dundee.ac.uk	Wodarz, Andreas/D-4642-2013; thery, manuel/G-2181-2011	Wodarz, Andreas/0000-0002-0007-6289; Nathke, Inke/0000-0003-2420-4385				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barry RE, 2004, TRENDS MOL MED, V10, P466, DOI 10.1016/j.molmed.2004.07.008; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Calzada MJ, 2006, CANCER RES, V66, P1553, DOI 10.1158/0008-5472.CAN-05-3236; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cavatorta AL, 2004, INT J CANCER, V111, P373, DOI 10.1002/ijc.20275; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Giebel B, 2006, CURR BIOL, V16, pR91, DOI 10.1016/j.cub.2006.01.022; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Graziano F, 2003, ANN ONCOL, V14, P1705, DOI 10.1093/annonc/mdg486; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li L, 2000, GENE DEV, V14, P147; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Massimi P, 2006, ONCOGENE, V25, P4276, DOI 10.1038/sj.onc.1209457; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nakagawa S, 2004, BRIT J CANCER, V90, P194, DOI 10.1038/sj.bjc.6601465; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Potten CS, 2002, J CELL SCI, V115, P2381; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas M, 2005, ONCOGENE, V24, P6222, DOI 10.1038/sj.onc.1208757; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	106	264	269	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1016	1024		10.1038/ncb433	http://dx.doi.org/10.1038/ncb433			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762893				2022-12-27	WOS:000249256500007
J	Katz, M; Amit, I; Citri, A; Shay, T; Carvalho, S; Lavi, S; Milanezi, F; Lyass, L; Amariglio, N; Jacob-Hirsch, J; Ben-Chetrit, N; Tarcic, G; Lindzen, M; Avraham, R; Liao, YC; Trusk, P; Lyass, A; Rechavi, G; Spector, NL; Lo, SH; Schmitt, F; Bacus, SS; Yarden, Y				Katz, Menachem; Amit, Ido; Citri, Ami; Shay, Tal; Carvalho, Silvia; Lavi, Sara; Milanezi, Fernanda; Lyass, Ljuba; Amariglio, Ninette; Jacob-Hirsch, Jasmine; Ben-Chetrit, Nir; Tarcic, Gabi; Lindzen, Moshit; Avraham, Roi; Liao, Yi-Chun; Trusk, Patricia; Lyass, Asya; Rechavi, Gideon; Spector, Neil L.; Lo, Su Hao; Schmitt, Fernando; Bacus, Sarah S.; Yarden, Yosef			A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA EXPRESSION; TUMOR PROGRESSION; GROWTH; TENSIN; CYTOSKELETON; PROTEIN; CTEN; ACTIVATION; INHIBITOR; DIVERSITY	Cell migration driven by the epidermal growth factor receptor ( EGFR) propels morphogenesis(1) and involves reorganization of the actin cytoskeleton(2). Although de novo transcription precedes migration(3,4), transcript identity remains largely unknown. Through their actin-binding domains, tensins link the cytoskeleton to integrin-based adhesion sites(5). Here we report that EGF downregulates tensin-3 expression, and concomitantly upregulates cten, a tensin family member that lacks the actin-binding domain(6). Knockdown of cten or tensin-3, respectively, impairs or enhances mammary cell migration. Furthermore, cten displaces tensin-3 from the cytoplasmic tail of integrin beta(1), thereby instigating actin fibre disassembly. In invasive breast cancer, cten expression correlates not only with high EGFR and HER2, but also with metastasis to lymph nodes. Moreover, treatment of inflammatory breast cancer patients with an EGFR/HER2 dual-specificity kinase inhibitor significantly downregulated cten expression. In conclusion, a transcriptional tensin-3-cten switch may contribute to the metastasis of mammary cancer.	Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; Targeted Mol Diagnost, Westmont, IL 60559 USA; Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Pediat Hemato Oncol & Funct Genom, IL-69978 Tel Aviv, Israel; Univ Calif Davis, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA; Boston Univ, Boston, MA 02215 USA; Univ GlaxosmithKline, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA; Boston Univ, Boston, MA 02215 USA; GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Univ Porto, Med Fac, P-4200465 Oporto, Portugal	Weizmann Institute of Science; Weizmann Institute of Science; Universidade do Porto; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Davis; Boston University; GlaxoSmithKline; Boston University; GlaxoSmithKline; Universidade do Porto	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012; Liao, Yi-Chun/H-2383-2014; Citri, Ami/R-8973-2019; Schmitt, Fernando/A-5270-2008; Hsiao, Wei-Hung/B-9931-2013; Shay, Tal/J-4028-2016	Citri, Ami/0000-0002-9914-0278; Schmitt, Fernando/0000-0002-3711-8681; Shay, Tal/0000-0003-0755-1350; Avraham, Roi/0000-0002-9098-3885; Schmitt, Fernando/0000-0003-1006-6946; Liao, Yi-Chun/0000-0002-0399-0201; Lo, Su Hao/0000-0002-2675-9387	NCI NIH HHS [CA72981, CA102537] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA102537, R01CA072981, R37CA072981, R01CA102537] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; ALLRED DC, 1992, J CLIN ONCOL, V10, P599, DOI 10.1200/JCO.1992.10.4.599; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Cui YM, 2004, MOL CANCER RES, V2, P225; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GORDON SR, 1990, CELL MOTIL CYTOSKEL, V16, P47, DOI 10.1002/cm.970160107; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kook S, 2003, BIOCHEM BIOPH RES CO, V303, P37, DOI 10.1016/S0006-291X(03)00280-8; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Manos EJ, 2001, ONCOGENE, V20, P2781, DOI 10.1038/sj.onc.1204379; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodrigue CM, 2005, ONCOGENE, V24, P3274, DOI 10.1038/sj.onc.1208485; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Wu Mei, 2005, Breast Dis, V22, P25; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	30	143	149	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					961	U124		10.1038/ncb1622	http://dx.doi.org/10.1038/ncb1622			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643115				2022-12-27	WOS:000248486700018
J	Mora-Bermudez, F; Gerlich, D; Ellenberg, J				Mora-Bermudez, Felipe; Gerlich, Daniel; Ellenberg, Jan			Maximal chromosome compaction occurs by axial shortening in anaphase and depends on Aurora kinase	NATURE CELL BIOLOGY			English	Article							MITOTIC CHROMOSOME; IN-VIVO; TIME-LAPSE; CHROMATID SEGREGATION; CONDENSIN-I; HUMAN-CELLS; DYNAMICS; MITOSIS; ORGANIZATION; ARCHITECTURE	Eukaryotic cells must first compact their chromosomes before faithfully segregating them during cell division. Failure to do so can lead to segregation defects with pathological consequences, such as aneuploidy and cancer(1,2). Duplicated interphase chromosomes are, therefore, reorganized into tight rods before being separated and directed to the newly forming daughter cells(3). This vital reorganization of chromatin remains poorly understood. To address the dynamics of mitotic condensation of single chromosomes in intact cells, we developed quantitative assays based on confocal time-lapse microscopy of live mammalian cells stably expressing fluorescently tagged core histones. Surprisingly, maximal compaction was not reached in metaphase, but in late anaphase, after sister chromatid segregation. We show that anaphase compaction proceeds by a mechanism of axial shortening of the chromatid arms from telomere to centromere. Chromatid axial shortening was not affected in condensin-depleted cells, but depended instead on dynamic microtubules and Aurora kinase. Acute perturbation of this compaction resulted in failure to rescue segregation defects and in multilobed daughter nuclei, suggesting functions in chromosome segregation and nuclear architecture.	European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Gerlich, Daniel Wolfram W/A-6991-2016; Ellenberg, Jan/I-4688-2014	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Ellenberg, Jan/0000-0001-5909-701X				Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Cimini D, 2002, J CELL SCI, V115, P507; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Gerlich D, 2003, NAT CELL BIOL, pS14, DOI 10.1038/ncb1033; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HIRAOKA Y, 1989, NATURE, V342, P293, DOI 10.1038/342293a0; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Manders EMM, 2003, CHROMOSOME RES, V11, P537, DOI 10.1023/A:1024995215340; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; SWEDLOW JR, 1993, CELL, V73, P97, DOI 10.1016/0092-8674(93)90163-K; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	39	127	128	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					822	U170		10.1038/ncb1606	http://dx.doi.org/10.1038/ncb1606			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558394				2022-12-27	WOS:000247760700018
J	Fukuda, T; Yamagata, K; Fujiyama, S; Matsumoto, T; Koshida, I; Yoshimura, K; Mihara, M; Naitou, M; Endoh, H; Nakamura, T; Akimoto, C; Yamamoto, Y; Katagiri, T; Foulds, C; Takezawa, S; Kitagawa, H; Takeyama, K; O'Malley, BW; Kato, S				Fukuda, Toru; Yamagata, Kaoru; Fujiyama, Sally; Matsumoto, Takahiro; Koshida, Iori; Yoshimura, Kimihiro; Mihara, Masatomo; Naitou, Masanori; Endoh, Hideki; Nakamura, Takashi; Akimoto, Chihiro; Yamamoto, Yoko; Katagiri, Takenobu; Foulds, Charles; Takezawa, Shinichiro; Kitagawa, Hirochika; Takeyama, Ken-ichi; O'Malley, Bert W.; Kato, Shigeaki			DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs	NATURE CELL BIOLOGY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL COACTIVATOR; MICROPROCESSOR COMPLEX; MOUSE DEVELOPMENT; NUCLEAR RECEPTOR; P68; PROTEIN; P72; ASSOCIATION	MicroRNAs (miRNAs) control cell proliferation, differentiation and fate through modulation of gene expression by partially base-pairing with target mRNA sequences(1-6). Drosha is an RNase III enzyme that is the catalytic subunit of a large complex that cleaves pri-miRNAs with distinct structures into pre-miRNAs(7). Here, we show that both the p68 and p72 DEAD-box RNA helicase subunits(8-10) in the mouse Drosha complex are indispensable for survival in mice, and both are required for primary miRNA and rRNA processing. Gene disruption of either p68 or p72 in mice resulted in early lethality, and in both p68(-/-) and p72(-/-) embryos, expression levels of a set of, but not all, miRNAs and 5.8S rRNA were significantly lowered. In p72(-/-) MEF cells, expression of p72, but not a mutant lacking ATPase activity, restored the impaired expression of miRNAs and 5.8S rRNA. Furthermore, we purified the large complex of mouse Drosha and showed it could generate pre-miRNA and 5.8S rRNA in vitro. Thus, we suggest that DEAD-box RNA helicase subunits are required for recognition of a subset of primary miRNAs in mDrosha-mediated processing.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, ERATO, Kawaguchi, Saitama 3320012, Japan; Astellas Pharma Inc, Drug Discovery Res, Mol Med Labs, Appl Genom, Ibaraki 3058585, Japan; Saitama Med Sch, Res Ctr Genom Med, Hidakashi, Saitama 3501242, Japan; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Tokyo; Japan Science & Technology Agency (JST); Astellas Pharmaceuticals; Saitama Medical University; Baylor College of Medicine	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp		Nakamura, Takashi/0000-0002-6124-061X				Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kircher SG, 2002, NEUROCHEM RES, V27, P1141, DOI 10.1023/A:1020921324871; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morgenstern B, 1998, BIOINFORMATICS, V14, P290, DOI 10.1093/bioinformatics/14.3.290; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	41	329	338	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					604	U221		10.1038/ncb1577	http://dx.doi.org/10.1038/ncb1577			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435748				2022-12-27	WOS:000246181500020
J	Regad, T; Roth, M; Bredenkamp, N; Illing, N; Papalopulu, N				Regad, Tarik; Roth, Martin; Bredenkamp, Nicholas; Illing, Nicola; Papalopulu, Nancy			The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF	NATURE CELL BIOLOGY			English	Article							HELIX TRANSCRIPTION FACTOR; CASEIN KINASE-I; CORTICAL NEUROGENESIS; CELL-PROLIFERATION; CEREBRAL-CORTEX; PROTEIN; XENOPUS; DIFFERENTIATION; REPRESSION; SMAD	FoxG1 is an evolutionarily conserved, winged-helix transcriptional repressor that maintains progenitor cells in the vertebrate forebrain. How the activity of FoxG1 is regulated is not known. Here, we report that in the developing Xenopus and mouse forebrain, FoxG1 is nuclear in progenitor cells but cytoplasmic in differentiating cells. The subcellular localisation of FoxG1 is regulated at the post-translational level by casein kinase I (CKI) and fibroblast growth factor (FGF) signalling. CKI phosphorylation of Ser 19 of FoxG1 promotes nuclear import, whereas FGF-induced phosphorylation of Thr 226 promotes nuclear export. Interestingly, FGF-induced phosphorylation of FoxG1 is mediated Akt kinase (also known as protein B kinase, PKB) kinase, rather than the MAPK pathway. Phosphorylation of endogenous FoxG1 is blocked by CKI and Akt inhibitors. In the mouse olfactory placode cell line OP27, and in cortical progenitors, increased FGF signalling causes FoxG1 to exit the nucleus and promotes neuronal differentiation, whereas FGF and Akt inhibitors block this effect. Thus, CKI and FGF signalling converge on an antagonistic regulation of FoxG1, which in turn controls neurogenesis in the forebrain.	Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; Canc Res UK Gurdon Inst, Wellcome Trust, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	University of Cape Town; Cancer Research UK; Wellcome Trust Sanger Institute; University of Cambridge	Papalopulu, N (corresponding author), MRC Toxicol Unit, Leicester LE1 9HN, Leics, England.	nancy.papalopulu@manchester.ac.uk	Regad, Tarik/A-6095-2012	Regad, Tarik/0000-0003-4028-6368; Papalopulu, Nancy/0000-0001-6992-6870	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Chen JA, 2005, MECH DEVELOP, V122, P307, DOI 10.1016/j.mod.2004.11.008; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dou CL, 2000, MOL CELL BIOL, V20, P6201, DOI 10.1128/MCB.20.17.6201-6211.2000; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Kaestner KH, 2000, GENE DEV, V14, P142; Li J, 1997, P NATL ACAD SCI USA, V94, P10885, DOI 10.1073/pnas.94.20.10885; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Raballo R, 2000, J NEUROSCI, V20, P5012; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rodriguez C, 2001, J BIOL CHEM, V276, P30224, DOI 10.1074/jbc.M102759200; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; Vaccarino FM, 2001, NEUROPSYCHOPHARMACOL, V25, P805, DOI 10.1016/S0893-133X(01)00349-9; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Zhang C, 2004, DEV BIOL, V273, P23, DOI 10.1016/j.ydbio.2004.05.019; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	35	70	74	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					531	U87		10.1038/ncb1573	http://dx.doi.org/10.1038/ncb1573			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435750				2022-12-27	WOS:000246181500011
J	Zhang, Q; Bengtsson, M; Partridge, C; Salehi, A; Braun, M; Cox, R; Eliasson, L; Johnson, PRV; Renstrom, E; Schneider, T; Berggren, PO; Gopel, S; Ashcroft, FM; Rorsman, P				Zhang, Quan; Bengtsson, Martin; Partridge, Chris; Salehi, Albert; Braun, Matthias; Cox, Roger; Eliasson, Lena; Johnson, Paul R. V.; Renstrom, Erik; Schneider, Toni; Berggren, Per-Olof; Gopel, Sven; Ashcroft, Frances M.; Rorsman, Patrik			R-type Ca2+-channel-evoked CICR regulates glucose-induced somatostatin secretion	NATURE CELL BIOLOGY			English	Article							PANCREATIC BETA-CELLS; PERFUSED RAT PANCREAS; DELTA-CELLS; INSULIN-SECRETION; RYANODINE RECEPTOR; INTACT ISLETS; ALPHA-CELLS; CAPACITANCE MEASUREMENTS; GLUCAGON-SECRETION; CALCIUM-RELEASE	Pancreatic islets have a central role in blood glucose homeostasis. In addition to insulin-producing beta-cells and glucagon-secreting alpha-cells, the islets contain somatostatin-releasing delta-cells(1). Somatostatin is a powerful inhibitor of insulin and glucagon secretion(2). It is normally secreted in response to glucose(3) and there is evidence suggesting its release becomes perturbed in diabetes(4). Little is known about the control of somatostatin release. Closure of ATP-regulated K+-channels (K-ATP-channels)(5) and a depolarization-evoked increase in cytoplasmic free Ca2+ concentration ([Ca2+](i))(6-8) have been proposed to be essential. Here, we report that somatostatin release evoked by high glucose (>= 10 mM) is unaffected by the K-ATP-channel activator diazoxide and proceeds normally in K-ATP-channel-deficient islets. Glucose-induced somatostatin secretion is instead primarily dependent on Ca2+-induced Ca2+-release (CICR). This constitutes a novel mechanism for K-ATP-channel-independent metabolic control of pancreatic hormone secretion.	Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Lund Univ, Clin Res Ctr, Dept Clin Sci, SE-20502 Malmo, Sweden; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; John Radcliffe Hosp, Suffield Dept Surg, Oxford OX3 9DU, England; Univ Cologne, Insneurophysiol, D-50931 Cologne, Germany; Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; AstraZeneca R&D, SE-43183 Molndal, Sweden; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford; Lund University; MRC Harwell; University of Oxford; University of Cologne; Karolinska Institutet; AstraZeneca; University of Oxford	Rorsman, P (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	patrik.rorsman@drl.ox.ac.uk	Tuluc, Petronel/C-2527-2011; Rorsman, Patrik/A-4331-2016; Zhang, Quan/AAZ-1154-2021; Salehi, Albert/F-7768-2018; Eliasson, Lena/E-9294-2012	Rorsman, Patrik/0000-0001-7578-0767; Salehi, Albert/0000-0001-6120-3539; Eliasson, Lena/0000-0002-6467-5029; Zhang, Quan/0000-0002-3626-4855; Cox, Roger/0000-0001-7170-5014; Berggren, Per-Olof/0000-0001-8991-413X	MRC [MC_U142684172, MC_U142661184, MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684175, MC_U142661184] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ABDELHALIM SM, 1993, ACTA PHYSIOL SCAND, V148, P219, DOI 10.1111/j.1748-1716.1993.tb09551.x; BISHOP AE, 1997, TXB DIABETES, V1, P6; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; EFENDIC S, 1979, P NATL ACAD SCI USA, V76, P5901, DOI 10.1073/pnas.76.11.5901; EFENDIC S, 1982, DIABETOLOGIA, V22, P475, DOI 10.1007/BF00282593; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kanno T, 2004, METHODS, V33, P302, DOI 10.1016/j.ymeth.2004.01.003; LEITER EH, 1979, DIABETOLOGIA, V17, P297, DOI 10.1007/BF01235886; Lollike K, 1999, J IMMUNOL METHODS, V232, P111, DOI 10.1016/S0022-1759(99)00169-6; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; SCHUIT FC, 1989, DIABETOLOGIA, V32, P207, DOI 10.1007/BF00265096; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; SQUIRES PE, 1994, PFLUG ARCH EUR J PHY, V428, P275, DOI 10.1007/BF00724507; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038	30	81	83	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					453	U171		10.1038/ncb1563	http://dx.doi.org/10.1038/ncb1563			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369816				2022-12-27	WOS:000245359400017
J	Santos, SDM; Verveer, PJ; Bastiaens, PIH				Santos, Silvia D. M.; Verveer, Peter J.; Bastiaens, Philippe I. H.			Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate	NATURE CELL BIOLOGY			English	Article							SIGNAL-REGULATED KINASE; ACTIVATION; PHOSPHORYLATION; PROTEIN; RAF-1; IDENTIFICATION; DYNAMICS; CASCADE; SPECIFICITY; TRANSIENT	The mitogen-activated protein kinase ( MAPK) network is a conserved signalling module that regulates cell fate by transducing a myriad of growth-factor signals(1). The ability of this network to coordinate and process a variety of inputs from different growth-factor receptors into specific biological responses is, however, still not understood. We investigated how the MAPK network brings about signal specificity in PC-12 cells, a model for neuronal differentiation(2). Reverse engineering by modular-response analysis(3) uncovered topological differences in the MAPK core network dependent on whether cells were activated with epidermal or neuronal growth factor (EGF or NGF). On EGF stimulation, the network exhibited negative feedback only, whereas a positive feedback was apparent on NGF stimulation. The latter allows for bi-stable Erk activation dynamics, which were indeed observed. By rewiring these regulatory feedbacks, we were able to reverse the specific cell responses to EGF and NGF. These results show that growth factor context determines the topology of the MAPK signalling network and that the resulting dynamics govern cell fate.	European Mol Biol Lab, D-69117 Heidelberg, Germany; MPI Mol Physiol, Dept Syst Biol, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de						ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Andrec M, 2005, J THEOR BIOL, V232, P427, DOI 10.1016/j.jtbi.2004.08.022; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; BUDAY L, 1995, ONCOGENE, V11, P1327; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Ferrell JE, 1999, BIOESSAYS, V21, P866, DOI 10.1002/(SICI)1521-1878(199910)21:10<866::AID-BIES9>3.0.CO;2-1; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	24	483	489	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					324	U139		10.1038/ncb1543	http://dx.doi.org/10.1038/ncb1543			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310240				2022-12-27	WOS:000244558600017
J	Gavard, J; Gutkind, JS				Gavard, Julie; Gutkind, J. Silvio			VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin	NATURE CELL BIOLOGY			English	Article							COUPLED RECEPTOR TRAFFICKING; FOCAL ADHESION KINASE; VASCULAR-PERMEABILITY; TYROSINE PHOSPHORYLATION; ADRENERGIC-RECEPTOR; DOWN-REGULATION; SRC ACTIVITY; GROWTH; PROTEIN; ANGIOGENESIS	How vascular endothelial growth factor (VEGF) induces vascular permeability, its first described function, remains poorly understood. Here, we provide evidence of a novel signalling pathway by which VEGF stimulation promotes the rapid endocytosis of a key endothelial cell adhesion molecule, VE-cadherin, thereby disrupting the endothelial barrier function. This process is initiated by the activation of the small GTPase Rac by VEGFR-2 through the Src-dependent phosphorylation of Vav2, a guanine nucleotide-exchange factor. Rac activation, in turn, promotes the p21-activated kinase (PAK)-mediated phosphorylation of a highly conserved motif within the intracellular tail of VE-cadherin. Surprisingly, this results in the recruitment of beta-arrestin2 to serine-phosphorylated VE-cadherin, thereby promoting its internalization into clathrin-coated vesicles and the consequent disassembly of intercellular junctions. Ultimately, this novel biochemical route by which VEGF promotes endothelial permeability through the beta-arrestin2-dependent endocytosis of VE-cadherin may help identify new therapeutic targets for the treatment of many human diseases that are characterized by vascular leakage.	Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, DHHS, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gavard, Julie/I-5487-2012; Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Gutkind, J. Silvio/0000-0002-5150-4482; Gavard, Julie/0000-0003-3107-2026	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Montaner S, 2004, BLOOD, V104, P2903, DOI 10.1182/blood-2003-12-4436; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Vincent L, 2005, J CLIN INVEST, V115, P2992, DOI 10.1172/JCI24586; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wong EYM, 2000, BIOCHEM J, V346, P209, DOI 10.1042/0264-6021:3460209; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200	49	745	793	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1223	U17		10.1038/ncb1486	http://dx.doi.org/10.1038/ncb1486			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060906				2022-12-27	WOS:000241732400011
J	Kubagawa, HM; Watts, JL; Corrigan, C; Edmonds, JW; Sztul, E; Browse, J; Miller, MA				Kubagawa, Homare M.; Watts, Jennifer L.; Corrigan, Chad; Edmonds, Johnathan W.; Sztul, Elizabeth; Browse, John; Miller, Michael A.			Oocyte signals derived from polyunsaturated fatty acids control sperm recruitment in vivo	NATURE CELL BIOLOGY			English	Article							T-CELL RECRUITMENT; CAENORHABDITIS-ELEGANS; MEIOTIC MATURATION; GERM-LINE; C-ELEGANS; ARACHIDONIC-ACID; LEUKOTRIENE B-4; GENE; PROSTAGLANDINS; IDENTIFICATION	A fundamental question in animal development is how motile cells find their correct target destinations. During mating in the nematode Caenorhabditis elegans, males inject sperm through the hermaphrodite vulva into the uterus. Amoeboid sperm crawl around fertilized eggs to the spermatheca - a convoluted tube where fertilization occurs(1,2). Here, we show that polyunsaturated fatty acids (PUFAs), the precursors of eicosanoid signalling molecules, function in oocytes to control directional sperm motility within the uterus. PUFAs are transported from the intestine, the site of fat metabolism, to the oocytes yolk, which is a lipoprotein complex. Loss of the RME-2 low-density lipoprotein (LDL) receptor, which mediates yolk endocytosis(3) and fatty acid transport into oocytes, causes severe defects in sperm targeting. We used an RNAi screen to identify lipid regulators required for directional sperm motility. Our results support the hypothesis that PUFAs function in oocytes as precursors of signals that control sperm recruitment to the spermatheca. A common property of PUFAs in mammals and C. elegans is that these fats control local recruitment of motile cells to their target tissues.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Alabama System; University of Alabama Birmingham; Washington State University	Miller, MA (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.	mamiller@uab.edu	Watts, Jennifer/AAC-7425-2020	Browse, John/0000-0002-2554-2821; Watts, Jennifer/0000-0003-4349-0639; Miller, Michael/0000-0003-4872-7121	NIDDK NIH HHS [R01DK074114, R01 DK074114-01, R01 DK074114] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTON MK, 1987, GENETICS, V115, P107; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BRENNER S, 1974, GENETICS, V77, P71; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Dey I, 2003, P NATL ACAD SCI USA, V100, P13561, DOI 10.1073/pnas.1835863100; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; FRANCIS R, 1995, GENETICS, V139, P579; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; GRAHAM PL, 1993, DEV GENET, V14, P471, DOI 10.1002/dvg.1020140608; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; HABENICHT AJR, 1990, NATURE, V345, P634, DOI 10.1038/345634a0; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hill KL, 2001, DEV BIOL, V232, P105, DOI 10.1006/dbio.2000.0136; JANSSENTIMMEN U, 1994, ANN NY ACAD SCI, V733, P325, DOI 10.1111/j.1749-6632.1994.tb17282.x; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kohara Y, 2001, Tanpakushitsu Kakusan Koso, V46, P2425; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; SALBACH PB, 1992, P NATL ACAD SCI USA, V89, P2439, DOI 10.1073/pnas.89.6.2439; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Singson A, 2001, DEV BIOL, V230, P101, DOI 10.1006/dbio.2000.0118; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	39	110	150	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1143	U183		10.1038/ncb1476	http://dx.doi.org/10.1038/ncb1476			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998478				2022-12-27	WOS:000241395300019
J	Mabb, AM; Wuerzberger-Davis, SM; Miyamoto, S				Mabb, Angela M.; Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki			PIASy mediates NEMO sumoylation and NF-kappa B activation in response to genotoxic stress	NATURE CELL BIOLOGY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; RADIATION; APOPTOSIS; LINKAGE; SUMO-1; CELLS; UBC9; ATM	Protein modification by SUMO (small ubiquitin-like modifier) is an important regulatory mechanism for multiple cellular processes(1,2). SUMO-1 modification of NEMO (NF-kappa B essential modulator), the I kappa B kinase (IKK) regulatory subunit, is critical for activation of NF-kappa B by genotoxic agents(3). However, the SUMO ligase, and the mechanisms involved in NEMO sumoylation, remain unknown. Here, we demonstrate that although small interfering RNAs (siRNAs) against PIASy (protein inhibitor of activated STATy) inhibit NEMO sumoylation and NF-kappa B activation in response to genotoxic agents, overexpression of PIASy enhances these events. PIASy preferentially stimulates site-selective modification of NEMO by SUMO-1, but not SUMO-2 and SUMO-3, in vitro. PIASy-NEMO interaction is increased by genotoxic stress and occurs in the nucleus in a manner mutually exclusive with IKK interaction. In addition, hydrogen peroxide (H2O2) also increases PIASy-NEMO interaction and NEMO sumoylation, whereas antioxidants prevent these events induced by DNA-damaging agents. Our findings demonstrate that PIASy is the first SUMO ligase for NEMO whose substrate specificity seems to be controlled by IKK interaction, subcellular targeting and oxidative stress conditions.	Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA.	smiyamot@wisc.edu		Mabb, Angela/0000-0002-3000-8690	NATIONAL CANCER INSTITUTE [R01CA077474, R01CA081065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA77474, R01CA81065, R01 CA077474] Funding Source: Medline; NIGMS NIH HHS [T32GM008688] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; England K, 2004, CELL DEATH DIFFER, V11, P252, DOI 10.1038/sj.cdd.4401338; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; Pham NA, 2001, EXP CELL RES, V264, P345, DOI 10.1006/excr.2000.5148; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028	26	176	187	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					986	U85		10.1038/ncb1458	http://dx.doi.org/10.1038/ncb1458			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906147				2022-12-27	WOS:000240241700015
J	Gonzalo, S; Jaco, I; Fraga, MF; Chen, TP; Li, E; Esteller, M; Blasco, MA				Gonzalo, S; Jaco, I; Fraga, MF; Chen, TP; Li, E; Esteller, M; Blasco, MA			DNA methyltransferases control telomere length and telomere recombination in mammalian cells	NATURE CELL BIOLOGY			English	Article							MAJOR SATELLITE REPEATS; RB FAMILY; METHYLATION; DNMT3A; MAINTENANCE; SEQUENCES	Here, we describe a role for mammalian DNA methyltransferases ( DNMTs) in telomere length control. Mouse embryonic stem ( ES) cells genetically deficient for DNMT1, or both DNMT3a and DNMT3b have dramatically elongated telomeres compared with wild-type controls. Mammalian telomere repeats ( TTAGGG) lack the canonical CpG methylation site. However, we demonstrate that mouse subtelomeric regions are heavily methylated, and that this modification is decreased in DNMT-deficient cells. We show that other heterochromatic marks, such as histone 3 Lys 9 (H3K9) and histone 4 Lys 20 (H4K20) trimethylation, remain at both subtelomeric and telomeric regions in these cells. Lack of DNMTs also resulted in increased telomeric recombination as indicated by sister-chromatid exchanges involving telomeric sequences, and by the presence of 'alternative lengthening of telomeres' (ALT)-associated promyelocytic leukaemia (PML) bodies (APBs). This increased telomeric recombination may lead to telomere-length changes, although our results do not exclude a potential involvement of telomerase and telomere-binding proteins in the aberrant telomere elongation observed in DNMT-deficient cells. Together, these results demonstrate a previously unappreciated role for DNA methylation in maintaining telomere integrity.	Spanish Natl Canc Ctr CNIO, Telomers & Telomerase Grp, Mol Oncol Program, E-28029 Madrid, Spain; Spanish Natl Canc Ctr CNIO, Epigenet Grp, Mol Pathol Program, E-28029 Madrid, Spain; Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Novartis	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Telomers & Telomerase Grp, Mol Oncol Program, E-28029 Madrid, Spain.	mblasco@cnio.es	Gonzalo, Susana/T-8275-2019; Fraga, Mario F/H-7824-2017; Blasco, Maria A./M-1694-2014; Esteller, Manel/L-5956-2014	Fraga, Mario F/0000-0001-8450-2603; Blasco, Maria A./0000-0002-4211-233X; Esteller, Manel/0000-0003-4490-6093; Gonzalo, Susana/0000-0001-9631-1206				Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Bender J, 1998, TRENDS BIOCHEM SCI, V23, P252, DOI 10.1016/S0968-0004(98)01225-0; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Brock GJR, 1999, GENE, V240, P269, DOI 10.1016/S0378-1119(99)00442-4; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dominguez-Bendala J, 2004, TRANSGENIC RES, V13, P69, DOI 10.1023/B:TRAG.0000017176.77847.80; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2005, CELL CYCLE, V4, P752, DOI 10.4161/cc.4.6.1720; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	33	464	495	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					416	U66		10.1038/ncb1386	http://dx.doi.org/10.1038/ncb1386			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16565708				2022-12-27	WOS:000236560000021
J	Lomberk, G; Bensi, D; Fernandez-Zapico, ME; Urrutia, R				Lomberk, G; Bensi, D; Fernandez-Zapico, ME; Urrutia, R			Evidence for the existence of an HP1-mediated subcode within the histone code	NATURE CELL BIOLOGY			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; TRANSCRIPTIONAL REPRESSION; CHROMO DOMAIN; SHADOW DOMAIN; LYSINE 9; PHOSPHORYLATION; RECOGNITION; DROSOPHILA; MUTATIONS; KINASE	Currently, the mammalian heterochromatic proteins HP1 alpha, HP1 beta and the pan-nuclear HP1 gamma. are considered 'gatekeepers' of methyl-K9-H3-mediated silencing. Understanding how the binding of these proteins to post-translationally modified histones is switched on and off will further our knowledge of how the histone code is modulated. Here, we report that all three HP1 isoforms can be extensively modified, similar to histones, suggesting that the silencing of gene expression may be further regulated beyond the histone code. To assess the potential impact of these modifications, we analysed the phosphorylation of HP1 gamma at Ser 83 as a 'model modification'. We demonstrate that P-Ser 83-HP1 gamma has an exclusively euchromatic localization, interacts with Ku70 ( a regulatory protein involved in multiple nuclear procesess), has impaired silencing activity and serves as a marker for transcription elongation. These observations predict that regulation of silencing by methyl-K9-H3 through modification of mammalian HP1 proteins may be more complex than previously thought and suggests the existence of an HP1-mediated 'silencing subcode' that underlies the instructions of the histone code.	Dept Med, Gastroenterol Res Unit, Rochester, MN 55605 USA; Mayo Clin Canc Ctr, Rochester, MN 55605 USA	Mayo Clinic	Urrutia, R (corresponding author), Dept Med, Gastroenterol Res Unit, Rochester, MN 55605 USA.	urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R01DK056620, R56DK052913] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052913-08, R01 DK052913, R01 DK052913-09, DK52913, DK56620] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; EISSENBERG JC, 1994, J BIOL CHEM, V269, P21315; Eissenberg JC, 2001, GENE, V275, P19, DOI 10.1016/S0378-1119(01)00628-X; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Huang DW, 1998, J CELL BIOL, V142, P307, DOI 10.1083/jcb.142.2.307; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Song KY, 2001, J BIOL CHEM, V276, P8321, DOI 10.1074/jbc.M008779200; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; ZHOU XM, 1991, J BIOL CHEM, V266, P7462	23	143	145	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					407	U62		10.1038/ncb1383	http://dx.doi.org/10.1038/ncb1383			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16531993				2022-12-27	WOS:000236560000020
J	Naguibneva, I; Ameyar-Zazoua, M; Polesskaya, A; Ait-Si-Ali, S; Groisman, R; Souidi, M; Cuvellier, S; Harel-Bellan, A				Naguibneva, I; Ameyar-Zazoua, M; Polesskaya, A; Ait-Si-Ali, S; Groisman, R; Souidi, M; Cuvellier, S; Harel-Bellan, A			The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation	NATURE CELL BIOLOGY			English	Letter							STEM-CELLS; MUSCLE; EXPRESSION; INHIBITION; PREDICTION; INITIATION; HOXA-13; MYOD	Deciphering the mechanisms underlying skeletal muscle-cell differentiation in mammals is an important challenge. Cell differentiation involves complex pathways regulated at both transcriptional and post-transcriptional levels. Recent observations have revealed the importance of small (20-25 base pair) non-coding RNAs ( microRNAs or miRNAs) that are expressed in both lower organisms(1) and in mammals(2,3). miRNAs modulate gene expression by affecting mRNA translation(4) or stability(5). In lower organisms, miRNAs are essential for cell differentiation during development(6-9); some miRNAs are involved in maintenance of the differentiated state. Here, we show that miR-181, a microRNA that is strongly upregulated during differentiation, participates in establishing the muscle phenotype. Moreover, our results suggest that miR-181 downregulates the homeobox protein Hox-A11 (a repressor of the differentiation process), thus establishing a functional link between miR-181 and the complex process of mammalian skeletal-muscle differentiation. Therefore, miRNAs can be involved in the establishment of a differentiated phenotype - even when they are not expressed in the corresponding fully differentiated tissue.	Ligue Natl Contre Canc, CNRS, UPR9079, F-94801 Villejuif, France	Centre National de la Recherche Scientifique (CNRS)	Harel-Bellan, A (corresponding author), Ligue Natl Contre Canc, CNRS, UPR9079, 7 Rue Guy Moquet, F-94801 Villejuif, France.	ahbellan@vjf.cnrs.fr	SOUIDI, Mouloud/ABI-1444-2020; Harel-Bellan, Annick/M-9795-2015	Naguibneva, Irina/0000-0001-9566-6152; Groisman, Sonia/0000-0003-1153-3841; Harel-Bellan, Annick/0000-0002-2339-153X; Groisman, Regina/0000-0003-3990-7622				Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; DENARDI C, 1993, J CELL BIOL, V123, P823, DOI 10.1083/jcb.123.4.823; Dinsmore J, 1996, CELL TRANSPLANT, V5, P131, DOI 10.1016/0963-6897(95)02040-3; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; FUCHTBAUER EM, 1992, DEV DYNAM, V193, P34; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Koshkin AA, 1998, J AM CHEM SOC, V120, P13252, DOI 10.1021/ja9822862; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Patterson LT, 2001, DEVELOPMENT, V128, P2153; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Yamamoto M, 2003, DEV GROWTH DIFFER, V45, P485; Yamamoto M, 1998, DEVELOPMENT, V125, P1325; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	30	459	539	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					278	284		10.1038/ncb1373	http://dx.doi.org/10.1038/ncb1373			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16489342				2022-12-27	WOS:000235708000014
J	Pugacheva, EN; Golemis, EA				Pugacheva, EN; Golemis, EA			The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; CELL POLARITY; CYTOSKELETON; ORIENTATION; TARGETS; CYCLE; CAS	Although HEF1 has a well-defined role in integrin-dependentattachment signalling at focal adhesions, it relocalizes to the spindle asters at mitosis. We report here that overexpression of HEF1 causes an increase in centrosome numbers and multipolar spindles, resembling defects induced by manipulation of the mitotic regulatory kinase Aurora-A (AurA). We show that HEF1 associates with and controls activation of AurA. We also show that HEF1 depletion causes centrosomal splitting, mono-astral spindles and hyperactivation of Nek2, implying additional action earlier in the cell cycle. These results provide new insight into the role of an adhesion protein in coordination of cell attachment and division.	Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Golemis, EA (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	EA_Golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673; Pugacheva, Elena/0000-0001-9814-7446	NATIONAL CANCER INSTITUTE [P30CA006927, R01CA063366, R29CA063366] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006927, P30 CA006927-44, CA63366, R01 CA063366-11, R01 CA063366, CA-06927] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; D'Assoro AB, 2001, MARC MALPIG SYMP SER, V7, P103; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fashena SJ, 2002, J CELL SCI, V115, P99; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hakak Y, 1999, MOL CELL BIOL, V19, P6953; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Mayor T, 2002, J CELL SCI, V115, P3275; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Salisbury JL, 2003, CURR BIOL, V13, pR88, DOI 10.1016/S0960-9822(03)00033-2; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Serebriiskii IG, 2002, GENOME RES, V12, P1785, DOI 10.1101/gr.450702; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Warner SL, 2003, MOL CANCER THER, V2, P589; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539	34	188	189	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2005	7	10					937	U18		10.1038/ncb1309	http://dx.doi.org/10.1038/ncb1309			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	971BM	16184168	Green Accepted			2022-12-27	WOS:000232356100007
J	Haas, AK; Fuchs, E; Kopajtich, R; Barr, FA				Haas, AK; Fuchs, E; Kopajtich, R; Barr, FA			A GTPase-activating protein controls Rab5 function in endocytic trafficking	NATURE CELL BIOLOGY			English	Article							MEMBRANE-FUSION; EARLY ENDOSOMES; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; NUCLEOTIDE EXCHANGE; YPT1 GTPASE; EEA1; TRANSPORT; BINDING; FAMILY; DOMAIN	Rab- family GTPases are conserved regulators of membrane trafficking that cycle between inactive GDP- bound and activated GTP- bound states(1,2). A key determinant of Rab function is the lifetime of the GTP- bound state(3). As Rabs have a low intrinsic rate of GTP hydrolysis, this process is under the control of GTP-hydrolysis-activating proteins ( GAPs) (1). Due to the large number of Rabs and GAPs that are encoded by the human genome, it has proven difficult to assign specific functional relationships to these proteins. Here, we identify a Rab5- specific GAP ( RabGAP5), and show that RN- Tre ( previously described as a Rab5 GAP) acts on Rab41. RabGAP- 5 overexpression triggers a loss of the Rab5 effector EEA1 from endosomes and blocks endocytic trafficking. By contrast, depletion of RabGAP- 5 results in increased endosome size, more endosome- associated EEA1, and disrupts the trafficking of EGF and LAMP1. RabGAP- 5 therefore limits the amount of activated Rab5, and thereby regulates trafficking through endosomes.	Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Barr, FA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	barr@biochem.mpg.de		Barr, Francis/0000-0001-7518-253X				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Clague MJ, 2001, J CELL SCI, V114, P3075; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; de Leeuw HPJC, 1998, BRIT J HAEMATOL, V103, P15, DOI 10.1046/j.1365-2141.1998.00965.x; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Du LL, 2001, METHOD ENZYMOL, V329, P91; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Ichioka F, 2005, BIOSCI BIOTECH BIOCH, V69, P861, DOI 10.1271/bbb.69.861; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Lee IK, 2004, BIOCHEM BIOPH RES CO, V325, P774, DOI 10.1016/j.bbrc.2004.10.095; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Richardson CJ, 1998, MOL CELL BIOL, V18, P827, DOI 10.1128/MCB.18.2.827; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Segev N, 2001, SCI STKE, pre11, DOI DOI 10.1126/STKE.2001.100.RE11; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	161	166	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					887	U36		10.1038/ncb1290	http://dx.doi.org/10.1038/ncb1290			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16086013				2022-12-27	WOS:000231601600012
J	Elsasser, S; Finley, D				Elsasser, S; Finley, D			Delivery of ubiquitinated substrates to protein-unfolding machines	NATURE CELL BIOLOGY			English	Review							AAA-ATPASE CDC48/P97; DNA-REPAIR; ENDOPLASMIC-RETICULUM; DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTOR; INTERACTING MOTIF; UBA DOMAINS; BINDING; PROTEASOME; DEGRADATION	Recent work has shown that ubiquitination leads to recognition of target proteins by diverse ubiquitin receptors. One family of receptors delivers the ubiquitinated proteins to the proteasome resulting in ATP-dependent substrate unfolding and proteolysis. A related family of ubiquitin-binding proteins seems to recruit ubiquitinated proteins to Cdc48, an ATPase ring complex that can also unfold proteins. Some targets seem to dock at Cdc48 before the proteasome does, in an ordered pathway. The intimate interplay between the proteasome and Cdc48, mediated in part by loosely associated ubiquitin receptors, has important functions in cellular regulation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Elsasser, S (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Daniel_Finley@hms.harvard.edu						Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kawahara H, 2000, EMBO J, V19, P4144, DOI 10.1093/emboj/19.15.4144; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lambertson D, 1999, GENETICS, V153, P69; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; MACLURA K, 2004, TRNEDS BIOCH SCI, V29, P637; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schauber C, 1998, GENES CELLS, V3, P307, DOI 10.1046/j.1365-2443.1998.00192.x; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	95	277	286	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					742	U10		10.1038/ncb0805-742	http://dx.doi.org/10.1038/ncb0805-742			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056265				2022-12-27	WOS:000230881500004
J	Litvak, V; Dahan, N; Ramachandran, S; Sabanay, H; Lev, S				Litvak, V; Dahan, N; Ramachandran, S; Sabanay, H; Lev, S			Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; RETINAL-DEGENERATION-B; CDP-CHOLINE PATHWAY; LIPID-METABOLISM; PHOSPHATIDYLCHOLINE SYNTHESIS; SPHINGOLIPID BIOSYNTHESIS; MEMBRANE TRAFFICKING; PLASMA-MEMBRANE; KINASE-D; TRANSPORT	The level of diacylglycerol (DAG) in the Golgi apparatus is crucial for protein transport to the plasma membrane. Studies in budding yeast indicate that Sec14p, a phosphatidylinositol ( PI)-transfer protein, is involved in regulating DAG homeostasis in the Golgi complex. Here, we show that Nir2, a peripheral Golgi protein containing a PI-transfer domain, is essential for maintaining the structural and functional integrity of the Golgi apparatus in mammalian cells. Depletion of Nir2 by RNAi leads to substantial inhibition of protein transport from the trans-Golgi network to the plasma membrane, and causes a reduction in the DAG level in the Golgi apparatus. Remarkably, inactivation of the cytosine 5'-diphosphate (CDP)-choline pathway for phosphatidylcholine biosynthesis restores both effects. These results indicate that Nir2 is involved in maintaining a critical DAG pool in the Golgi apparatus by regulating its consumption via the CDP-choline pathway, demonstrating the interface between secretion from the Golgi and lipid homeostasis.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Electron Microscopy Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Lev, S (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	sima.lev@weizmann.ac.il	Lev, Sima/AAP-7880-2020; Ramachandran, Sreekumar/H-4746-2019	Lev, Sima/0000-0002-2108-3330; Ramachandran, Sreekumar/0000-0002-6020-1344				Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; BALCH WE, 1986, J BIOL CHEM, V261, P4690; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; Bankaitis VA, 2002, SCIENCE, V295, P290, DOI 10.1126/science.1068446; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Buccione R, 1996, J BIOL CHEM, V271, P3523; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Cockcroft S, 1998, BIOESSAYS, V20, P423, DOI 10.1002/(SICI)1521-1878(199805)20:5<423::AID-BIES9>3.3.CO;2-U; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kearns BG, 1998, TRENDS CELL BIOL, V8, P276, DOI 10.1016/S0962-8924(98)01281-1; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Lev S, 1999, MOL CELL BIOL, V19, P2278; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; Litvak V, 2004, MOL CELL, V14, P319, DOI 10.1016/S1097-2765(04)00214-X; Litvak V, 2002, CURR BIOL, V12, P1513, DOI 10.1016/S0960-9822(02)01107-7; Litvak V, 2002, MOL CELL BIOL, V22, P5064, DOI 10.1128/MCB.22.14.5064-5075.2002; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MOLLENHAUER HH, 1991, J ELECTRON MICR TECH, V17, P2, DOI 10.1002/jemt.1060170103; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Rothman JE, 1996, PROTEIN SCI, V5, P185; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; van Tiel CM, 2002, FEBS LETT, V531, P69, DOI 10.1016/S0014-5793(02)03403-8; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353	50	136	142	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					225	U14		10.1038/ncb1221	http://dx.doi.org/10.1038/ncb1221			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723057				2022-12-27	WOS:000227329800010
J	Rosenblatt, J				Rosenblatt, J			Spindle assembly: asters part their separate ways	NATURE CELL BIOLOGY			English	Editorial Material							KINESIN-LIKE PROTEIN; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CORTICAL FLOW; CELL-DIVISION; MITOSIS; CENTROSOME; MOTOR; MICROTUBULES; DROSOPHILA	Cells have developed diverse ways to separate two microtubule asters to form a mitotic spindle. Here, I focus on two mechanisms used to position asters around chromosomes during mitosis: first, aster migration around the nuclear envelope and, second, aster attachment to a contractile cortex at the plasma membrane after the nuclear envelope has broken down. Although certain cell types use one mechanism predominantly, most rely on both to ensure proper spindle assembly.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London	Rosenblatt, J (corresponding author), UCL, MRC, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	jody.rosenblatt@ucl.ac.uk	Rosenblatt, Jody/AAD-4260-2019	Rosenblatt, Jody/0000-0001-9460-5868				BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Canman JC, 1997, J CELL SCI, V110, P1907; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; Giet R, 2000, EXP CELL RES, V258, P145, DOI 10.1006/excr.2000.4903; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Heald R, 1999, CURR OPIN STRUC BIOL, V9, P268, DOI 10.1016/S0959-440X(99)80037-2; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Nedelec F, 2003, CURR OPIN CELL BIOL, V15, P118, DOI 10.1016/S0955-0674(02)00014-5; Phalle BD, 1998, J CELL BIOL, V141, P1383, DOI 10.1083/jcb.141.6.1383; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SCHROEDER TE, 1981, EXP CELL RES, V134, P231, DOI 10.1016/0014-4827(81)90480-8; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Ueda M, 1999, MOL BIOL CELL, V10, P151, DOI 10.1091/mbc.10.1.151; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; WOLPERT L, 1960, INT REV CYTOL, V10, P163	35	37	37	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					219	222		10.1038/ncb0305-219	http://dx.doi.org/10.1038/ncb0305-219			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15738974				2022-12-27	WOS:000227329800009
J	Maeder, CI; Hink, MA; Kinkhabwala, A; Mayr, R; Bastiaens, PIH; Knop, M				Maeder, Celine I.; Hink, Mark A.; Kinkhabwala, Ali; Mayr, Reinhard; Bastiaens, Philippe I. H.; Knop, Michael			Spatial regulation of Fus3 MAP kinase activity through a reaction-diffusion mechanism in yeast pheromone signalling	NATURE CELL BIOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; CORRELATION SPECTROSCOPY; STE5 SCAFFOLD; FLUCTUATION SPECTROSCOPY; MITOTIC SPINDLE; GENE-EXPRESSION; BUDDING YEAST; CELL POLARITY; ACTIN CABLES	Signal transduction through mitogen-activated protein kinase ( MAPK) cascades is thought to occur through the assembly of macromolecular complexes. We quantified the abundance of complexes in the cytoplasm among the MAPKs Ste11, Ste7, Fus3 and the scaffold protein Ste5 in yeast pheromone signalling using fluorescence cross-correlation spectroscopy ( FCCS). Significant complex concentrations were observed that remained unchanged on pheromone stimulation, demonstrating that global changes in complex abundances do not contribute to the transmission of signal through the cytoplasm. On the other hand, investigation of the distribution of active Fus3 ( Fus3(PP)) across the cytoplasm using fluorescence lifetime imaging microscopy ( FLIM) revealed a gradient of Fus3PP activity emanating from the tip of the mating projection. Spatial partitioning of Fus3 activating kinases to this site and deactivating phosphatases in the cytoplasm maintain this Fus3(PP)-activity distribution. Propagation of signalling from the shmoo is, therefore, spatially constrained by a gradient-generating reaction-diffusion mechanism.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Bastiaens, PIH (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bastiaens@mpi-dortmund.mpg.de; knop@embl.de						Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 2005, BIOPHYS J, V88, P4366, DOI 10.1529/biophysj.105.059170; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Delon A, 2004, J FLUORESC, V14, P255, DOI 10.1023/B:JOFL.0000024557.73246.f9; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Eid JS, 2000, REV SCI INSTRUM, V71, P361, DOI 10.1063/1.1150208; Elion EA, 2001, J CELL SCI, V114, P3967; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Fink GR, 1991, METHOD ENZYMOL, V194, P663; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Guthrie C., 1991, METHOD ENZYMOL, V194, P429; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Lew DJ, 2005, CURR BIOL, V15, pR994, DOI 10.1016/j.cub.2005.11.048; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Qi MS, 2005, J CELL SCI, V118, P2837, DOI 10.1242/jcs.02418; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Skakun VV, 2005, EUR BIOPHYS J BIOPHY, V34, P323, DOI 10.1007/s00249-004-0453-9; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Valtz N, 1997, METHOD ENZYMOL, V283, P350; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Wang YM, 2003, MOL BIOL CELL, V14, P2543, DOI 10.1091/mbc.E02-10-0699; Wang ZX, 2002, BIOCHEMISTRY-US, V41, P7849, DOI 10.1021/bi025776m; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhan XL, 1999, GENE DEV, V13, P2811, DOI 10.1101/gad.13.21.2811; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	57	189	190	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1319	U226		10.1038/ncb1652	http://dx.doi.org/10.1038/ncb1652			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952059				2022-12-27	WOS:000250659600018
J	Koyama-Nasu, R; David, G; Tanese, N				Koyama-Nasu, Ryo; David, Gregory; Tanese, Naoko			The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN UV RESPONSE; DNA METHYLTRANSFERASE; CPG ISLANDS; GENE; ACTIVATION; DOMAIN; INDUCTION; ONCOGENE; GROWTH	c-Jun is a component of the heterodimeric transcription factor AP-1 that is rapidly activated in response to ultraviolet light (UV)(1). In unstressed cells, c-Jun activity is negatively regulated by transcriptional repressor complexes. Here we show that the F-box protein Fbl10/JHDM1B interacts with c-Jun and represses c-Jun-mediated transcription. Chromatin-immunoprecipitation assays demonstrate that Fbl10 is present at the c-jun promoter, and that c-Jun is required for the recruitment of Fbl10. Fbl10 binds to the unmethylated CpG sequences in the c-jun promoter through the CxxC zinc finger and tethers transcriptional repressor complexes. Suppression of Fbl10 expression by RNA interference (RNAi) induces transcription of c-jun and other c-Jun-target genes, and causes an aberrant cell-cycle progression and increased UV-induced cell death. Furthermore, Fbl10 protein and messenger RNA are downregulated in response to UV in an inverse correlation with c-Jun. Taken together, our results demonstrate that Fbl10 is a key regulator of c-Jun function.	NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; NYU Canc Inst, Dept Microbiol, New York, NY 10016 USA; NYU Canc Inst, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Koyama-Nasu, R (corresponding author), NYU Canc Inst, Dept Pathol, New York, NY 10016 USA.	ryo.nasu@med.nyu.edu		, gregory/0000-0002-3371-4558; Tanese, Naoko/0000-0002-1946-3211				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCH TM, 1989, MOL CELL BIOL, V9, P1327, DOI 10.1128/MCB.9.3.1327; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VANDAM H, 1990, MOL CELL BIOL, V10, P5857, DOI 10.1128/MCB.10.11.5857; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	30	49	49	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1074	U49		10.1038/ncb1628	http://dx.doi.org/10.1038/ncb1628			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704768				2022-12-27	WOS:000249256500015
J	Zhang, ZJ; Chen, G; Zhou, W; Song, AH; Xu, T; Luo, QM; Wang, W; Gu, XS; Duan, SM				Zhang, Zhijun; Chen, Gang; Zhou, Wei; Song, Aihong; Xu, Tao; Luo, Qingming; Wang, Wei; Gu, Xiao-song; Duan, Shumin			Regulated ATP release from astrocytes through lysosome exocytosis	NATURE CELL BIOLOGY			English	Article							KISS-AND-RUN; HIPPOCAMPAL SYNAPSES; MULTIDRUG-RESISTANCE; SECRETORY LYSOSOMES; CALCIUM WAVES; CELLS; VESICLES; RECEPTORS; RELEVANCE; PROTEINS	Release of ATP from astrocytes is required for Ca2+ wave propagation among astrocytes(1-3) and for feedback modulation of synaptic functions(2,4,5). However, the mechanism of ATP release and the source of ATP in astrocytes are still not known. Here we show that incubation of astrocytes with FM dyes leads to selective labelling of lysosomes. Time-lapse confocal imaging of FM dye-labelled fluorescent puncta, together with extracellular quenching and total-internal-reflection fluorescence microscopy (TIRFM), demonstrated directly that extracellular ATP or glutamate induced partial exocytosis of lysosomes, whereas an ischaemic insult with potassium cyanide induced both partial and full exocytosis of these organelles. We found that lysosomes contain abundant ATP, which could be released in a stimulus-dependent manner. Selective lysis of lysosomes abolished both ATP release and Ca2+ wave propagation among astrocytes, implicating physiological and pathological functions of regulated lysosome exocytosis in these cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Nantong Univ, Jiangsu Key Lab Neuroregenerat, Jiangsu 226001, Peoples R China; Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; Chinese Acad Sci, Wuhan Biophys, Britton Chance Ctr Biomed Photon, Beijing 100101, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Dept Neurol, Wuhan 430030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nantong University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Huazhong University of Science & Technology	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn		Chen, Gang/0000-0003-3669-5687; Luo, Qingming/0000-0002-6725-9311				ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; Ballerini P, 2002, NEUROREPORT, V13, P1789, DOI 10.1097/00001756-200210070-00019; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Brake AJ, 1996, ANNU REV CELL DEV BI, V12, P519, DOI 10.1146/annurev.cellbio.12.1.519; Cabrita MA, 1999, CANCER RES, V59, P4890; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HARIKUMAR P, 1983, J BIOL CHEM, V258, P403; Hassinger TD, 1996, P NATL ACAD SCI USA, V93, P13268, DOI 10.1073/pnas.93.23.13268; Hayashi Takeshi, 2006, Current Alzheimer Research, V3, P351, DOI 10.2174/156720506778249498; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rizzoli SO, 2003, J NEUROCYTOL, V32, P539, DOI 10.1023/B:NEUR.0000020609.19873.e8; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Sperlagh B, 1996, SEMIN NEUROSCI, V8, P175, DOI 10.1006/smns.1996.0023; VAN LF, 1980, CELL, V20, P37; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	38	388	401	4	415	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					945	U115		10.1038/ncb1620	http://dx.doi.org/10.1038/ncb1620			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618272				2022-12-27	WOS:000248486700016
J	Zippo, A; De Robertis, A; Serafini, R; Oliviero, S				Zippo, Alessio; De Robertis, Alessandra; Serafini, Riccardo; Oliviero, Salvatore			PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation	NATURE CELL BIOLOGY			English	Article							E-MU-MYC; C-MYC; TRANSGENIC MICE; RIBOSOMAL DNA; GENE; BINDING; TARGET; GROWTH; LYMPHOMAGENESIS; IDENTIFICATION	The serine/threonine kinase human Pim1 ( hereafter PIM1) cooperates with human c-Myc ( hereafter MYC) in cell cycle progression and tumorigenesis. However, the nature of this cooperation is still unknown. Here we show that, after stimulation with growth factor, PIM1 forms a complex with the dimer of MYC with MAX ( Myc-associated factor X) via the MYC BoxII (MBII) domain. MYC recruits PIM1 to the E boxes of the MYC-target genes FOSL1 (FRA-1) and ID2, and PIM1 phosphorylates serine 10 of histone H3 (H3S10) on the nucleosome at the MYC-binding sites, contributing to their transcriptional activation. MYC and PIM1 colocalize at sites of active transcription, and expression profile analysis revealed that PIM1 contributes to the regulation of 20% of the MYC-regulated genes. Moreover, PIM1-dependent H3S10 phosphorylation contributes to MYC transforming capacity. These results establish a new function for PIM1 as a MYC cofactor that phosphorylates the chromatin at MYC-target loci and suggest that nucleosome phosphorylation, at E boxes, contributes to MYC-dependent transcriptional activation and cellular transformation.	Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.	oliviero@unisi.it	oliviero, salvatore/R-6657-2019	oliviero, salvatore/0000-0002-3405-765X; zippo, Alessio/0000-0002-3686-6151				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cirillo LA, 2004, METHOD ENZYMOL, V375, P131; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; CUYPERS HT, 1984, CELL, V37, P141; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang Z, 2001, J Vet Sci, V2, P167; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang SS, 1999, J CELL SCI, V112, P2693; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827	50	209	224	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					932	U106		10.1038/ncb1618	http://dx.doi.org/10.1038/ncb1618			47	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643117	Green Submitted			2022-12-27	WOS:000248486700015
J	Vikhanskaya, F; Toh, WH; Dulloo, I; Wu, Q; Boominathan, L; Ng, HH; Vousden, KH; Sabapathy, K				Vikhanskaya, Faina; Toh, Wen Hong; Dulloo, Iqbal; Wu, Qiang; Boominathan, Lakshmanane; Ng, Huck Hui; Vousden, Karen H.; Sabapathy, Kanaga			p73 supports cellular growth through c-Jun-dependent AP-1 transactivation	NATURE CELL BIOLOGY			English	Article							PHOSPHORYLATION; ABL; CYCLIN-D1; TARGET; CANCER	The cause or consequence of overexpression of p73 (refs 1, 2), the structural and functional homologue of the tumour-suppressor gene product p53 (refs 3, 4), in human cancers is poorly understood. Here, we report a role for p73 in supporting cellular growth through the upregulation of AP-1 transcriptional activity. p73 suppresses growth when overexpressed alone, but synergises with the proto-oncogene c-Jun to promote cellular survival. Conversely, silencing of p73 expression compromises cellular proliferation. Molecular analysis revealed that expression of the AP-1 target-gene product cyclinD1 (ref. 5) is reduced concomitant with p73, but not p53, silencing. Moreover, cyclinD1 was induced by p73 expression in a c-Jun-dependent manner, and was required for p73-mediated cell survival. Furthermore, c-Jun-dependent AP-1 transcriptional activity was augmented by p73 and, consistently, induction of endogenous AP-1 target genes was compromised in the absence of p73. Chromatin immunoprecipitation and electrophoretic mobility shift analysis indicated that p73 enhanced the binding of phosphorylated c-Jun and Fra1, another AP-1 family member, to AP-1 consensus DNA sequences, by regulating c-Jun phosphorylation and Fra-1 expression. Collectively, our data demonstrates a novel and unexpected role of p73 in augmenting AP-1 transcriptional activity through which it supports cellular growth.	Natl Canc Ctr, Lab Mol Carcinogenesis, Singapore, Singapore; Genome Inst Singapore, Biopolis, Singapore 138672, Singapore; Natl Univ Singapore, Dept Physiol, Singapore 119260, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore	National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Beatson Institute; National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Lab Mol Carcinogenesis, 11 Hosp Dr, Singapore, Singapore.	cmrksb@nccs.com.sg	Lakshamanane, Boominathan/AAW-5331-2020; Ng, Huck Hui/A-1135-2009	Wu, Qiang/0000-0003-2049-1639; NG, HUCK HUI/0000-0001-6352-8417; Dulloo, Iqbal/0000-0001-6899-8338				Agami R, 1999, NATURE, V399, P809; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; EL DW, 1993, CELL, V75, P817; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fulco M, 2003, J BIOL CHEM, V278, P49196, DOI 10.1074/jbc.M304921200; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; HARVEY M, 1993, ONCOGENE, V8, P2457; HERBER B, 1994, ONCOGENE, V9, P1295; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika AI, 1999, CANCER RES, V59, P3257; Zhu JH, 1998, CANCER RES, V58, P5061	30	49	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					698	U162		10.1038/ncb1598	http://dx.doi.org/10.1038/ncb1598			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17496887				2022-12-27	WOS:000246922700016
J	Disanza, A; Mantoani, S; Hertzog, M; Gerboth, S; Frittoli, E; Steffen, A; Berhoerster, K; Kreienkamp, HJ; Milanesi, F; Di Fiore, PP; Ciliberto, A; Stradal, TEB; Scita, G				Disanza, Andrea; Mantoani, Sara; Hertzog, Maud; Gerboth, Silke; Frittoli, Emanuela; Steffen, Anika; Berhoerster, Kerstin; Kreienkamp, Hans-Juergen; Milanesi, Francesca; Di Fiore, Pier Paolo; Ciliberto, Andrea; Stradal, Theresia E. B.; Scita, Giorgio			Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex	NATURE CELL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASE; ENA/VASP PROTEINS; N-WASP; FILOPODIUM FORMATION; FIBROBLAST MOTILITY; CROSS-LINKING; RAC; IRSP53; EPS8; REORGANIZATION	Actin-crosslinking proteins organize actin into highly dynamic and architecturally diverse subcellular scaffolds that orchestrate a variety of mechanical processes, including lamellipodial and filopodial protrusions in motile cells. How signalling pathways control and coordinate the activity of these crosslinkers is poorly defined. IRSp53, a multi-domain protein that can associate with the Rho-GTPases Rac and Cdc42, participates in these processes mainly through its amino-terminal IMD (IRSp53 and MIM domain). The isolated IMD has actin-bundling activity in vitro and is sufficient to induce filopodia in vivo. However, the manner of regulation of this activity in the full-length protein remains largely unknown. Eps8 is involved in actin dynamics through its actin barbed-ends capping activity and its ability to modulate Rac activity. Moreover, Eps8 binds to IRSp53. Here, we describe a novel actin crosslinking activity of Eps8. Additionally, Eps8 activates and synergizes with IRSp53 in mediating actin bundling in vitro, enhancing IRSp53-dependent membrane extensions in vivo. Cdc42 binds to and controls the cellular distribution of the IRSp53-Eps8 complex, supporting the existence of a Cdc42-IRSp53-Eps8 signalling pathway. Consistently, Cdc42-induced filopodia are inhibited following individual removal of either IRSp53 or Eps8. Collectively, these results support a model whereby the synergic bundling activity of the IRSp53-Eps8 complex, regulated by Cdc42, contributes to the generation of actin bundles, thus promoting filopodial protrusions.	IFOM, I-20139 Milan, Italy; Ist Europeo Oncol, Dept Expt Oncol, I-20141 Milan, Italy; German Res Ctr Biotechnol, Signalling & Motil Grp, D-38124 Braunschweig, Germany; Univ Hamburg, Hosp Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; Univ Milan, Dipartimento Med Chirurg & Odonoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Helmholtz Association; Helmholtz-Center for Infection Research; University of Hamburg; University of Milan	Scita, G (corresponding author), IFOM, Via Adamello 16, I-20139 Milan, Italy.	giorgio.scita@ifom-ieo-campus.it	Scita, Giorgio/J-9670-2012; Di Fiore, Pier Paolo/K-2130-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Scita, Giorgio/0000-0001-7984-1889; Stradal, Theresia/0000-0002-0352-9474; Disanza, Andrea/0000-0001-5101-2907; Steffen, Anika/0000-0002-2933-0543				Auerbuch V, 2003, MOL MICROBIOL, V49, P1361, DOI 10.1046/j.1365-2958.2003.03639.x; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; KOLESKO AJ, 2003, SCI STKE PE20; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2004, DEV CELL, V6, P312, DOI 10.1016/S1534-5807(04)00073-5; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tilney LG, 2000, J CELL SCI, V113, P1255; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2002, J BIOL CHEM, V277, P25609, DOI 10.1074/jbc.M202609200; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yeh TC, 1996, J BIOL CHEM, V271, P2921, DOI 10.1074/jbc.271.6.2921	52	172	183	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1337	U15		10.1038/ncb1502	http://dx.doi.org/10.1038/ncb1502			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115031				2022-12-27	WOS:000242419800009
J	Weirich, CS; Erzberger, JP; Flick, JS; Berger, JM; Thorner, J; Weis, K				Weirich, Christine S.; Erzberger, Jan P.; Flick, Jeffrey S.; Berger, James M.; Thorner, Jeremy; Weis, Karsten			Activation of the DExD/H-box protein Dbp5 by the nuclear-pore protein Gle1 and its coactivator InsP(6) is required for mRNA export	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; INOSITOL HEXAKISPHOSPHATE; CYTOPLASMIC FIBRILS; NUCLEOPORIN RIP1P; PHOSPHOLIPASE-C; TELOMERE LENGTH; POLY(A)(+) RNA; DNA-PK; YEAST	The DExD/H-box ATPase Dbp5 is essential for nuclear mRNA export, although its precise role in this process remains poorly understood. Here, we identify the nuclear pore protein Gle1 as a cellular activator of Dbp5. Dbp5 alone is unable to stably bind RNA or effectively hydrolyse ATP under physiological conditions, but addition of Gle1 dramatically stimulates these activities. A gle1 point mutant deficient for Dbp5 stimulation in vitro displays an mRNA export defect in vivo, indicating that activation of Dbp5 is an essential function of Gle1. Interestingly, Gle1 binds directly to inositol hexakisphosphate ( InsP(6)) and InsP(6) potentiates the Gle1-mediated stimulation of Dbp5. Dominant mutations in DBP5 and GLE1 that rescue mRNA export phenotypes associated with the lack of InsP(6) mimic the InsP(6) effects in vitro. Our results define specific functions for Gle1 and InsP(6) in mRNA export and suggest that local activation of Dbp5 at the nuclear pore is critical for mRNA export.	Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Div Biochem & Mol Biol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Vanderbilt University	Weis, K (corresponding author), Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	kweis@berkeley.edu	Weis, Karsten/F-5719-2011; THORNER, Jeremy/O-6132-2019	Weis, Karsten/0000-0001-7224-925X; THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021841, R01GM071747, R37GM021841, R01GM058065] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM71747, GM58065, GM21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Cartwright JL, 1999, J BIOL CHEM, V274, P8604, DOI 10.1074/jbc.274.13.8604; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Estruch F, 2005, J BIOL CHEM, V280, P9691, DOI 10.1074/jbc.M413025200; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Larsson C, 1997, J BACTERIOL, V179, P7243, DOI 10.1128/jb.179.23.7243-7250.1997; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rollenhagen C, 2004, MOL CELL BIOL, V24, P4869, DOI 10.1128/MCB.24.11.4869-4879.2004; Saavedra CA, 1997, GENE DEV, V11, P2845, DOI 10.1101/gad.11.21.2845; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Stutz F, 1997, GENE DEV, V11, P2857, DOI 10.1101/gad.11.21.2857; Takemura R, 2004, J CELL SCI, V117, P4189, DOI 10.1242/jcs.01296; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vainberg IE, 2000, MOL CELL BIOL, V20, P3996, DOI 10.1128/MCB.20.11.3996-4005.2000; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	49	206	213	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					668	U54		10.1038/ncb1424	http://dx.doi.org/10.1038/ncb1424			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16783364				2022-12-27	WOS:000238837800009
J	Kim, JH; Choi, HJ; Kim, B; Kim, MH; Lee, JM; Kim, IS; Lee, MH; Choi, SJ; Kim, KI; Kim, SI; Chung, CH; Baek, SH				Kim, Jung Hwa; Choi, Hee June; Kim, Bogyou; Kim, Mi Hyang; Lee, Ji Min; Kim, Ik Soo; Lee, Moon Hee; Choi, Soo Joon; Kim, Keun Il; Kim, Su-Il; Chung, Chin Ha; Baek, Sung Hee			Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL ACTIVATION; SUMO-1 MODIFICATION; GENE-TRANSCRIPTION; NUCLEAR RECEPTORS; PROSTATE-CANCER; SUPPRESSOR GENE; PROTEIN; EXPRESSION; TIP60	Defining the functional modules within transcriptional regulatory factors that govern switching between repression and activation events is a central issue in biology. Recently, we have reported the dynamic role of a beta-catenin-reptin chromatin remodelling complex in regulating a metastasis suppressor gene KAI1 (ref.1), which is capable of inhibiting the progression of tumour metastasis2-5. Here, we identify signalling factors that confer repressive function on reptin and hence repress the expression of KAI1. Biochemical purification of a reptin-containing complex has revealed the presence of specific desumoylating enzymes that reverse the sumoylation of reptin that underlies its function as a repressor. Desumoylation of reptin alters the repressive function of reptin and its association with HDAC1. Furthermore, the sumoylation status of reptin modulates the invasive activity of cancer cells with metastatic potential. These data clearly define a functional model and provide a novel link for SUMO modification in cancer metastasis.	Seoul Natl Univ, Dept Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea; Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151742, South Korea; Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sookmyung Women's University	Baek, SH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Res Ctr Funct Cellul, Seoul 151742, South Korea.	sbaek@snu.ac.kr	KIM, KEUN IL/D-2959-2011; Kim, Ik Soo/AAM-7787-2020					Alarcon-Vargas D, 2002, CANCER BIOL THER, V1, P237, DOI 10.4161/cbt.74; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baek SH, 2004, BIOCHEM BIOPH RES CO, V319, P707, DOI 10.1016/j.bbrc.2004.04.169; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feng Y, 2003, CANCER RES, V63, P8726; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Glass CK, 2000, GENE DEV, V14, P121; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; PETRYLAK DP, 1995, NAT MED, V1, P739, DOI 10.1038/nm0895-739; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Shevde LA, 2003, CANCER LETT, V198, P1, DOI 10.1016/S0304-3835(03)00304-5; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Zheng G, 2004, J BIOL CHEM, V279, P42410, DOI 10.1074/jbc.M407287200	35	125	129	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					631	639		10.1038/ncb1415	http://dx.doi.org/10.1038/ncb1415			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16699503				2022-12-27	WOS:000238029000017
J	Pinsky, BA; Kung, C; Shokat, KM; Biggins, S				Pinsky, BA; Kung, C; Shokat, KM; Biggins, S			The Ipl1-Aurora protein kinase activates the spindle checkpoint by creating unattached kinetochores	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; TENSION; POLE; COMPLEX; ATTACHMENT	The spindle checkpoint ensures accurate chromosome segregation by delaying cell- cycle progression until all sister kinetochores capture microtubules from opposite poles and come under tension ( for reviews, see refs 1, 2). Although the checkpoint is activated by either the lack of kinetochore-microtubule attachments or defects in the tension exerted by microtubule- generated forces, it is not clear whether these signals are linked. We investigated the connection between tension and attachment by studying the conserved budding yeast Ipl1- Aurora protein kinase that is required for checkpoint activation in the absence of tension but not attachment(3). Here, we show that spindle- checkpoint activation in kinetochore mutants that seem to have unattached kinetochores depends on Ipl1 activity. When Ipl1 function was impaired in these kinetochore mutants, the attachments were restored and the checkpoint was turned off. These data indicate that Ipl1 activates the checkpoint in response to tension defects by creating unattached kinetochores. Moreover, although the Dam1 kinetochore complex has been implicated as a key downstream target, we found the existence of unidentified Ipl1 sites on Dam1 or additional important substrates that regulate both microtuble detachment and the checkpoint.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Biggins, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	sbiggins@fhcrc.org		Biggins, Susan/0000-0002-4499-6319; Pinsky, Benjamin/0000-0001-8751-4810	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI44009] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; King JM, 2000, J CELL SCI, V113, P3815; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 2001, J CELL SCI, V114, P4173; OSBORNE MA, 1994, J CELL BIOL, V125, P853, DOI 10.1083/jcb.125.4.853; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Rose MD., 1990, METHODS YEAST GENETI; Sherman F., 1974, METHODS YEAST GENETI; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	29	222	228	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					78	U28		10.1038/ncb1341	http://dx.doi.org/10.1038/ncb1341			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16327780				2022-12-27	WOS:000234651500015
J	Wang, W; Budhu, A; Forgues, M; Wang, XW				Wang, W; Budhu, A; Forgues, M; Wang, XW			Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication	NATURE CELL BIOLOGY			English	Letter							VIRUS-X PROTEIN; RIBOSOME BIOGENESIS; DEPENDENT KINASE; CELL-DIVISION; RAN GTPASE; RIGHT TIME; CYCLE; P53; PHOSPHORYLATION; LOCALIZATION	Centrosome duplication is tightly controlled during faithful cell division, and unnecessary reduplication can lead to supernumerary centrosomes and multipolar spindles that are associated with most human cancer cells(1-5). In addition to nucleocytoplasmic transport, the Ran-Crm1 network is involved in regulating centrosome duplication to ensure the formation of a bipolar spindle(6-8). Here, we discover that nucleophosmin (NPM) may be a Ran-Crm1 substrate that controls centrosome duplication. NPM contains a functional nuclear export signal (NES) that is responsible for both its nucleocytoplasmic shuttling and its association with centrosomes, which are Ran-Crm1-dependent as they are sensitive to Crm1-specific nuclear export inhibition, either by leptomycin B (LMB) or by the expression of a Ran-binding protein, RanBP1. Notably, LMB treatment induces premature centrosome duplication in quiescent cells, which coincides with NPM dissociation from centrosomes. Moreover, deficiency of NPM by RNA interference results in supernumerary centrosomes, which can be reversed by reintroducing wild-type but not NES-mutated NPM. Mutation of a potential proline-dependent kinase phosphorylation site at residue 95, from threonine to aspartic acid (T95D) within the NES motif, abolishes NPM association and inhibition of centrosome duplication. Our results are consistent with the hypothesis that the Ran-Crm1 complex may promote a local enrichment of NPM on centrosomes, thereby preventing centrosome reduplication.	NCI, Liver Carcinogenesis Sect, Human Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, XW (corresponding author), NCI, Liver Carcinogenesis Sect, Human Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	xw3u@nih.gov	Wang, Xin Wei/B-6162-2009	Wang, Xin Wei/0000-0001-9735-606X	NATIONAL CANCER INSTITUTE [Z01BC005793, ZIABC005793] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Di Fiore B, 2004, CELL CYCLE, V3, P305; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Moudjou M, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P111; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tarapore P, 2002, CELL CYCLE, V1, P75, DOI 10.4161/cc.1.1.103; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zatsepina OV, 1999, J CELL SCI, V112, P455	28	225	232	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					823	830		10.1038/ncb1282	http://dx.doi.org/10.1038/ncb1282			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16041368				2022-12-27	WOS:000230881500017
J	Difilippantonio, S; Celeste, A; Fernandez-Capetillo, O; Chen, HT; San Martin, BR; Van Laethem, F; Yang, YP; Petukhova, GV; Eckhaus, M; Feigenbaum, L; Manova, K; Kruhlak, M; Camerini-Otero, RD; Sharan, S; Nussenzweig, M; Nussenzweig, A				Difilippantonio, S; Celeste, A; Fernandez-Capetillo, O; Chen, HT; San Martin, BR; Van Laethem, F; Yang, YP; Petukhova, GV; Eckhaus, M; Feigenbaum, L; Manova, K; Kruhlak, M; Camerini-Otero, RD; Sharan, S; Nussenzweig, M; Nussenzweig, A			Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models	NATURE CELL BIOLOGY			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; FORKHEAD-ASSOCIATED DOMAIN; S-PHASE CHECKPOINT; DNA-DAMAGE; MRE11 COMPLEX; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; HISTONE H2AX	Nijmegen breakage syndrome ( NBS) is a chromosomal fragility disorder that shares clinical and cellular features with ataxia telangiectasia. Here we demonstrate that Nbs1- null B cells are defective in the activation of ataxia- telangiectasia- mutated ( Atm) in response to ionizing radiation, whereas ataxia- telangiectasia- and Rad3- related ( Atr)- dependent signalling and Atm activation in response to ultraviolet light, inhibitors of DNA replication, or hypotonic stress are intact. Expression of the main human NBS allele rescues the lethality of Nbs1(-/-) mice, but leads to immunodeficiency, cancer predisposition, a defect in meiotic progression in females and cell- cycle checkpoint defects that are associated with a partial reduction in Atm activity. The Mre11 interaction domain of Nbs1 is essential for viability, whereas the Forkhead- associated ( FHA) domain is required for T- cell and oocyte development and efficient DNA damage signalling. Reconstitution of Nbs1 knockout mice with various mutant isoforms demonstrates the biological impact of impaired Nbs1 function at the cellular and organismal level.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; NIDDKD, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; NIH, Div Vet Resources, Off Res Serv, Off Director, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Reina-San-Martin, Bernardo/I-9484-2016; Nussenzweig, Michel/AAE-7292-2019; Fernandez-Capetillo, Oscar/H-3508-2015	Reina-San-Martin, Bernardo/0000-0003-2083-6166; Fernandez-Capetillo, Oscar/0000-0002-2690-6885	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC009255, ZICBC009255, Z01BC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052008] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Davalos AR, 2004, CELL CYCLE, V3, P1579, DOI 10.4161/cc.3.12.1286; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; FERNANDEZCAPETILLO, 2003, DEV CELL, V4, P497; FERNANDEZCAPETILLO, 2002, NAT CELL BIOL, V4, P993; Gregorek H, 2002, CLIN EXP IMMUNOL, V130, P319, DOI 10.1046/j.1365-2249.2002.01971.x; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2003, MOL CANCER RES, V1, P674; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lista F, 1997, CANCER RES, V57, P4408; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Mochan TA, 2003, CANCER RES, V63, P8586; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; Tauchi H, 1999, GENOMICS, V55, P242, DOI 10.1006/geno.1998.5657; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	52	178	183	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					675	U56		10.1038/ncb1270	http://dx.doi.org/10.1038/ncb1270			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15965469	Green Published			2022-12-27	WOS:000230190800011
J	Chen, XY; Macara, IG				Chen, XY; Macara, IG			Par-3 controls tight junction assembly through the Rac exchange factor Tiam1	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; POLARITY PROTEIN PAR-3; EPITHELIAL TIGHT; KINASE-C; DROSOPHILA; RHO; DOMAIN; PHOSPHORYLATION; LOCALIZATION; ASIP/PAR-3	The par (partitioning-defective) genes express a set of conserved proteins that function in polarization and asymmetric cell division(1,2). Par-3 has multiple protein-interaction domains, and associates with Par-6 and atypical protein kinase C (aPKC)(3-5). In Drosophila, Par-3 is essential for epithelial cell polarization(6). However, its function in mammals is unclear. Here we show that depletion of Par-3 in mammalian epithelial cells profoundly disrupts tight junction assembly. Expression of a carboxyterminal fragment plus the third PDZ domain of Par-3 partially rescues junction assembly, but neither Par-6 nor aPKC binding is required. Unexpectedly, Rac is constitutively activated in cells lacking Par-3, and the assembly of tight junctions is efficiently restored by a dominant-negative Rac mutant. The Rac exchange factor Tiam1 (ref. 7) binds directly to the carboxy-terminal region of Par-3, and knockdown of Tiam1 enhances tight junction formation in cells lacking Par-3. These results define a critical function for Par-3 in tight junction assembly, and reveal a novel mechanism through which Par-3 engages in the spatial regulation of Rac activity and establishment of epithelial polarity.	Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia	Chen, XY (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	xc2d@virginia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER; NCI NIH HHS [CA40042] Funding Source: Medline; NIGMS NIH HHS [GM070902] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Hirose T, 2002, J CELL SCI, V115, P2485; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mizuno K, 2003, J BIOL CHEM, V278, P31240, DOI 10.1074/jbc.M303593200; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361	30	348	354	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					262	U72		10.1038/ncb1226	http://dx.doi.org/10.1038/ncb1226			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723052				2022-12-27	WOS:000227329800014
J	Antonin, W; Mattaj, IW				Antonin, W; Mattaj, IW			Nuclear pore complexes: Round the bend?	NATURE CELL BIOLOGY			English	Editorial Material							NUCLEOPORINS; SUBCOMPLEX; COMPONENTS; CLATHRIN; ORIGIN; SYSTEM; COAT	Nuclear pore complexes intuitively seem functionally analogous to transmembrane channels. Recent bioinformatic analysis, however, suggests a quite different evolutionary relationship: one between nuclear pore complexes and vesicle coat components. This has led to the provocative hypothesis that these distinct structures share a common role in bending membranes.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Antonin, W (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mattaj@embl.de	Antonin, Wolfram/P-3648-2019; Antonin, Wolfram/A-8656-2014	Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; Mattaj, Iain/0000-0002-5537-8284				Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Kinch LN, 2002, TRENDS BIOCHEM SCI, V27, P170, DOI 10.1016/S0968-0004(01)02055-2; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6	15	24	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					10	12		10.1038/ncb0105-10	http://dx.doi.org/10.1038/ncb0105-10			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632943				2022-12-27	WOS:000226113500006
J	Kittler, R; Pelletier, L; Heninger, AK; Slabicki, M; Theis, M; Miroslaw, L; Poser, I; Lawo, S; Grabner, H; Kozak, K; Wagner, J; Surendranath, V; Richter, C; Bowen, W; Jackson, AL; Habermann, B; Hyman, AA; Buchholz, F				Kittler, Ralf; Pelletier, Laurence; Heninger, Anne-Kristine; Slabicki, Mikolaj; Theis, Mirko; Miroslaw, Lukasz; Poser, Ina; Lawo, Steffen; Grabner, Hannes; Kozak, Karol; Wagner, Jan; Surendranath, Vineeth; Richter, Constance; Bowen, Wayne; Jackson, Aimee L.; Habermann, Bianca; Hyman, Anthony A.; Buchholz, Frank			Genome-scale RNAi profiling of cell division in human tissue culture cells	NATURE CELL BIOLOGY			English	Article							SHORT INTERFERING RNAS; CYCLE PROGRESSION; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; OUTER KINETOCHORE; PROTEIN COMPLEX; C.-ELEGANS; GENES; CANCER; REPLICATION	Cell division is fundamental for all organisms. Here we report a genome-scale RNA-mediated interference screen in HeLa cells designed to identify human genes that are important for cell division. We have used a library of endoribonuclease-prepared short interfering RNAs for gene silencing and have used DNA content analysis to identify genes that induced cell cycle arrest or altered ploidy on silencing. Validation and secondary assays were performed to generate a nine-parameter loss-of-function phenoprint for each of the genes. These phenotypic signatures allowed the assignment of genes to specific functional classes by combining hierarchical clustering, cross-species analysis and proteomic data mining. We highlight the richness of our dataset by ascribing novel functions to genes in mitosis and cytokinesis. In particular, we identify two evolutionarily conserved transcriptional regulatory networks that govern cytokinesis. Our work provides an experimental framework from which the systematic analysis of novel genes necessary for cell division in human cells can begin.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; Technol Dev Studio, D-01307 Dresden, Germany; TTP LabTech Ltd, Melbourn SG8 6EE, Herts, England; Rosetta Inpharmat LLC, Seattle, WA 98109 USA; Scio Comp Innovat GmbH, D-01307 Dresden, Germany; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Max Planck Society; Merck & Company; University of Chicago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Buchholz, F (corresponding author), Max Planck Inst Cell Biol & Genet, Pfotenhauetstr 108, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Hyman, Tony/F-1923-2011; Kittler, Ralf/I-4662-2013; Richter, Constance/P-8714-2019; Pelletier, Laurence/F-8858-2013; Habermann, Bianca/N-4886-2016; Kittler, Ralf/AAD-4258-2020; Buchholz, Frank/B-4700-2017; Hyman, Anthony A/B-3917-2017	Kittler, Ralf/0000-0002-0098-6792; Habermann, Bianca/0000-0002-2457-7504; Kittler, Ralf/0000-0002-0098-6792; Buchholz, Frank/0000-0002-4577-3344; Hyman, Anthony A/0000-0003-3664-154X; Jackson, Aimee/0000-0002-3786-7391; Lawo, Steffen/0000-0002-9659-7416; Surendranath, Vineeth/0000-0003-1593-6461; Heninger, Anne-Kristin/0000-0003-3151-826X; Richter, Constance/0000-0003-3312-0941				Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chinwalla V, 2003, ONCOGENE, V22, P1400, DOI 10.1038/sj.onc.1206273; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A., 2005, SCI STKE, V2005; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Hauser BA, 2000, DEVELOPMENT, V127, P2219; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jepsen K, 2002, J CELL SCI, V115, P689; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; KITTLER R, 2004, NATURE METHODS, V4, P337; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Kuefer MU, 2003, ONCOGENE, V22, P1418, DOI 10.1038/sj.onc.1206272; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takimoto M, 2002, BRIT J CANCER, V86, P1757, DOI 10.1038/sj.bjc.6600328; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6	50	242	250	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1401	U116		10.1038/ncb1659	http://dx.doi.org/10.1038/ncb1659			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17994010				2022-12-27	WOS:000251317300013
J	Yang, YH; Fu, W; Chen, JD; Olashaw, N; Zhang, XH; Nicosia, SV; Bhalla, K; Bai, WL				Yang, Yonghua; Fu, Wei; Chen, Jiandong; Olashaw, Nancy; Zhang, Xiaohong; Nicosia, Santo V.; Bhalla, Kapil; Bai, Wenlong			SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DNA-DAMAGE; LIFE-SPAN; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; PROTEIN DEACETYLASES; HISTONE DEACETYLASE; NAD; LONGEVITY	SIRT1 is the closest mammalian homologue of yeast SIR2, an important ageing regulator that prolongs lifespan in response to caloric restriction. Despite its importance, the mechanisms that regulate SIRT1 activity are unclear. Our study identifies a novel post-translational modification of SIRT1, namely sumoylation at Lys 734. In vitro sumoylation of SIRT1 increased its deacetylase activity. Conversely, mutation of SIRT1 at Lys 734 or desumoylation by SENP1, a nuclear desumoylase, reduced its deacetylase activity. Stress-inducing agents promoted the association of SIRT1 with SENP1 and cells depleted of SENP1 ( but not of SENP1 and SIRT1) were more resistant to stress-induced apoptosis than control cells. We suggest that stress-inducing agents counteract the anti-apoptotic activity of SIRT1 by recruiting SENP1 to SIRT1, which results in the desumoylation and inactivation of SIRT1 and the consequent acetylation and activation of apoptotic proteins.	Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Cell Biol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA; Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University System of Georgia; Augusta University	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	wbai@health.usf.edu	Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Bhalla, Kapil/0000-0001-5209-5126; Fu, Wei/0000-0003-0506-5594	NCI NIH HHS [R01 CA093666, R01 CA111334, CA93666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093666, R01CA111334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buschmann T, 2001, J BIOL CHEM, V276, P40389, DOI 10.1074/jbc.M103786200; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Moschos SJ, 2006, J MOL HISTOL, V37, P309, DOI 10.1007/s10735-006-9030-0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	37	251	261	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1253	U80		10.1038/ncb1645	http://dx.doi.org/10.1038/ncb1645			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17934453	Green Accepted			2022-12-27	WOS:000250659600011
J	Anderson, DJ; Hetzer, MW				Anderson, Daniel J.; Hetzer, Martin W.			Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; MEMBRANE PROTEIN; GTP HYDROLYSIS; IN-VITRO; ORGANIZATION; DYNAMICS; MITOSIS; MICROTUBULES; NUCLEOPORINS; FUSION	The formation of the nuclear envelope ( NE) around chromatin is a major membrane-remodelling event that occurs during cell division of metazoa. It is unclear whether the nuclear membrane reforms by the fusion of NE fragments or if it reemerges from an intact tubular network of the endoplasmic reticulum ( ER). Here, we show that NE formation and expansion requires a tubular ER network and occurs efficiently in the presence of the membrane fusion inhibitor GTP gamma S. Chromatin recruitment of membranes, which is initiated by tubule-end binding, followed by the formation, expansion and sealing of flat membrane sheets, is mediated by DNA-binding proteins residing in the ER. Thus, chromatin plays an active role in reshaping of the ER during NE formation.	Salk Inst Biol Studies, Mol Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Anderson, Daniel/0000-0002-3249-2439	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073994] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073994, GM0739994-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOMAN AL, 1992, J CELL BIOL, V116, P281, DOI 10.1083/jcb.116.2.281; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; Cotter L, 2007, J MOL BIOL, V369, P683, DOI 10.1016/j.jmb.2007.03.051; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4; LOHKA MJ, 1983, EXP CELL RES, V148, P481, DOI 10.1016/0014-4827(83)90169-6; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PORTER KR, 1960, J BIOPHYS BIOCHEM CY, V7, P167, DOI 10.1083/jcb.7.1.167; Powell KS, 2000, TRAFFIC, V1, P689, DOI 10.1034/j.1600-0854.2000.010901.x; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	29	149	152	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1160	1166		10.1038/ncb1636	http://dx.doi.org/10.1038/ncb1636			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828249				2022-12-27	WOS:000249882300011
J	Rhee, J; Buchan, T; Zukerberg, L; Lilien, J; Balsamo, J				Rhee, Jinseol; Buchan, Tim; Zukerberg, Lawrence; Lilien, Jack; Balsamo, Janne			Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription	NATURE CELL BIOLOGY			English	Article							TYROSINE-KINASE; AXON GUIDANCE; C-ABL; ASSOCIATION; PHOSPHORYLATION; PROTEINS; GROWTH; CDK5; RECOGNITION; INHIBITION	Binding of the secreted axon guidance cue Slit to its Robo receptor results in inactivation of the neural, calcium-dependent cell cell adhesion molecule N-cadherin, providing a rapid epigenetic mechanism for integrating guidance and adhesion information. This requires the formation of a multimolecular complex containing Robo, Abl tyrosine kinase and N-cadherin. Here we show that on binding of Slit to Robo, the adaptor protein Cables is recruited to Robo-associated Abl and forms a multimeric complex by binding directly to N-cadherin-associated beta-catenin. Complex formation results in Abl-mediated phosphorylation of beta-catenin on tyrosine 489, leading to a decrease in its affinity for N-cadherin, loss of N-cadherin function, and targeting of phospho-Y489-beta-catenin to the nucleus. Nuclear beta-catenin combines with the transcription factor Tcf/Lef and activates transcription. Thus, Slit-induced formation of the Robo-N-cadherin complex results in a rapid loss of cadherin-mediated adhesion and has more lasting effects on gene transcription.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	University of Iowa; Harvard University; Massachusetts General Hospital	Lilien, J (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.	jack-lilien@uiowa.edu			NEI NIH HHS [EY13363] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013363] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; BALSAMO J, 1995, J CELL BIOL, V129, P1391, DOI 10.1083/jcb.129.5.1391; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; FAISSNER A, 1995, GLIA, V13, P233, DOI 10.1002/glia.440130402; Gao CY, 2004, J CELL SCI, V117, P4089, DOI 10.1242/jcs.01271; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hoffmans R, 2007, MECH DEVELOP, V124, P59, DOI 10.1016/j.mod.2006.09.006; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jin Z, 2003, DEVELOPMENT, V130, P1037, DOI 10.1242/dev.00326; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li HD, 2000, J CELL BIOL, V149, P1275, DOI 10.1083/jcb.149.6.1275; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Monga SPS, 2002, CANCER RES, V62, P2064; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Thompson H, 2006, J NEUROSCI, V26, P8082, DOI 10.1523/JNEUROSCI.1342-06.2006; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wu JJ, 2002, COMB CHEM HIGH T SCR, V5, P83, DOI 10.2174/1386207023330516; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	40	123	128	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					883	U30		10.1038/ncb1614	http://dx.doi.org/10.1038/ncb1614			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618275				2022-12-27	WOS:000248486700010
J	Torres-Rosell, J; Sunjevaric, I; De Piccoli, G; Sacher, M; Eckert-Boulet, N; Reid, R; Jentsch, S; Rothstein, R; Aragon, L; Lisby, M				Torres-Rosell, Jordi; Sunjevaric, Ivana; De Piccoli, Giacomo; Sacher, Meik; Eckert-Boulet, Nadine; Reid, Robert; Jentsch, Stefan; Rothstein, Rodney; Aragon, Luis; Lisby, Michael			The Smc5-Smc6 complex and SUMO modification of Rad52 regulates recombinational repair at the ribosomal gene locus	NATURE CELL BIOLOGY			English	Article							STRAND-BREAK REPAIR; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; PROTEIN; HELICASE; REPLICATION; CHECKPOINT; REPEATS; RNA	Homologous recombination (HR) is crucial for maintaining genome integrity by repairing DNA double-strand breaks (DSBs) and rescuing collapsed replication forks. In contrast, uncontrolled HR can lead to chromosome translocations, loss of heterozygosity, and deletion of repetitive sequences. Controlled HR is particularly important for the preservation of repetitive sequences of the ribosomal gene ( rDNA) cluster. Here we show that recombinational repair of a DSB in rDNA in Saccharomyces cerevisiae involves the transient relocalization of the lesion to associate with the recombination machinery at an extranucleolar site. The nucleolar exclusion of Rad52 recombination foci entails Mre11 and Smc5-Smc6 complexes and depends on Rad52 SUMO ( small ubiquitin-related modifier) modification. Remarkably, mutations that abrogate these activities result in the formation of Rad52 foci within the nucleolus and cause rDNA hyperrecombination and the excision of extrachromosomal rDNA circles. Our study also suggests a key role of sumoylation for nucleolar dynamics, perhaps in the compartmentalization of nuclear activities.	Imperial Coll London, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England; Columbia Univ, Ctr Med, Dept Genet & Dev, New York, NY 10032 USA; Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Imperial College London; Columbia University; Max Planck Society	Lisby, M (corresponding author), Imperial Coll London, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	mlisby@my.molbio.ku.dk	Lisby, Michael/K-9814-2014; Torres-Rosell, Jordi/A-4213-2010; Reid, Robert/AAR-1560-2020	Lisby, Michael/0000-0002-4830-5247; Torres-Rosell, Jordi/0000-0003-1308-6926; Reid, Robert/0000-0002-7424-3537; Rothstein, Rodney/0000-0002-4107-9654	Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [GM67055, GM50237] Funding Source: Medline; MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM050237, R01GM067055, R01GM050237] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aragon L, 2005, P NATL ACAD SCI USA, V102, P4661, DOI 10.1073/pnas.0501342102; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Merker RJ, 2002, MOL CELL BIOL, V22, P421, DOI 10.1128/MCB.22.2.421-429.2002; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; Moore CW, 2000, GENETICS, V154, P1085; Park PU, 1999, MOL CELL BIOL, V19, P3848; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; THOMAS BJ, 1989, GENETICS, V123, P725; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	284	288	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					923	U72		10.1038/ncb1619	http://dx.doi.org/10.1038/ncb1619			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643116				2022-12-27	WOS:000248486700014
J	Jimenez-Baranda, S; Gomez-Mouton, C; Rojas, A; Martinez-Prats, L; Mira, E; Lacalle, RA; Valencia, A; Dimitrov, DS; Viola, A; Delgado, R; Martinez, C; Manes, S				Jimenez-Baranda, Sonia; Gomez-Mouton, Concepcion; Rojas, Ana; Martinez-Prats, Lorena; Mira, Emilia; Lacalle, Rosa Ana; Valencia, Alfonso; Dimitrov, Dimiter S.; Viola, Antonella; Delgado, Rafael; Martinez, Carlos; Manes, Santos			Filamin-A regulates actin-dependent clustering of HIV receptors	NATURE CELL BIOLOGY			English	Article							CHEMOKINE RECEPTORS; LIPID RAFTS; VIRUS ENTRY; HOST-CELLS; CD4; INFECTION; TYPE-1; CHOLESTEROL; BINDING; ROCK	Human immunodeficiency virus ( HIV)-1 infection requires envelope ( Env) glycoprotein gp120-induced clustering of CD4 and coreceptors (CCR5 or CXCR4) on the cell surface; this enables Env gp41 activation and formation of a complex that mediates fusion between Env-containing and target-cell membranes(1). Kinetic studies show that viral receptors are actively transported to the Env-receptor interface in a process that depends on plasma membrane composition and the actin cytoskeleton(2-7). The mechanisms by which HIV-1 induces F-actin rearrangement in the target cell remain largely unknown. Here, we show that CD4 and the coreceptors interact with the actin-binding protein filamin-A, whose binding to HIV-1 receptors regulates their clustering on the cell surface. We found that gp120 binding to cell receptors induces transient cofilin-phosphorylation inactivation through a RhoA-ROCK-dependent mechanism. Blockade of filamin-A interaction with CD4 and/or coreceptors inhibits gp120-induced RhoA activation and cofilin inactivation. Our results thus identify filamin-A as an adaptor protein that links HIV-1 receptors to the actin cytoskeleton remodelling machinery, which may facilitate virus infection.	CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Bioinformat Unit, E-28049 Madrid, Spain; Hosp 12 Octubre, Microbiol Serv, E-28041 Madrid, Spain; NCI, CCR Nanobiol Program, NIH, Ft Detrick, MD 21702 USA; Univ Padua, Venetian Inst Mol Med, I-35100 Padua, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitario 12 de Octubre; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua; Veneto Institute Molecular Medicine	Manes, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,Campus Cantoblanco, E-28049 Madrid, Spain.	smanes@cnb.uam.es	Manes, Santos/E-4725-2011; Rojas, Ana M/C-3022-2008; Rojas, Ana M/D-5777-2011; Valencia, Alfonso/I-3127-2015; IBIS, BIOINFORMATICA/O-1882-2015; Agatea, Lisa/L-8267-2016; DELGADO, RAFAEL/A-2938-2012; Delgado, Rafael/C-4910-2016; Rojas, Ana M./I-2882-2019; MIRA, EMILIA/K-2456-2014; Viola, Antonella/A-4321-2015	Rojas, Ana M/0000-0003-0750-9099; Valencia, Alfonso/0000-0002-8937-6789; Delgado, Rafael/0000-0002-6912-4736; Rojas, Ana M./0000-0003-0750-9099; MIRA, EMILIA/0000-0002-4226-1829; Lacalle, Rosa Ana/0000-0003-0082-167X; Viola, Antonella/0000-0002-0125-9271; Manes, Santos/0000-0001-8023-957X; GOMEZ-MOUTON, CONCEPCION/0000-0002-1595-6027	NATIONAL CANCER INSTITUTE [ZIABC010701, Z01BC010701] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; del Real G, 2002, J EXP MED, V196, P293, DOI 10.1084/jem.20020308; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; SHIN J, 1990, EMBO J, V9, P425, DOI 10.1002/j.1460-2075.1990.tb08127.x; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055	32	142	144	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					838	+		10.1038/ncb1610	http://dx.doi.org/10.1038/ncb1610			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17572668				2022-12-27	WOS:000247760700020
J	Popov, N; Wanzel, M; Madiredjo, M; Zhang, D; Beijersbergen, R; Bernards, R; Moll, R; Elledge, SJ; Eilers, M				Popov, Nikita; Wanzel, Michael; Madiredjo, Mandy; Zhang, Dong; Beijersbergen, Roderick; Bernards, Rene; Moll, Roland; Elledge, Stephen J.; Eilers, Martin			The ubiquitin-specific protease USP28 is required for MYC stability	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; C-MYC; DEUBIQUITINATING ENZYME; RNA INTERFERENCE; BINDING DOMAIN; S-PHASE; DEGRADATION; CANCER; PHOSPHORYLATION; PATHWAY	The MYC proto-oncogene encodes a transcription factor that has been implicated in the genesis of many human tumours. Here, we used a bar-code short hairpin RNA (shRNA) screen to identify multiple genes that are required for MYC function. One of these genes encodes USP28, an ubiquitin-specific protease. USP28 is required for MYC stability in human tumour cells. USP28 binds to MYC through an interaction with FBW7 alpha, an F-box protein that is part of an SCF-type ubiquitin ligase. Therefore, it stabilizes MYC in the nucleus, but not in the nucleolus, where MYC is degraded by FBW gamma.. High expression levels of USP28 are found in colon and breast carcinomas, and stabilization of MYC by USP28 is essential for tumour-cell proliferation.	Inst Mol Biol & Tumor Res, D-35033 Marburg, Germany; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Ctr Genet & Genom, Dept Genet, Boston, MA 02115 USA; Univ Marburg, Dept Pathol, D-35033 Marburg, Germany	Netherlands Cancer Institute; Harvard University; Harvard Medical School; Philipps University Marburg	Eilers, M (corresponding author), Inst Mol Biol & Tumor Res, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	eilers@imt.uni-marburg.de		Bernards, Rene/0000-0001-8677-3423; Zhang, Dong/0000-0002-4515-2070; Beijersbergen, Roderick/0000-0003-0116-4130; Eilers, Martin/0000-0002-0376-6533				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leung-Toung R, 2006, CURR MED CHEM, V13, P547, DOI 10.2174/092986706776055733; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	49	313	335	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					765	U71		10.1038/ncb1601	http://dx.doi.org/10.1038/ncb1601			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558397				2022-12-27	WOS:000247760700012
J	Gassama-Diagne, A; Yu, W; ter Beest, M; Martin-Belmonte, F; Kierbel, A; Engel, J; Mostov, K				Gassama-Diagne, Ama; Yu, Wei; ter Beest, Martin; Martin-Belmonte, Fernando; Kierbel, Arlinet; Engel, Joanne; Mostov, Keith			Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells	NATURE CELL BIOLOGY			English	Article							POLARITY; MORPHOGENESIS; LOCALIZATION; NEUTROPHILS; ISOFORMS; PATHWAY; COMPLEX	Polarity is a central feature of eukaryotic cells and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) has a central role in the polarization of neurons and chemotaxing cells. In polarized epithelial cells, PtdIns(3,4,5)P-3 is stably localized at the basolateral plasma membrane, but excluded from the apical plasma membrane, as shown by localization of GFP fused to the PtdIns(3,4,5)P-3-binding pleckstrin-homology domain of Akt (GFP-PH-Akt), a fusion protein that indicates the location of PtdIns(3,4,5)P-3. Here, we ectopically inserted exogenous PtdIns(3,4,5)P-3 into the apical plasma membrane of polarized Madin-Darby canine kidney (MDCK) cells. Within 5 min many cells formed protrusions that extended above the apical surface. These protrusions contained basolateral plasma membrane proteins and excluded apical proteins, indicating that their plasma membrane was transformed from apical to basolateral. Addition of PtdIns(3,4,5)P-3 to the basolateral surface of MDCK cells grown as cysts caused basolateral protrusions. MDCK cells grown in the presence of a phosphatidylinositol 3-kinase inhibitor had abnormally short lateral surfaces, indicating that PtdIns(3,4,5)P-3 regulates the formation of the basolateral surface.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Hop Purpan, Inst Federatif Rech Claude Preval, INSERM Unite 563, IFR30,Dept Lipoprot & Mediateurs Lipid, F-31059 Toulouse, France; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gassama-Diagne, A (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	gassama@toulouse.inserm.fr	Martin-Belmonte, Fernando/J-8029-2014	Martin-Belmonte, Fernando/0000-0002-2564-4430; mostov, keith/0000-0002-8123-6247				Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; LIPSHUTZ JH, 2001, CURRENT PROTOCOLS CE; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Tian W, 2003, EMBO REP, V4, P982, DOI 10.1038/sj.embor.embor947; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350	29	226	231	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					963	U64		10.1038/ncb1461	http://dx.doi.org/10.1038/ncb1461			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16921364				2022-12-27	WOS:000240241700012
J	Jazayeri, A; Falck, J; Lukas, C; Bartek, J; Smith, GCM; Lukas, J; Jackson, SP				Jazayeri, A; Falck, J; Lukas, C; Bartek, J; Smith, GCM; Lukas, J; Jackson, SP			ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks	NATURE CELL BIOLOGY			English	Article							S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA; DAMAGE CHECKPOINT; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; GENOTOXIC STRESS; HUMAN RAD17; PHOSPHORYLATION; ACTIVATION; REPAIR	It is generally thought that the DNA- damage checkpoint kinases, ataxia- telangiectasia mutated ( ATM) and ATM- and Rad3-related ( ATR), work independently of one another. Here, we show that ATM and the nuclease activity of meiotic recombination 11 ( Mre11) are required for the processing of DNA double- strand breaks ( DSBs) to generate the replication protein A ( RPA)- coated ssDNA that is needed for ATR recruitment and the subsequent phosphorylation and activation of Chk1. Moreover, we show that efficient ATM- dependent ATR activation in response to DSBs is restricted to the S and G2 cell cycle phases and requires CDK kinase activity. Thus, in response to DSBs, ATR activation is regulated by ATM in a cell- cycle dependent manner.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	University of Cambridge; University of Cambridge; AstraZeneca; Danish Cancer Society; Danish Cancer Society	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Bartek, Jiri/G-5870-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brown EJ, 2000, GENE DEV, V14, P397; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DANDREA AD, 1978, P NATL ACAD SCI USA, V75, P3608, DOI 10.1073/pnas.75.8.3608; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu QH, 2000, GENE DEV, V14, P1448; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Moreau S, 1999, MOL CELL BIOL, V19, P556; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yuan SSF, 2003, MUTAT RES-FUND MOL M, V525, P85, DOI 10.1016/S0027-5107(03)00009-5; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	45	845	877	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					37	U13		10.1038/ncb1337	http://dx.doi.org/10.1038/ncb1337			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16327781				2022-12-27	WOS:000234651500010
J	Mori, T; Kuroiwa, H; Higashiyama, T; Kuroiwa, T				Mori, T; Kuroiwa, H; Higashiyama, T; Kuroiwa, T			GENERATIVE CELL SPECIFIC 1 is essential for angiosperm fertilization	NATURE CELL BIOLOGY			English	Article							LILIUM-LONGIFLORUM; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; GAMETIC CELLS; POLLEN; SPERM; PLANTS; MAIZE; GENE; DIFFERENTIATION	The double fertilization process in angiosperms is based on the delivery of a pair of sperm cells by the pollen tube ( the male gametophyte), which elongates towards an embryo sac ( the female gametophyte) enclosing an egg and a central cell. Several studies have described the mechanisms of gametophyte interaction(1), and also the fertilization process - from pollination to pollen tube acceptance(2-5). However, the mechanisms of gamete interaction are not fully understood(6,7). Cytological studies have shown that male gametes possess distinct cell- surface structures(8,9) and genes specific to male gametes have been detected in cDNA libraries(10-14). Thus, studies of isolated gametes may offer clues to understanding the sperm - egg interaction. In this study, we identified a novel protein, designated GCS1 ( GENERATIVE CELL SPECIFIC 1), using generative cells isolated from Lilium longiflorum pollen. GCS1 possesses a carboxy- terminal transmembrane domain, and homologues are present in various species, including non-angiosperms. Immunological assays indicate that GCS1 is accumulated during late gametogenesis and is localized on the plasma membrane of generative cells. In addition, Arabidopsis thaliana GCS1 mutant gametes fail to fuse, resulting in male sterility and suggesting that GCS1 is a critical fertilization factor in angiosperms.	Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Mori, T (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Nishiikebukuro 3-34-1, Tokyo 1718501, Japan.	z2002377@tvr.rikkyo.ne.jp	Higashiyama, Tetsuya/C-2882-2012; Mori, Toshiyuki/F-8488-2013	Higashiyama, Tetsuya/0000-0002-7346-360X; 				Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; BLOMSTEDT CK, 1992, PHYSIOL PLANTARUM, V85, P396, DOI 10.1111/j.1399-3054.1992.tb04753.x; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Engel ML, 2003, PLANT J, V34, P697, DOI 10.1046/j.1365-313X.2003.01761.x; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; FAURE JE, 1994, SCIENCE, V263, P1598, DOI 10.1126/science.263.5153.1598; Faure JE, 2003, PLANT J, V33, P1051, DOI 10.1046/j.1365-313X.2003.01692.x; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; May ST, 2002, MOL BIOTECHNOL, V20, P209, DOI 10.1385/MB:20:2:209; Misumi O, 1999, PROTOPLASMA, V209, P273, DOI 10.1007/BF01453455; Mori T, 2000, PROTOPLASMA, V214, P57, DOI 10.1007/BF02524262; Mori T, 2003, BIOCHEM BIOPH RES CO, V306, P564, DOI 10.1016/S0006-291X(03)01005-2; Moriyama Y, 2003, GENETICS, V164, P963; Nishimura Y, 2002, GENE DEV, V16, P1116, DOI 10.1101/gad.979902; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Southworth D, 1996, SEX PLANT REPROD, V9, P269, DOI 10.1007/BF02152701; TANAKA I, 1988, PROTOPLASMA, V142, P68, DOI 10.1007/BF01273227; Tanaka I, 1997, SEX PLANT REPROD, V10, P1, DOI 10.1007/s004970050060; Ueda K, 2000, CHROMOSOMA, V108, P491; Weterings K, 2004, PLANT CELL, V16, pS107, DOI 10.1105/tpc.016873; Xu HL, 1999, PLANT MOL BIOL, V39, P607, DOI 10.1023/A:1006162120037; Xu HL, 1999, P NATL ACAD SCI USA, V96, P2554, DOI 10.1073/pnas.96.5.2554; Xu HP, 2002, SEX PLANT REPROD, V14, P339, DOI 10.1007/s00497-002-0128-6; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713	31	320	336	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					64	71		10.1038/ncb1345	http://dx.doi.org/10.1038/ncb1345			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16378100				2022-12-27	WOS:000234651500013
J	Aleem, E; Kiyokawa, H; Kaldis, P				Aleem, E; Kiyokawa, H; Kaldis, P			Cdc2-cyclin E complexes regulate the G1/S phase transition	NATURE CELL BIOLOGY			English	Letter							DEPENDENT-KINASE INHIBITOR; CYCLIN-E; MAMMALIAN-CELLS; MICE LACKING; P27(KIP1); ENTRY; CDK2; HYPERPLASIA; GROWTH; MOUSE	The cyclin-dependent kinase inhibitor p27(Kip1) is known as a negative regulator of cell-cycle progression and as a tumour suppressor(1). Cdk2 is the main target of p27 (refs 2, 3) and therefore we hypothesized that loss of Cdk2 activity should modify the p27(-/-) mouse phenotype(4-6). Here, we show that although p27(-/-) Cdk2(-/-) mice developed ovary tumours and tumours in the anterior lobe of the pituitary, we failed to detect any functional complementation in p27(-/-) Cdk2(-/-) double-knockout mice, indicating a parallel pathway regulated by p27. We observed elevated levels of S phase and mitosis in tissues of p27(-/-) Cdk2(-/-) mice concomitantly with elevated Cdc2 activity in p27(-/-) Cdk2(-/-) extracts. p27 binds to Cdc2, cyclin B1, cyclin A2, or suc1 complexes in wild-type and Cdk2(-/-) extracts. In addition, cyclin E binds to and activates Cdc2. Our in vivo results provide strong evidence that Cdc2 may compensate the loss of Cdk2 function.	NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaldis, P (corresponding author), NCI, Mouse Canc Genet Program, Bldg 560-22-56,1050 Boyles St, Frederick, MD 21702 USA.	kaldis@ncifcrf.gov	Kaldis, Philipp/G-2714-2010; Aleem, Eiman/AAK-3208-2021	Kaldis, Philipp/0000-0002-7247-7591; Aleem, Eiman/0000-0002-9215-8213; Kiyokawa, Hiroaki/0000-0002-7942-6455	NATIONAL CANCER INSTITUTE [Z01SC010367] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Aleem E, 2004, CELL CYCLE, V3, P35; AYSCOUGH K, 1992, MOL GEN GENET, V232, P344, DOI 10.1007/BF00266236; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Brenner RM, 2003, HUM REPROD, V18, P1185, DOI 10.1093/humrep/deg255; Dai Y, 2002, CELL CYCLE, V1, P143, DOI 10.4161/cc.1.2.116; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Harborth J, 2001, J CELL SCI, V114, P4557; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sotillo R, 2005, CANCER RES, V65, P3846, DOI 10.1158/0008-5472.CAN-04-4195; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011	24	312	318	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					831	U93		10.1038/ncb1284	http://dx.doi.org/10.1038/ncb1284			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16007079				2022-12-27	WOS:000230881500018
J	McClellan, AJ; Tam, S; Kaganovich, D; Frydman, J				McClellan, AJ; Tam, S; Kaganovich, D; Frydman, J			Protein quality control: chaperones culling corrupt conformations	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; TUMOR-SUPPRESSOR COMPLEX; MOLECULAR CHAPERONES; PARKINSONS-DISEASE; CELLULAR TOXICITY; CYSTIC-FIBROSIS; IN-VIVO; CHIP; PROTEASOME; LIGASE	Achieving the correct balance between folding and degradation of misfolded proteins is critical for cell viability. The importance of defining the mechanisms and factors that mediate cytoplasmic quality control is underscored by the growing list of diseases associated with protein misfolding and aggregation. Molecular chaperones assist protein folding and also facilitate degradation of misfolded polypeptides by the ubiquitin-proteasome system. Here we discuss emerging links between folding and degradation machineries and highlight challenges for future research.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Clark Ctr E200, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University	McClellan, AJ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Kaganovich, Daniel/K-2376-2012; McClellan, Amie/V-8950-2019	Kaganovich, Daniel/0000-0003-2398-1596; , judith/0000-0003-2302-6943; McClellan, Amie/0000-0002-8033-6748				Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scott Melissa D, 2003, Methods Mol Biol, V232, P67; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	45	218	220	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					736	741		10.1038/ncb0805-736	http://dx.doi.org/10.1038/ncb0805-736			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056264				2022-12-27	WOS:000230881500003
J	Ishikawa, H; Kubo, A; Tsukita, S; Tsukita, S				Ishikawa, H; Kubo, A; Tsukita, S; Tsukita, S			Odf2-deficient mother centrioles lack distal/subdistal appendages and the ability to generate primary cilia	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; LEFT-RIGHT ASYMMETRY; MICROTUBULE ORGANIZATION; INTRAFLAGELLAR TRANSPORT; CENTROSOME CYCLE; NODAL CILIA; CELL-CYCLE; PROTEIN; MOUSE; DUPLICATION	Outer dense fibre 2 (Odf2; also known as cenexin) was initially identified as a main component of the sperm tail cytoskeleton, but was later shown to be a general scaffold protein that is specifically localized at the distal/subdistal appendages of mother centrioles(1,2). Here we show that Odf2 expression is suppressed in mouse F9 cells when both alleles of Odf2 genes are deleted. Unexpectedly, the cell cycle of Odf2(-/-) cells does not seem to be affected. Immunofluorescence and ultrathin-section electron microscopy reveals that in Odf2(-/-) cells, distal/subdistal appendages disappear from mother centrioles, making it difficult to distinguish mother from daughter centrioles. In Odf2(-/-) cells, however, the formation of primary cilia is completely suppressed, although similar to 25% of wild-type F9 cells are ciliated under the steady-state cell cycle. The loss of primary cilia in Odf2(-/-) F9 cells can be rescued by exogenous Odf2 expression. These findings indicate that Odf2 is indispensable for the formation of distal/subdistal appendages and the generation of primary cilia, but not for other cell-cycle-related centriolar functions.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Sch Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan.	atsukita@mfour.med.kyoto-u.ac.jp	Kubo, Akiharu/I-2711-2014	Kubo, Akiharu/0000-0003-0902-3586				Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chang P, 2003, NAT CELL BIOL, V5, P71, DOI 10.1038/ncb900; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Ou YY, 2002, J CELL SCI, V115, P1825; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; RIEDER CL, 1982, BIOL CELL, V44, P117; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SOROKIN SP, 1968, J CELL SCI, V3, P207; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; WARD CJ, 1994, CELL, V77, P881; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; WHEATLEY DN, 1982, CENTRIOLE CENTRAL EN; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25	30	216	224	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					517	U79		10.1038/ncb1251	http://dx.doi.org/10.1038/ncb1251			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15852003				2022-12-27	WOS:000229123500019
J	Teng, JL; Rai, T; Tanaka, Y; Takei, Y; Nakata, T; Hirasawa, M; Kulkarni, AB; Hirokawa, N				Teng, JL; Rai, T; Tanaka, Y; Takei, Y; Nakata, T; Hirasawa, M; Kulkarni, AB; Hirokawa, N			The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium	NATURE CELL BIOLOGY			English	Article							KINESIN SUPERFAMILY PROTEIN; LEFT-RIGHT ASYMMETRY; CYCLIN D1; CRE RECOMBINASE; BETA-CATENIN; WNT; EXPRESSION; MORPHOGENESIS; MECHANISM; MEMBRANE	In the developing brain, the organization of the neuroepithelium is maintained by a critical balance between proliferation and cell - cell adhesion of neural progenitor cells. The molecular mechanisms that underlie this are still largely unknown. Here, through analysis of a conditional knockout mouse for the Kap3 gene, we show that post-Golgi transport of N-cadherin by the KIF3 molecular motor complex is crucial for maintaining this balance. N-cadherin and beta-catenin associate with the KIF3 complex by co-immunoprecipitation, and colocalize with KIF3 in cells. Furthermore, in KAP3-deficient cells, the subcellular localization of N-cadherin was disrupted. Taken together, these results suggest a potential tumour-suppressing activity for this molecular motor.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp		Nakata, Takao/0000-0002-0629-0518; Tanaka, Yosuke/0000-0001-5376-5726	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000664] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; BURGER PC, 1994, ATLAS TUMOR PATHOLOG; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Herrup Karl, 1994, Current Opinion in Neurobiology, V4, P108, DOI 10.1016/0959-4388(94)90039-6; Hirasawa M, 2001, NEUROSCI RES, V40, P125, DOI 10.1016/S0168-0102(01)00216-4; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lele Z, 2002, DEVELOPMENT, V129, P3281; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 2000, GENE DEV, V14, P1837; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shimizu K, 1996, J BIOL CHEM, V271, P27013, DOI 10.1074/jbc.271.43.27013; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200	50	133	138	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					474	U31		10.1038/ncb1249	http://dx.doi.org/10.1038/ncb1249			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15834408				2022-12-27	WOS:000229123500014
J	Meshel, AS; Wei, Q; Adelstein, RS; Sheetz, MP				Meshel, AS; Wei, Q; Adelstein, RS; Sheetz, MP			Basic mechanism of three-dimensional collagen fibre transport by fibroblasts	NATURE CELL BIOLOGY			English	Article							MYOSIN HEAVY-CHAIN; CELL-MIGRATION; II-B; MATRIX; EXPRESSION; REORGANIZATION; CYTOSKELETON; CONTRACTION; LOCOMOTION; RECEPTORS	Collagen remodelling by fibroblasts has a crucial role in organizing tissue structures that are essential to motility during wound repair, development and regulation of cell growth. However, the mechanism of collagen fibre movement in three-dimensional (3D) matrices is not understood. Here, we show that fibroblast lamellipodia extend along held collagen fibres, bind, and retract them in a 'hand-over-hand' cycle, involving alpha2beta1 integrin. Wild-type fibroblasts move collagen fibres three to four times farther per cycle than fibroblasts lacking myosin II-B (myosin II- B-/-). Similarly, myosin II-B-/- fibroblasts contract 3D collagen gels threefold less than controls. On two-dimensional (2D) substrates, however, rates of collagen bead and cell movement are not affected by loss of myosin II- B. Green fluorescent protein (GFP)-tagged myosin II- B, but not II- A, restores normal function in knockout cells and localizes to cell processes, whereas myosin II- A is more centrally located. Additionally, GFP - myosin II- B moves out to the periphery and back during hand-over-hand fibre movement, whereas on 2D collagen, myosin II- B is more centrally distributed. Thus, we suggest that cyclic myosin II- B assembly and contraction in lamellipodia power 3D fibre movements.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu		Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004235, Z01HL004235] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; EASTWOOD M, 1994, BBA-GEN SUBJECTS, V1201, P186, DOI 10.1016/0304-4165(94)90040-X; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; JAY PY, 1995, J CELL SCI, V108, P387; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Lee GM, 1999, EXP CELL RES, V248, P294, DOI 10.1006/excr.1999.4418; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Maaser K, 1999, MOL BIOL CELL, V10, P3067, DOI 10.1091/mbc.10.10.3067; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saitoh T, 2001, FEBS LETT, V509, P365, DOI 10.1016/S0014-5793(01)03186-6; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Uren D, 2000, J CLIN INVEST, V105, P663, DOI 10.1172/JCI8199; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	30	228	231	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					157	U70		10.1038/ncb1216	http://dx.doi.org/10.1038/ncb1216			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15654332				2022-12-27	WOS:000226719500012
J	Yang, G; Houghtaling, BR; Gaetz, J; Liu, JZ; Danuser, G; Kapoor, TM				Yang, Ge; Houghtaling, Benjamin R.; Gaetz, Jedidiah; Liu, Jenny Z.; Danuser, Gaudenz; Kapoor, Tarun M.			Architectural dynamics of the meiotic spindle revealed by single-fluorophore imaging	NATURE CELL BIOLOGY			English	Article							MICROTUBULE DYNAMICS; KINETOCHORE MICROTUBULES; MITOTIC SPINDLE; POLEWARD FLUX; EGG EXTRACTS; LENGTH; ACTIN; VISUALIZATION	Bipolarity of the meiotic spindle, required for proper chromosome segregation, is maintained throughout cell division despite rapid microtubule turnover. How this is achieved has remained mysterious, as determining the organization of individual spindle microtubules has been difficult. Here, we develop single-fluorophore speckle imaging to examine microtubule organization in the vertebrate meiotic spindle. We find that the mean length of microtubules is similar to 40% of spindle length. Long and short filaments distribute randomly throughout the spindle and those in close proximity can move in the same direction with highly heterogeneous velocities. The ratio between microtubule and spindle lengths remains unchanged as spindles elongate upon dynein-dynactin inhibition. However, maintaining this ratio depends on proper kinesin-5 function. Our data suggest that force transmission within the spindle must be understood in terms of the crosslinking dynamics of a tiled array of individual filaments, most of which do not span the distance from the pole to the metaphase plate.	Scripps Res Inst, Lab Computat Cell Biol, La Jolla, CA 92037 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Scripps Research Institute; Rockefeller University	Danuser, G (corresponding author), Scripps Res Inst, Lab Computat Cell Biol, 10550 N Torrey Pines Rd,Mail Box CB 167, La Jolla, CA 92037 USA.	gdanuser@scripps.edu; kapoor@rockefeller.edu		Danuser, Gaudenz/0000-0001-8583-2014; Gaetz, Jedidiah/0000-0002-7103-6241	NIGMS NIH HHS [R01 GM65933, R01 GM0678] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barr DR, 1999, AM STAT, V53, P357, DOI 10.2307/2686057; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Desai A, 1999, METHOD CELL BIOL, V61, P385; Do Carmo P., 1976, DIFFERENTIAL GEOMETR; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; HALLETT FR, 1985, BIOPOLYMERS, V24, P2403, DOI 10.1002/bip.360241216; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HILL T, 1987, LINEARY AGGREGATION; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maly IV, 2002, B MATH BIOL, V64, P213, DOI 10.1006/bulm.2001.0265; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mitchison TJ, 2004, MOL BIOL CELL, V15, P5603, DOI 10.1091/mbc.E04-05-0440; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; OHBA S, 1993, BIOCHIM BIOPHYS ACTA, V1158, P323, DOI 10.1016/0304-4165(93)90031-3; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; PAPOULIS A, 2002, PROBABILTY RANDOM VA; Pierce DW, 1999, METHOD CELL BIOL, V58, P49; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yang G., 2005, 2005 IEEE COMP SOC C, P138, DOI [DOI 10.1109/CVPR.2005.519, 10.1109/CVPR.2005.519]	41	82	82	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1233	U45		10.1038/ncb1643	http://dx.doi.org/10.1038/ncb1643			37	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17934454				2022-12-27	WOS:000250659600009
J	Chhabra, ES; Higgs, HN				Chhabra, Ekta Seth; Higgs, Henry N.			The many faces of actin: Matching assembly factors with cellular structures	NATURE CELL BIOLOGY			English	Review							ALDRICH-SYNDROME PROTEIN; INTESTINAL EPITHELIAL-CELLS; ARP2/3 COMPLEX; LEADING-EDGE; MIGRATING CELLS; ADHERENS JUNCTIONS; N-WASP; MICROFILAMENT DYNAMICS; IMMUNOLOGICAL SYNAPSE; FILAMENT ORGANIZATION	Actin filaments are major components of at least 15 distinct structures in metazoan cells. These filaments assemble from a common pool of actin monomers, but do so at different times and places, and in response to different stimuli. All of these structures require actin-filament assembly factors. To date, many assembly factors have been identified, including Arp2/3 complex, multiple formin isoforms and spire. Now, a major task is to figure out which factors assemble which actin-based structures. Here, we focus on structures at the plasma membrane, including both sheet-like protrusive structures ( such as lamellipodia and ruffles) and finger-like protrusions ( such as filopodia and microvilli). Insights gained from studies of adherens junctions and the immunological synapse are also considered.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Higgs, HN (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.	henry.n.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	NIGMS NIH HHS [GM069818] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X; ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; ABERLE H, 1994, J CELL SCI, V107, P3655; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; HEINTZELMAN MB, 1992, CURR TOP DEV BIOL, V26, P93, DOI 10.1016/S0070-2153(08)60442-1; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; Hudson AM, 2002, J CELL BIOL, V156, P677, DOI 10.1083/jcb.200109065; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; INGRAM VM, 1969, NATURE, V222, P641, DOI 10.1038/222641a0; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; IZZARD CS, 1976, J CELL SCI, V21, P129; Jay P, 2000, EUR J BIOCHEM, V267, P2921, DOI 10.1046/j.1432-1327.2000.01306.x; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kerkhoff E, 2006, TRENDS CELL BIOL, V16, P477, DOI 10.1016/j.tcb.2006.07.005; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; LINDBERG U, 1981, BIOCHIMIE, V63, P307, DOI 10.1016/S0300-9084(81)80119-8; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Machesky LM, 1997, BIOCHEM J, V328, P105; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mizutani K, 2002, CANCER RES, V62, P669; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Moreau V, 2006, EUR J CELL BIOL, V85, P319, DOI 10.1016/j.ejcb.2005.09.009; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; SMALL JV, 1981, COLD SPRING HARB SYM, V46, P599, DOI 10.1101/SQB.1982.046.01.056; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; SVITKINA TM, 1984, EUR J CELL BIOL, V34, P64; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; YONEMURA S, 1995, J CELL SCI, V108, P127; Zheng JQ, 1996, J NEUROSCI, V16, P1140	134	539	545	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1110	1121		10.1038/ncb1007-1110	http://dx.doi.org/10.1038/ncb1007-1110			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17909522				2022-12-27	WOS:000249882300003
J	Yang, M; Zhang, Y; Pan, J; Sun, J; Liu, J; Libby, P; Sukhova, GK; Doria, A; Katunuma, N; Peroni, OD; Guerre-Millo, M; Kahn, BB; Clement, K; Shi, GP				Yang, Min; Zhang, Yaou; Pan, Jiehong; Sun, Jiusong; Liu, Jian; Libby, Peter; Sukhova, Galina K.; Doria, Alessandro; Katunuma, Nobuhiko; Peroni, Odile D.; Guerre-Millo, Michele; Kahn, Barbara B.; Clement, Karine; Shi, Guo-Ping			Cathepsin L activity controls adipogenesis and glucose tolerance	NATURE CELL BIOLOGY			English	Article							ADIPOCYTE DIFFERENTIATION; INSULIN-RECEPTORS; GENE-EXPRESSION; VASCULAR CELLS; MUSCLE-CELLS; MICE; RESISTANCE; DEGRADATION; INHIBITION; PROTEASES	Cysteine proteases play an important part in human pathobiology(1). This report shows the participation of cathepsin L (CatL) in adipogenesis and glucose intolerance. In vitro studies demonstrate the role of CatL in the degradation of the matrix protein fibronectin, insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R), essential molecules for adipogenesis and glucose metabolism(2-5). CatL inhibition leads to the reduction of human and murine pre-adipocyte adipogenesis or lipid accumulation, protection of fibronectin from degradation, accumulation of IR and IGF-1R beta-subunits, and an increase in glucose uptake. CatL-deficient mice are lean and have reduced levels of serum glucose and insulin but increased levels of muscle IR beta-subunits, fibronectin and glucose transporter (Glut)-4, although food/water intake and energy expenditure of these mice are no less than their wildtype littermates. Importantly, the pharmacological inhibition of CatL also demonstrates reduced body weight gain and serum insulin levels, and increased glucose tolerance, probably due to increased levels of muscle IR beta-subunits, fibronectin and Glut-4 in both diet-induced obese mice and ob/ob mice. Increased levels of CatL in obese and diabetic patients suggest that this protease is a novel target for these metabolic disorders.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Med Sch, Boston, MA 02115 USA; Nanfang Hosp, Dept Rheumatol, Guangzhou 510515, Peoples R China; Nanfang Med Univ, Guangzhou 510515, Peoples R China; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Joslin Diabet Ctr, Sect Genet & Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; INSERM, U872, F-75006 Paris, France; Univ Paris 06, Ctr Rech Cordeliers, UMRS 872, F-75006 Paris, France; Univ Paris 05, UMRS 872, F-75006 Paris, France; Hop La Pitie Salpetriere, AP HP, Nutr Dept, F-75013 Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Southern Medical University - China; Southern Medical University - China; University of California System; University of California San Francisco; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Tokushima Bunri University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Shi, GP (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu	Guerre-Millo, Michele/G-7253-2017; Libby, Peter/AAY-6404-2021; Clément, karine/R-1120-2017; Doria, Alessandro/H-9157-2018; BRUNET, ERIKA/H-9297-2017	Libby, Peter/0000-0002-1502-502X; Doria, Alessandro/0000-0002-3830-4304; BRUNET, ERIKA/0000-0002-1726-4673; Zhang, Yaou/0000-0002-2501-8093	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL060942] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60942, HL073168] Funding Source: Medline; NIDDK NIH HHS [R01 DK043051] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; CHANG PY, 1995, J BIOL CHEM, V270, P12593, DOI 10.1074/jbc.270.21.12593; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Gagnon AM, 1998, J CELL PHYSIOL, V175, P370, DOI 10.1002/(SICI)1097-4652(199806)175:3<370::AID-JCP15>3.0.CO;2-9; Grabowska UB, 2005, CURR OPIN DRUG DISC, V8, P619; Huang XD, 2003, DIABETES, V52, P2411, DOI 10.2337/diabetes.52.9.2411; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; KNUTSON VP, 1995, J BIOL CHEM, V270, P24972, DOI 10.1074/jbc.270.42.24972; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MARSHALL S, 1981, J BIOL CHEM, V256, P1464; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Roberts R, 2005, DRUG NEWS PERSPECT, V18, P605, DOI 10.1358/dnp.2005.18.10.949485; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Shi GP, 2006, STROKE, V37, P537, DOI 10.1161/01.STR.0000198816.62266.e9; SHI GP, 1992, J BIOL CHEM, V267, P7258; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yajima Y, 2006, ENDOCRINOLOGY, V147, P4811, DOI 10.1210/en.2005-1647	29	97	104	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					970	U130		10.1038/ncb1623	http://dx.doi.org/10.1038/ncb1623			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17643114	Green Accepted			2022-12-27	WOS:000248486700019
J	Novak, B; Tyson, JJ; Gyorffy, B; Csikasz-Nagy, A				Novak, Bela; Tyson, John J.; Gyorffy, Bela; Csikasz-Nagy, Attila			Irreversible cell-cycle transitions are due to systems-level feedback	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; FISSION YEAST; S-PHASE; PROTEOLYSIS; MITOSIS; MODEL; DEGRADATION; HYSTERESIS; OSCILLATOR; ACTIVATION	The irreversibility of cell-cycle transitions is commonly thought to derive from the irreversible degradation of certain regulatory proteins. We argue that irreversible transitions in the cell cycle ( or in any other molecular control system) cannot be attributed to a single molecule or reaction, but that they derive from feedback signals in reaction networks. This systems-level view of irreversibility is supported by many experimental observations.	Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; Hungarian Acad Sci, Mol Network Dynam Res Grp, H-1521 Budapest, Hungary; Budapest Univ Technol & Econ, H-1521 Budapest, Hungary; Univ Trent, Microsoft Res, Ctr Computat & Syst Biol, I-38100 Povo, Trento, Italy	University of Oxford; Virginia Polytechnic Institute & State University; Hungarian Academy of Sciences; Budapest University of Technology & Economics; University of Trento	Novak, B (corresponding author), Univ Oxford, Oxford Ctr Integrat Syst Biol, S Parks Rd, Oxford OX1 3QU, England.	bela.novak@bioch.ox.ac.uk	Csikasz-Nagy, Attila/A-3487-2009; Tyson, John J/A-2942-2014; Novak, Bela/D-5365-2009	Csikasz-Nagy, Attila/0000-0002-2919-5601; Tyson, John J/0000-0001-7560-6013; Novak, Bela/0000-0002-6961-1366				AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lodish H., 2004, MOL CELL BIOL; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Novak B, 1998, PHILOS T ROY SOC B, V353, P2063, DOI 10.1098/rstb.1998.0352; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sveiczer A, 1999, J CELL SCI, V112, P1085; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	31	141	142	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					724	728		10.1038/ncb0707-724	http://dx.doi.org/10.1038/ncb0707-724			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17603504				2022-12-27	WOS:000247760700003
J	Manak, R; Wen, H; Van, T; Andrejka, L; Lipsick, JS				Manak, Robert; Wen, Hong; Van, Tran; Andrejka, Laura; Lipsick, Joseph S.			Loss of Drosophila Myb interrupts the progression of chromosome condensation	NATURE CELL BIOLOGY			English	Article							HISTONE H3; B-MYB; GENOMIC INSTABILITY; HETEROCHROMATIN; MITOSIS; CELLS; PHOSPHORYLATION; EXPRESSION; COMPLEX; MELANOGASTER	Completion of chromosome condensation is required before segregation during the mitotic cell cycle to ensure the transmission of genetic material with high fidelity in a timely fashion. In many eukaryotes this condensation is regulated by phosphorylation of histone H3 on Ser 10 (H3S10). This phosphorylation normally begins in the late-replicating pericentric heterochromatin and then spreads to the earlier replicating euchromatin. Here, we show that these phases of condensation are genetically separable in that the absence of Drosophila Myb causes cells to arrest with H3S10 phosphorylation of heterochromatin but not euchromatin. In addition, we used mosaic analysis to demonstrate that although the Myb protein can be removed in a single cell cycle, the failure of chromosome condensation occurs only after many cell divisions in the absence of Myb protein. The Myb protein is normally located in euchromatic but not heterochromatic regions of the nucleus, suggesting that Myb may be essential for a modification of euchromatin that is required for the efficient spread of chromosome condensation.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Lipsick, JS (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.	lipsick@stanford.edu		Wen, Hong/0000-0001-8739-4572; Manak, John/0000-0002-6562-7694	NATIONAL CANCER INSTITUTE [R01CA090307] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA90307] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Ahlbory DR, 2005, ONCOGENE, V24, P7127, DOI 10.1038/sj.onc.1208869; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fung SM, 2002, DEVELOPMENT, V129, P347; Garcia BA, 2005, BIOCHEMISTRY-US, V44, P13202, DOI 10.1021/bi050906n; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GATTI M, 1983, SCIENCE, V221, P83, DOI 10.1126/science.6407113; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Katzen AL, 1998, GENE DEV, V12, P831, DOI 10.1101/gad.12.6.831; Katzen AL, 1996, P NATL ACAD SCI USA, V93, P13955, DOI 10.1073/pnas.93.24.13955; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Lipsick JS, 2004, GENE DEV, V18, P2837, DOI 10.1101/gad.1274804; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Okada M, 2002, EMBO J, V21, P675, DOI 10.1093/emboj/21.4.675; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; Stowers RS, 1999, GENETICS, V152, P1631; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277	34	30	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					581	U177		10.1038/ncb1580	http://dx.doi.org/10.1038/ncb1580			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450131				2022-12-27	WOS:000246181500017
J	McCusker, D; Denison, C; Anderson, S; Egelhofer, TA; Yates, JR; Gygi, SP; Kellogg, DR				McCusker, Derek; Denison, Carilee; Anderson, Scott; Egelhofer, Thea A.; Yates, John R., III; Gygi, Steven P.; Kellogg, Douglas R.			Cdk1 coordinates cell-surface growth with the cell cycle	NATURE CELL BIOLOGY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; EXCHANGE FACTOR CDC24; RHO-TYPE GTPASES; POLARIZED GROWTH; BUDDING YEAST; GENETIC CONTROL; DIVISION CYCLE; BUD EMERGENCE; G1 CYCLINS; PHOSPHORYLATION	The mechanisms that control cell growth during the cell cycle are poorly understood. In budding yeast, cyclin dependent kinase 1 (Cdk1) triggers polarization of the actin cytoskeleton and bud emergence in late G1 through activation of the Cdc42 GTPase. However, Cdk1 is not thought to be required for subsequent growth of the bud. Here, we show that Cdk1 has an unexpected role in controlling bud growth after bud emergence. Moreover, we show that G1 cyclin-Cdk1 complexes specifically phosphorylate multiple proteins associated with Cdc24, the guanine nucleotide-exchange factor (GEF) that activates the Cdc42 GTPase. A mutant form of a Cdc24- associated protein that fails to undergo Cdk1-dependent phosphorylation causes defects in bud growth. These results provide a direct link between Cdk1 activity and the control of polarized cell growth.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Cell Biol, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; Scripps Research Institute	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	kellogg@biology.ucsc.edu		McCusker, Derek/0000-0003-1455-1711	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; CROSS FR, 1990, MOL CELL BIOL, V10, P6482, DOI 10.1128/MCB.10.12.6482; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; GYGI MP, 2004, PROTEINS PROTEOMICS; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; KELLOGG DR, 1992, MOL BIOL CELL, V3, P1, DOI 10.1091/mbc.3.1.1; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; SLOAT BF, 1978, SCIENCE, V200, P1171, DOI 10.1126/science.349694; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	50	108	111	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					506	U45		10.1038/ncb1568	http://dx.doi.org/10.1038/ncb1568			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417630				2022-12-27	WOS:000246181500008
J	Wolf, A; Keil, R; Gotzl, O; Mun, A; Schwarze, K; Lederer, M; Huttelmaier, S; Hatzfeld, M				Wolf, Annika; Keil, Rene; Goetzl, Oliver; Mun, Andrej; Schwarze, Katrin; Lederer, Marcell; Huettelmaier, Stefan; Hatzfeld, Mechthild			The armadillo protein p0071 regulates Rho signalling during cytokinesis	NATURE CELL BIOLOGY			English	Article							FAMILY GTPASES; LIVING CELLS; EXCHANGE FACTOR; ECT2; ADHESION; DOMAINS; ACTIN; VISUALIZATION; ACCUMULATION; MEMBRANE	Cytokinesis requires the spatio-temporal coordination of cell-cycle control and cytoskeletal reorganization. Members of the Rho-family of GTPases are crucial regulators of this process and assembly of the contractile ring depends on local activation of Rho signalling(1-4). Here, we show that the armadillo protein p0071, unlike its relative p120(ctn), is localized at the midbody during cytokinesis and is essential for cell division. Both knockdown and overexpression of p0071 interfered with normal cell growth and survival due to cytokinesis defects with formation of multinucleated cells and induction of apoptosis. This failure of cytokinesis seemingly correlated with the deregulation of Rho activity in response to altered p0071 expression. The function of p0071 in regulating Rho activity occurred through an association of p0071 with RhoA, as well as the physical and functional interaction of p0071 with Ect2, the one Rho guanine-nucleotide exchange factor (GEF) essential for cytokinesis. These findings support an essential role for p0071 in spatially regulating restricted Rho signalling during cytokinesis.	Univ Halle Wittenberg, Inst Pathophysiol, Div Pathobiochem, D-06114 Halle, Germany; Univ Halle Wittenberg, Jr Grp Posttranscript Gene Regulat, ZAMED, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hatzfeld, M (corresponding author), Univ Halle Wittenberg, Inst Pathophysiol, Div Pathobiochem, Hollystr 1, D-06114 Halle, Germany.	mechthild.hatzfeld@medizin.uni-halle.de	Hüttelmaier, Stefan/AAQ-1203-2021					Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 2003, J CELL SCI, V116, P1219, DOI 10.1242/jcs.00275; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Saito S, 2003, J CELL BIOCHEM, V90, P819, DOI 10.1002/jcb.10688; Schmidt A, 2005, EUR J CELL BIOL, V84, P189, DOI 10.1016/j.ejcb.2004.12.020; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	29	53	57	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1432	U78		10.1038/ncb1504	http://dx.doi.org/10.1038/ncb1504			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115030				2022-12-27	WOS:000242419800020
J	Woelk, T; Oldrini, B; Maspero, E; Confalonieri, S; Cavallaro, E; Di Fiore, PP; Polo, S				Woelk, Tanja; Oldrini, Barbara; Maspero, Elena; Confalonieri, Stefano; Cavallaro, Elena; Di Fiore, Pier Paolo; Polo, Simona			Molecular mechanisms of coupled monoubiquitination	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-INTERACTING MOTIFS; GROWTH-FACTOR RECEPTOR; FUNCTIONAL DIVERSITY; BINDING DOMAINS; NEDD4 FAMILY; PROTEIN; TARGET; IDENTIFICATION; UBIQUITYLATION; ENDOCYTOSIS	Many proteins contain ubiquitin-binding domains or motifs (UBDs), such as the UIM (ubiquitin-interacting motif) and are referred to as ubiquitin receptors. Ubiquitin receptors themselves are frequently monoubiquitinated by a process that requires the presence of a UBD and is referred to as coupled monoubiquitination. Using a UIM-containing protein, eps15, as a model, we show here that coupled monoubiquitination strictly depends on the ability of the UIM to bind to monoubiquitin (mUb). We found that the underlying molecular mechanism is based on interaction between the UIM and a ubiquitin ligase (E3), which has itself been modified by ubiquitination. Furthermore, we demonstrate that the in vivo ubiquitination of members of the Nedd4 family of E3 ligases correlates with their ability to monoubiquitinate eps15. Thus, our results clarify the mechanism of coupled monoubiquitination and identify the ubiquitination of E3 ligases as a critical determinant in this process.	FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; European Inst Oncol, I-20141 Milan, Italy; Univ Milan, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Di Fiore, PP (corresponding author), FIRC Inst Mol Oncol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; simona.polo@ifom-ieo-campus.it	Polo, Simona/P-3509-2014; Confalonieri, Stefano/AAQ-6786-2020; Maspero, Elena/E-5735-2016; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Maspero, Elena/0000-0001-6468-4796; Di Fiore, Pier Paolo/0000-0002-2252-0950; Polo, Simona/0000-0001-5536-9399				Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; FAZIOLI F, 1992, J BIOL CHEM, V267, P5155; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Polo Simona, 2003, Sci STKE, V2003, pre17, DOI 10.1126/stke.2132003re17; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	40	149	150	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1246	U23		10.1038/ncb1484	http://dx.doi.org/10.1038/ncb1484			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17013377				2022-12-27	WOS:000241732400013
J	Kitamura, A; Kubota, H; Pack, CG; Matsumoto, G; Hirayama, S; Takahashi, Y; Kimura, H; Kinjo, M; Morimoto, RI; Nagata, K				Kitamura, Akira; Kubota, Hiroshi; Pack, Chan-Gi; Matsumoto, Gen; Hirayama, Shoshiro; Takahashi, Yasuo; Kimura, Hiroshi; Kinjo, Masataka; Morimoto, Richard I.; Nagata, Kazuhiro			Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state	NATURE CELL BIOLOGY			English	Article							EUKARYOTIC CHAPERONIN; IN-VITRO; PROTEINS; TUBULIN; TRANSITION; MECHANISMS; HUNTINGTIN; EXPANSION; CHAMBER; VIVO	Polyglutamine (polyQ)-expansion proteins cause neurodegenerative disorders including Huntington's disease, Kennedy's disease and various ataxias. The cytotoxicity of these proteins is associated with the formation of aggregates or other conformationally toxic species. Here, we show that the cytosolic chaperonin CCT (also known as TRiC) can alter the course of aggregation and cytotoxicity of huntingtin (Htt) - polyQ proteins in mammalian cells. Disruption of the CCT complex by RNA-imediated knockdown enhanced Htt - polyQ aggregate formation and cellular toxicity. Analysis of the aggregation states of the Htt - polyQ proteins by fluorescence correlation spectroscopy revealed that CCT depletion results in the appearance of soluble Htt - polyQ aggregates. Similarly, overexpression of all eight subunits of CCT suppressed Htt aggregation and neuronal cell death. These results indicate that CCT has an essential role in protecting against the cytotoxicity of polyQ proteins by affecting the course of aggregation.	Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan; Kyoto Univ, Inst Frontier Med Sci, CREST, JST, Kyoto 6068397, Japan; Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Olympus Corp, Hachioji, Tokyo 1928512, Japan; Kyoto Univ, Sch Med, HMRO, Nucl Funct & Dynam Unit,Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Hokkaido University; Northwestern University; Olympus Corporation; Kyoto University	Kubota, H (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068397, Japan.	hkubota@frontier.kyoto-u.ac.jp	Kinjo, Masataka/F-5267-2011; Kimura, Hiroshi/B-9524-2015	Kinjo, Masataka/0000-0001-8889-8369; Kimura, Hiroshi/0000-0003-0854-083X; Matsumoto, Gen/0000-0002-9339-1682	NIGMS NIH HHS [R37 GM038109] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Yokota S, 1999, J BIOL CHEM, V274, P37070, DOI 10.1074/jbc.274.52.37070; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	33	204	213	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1163	U224		10.1038/ncb1478	http://dx.doi.org/10.1038/ncb1478			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16980958	Green Submitted			2022-12-27	WOS:000241395300022
J	Hamaratoglu, F; Willecke, M; Kango-Singh, M; Nolo, R; Hyun, E; Tao, CY; Jafar-Nejad, H; Halder, G				Hamaratoglu, F; Willecke, M; Kango-Singh, M; Nolo, R; Hyun, E; Tao, CY; Jafar-Nejad, H; Halder, G			The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis	NATURE CELL BIOLOGY			English	Article							PROMOTES APOPTOSIS; NEUROFIBROMATOSIS TYPE-2; PATTERN-FORMATION; DROSOPHILA EYE; PROTEIN-KINASE; GROWTH-CONTROL; IMAGINAL DISC; ERM PROTEINS; CYCLE EXIT; ORGAN SIZE	Merlin, the protein product of the Neurofibromatosis type- 2 gene, acts as a tumour suppressor in mice and humans. Merlin is an adaptor protein with a FERM domain and it is thought to transduce a growth- regulatory signal. However, the pathway through which Merlin acts as a tumour suppressor is poorly understood. Merlin, and its function as a negative regulator of growth, is conserved in Drosophila, where it functions with Expanded, a related FERM domain protein. Here, we show that Drosophila Merlin and Expanded are components of the Hippo signalling pathway, an emerging tumour- suppressor pathway. We find that Merlin and Expanded, similar to other components of the Hippo pathway, are required for proliferation arrest and apoptosis in developing imaginal discs. Our genetic and biochemical data place Merlin and Expanded upstream of Hippo and identify a pathway through which they act as tumour- suppressor genes.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Tubingen, Interfak Inst Zellbiol, Abt Genet Tiere, D-72076 Tubingen, Germany; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Eberhard Karls University of Tubingen; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Halder, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	ghalder@mdanderson.org	Jafar-Nejad, Hamed/B-9216-2008; Kango-Singh, Madhuri/F-3647-2011; Halder, Georg/F-2966-2015	Halder, Georg/0000-0001-7580-3236; Hamaratoglu, Fisun/0000-0002-1461-9248				Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Blaumueller CM, 2000, MECH DEVELOP, V92, P251, DOI 10.1016/S0925-4773(00)00246-X; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Boedigheimer MJ, 1997, DEV GENET, V20, P103, DOI 10.1002/(SICI)1520-6408(1997)20:2<103::AID-DVG3>3.0.CO;2-B; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Jones L, 2000, DEVELOPMENT, V127, P4619; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; LUTCHMAN M, 1995, CANCER RES, V55, P2270; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Newsome TP, 2000, DEVELOPMENT, V127, P851; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Trofatter J A, 1993, Cell, V75, P826; Turenchalk GS, 1999, BBA-REV CANCER, V1424, pM9, DOI 10.1016/S0304-419X(99)00021-9; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WOLFF T, 1991, DEVELOPMENT, V113, P841; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiao GH, 2003, GENE CHROMOSOME CANC, V38, P389, DOI 10.1002/gcc.10282; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	48	565	581	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					27	U9		10.1038/ncb1339	http://dx.doi.org/10.1038/ncb1339			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16341207				2022-12-27	WOS:000234651500009
J	Tergaonkar, V; Correa, RG; Ikawa, M; Verma, IM				Tergaonkar, V; Correa, RG; Ikawa, M; Verma, IM			Distinct roles of I kappa B proteins in regulating constitutive NF-kappa B activity	NATURE CELL BIOLOGY			English	Article							ALPHA; MICE; LOCALIZATION	The inhibitor of NF-kappa B ( I kappa B) family of proteins is believed to regulate NF-kappa B activity by cytoplasmic sequestration. We show that in cells depleted of I kappa B alpha, I kappa B beta and I kappa B epsilon proteins, a small fraction of p65 binds DNA and leads to constitutive activation of NF-kappa B target genes, even without stimulation, whereas most of the p65 remains cytoplasmic. These results indicate that although I kappa B alpha, I kappa B beta and I kappa B epsilon proteins could be dispensable for cytoplasmic retention of NF-kappa B, they are essential for preventing NF-kappa B dependent gene expression in the basal state. We also show that in the absence of I kappa B alpha, I kappa B beta and I kappa B epsilon proteins, cytoplasmic retention of NF-kappa B by other cellular proteins renders the pathway unresponsive to activation.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Correa, Ricardo G/G-7613-2012; ikawa, masahito/A-5315-2009	Correa, Ricardo G/0000-0001-6940-7034; ikawa, masahito/0000-0001-9859-6217				BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bell S, 1996, MOL CELL BIOL, V16, P6477; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Memet S, 1999, J IMMUNOL, V163, P5994; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723	15	124	128	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					921	U89		10.1038/ncb1296	http://dx.doi.org/10.1038/ncb1296			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16136188				2022-12-27	WOS:000231601600018
J	Jenny, A; Reynolds-Kenneally, J; Das, G; Burnett, M; Mlodzik, M				Jenny, A; Reynolds-Kenneally, J; Das, G; Burnett, M; Mlodzik, M			Diego and Prickle regulate Frizzled planar cell polarity signalling by competing for Dishevelled binding	NATURE CELL BIOLOGY			English	Letter							DROSOPHILA TISSUE POLARITY; ASYMMETRIC LOCALIZATION; PROTEIN; GENE; POLARIZATION; STRABISMUS; FATE; GASTRULATION; MECHANISMS; MOVEMENTS	Epithelial planar cell polarity ( PCP) is evident in the cellular organization of many tissues in vertebrates and invertebrates(1-5). In mammals, PCP signalling governs convergent extension during gastrulation and the organization of a wide variety of structures, including the orientation of body hair and sensory hair cells of the inner ear(6,7). In Drosophila melanogaster, PCP is manifest in adult tissues, including ommatidial arrangement in the compound eye and hair orientation in wing cells(1,2,4). PCP establishment requires the conserved Frizzled/ Dishevelled PCP pathway(1-5). Mutations in PCP- pathway- associated genes cause aberrant orientation of body hair or inner- ear sensory cells in mice(6,7), or misorientation of ommatidia and wing hair in D. melanogaster(1,2,4). Here we provide mechanistic insight into Frizzled/ Dishevelled signalling regulation. We show that the ankyrin- repeat protein Diego binds directly to Dishevelled and promotes Frizzled signalling. Dishevelled can also be bound by the Frizzled PCP antagonist Prickle(8). Strikingly, Diego and Prickle compete with one another for Dishevelled binding, thereby modulating Frizzled/ Dishevelled activity and ensuring tight control over Frizzled PCP signalling.	CUNY Mt Sinai Sch Med, Brookdale Dept Mol Cellular & Dev Biol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), CUNY Mt Sinai Sch Med, Brookdale Dept Mol Cellular & Dev Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	marek.mlodzik@mssm.edu			NIGMS NIH HHS [R01 GM62917] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062917] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Axelrod JD, 2001, GENE DEV, V15, P1182; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Penton A, 2002, GENETICS, V161, P747; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; ZHENG L, 1995, DEVELOPMENT, V121, P3045	30	147	151	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					691	U78		10.1038/ncb1271	http://dx.doi.org/10.1038/ncb1271			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15937478				2022-12-27	WOS:000230190800013
J	Arnaoutov, A; Azuma, Y; Ribbeck, K; Joseph, J; Boyarchuk, Y; Karpova, T; McNally, J; Dasso, M				Arnaoutov, A; Azuma, Y; Ribbeck, K; Joseph, J; Boyarchuk, Y; Karpova, T; McNally, J; Dasso, M			Crm1 is a mitotic effector of Ran-GTP in somatic cells	NATURE CELL BIOLOGY			English	Article							KINETOCHORE FIBERS; BINDING PROTEIN-2; MICROTUBULE; SPINDLE; ATTACHMENT; NUCLEOPORIN; ASSOCIATION; TRANSPORT; DYNAMICS; COMPLEX	The Ran GTPase controls multiple cellular processes, including nuclear transport, mitotic checkpoints, spindle assembly and post-mitotic nuclear envelope reassembly(1,2). Here we examine the mitotic function of Crm1, the Ran-GTP-binding nuclear export receptor for leucine-rich cargo ( bearing nuclear export sequence) and Snurportin-1 (ref. 3). We find that Crm1 localizes to kinetochores, and that Crm1 ternary complex assembly is essential for Ran-GTP-dependent recruitment of Ran GTPase-activating protein 1 (Ran-GAP1) and Ran-binding protein 2 (Ran-BP2) to kinetochores. We further show that Crm1 inhibition by leptomycin B disrupts mitotic progression and chromosome segregation. Analysis of spindles within leptomycin B-treated cells shows that their centromeres were under increased tension. In leptomycin B-treated cells, centromeres frequently associated with continuous microtubule bundles that spanned the centromeres, indicating that their kinetochores do not maintain discrete end-on attachments to single kinetochore fibres. Similar spindle defects were observed in temperature-sensitive Ran pathway mutants (tsBN2 cells). Taken together, our findings demonstrate that Crm1 and Ran-GTP are essential for Ran-BP2/Ran-GAP1 recruitment to kinetochores, for definition of kinetochore fibres and for chromosome segregation at anaphase. Thus, Crm1 is a critical Ran-GTP effector for mitotic spindle assembly and function in somatic cells.	NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; NCI Core Fluorescence Imaging Facil, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); European Molecular Biology Laboratory (EMBL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dasso, M (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bldg 18,Room 16, Bethesda, MD 20892 USA.	mdasso@helix.nih.gov	Joseph, Jomon/C-1397-2009	Dasso, Mary/0000-0002-5410-1371; Joseph, Jomon/0000-0002-3042-6286; Arnaoutov, Alexei/0000-0001-7647-7217; Karpova, Tatiana/0000-0001-6025-2128	Intramural NIH HHS [Z01 HD008740-06] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008740] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010571] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; MERDES A, 1990, EUR J CELL BIOL, V53, P313; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; NISHI K, 1994, J BIOL CHEM, V269, P6320; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Saitoh H, 1996, MOL BIOL CELL, V7, P1319, DOI 10.1091/mbc.7.9.1319; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Waters JC, 1996, J CELL SCI, V109, P2823; WITT PL, 1981, CHROMOSOMA, V83, P523, DOI 10.1007/BF00328277; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	30	157	158	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					626	U27		10.1038/ncb1263	http://dx.doi.org/10.1038/ncb1263			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15908946				2022-12-27	WOS:000229562100017
J	Lau, A; Swinbank, KM; Ahmed, PS; Taylor, DL; Jackson, SP; Smith, GCM; O'Connor, MJ				Lau, A; Swinbank, KM; Ahmed, PS; Taylor, DL; Jackson, SP; Smith, GCM; O'Connor, MJ			Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase	NATURE CELL BIOLOGY			English	Article							RETROVIRAL DNA INTEGRATION; EARLY EMBRYONIC LETHALITY; DEPENDENT PROTEIN-KINASE; VIRUS TYPE-1 INTEGRATION; POLY(ADP-RIBOSE) POLYMERASE-1; STABLE TRANSDUCTION; IONIZING-RADIATION; IN-VIVO; DAMAGE; CHECKPOINT	Chemotherapy that is used to treat human immunodeficiency virus type-1 (HIV-1) infection focuses primarily on targeting virally encoded proteins. However, the combination of a short retroviral life cycle and high mutation rate leads to the selection of drug-resistant HIV-1 variants. One way to address this problem is to inhibit non-essential host cell proteins that are required for viral replication. Here we show that the activity of HIV-1 integrase stimulates an ataxia-telangiectasia-mutated (ATM)-dependent DNA damage response, and that a deficiency of this ATM kinase sensitizes cells to retrovirus-induced cell death. Consistent with these observations, we demonstrate that a novel and specific small molecule inhibitor of ATM kinase activity, KU-55933, is capable of suppressing the replication of both wild-type and drug-resistant HIV-1.	KuDOS Pharmaceut Ltd, Cambridge CB4 0WG, England; MRC Technol, London NW7 1AD, England; Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB3 1QN, England	AstraZeneca	O'Connor, MJ (corresponding author), KuDOS Pharmaceut Ltd, 327 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England.	mjoconnor@kudospharma.co.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Lau, Alan/0000-0003-1055-9812				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Brown EJ, 2000, GENE DEV, V14, P397; Brown P. O., 1997, P161; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Daniel R, 2004, J BIOL CHEM, V279, P45810, DOI 10.1074/jbc.M407886200; Daniel R, 2003, P NATL ACAD SCI USA, V100, P4778, DOI 10.1073/pnas.0730887100; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; DeHart JL, 2005, J VIROL, V79, P1389, DOI 10.1128/JVI.79.3.1389-1396.2005; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Faust EA, 2002, J BIOMED SCI, V9, P273, DOI 10.1007/BF02256074; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Gaken JA, 1996, J VIROL, V70, P3992; Ha HC, 2001, P NATL ACAD SCI USA, V98, P3364, DOI 10.1073/pnas.051633498; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Rumbaugh JA, 1998, J BIOL CHEM, V273, P28740, DOI 10.1074/jbc.273.44.28740; SAKARIA JN, 1999, CANCER RES, V59, P4375; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siva AC, 2002, J VIROL, V76, P11904, DOI 10.1128/JVI.76.23.11904-11910.2002; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; SUHNEL J, 1990, ANTIVIR RES, V13, P23, DOI 10.1016/0166-3542(90)90042-6; Taylor DL, 2000, ANTIVIR CHEM CHEMOTH, V11, P291, DOI 10.1177/095632020001100405; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Veuger SJ, 2003, CANCER RES, V63, P6008; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	46	123	133	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					493	U57		10.1038/ncb1250	http://dx.doi.org/10.1038/ncb1250			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15834407				2022-12-27	WOS:000229123500016
J	Arabi, A; Wu, SQ; Ridderstrale, K; Bierhoff, H; Shiue, C; Fatyol, K; Fahlen, S; Hydbring, P; Soderberg, O; Grummt, I; Larsson, LG; Wright, APH				Arabi, A; Wu, SQ; Ridderstrale, K; Bierhoff, H; Shiue, C; Fatyol, K; Fahlen, S; Hydbring, P; Soderberg, O; Grummt, I; Larsson, LG; Wright, APH			c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription	NATURE CELL BIOLOGY			English	Article							PROTEIN-DEGRADATION; GENE-TRANSCRIPTION; BINDING; CELLS; NUCLEOLUS; CHROMATIN; COFACTOR; RECRUITS; COMPLEX; GROWTH	The c-Myc oncoprotein regulates transcription of genes that are associated with cell growth, proliferation and apoptosis(1). c-Myc levels are modulated by ubiquitin/proteasome-mediated degradation(1). Proteasome inhibition leads to c-Myc accumulation within nucleoli(2), indicating that c-Myc might have a nucleolar function. Here we show that the proteins c-Myc and Max interact in nucleoli and are associated with ribosomal DNA. This association is increased upon activation of quiescent cells and is followed by recruitment of the Myc cofactor TRRAP, enhanced histone acetylation, recruitment of RNA polymerase I (Pol I), and activation of rDNA transcription. Using small interfering RNAs (siRNAs) against c-Myc and an inhibitor of Myc - Max interactions, we demonstrate that c-Myc is required for activating rDNA transcription in response to mitogenic signals. Furthermore, using the ligand-activated MycER ( ER, oestrogen receptor) system, we show that c-Myc can activate Pol I transcription in the absence of Pol II transcription. These results suggest that c-Myc coordinates the activity of all three nuclear RNA polymerases, and thereby plays a key role in regulating ribosome biogenesis and cell growth.	Sodertorns Hogskola, S-14189 Huddinge, Sweden; Karolinska Inst, Dept Biosci, S-14157 Huddinge, Sweden; Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, S-75007 Uppsala, Sweden; German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany; Univ Uppsala, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden	Sodertorn University; Karolinska Institutet; Swedish University of Agricultural Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University	Arabi, A (corresponding author), Sodertorns Hogskola, S-14189 Huddinge, Sweden.	azadeh.arabi@sh.se	Larsson, Lars-Gunnar/D-9747-2012; Söderberg, Ola/O-5130-2017; Wright, Anthony/J-8187-2015	Söderberg, Ola/0000-0003-2883-1925; Wright, Anthony/0000-0003-1029-9969				Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Cheutin T, 2002, J CELL SCI, V115, P3297; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Halkidou K, 2004, NUCLEIC ACIDS RES, V32, P1654, DOI 10.1093/nar/gkh296; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koberna K, 2002, J CELL BIOL, V157, P743, DOI 10.1083/jcb.200202007; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mutskov VJ, 1996, J BIOL CHEM, V271, P11852, DOI 10.1074/jbc.271.20.11852; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Seither P, 1996, GENOMICS, V37, P135, DOI 10.1006/geno.1996.0531; Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	30	353	365	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					303	310		10.1038/ncb1225	http://dx.doi.org/10.1038/ncb1225			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723053				2022-12-27	WOS:000227329800019
J	Grandori, C; Gomez-Roman, N; Felton-Edkins, ZA; Ngouenet, C; Galloway, DA; Eisenman, RN; White, RJ				Grandori, C; Gomez-Roman, N; Felton-Edkins, ZA; Ngouenet, C; Galloway, DA; Eisenman, RN; White, RJ			c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I	NATURE CELL BIOLOGY			English	Article							PROTEIN-SYNTHESIS; DROSOPHILA-MYC; CELL-GROWTH; N-MYC; SIZE; MAX; DIFFERENTIATION; DEGRADATION; ONCOPROTEIN; EXPRESSION	c-Myc coordinates cell growth and division through a transcriptional programme that involves both RNA polymerase (Pol) II- and Pol III-transcribed genes. Here, we demonstrate that human c-Myc also directly enhances Pol I transcription of ribosomal RNA ( rRNA) genes. rRNA synthesis and accumulation occurs rapidly following activation of a conditional MYC-ER allele ( coding for a Myc-oestrogen-receptor fusion protein), is resistant to inhibition of Pol II transcription and is markedly reduced by c-MYC RNA interference. Furthermore, by using combined immunofluorescence and rRNA-FISH, we have detected endogenous c-Myc in nucleoli at sites of active ribosomal DNA ( rDNA) transcription. Our data also show that c-Myc binds to specific consensus elements located in human rDNA and associates with the Pol I-specific factor SL1. The presence of c-Myc at specific sites on rDNA coincides with the recruitment of SL1 to the rDNA promoter and with increased histone acetylation. We propose that stimulation of rRNA synthesis by c-Myc is a key pathway driving cell growth and tumorigenesis.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Glasgow; Fred Hutchinson Cancer Center	Grandori, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	cgrandor@fhcrc.org		Gomez-Roman, Natividad/0000-0002-2325-7517				Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dang CV, 1999, MOL CELL BIOL, V19, P1; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo QM, 2000, CANCER RES, V60, P5922; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KULKENS T, 1992, EMBO J, V11, P4665, DOI 10.1002/j.1460-2075.1992.tb05568.x; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551	33	472	485	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					311	U121		10.1038/ncb1224	http://dx.doi.org/10.1038/ncb1224			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723054				2022-12-27	WOS:000227329800020
J	Grewal, SS; Li, L; Orian, A; Eisenman, RN; Edgar, BA				Grewal, SS; Li, L; Orian, A; Eisenman, RN; Edgar, BA			Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development	NATURE CELL BIOLOGY			English	Article							CELL-GROWTH; C-MYC; IN-VIVO; TRANSLATIONAL CONTROL; POLYMERASE-III; GENES; IDENTIFICATION; PROTEIN; YEAST; DMYC	Regulating ribosome number is thought to control cellular growth(1). Synthesis of ribosomal RNA ( rRNA) is a limiting step in ribosome biogenesis and rates of rRNA synthesis are generally altered depending on the growth status of a cell(2,3). Although studies in unicellular systems have addressed the mechanisms by which this occurs(4,5), few studies have applied a genetic approach to examine growth-dependent control of rRNA synthesis in metazoans. Here, we show that in Drosophila melanogaster Myc ( dMyc) is a regulator of rRNA synthesis. Expression of dMyc is both necessary and sufficient to control rRNA synthesis and ribosome biogenesis during larval development. Stimulation of rRNA synthesis by dMyc is mediated through a rapid, coordinated increase in the levels of the Pol I transcriptional machinery. In addition, the growth effects of dMyc in larval wing imaginal discs require de novo rRNA synthesis. We suggest that during animal development, the control of rRNA synthesis and ribosome biogenesis is an essential Myc function.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	bedgar@fhcrc.org			NCI NIH HHS [R01CA57138] Funding Source: Medline; NIGMS NIH HHS [GM51186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Campbell G, 1998, DEVELOPMENT, V125, P4483; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Daga RR, 1999, J CELL SCI, V112, P3137; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Derenzini M, 1998, AM J PATHOL, V152, P1291; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guo QM, 2000, CANCER RES, V60, P5922; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Perrin L, 2003, MECH DEVELOP, V120, P645, DOI 10.1016/S0925-4773(03)00049-2; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; SchreiberAgus N, 1997, P NATL ACAD SCI USA, V94, P1235, DOI 10.1073/pnas.94.4.1235; SEIFARTH W, 1991, MOL GEN GENET, V228, P424, DOI 10.1007/BF00260636; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zaffran S, 1998, DEVELOPMENT, V125, P3571	37	290	292	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					295	U109		10.1038/ncb1223	http://dx.doi.org/10.1038/ncb1223			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723055				2022-12-27	WOS:000227329800018
J	Mennella, V; Rogers, GC; Rogers, SL; Buster, DW; Vale, RD; Sharp, DJ				Mennella, V; Rogers, GC; Rogers, SL; Buster, DW; Vale, RD; Sharp, DJ			Functionally distinct kinesin-13 family members cooperate to regulate microtubule dynamics during interphase	NATURE CELL BIOLOGY			English	Article							DEPOLYMERIZING ACTIVITY; SUPERFAMILY PROTEIN; CENTROMERIC MCAK; PLUS; INSTABILITY; XKCM1; STABILIZATION; DOWNSTREAM; STATE; EB1	Regulation of microtubule polymerization and depolymerization is required for proper cell development. Here, we report that two proteins of the Drosophila melanogaster kinesin-13 family, KLP10A and KLP59C, cooperate to drive microtubule depolymerization in interphase cells. Analyses of microtubule dynamics in S2 cells depleted of these proteins indicate that both proteins stimulate depolymerization, but alter distinct parameters of dynamic instability; KLP10A stimulates catastrophe ( a switch from growth to shrinkage) whereas KLP59C suppresses rescue ( a switch from shrinkage to growth). Moreover, immunofluorescence and live analyses of cells expressing tagged kinesins reveal that KLP10A and KLP59C target to polymerizing and depolymerizing microtubule plus ends, respectively. Our data also suggest that KLP10A is deposited on microtubules by the plus-end tracking protein, EB1. Our findings support a model in which these two members of the kinesin-13 family divide the labour of microtubule depolymerization.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sharp, DJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	dsharp@aecom.yu.edu	Mennella, Vito/GZL-7765-2022	Mennella, Vito/0000-0002-4842-9012				Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Gandhi R, 2004, MOL BIOL CELL, V15, P121, DOI 10.1091/mbc.E03-05-0342; Holmfeldt P, 2004, EMBO J, V23, P627, DOI 10.1038/sj.emboj.7600076; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Newton CN, 2004, FEBS LETT, V572, P80, DOI 10.1016/j.febslet.2004.06.093; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082	46	115	118	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					235	U39		10.1038/ncb1222	http://dx.doi.org/10.1038/ncb1222			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723056				2022-12-27	WOS:000227329800011
J	Nishimura, T; Yamaguchi, T; Kato, K; Yoshizawa, M; Nabeshima, Y; Ohno, S; Hoshino, M; Kaibuchi, K				Nishimura, T; Yamaguchi, T; Kato, K; Yoshizawa, M; Nabeshima, Y; Ohno, S; Hoshino, M; Kaibuchi, K			PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; NEURONAL POLARITY; HIPPOCAMPAL-NEURONS; EPITHELIAL-CELLS; AXON FORMATION; GROWTH; APKC; COMPLEX; TIAM1	A polarity complex of PAR-3, PAR-6 and atypical protein kinase C ( aPKC) functions in various cell-polarization events, including neuron specification(1-4). The small GTPase Cdc42 binds to PAR-6 and regulates cell polarity. However, little is known about the downstream signals of the Cdc42 - PAR protein complex. Here, we found that PAR-3 directly interacted with STEF/Tiam1, which are Rac-specific guanine nucleotide-exchange factors, and that STEF formed a complex with PAR-3 - aPKC - PAR-6 - Cdc42-GTP. Cdc42 induces lamellipodia in a Rac-dependent manner in N1E-115 neuroblastoma cells. Disruption of Cdc42 PAR- 6 or PAR- 3 - STEF binding inhibited Cdc42-induced lamellipodia but not filopodia. The isolated STEF-binding PAR-3 fragment was sufficient to induce lamellipodia independently of Cdc42 and PAR-6. PAR-3 is required for Cdc42-induced Rac activation, but is not essential for lamellipodia formation itself. In cultured hippocampal neurons, STEF accumulated at the tip of the growing axon and colocalized with PAR-3. The spatio-temporal activation and signalling of Cdc42 - PAR- 6 - PAR-3 - STEF/Tiam1 - Rac seem to be involved in neurite growth and axon specification. We propose that the PAR- 6 - PAR- 3 complex mediates Cdc42-induced Rac activation by means of STEF/Tiam1, and that this process seems to be required for the establishment of neuronal polarity.	Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Aichi 4668550, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Kyoto University; Yokohama City University; Japan Science & Technology Agency (JST)	Kaibuchi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp	Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/D-6276-2013; Nishimura, Takashi/AAQ-9299-2020; Yoshizawa, Masato/AFD-8467-2022; Nishimura, Takashi/D-7672-2017; Yamaguchi, Tomoya/AAN-7524-2020; Kato, Katsuhiro/AAV-8356-2020; Ohno, Shigeo/B-1768-2010	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-9488-2283; Nishimura, Takashi/0000-0002-6773-0302; Yoshizawa, Masato/0000-0001-8455-8252; Nishimura, Takashi/0000-0002-6773-0302; Yamaguchi, Tomoya/0000-0001-6933-543X; Ohno, Shigeo/0000-0002-1294-5269				Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Mishima A, 2002, GENES CELLS, V7, P581, DOI 10.1046/j.1365-2443.2002.00540.x; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	30	289	301	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					270	U77		10.1038/ncb1227	http://dx.doi.org/10.1038/ncb1227			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723051				2022-12-27	WOS:000227329800015
J	Lee, HJ; Pyo, JO; Oh, Y; Kim, HJ; Hong, SH; Jeon, YJ; Kim, H; Cho, DH; Woo, HN; Song, S; Nam, JH; Kim, HJ; Kim, KS; Jung, YK				Lee, Ho-June; Pyo, Jong-Ok; Oh, Yumin; Kim, Hyo-Jin; Hong, Se-Hoon; Jeon, Young-Jun; Kim, Hyunjoo; Cho, Dong-Hyung; Woo, Ha-Na; Song, Sungmin; Nam, Jung-Hyun; Kim, Hyo Joon; Kim, Key-Sun; Jung, Yong-Keun			AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10	NATURE CELL BIOLOGY			English	Article							FAS-ASSOCIATED PROTEIN; DEATH DOMAIN; ADENYLATE KINASE; MEDIATED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; PHOSPHORYLATION; FADD/MORT1; RECEPTOR; PERMEABILIZATION	Mitochondrial proteins function as essential regulators in apoptosis. Here, we show that mitochondrial adenylate kinase 2 ( AK2) mediates mitochondrial apoptosis through the formation of an AK2-FADD-caspase-10 (AFAC10) complex. Downregulation of AK2 attenuates etoposide- or staurosporine-induced apoptosis in human cells, but not that induced by tumour-necrosis-factor-related apoptosis-inducing ligand ( TRAIL) or Fas ligand ( FasL). During intrinsic apoptosis, AK2 translocates to the cytoplasm, whereas this event is diminished in Apaf-1 knockdown cells and prevented by Bcl-2 or Bcl-X-L. Addition of purified AK2 protein to cell extracts first induces activation of caspase-10 via FADD and subsequently caspase-3 activation, but does not affect caspase-8. AFAC10 complexes are detected in cells undergoing intrinsic cell death and AK2 promotes the association of caspase-10 with FADD. In contrast, AFAC10 complexes are not detected in several etoposide-resistant human tumour cell lines. Taken together, these results suggest that, acting in concert with FADD and caspase-10, AK2 mediates a novel intrinsic apoptotic pathway that may be involved in tumorigenesis.	Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Seoul Natl Univ, Sch Biol Sci, BioMax Inst, Seoul 151742, South Korea; Hanyang Univ, Div Mol & Life Sci, Ansan 426791, Gyeonggi, South Korea; Korea Adv Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Hanyang University; Korea Advanced Institute of Science & Technology (KAIST)	Jung, YK (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, 261 Cheomdan Gwagiro, Kwangju 500712, South Korea.	ykjung@snu.ac.kr	Lee, Ho-June/D-8855-2014; Oh, Yumin/AAU-1302-2021; OH, YUMIN/M-6312-2017	Lee, Ho-June/0000-0002-7019-2533; Oh, Yumin/0000-0003-1456-4045; OH, YUMIN/0000-0003-1456-4045; Woo, Ha-Na/0000-0002-6771-8151; Jeon, Young-Jun/0000-0002-5998-9605; Jung, Yong-Keun/0000-0002-9686-3120				Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Bang S, 2000, J BIOL CHEM, V275, P36217, DOI 10.1074/jbc.M006620200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; KIM HJ, 1990, BIOCHEMISTRY-US, V29, P1107, DOI 10.1021/bi00457a002; Kim PKM, 2002, J BIOL CHEM, V277, P38855, DOI 10.1074/jbc.M203484200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Schlauderer GJ, 1996, PROTEIN SCI, V5, P434; Shimada K, 2002, JPN J CANCER RES, V93, P1164, DOI 10.1111/j.1349-7006.2002.tb01219.x; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	31	63	69	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1303	U176		10.1038/ncb1650	http://dx.doi.org/10.1038/ncb1650			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952061				2022-12-27	WOS:000250659600016
J	Rohatgi, R; Scott, MP				Rohatgi, Rajat; Scott, Matthew P.			Patching the gaps in Hedgehog signalling	NATURE CELL BIOLOGY			English	Article							STEROL-SENSING DOMAIN; REPRESSOR FUNCTIONS; HUMAN HOMOLOG; LOCALIZATION; MUTATIONS; DROSOPHILA; TRANSPORT; PATHWAY; BINDING; SMO	The Hedgehog (Hh) pathway plays central roles in animal development and stem-cell function. Defects in Hh signalling lead to birth defects and cancer in humans. The first and often genetically damaged step in this pathway is the interaction between two membrane proteins-Patched (Ptc), encoded by a tumour suppressor gene, and Smoothened (Smo), encoded by a protooncogene. Recent work linking Hh signalling to sterol metabolites and protein-trafficking events at the primary cilium promises to shed light on the biochemical basis of how Patched inhibits Smoothened, and to provide new avenues for cancer treatment.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, W W252,318 Campus Dr, Stanford, CA 94305 USA.	mscott@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kuwabara PE, 2000, GENE DEV, V14, P1933; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ruiz-Gomez A, 2007, BBA-BIOMEMBRANES, V1768, P901, DOI 10.1016/j.bbamem.2006.09.020; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	51	152	161	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1005	1009		10.1038/ncb435	http://dx.doi.org/10.1038/ncb435			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762891				2022-12-27	WOS:000249256500005
J	Choi, SY; Huang, P; Jenkins, GM; Chan, DC; Schiller, J; Frohman, MA				Choi, Seok-Yong; Huang, Ping; Jenkins, Gary M.; Chan, David C.; Schiller, Juergen; Frohman, Michael A.			A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis	NATURE CELL BIOLOGY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PHOSPHOLIPASE-D DEFINES; RAT-LIVER MITOCHONDRIA; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; OUTER-MEMBRANE; CELLS; CARDIOLIPIN; PROTEIN; APOPTOSIS	Fusion of vesicles into target membranes during many types of regulated exocytosis requires both SNARE-complex proteins and fusogenic lipids, such as phosphatidic acid. Mitochondrial fusion is less well understood but distinct, as it is mediated instead by the protein Mitofusin (Mfn). Here, we identify an ancestral member of the phospholipase D (PLD) superfamily of lipid-modifying enzymes that is required for mitochondrial fusion. Mitochondrial PLD (MitoPLD) targets to the external face of mitochondria and promotes transmitochondrial membrane adherence in a Mfn-dependent manner by hydrolysing cardiolipin to generate phosphatidic acid. These findings reveal that although mitochondrial fusion and regulated exocytic fusion are mediated by distinct sets of protein machinery, the underlying processes are unexpectedly linked by the generation of a common fusogenic lipid. Moreover, our findings suggest a novel basis for the mitochondrial fragmentation observed during apoptosis.	SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Pharmacol, Ctr Dev Genet, Stony Brook, NY 11794 USA; CALTECH, Beckman Inst, Div Biol, Pasadena, CA 91125 USA; Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California Institute of Technology; Leipzig University	Frohman, MA (corresponding author), SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA.	Michael@pharm.stonybrook.edu	Schiller, Jürgen/A-1500-2008	Schiller, Jürgen/0000-0002-4328-8652; Choi, Seok-Yong/0000-0001-7193-292X	PHS HHS [64166, 71520] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CABLE MB, 1978, P NATL ACAD SCI USA, V75, P1227, DOI 10.1073/pnas.75.3.1227; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; HOVIUS R, 1993, FEBS LETT, V330, P71, DOI 10.1016/0014-5793(93)80922-H; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kuhlenbaumer G, 2002, J NEUROL, V249, P1629, DOI 10.1007/s00415-002-0946-3; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; VICOGNE J, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS0606881103; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	40	322	332	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1255	U29		10.1038/ncb1487	http://dx.doi.org/10.1038/ncb1487			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17028579				2022-12-27	WOS:000241732400014
J	Alcazar-Roman, AR; Tran, EJ; Guo, SL; Wente, SR				Alcazar-Roman, Abel R.; Tran, Elizabeth J.; Guo, Shuangli; Wente, Susan R.			Inositol hexakisphosphate and Gle1 activate the DEAD-box protein Dbp5 for nuclear mRNA export	NATURE CELL BIOLOGY			English	Article							PORE COMPLEX; CYTOPLASMIC FIBRILS; INTERACTS; RAT8P/DBP5P; HELICASE; IMPORT; DBP5P/RAT8P; NUP116P; KAP95P; KINASE	Regulation of nuclear mRNA export is critical for proper eukaryotic gene expression. A key step in this process is the directional translocation of mRNA-ribonucleoprotein particles ( mRNPs) through nuclear pore complexes ( NPCs) that are embedded in the nuclear envelope1. Our previous studies in Saccharomyces cerevisiae defined an in vivo role for inositol hexakisphosphate ( InsP(6)) and NPC-associated Gle1 in mRNA export(2). Here, we show that Gle1 and InsP(6) act together to stimulate the RNA-dependent ATPase activity of the essential DEAD-box protein Dbp5. Overexpression of DBP5 specifically suppressed mRNA export and growth defects of an ipk1 nup42 mutant defective in InsP(6) production and Gle1 localization. In vitro kinetic analysis showed that InsP(6) significantly increased Dbp5 ATPase activity in a Gle1-dependent manner and lowered the effective RNA concentration for half-maximal ATPase activity. Gle1 alone had minimal effects. Maximal InsP(6) binding required both Dbp5 and Gle1. It has been suggested that Dbp5 requires unidentified cofactors(3, 4). We now propose that Dbp5 activation at NPCs requires Gle1 and InsP(6). This would facilitate spatial control of the remodelling of mRNP protein composition during directional transport and provide energy to power transport cycles.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, U-3209 MRBIII,465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu	; Tran, Elizabeth/G-7818-2018	Alcazar-Roman, Abel R./0000-0003-1668-1886; Tran, Elizabeth/0000-0002-9541-004X	NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051219, F32GM075459] Funding Source: NIH RePORTER; NCI NIH HHS [5T32-CA009385] Funding Source: Medline; NIGMS NIH HHS [1F32-GM075459, R01-GM51219] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chaves SR, 2001, J BIOL CHEM, V276, P17712, DOI 10.1074/jbc.M010760200; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Ives EB, 2000, J BIOL CHEM, V275, P36575, DOI 10.1074/jbc.M007586200; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Liang WQ, 1997, MOL CELL BIOL, V17, P4124, DOI 10.1128/MCB.17.7.4124; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; NASMYTH KA, 1980, CELL, V19, P753, DOI 10.1016/S0092-8674(80)80051-1; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rollenhagen C, 2004, MOL CELL BIOL, V24, P4869, DOI 10.1128/MCB.24.11.4869-4879.2004; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; SHEARS SB, 1997, SIGNALING INOSITIDES, P134; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	40	214	222	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					711	U131		10.1038/ncb1427	http://dx.doi.org/10.1038/ncb1427			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16783363				2022-12-27	WOS:000238837800013
J	Tanentzapf, G; Brown, NH				Tanentzapf, Guy; Brown, Nicholas H.			An interaction between integrin and the talin FERM domain mediates integrin activation but not linkage to the cytoskeleton	NATURE CELL BIOLOGY			English	Article							CYTOPLASMIC DOMAIN; DROSOPHILA; MEMBRANE; ADHESION; SUBUNIT; BINDING; REQUIREMENT; PROTEINS; DYNAMICS; TAILS	Transmembrane adhesion receptors, such as integrins, mediate cell adhesion by interacting with intracellular proteins that connect to the cytoskeleton. Talin, one such linker protein, is thought to have two roles: mediating inside-out activation of integrins, and connecting extracellular matrix (ECM)-bound integrins to the cytoskeleton(1). Talin's amino-terminal head, which consists of a FERM domain, binds an NPxY motif within the cytoplasmic tail of most integrin beta subunits(2). This is consistent with the role of FERM domains in recruiting other proteins to the plasma membrane(3). We tested the role of the talin-head-NPxY interaction in integrin function in Drosophila. We found that introduction of a mutation that perturbs this binding in vitro(2) into the isolated talin head disrupts its recruitment by integrins in vivo. Surprisingly, when engineered into the full-length talin, this mutation did not disrupt talin recruitment by integrins nor its ability to connect integrins to the cytoskeleton. However, it reduced the ability of talin to strengthen integrin adhesion to the ECM, indicating that the function of the talin-head-NPxY interaction is solely to regulate integrin adhesion.	Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Brown, NH (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	n.brown@gurdon.cam.ac.uk	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; Brown, Nicholas/0000-0002-8958-7017	Wellcome Trust [69943] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Chou TB, 1996, GENETICS, V144, P1673; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Grabbe C, 2004, DEVELOPMENT, V131, P5795, DOI 10.1242/dev.01462; GRINBLAT Y, 1994, DEVELOPMENT, V120, P91; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jannuzi AL, 2002, MOL BIOL CELL, V13, P1352, DOI 10.1091/mbc.01-08-0429; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, J CELL SCI, V119, P1632, DOI 10.1242/jcs.02859; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Yagi R, 2001, EMBO REP, V2, P814, DOI 10.1093/embo-reports/kve178	30	103	104	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					601	606		10.1038/ncb1411	http://dx.doi.org/10.1038/ncb1411			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16648844				2022-12-27	WOS:000238029000013
J	Glebov, OO; Bright, NA; Nichols, BJ				Glebov, OO; Bright, NA; Nichols, BJ			Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells	NATURE CELL BIOLOGY			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; PLASMA-MEMBRANE; GOLGI-COMPLEX; CAVEOLAE; LOCALIZATION; DOMAINS; INTERNALIZATION; IDENTIFICATION; TRANSPORT	Previous studies provide evidence for an endocytic mechanism in mammalian cells that is distinct from both clathrin- coated pits and caveolae(1-5), and is not inhibited by overexpression of GTPase- null dynamin mutants(1-4,6). This mechanism, however, has been defined largely in these negative terms. We applied a ferro- fluid- based purification of endosomes to identify endosomal proteins. One of the proteins identified in this way was flotillin- 1 ( also called reggie- 2)(7,8). Here, we show that flotillin- 1 resides in punctate structures within the plasma membrane and in a specific population of endocytic intermediates. These intermediates accumulate both glycosyl phosphatidylinositol ( GPI)- linked proteins and cholera toxin B subunit(4,9). Endocytosis in flotillin- 1- containing intermediates is clathrin- independent. Total internal reflection microscopy and immuno- electron microscopy revealed that flotillin- 1-containing regions of the plasma membrane seem to bud into the cell, and are distinct from clathrin- coated pits and caveolin- 1- positive caveolae(10). Flotillin- 1 small interfering RNA ( siRNA) inhibited both clathrin- independent uptake of cholera toxin and endocytosis of a GPI- linked protein. We propose that flotillin- 1 is one determinant of a clathrin- independent endocytic pathway in mammalian cells.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Cambridge Inst Med Res, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; University of Cambridge	Nichols, BJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ben@mrc-lmb.cam.ac.uk	Glebov, Oleg/AAV-3201-2021	Glebov, Oleg/0000-0002-3312-5470	MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [MC_U105178778] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bright NA, 1997, J CELL SCI, V110, P2027; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; NOLTA KV, 1994, BBA-MOL CELL RES, V1224, P237, DOI 10.1016/0167-4889(94)90196-1; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702	35	418	432	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					46	U16		10.1038/ncb1342	http://dx.doi.org/10.1038/ncb1342			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16341206				2022-12-27	WOS:000234651500011
J	Laoukili, J; Kooistra, MRH; Bras, A; Kauw, J; Kerkhoven, RM; Morrison, A; Clevers, H; Medema, RH				Laoukili, J; Kooistra, MRH; Bras, A; Kauw, J; Kerkhoven, RM; Morrison, A; Clevers, H; Medema, RH			FoxM1 is required for execution of the mitotic programme and chromosome stability	NATURE CELL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; YEAST-CELL CYCLE; CENP-F; BINDING DOMAIN; FACTOR TRIDENT; S PHASE; PROTEIN; EXPRESSION; MITOSIS; CHECKPOINT	Transcriptional induction of cell-cycle regulatory proteins ensures proper timing of subsequent cell-cycle events. Here we show that the Forkhead transcription factor FoxM1 regulates expression of many G2-specific genes and is essential for chromosome stability. Loss of FoxM1 leads to pleiotropic cell-cycle defects, including a delay in G2, chromosome mis-segregation and frequent failure of cytokinesis. We show that transcriptional activation of cyclin B by FoxM1 is essential for timely mitotic entry, whereas CENP-F, another direct target of FoxM1 identified here, is essential for precise functioning of the mitotic spindle checkpoint. Thus, our data uncover a transcriptional cluster regulated by FoxM1 that is essential for proper mitotic progression.	Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Baylor College of Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Medema, RH (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.medema@nki.nl	Medema, Rene H/G-5415-2011; Morrison, Ashby/AHE-2820-2022; Medema, Rene H/E-2981-2013	Medema, Rene/0000-0002-6754-0381; Morrison, Ashby/0000-0003-1228-5093	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER; NIGMS NIH HHS [R25 GM056929] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Hussein D, 2002, J CELL SCI, V115, P3403; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Jorgensen P, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1022, DOI 10.1186/GB-2000-1-3-REVIEWS1022]; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Korver W, 1997, IMMUNOBIOLOGY, V198, P157, DOI 10.1016/S0171-2985(97)80036-8; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	36	610	632	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					126	U34		10.1038/ncb1217	http://dx.doi.org/10.1038/ncb1217			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15654331				2022-12-27	WOS:000226719500009
J	Rosenthal, N; Brown, S				Rosenthal, Nadia; Brown, Steve			The mouse ascending: perspectives for human-disease models	NATURE CELL BIOLOGY			English	Article							OTITIS-MEDIA; GENE; MUTAGENESIS; RESOURCE	The laboratory mouse is widely considered the model organism of choice for studying the diseases of humans, with whom they share 99% of their genes. A distinguished history of mouse genetic experimentation has been further advanced by the development of powerful new tools to manipulate the mouse genome. The recent launch of several international initiatives to analyse the function of all mouse genes through mutagenesis, molecular analysis and phenotyping underscores the utility of the mouse for translating the information stored in the human genome into increasingly accurate models of human disease.	Mouse Biol Unit, I-00016 Rome, Italy; MRC, Mammalian Genet Unit, Didcot OX11 ORD, Oxon, England		Rosenthal, N (corresponding author), Mouse Biol Unit, EMBL Monterotondo Outstn,Via Ramarina, I-00016 Rome, Italy.	rsn@embl-monterotondo.it	Rose, Rebecca J/B-7812-2011; Rosenthal, Nadia/O-7009-2015	Rosenthal, Nadia/0000-0002-7599-7365	Medical Research Council [MC_U142684172, MC_U142684175, MC_UP_1502/1] Funding Source: Medline; MRC [MC_UP_1502/1, MC_U142684172, MC_U142684175] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown SDM, 2006, PLOS GENET, V2, P1131, DOI 10.1371/journal.pgen.0020118; CARDINANOS J, 2007, NUCLEIC ACIDS RES, V35, pE87; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; *COMPL TRAIT CONS, 2004, NATURE, V26, P1133; Cook MC, 2006, CURR OPIN IMMUNOL, V18, P627, DOI 10.1016/j.coi.2006.07.011; Davisson M, 2006, MAMM GENOME, V17, P363, DOI 10.1007/s00335-006-0001-2; Deidda G, 2003, NAT BIOTECHNOL, V21, P1499, DOI 10.1038/nbt908; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Eisen EJ, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P1, DOI 10.1142/9781860947162; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hardisty-Hughes RE, 2006, HUM MOL GENET, V15, P3273, DOI 10.1093/hmg/ddl403; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Oliver PL, 2007, MAMM GENOME, V18, P412, DOI 10.1007/s00335-007-9014-8; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Paigen K, 2003, GENETICS, V163, P1; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Rubio-Aliaga I, 2007, GENETICS, V175, P1451, DOI 10.1534/genetics.106.067298; Segade F, 2006, ARCH OTOLARYNGOL, V132, P729, DOI 10.1001/archotol.132.7.729; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060	33	256	269	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					993	999		10.1038/ncb437	http://dx.doi.org/10.1038/ncb437			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17762889				2022-12-27	WOS:000249256500003
J	Salman, H; Libchaber, A				Salman, Hanna; Libchaber, Albert			A concentration-dependent switch in the bacterial response to temperature	NATURE CELL BIOLOGY			English	Article							ESCHERICHIA-COLI; CHEMOTAXIS; THERMORESPONSE	We observed that bacteria grown below a critical concentration, in batch-mode cultures, swim towards warm regions when subjected to a temperature gradient. above that concentration, they swim towards colder regions. our findings indicate that the secreted intercellular signal, glycine, mediates this switch through methylation of Tsr receptors. at high bacterial concentration, the switch is reinforced by an inversion of the Tar/Tsr expression ratio.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA	Rockefeller University	Salman, H (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA.	salmanh@rockefeller.edu	Buma, P./H-8019-2014; Buma, Pieter/C-9828-2013; Schreurs, B.W./L-4639-2015	Salman, Hanna/0000-0002-5847-524X				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Berg H. C. E., 2003, COLI MOTION; Braun D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.188103; Imae Y., 1985, SENSING RESPONSE MIC, P73; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; MAEDA K, 1979, P NATL ACAD SCI USA, V76, P91, DOI 10.1073/pnas.76.1.91; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MIZUNO T, 1984, J BACTERIOL, V159, P360, DOI 10.1128/JB.159.1.360-367.1984; Nishiyama S, 1999, MOL MICROBIOL, V32, P357, DOI 10.1046/j.1365-2958.1999.01355.x; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Salman H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118101; Staropoli JF, 2000, BIOPHYS J, V78, P513, DOI 10.1016/S0006-3495(00)76613-6; STEWART RC, 1987, CHEM REV, V87, P997, DOI 10.1021/cr00081a007; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0	17	63	63	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1098	U78		10.1038/ncb1632	http://dx.doi.org/10.1038/ncb1632			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17694049				2022-12-27	WOS:000249256500018
J	Bennett, G; Bergeron, J				Bennett, Gary; Bergeron, John			Charles Leblond - 1910-2007	NATURE CELL BIOLOGY			English	Biographical-Item									McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University	Bennett, G (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	john.bergeron@Mcgill.ca	Bergeron, John/AAW-1893-2021						0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					723	723		10.1038/ncb0707-723	http://dx.doi.org/10.1038/ncb0707-723			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17603503	Bronze			2022-12-27	WOS:000247760700002
J	Kai, M; Furuya, K; Paderi, F; Carr, AM; Wang, TSF				Kai, Mihoko; Furuya, Kanji; Paderi, Francesca; Carr, Antony M.; Wang, Teresa S. F.			Rad3-dependent phosphorylation of the checkpoint clamp regulates repair-pathway choice	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE CONTROL; BOX DNA HELICASE; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SRS2 HELICASE; HOMOLOGOUS RECOMBINATION; CANCER; INVOLVEMENT; CEREVISIAE; DAMAGE	When replication forks collapse, Rad3 phosphorylates the checkpoint-clamp protein Rad9 in a manner that depends on Thr 225, a residue within the PCNA-like domain. The physiological function of Thr 225-dependent Rad9 phosphorylation, however, remains elusive. Here, we show that Thr 225-dependent Rad9 phosphorylation by Rad3 regulates DNA repair pathways. A rad9T225C mutant induces a translesion synthesis (TLS)-dependent high spontaneous mutation rate and a hyper-recombination phenotype. Consistent with this, Rad9 coprecipitates with the post-replication repair protein Mms2. This interaction is dependent on Rad9 Thr 225 and is enhanced by DNA damage. Genetic analyses indicate that Thr 225-dependent Rad9 phosphorylation prevents inappropriate Rhp51-dependent recombination, potentially by redirecting the repair through a Pli1-mediated sumoylation pathway into the error-free branch of the Rhp6 repair pathway. Our findings reveal a new mechanism by which phosphorylation of Rad9 at Thr 225 regulates the choice of repair pathways for maintaining genomic integrity during the cell cycle.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Stanford University; University of Sussex	Wang, TSF (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	tswang@stanford.edu	paderi, francesca/K-1798-2014	Carr, Antony Michael/0000-0002-2028-2389	NATIONAL CANCER INSTITUTE [R01CA054415] Funding Source: NIH RePORTER; MRC [G0001129] Funding Source: UKRI; Medical Research Council [G0001129] Funding Source: Medline; NCI NIH HHS [CA54415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Kai M, 2005, GENE DEV, V19, P919, DOI 10.1101/gad.1304305; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kai M, 2001, MOL CELL BIOL, V21, P3289, DOI 10.1128/MCB.21.10.3289-3301.2001; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liberles DA, 2001, GENOME BIOL, V2; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maftahi M, 2002, NUCLEIC ACIDS RES, V30, P4781, DOI 10.1093/nar/gkf581; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang SW, 2001, NUCLEIC ACIDS RES, V29, P2963, DOI 10.1093/nar/29.14.2963	25	28	29	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					691	U148		10.1038/ncb1600	http://dx.doi.org/10.1038/ncb1600			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515930				2022-12-27	WOS:000246922700015
J	Nishio, M; Watanabe, KI; Sasaki, J; Taya, C; Takasuga, S; Iizuka, R; Balla, T; Yamazaki, M; Watanabe, H; Itoh, R; Kuroda, S; Horie, Y; Forster, I; Mak, TW; Yonekawa, H; Penninger, JM; Kanaho, Y; Suzuki, A; Sasaki, T				Nishio, Miki; Watanabe, Ken-ichi; Sasaki, Junko; Taya, Choji; Takasuga, Shunsuke; Iizuka, Ryota; Balla, Tamas; Yamazaki, Masakazu; Watanabe, Hiroshi; Itoh, Reietsu; Kuroda, Shoko; Horie, Yasuo; Forster, Irmgard; Mak, Tak W.; Yonekawa, Hiromichi; Penninger, Josef M.; Kanaho, Yasunori; Suzuki, Akira; Sasaki, Takehiko			Control of cell polarity and motility by the PtdIns(3,4,5)P-3 phosphatase SHIP1	NATURE CELL BIOLOGY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GREEN FLUORESCENT PROTEIN; PHOSPHOINOSITIDE 3-KINASES; CHEMOATTRACTANT RECEPTOR; CHEMOTAXIS; ACTIVATION; ROLES; PTEN; PI3K-GAMMA; GAMMA	Proper neutrophil migration into inflammatory sites ensures host defense without tissue damage. Phosphoinositide 3-kinase (PI(3)K) and its lipid product phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) regulate cell migration, but the role of PtdIns(3,4,5)P-3-degrading enzymes in this process is poorly understood. Here, we show that Src homology 2 (SH2) domain-containing inositol-5-phosphatase 1 (SHIP1), a PtdIns(3,4,5)P-3 phosphatase, is a key regulator of neutrophil migration. Genetic inactivation of SHIP1 led to severe defects in neutrophil polarization and motility. In contrast, loss of the PtdIns(3,4,5)P-3 phosphatase PTEN had no impact on neutrophil chemotaxis. To study PtdIns(3,4,5)P-3 metabolism in living primary cells, we generated a novel transgenic mouse (AktPH-GFP Tg) expressing a bioprobe for PtdIns(3,4,5)P-3. Time-lapse footage showed rapid, localized binding of AktPH-GFP to the leading edge membrane of chemotaxing ship1(+/+)AktPH-GFP Tg neutrophils, but only diffuse localization in ship1(-/-)AktPH-GFP Tg neutrophils. By directing where PtdIns(3,4,5)P-3 accumulates, SHIP1 governs the formation of the leading edge and polarization required for chemotaxis.	Akita Univ, Sch Med, Dept Pathol & Immunol, Akita 0108543, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Akita Univ, Sch Med, Dept Mol Biol, Akita 0108543, Japan; Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, Tokyo 1138613, Japan; NICHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA; Akita Univ, Sch Med, Dept Gastroenterol, Akita 0108543, Japan; Univ Dusseldorf, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; Campbell Familly Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Austrian Acad Sci, Inst Mol & Biotechnol, A-1030 Vienna, Austria	Akita University; Japan Science & Technology Agency (JST); Akita University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Akita University; Heinrich Heine University Dusseldorf; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Sasaki, T (corresponding author), Akita Univ, Sch Med, Dept Pathol & Immunol, 1-1-1 Hondo, Akita 0108543, Japan.	tsasaki@med.akita-u.ac.jp	Penninger, Josef M/I-6860-2013; Suzuki, Akira/GYD-6697-2022; Förster, Irmgard/P-8545-2016; Watanabe, Hiroshi/GOP-0177-2022	Penninger, Josef M/0000-0002-8194-3777; Suzuki, Akira/0000-0002-5950-8808; Förster, Irmgard/0000-0002-7644-5642; Watanabe, Hiroshi/0000-0001-8887-5407; Sasaki, Takehiko/0000-0003-1837-3748; Balla, Tamas/0000-0002-9077-3335	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balla Tamas, 2002, Sci STKE, V2002, ppl3, DOI 10.1126/stke.2002.125.pl3; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Lacalle RA, 2004, J CELL SCI, V117, P6207, DOI 10.1242/jcs.01545; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park HT, 2002, BIOESSAYS, V24, P821, DOI 10.1002/bies.10141; Patel DD, 2001, CURR DIRECT AUTOIMMU, V3, P133; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	49	222	229	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					36	U40		10.1038/ncb1515	http://dx.doi.org/10.1038/ncb1515			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173042				2022-12-27	WOS:000243255100010
J	Wang, SC; Nakajima, Y; Yu, YL; Xia, WY; Chen, CT; Yang, CC; McIntush, EW; Li, LY; Hawke, DH; Kobayashi, R; Hung, MC				Wang, Shao-Chun; Nakajima, Yusuke; Yu, Yung-Luen; Xia, Weiya; Chen, Chun-Te; Yang, Cheng-Chieh; McIntush, Eric W.; Li, Long-Yuan; Hawke, David H.; Kobayashi, Ryuji; Hung, Mien-Chie			Tyrosine phosphorylation controls PCNA function through protein stability	NATURE CELL BIOLOGY			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL NUCLEAR ANTIGEN; FACTOR RECEPTOR; EGF RECEPTOR; DNA-REPAIR; BREAST; EXPRESSION; LOCALIZATION; CANCER; UBIQUITIN	The proliferating cell nuclear antigen (PCNA) is an essential protein for DNA replication and damage repair. How its function is controlled remains an important question. Here, we show that the chromatin-bound PCNA protein is phosphorylated on Tyr 211, which is required for maintaining its function on chromatin and is dependent on the tyrosine kinase activity of EGF receptor (EGFR) in the nucleus. Phosphorylation on Tyr 211 by EGFR stabilizes chromatin-bound PCNA protein and associated functions. Consistently, increased PCNA Tyr 211 phosphorylation coincides with pronounced cell proliferation, and is better correlated with poor survival of breast cancer patients, as well as nuclear EGFR in tumours, than is the total PCNA level. These results identify a novel nuclear mechanism linking tyrosine kinase receptor function with the regulation of the PCNA sliding clamp.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; Bethyl Labs Inc, Montgomery, TX 77356 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hung, MC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Wang, Shao-Chun/P-9904-2019	Hung, Mien-Chie/0000-0003-4317-4740; Wang, Shao-Chun/0000-0002-5477-1682; Hawke, David/0000-0002-6102-7843; Li, Long-Yuan/0000-0001-7472-8318	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; PHS HHS [P01 099031, R01 109311] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Assy N, 1997, J HEPATOL, V26, P945, DOI 10.1016/S0168-8278(97)80266-8; Baselga J, 2002, ONCOLOGIST, V7, P2; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Bukholm IRK, 2003, J CLIN PATHOL, V56, P368, DOI 10.1136/jcp.56.5.368; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Frassoldati A, 1997, BREAST CANCER RES TR, V44, P185, DOI 10.1023/A:1005875002458; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Grossi F, 2003, EUR J CANCER, V39, P1242, DOI 10.1016/S0959-8049(03)00232-6; Hanada N, 2006, MOL CARCINOGEN, V45, P10, DOI 10.1002/mc.20147; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Heimann R, 1997, CANCER J, V3, P224; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jeziorski A, 2000, J EXP CLIN CANC RES, V19, P61; JONSSON ZO, 1995, EMBO J, V14, P5745, DOI 10.1002/j.1460-2075.1995.tb00261.x; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kato, 1999, Breast Cancer, V6, P370, DOI 10.1007/BF02966456; Kato T, 2003, BRIT J CANCER, V88, P1900, DOI 10.1038/sj.bjc.6600921; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Kiyokawa N, 1997, J BIOL CHEM, V272, P18656, DOI 10.1074/jbc.272.30.18656; Lee JS, 2001, ANAL QUANT CYTOL, V23, P161; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; MARTI U, 1995, J HEPATOL, V23, P318, DOI 10.1016/S0168-8278(95)80011-5; Marti U, 2001, THYROID, V11, P137, DOI 10.1089/105072501300042785; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; SHRESTHA P, 1992, VIRCHOWS ARCH A, V421, P193, DOI 10.1007/BF01611175; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tao YG, 2005, EXP CELL RES, V303, P240, DOI 10.1016/j.yexcr.2004.09.030; Ulrich HD, 2004, CELL CYCLE, V3, P15; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	48	230	245	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1359	U24		10.1038/ncb1501	http://dx.doi.org/10.1038/ncb1501			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115032				2022-12-27	WOS:000242419800011
J	Orme, MH; Alrubaie, S; Bradley, GL; Walker, CD; Leevers, SJ				Orme, Mariam H.; Alrubaie, Saif; Bradley, Gemma L.; Walker, Cherryl D.; Leevers, Sally J.			Input from Ras is required for maximal PI(3)K signalling in Drosophila	NATURE CELL BIOLOGY			English	Article							PHOSPHOINOSITIDE 3-KINASE; KINASE; GROWTH; ACTIVATION; INSULIN; COMPLEX; ADAPTER; DP110	Class I phosphoinositide 3-kinases (PI(3)Ks) are activated through associated adaptor molecules in response to G protein-coupled and tyrosine kinase receptor signalling(1). They contain Ras-binding domains (RBDs) and can also be activated through direct association with active GTP-bound Ras(2-10). The ability of Ras to activate PI(3)K has been established in vitro and by overexpression analysis, but its relevance for normal PI(3)K function in vivo is unknown. The Drosophila class I PI(3)K, Dp110, is activated by nutrient-responsive insulin signalling and modulates growth, oogenesis and metabolism(11-15). To investigate the importance of Ras-mediated PI(3)K activation for normal PI(3)K function, we replaced Dp110 with Dp110(RBD), which is unable to bind to Ras but otherwise biochemically normal. We found that Ras-mediated Dp110 regulation is dispensable for viability. However, egg production, which requires large amounts of growth, is dramatically lowered in Dp110(RBD) flies. Furthermore, insulin cannot maximally activate PI(3)K signalling in Dp110(RBD) imaginal discs and Dp110(RBD) flies are small. Thus, Dp110 integrates inputs from its phosphotyrosine-binding adaptor and Ras to achieve maximal PI(3)K signalling in specific biological situations.	Canc Res UK London Res Inst, Growth Regulat Lab, London WC2A 3PX, England	Cancer Research UK	Leevers, SJ (corresponding author), Canc Res UK London Res Inst, Growth Regulat Lab, POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.	sally.leevers@cancer.org.uk						Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Karim FD, 1998, DEVELOPMENT, V125, P1; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Leevers Sally J., 2004, VVolume 42, P167; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Rubio I, 1997, BIOCHEM J, V326, P891, DOI 10.1042/bj3260891; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	26	51	52	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1298	U67		10.1038/ncb1493	http://dx.doi.org/10.1038/ncb1493			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17041587				2022-12-27	WOS:000241732400020
J	Gao, F; Cheng, JK; Shi, T; Yeh, ETH				Gao, Fei; Cheng, Jinke; Shi, Tong; Yeh, Edward T. H.			Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NF kappa B-dependent transcription	NATURE CELL BIOLOGY			English	Article							UBIQUITIN-LIKE PROTEIN; RBP-J; LIM PROTEIN; CYCLIN D1; NEDD8; IDENTIFICATION; CONJUGATION; CULLIN-2; BINDING; FAMILY	Neddylation has an important role in ubiquitin- mediated protein degradation through modification of cullins, which are the main substrates for NEDD8 modification. Here, we show that breast cancer-associated protein 3 (BCA3) is a NEDD8 substrate. BCA3 suppressed NF kappa B-dependent transcription through its ability to bind to p65 and the cyclin D1 promoter in a neddylation- dependent manner. Transcriptional suppression mediated by BCA3 may be attributed to the ability of neddylated BCA3 to recruit SIRT1, a class III histone deacetylase. Silencing of endogenous BCA3 in DU145 and MCF7 cells enhanced NF kappa B transcription and inhibited tumour necrosis factor (TNF) alpha-induced apoptosis. Conversely, BCA3 silencing could be reversed by over-expression of wild-type BCA3 and SENP8, a NEDD8-specific protease, but not by neddylation- deficient BCA3 or a SENP8 mutant. These results provide a crucial link between neddylation and transcriptional regulation by SIRT1, a NAD-dependent histone deacetylase that prolongs life span in yeast and worms.	Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Brown Fdn Inst Mol Med Prevent Human Dis, Res Ctr Cardiovasc Dis, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Sch Med, Dept Cell Biol, Minist Educ China,Key Lab Cell Differentiat & Apo, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Inst Digest Dis, Shanghai 200001, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Ministry of Education, China; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yeh, ETH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, 1515 Holocombe Blvd,Unit 449, Houston, TX 77030 USA.	etyeh@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA080089, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16672, R01 CA 80089] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Qin HY, 2004, NUCLEIC ACIDS RES, V32, P1492, DOI 10.1093/nar/gkh295; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	30	110	121	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1171	U236		10.1038/ncb1483	http://dx.doi.org/10.1038/ncb1483			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998474				2022-12-27	WOS:000241395300023
J	Hayes, MJ; Kimata, Y; Wattam, SL; Lindon, C; Mao, GJ; Yamano, H; Fry, AM				Hayes, Michelle J.; Kimata, Yuu; Wattam, Samantha L.; Lindon, Catherine; Mao, Guojie; Yamano, Hiroyuki; Fry, Andrew M.			Early mitotic degradation of Nek2A depends on Cdc20-indedpenent interaction with the APC/C	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; DESTRUCTION BOX; CELL-CYCLE; SUBSTRATE RECOGNITION; PROTEIN-KINASE; KEN BOX; CDC20; CDH1; PROTEOLYSIS; CHECKPOINT	The temporal control of mitotic protein degradation remains incompletely understood. In particular, it is unclear why the mitotic checkpoint prevents the anaphase-promoting complex/cyclosome (APC/C)-mediated degradation of cyclin B and securin in early mitosis, but not cyclin A(1-3). Here, we show that another APC/C substrate, NIMA-related kinase 2A (Nek2A), is also destroyed in pro-metaphase in a checkpoint-independent manner and that this depends on an exposed carboxy-terminal methionine-arginine (MR) dipeptide tail. Truncation of the Nek2A C terminus delays its degradation until late mitosis, whereas Nek2A C-terminal peptides interfere with APC/C activity in an MR-dependent manner. Most importantly, we show that Nek2A binds directly to the APC/C, also in an MR-dependent manner, even in the absence of the adaptor protein Cdc20. As similar C-terminal dipeptide tails promote direct association of Cdc20, Cdh1 and Apc10-Doc1 with core APC/C subunits, we propose that this sequence also allows a substrate, Nek2A, to directly bind the APC/C. Thus, although Cdc20 is required for the degradation of Nek2A, it is not required for its recruitment and this renders its degradation insensitive to the mitotic checkpoint.	Univ Leicester, Dept Biochem, Leicester, Leics, England; Marie Curie Res Inst, Surrey RH8 0TL, England; Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England	University of Leicester; University of Cambridge; University of Cambridge	Fry, AM (corresponding author), Univ Leicester, Dept Biochem, Leicester, Leics, England.	amf5@le.ac.uk	Kimata, Yuu/U-2311-2017; Hayes, Michelle/HCI-5829-2022	Kimata, Yuu/0000-0001-6223-1320; Lindon, Catherine/0000-0003-3554-2574	MRC [G120/892] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C000013/1] Funding Source: Medline; Medical Research Council [G120/892] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Uto K, 2000, EMBO J, V19, P1816, DOI 10.1093/emboj/19.8.1816; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	35	126	129	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					607	614		10.1038/ncb1410	http://dx.doi.org/10.1038/ncb1410			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16648845				2022-12-27	WOS:000238029000014
J	Lee, CS; Kim, IS; Park, JB; Lee, MN; Lee, HY; Suh, PG; Ryu, SH				Lee, CS; Kim, IS; Park, JB; Lee, MN; Lee, HY; Suh, PG; Ryu, SH			The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis	NATURE CELL BIOLOGY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PX DOMAIN; BINDING; PHOSPHORYLATION; LOCALIZES; INDUCTION; MEMBRANE	Dynamin is a large GTP-binding protein that mediates endocytosis by hydrolyzing GTP(1,2,3). Previously, we reported that phospholipase D2 (PLD2) interacts with dynamin in a GTP-dependent manner(4). This implies that PLD may regulate the GTPase cycle of dynamin. Here, we show that PLD functions as a GTPase activating protein (GAP) through its phox homology domain (PX), which directly activates the GTPase domain of dynamin, and that the arginine residues in the PLD-PX are vital for this GAP function. Moreover, wild-type PLD-PX, but not mutated PLD-PXs defective for GAP function in vitro, increased epidermal growth factor receptor (EGFR) endocytosis at physiological EGF concentrations. In addition, the silencing of PLDs was shown to retard EGFR endocytosis and the addition of wild-type PLDs or lipase-inactive PLDs, but not PLD1 mutants with defective GAP activity for dynamin in vitro, resulted in the recovery of EGFR endocytosis. These findings suggest that PLD, functioning as an intermolecular GAP for dynamin, accelerates EGFR endocytosis. Moreover, we determined that the phox homology domain itself had GAP activity - a novel function in addition to its role as a binding motif for proteins or lipids.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Ryu, SH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	sungho@postech.ac.kr	Lee, Mi Nam/A-2357-2012; Suh, Pann-Ghill/F-3610-2010	Ryu, Sung Ho/0000-0003-0913-3048				Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Ellson CD, 2002, J CELL SCI, V115, P1099; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jang IH, 2003, J BIOL CHEM, V278, P18184, DOI 10.1074/jbc.M208438200; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim Y, 1999, BIOCHEMISTRY-US, V38, P10344, DOI 10.1021/bi990579h; LEMBACH KJ, 1976, P NATL ACAD SCI USA, V73, P183, DOI 10.1073/pnas.73.1.183; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Park JB, 2004, ADV ENZYME REGUL, V44, P249, DOI 10.1016/j.advenzreg.2003.11.021; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; TUMA PL, 1993, J BIOL CHEM, V268, P17240; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107	30	104	109	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					477	U101		10.1038/ncb1401	http://dx.doi.org/10.1038/ncb1401			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622417				2022-12-27	WOS:000237299400011
J	Rowland, BD; Bernards, R; Peeper, DS				Rowland, BD; Bernards, R; Peeper, DS			The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene	NATURE CELL BIOLOGY			English	Article							KRUPPEL-LIKE FACTOR; CELL-LINE RKO; DOWN-REGULATION; BREAST-CANCER; ONCOSTATIN-M; FACTOR GENE; TGF-BETA; EXPRESSION; GROWTH; RAS	KLF4 (GKLF/EZF) encodes a transcription factor that is associated with both tumour suppression and oncogenesis. We describe the identification of KLF4 in a functional genomic screen for genes that bypass RAS(V12)-induced senescence. However, in untransformed cells, KLF4 acts as a potent inhibitor of proliferation. KLF4-induced arrest is bypassed by oncogenic RAS(V12) or by the RAS target cyclin-D1. Remarkably, inactivation of the cyclin-D1 target and the cell-cycle inhibitor p21(CIP1) not only neutralizes the cytostatic action of KLF4, but also collaborates with KLF4 in oncogenic transformation. Conversely, KLF4 suppresses the expression of p53 by directly acting on its promoter, thereby allowing for RAS(V12)-mediated transformation and causing resistance to DNA-damage-induced apoptosis. Consistently, KLF4 depletion from breast cancer cells restores p53 levels and causes p53-dependent apoptosis. These results unmask KLF4 as a regulator of p53 that oncogenically transforms cells as a function of p21(CIP1) status. Furthermore, they provide a mechanistic explanation for the context-dependent oncogenic or tumour-suppressor functions of KLF4.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	Bernards, Rene/0000-0001-8677-3423				Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BOS JL, 1989, CANCER RES, V49, P4682; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301; FILMUS J, 1994, ONCOGENE, V9, P3627; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Jenkins TD, 1998, J BIOL CHEM, V273, P10747, DOI 10.1074/jbc.273.17.10747; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Li C, 2001, ONCOGENE, V20, P8193, DOI 10.1038/sj.onc.1205046; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; LUO A, 2003, ONCOGENE, V1, P1; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	50	444	472	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1074	1082		10.1038/ncb1314	http://dx.doi.org/10.1038/ncb1314			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16244670	Green Published			2022-12-27	WOS:000232930400010
J	Li, J; Wang, CY				Li, Jiong; Wang, Cun-Yu			TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis	NATURE CELL BIOLOGY			English	Article							RECEPTOR-RELATED PROTEIN-5; CELL FACTOR; C-MYC; PATHWAY; APC; APOPTOSIS; COMPLEX; EXPRESSION; REPRESSOR; DEFECTS	Aberrant Wnt signalling promotes oncogenesis by increasing the nuclear accumulation of beta-catenin to activate downstream target genes. However, the mechanism of beta-catenin recruitment to the Wnt target-gene promoter, a critical step for removing the co-repressor complex, is largely unknown. Here, we report that transducin beta-like protein 1 (TBL1) and its highly related family member TBLR1 were required for Wnt-beta-catenin-mediated transcription. Wnt signalling induced the interaction between beta-catenin and TBL1-TBLR1, as well as their binding to Wnt target genes. Importantly, the recruitment of TBL1-TBLR1 and beta-catenin to Wnt target-gene promoters was mutually dependent on each other. Furthermore, the depletion of TBL1-TBLR1 significantly inhibited Wnt-beta-catenin-induced gene expression and oncogenic growth in vitro and in vivo. Our results unravel two new components required for nuclear beta-catenin function, and have important implications in developing new strategies for inhibiting Wnt-beta-catenin-mediated tumorigenesis.	[Li, Jiong; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Mol Signalling Lab, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu						Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; ZENG W, 1998, NATURE, V403, P789; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	41	134	138	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					160	U36		10.1038/ncb1684	http://dx.doi.org/10.1038/ncb1684			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193033				2022-12-27	WOS:000252897800011
J	Yang, JY; Zong, CS; Xia, WY; Yamaguchi, H; Ding, QQ; Xie, XM; Lang, JY; Lai, CC; Chang, CJ; Huang, WC; Huang, H; Kuo, HP; Lee, DF; Li, LY; Lien, HC; Cheng, XY; Chang, KJ; Hsiao, CD; Tsai, FJ; Tsai, CH; Sahin, AA; Muller, WJ; Mills, GB; Yu, DH; Hortobagyi, GN; Hung, MC				Yang, Jer-Yen; Zong, Cong S.; Xia, Weiya; Yamaguchi, Hirohito; Ding, Qingqing; Xie, Xiaoming; Lang, Jing-Yu; Lai, Chien-Chen; Chang, Chun-Ju; Huang, Wei-Chien; Huang, Hsin; Kuo, Hsu-Ping; Lee, Dung-Fang; Li, Long-Yuan; Lien, Huang-Chun; Cheng, Xiaoyun; Chang, King-Jen; Hsiao, Chwan-Deng; Tsai, Fuu-Jen; Tsai, Chang-Hai; Sahin, Aysegul A.; Muller, William J.; Mills, Gordon B.; Yu, Dihua; Hortobagyi, Gabriel N.; Hung, Mien-Chie			ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation	NATURE CELL BIOLOGY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR P53; UBIQUITIN LIGASE; BETA-CATENIN; CELL-CYCLE; BREAST-CANCER; KAPPA-B; MDM2; EXPRESSION; RAS	The RAS-ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that ERK downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylated FOXO3a degrades via an MDM2-mediated ubiquitin-proteasome pathway. However, the non-phosphorylated FOXO3a mutant is resistant to the interaction and degradation by murine double minute 2 (MDM2), thereby resulting in a strong inhibition of cell proliferation and tumorigenicity. Taken together, our study elucidates a novel pathway in cell growth and tumorigenesis through negative regulation of FOXO3a by RAS-ERK and MDM2.	[Yang, Jer-Yen; Zong, Cong S.; Xia, Weiya; Yamaguchi, Hirohito; Ding, Qingqing; Xie, Xiaoming; Lang, Jing-Yu; Chang, Chun-Ju; Huang, Wei-Chien; Huang, Hsin; Kuo, Hsu-Ping; Lee, Dung-Fang; Cheng, Xiaoyun; Yu, Dihua; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Jer-Yen; Kuo, Hsu-Ping; Lee, Dung-Fang; Cheng, Xiaoyun; Yu, Dihua; Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lai, Chien-Chen; Li, Long-Yuan; Tsai, Fuu-Jen; Tsai, Chang-Hai; Hung, Mien-Chie] China Med Univ Hosp, Taichung 404, Taiwan; [Huang, Hsin] Univ Calif Davis, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA; [Li, Long-Yuan; Tsai, Chang-Hai; Hung, Mien-Chie] Asian Univ, Taichung 413, Taiwan; [Lien, Huang-Chun] Natl Taiwan Univ, Dept Pathol, Taipei 106, Taiwan; [Chang, King-Jen] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 106, Taiwan; [Chang, King-Jen] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 106, Taiwan; [Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Sahin, Aysegul A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Muller, William J.] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Muller, William J.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of California System; University of California Davis; Asia University Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; University of Texas System; UTMD Anderson Cancer Center; McGill University; McGill University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mhung@mdanderson.org	Hsiao, Chwan-Deng/AAZ-8869-2021; Tsai, Fuu-Jen/J-4140-2015; Cheng, Xiaoyun/HDM-5535-2022; Huang, Wei-Chien/D-1740-2012; Hung, Mien-Chie/ABD-5911-2021; /AGZ-4617-2022; Huang, Wei-Chien/H-3126-2019	Hsiao, Chwan-Deng/0000-0002-7012-1532; Huang, Wei-Chien/0000-0001-6467-8716; Hung, Mien-Chie/0000-0003-4317-4740; /0000-0002-7133-8266; Huang, Wei-Chien/0000-0001-6467-8716; Li, Long-Yuan/0000-0001-7472-8318; Yu, Dihua/0000-0001-6231-9381; Chang, King jen/0000-0001-9811-3422; LIEN, HUANG-CHUN/0000-0003-1472-1231; Lee, Dung-Fang/0000-0003-2387-597X; Chang, Chunju/0000-0003-2887-9603	NATIONAL CANCER INSTITUTE [P50CA116199, P30CA016672, P01CA099031, R01CA109311] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA099031, P30 CA016672, P50 CA116199, R01 CA109311, CA116199, P01 CA099031-01, CA16672, P50 CA116199-01, P01 CA 099031, P01 CA099031-010001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hu Mickey C-T, 2005, Future Oncol, V1, P67, DOI 10.1517/14796694.1.1.67; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Phelps M, 2005, J BIOL CHEM, V280, P16651, DOI 10.1074/jbc.M412334200; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Scholl FA, 2005, CANCER LETT, V230, P1, DOI 10.1016/j.canlet.2004.12.013; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Terry DE, 2004, J AM SOC MASS SPECTR, V15, P784, DOI 10.1016/j.jasms.2004.02.005; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; TRAN H, 2003, SCI STKE RE, V5; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINBERG RA, 1984, BLOOD, V64, P1143; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang JY, 2006, INT J ONCOL, V29, P643; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	41	501	524	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					138	U22		10.1038/ncb1676	http://dx.doi.org/10.1038/ncb1676			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18204439	Green Accepted			2022-12-27	WOS:000252897800009
J	Ng, RK; Gurdon, JB				Ng, Ray Kit; Gurdon, J. B.			Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription	NATURE CELL BIOLOGY			English	Article							CELL; METHYLATION; EXPRESSION; VARIANTS; LYSINE-4; POLYCOMB; CAPACITY	The remarkable stability of gene expression in somatic cells is exemplified by the way memory of an active gene state is retained when an endoderm cell nucleus is transplanted to an enucleated egg(1). Here we analyse the mechanism of a similar example of epigenetic memory. We find that memory can persist through 24 cell divisions in the absence of transcription and applies to the expression of the myogenic gene MyoD in non-muscle cell lineages of nuclear transplant embryos. We show that memory is not explained by the methylation of promoter DNA. However, we demonstrate that epigenetic memory correlates with the association of histone H3.3 with the MyoD promoter in embryos that display memory but not in those where memory has been lost. The association of a mutated histone H3.3 ( H3.3 E4, which lacks the methylatable H3.3 lysine 4) with promoter DNA eliminates memory, indicating a requirement of H3.3 K4 for memory. We also show that overexpression of H3.3 can enhance memory in transplanted nuclei. We therefore conclude that the association of histone H3.3 with the MyoD promoter makes a necessary contribution to this example of memory. Hence, we suggest that epigenetic memory helps to stabilize gene expression in normal development; it might also help to account for the inefficient reprogramming in some transplanted nuclei.	[Ng, Ray Kit; Gurdon, J. B.] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Ng, Ray Kit; Gurdon, J. B.] Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England	University of Cambridge	Gurdon, JB (corresponding author), Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	j.gurdon@gurdon.cam.ac.uk		GURDON, JOHN/0000-0002-5621-3799	Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Feng YQ, 2006, PLOS GENET, V2, P461, DOI 10.1371/journal.pgen.0020065; GEHRING WJ, 1978, GENETICS BIOL DROS C, V2, P511; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; HADORN E, 1965, BROOKHAVEN SYM BIOL, P148; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Stewart MD, 2006, MOL CELL BIOL, V26, P6890, DOI 10.1128/MCB.00948-06; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	30	239	248	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					102	U83		10.1038/ncb1674	http://dx.doi.org/10.1038/ncb1674			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066050				2022-12-27	WOS:000252116100018
J	Gaggioli, C; Hooper, S; Hidalgo-Carcedo, C; Grosse, R; Marshall, JF; Harrington, K; Sahai, E				Gaggioli, Cedric; Hooper, Steven; Hidalgo-Carcedo, Cristina; Grosse, Robert; Marshall, John F.; Harrington, Kevin; Sahai, Erik			Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells	NATURE CELL BIOLOGY			English	Article							STROMAL FIBROBLASTS; TENASCIN-C; RHO; CANCER; MIGRATION; PHOSPHORYLATION; MYOFIBROBLASTS; MELANOMA; CULTURE; GROWTH	Imaging of collectively invading cocultures of carcinoma cells and stromal fibroblasts reveals that the leading cell is always a fibroblast and that carcinoma cells move within tracks in the extracellular matrix behind the fibroblast. The generation of these tracks by fibroblasts is sufficient to enable the collective invasion of the squamous cell carcinoma ( SCC) cells and requires both protease- and force-mediated matrix remodelling. Force-mediated matrix remodelling depends on integrins alpha 3 and alpha 5, and Rho-mediated regulation of myosin light chain ( MLC) activity in fibroblasts, but these factors are not required in carcinoma cells. Instead, carcinoma cells use Cdc42 and MRCK ( myotonic dystrophy kinase-related CDC42-binding protein kinases) mediated regulation of MLC to follow the tracks generated by fibroblasts.	Canc Res UK London Res Inst, London WC2A 3PX, England; Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Barts & London Med & Dent Sch, Queen Marys Coll, Canc Res UK Clin Ctr, Tumour Biol Ctr, London EC1M 6BQ, England; Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, Chester Beatty Labs, London SW3 6JB, England	Cancer Research UK; Ruprecht Karls University Heidelberg; Cancer Research UK; University of London; Queen Mary University London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Sahai, E (corresponding author), Canc Res UK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Erik.Sahai@cancer.org.uk	Gaggioli, Cedric/F-3658-2011; Gaggioli, Cedric/Q-2642-2019; hidalgo carcedo, cristina/M-6908-2015; Hidalgo-Carcedo, Cristina/K-8876-2017; gaggioli, cedric/L-5363-2019	Gaggioli, Cedric/0000-0002-4710-1605; Gaggioli, Cedric/0000-0002-4710-1605; hidalgo carcedo, cristina/0000-0003-3571-2449; Hidalgo-Carcedo, Cristina/0000-0003-3571-2449; Sahai, Erik/0000-0002-3932-5086; Marshall, John/0000-0002-0494-2295; Harrington, Kevin/0000-0002-6014-348X; Grosse, Robert/0000-0002-3380-5273				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Costea DE, 2006, AM J PATHOL, V168, P1889, DOI 10.2353/ajpath.2006.050843; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Cukierman Edna, 2004, V294, P79; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; DICOSTANZO D, 1990, AM J SURG PATHOL, V14, P12, DOI 10.1097/00000478-199001000-00002; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Kaarianen E, 2006, J PATHOL, V210, P181, DOI 10.1002/path.2045; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; Mackenzie IC, 2004, J ORAL PATHOL MED, V33, P71, DOI 10.1111/j.1600-0714.2004.00157.x; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M	32	1023	1048	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1392	U92		10.1038/ncb1658	http://dx.doi.org/10.1038/ncb1658			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037882				2022-12-27	WOS:000251317300012
J	Dong, YM; VandenBeldt, KJ; Meng, X; Khodjakov, A; McEwen, BF				Dong, Yimin; VandenBeldt, Kristin J.; Meng, Xing; Khodjakov, Alexey; McEwen, Bruce F.			The outer plate in vertebrate kinetochores is a flexible network with multiple microtubule interactions	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST; COMPLEX; ATTACHMENT; SPINDLE; CELLS; ARCHITECTURE; DYNAMICS; ORIENTATION; CENTROMERES; TOMOGRAPHY	Intricate interactions between kinetochores and microtubules are essential for the proper distribution of chromosomes during mitosis. A crucial long-standing question is how vertebrate kinetochores generate chromosome motion while maintaining attachments to the dynamic plus ends of the multiple kinetochore MTs (kMTs) in a kinetochore fibre. Here, we demonstrate that individual kMTs in PtK1 cells are attached to the kinetochore outer plate by several fibres that either embed the microtubule plus- end tips in a radial mesh, or extend out from the outer plate to bind microtubule walls. The extended fibres also interact with the walls of nearby microtubules that are not part of the kinetochore fibre. These structural data, in combination with other recent reports, support a network model of kMT attachment wherein the fibrous network in the unbound outer plate, including the Hec1-Ndc80 complex, dissociates and rearranges to form kMT attachments.	SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	McEwen, BF (corresponding author), SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA.	bruce.mcewen@wadsworth.org			NCRR NIH HHS [P41 RR01219, P41 RR001219] Funding Source: Medline; NIGMS NIH HHS [R01 GM059363, GM59363, R01 GM06627, R01 GM066270-05A1, R01 GM059363-09, R01 GM066270] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363, R01GM066270] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; McEwen BF, 2002, J STRUCT BIOL, V138, P47, DOI 10.1016/S1047-8477(02)00020-5; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	32	101	104	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					516	U56		10.1038/ncb1576	http://dx.doi.org/10.1038/ncb1576			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17435749	Green Accepted			2022-12-27	WOS:000246181500009
J	Cowan, CR; Hyman, AA				Cowan, Carrie R.; Hyman, Anthony A.			Cyclin E-Cdk2 temporally regulates centrosome assembly and establishment of polarity in Caenorhabditis elegans embryos	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; C-ELEGANS; PAR PROTEINS; S-PHASE; POLARIZATION; DUPLICATION; PROGRESSION; ZYGOTE; INTERFERENCE; CYTOSKELETON	Establishment of polarity in C. elegans embryos is dependent on the centrosome(1). The sperm contributes a pair of centrioles to the egg and these centrioles remain incapable of polarizing the cortex while the egg completes meiosis. Coincident with the establishment of polarity, the centrioles recruit centrosomal proteins(1), several of which are required for polarity(1-3), suggesting that the temporal regulation of centrosome assembly may control the initiation of polarization. We found that cyclin E-Cdk2 is required for the establishment of polarity. Cyclin E-Cdk2 controls the recruitment of centrosomal proteins specifically at the time of polarity establishment. Cyclin E is required for several examples of asymmetric cell division and fate determination in C. elegans and Drosophila(4-6). Here, we suggest a possible mechanism for cyclin E-Cdk2-dependent differentiation: the establishment of cortical polarity by the centrosome.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Cowan, CR (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	cowan@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Cowan, Carrie/0000-0002-2867-1733				Balczon R, 2002, CELL MOTIL CYTOSKEL, V52, P183, DOI 10.1002/cm.10043; Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Bhat KM, 2004, DEVELOPMENT, V131, P1123, DOI 10.1242/dev.01014; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fay DS, 2005, SEMIN CELL DEV BIOL, V16, P397, DOI 10.1016/j.semcdb.2005.02.002; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Hird S, 1996, J CELL SCI, V109, P525; Kamath R.S., 2001, GENOME BIOL, V2; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Koreth J, 2005, ONCOGENE, V24, P2756, DOI 10.1038/sj.onc.1208607; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Liu J, 2000, MOL BIOL EVOL, V17, P1061, DOI 10.1093/oxfordjournals.molbev.a026387; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; SEYDOUX G, 1993, DEV BIOL, V157, P423, DOI 10.1006/dbio.1993.1146; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tilmann C, 2005, DEV CELL, V9, P489, DOI 10.1016/j.devcel.2005.09.004; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	42	54	74	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1441	U82		10.1038/ncb1511	http://dx.doi.org/10.1038/ncb1511			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115027				2022-12-27	WOS:000242419800021
J	Di Marcotullio, L; Ferretti, E; Greco, A; De Smaele, E; Po, A; Sico, MA; Alimandi, M; Giannini, G; Maroder, M; Screpanti, I; Gulino, A				Di Marcotullio, Lucia; Ferretti, Elisabetta; Greco, Azzura; De Smaele, Enrico; Po, Agnese; Sico, Maria Anna; Alimandi, Maurizio; Giannini, Giuseppe; Maroder, Marella; Screpanti, Isabella; Gulino, Alberto			Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch- dependent ubiquitination	NATURE CELL BIOLOGY			English	Article							PROGENITOR-CELL MAINTENANCE; SONIC HEDGEHOG; ASYMMETRIC DIVISION; MOUSE MODEL; STEM-CELLS; PROTEIN; PROLIFERATION; NOTCH; EXPRESSION; DIFFERENTIATION	The developmental protein Numb is a major determinant of binary cell fates(1-3). It is also required for the differentiation of cerebellar granule cell progenitors (GCPs)(4) at a stage of development responsive to the morphogenic glycoprotein Hedehog(5,6). Hedgehog signalling is crucial for the physiological maintenance and self-renewal of neural stem cells and its deregulation is responsible for their progression towards tumorigenesis(5,7-11). The mechanisms that inhibit this pathway during the differentiation stage are poorly understood. Here, we identify Numb as a Hedgehog-pathway inhibitor that is downregulated in early GCPs and GCP-derived cancer cells. We demonstrate that the Hedgehog transcription factor Gli1 is targeted by Numb for Itch-dependent ubiquitination, which suppresses Hedgehog signals, thus arresting growth and promoting cell differentiation. This novel Numb-dependent regulatory loop may limit the extent and duration of Hedgehog signalling during neural-progenitor differentiation, and its subversion may be a relevant event in brain tumorigenesis.	Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00161 Rome, Italy; Neuromed Inst, I-86077 Pozzilli, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Neuromed	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med & Pathol, 324 Viale Regina Elena, I-00161 Rome, Italy.	alberto.gulino@uniroma1.it	Po, Agnese/G-8754-2015; Alimandi, Maurizio/AAG-9246-2019; 高, 雨莉/HGU-8187-2022; De Smaele, Enrico/C-1124-2013; Giannini, Giuseppe/B-5672-2013; Po, Agnese/AEQ-0192-2022; Ferretti, Elisabetta/G-5413-2013	Po, Agnese/0000-0002-9346-8782; Alimandi, Maurizio/0000-0002-1409-6803; De Smaele, Enrico/0000-0003-4524-4423; Giannini, Giuseppe/0000-0003-0299-4056; Po, Agnese/0000-0002-9346-8782; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; Ferretti, Elisabetta/0000-0001-7265-6429	Telethon [GGP04168] Funding Source: Medline	Telethon(Fondazione Telethon)		Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ali-Seyed M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-54; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Argenti B, 2005, J NEUROSCI, V25, P8338, DOI 10.1523/JNEUROSCI.2438-05.2005; Barnes EA, 2005, ONCOGENE, V24, P902, DOI 10.1038/sj.onc.1208240; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Ferretti E, 2005, TRENDS MOL MED, V11, P537, DOI 10.1016/j.molmed.2005.10.005; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shen Q, 2002, DEVELOPMENT, V129, P4843; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	43	225	230	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1415	U68		10.1038/ncb1510	http://dx.doi.org/10.1038/ncb1510			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115028				2022-12-27	WOS:000242419800018
J	Zuo, XF; Zhang, J; Zhang, Y; Hsu, SC; Zhou, DG; Guo, W				Zuo, Xiaofeng; Zhang, Jian; Zhang, Ying; Hsu, Shu-Chan; Zhou, Daoguo; Guo, Wei			Exo70 interacts with the Arp2/3 complex and regulates cell migration	NATURE CELL BIOLOGY			English	Article							EXOCYST COMPLEX; ACTIN; PROTEIN; LAMELLIPODIA; CYTOSKELETON; MEMBRANE; REGIONS; RHO	The exocyst is a multiprotein complex essential for tethering secretory vesicles to specific domains of the plasma membrane for exocytosis(1-3). Here, we report that the exocyst component Exo70 interacts with the Arp2/3 complex, a key regulator of actin polymerization(4,5). We further show that the exocyst Arp2/3 interaction is regulated by epidermal growth factor (EGF) signalling. Inhibition of Exo70 by RNA interference (RNAi) or antibody microinjection blocks the formation of actin-based membrane protrusions and affects various aspects of cell motility. We propose that Exo70, in addition to functioning in exocytosis, also regulates actin at the leading edges of migrating cells, therefore coordinating cytoskeleton and membrane traffic during cell migration.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Pennsylvania; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rutgers State University New Brunswick	Guo, W (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	guowei@sas.upenn.edu						Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Wang S, 2004, J BIOL CHEM, V279, P35958, DOI 10.1074/jbc.M313778200; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Xu KF, 2005, P NATL ACAD SCI USA, V102, P2784, DOI 10.1073/pnas.0409871102	17	138	143	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1383	U38		10.1038/ncb1505	http://dx.doi.org/10.1038/ncb1505			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17086175				2022-12-27	WOS:000242419800014
J	Gutierrez, GJ; Vogtlin, A; Castro, A; Ferby, I; Salvagiotto, G; Ronai, Z; Lorca, T; Nebreda, AR				Gutierrez, Gustavo J.; Voegtlin, Andrea; Castro, Ana; Ferby, Ingvar; Salvagiotto, Giorgia; Ronai, Ze'ev; Lorca, Thierry; Nebreda, Angel R.			Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B1 PRECURSOR PROTEIN; CELL-CYCLE REGULATOR; SOMATIC WEE1; XENOPUS; KINASE; PHOSPHORYLATION; TRANSLATION; PROTEOLYSIS; PROGRESSION; EXPRESSION	Xenopus RINGO/Speedy (XRINGO) is a potent inducer of oocyte meiotic maturation that can directly activate Cdk1 and Cdk2. Here, we show that endogenous XRINGO protein accumulates transiently during meiosis I entry and then is downregulated. This tight regulation of XRINGO expression is the consequence of two interconnected mechanisms: processing and degradation. XRINGO processing involves recognition of at least three distinct phosphorylated recognition motifs by the SCF beta TrCP ubiquitin ligase, followed by proteasome-mediated limited degradation, resulting in an amino-terminal XRINGO fragment. XRINGO processing is directly stimulated by several kinases, including protein kinase A and glycogen synthase kinase-3 beta, and may contribute to the maintenance of G2 arrest. On the other hand, XRINGO degradation after meiosis I is mediated by the ubiquitin ligase Siah-2, which probably requires phosphorylation of XRINGO on Ser 243 and may be important for the omission of S phase at the meiosis-I-meiosis-II transition in Xenopus oocytes.	EMBL, D-69117 Heidelberg, Germany; BIMR, La Jolla, CA 92037 USA; Univ Zurich, Fac Vet Med, Inst Virol, CH-8057 Zurich, Switzerland; CNRS, CRBM, F-34096 Montpellier, France; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Inst Mol Pathol, A-1030 Vienna, Austria; Spanish Natl Canc Ctr, CNIO, E-28029 Madrid, Spain	European Molecular Biology Laboratory (EMBL); University of Zurich; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centro Nacional de Investigaciones Oncologicas (CNIO)	Nebreda, AR (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gustavo@burnham.org; anebreda@cnio.es	Gutierrez, Gustavo/AAO-9957-2021; Ferby, Ingvar/B-7895-2008; Nebreda, Angel Rodriguez/R-9594-2019; CASTRO, ANNA/F-4350-2010; Gutierrez, Gustavo/B-6771-2013	Gutierrez, Gustavo/0000-0001-8652-972X; CASTRO, ANNA/0000-0002-3655-1352; Gutierrez, Gustavo/0000-0003-4133-5002; Lorca, Thierry/0000-0003-2007-8924; Ferby, Ingvar/0000-0002-3435-1728; RONAI, ZEEV/0000-0002-3859-0400	NATIONAL CANCER INSTITUTE [R01CA111515, R01CA078419] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bogdan S, 2001, MECH DEVELOP, V103, P61, DOI 10.1016/S0925-4773(01)00332-X; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Cheng Aiyang, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-19; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DELLA NG, 1995, CELL TISSUE RES, V279, P411, DOI 10.1007/s004410050298; Dinarina A, 2005, BIOCHEM J, V386, P349, DOI 10.1042/BJ20041779; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; MACKETT M, 1990, NUCLEIC ACIDS RES, V18, P1082, DOI 10.1093/nar/18.4.1082; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Nebreda AR, 2006, CURR OPIN CELL BIOL, V18, P192, DOI 10.1016/j.ceb.2006.01.001; NEWPORT JW, 1984, CELL, V37, P731, DOI 10.1016/0092-8674(84)90409-4; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perez LH, 2002, NAT CELL BIOL, V4, P737, DOI 10.1038/ncb850; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Schmitt A, 2002, P NATL ACAD SCI USA, V99, P4361, DOI 10.1073/pnas.022056399; SPEVAK W, 1993, MOL CELL BIOL, V13, P4953, DOI 10.1128/MCB.13.8.4953; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102	42	39	42	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1084	U75		10.1038/ncb1472	http://dx.doi.org/10.1038/ncb1472			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16964245				2022-12-27	WOS:000241395300012
J	Okada, Y; Jiang, Q; Lemieux, M; Jeannotte, L; Su, LS; Zhang, Y				Okada, Yuki; Jiang, Qi; Lemieux, Margot; Jeannotte, Lucie; Su, Lishan; Zhang, Yi			Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L	NATURE CELL BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; U937 CELL-LINE; HEMATOPOIETIC PROGENITORS; LEUCINE-ZIPPER; MLL; EXPRESSION; AF10; GENE; LEUKEMOGENESIS; CLATHRIN	Chromosomal translocation is a common cause of leukaemia(1) and the most common chromosome translocations found in leukaemia patients involve the mixed lineage leukaemia (MLL) gene(2,3). AF10 is one of more than 30 MLL fusion partners in leukaemia(4). We have recently demonstrated that the H3K79 methyltransferase hDOT1L contributes to MLL-AF10-mediated leukaemogenesis through its interaction with AF10 (ref. 5). In addition to MLL, AF10 has also been reported to fuse to CALM (clathrin-assembly protein-like lymphoid-myeloid) in patients with T-cell acute lymphoblastic leukaemia (T-ALL) and acute myeloid leukaemia (AML)(6,7). Here, we analysed the molecular mechanism of leukaemogenesis by CALM-AF10. We demonstrate that CALM-AF10 fusion is both necessary and sufficient for leukaemic transformation. Additionally, we provide evidence that hDOT1L has an important role in the transformation process. hDOT1L contributes to CALM-AF10-mediated leukaemic transformation by preventing nuclear export of CALM-AF10 and by upregulating the Hoxa5 gene through H3K79 methylation. Thus, our study establishes CALM-AF10 fusion as a cause of leukaemia and reveals that mistargeting of hDOT1L and upregulation of Hoxa5 through H3K79 methylation is the underlying mechanism behind leukaemia caused by CALM-AF10 fusion.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Ctr Rechg Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Laval University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Jeannotte, Lucie/0000-0001-5578-420X; Zhang, Yi/0000-0002-2789-0811	NHLBI NIH HHS [R21 HL072240, HL72240] Funding Source: Medline; NIAID NIH HHS [R01 AI080432, AI48407, R01 AI048407, R01 AI077454, R56 AI048407] Funding Source: Medline; NIGMS NIH HHS [GM68804, R01 GM068804] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL072240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077454, R56AI048407, R01AI080432, R01AI048407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Carlson KM, 2000, LEUKEMIA, V14, P100, DOI 10.1038/sj.leu.2401629; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Dik WA, 2005, LEUKEMIA, V19, P1948, DOI 10.1038/sj.leu.2403891; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Dreyling MH, 1998, BLOOD, V91, P4662; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Kobayashi H, 1997, GENE CHROMOSOME CANC, V20, P253, DOI 10.1002/(SICI)1098-2264(199711)20:3<253::AID-GCC5>3.0.CO;2-1; KOBAYASHI H, 1995, GENE CHROMOSOME CANC, V13, P217, DOI 10.1002/gcc.2870130312; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	24	150	153	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1017	U105		10.1038/ncb1464	http://dx.doi.org/10.1038/ncb1464			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16921363	Green Accepted, Green Published			2022-12-27	WOS:000240241700019
J	Gauss, R; Jarosch, E; Sommer, T; Hirsch, C				Gauss, Robert; Jarosch, Ernst; Sommer, Thomas; Hirsch, Christian			A complex of Yos9p and the HRD ligase integrates endoplasmic reticulum quality control into the degradation machinery	NATURE CELL BIOLOGY			English	Article							ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; MISFOLDED GLYCOPROTEINS; SACCHAROMYCES-CEREVISIAE; YEAST GENES; TRANSPORT; VERSATILE; GLYCANS; MODULES; LECTIN	quality-control system surveys the lumen of the endoplasmic reticulum for terminally misfolded proteins. Polypeptides singled out by this system are ultimately degraded by the cytosolic ubiquitin-proteasome pathway. Key components of both the endoplasmic reticulum quality-control system and the degradation machinery have been identified, but a connection between the two systems has remained elusive. Here, we report an association between the endoplasmic reticulum quality-control lectin Yos9p and Hrd3p, a component of the ubiquitin-proteasome system that links these pathways. We identify designated regions in the luminal domain of Hrd3p that interact with Yos9p and the ubiquitin ligase Hrd1p. Binding of misfolded proteins occurs through Hrd3p, suggesting that Hrd3p recognises proteins that deviate from their native conformation, whereas Yos9p ensures that only terminally misfolded polypeptides are degraded.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sommer, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	tsommer@mdc-berlin.de		Jarosch, Ernst/0000-0002-5897-3492				Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; GUELMAN R, 2002, BONE, V30, P23; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hitt R, 2004, FEMS YEAST RES, V4, P815, DOI 10.1016/j.femsyr.2004.04.002; Jakob CA, 2001, EMBO REP, V2, P423; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Plemper RK, 1999, J CELL SCI, V112, P4123; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015	28	181	184	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					849	U102		10.1038/ncb1445	http://dx.doi.org/10.1038/ncb1445			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16845381				2022-12-27	WOS:000239423000015
J	Asanuma, K; Yanagida-Asanuma, E; Faul, C; Tomino, Y; Kim, K; Mundel, P				Asanuma, K; Yanagida-Asanuma, E; Faul, C; Tomino, Y; Kim, K; Mundel, P			Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling	NATURE CELL BIOLOGY			English	Article							BIOLOGY; PROTEIN; GTPASES; DEGRADATION; PLASTICITY; PODOCYTES; POLARITY	The Rho family of small GTPases (RhoA, Rac1 and Cdc42) controls signal-transduction pathways that influence many aspects of cell behaviour, including cytoskeletal dynamics(1-3). At the leading edge, Rac1 and Cdc42 promote cell motility through the formation of lamellipodia and filopodia, respectively. On the contrary, RhoA promotes the formation of contractile actin-myosin-containing stress fibres in the cell body and at the rear(1,2,4). Here, we identify synaptopodin, an actin-associated protein, as a novel regulator of RhoA signalling and cell migration in kidney podocytes. We show that synaptopodin induces stress fibres by competitive blocking of Smurf1-mediated ubiquitination of RhoA, thereby preventing the targeting of RhoA for proteasomal degradation. Gene silencing of synaptopodin in kidney podocytes causes the loss of stress fibres and the formation of aberrant non-polarized filopodia and impairment of cell migration. Together, these data show that synaptopodin is essential for the integrity of the podocyte actin cytoskeleton and for the regulation of podocyte cell migration.	Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Juntendo Univ, Sch Med, Dept Internal Med, Tokyo 1138421, Japan	Icahn School of Medicine at Mount Sinai; Juntendo University	Mundel, P (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	peter.mundel@mssm.edu	Faul, Christian/D-1549-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683, P50DK064236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018886] Funding Source: NIH RePORTER; NIDA NIH HHS [DA18886] Funding Source: Medline; NIDDK NIH HHS [DK064236, DK57683] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2003, SCIENCE, V302, P1690, DOI 10.1126/science.1092874; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772	16	309	343	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					485	U109		10.1038/ncb1400	http://dx.doi.org/10.1038/ncb1400			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622418				2022-12-27	WOS:000237299400012
J	Azuara, V; Perry, P; Sauer, S; Spivakov, M; Jorgensen, HF; John, RM; Gouti, M; Casanova, M; Warnes, G; Merkenschlager, M; Fisher, AG				Azuara, V; Perry, P; Sauer, S; Spivakov, M; Jorgensen, HF; John, RM; Gouti, M; Casanova, M; Warnes, G; Merkenschlager, M; Fisher, AG			Chromatin signatures of pluripotent cell lines	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; SELF-RENEWAL; REPLICATION; DIFFERENTIATION; METHYLATION; GENOME; GENES; ESTABLISHMENT; TRANSCRIPTION	Epigenetic genome modifications are thought to be important for specifying the lineage and developmental stage of cells within a multicellular organism. Here, we show that the epigenetic profile of pluripotent embryonic stem cells (ES) is distinct from that of embryonic carcinoma cells, haematopoietic stem cells (HSC) and their differentiated progeny. Silent, lineage-specific genes replicated earlier in pluripotent cells than in tissue-specific stem cells or differentiated cells and had unexpectedly high levels of acetylated H3K9 and methylated H3K4. Unusually, in ES cells these markers of open chromatin were also combined with H3K27 trimethylation at some non-expressed genes. Thus, pluripotency of ES cells is characterized by a specific epigenetic profile where lineage-specific genes may be accessible but, if so, carry repressive H3K27 trimethylation modifications. H3K27 methylation is functionally important for preventing expression of these genes in ES cells as premature expression occurs in embryonic ectoderm development (Eed)-deficient ES cells. Our data suggest that lineage-specific genes are primed for expression in ES cells but are held in check by opposing chromatin modifications.	Imperial Coll Sch Med, Hammersmith Hosp, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; Imperial Coll Sch Med, Hammersmith Hosp, MRC Clin Sci Ctr, Dev Epigenet Grp, London W12 0NN, England; Canc Res UK, FACS Lab, London WC2A 3PX, England	Imperial College London; Imperial College London; Cancer Research UK	Azuara, V (corresponding author), Imperial Coll Sch Med, Hammersmith Hosp, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England.	v.azuara@imperial.ac.uk; amanda.fisher@csc.mrc.ac.uk	Gouti, Mina/D-3235-2018; John, Rosalind M/A-4491-2010; John, Ros/AAF-4229-2022; Warnes, Gary/I-1110-2019; John, Ros/AFI-8619-2022; John, Rosalind/AAQ-8221-2021	Gouti, Mina/0000-0001-7422-1605; John, Rosalind M/0000-0002-3827-7617; John, Ros/0000-0002-3827-7617; Warnes, Gary/0000-0001-7614-6266; John, Ros/0000-0002-3827-7617; Jorgensen, Helle/0000-0002-7909-2977; Merkenschlager, Matthias/0000-0003-2889-3288; Spivakov, Mikhail/0000-0002-0383-3943; Azuara, Veronique/0000-0003-4608-3713; Casanova, Miguel/0000-0001-8622-6550	Medical Research Council [MC_U120027516] Funding Source: Medline; Parkinson&apos;s UK [G-4045] Funding Source: Medline; MRC [MC_U120027516] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Evans M, 2002, CR BIOL, V325, P1003, DOI 10.1016/S1631-0691(02)01527-5; Evsikov AV, 2003, SCIENCE, V302; Faust C, 1998, DEVELOPMENT, V125, P4495; Fortunel NO, 2003, SCIENCE, V302, P393; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gomez M, 2004, P NATL ACAD SCI USA, V101, P6923, DOI 10.1073/pnas.0401854101; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; Hiratani I, 2004, P NATL ACAD SCI USA, V101, P16861, DOI 10.1073/pnas.0406687101; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Lin CM, 2003, CURR BIOL, V13, P1019, DOI 10.1016/S0960-9822(03)00382-8; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Perry P, 2004, CELL CYCLE, V3, P1645; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel G, 2003, SCIENCE, V302, P371; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150	37	1003	1037	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					532	U189		10.1038/ncb1403	http://dx.doi.org/10.1038/ncb1403			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16570078				2022-12-27	WOS:000237299400018
J	Foltz, DR; Jansen, LET; Black, BE; Bailey, AO; Yates, JR; Cleveland, DW				Foltz, DR; Jansen, LET; Black, BE; Bailey, AO; Yates, JR; Cleveland, DW			The human CENP-A centromeric nucleosome-associated complex	NATURE CELL BIOLOGY			English	Article							CHROMOSOME SEGREGATION; MICROTUBULE CAPTURE; BUDDING YEAST; PROTEIN; CHROMATIN; KINETOCHORE; DNA; COMPONENT; CELLS; TRANSCRIPTION	The basic element for chromosome inheritance, the centromere, is epigenetically determined in mammals. The prime candidate for specifying centromere identity is the array of nucleosomes assembled with CENP-A, the centromere-specific histone H3 variant. Here, we show that CENP-A nucleosomes directly recruit a proximal CENP-A nucleosome associated complex (NAC) comprised of three new human centromere proteins (CENP-M, CENP-N and CENP-T), along with CENP-U(50), CENPC and CENP-H. Assembly of the CENP-A NAC at centromeres is dependent on CENP-M, CENP-N and CENP-T. Facilitates chromatin transcription (FACT) and nucleophosmin-1 (previously implicated in transcriptional chromatin remodelling and as a multifunctional nuclear chaperone, respectively) are absent from histone H3-containing nucleosomes, but are stably recruited to CENP-A nucleosomes independent of CENP-A NAC. Seven new CENP-A-nucleosome distal (CAD) centromere components (CENP-K, CENP-L, CENP-O, CENP-P, CENP-Q, CENP-R and CENP-S) are identified as assembling on the CENP-A NAC. The CENP-A NAC is essential, as disruption of the complex causes errors of chromosome alignment and segregation that preclude cell survival despite continued centromere-derived mitotic checkpoint signalling.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Bailey, Aaron/ABB-8522-2021; Cleveland, Don/AAN-9783-2021	Bailey, Aaron/0000-0001-8063-3032; Cleveland, Don/0000-0002-1934-3682; Jansen, Lars/0000-0002-2158-0345	NCRR NIH HHS [RR11823] Funding Source: Medline; NIGMS NIH HHS [GM 29513] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bierie B, 2004, GENE EXPR PATTERNS, V4, P389, DOI 10.1016/j.modgep.2004.01.008; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; CHEESEMAN IM, 2005, SCI STKE; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Yoda K, 2004, METHOD ENZYMOL, V375, P253; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	49	521	559	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					458	U77		10.1038/ncb1397	http://dx.doi.org/10.1038/ncb1397			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622419				2022-12-27	WOS:000237299400009
J	Angers, S; Thorpe, CJ; Biechele, TL; Goldenberg, SJ; Zheng, N; MacCoss, MJ; Moon, RT				Angers, S; Thorpe, CJ; Biechele, TL; Goldenberg, SJ; Zheng, N; MacCoss, MJ; Moon, RT			The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation	NATURE CELL BIOLOGY			English	Article							SUBSTRATE ADAPTER PROTEIN; CUL3-BASED E3 LIGASE; SIGNAL-TRANSDUCTION; XENOPUS DEVELOPMENT; VERTEBRATE EMBRYOS; CELL-POLARITY; BTB PROTEINS; LUNG-CANCER; COMPLEX; KEAP1	Dishevelled is a conserved protein that interprets signals received by Frizzled receptors. Using a tandem-affinity purification strategy and mass spectrometry we have identified proteins associated with Dishevelled, including a Cullin-3 ubiquitin ligase complex containing the Broad Complex, Tramtrack and Bric a Brac (BTB) protein Kelch-like 12 (KLHL12). This E3 ubiquitin ligase complex is recruited to Dishevelled in a Wnt-dependent manner that promotes its poly-ubiquitination and degradation. Functional analyses demonstrate that regulation of Dishevelled by this ubiquitin ligase antagonizes the Wnt-beta-catenin pathway in cultured cells, as well as in Xenopus and zebrafish embryos. Considered with evidence that the distinct Cullin-1 based SCF beta-TrCP complex regulates beta-catenin stability, our data on the stability of Dishevelled demonstrates that two distinct ubiquitin ligase complexes regulate the Wnt-beta-catenin pathway.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moon, RT (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Moon, Randall/M-5605-2019; 高, 雨莉/HGU-8187-2022; Moon, Randall T/B-1743-2014; Angers, Stephane/E-1432-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Angers, Stephane/0000-0001-7241-9044	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR011823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Choi J, 2004, J BIOL CHEM, V279, P49188, DOI 10.1074/jbc.M404655200; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Ratcliffe MJ, 2000, J BIOL CHEM, V275, P35680, DOI 10.1074/jbc.C000639200; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	48	291	303	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					348	U16		10.1038/ncb1381	http://dx.doi.org/10.1038/ncb1381			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16547521				2022-12-27	WOS:000236560000013
J	Rosales-Nieves, AE; Johndrow, JE; Keller, LC; Magie, CR; Pinto-Santini, DM; Parkhurst, SM				Rosales-Nieves, AE; Johndrow, JE; Keller, LC; Magie, CR; Pinto-Santini, DM; Parkhurst, SM			Coordination of microtubule and microfilament dynamics by Drosophila Rho1, Spire and Cappuccino	NATURE CELL BIOLOGY			English	Article							ACTIN NUCLEATION FACTOR; POSTERIOR; OOCYTE; CYTOSKELETON; FORMINS; GENE; EXPRESSION; FILAMENTS; EMBRYO; MDIA1	The actin-nucleation factors Spire and Cappuccino ( Capu) regulate the onset of ooplasmic streaming in Drosophila melanogaster(1-5). Although this streaming event is microtubule-based, actin assembly is required for its timing. It is not understood how the interaction of microtubules and microfilaments is mediated in this context. Here, we demonstrate that Capu and Spire have microtubule and microfilament crosslinking activity. The spire locus encodes several distinct protein isoforms (SpireA, SpireC and SpireD). SpireD was recently shown to nucleate actin, but the activity of the other isoforms has not been addressed. We find that SpireD does not have crosslinking activity, whereas SpireC is a potent crosslinker. We show that SpireD binds to Capu and inhibits F-actin/microtubule crosslinking, and activated Rho1 abolishes this inhibition, establishing a mechanistic basis for the regulation of Capu and Spire activity. We propose that Rho1, cappuccino and spire are elements of a conserved developmental cassette that is capable of directly mediating crosstalk between microtubules and microfilaments.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Parkhurst, SM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	susanp@fhcrc.org	Rosales-Nieves, Alicia E./ABA-2600-2021	Rosales-Nieves, Alicia E./0000-0001-9119-1604; Parkhurst, Susan/0000-0001-5806-9930	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066847] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066847-02, R01 GM066847-01, R01 GM066847, GM066847, R01 GM066847-04, R01 GM066847-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Magie CR, 1999, DEVELOPMENT, V126, P5353; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Manseau L, 1996, DEVELOPMENT, V122, P2109; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Olson MF, 2003, CURR BIOL, V13, pR360, DOI 10.1016/S0960-9822(03)00277-X; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Ryley DA, 2005, FERTIL STERIL, V83, P1363, DOI 10.1016/j.fertnstert.2004.10.051; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wellington A, 1999, DEVELOPMENT, V126, P5267; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wittmann T, 2001, J CELL SCI, V114, P3795; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	30	112	117	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					367	U47		10.1038/ncb1385	http://dx.doi.org/10.1038/ncb1385			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16518391	Green Accepted			2022-12-27	WOS:000236560000015
J	Zhao, Z; Yu, Y; Meyer, D; Wu, CJ; Shen, WH				Zhao, Z; Yu, Y; Meyer, D; Wu, CJ; Shen, WH			Prevention of early flowering by expression of FLOWERING LOCUS C requires methylation of histone H3K36	NATURE CELL BIOLOGY			English	Article							MADS DOMAIN PROTEIN; RNA-POLYMERASE-II; ARABIDOPSIS-THALIANA; SET DOMAIN; BOX GENE; VERNALIZATION; H3; REPRESSION; REGULATOR; PATHWAYS	Flowering represents a crucial transition from a vegetative to a reproductive phase of the plant life cycle. Despite extensive studies, the molecular mechanisms controlling flowering remain elusive. Although the enzymes involved are unknown, methylation of histone H3 K9 and K27 correlates with repression of FLOWERING LOCUS C (FLC, an essential transcriptional repressor involved in flowering time control in Arabidopsis thaliana; in contrast, methylation of H3K4 correlates with FLC activation(1-4). Here we show that loss-of-function of SET DOMAIN GROUP 8 (SDG 8), which encodes a homologue of the yeast SET2 histone methyltransferase, results in reduced dimethylation of histone H3K36, particularly in chromatin associated with the FLC promoter and the first intron, regions that contain essential cis-elements for transcription. sdg8 mutants display reduced FLC expression and flower early, establishing SDG8-mediated H3K36 methylation as a novel epigenetic memory code required for FLC expression in preventing early flowering. This is the first demonstrated role of H3K36 methylation in eukaryote development.	Univ Louis Pasteur Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Shen, WH (corresponding author), Univ Louis Pasteur Strasbourg, CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	Wen-Hui.Shen@ibmp-ulp.u-strasbg.fr	Zhao, Zhong/N-1999-2013; Shen, Wen Hui/E-7941-2017	Zhao, Zhong/0000-0001-8044-0409; Shen, Wen-Hui/0000-0001-7988-6382				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; BANNISTER AJ, J BIOL CHEM, V280, P17732; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gatz C, 1995, METHOD CELL BIOL, V50, P411, DOI 10.1016/S0091-679X(08)61047-X; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Jackson DP, 1991, MOL PLANT PATHOL, P163; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Oh S, 2004, PLANT CELL, V16, P2940, DOI 10.1105/tpc.104.026062; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yu Y, 2004, PLANT J, V40, P699, DOI 10.1111/j.1365-313X.2004.02240.x; Zhang H, 2002, PLANT J, V31, P663, DOI 10.1046/j.1365-313X.2002.01380.x	29	226	246	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1256	1260		10.1038/ncb1329	http://dx.doi.org/10.1038/ncb1329			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16299497				2022-12-27	WOS:000233748900020
J	Celli, GB; de Lange, T				Celli, GB; de Lange, T			DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion	NATURE CELL BIOLOGY			English	Letter							MAMMALIAN TELOMERES; V(D)J RECOMBINATION; HUMAN-CELLS; LIGASE IV; SENESCENCE; DYSFUNCTION; OVERHANG; COMPLEX; LENGTH; TIN2	Telomere attrition and other forms of telomere damage can activate the ATM kinase pathway. What generates the DNA damage signal at mammalian chromosome ends or at other double- strand breaks is not known. Telomere dysfunction is often accompanied by disappearance of the 3 ' telomeric overhang(1,2), raising the possibility that DNA degradation could generate the structure that signals(2). Here we address these issues by studying telomere structure after conditional deletion of mouse TRF2, the protective factor at telomeres. Upon removal of TRF2 from TRF2(Fl/-) p53(-/-) mouse embryo fibroblasts, a telomere damage response is observed at most chromosome ends. As expected, the telomeres lose the 3 ' overhang and are processed by the non- homologous end- joining pathway. Non-homologous end joining of telomeres was abrogated in DNA ligase IV- deficient ( Lig4(-/-)) cells. Unexpectedly, the telomeres of TRF2(-/-) Lig4(-/-) p53(-/-) cells persisted in a free state without undergoing detectable DNA degradation. Notably, the telomeres retained their 3 ' overhangs, but they were recognized as sites of DNA damage, accumulating the DNA damage response factors 53BP1 and gamma-H2AX, and activating the ATM kinase. Thus, activation of the ATM kinase pathway at chromosome ends does not require overhang degradation or other overt DNA processing.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIGMS NIH HHS [GM49046-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	36	452	464	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					712	U110		10.1038/ncb1275	http://dx.doi.org/10.1038/ncb1275			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15968270				2022-12-27	WOS:000230190800016
J	Sorensen, CS; Hansen, LT; Dziegielewski, J; Syljuasen, RG; Lundin, C; Bartek, J; Helleday, T				Sorensen, CS; Hansen, LT; Dziegielewski, J; Syljuasen, RG; Lundin, C; Bartek, J; Helleday, T			The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; S-PHASE CHECKPOINT; EARLY EMBRYONIC LETHALITY; DNA-DAMAGE CHECKPOINT; RADIOSENSITIZING AGENT; TARGETED DISRUPTION; REPLICATION ARREST; IONIZING-RADIATION; ATR; GENE	The essential checkpoint kinase Chk1 is required for cell-cycle delays after DNA damage or blocked DNA replication(1,2). However, it is unclear whether Chk1 is involved in the repair of damaged DNA. Here we establish that Chk1 is a key regulator of genome maintenance by the homologous recombination repair (HRR) system. Abrogation of Chk1 function with small interfering RNA or chemical antagonists inhibits HRR, leading to persistent unrepaired DNA double-strand breaks (DSBs) and cell death after replication inhibition with hydroxyurea or DNA-damage caused by camptothecin. After hydroxyurea treatment, the essential recombination repair protein RAD51 is recruited to DNA repair foci performing a vital role in correct HRR3,4. We demonstrate that Chk1 interacts with RAD51, and that RAD51 is phosphorylated on Thr 309 in a Chk1-dependent manner. Consistent with a functional interplay between Chk1 and RAD51, Chk1-depleted cells failed to form RAD51 nuclear foci after exposure to hydroxyurea, and cells expressing a phosphorylation-deficient mutant RAD51(T309A) were hypersensitive to hydroxyurea. These results highlight a crucial role for the Chk1 signalling pathway in protecting cells against lethal DNA lesions through regulation of HRR.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Inst Mol Pathol, DK-2100 Copenhagen, Denmark; Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Danish Cancer Society; University of Copenhagen; University of Sheffield; Stockholm University	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; t.helleday@sheffield.ac.uk	Helleday, Thomas/D-5224-2013; Bartek, Jiri/G-5870-2014	Sorensen, Claus/0000-0001-6022-9710; Helleday, Thomas/0000-0002-7384-092X				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Busby EC, 2000, CANCER RES, V60, P2108; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Takai H, 2000, GENE DEV, V14, P1439; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	32	499	519	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					195	U121		10.1038/ncb1212	http://dx.doi.org/10.1038/ncb1212			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15665856				2022-12-27	WOS:000226719500017
J	McKinnell, IW; Ishibashi, J; Le Grand, F; Punch, VGJ; Addicks, GC; Greenblatt, JF; Dilworth, FJ; Rudnicki, MA				McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Greenblatt, Jack F.; Dilworth, F. Jeffrey; Rudnicki, Michael A.			Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex	NATURE CELL BIOLOGY			English	Article							PROGENITOR CELLS; SATELLITE CELLS; H3; RECOGNITION; METHYLATION; DISTINCT; MENIN; MYOD; DIFFERENTIATION; POPULATION	Satellite cells purified from adult skeletal muscle can participate extensively in muscle regeneration and can also re-populate the satellite cell pool, suggesting that they have direct therapeutic potential for treating degenerative muscle diseases(1,2). The paired-box transcription factor Pax7 is required for satellite cells to generate committed myogenic progenitors(3). In this study we undertook a multi-level approach to define the role of Pax7 in satellite cell function. Using comparative microarray analysis, we identified several novel and strongly regulated targets; in particular, we identified Myf5 as a gene whose expression was regulated by Pax7. Using siRNA, fluorescence-activated cell sorting (FACS) and chromatin immunoprecipitation (ChIP) studies we confirmed that Myf5 is directly regulated by Pax7 in myoblasts derived from satellite cells. Tandem affinity purification (TAP) and mass spectrometry were used to purify Pax7 together with its co-factors. This revealed that Pax7 associates with the Wdr5-Ash2L-MLL2 histone methyltransferase (HMT) complex that directs methylation of histone H3 lysine 4 ( H3K4, refs 4-10). Binding of the Pax7-HMT complex to Myf5 resulted in H3K4 tri-methylation of surrounding chromatin. Thus, Pax7 induces chromatin modifications that stimulate transcriptional activation of target genes to regulate entry into the myogenic developmental programme.	[McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Dilworth, F. Jeffrey; Rudnicki, Michael A.] Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [McKinnell, Iain W.; Ishibashi, Jeff; Le Grand, Fabien; Punch, Vincent G. J.; Addicks, Gregory C.; Dilworth, F. Jeffrey; Rudnicki, Michael A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada; [Greenblatt, Jack F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto	Rudnicki, MA (corresponding author), Ottawa Hlth Res Inst, Sprott Ctr Stem Cell Res, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249; Dilworth, F. Jeffrey/0000-0002-6265-8102	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044031, R01 AR044031-12] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Buchberger A, 2007, DEVELOPMENT, V134, P1171, DOI 10.1242/dev.02798; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	34	271	287	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					77	U60		10.1038/ncb1671	http://dx.doi.org/10.1038/ncb1671			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066051	Green Accepted			2022-12-27	WOS:000252116100015
J	Nguyen-Ngoc, T; Afshar, K; Gonczy, P				Nguyen-Ngoc, Tu; Afshar, Katayoun; Goenczy, Pierre			Coupling of cortical dynein and G alpha proteins mediates spindle positioning in Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEINS; MITOTIC SPINDLE; C-ELEGANS; CYTOPLASMIC DYNEIN; FORCE GENERATORS; EMBRYOS; ORIENTATION; NUMA; COMPLEX	Despite being essential for spatial cell division control, the mechanisms governing spindle positioning remain incompletely understood. In the Caenorhabditis elegans one-cell stage embryo, the spindle becomes asymmetrically positioned during anaphase through the action of as-yet unidentified cortical force generators that pull on astral microtubules and that depend on two G alpha proteins and associated proteins(1,2). We performed spindle-severing experiments following temporally restricted gene inactivation and drug exposure, and established that microtubule dynamics and dynein are both required for generating efficient pulling forces. We found that the G alpha-associated proteins GPR-1/2 and LIN-5 interact in vivo with LIS-1, a component of the dynein complex. Moreover, we discovered that the LIN-5, GPR-1/2 and the G alpha proteins promote the presence of the dynein complex at the cell cortex. Our findings suggest a mechanism by which the G alpha proteins enable GPR-1/2 and LIN-5 recruitment to the cortex, thus ensuring the presence of cortical dynein. Together with microtubule dynamics, this allows pulling forces to be exerted and proper cell division to be achieved.	Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1066 Lausanne, Switzerland.	Pierre.Gonczy@isrec.unil.ch		Nguyen-Ngoc, Tu/0000-0001-7574-2947; Gonczy, Pierre/0000-0002-6305-6883				Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cockell MM, 2004, J CELL SCI, V117, P4571, DOI 10.1242/jcs.01344; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Fink G, 2006, EMBO J, V25, P4897, DOI 10.1038/sj.emboj.7601354; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017	35	183	195	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1294	U158		10.1038/ncb1649	http://dx.doi.org/10.1038/ncb1649			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17922003				2022-12-27	WOS:000250659600015
J	Lanzuolo, C; Roure, V; Dekker, J; Bantignies, F; Orlando, V				Lanzuolo, Chiara; Roure, Virginie; Dekker, Job; Bantignies, Frederic; Orlando, Valerio			Polycomb response elements mediate the formation of chromosome higher-order structures in the bithorax complex	NATURE CELL BIOLOGY			English	Article							NUCLEAR REORGANIZATION; RNA INTERFERENCE; GENE-EXPRESSION; GROUP PROTEINS; TRANSCRIPTION; ORGANIZATION; ARCHITECTURE; TRITHORAX; HETEROCHROMATIN; EPIGENOME	In Drosophila, the function of the Polycomb group genes ( PcGs) and their target sequences ( Polycomb response elements ( PREs)) is to convey mitotic heritability of transcription programmes-in particular, gene silencing. As part of the mechanisms involved, PREs are thought to mediate this transcriptional memory function by building up higher-order structures in the nucleus. To address this question, we analysed in vivo the three-dimensional structure of the homeotic locus bithorax complex ( BX-C) by combining chromosome conformation capture (3C) with fluorescent in situ hybridization ( FISH) and FISH immunostaining ( FISH-I) analysis. We found that, in the repressed state, all major elements that have been shown to bind PcG proteins, including PREs and core promoters, interact at a distance, giving rise to a topologically complex structure. We show that this structure is important for epigenetic silencing of the BX-C, as we find that major changes in higher-order structures must occur to stably maintain alternative transcription states, whereas histone modification and reduced levels of PcG proteins determine an epigenetic switch that is only partially heritable.	Dulbecco Telethon Inst, CNR, IGB, I-80131 Naples, Italy; CNRS, Inst Human Genet, UPR 1142, Chromatin & Cell Biol Lab, F-34396 Montpellier, France; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Gene Funct & Expt, Worcester, MA 01605 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Massachusetts System; University of Massachusetts Worcester	Orlando, V (corresponding author), Dulbecco Telethon Inst, CNR, IGB, Via Pietro Castellino 111, I-80131 Naples, Italy.	orlando@igb.cnr.it	Lanzuolo, Chiara/AAB-1037-2019	Lanzuolo, Chiara/0000-0003-2649-6334	NHGRI NIH HHS [HG03143] Funding Source: Medline; Telethon [TCR05001] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Telethon(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lanzuolo C, 2007, CELL MOL LIFE SCI, V64, P1043, DOI 10.1007/s00018-007-6420-8; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	36	225	231	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1167	1174		10.1038/ncb1637	http://dx.doi.org/10.1038/ncb1637			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17828248				2022-12-27	WOS:000249882300012
J	Martindill, DMJ; Risebro, CA; Smart, N; Franco-Viseras, MDM; Rosario, CO; Swallow, CJ; Dennis, JW; Riley, PR				Martindill, David M. J.; Risebro, Catherine A.; Smart, Nicola; Franco-Viseras, Maria Del Mar; Rosario, Carla O.; Swallow, Carol J.; Dennis, James W.; Riley, Paul R.			Nucleolar release of Hand1 acts as a molecular switch to determine cell fate	NATURE CELL BIOLOGY			English	Article							DOMAIN-CONTAINING PROTEIN; HELIX TRANSCRIPTION FACTOR; TROPHOBLAST STEM-CELLS; PLACENTAL DEVELOPMENT; MOUSE EMBRYOS; POLO KINASE; DIFFERENTIATION; LOCALIZATION; FAMILY; EXPRESSION	The bHLH transcription factor Hand1 is essential for placentation and cardiac morphogenesis in the developing embryo. Here we implicate Hand1 as a molecular switch that determines whether a trophoblast stem cell continues to proliferate or commits to differentiation. We identify a novel interaction of Hand1 with a protein that contains an I- mfa ( inhibitor of myogenic factor) domain that anchors Hand1 in the nucleolus where it negatively regulates Hand1 activity. In the trophoblast stem-cell line Rcho-1, nucleolar sequestration of Hand1 accompanies sustained cell proliferation and renewal, whereas release of Hand1 into the nucleus leads to its activation, thus committing cells to a differentiated giant-cell fate. Site-specific phosphorylation is required for nucleolar release of Hand1, for its dimerization and biological function, and this is mediated by the non-canonical polo-like kinase Plk4 ( Sak). Sak is co-expressed in Rcho-1 cells, localizes to the nucleolus during G2 and phosphorylates Hand1 as a requirement for trophoblast stem-cell commitment to a giant-cell fate. This study defines a novel cellular mechanism for regulating Hand1 that is a crucial step in the stem-cell differentiation pathway.	UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of London; University College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Riley, PR (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	P.Riley@ich.ucl.ac.uk	Smart, Nicola/AAN-4011-2020; Smart, Nicola/AAD-3874-2020; Dennis, James/E-7268-2013	Smart, Nicola/0000-0002-3501-7254; 				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Centonze Victoria E., 2004, Biol Proced Online, V6, P78, DOI 10.1251/bpo75; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9; HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390; Hill AA, 2004, MOL CELL BIOL, V24, P9835, DOI 10.1128/MCB.24.22.9835-9847.2004; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Leung GC, 2007, FEBS LETT, V581, P77, DOI 10.1016/j.febslet.2006.11.080; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Ma GT, 2000, BIOL REPROD, V63, P570, DOI 10.1095/biolreprod63.2.570; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Riley PR, 2000, DEV BIOL, V227, P156, DOI 10.1006/dbio.2000.9864; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sahgal N, 2006, METH MOLEC MED, V121, P159; Sahgal N, 2005, DIFFERENTIATION, V73, P452, DOI 10.1111/j.1432-0436.2005.00044.x; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Stark LA, 2005, MOL CELL BIOL, V25, P5985, DOI 10.1128/MCB.25.14.5985-6004.2005; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Thebault S, 2000, EUR J CELL BIOL, V79, P834, DOI 10.1078/0171-9335-00111; Thebault S, 2001, CURR PROTEIN PEPT SC, V2, P155, DOI 10.2174/1389203013381143; Thebault S, 2000, J BIOL CHEM, V275, P4848, DOI 10.1074/jbc.275.7.4848; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	50	59	62	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1131	1141		10.1038/ncb1633	http://dx.doi.org/10.1038/ncb1633			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891141				2022-12-27	WOS:000249882300008
J	Balklava, Z; Pant, S; Fares, H; Grant, BD				Balklava, Zita; Pant, Saumya; Fares, Hanna; Grant, Barth D.			Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic	NATURE CELL BIOLOGY			English	Article							J-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; CELL-POLARITY; C-ELEGANS; N-WASP; VESICULAR TRANSPORT; SPINDLE ORIENTATION; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE	In a genome-wide RNA-mediated interference screen for genes required in membrane traffic-including endocytic uptake, recycling from endosomes to the plasma membrane, and secretion-we identified 168 candidate endocytosis regulators and 100 candidate secretion regulators. Many of these candidates are highly conserved among metazoans but have not been previously implicated in these processes. Among the positives from the screen, we identified PAR-3, PAR-6, PKC-3 and CDC-42, proteins that are well known for their importance in the generation of embryonic and epithelial-cell polarity. Further analysis showed that endocytic transport in Caenorhabditis elegans coelomocytes and human HeLa cells was also compromised after perturbation of CDC-42/Cdc42 or PAR-6/Par6 function, indicating a general requirement for these proteins in regulating endocytic traffic. Consistent with these results, we found that tagged CDC-42/Cdc42 is enriched on recycling endosomes in C. elegans and mammalian cells, suggesting a direct function in the regulation of transport.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Arizona, Dept Mol & Cell Biol, Tucson, AZ 85721 USA	Rutgers State University New Brunswick; University of Arizona	Grant, BD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	grant@biology.rutgers.edu	Balklava, Zita/AAU-6146-2021	Balklava, Zita/0000-0001-9039-9710; Grant, Barth/0000-0002-5943-8336	NIGMS NIH HHS [GM65235, R01 GM067237-05, R01 GM067237, R01 GM067237-06, GM67237] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237, R01GM065235] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; BRENNER S, 1974, GENETICS, V77, P71; BRODSKY FM, 1985, J CELL BIOL, V101, P2055, DOI 10.1083/jcb.101.6.2055; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chang HC, 2004, J CELL BIOL, V164, P1055, DOI 10.1083/jcb.200311084; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Chin WC, 2002, NOVART FDN SYMP, V248, P132; CHIN WC, 2002, NOVART FDN SYMP, V248, P277; CHIN WC, 2002, NOVART FDN SYMP, V248, P141; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cowan CR, 2007, DEVELOPMENT, V134, P1035, DOI 10.1242/dev.000513; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; KUGE O, 1993, J CELL BIOL, V123, P1727, DOI 10.1083/jcb.123.6.1727; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; POTENZA M, 1992, YEAST, V8, P549, DOI 10.1002/yea.320080706; Praitis V, 2001, GENETICS, V157, P1217; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; SATO M, 2005, NAT CELL BIOL; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Soroka CJ, 1999, J BIOL CHEM, V274, P26416, DOI 10.1074/jbc.274.37.26416; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; STENBECK G, 1992, FEBS LETT, V314, P195, DOI 10.1016/0014-5793(92)80973-K; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; Straight SW, 2001, MOL BIOL CELL, V12, P1329, DOI 10.1091/mbc.12.5.1329; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; Weigert R, 2005, METHOD ENZYMOL, V403, P243, DOI 10.1016/S0076-6879(05)03020-X; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011	91	202	217	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1066	U35		10.1038/ncb1627	http://dx.doi.org/10.1038/ncb1627			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17704769				2022-12-27	WOS:000249256500014
J	Miyanari, Y; Atsuzawa, K; Usuda, N; Watashi, K; Hishiki, T; Zayas, M; Bartenschlager, R; Wakita, T; Hijikata, M; Shimotohno, K				Miyanari, Yusuke; Atsuzawa, Kimie; Usuda, Nobuteru; Watashi, Koichi; Hishiki, Takayuki; Zayas, Margarita; Bartenschlager, Ralf; Wakita, Takaji; Hijikata, Makoto; Shimotohno, Kunitada			The lipid droplet is an important organelle for hepatitis C virus production	NATURE CELL BIOLOGY			English	Article							CORE PROTEIN; CELL-LINES; REPLICATION; IDENTIFICATION; EXPRESSION; SURFACE; GENOME	The lipid droplet (LD) is an organelle that is used for the storage of neutral lipids. It dynamically moves through the cytoplasm, interacting with other organelles, including the endoplasmic reticulum ( ER)(1-3). These interactions are thought to facilitate the transport of lipids and proteins to other organelles. The hepatitis C virus (HCV) is a causative agent of chronic liver diseases(4). HCV capsid protein ( Core) associates with the LD5, envelope proteins E1 and E2 reside in the ER lumen(6), and the viral replicase is assumed to localize on ER- derived membranes. How and where HCV particles are assembled, however, is poorly understood. Here, we show that the LD is involved in the production of infectious virus particles. We demonstrate that Core recruits nonstructural (NS) proteins and replication complexes to LD-associated membranes, and that this recruitment is critical for producing infectious viruses. Furthermore, virus particles were observed in close proximity to LDs, indicating that some steps of virus assembly take place around LDs. This study reveals a novel function of LDs in the assembly of infectious HCV and provides a new perspective on how viruses usurp cellular functions.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068507, Japan; Fujita Hlth Univ, Dept Anat, Toyoake, Aichi 4701192, Japan; Heidelberg Univ, Dept Mol Biol, D-69120 Heidelberg, Germany; Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Kyoto University; Kyoto University; Fujita Health University; Ruprecht Karls University Heidelberg; National Institute of Infectious Diseases (NIID)	Shimotohno, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan.	shimkuni@z8.keio.jp	Bartenschlager, Ralf/L-2582-2015	Bartenschlager, Ralf/0000-0001-5601-9307				BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Hijikata M, 1993, Uirusu, V43, P293; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Vock R, 1996, J EXP BIOL, V199, P1689; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	28	916	944	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1089	U74		10.1038/ncb1631	http://dx.doi.org/10.1038/ncb1631			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721513				2022-12-27	WOS:000249256500017
J	Toya, M; Sato, M; Haselmann, U; Asakawa, K; Brunner, D; Antony, C; Toda, T				Toya, Mika; Sato, Masamitsu; Haselmann, Uta; Asakawa, Kazuhide; Brunner, Damian; Antony, Claude; Toda, Takashi			gamma-Tubulin complex-mediated anchoring of spindle microtubules to spindle-pole bodies requires Msd1 in fission yeast	NATURE CELL BIOLOGY			English	Article							SCHIZOSACCHAROMYCES-POMBE; ORGANIZING CENTERS; MITOTIC SPINDLE; SACCHAROMYCES-CEREVISIAE; INTERPHASE MICROTUBULES; CENTROSOMAL PROTEINS; RING COMPLEX; CELL-CYCLE; BODY; CHECKPOINT	The anchoring of microtubules to subcellular structures is critical for cell polarity and motility. Although the process of anchoring cytoplasmic microtubules to the centrosome has been studied in some detail(1-4), it is not known how spindle microtubules are anchored to the mitotic centrosome and, particularly, whether anchoring and nucleation of mitotic spindles are functionally separate. Here, we show that a fission yeast coiled-coil protein, Msd1, is required for anchoring the minus end of spindle microtubules to the centrosome equivalent, the spindle-pole body (SPB). msd1 deletion causes spindle microtubules to abnormally extend beyond SPBs, which results in chromosome missegregation. Importantly, this protruding spindle is phenocopied by the amino-terminal deletion mutant of Alp4, a component of the gamma-tubulin complex(5) (gamma-TuC), which lacks the potential Msd1-interacting domain. We propose that Msd1 interacts with gamma-TuC, thereby specifically anchoring the minus end of microtubules to SPBs without affecting microtubule nucleation.	Canc Res UK, Lab Cell Regulat, London Res Inst, Lincolns Inn Field Lab, London WC2A 3PX, England; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	Cancer Research UK; European Molecular Biology Laboratory (EMBL)	Toda, T (corresponding author), Canc Res UK, Lab Cell Regulat, London Res Inst, Lincolns Inn Field Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	toda@cancer.org.uk	Asakawa, Kazuhide/ABD-2065-2020; antony, claude/K-5342-2013; Brunner, Damian/F-2024-2011	Asakawa, Kazuhide/0000-0003-0628-1176; Toya, Mika/0000-0003-0999-3021; Brunner, Damian/0000-0001-5250-492X				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hagan IM, 2000, CURR TOP DEV BIOL, V49, P133; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kilmartin JV, 1996, EMBO J, V15, P4592, DOI 10.1002/j.1460-2075.1996.tb00837.x; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Krien MJE, 1998, J CELL SCI, V111, P967; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Osmani AH, 2003, MOL BIOL CELL, V14, P3169, DOI 10.1091/mbc.E02-11-0715; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Saito TT, 2005, J CELL SCI, V118, P447, DOI 10.1242/jcs.01629; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2002, CURR BIOL, V12, P141, DOI 10.1016/S0960-9822(01)00654-6; Saunders William S., 1993, Trends in Cell Biology, V3, P432, DOI 10.1016/0962-8924(93)90032-V; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tanaka K, 2005, CURR BIOL, V15, P1479, DOI 10.1016/j.cub.2005.07.058; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yoder TJ, 2005, MOL BIOL CELL, V16, P141, DOI 10.1091/mbc.E04-08-0703; Zimmerman S, 2004, DEV CELL, V6, P497, DOI 10.1016/S1534-5807(04)00096-6	43	44	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					646	U55		10.1038/ncb1593	http://dx.doi.org/10.1038/ncb1593			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486116				2022-12-27	WOS:000246922700009
J	Peng, JC; Karpen, GH				Peng, Jamy C.; Karpen, Gary H.			H3K9 methylation and RNA interference regulate nucleolar organization and repeated DNA stability	NATURE CELL BIOLOGY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; EPIGENETIC CONTROL; GENE; HETEROCHROMATIN; REPLICATION; RECOMBINATION; TRANSCRIPTION; FAMILY; IDENTIFICATION	Investigations aimed at identifying regulators of nuclear architecture in Drosophila demonstrated that cells lacking H3K9 methylation and RNA interference (RNAi) pathway components displayed disorganized nucleoli, ribosomal DNA (rDNA) and satellite DNAs. The levels of H3K9 dimethylation (H3K9me2) in chromatin associated with repeated DNAs decreased dramatically in Su(var)3-9 and dcr-2 (dicer-2) mutant tissues compared with wild type. We also observed a substantial increase in extrachromosomal circular (ecc) repeated DNAs in mutant tissues. The disorganized nucleolus phenotype depends on the presence of Ligase 4 and ecc DNA formation is not induced by removal of cohesin. We conclude that the structural integrity and organization of repeated DNAs and nucleoli are regulated by the H3K9 methylation and RNAi pathways, and other regulators of heterochromatin-mediated silencing. In addition, repeated DNA stability involves suppression of non-homologous end joining (NHEJ) or other recombination pathways. These results suggest a mechanism for how local chromatin structure can regulate genome stability, and the organization of chromosomal elements and nuclear organelles.	Lawrence Berkeley Natl Lab, Dept Genom & Bioinformat, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Karpen, GH (corresponding author), Lawrence Berkeley Natl Lab, Dept Genom & Bioinformat, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	karpen@fruitfly.org	Peng, Jamy/N-1134-2018	Peng, Jamy/0000-0002-4043-8475	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272, R01GM061169] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM061169, R01 GM066272, R01 GM061169-04, R01 GM061169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Astrom SU, 2003, GENETICS, V163, P931; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cartwright IL, 1999, METHOD ENZYMOL, V304, P462; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen Z, 2006, ONCOGENE, V25, P4515, DOI 10.1038/sj.onc.1209485; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Donaldson KM, 2002, GENETICS, V160, P995; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; GINDHART JG, 1995, GENETICS, V139, P797; GLASER RL, 1992, CHROMOSOMA, V102, P15, DOI 10.1007/BF00352285; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; HAWLEY RS, 1989, ANNU REV GENET, V23, P87, DOI 10.1146/annurev.genet.23.1.87; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hodgson JW, 1997, MECH DEVELOP, V66, P69, DOI 10.1016/S0925-4773(97)00091-9; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; John B, 1988, HETEROCHROMATIN MOL, P1; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KARPEN GH, 1988, GENE DEV, V2, P1745, DOI 10.1101/gad.2.12b.1745; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kuschak TI, 2001, BIOTECHNIQUES, V30, P1064, DOI 10.2144/01305rr05; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin HF, 1997, DEVELOPMENT, V124, P2463; LIN YH, 1991, GENETICS, V127, P31; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCKEE BD, 1990, CELL, V61, P61, DOI 10.1016/0092-8674(90)90215-Z; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Osipovich O, 2004, NAT IMMUNOL, V5, P309, DOI 10.1038/ni1042; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; PONT G, 1987, J MOL BIOL, V195, P447, DOI 10.1016/0022-2836(87)90665-6; ROMEIJN R, 2004, LIGASE4 MUTATIONS; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; SPRADLING A, 1987, ANNU REV GENET, V21, P373, DOI 10.1146/annurev.ge.21.120187.002105; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Westphal T, 2002, GENETICS, V160, P609; Wilson JE, 1996, DEV GENET, V19, P199, DOI 10.1002/(SICI)1520-6408(1996)19:3<199::AID-DVG3>3.0.CO;2-4; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055	59	283	299	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					25	U24		10.1038/ncb1514	http://dx.doi.org/10.1038/ncb1514			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17159999	Green Accepted			2022-12-27	WOS:000243255100009
J	Hiratsuka, S; Watanabe, A; Aburatani, H; Maru, Y				Hiratsuka, Sachie; Watanabe, Akira; Aburatani, Hiroyuki; Maru, Yoshiro			Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis	NATURE CELL BIOLOGY			English	Article							MIGRATION; INFLAMMATION; EXPRESSION; CANCER; DOMAIN; TWIST	Primary tumours influence the environment in the lungs before metastasis(1,2). However, the mechanism of metastasis is not well understood. Here, we show that the inflammatory chemoattractants S100A8 and S100A9, whose expression is induced by distant primary tumours, attract Mac 1 (macrophage antigen 1)(+)-myeloid cells in the premetastatic lung. In addition, tumour cells use this mechanism, through activation of the mitogen-activated protein kinase (MAPK) p38, to acquire migration activity with pseudopodia for invasion (invadopodia). The expression of S100A8 and S100A9 was eliminated in lung Mac 1(+)-myeloid cells and endothelial cells deprived of soluble factors, such as vascular endothelial growth factor A (VEGF-A), tumour necrosis factor a (TNF alpha) and transforming growth factor beta (TGF beta) both in vitro and in vivo. Neutralizing anti-S100A8 and anti-S100A9 antibodies blocked the morphological changes and migration of tumour cells and Mac 1+-myeloid cells. Thus, the S100A8 and S100A9 pathway may be common to both myeloid cell recruitment and tumour-cell invasion.	Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1628666, Japan; Univ Tokyo, Genome Sci Div, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Tokyo Women's Medical University; University of Tokyo	Maru, Y (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp						Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Chen S, 2005, IMMUNOLOGY, V114, P565, DOI 10.1111/j.1365-2567.2004.02110.x; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Couzin J, 2003, SCIENCE, V299, P1002, DOI 10.1126/science.299.5609.1002; DEVERY JM, 1994, J IMMUNOL, V152, P1888; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Folkman J, 1992, Semin Cancer Biol, V3, P65; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Ohira S, 2006, AM J PATHOL, V168, P1155, DOI 10.2353/ajpath.2006.050204; Roth J, 2003, J IMMUNOL, V171, P5651, DOI 10.4049/jimmunol.171.11.5651; TODA KI, 1990, CANCER RES, V50, P5526; Watanabe T, 2004, AM J PHYSIOL-GASTR L, V287, pG919, DOI 10.1152/ajpgi.00372.2003; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	25	770	813	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1369	U31		10.1038/ncb1507	http://dx.doi.org/10.1038/ncb1507			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17128264				2022-12-27	WOS:000242419800012
J	Gorr, IH; Reis, A; Boos, D; Wuhr, M; Madgwick, S; Jones, KT; Stemmann, O				Gorr, Ingo H.; Reis, Alexandra; Boos, Dominik; Wuehr, Martin; Madgwick, Suzanne; Jones, Keith T.; Stemmann, Olaf			Essential CDK1-inhibitory role for separase during meiosis I in vertebrate oocytes	NATURE CELL BIOLOGY			English	Article							MOUSE EGGS; XENOPUS OOCYTES; METAPHASE; MATURATION; INHIBITION; ANAPHASE; SECURIN; COHESIN; ARREST; CDC14	Separase not only triggers anaphase of meiosis I by proteolytic cleavage of cohesin on chromosome arms, but in vitro vertebrate separase also acts as a direct inhibitor of cyclin-dependent kinase 1 (Cdk1) on liberation from the inhibitory protein, securin. Blocking separase-Cdk1 complex formation by microinjection of anti-separase antibodies prevents polarbody extrusion in vertebrate oocytes. Importantly, proper meiotic maturation is rescued by chemical inhibition of Cdk1 or expression of Cdk1-binding separase fragments lacking cohesin-cleaving activity.	Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Newcastle University - UK; Max Planck Society	Jones, KT (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	k.t.jones@newcastle.ac.uk; stemann@biochem.mpg.de	Holt, Janet E/B-2415-2013; Wühr, Martin/A-2447-2009; Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Wühr, Martin/0000-0002-0244-8947; Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851; Boos, Dominik/0000-0003-0018-4375; Stemmann, Olaf/0000-0003-3044-2515	Wellcome Trust [075744] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; DONAHUE RP, 1968, J EXP ZOOL, V169, P237, DOI 10.1002/jez.1401690210; Fan HY, 2006, CELL CYCLE, V5, P198, DOI 10.4161/cc.5.2.2321; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HAMPL A, 1995, DEVELOPMENT, V121, P925; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Madgwick S, 2004, DEV BIOL, V275, P68, DOI 10.1016/j.ydbio.2004.07.024; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nixon VL, 2002, CURR BIOL, V12, P746, DOI 10.1016/S0960-9822(02)00811-4; OHSUMI K, 1994, J CELL SCI, V107, P3005; SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6	17	48	52	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1035	U120		10.1038/ncb1467	http://dx.doi.org/10.1038/ncb1467			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906143	Green Accepted			2022-12-27	WOS:000240241700022
J	Motegi, F; Sugimoto, A				Motegi, Fumio; Sugimoto, Asako			Sequential functioning of the ECT-2 RhoGEF, RHO-1 and CDC-42 establishes cell polarity in Caenorhabditis elegans embryos	NATURE CELL BIOLOGY			English	Article							ANTERIOR-POSTERIOR POLARITY; C-ELEGANS; CENTROSOME MATURATION; PAR PROTEINS; CYTOKINESIS; LOCALIZATION; MYOSIN; POLARIZATION; MAINTENANCE; COMPLEX	During development, the establishment of cell polarity is important for cells to undergo asymmetric cell divisions that give rise to diverse cell types. In C. elegans embryos, cues from the centrosome trigger the cortical flow of an actomyosin network, leading to the formation of anterior-posterior polarity(1). However, its precise mechanism is poorly understood. Here, we show that small GTPases have sequential and crucial functions in this process. ECT-2, a potential guanine nucleotide-exchange factor (GEF)(2) for RHO-1, was uniformly distributed at the cortex before polarization, but was excluded from the posterior cortex by the polarity cue from the centrosomes. This local exclusion of ECT-2 led to an asymmetric RHO-1 distribution, which generated a cortical flow of the actomyosin that translocated PAR proteins(3) and CDC-42 (refs 4, 5) to the anterior cortex. Polarized CDC-42 was, in turn, involved in maintaining the established anterior-cortical domains. Our results suggest that a local change in the function of ECT-2 and RHO-1 links the centrosomal polarity cue with the polarization of the cell cortex.	RIKEN, Ctr Dev Biol, Lab Dev Genom, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Sugimoto, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Dev Genom, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	sugimoto@cdb.riken.jp	Sugimoto, Asako/U-3707-2019; Sugimoto, Asako/I-7239-2015	Sugimoto, Asako/0000-0001-6001-4293; Sugimoto, Asako/0000-0001-6001-4293				Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; EDGER LG, 1995, METHOD CELL BIOL, V48, P303; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Morita K, 2005, EMBO REP, V6, P1163, DOI 10.1038/sj.embor.7400533; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Praitis V, 2001, GENETICS, V157, P1217; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	30	125	138	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					978	U80		10.1038/ncb1459	http://dx.doi.org/10.1038/ncb1459			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16921365				2022-12-27	WOS:000240241700014
J	Murata, T; Delprato, A; Ingmundson, A; Toomre, DK; Lambright, DG; Roy, CR				Murata, Takahiro; Delprato, Anna; Ingmundson, Alyssa; Toomre, Derek K.; Lambright, David G.; Roy, Craig R.			The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor	NATURE CELL BIOLOGY			English	Article							GTP-BINDING PROTEINS; INTRACELLULAR GROWTH; TRANSLOCATED SUBSTRATE; PHAGOSOME TRAFFICKING; ENDOPLASMIC-RETICULUM; DOTA PROTEIN; SYSTEM; CELLS; ORGANELLE; FUSION	The intracellular pathogen Legionella pneumophila avoids fusion with lysosomes and subverts membrane transport from the endoplasmic reticulum to create an organelle that supports bacterial replication(1,2). Transport of endoplasmic reticulum-derived vesicles to the Legionella-containing vacuole ( LCV) requires bacterial proteins that are translocated into host cells by a type IV secretion apparatus called Dot/Icm(3-7). Recent observations have revealed recruitment of the host GTPase Rab1 to the LCV by a process requiring the Dot/Icm system(8,9). Here, a visual screen was used to identify L. pneumophila mutants with defects in Rab1 recruitment. One of the factors identified in this screen was DrrA, a new Dot/Icm substrate protein translocated into host cells. We show that DrrA is a potent and highly specific Rab1 guanine nucleotide-exchange factor ( GEF). DrrA can disrupt Rab1-mediated secretory transport to the Golgi apparatus by competing with endogenous exchange factors to recruit and activate Rab1 on plasma membrane-derived organelles. These data establish that intracellular pathogens have the capacity to directly modulate the activation state of a specific member of the Rab family of GTPases and thus further our understanding of the mechanisms used by bacterial pathogens to manipulate host vesicular transport.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01605 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu		Delprato, Anna/0000-0002-6134-2560; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [R01 AI041699, AI41699, R01 AI041699-10] Funding Source: Medline; NIGMS NIH HHS [GM56324] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041699, R37AI041699, R01AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Roy CR, 1997, INFECT IMMUN, V65, P571, DOI 10.1128/IAI.65.2.571-578.1997; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; YU H, 1993, GENE, V132, P273, DOI 10.1016/0378-1119(93)90207-J; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; ZHU AX, 1994, BIOCHEM BIOPH RES CO, V205, P1875, DOI 10.1006/bbrc.1994.2889; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	37	272	284	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					971	U76		10.1038/ncb1463	http://dx.doi.org/10.1038/ncb1463			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906144				2022-12-27	WOS:000240241700013
J	Kamiya, A; Kubo, K; Tomoda, T; Takaki, M; Youn, R; Ozeki, Y; Sawamura, N; Park, U; Kudo, C; Okawa, M; Ross, CA; Hatten, ME; Nakajima, K; Sawa, A				Kamiya, A; Kubo, K; Tomoda, T; Takaki, M; Youn, R; Ozeki, Y; Sawamura, N; Park, U; Kudo, C; Okawa, M; Ross, CA; Hatten, ME; Nakajima, K; Sawa, A			A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development	NATURE CELL BIOLOGY			English	Article							NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; BRAIN-DEVELOPMENT; MICROTUBULE ORGANIZATION; SCHIZOAFFECTIVE DISORDER; NEURITE OUTGROWTH; LIS1; NUDEL; GENE; DISRUPTED-IN-SCHIZOPHRENIA-1	Disrupted-In-Schizophrenia-1 (DISC1), originally identified at the breakpoint of a chromosomal translocation that is linked to a rare familial schizophrenia, has been genetically implicated in schizophrenia in other populations. Schizophrenia involves subtle cytoarchitectural abnormalities that arise during neurodevelopment, but the underlying molecular mechanisms are unclear. Here, we demonstrate that DISC1 is a component of the microtubule-associated dynein motor complex and is essential for maintaining the complex at the centrosome, hence contributing to normal microtubular dynamics. Carboxy-terminal-truncated mutant DISC1 (mutDISC1), which results from a chromosomal translocation, functions in a dominant-negative manner by redistributing wildtype DISC1 through self-association and by dissociating the DISC1-dynein complex from the centrosome. Consequently, either depletion of endogenous DISC1 or expression of mutDISC1 impairs neurite outgrowth in vitro and proper development of the cerebral cortex in vivo. These results indicate that DISC1 is involved in cerebral cortex development, and suggest that loss of DISCI function may underlie neurodevelopmental dysfunction in schizophrenia.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Neurobiol, Baltimore, MD 21287 USA; Shiga Univ Med Sci, Dept Psychiat, Shiga 52021, Japan; Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Beckman Res Inst City Hope, Div Neurosci, Duarte, CA 91010 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Jikei Univ, Sch Med, Inst DNA Med, Dept Mol Neurobiol, Tokyo 1058471, Japan; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Shiga University of Medical Science; Keio University; Rockefeller University; City of Hope; Beckman Research Institute of City of Hope; Johns Hopkins University; Jikei University; Johns Hopkins University; Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Neurobiol, 600 N Wolfe St,CMSC 8-117, Baltimore, MD 21287 USA.	asawal@jhmi.edu	Nakajima, Kazunori/L-3396-2013; Sawamura, Naoya/K-1663-2018; Takaki, Manabu/AFK-8037-2022; Ross, Christopher A/H-8395-2013; Kubo, Ken-ichiro/B-2520-2015; kamiya, atsushi/L-8550-2016	Nakajima, Kazunori/0000-0003-1864-9425; Sawamura, Naoya/0000-0003-4753-1119; Takaki, Manabu/0000-0002-7371-2821; Kubo, Ken-ichiro/0000-0003-4023-5069; kamiya, atsushi/0000-0002-4274-5567	NCRR NIH HHS [P41 RR001192] Funding Source: Medline; NIMH NIH HHS [MH-069853] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P169; Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hayashi MAF, 2005, P NATL ACAD SCI USA, V102, P3828, DOI 10.1073/pnas.0500330102; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	46	425	443	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1167	1178		10.1038/ncb1328	http://dx.doi.org/10.1038/ncb1328			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16299498				2022-12-27	WOS:000233748900010
J	Wilkinson, S; Paterson, HF; Marshall, CJ				Wilkinson, S; Paterson, HF; Marshall, CJ			Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion	NATURE CELL BIOLOGY			English	Article							SMOOTH-MUSCLE MYOSIN; BINDING SUBUNIT; PROTEIN-KINASE; MIGRATION; PHOSPHATASE; MOTILITY; INHIBITION; ACTIVATION; MECHANISM; GTPASES	Actomyosin contractility is a mechanism by which cells exert locomotory force against their environment(1). Signalling downstream of the small GTPase Rho increases contractility through Rho-kinase (ROCK)-mediated regulation of myosin-II light chain (MLC2) phosphorylation. Cdc42 signalling has been shown to control cell polarity(2). Tumour cells can move through a three-dimensional matrix with either a rounded morphology(3,4) characterized by Rho - ROCK dependence(5) or with an elongated morphology3,4 characterized by Rho - ROCK independence(5). Here we show that contractility necessary for elongated morphology and invasion can be generated by Cdc42 - MRCK signalling. MRCK ( myotonic dystrophy kinase-related Cdc42-binding kinase) cooperates with ROCK in the maintenance of elongated morphology and invasion and either MRCK or ROCK is sufficient for MLC2 phosphorylation, through the inhibitory phosphorylation of myosin phosphatase. By contrast, in rounded ROCK-dependent movement, where MLC2 phosphorylation is higher, MRCK has a smaller role. Our data show that a Cdc42 MRCK signal mediates myosin-dependent cell motility and highlight convergence between Rho and Cdc42 signalling.	Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Marshall, CJ (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	chris.marshall@icr.ac.uk		Wilkinson, Simon/0000-0003-1082-8218				Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Dong JM, 2002, EUR J CELL BIOL, V81, P231, DOI 10.1078/0171-9335-00238; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; IKEBE M, 1985, J BIOL CHEM, V260, P27; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1996, MOL CELL BIOL, V16, P5313; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006	30	297	307	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					255	U45		10.1038/ncb1230	http://dx.doi.org/10.1038/ncb1230			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723050				2022-12-27	WOS:000227329800013
J	Ukai, H; Kobayashi, TJ; Nagano, M; Masumoto, K; Sujino, M; Kondo, T; Yagita, K; Shigeyoshi, Y; Ueda, HR				Ukai, Hideki; Kobayashi, Tetsuya J.; Nagano, Mamoru; Masumoto, Koh-hei; Sujino, Mitsugu; Kondo, Takao; Yagita, Kazuhiro; Shigeyoshi, Yasufumi; Ueda, Hiroki R.			Melanopsin-dependent photo-perturbation reveals desynchronization underlying the singularity of mammalian circadian clocks	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; CELLS; OSCILLATORS; RHYTHMS; RAT; SYNCHRONIZATION; SUPPRESSION; BEHAVIOR	Singularity behaviour in circadian clocks(1,2) - the loss of robust circadian rhythms following exposure to a stimulus such as a pulse of bright light - is one of the fundamental but mysterious properties of clocks. To quantitatively perturb and accurately measure the dynamics of cellular clocks(3,4), we synthetically produced photo-responsiveness within mammalian cells by exogenously introducing the photoreceptor melanopsin(5-8) and continuously monitoring the effect of photo-perturbation on the state of cellular clocks. Here we report that a critical light pulse drives cellular clocks into singularity behaviour. Our theoretical analysis consistently predicts and subsequent single-cell level observation directly proves that desynchronization of individual cellular clocks underlies singularity behaviour. Our theoretical framework also explains why singularity behaviours have been experimentally observed in various organisms, and it suggests that desynchronization is a plausible mechanism for the observable singularity of circadian clocks. Importantly, these in vitro and in silico findings are further supported by in vivo observations that desynchronization underlies the multicell-level amplitude decrease in the rat suprachiasmatic nucleus induced by critical light pulses.	RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; Osaka Univ, Grad Sch Sci, Dept Biosci, Osaka 5600043, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 5898511, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST & SORST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Chikusa Ku, Dept Biol Sci,Div Mol Genet,COE Unit Circadian Sy, Nagoya, Aichi 4648602, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan	RIKEN; RIKEN; Osaka University; Kindai University (Kinki University); Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Osaka University	Ueda, HR (corresponding author), RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176				Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Ban Y, 1997, J NEUROSCI, V17, P3920; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Forger DB, 2004, J THEOR BIOL, V230, P521, DOI 10.1016/j.jtbi.2004.04.043; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; HONNA S, 1999, AM JPHYSL, V276, pR1390; HUANG G, 2006, EMBO J; JEWETT ME, 1991, NATURE, V350, P59, DOI 10.1038/350059a0; Johnson Carl Hirschie, 2004, P67; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; JOHNSON CH, 1992, J BIOL RHYTHM, V7, P313, DOI 10.1177/074873049200700405; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Leloup JC, 1999, J BIOL RHYTHM, V14, P433, DOI 10.1177/074873099129000948; Leloup JC, 2001, AM J PHYSIOL-REG I, V280, pR1206, DOI 10.1152/ajpregu.2001.280.4.R1206; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagano M, 2003, J NEUROSCI, V23, P6141; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; WINFREE AT, 1975, NATURE, V253, P315, DOI 10.1038/253315a0; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	41	91	94	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1327	U280		10.1038/ncb1653	http://dx.doi.org/10.1038/ncb1653			54	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952058				2022-12-27	WOS:000250659600019
J	Song, H; Hollstein, M; Xu, Y				Song, Hoseok; Hollstein, Monica; Xu, Yang			P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM	NATURE CELL BIOLOGY			English	Article							EMBRYONIC STEM-CELLS; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; TARGETED DISRUPTION; THYMIC LYMPHOMA; HISTONE H2AX; MOUSE; ACTIVATION; MUTATIONS; RESPONSES	Tp53 is the most commonly mutated tumour- suppressor gene in human cancers(1). In addition to the loss of tumour-suppression function, some missense mutants gain novel oncogenic activities(2). To elucidate the nature of the gain of function, we introduced the most common p53 cancer mutations (R248W and R273H) independently into the humanized p53 knock-in (HUPKI) allele in mice. Tumour-suppressor functions of p53 are abolished in p53-mutant mice. Several lines of evidence further indicate gain-of-function of p53 mutants in promoting tumorigenesis. p53(R248W) mice rapidly succumb to certain types of cancers not commonly observed in p53(-/-) mice. Interchromosomal translocations, a type of genetic instability rarely observed in p53(-/-)-cells, are readily detectable in p53-mutant pre- tumor thymocytes. Although normal in p53(-/-) mouse cells, the G2-M checkpoint is impaired in p53-mutant cells after DNA damage. These acquired oncogenic properties of mutant p53 could be explained by the findings that these p53 mutants interact with the nuclease Mre11 and suppress the binding of the Mre11 Rad50-NBS1 ( MRN) complex to DNA double-stranded breaks ( DSBs), leading to impaired Ataxia-telangiectasia mutated ( ATM) activation. Therefore, p53 gain-of-function mutants promote tumorigenesis by a novel mechanism involving active disruption of critical DNA damage-response pathways.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; German Canc Res Ctr, Dept Genet Alterat Carcinogenesis, Heidelberg, Germany	University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ)	Xu, Y (corresponding author), Univ Leeds, Fac Med & Hlth, Light Labs, Leeds LS2 9JT, W Yorkshire, England.	yangxu@ucsd.edu		Xu, Yang/0000-0001-5574-921X	NCI NIH HHS [CA77563] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077563] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gudkov AV, 2003, CANCER BIOL THER, V2, P444, DOI 10.4161/cbt.2.4.480; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hergenhahn M, 2004, CELL CYCLE, V3, P738; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lista F, 1997, CANCER RES, V57, P4408; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Murphy ME, 2003, CANCER BIOL THER, V2, P381, DOI 10.4161/cbt.2.4.439; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sigal A, 2000, CANCER RES, V60, P6788; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804; Xu Y, 2005, CELL CYCLE, V4, P363, DOI 10.4161/cc.4.3.1529; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	30	306	321	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					573	U166		10.1038/ncb1571	http://dx.doi.org/10.1038/ncb1571			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417627				2022-12-27	WOS:000246181500016
J	Kaidi, A; Williams, AC; Paraskeva, C				Kaidi, Abderrahmane; Williams, Ann Caroline; Paraskeva, Christos			Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia	NATURE CELL BIOLOGY			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; FACTOR-I; TUMOR; CANCER; APOPTOSIS; COMPLEX; INHIBITION; ACTIVATION	Aberrant activation of beta-catenin promotes cell proliferation(1) and initiates colorectal tumorigenesis(2,3). However, the expansion of tumours and the inadequacy of their local vasculature results in areas of hypoxia where cell growth is typically constrained(4,5). Here, we report a novel diversion in beta-catenin signalling triggered by hypoxia. We show that hypoxia inhibits beta-catenin T-cell factor-4 (TCF-4) complex formation and transcriptional activity, resulting in a G1 arrest that involves the c-Myc-p21 axis. Additionally, we find that hypoxia inducible factor-1 alpha (HIF-1 alpha) competes with TCF-4 for direct binding to beta-catenin. DNA-protein interaction studies reveal that beta-catenin-HIF-1 alpha interaction occurs at the promoter region of HIF-1 target genes. Furthermore, rigorous analyses indicate that beta-catenin can enhance HIF-1-mediated transcription, thereby promoting cell survival and adaptation to hypoxia. These findings demonstrate a dynamic role for beta-catenin in colorectal tumorigenesis, where a functional switch is instigated to meet the ever-changing needs of the tumour. This study highlights the importance of the microenvironment in transcriptional regulation.	Univ Bristol, Dept Cellular & Mol Med, Canc Res UK, Colorectal Tumour Biol Res Grp, Bristol BS8 1TD, Avon, England	Cancer Research UK; University of Bristol	Paraskeva, C (corresponding author), Univ Bristol, Dept Cellular & Mol Med, Canc Res UK, Colorectal Tumour Biol Res Grp, Bristol BS8 1TD, Avon, England.	c.paraskeva@bristol.ac.uk		Kaidi, Abderrahmane/0000-0001-9411-8912; Williams, Ann/0000-0002-6009-7137				Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Elder DJE, 1996, CANCER RES, V56, P2273; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Giles RH, 2006, ONCOGENE, V25, P3065, DOI 10.1038/sj.onc.1209330; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Goethals L, 2006, INT J RADIAT ONCOL, V65, P246, DOI 10.1016/j.ijrobp.2006.01.007; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vaupel P, 1998, ADV EXP MED BIOL, V454, P591; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong H, 1999, CANCER RES, V59, P5830	30	371	389	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					210	U113		10.1038/ncb1534	http://dx.doi.org/10.1038/ncb1534			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220880				2022-12-27	WOS:000243903000014
J	Jacobson, K; Mouritsen, OG; Anderson, RGW				Jacobson, Ken; Mouritsen, Ole G.; Anderson, Richard G. W.			Lipid rafts: at a crossroad between cell biology and physics	NATURE CELL BIOLOGY			English	Review							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; H-RAS; CLASS-II; PHOSPHOLIPID INTERACTIONS; TRANSLATIONAL DIFFUSION; LATERAL DIFFUSION; K-RAS; CHOLESTEROL; DOMAINS	Membrane lateral heterogeneity is accepted as a requirement for the function of biological membranes and the notion of lipid rafts gives specificity to this broad concept. However, the lipid raft field is now at a technical impasse because the physical tools to study biological membranes as a liquid that is ordered in space and time are still being developed. This has lead to a disconnection between the concept of lipid rafts as derived from biochemical and biophysical assays and their existence in the cell. Here, we compare the concept of lipid rafts as it has emerged from the study of synthetic membranes with the reality of lateral heterogeneity in biological membranes. Further application of existing tools and the development of new tools are needed to understand the dynamic heterogeneity of biological membranes.	Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ So Denmark, Dept Phys, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense, Denmark; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern Denmark; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jacobson, K (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, 121 Taylor Hall,CB 7090, Chapel Hill, NC 27599 USA.	frap@med.unc.edu		Mouritsen, Ole G./0000-0002-4258-8960	NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 41402, GM 52016] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acasandrei MA, 2006, CHEM PHYS LETT, V419, P469, DOI 10.1016/j.cplett.2005.11.104; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BROWN D, 1994, BRAZ J MED BIOL RES, V27, P309; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Cherry RJ, 2003, BIOCHEM SOC T, V31, P1028; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; De Angelis AA, 2005, METHOD ENZYMOL, V394, P350; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Egner A, 2005, TRENDS CELL BIOL, V15, P207, DOI 10.1016/j.tcb.2005.02.003; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gheber LA, 1999, BIOPHYS J, V77, P3163, DOI 10.1016/S0006-3495(99)77147-X; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Grzybek M, 2006, CHEM PHYS LIPIDS, V141, P133, DOI 10.1016/j.chemphyslip.2006.02.008; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Heijnen HFG, 2003, J THROMB HAEMOST, V1, P1161, DOI 10.1046/j.1538-7836.2003.00316.x; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hsueh YW, 2005, BIOPHYS J, V88, P1799, DOI 10.1529/biophysj.104.051375; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Krishnan RV, 2001, J FLUORESC, V11, P211, DOI 10.1023/A:1012201201651; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lesniewska E, 2002, METHOD CELL BIOL, V68, P51; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; LOMMERSE PHM, 2004, BIOCHIM BIOPHYS ACTA, P119; Lukic B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160601; MAKSYMIW R, 1987, BIOCHEMISTRY-US, V26, P2983, DOI 10.1021/bi00385a005; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Marsh D, 2006, CHEM PHYS LIPIDS, V141, P48, DOI 10.1016/j.chemphyslip.2006.02.005; Marxer CG, 2005, BIOPHYS J, V88, P2965, DOI 10.1529/biophysj.104.057257; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 2004, BIOPHYS J, pSP23; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Morowitz H., 1968, ENERGY FLOW BIOL; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NAGLE J, 2004, BIOPHYS J, pSP28; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; NICOLIS G, 1989, EXLORING COMPLEXITY; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pencer J, 2005, EUR PHYS J E, V18, P447, DOI 10.1140/epje/e2005-00046-5; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; RYAN TA, 1988, SCIENCE, V239, P61, DOI 10.1126/science.2962287; Sabra MC, 1998, BIOPHYS J, V74, P745, DOI 10.1016/S0006-3495(98)73999-2; Sanchez SA, 2005, ACCOUNTS CHEM RES, V38, P469, DOI 10.1021/ar040026l; Schade AE, 2002, J IMMUNOL, V168, P2233, DOI 10.4049/jimmunol.168.5.2233; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Silvius JR, 2005, BBA-MOL CELL RES, V1746, P193, DOI 10.1016/j.bbamcr.2005.09.003; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; Szollosi J, 1996, J IMMUNOL, V157, P2939; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	111	872	896	1	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					7	14		10.1038/ncb0107-7	http://dx.doi.org/10.1038/ncb0107-7			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17199125				2022-12-27	WOS:000243255100003
J	Kim, H; Rafiuddin-Shah, M; Tu, HC; Jeffers, JR; Zambetti, GP; Hsieh, JJD; Cheng, EHY				Kim, Hyungjin; Rafiuddin-Shah, Mubina; Tu, Ho-Chou; Jeffers, John R.; Zambetti, Gerard P.; Hsieh, James J-D.; Cheng, Emily H-Y.			Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies	NATURE CELL BIOLOGY			English	Article							CYTOCHROME-C RELEASE; BH3-ONLY PROTEINS; FAMILY-MEMBER; X-L; CELL-DEATH; DEFICIENT MICE; BH3 DOMAINS; BAX; PUMA; BIM	'inactivator' BH3-only molecules including BAD, NOXA, BMF, BIK/BLK and HRK/DP5. BAD displaces tBID, BIM or PUMA from BCL-2-BCL-X-L to activate BAX-BAK, whereas NOXA specifically antagonizes MCL-1. Coexpression of BAD and NOXA killed wild-type but not Bax, Bak doubly deficient cells or Puma deficient cells with Bim knockdown, indicating that activator BH3-only molecules function downstream of inactivator BH3-only molecules to activate BAX-BAK. Our data establish a hierarchical regulation of mitochondrion-dependent apoptosis by various BCL-2 subfamilies.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; St Jude Childrens Hosp, Memphis, TN 38105 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital	Cheng, EHY (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	echeng@im.wustl.edu	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007	NCI NIH HHS [CA63230] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063230] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; BAK, 2000, MOL CELL, V6, P1389; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Horvitz HR, 2003, CHEMBIOCHEM, V4, P697, DOI 10.1002/cbic.200300614; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Morrison DJ, 2005, CANCER RES, V65, P8174, DOI 10.1158/0008-5472.CAN-04-3657; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Terradillos O, 2002, FEBS LETT, V522, P29, DOI 10.1016/S0014-5793(02)02871-5; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	50	674	701	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1348	U19		10.1038/ncb1499	http://dx.doi.org/10.1038/ncb1499			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115033				2022-12-27	WOS:000242419800010
J	Rhind, N				Rhind, Nicholas			DNA replication timing: random thoughts about origin firing	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; DIHYDROFOLATE-REDUCTASE ORIGIN; S-PHASE; FISSION YEAST; ARS ELEMENTS; HUMAN GENOME; ATR; CHROMOSOME; CHROMATIN; LAEVIS	Regions of metazoan genomes replicate at defined times within S phase. This observation suggests that replication origins fire with a defined timing pattern that remains the same from cycle to cycle. However, an alterative model based on the stochastic firing of origins may also explain replication timing. This model assumes varying origin efficiency instead of a strict origin-timing programme. Here, we discuss the evidence for both models.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rhind, N (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, 364 Plantat St,LRB904, Worcester, MA 01605 USA.	nick.rhind@umassmed.edu		Rhind, Nicholas/0000-0003-1758-7736	NIGMS NIH HHS [R01 GM069957-03, R01 GM069957] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; Diaz-Martinez L, 2003, CELL CYCLE, V2, P576, DOI 10.4161/cc.2.6.596; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Donaldson AD, 2005, TRENDS GENET, V21, P444, DOI 10.1016/j.tig.2005.05.012; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; DUBEY DD, 1994, EMBO J, V13, P3638, DOI 10.1002/j.1460-2075.1994.tb06671.x; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; JACOB F, 1963, CR HEBD ACAD SCI, V256, P298; Jun S, 2004, CELL CYCLE, V3, P223; LASKEY RA, 1985, J EMBRYOL EXP MORPH, V89, P285; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Miao H, 2003, J BIOL CHEM, V278, P4295, DOI 10.1074/jbc.M204264200; NEWLON CS, 1991, GENETICS, V129, P343; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sadoni N, 2004, J CELL SCI, V117, P5353, DOI 10.1242/jcs.01412; Shechter D, 2005, CELL CYCLE, V4, P235; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sorensen CS, 2004, CELL CYCLE, V3, P941; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; TALJANIDISZ J, 1989, MOL CELL BIOL, V9, P2881, DOI 10.1128/MCB.9.7.2881; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016	40	91	93	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1313	1316		10.1038/ncb1206-1313	http://dx.doi.org/10.1038/ncb1206-1313			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17139278	Green Accepted			2022-12-27	WOS:000242419800002
J	Strunker, T; Weyand, I; Bonigk, W; Van, Q; Loogen, A; Brown, JE; Kashikar, N; Hagen, V; Krause, E; Kaupp, UB				Struenker, Timo; Weyand, Ingo; Boenigk, Wolfgang; Van, Qui; Loogen, Astrid; Brown, Joel E.; Kashikar, Nachiket; Hagen, Volker; Krause, Eberhard; Kaupp, U. Benjamin			A K+-selective cGMP-gated ion channel controls chemosensation of sperm	NATURE CELL BIOLOGY			English	Article							CA2+; IDENTIFICATION; CHEMOTAXIS; ACTIVATION; SEQUENCE; CAMP	Eggs attract sperm by chemical factors, a process called chemotaxis. Sperm from marine invertebrates use cGMP signalling to transduce incident chemoattractants into changes in the Ca2+ concentration in the flagellum, which control the swimming behaviour during chemotaxis(1-3). The signalling pathway downstream of the synthesis of cGMP by a guanylyl cyclase is ill-defined. In particular, the ion channels that are involved in Ca2+ influx and their mechanisms of gating are not known(4). Using rapid voltage-sensitive dyes and kinetic techniques, we record the voltage response that is evoked by the chemoattractant in sperm from the sea urchin Arbacia punctulata. We show that the chemoattractant evokes a brief hyperpolarization followed by a sustained depolarization. The hyperpolarization is caused by the opening of K+-selective cyclic-nucleotide-gated ( CNG) channels in the flagellum. Ca2+ influx commences at the onset of recovery from hyperpolarization. The voltage threshold of Ca2+ entry indicates the involvement of low-voltage-activated Ca-v channels. These results establish a model of chemosensory transduction in sperm whereby a cGMP-induced hyperpolarization opens Ca-v channels by a 'recovery-from-inactivation' mechanism and unveil an evolutionary kinship between transduction mechanisms in sperm and photoreceptors.	Forschyngszentrum Julich, Inst Neurowissensch & Biophys, Abt Zellulare Signalverarbeitung, INB1, D-52425 Julich, Germany; Marine Biol Lab, Woods Hole, MA 02543 USA; Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany	Marine Biological Laboratory - Woods Hole	Kaupp, UB (corresponding author), Forschyngszentrum Julich, Inst Neurowissensch & Biophys, Abt Zellulare Signalverarbeitung, INB1, D-52425 Julich, Germany.	a.eckert@fz-juelich.de	Strünker, Timo/AAE-4722-2020	Kashikar, Nachiket/0000-0002-4466-7486				Beltran C, 1996, BIOCHEMISTRY-US, V35, P7591, DOI 10.1021/bi952806v; Bohmer M, 2005, EMBO J, V24, P2741, DOI 10.1038/sj.emboj.7600744; Bullen A, 1999, BIOPHYS J, V76, P2272, DOI 10.1016/S0006-3495(99)77383-2; COOK SP, 1993, J BIOL CHEM, V268, P22408; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387; FAIN GL, 1981, PROG BIOPHYS MOL BIO, V37, P91, DOI 10.1016/0079-6107(82)90021-9; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; Granados-Gonzalez G, 2005, FEBS LETT, V579, P6667, DOI 10.1016/j.febslet.2005.10.035; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; Hagen V, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P155, DOI 10.1002/3527605592.ch4; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Kaupp UB, 2006, J CELL PHYSIOL, V208, P487, DOI 10.1002/jcp.20669; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Matsumoto M, 2003, DEV BIOL, V260, P314, DOI 10.1016/S0012-1606(03)00236-7; Mengerink Kathryn J, 2004, Methods Mol Biol, V253, P141; Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Solzin J, 2004, J GEN PHYSIOL, V124, P115, DOI 10.1085/jgp.200409030; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; TITANI K, 1984, BIOCHEMISTRY-US, V23, P4193, DOI 10.1021/bi00313a028; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101	36	95	98	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1149	U198		10.1038/ncb1473	http://dx.doi.org/10.1038/ncb1473			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16964244				2022-12-27	WOS:000241395300020
J	Zhang, JQ; Tam, WL; Tong, GQ; Wu, Q; Chan, HY; Soh, BS; Lou, YF; Yang, JC; Ma, YP; Chai, L; Ng, HH; Lufkin, T; Robson, P; Lim, B				Zhang, Jinqiu; Tam, Wai-Leong; Tong, Guo Qing; Wu, Qiang; Chan, Hsiao-Yun; Soh, Boon-Seng; Lou, Yuefei; Yang, Jianchang; Ma, Yupo; Chai, Li; Ng, Huck-Hui; Lufkin, Thomas; Robson, Paul; Lim, Bing			Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1	NATURE CELL BIOLOGY			English	Article							OKIHIRO-SYNDROME; OCT4 EXPRESSION; MURINE HOMOLOG; NANOG; FATE; GENE; DIFFERENTIATION; PROLIFERATION; LINES	Embryonic stem (ES) cells are pluripotent cells that can self-renew or differentiate into many cell types. A unique network of transcription factors and signalling molecules are essential for maintaining this capability. Here, we report that a spalt family member, Sall4, is required for the pluripotency of ES cells. Similarly to Oct4, a reduction in Sall4 levels in mouse ES cells results in respecification, under the appropriate culture conditions, of ES cells to the trophoblast lineage. Sall4 regulates transcription of Pou5f1 which encodes Oct4. Sall4 binds to the highly conserved regulatory region of the Pou5f1 distal enhancer and activates Pou5f1 expression in vivo and in vitro. Microinjection of Sall4 small interfering (si) RNA into mouse zygotes resulted in reduction of Sall4 and Oct4 mRNAs in preimplantation embryos and significant expansion of Cdx2 expression into the inner cell mass. These results demonstrate that Sall4 is a transcriptional activator of Pou5f1 and has a critical role in the maintenance of ES cell pluripotency by modulating Oct4 expression. The data also indicates that Sall4 is important for early embryonic cell-fate decisions.	Genome Inst Singapore, Singapore 138672, Singapore; Natl Univ Singapore, Grad Sch IntegratSci & Engn, Singapore 117456, Singapore; Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; Nevada Canc Inst, Div Lab Med, Las Vegas, NV 89135 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Harvard Univ, Sch Med, Inst Med, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National University of Singapore; Harvard University; Harvard Medical School	Lim, B (corresponding author), Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore.	limb1@gis.a-star.edu.sg	Lufkin, Thomas/AAG-7476-2019; Robson, Paul/A-3464-2009; Lufkin, Thomas/B-5352-2011; Ng, Huck Hui/A-1135-2009; Tam, Wai Leong/P-1497-2019	Lufkin, Thomas/0000-0002-7902-4771; Robson, Paul/0000-0002-0191-3958; Lufkin, Thomas/0000-0002-7902-4771; Tam, Wai Leong/0000-0003-2365-5264; Chan, Hsiao Yun/0000-0001-7939-4134; Wu, Qiang/0000-0003-2049-1639; Chai, Li/0000-0003-1937-4750; NG, HUCK HUI/0000-0001-6352-8417	NCI NIH HHS [K08 CA097185] Funding Source: Medline; NCRR NIH HHS [P20 RR016464] Funding Source: Medline; NIAID NIH HHS [AI54973] Funding Source: Medline; NIDDK NIH HHS [K08 DK063220, DK04763] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA097185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK063220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Elstob PR, 2001, DEVELOPMENT, V128, P723; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MA Y, 2006, BLOOD, DOI DOI 10.1182/BLOOD-2006-02-001594V1; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Saburi S, 1997, DIFFERENTIATION, V62, P1, DOI 10.1046/j.1432-0436.1997.6210001.x; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Shimada H, 1999, MOL REPROD DEV, V52, P376, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;376::AID-MRD6&gt;3.0.CO;2-U; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yin YJ, 2004, ARTERIOSCL THROM VAS, V24, P691, DOI 10.1161/01.ATV.0000120375.51196.73; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003	27	416	449	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1114	U125		10.1038/ncb1481	http://dx.doi.org/10.1038/ncb1481			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16980957				2022-12-27	WOS:000241395300016
J	Fluhrer, R; Grammer, G; Israel, L; Condron, MM; Haffner, C; Friedmann, E; Bohland, C; Imhof, A; Martoglio, B; Teplow, DB; Haass, C				Fluhrer, Regina; Grammer, Gudula; Israel, Lars; Condron, Margaret M.; Haffner, Christof; Friedmann, Elena; Boehland, Claudia; Imhof, Axel; Martoglio, Bruno; Teplow, David B.; Haass, Christian			A gamma-secretase-like intramembrane cleavage of TNF alpha by the GxGD aspartyl protease SPPL2b	NATURE CELL BIOLOGY			English	Article							SIGNAL PEPTIDE PEPTIDASE; IDENTIFICATION; NICASTRIN; ENZYME	secretase and signal peptide peptidase ( SPP) are unusual GxGD aspartyl proteases, which mediate intramembrane proteolysis. In addition to SPP, a family of SPP-like proteins ( SPPLs) of unknown function has been identified. We demonstrate that SPPL2b utilizes multiple intramembrane cleavages to liberate the intracellular domain of tumor necrosis factor alpha ( TNF alpha) into the cytosol and the carboxy-terminal counterpart into the extracellular space. These findings suggest common principles for regulated intramembrane proteolysis by GxGD aspartyl proteases.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Prot Anal Unit, D-80336 Munich, Germany; Univ Calif Los Angeles, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; ETH Honggerberg, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland	University of Munich; University of Munich; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Swiss Federal Institutes of Technology Domain; ETH Zurich	Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Haffner, Christof/AAG-6676-2020; Fluhrer, Regina/F-2642-2011; Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018921] Funding Source: NIH RePORTER; NIA NIH HHS [AG18921] Funding Source: Medline; NINDS NIH HHS [NS38328, NS4414] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	14	110	116	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					894	U175		10.1038/ncb1450	http://dx.doi.org/10.1038/ncb1450			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16829951	Green Submitted			2022-12-27	WOS:000239423000022
J	Mao, XM; Kikani, CK; Riojas, RA; Langlais, P; Wang, LX; Ramos, FJ; Fang, QC; Christ-Roberts, CY; Hong, JY; Kim, RY; Liu, F; Dong, LQ				Mao, XM; Kikani, CK; Riojas, RA; Langlais, P; Wang, LX; Ramos, FJ; Fang, QC; Christ-Roberts, CY; Hong, JY; Kim, RY; Liu, F; Dong, LQ			APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; GLUCOSE-UPTAKE; MUSCLE-CELLS; RAB5; FAT; ACRP30/ADIPONECTIN; PHOSPHORYLATION; INHIBITION	Adiponectin, also known as Acrp30, is an adipose tissue-derived hormone with anti-atherogenic, anti-diabetic and insulin sensitizing properties(1-3). Two seven-transmembrane domain-containing proteins, AdipoR1 and AdipoR2, have recently been identified as adiponectin receptors(4), yet signalling events downstream of these receptors remain poorly defined. By using the cytoplasmic domain of AdipoR1 as bait, we screened a yeast two-hybrid cDNA library derived from human fetal brain. This screening led to the identification of a phosphotyrosine binding domain and a pleckstrin homology domain-containing adaptor protein, APPL1 (adaptor protein containing pleckstrin homology domain, phosphotyrosine binding (PTB) domain and leucine zipper motif). APPL1 interacts with adiponectin receptors in mammalian cells and the interaction is stimulated by adiponectin. Overexpression of APPL1 increases, and suppression of APPL1 level reduces, adiponectin signalling and adiponectin-mediated downstream events (such as lipid oxidation, glucose uptake and the membrane translocation of glucose transport 4 (GLUT4)). Adiponectin stimulates the interaction between APPL1 and Rab5 (a small GTPase) interaction, leading to increased GLUT4 membrane translocation. APPL1 also acts as a critical regulator of the crosstalk between adiponectin signalling and insulin signalling pathways. These results demonstrate a key function for APPL1 in adiponectin signalling and provide a molecular mechanism for the insulin sensitizing function of adiponectin.	Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; Shanghai Jiao Tong Univ, Affiliated Hosp 6, Shanghai Diabet Inst, Shanghai 200233, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Dong, LQ (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	dongq@uthscsa.edu		Kikani, Chintan/0000-0003-1140-0192	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069930, R01DK052933, F31DK068874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG021890] Funding Source: Medline; NIDDK NIH HHS [R01 DK52933, F31DK068874, R01 DK69930, R01 DK069930] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chen XM, 2001, EMBO REP, V2, P842, DOI 10.1093/embo-reports/kve179; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Langlais P, 2004, MOL ENDOCRINOL, V18, P350, DOI 10.1210/me.2003-0117; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Statnick M A, 2000, Int J Exp Diabetes Res, V1, P81, DOI 10.1155/EDR.2000.81; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	27	501	546	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					516	U165		10.1038/ncb1404	http://dx.doi.org/10.1038/ncb1404			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622416				2022-12-27	WOS:000237299400016
J	Murr, R; Loizou, JI; Yang, YG; Cuenin, C; Li, H; Wang, ZQ; Herceg, Z				Murr, R; Loizou, JI; Yang, YG; Cuenin, C; Li, H; Wang, ZQ; Herceg, Z			Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks	NATURE CELL BIOLOGY			English	Article							HAT COFACTOR TRRAP; BINDING PROTEIN; C-MYC; HOMOLOGOUS RECOMBINATION; NUCLEOSOME ACETYLATION; CELLULAR-RESPONSE; DAMAGE RESPONSE; COMPLEX; 53BP1; ROLES	DNA is packaged into chromatin, a highly compacted DNA protein complex; therefore, all cellular processes that use the DNA as a template, including DNA repair, require a high degree of coordination between the DNA- repair machinery and chromatin modification/ remodelling, which regulates the accessibility of DNA in chromatin. Recent studies have implicated histone acetyltransferase ( HAT) complexes and chromatin acetylation in DNA repair; however, the precise underlying mechanism remains poorly understood(1,2). Here, we show that the HAT cofactor Trrap and Tip60 HAT bind to the chromatin surrounding sites of DNA double- strand breaks ( DSBs) in vivo. Trrap depletion impairs both DNA- damage-induced histone H4 hyperacetylation and accumulation of repair molecules at sites of DSBs, resulting in defective homologous recombination ( HR) repair, albeit with the presence of a functional ATM- dependent DNA- damage signalling cascade. Importantly, the impaired loading of repair proteins and the defect in DNA repair in Trrap- deficient cells can be counteracted by chromatin relaxation, indicating that the DNA- repair defect that was observed in the absence of Trrap is due to impeded chromatin accessibility at sites of DNA breaks. Thus, these data reveal that cells may use the same basic mechanism involving HAT complexes to regulate distinct cellular processes, such as transcription and DNA repair.	Int Agcy Res Canc, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Herceg, Z (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.	herceg@iarc.fr		Murr, Rabih/0000-0002-3346-6590; Loizou, Joanna/0000-0003-1853-0424				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Cairns BR, 2001, TRENDS CELL BIOL, V11, pS15, DOI 10.1016/S0962-8924(01)02125-0; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Deleu L, 2001, ONCOGENE, V20, P8270, DOI 10.1038/sj.onc.1205159; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Herceg Z, 2003, NUCLEIC ACIDS RES, V31, P7011, DOI 10.1093/nar/gkg902; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li H, 2004, EMBO J, V23, P4824, DOI 10.1038/sj.emboj.7600479; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252	35	463	476	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					91	U36		10.1038/ncb1343	http://dx.doi.org/10.1038/ncb1343			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16341205				2022-12-27	WOS:000234651500017
J	Swarup, R; Kramer, EM; Perry, P; Knox, K; Leyser, HMO; Haseloff, J; Beemster, GTS; Bhalerao, R; Bennett, MJ				Swarup, R; Kramer, EM; Perry, P; Knox, K; Leyser, HMO; Haseloff, J; Beemster, GTS; Bhalerao, R; Bennett, MJ			Root gravitropism requires lateral root cap and epidermal cells for transport and response to a mobile auxin signal	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; MEMBRANE-PROTEIN; GRAVITY; ENCODES; GROWTH; REGULATOR; LOCUS; GENE; LOCALIZATION; PATHWAYS	Re-orientation of Arabidopsis seedlings induces a rapid, asymmetric release of the growth regulator auxin from gravity-sensing columella cells at the root apex. The resulting lateral auxin gradient is hypothesized to drive differential cell expansion in elongation-zone tissues. We mapped those root tissues that function to transport or respond to auxin during a gravitropic response. Targeted expression of the auxin influx facilitator AUX1 demonstrated that root gravitropism requires auxin to be transported via the lateral root cap to all elongating epidermal cells. A three-dimensional model of the root elongation zone predicted that AUX1 causes the majority of auxin to accumulate in the epidermis. Selectively disrupting the auxin responsiveness of expanding epidermal cells by expressing a mutant form of the AUX/IAA17 protein, axr3-1, abolished root gravitropism. We conclude that gravitropic curvature in Arabidopsis roots is primarily driven by the differential expansion of epidermal cells in response to an influx-carrier-dependent auxin gradient.	Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; Simons Rock Coll, Dept Phys, Great Barrington, MA 01230 USA; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; State Univ Ghent VIB, B-9052 Ghent, Belgium; SLU, Umea Plant Sci Ctr, SE-90183 Umea, Sweden	University of Nottingham; University of York - UK; University of Cambridge; Flanders Institute for Biotechnology (VIB); Ghent University; Swedish University of Agricultural Sciences; Umea University	Bennett, MJ (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	malcolm.bennett@nottingham.ac.uk	Kramer, Eric M/B-9752-2008; Beemster, Gerrit/E-6668-2016; Leyser, Ottoline/AAC-5577-2019; Bennett, Malcolm/G-4004-2010	Beemster, Gerrit/0000-0001-6014-053X; swarup, Ranjan/0000-0002-6438-9188; Haseloff, Jim/0000-0003-4793-8058; Bhalerao, Rishikesh/0000-0003-4384-7036; Knox, Kirsten/0000-0002-5487-1763; Bennett, Malcolm/0000-0003-0475-390X; Leyser, Ottoline/0000-0003-2161-3829; Kramer, Eric/0000-0002-1424-2356	Biotechnology and Biological Sciences Research Council [REI20541, BB/C514958/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Blancaflor EB, 2003, PLANT PHYSIOL, V133, P1677, DOI 10.1104/pp.103.032169; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Boonsirichai K, 2002, ANNU REV PLANT BIOL, V53, P421, DOI 10.1146/annurev.arplant.53.100301.135158; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Fasano JM, 2002, J PLANT GROWTH REGUL, V21, P71, DOI 10.1007/s003440010049; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; KONINGS H, 1967, ACTA BOT NEERL, V16, P161, DOI 10.1111/j.1438-8677.1967.tb00043.x; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; KUTSCHERA U, 1989, PHYSIOL PLANTARUM, V77, P157, DOI 10.1111/j.1399-3054.1989.tb05992.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Monshausen GB, 2002, PLANTA, V215, P980, DOI 10.1007/s00425-002-0880-8; Moore I, 2002, CURR BIOL, V12, pR452, DOI 10.1016/S0960-9822(02)00943-0; Morita MT, 2004, CURR OPIN PLANT BIOL, V7, P712, DOI 10.1016/j.pbi.2004.09.001; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Mullen JL, 1998, PLANTA, V206, P598, DOI 10.1007/s004250050437; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; OHWAKI Y, 1976, PLANT CELL PHYSIOL, V17, P1329; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peters WS, 2000, PLANT PHYSIOL, V123, P605, DOI 10.1104/pp.123.2.605; Plieth C, 2002, PLANT PHYSIOL, V129, P786, DOI 10.1104/pp.011007; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; SACK FD, 1991, INT REV CYTOL, V127, P193; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Tanaka A, 2002, J EXP BOT, V53, P683, DOI 10.1093/jexbot/53.369.683; Tian Q, 1999, DEVELOPMENT, V126, P711; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; TSURUMI S, 1978, PLANT CELL PHYSIOL, V19, P1195; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; van der Weele CM, 2003, PLANT PHYSIOL, V132, P1138, DOI 10.1104/pp.103.021345; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Weise SE, 2000, PLANT CELL PHYSIOL, V41, P702, DOI 10.1093/pcp/41.6.702; Wolverton C, 2002, PLANTA, V215, P153, DOI 10.1007/s00425-001-0726-9; Yamamoto M, 1998, PLANT CELL PHYSIOL, V39, P660, DOI 10.1093/oxfordjournals.pcp.a029419	49	430	448	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1057	1065		10.1038/ncb1316	http://dx.doi.org/10.1038/ncb1316			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16244669				2022-12-27	WOS:000232930400008
J	Gutierrez, C				Gutierrez, C			Coupling cell proliferation and development in plants	NATURE CELL BIOLOGY			English	Review							ANAPHASE-PROMOTING COMPLEX; GENOME-WIDE ANALYSIS; DNA-REPLICATION; RETINOBLASTOMA PROTEIN; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; FLOWERING-TIME; INHIBITOR ICK1; CYCLIN	Plant genome projects have revealed that both the cell-cycle components and the overall cell-cycle architecture are highly evolutionarily conserved. In addition to the temporal and spatial regulation of cell-cycle progression in individual cells, multicellularity has imposed extra layers of complexity that impinge on the balance of cell proliferation and growth, differentiation and organogenesis. In contrast to animals, organogenesis in plants is a postembryonic and continuous process. Differentiated plant cells can revert to a pluripotent state, proliferate and transdifferentiate. This unique potential is strikingly illustrated by the ability of certain cells to produce a mass of undifferentiated cells or a fully totipotent embryo, which can regenerate mature plants. Conversely, plant cells are highly resistant to oncogenic transformation. This review discusses the role that cell-cycle regulators may have at the interface between cell division and differentiation, and in the context of the high plasticity of plant cells.	CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Gutierrez, C (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain.	cgutierrez@cbm.uam.es	Gutierrez, Crisanto/ABH-8782-2020	Gutierrez, Crisanto/0000-0001-8905-8222				Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; Boudolf V, 2004, PLANT CELL, V16, P945, DOI 10.1105/tpc.021774; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Capron A, 2003, PLANT CELL, V15, P2370, DOI 10.1105/tpc.013847; Capron A, 2003, TRENDS PLANT SCI, V8, P83, DOI 10.1016/S1360-1385(02)00028-6; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Castellano MM, 2001, PLANT CELL, V13, P2671, DOI 10.1105/tpc.13.12.2671; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Cockcroft CE, 2000, NATURE, V405, P575, DOI 10.1038/35014621; Collinge MA, 2004, PLANT CELL, V16, P1035, DOI 10.1105/tpc.019059; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; de Jager SM, 2001, PLANT MOL BIOL, V47, P555, DOI 10.1023/A:1011848528377; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; De Veylder L, 2001, PLANT J, V25, P617, DOI 10.1046/j.1365-313x.2001.00996.x; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; del Pozo JC, 2002, PLANT CELL, V14, P3057, DOI 10.1105/tpc.006791; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Dewitte W, 2003, PLANT CELL, V15, P79, DOI 10.1105/tpc.004838; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Ehsan H, 2004, PLANT PHYSIOL, V134, P1488, DOI 10.1104/pp.103.038117; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; GRAFI G, 1995, SCIENCE, V269, P1262, DOI 10.1126/science.269.5228.1262; Grafi G, 1996, P NATL ACAD SCI USA, V93, P8962, DOI 10.1073/pnas.93.17.8962; Gutierrez C, 2002, CURR OPIN PLANT BIOL, V5, P480, DOI 10.1016/S1369-5266(02)00301-1; Gutierrez C, 2000, EMBO J, V19, P792, DOI 10.1093/emboj/19.5.792; Harrar Y, 2003, PLANT PHYSIOL, V132, P1217, DOI 10.1104/pp.102.019026; Hartung F, 2002, CURR BIOL, V12, P1787, DOI 10.1016/S0960-9822(02)01218-6; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Holding DR, 2002, PLANTA, V214, P373, DOI 10.1007/s00425-001-0686-0; Hulskamp M, 1999, INT REV CYTOL, V186, P147; Ikeda-Iwai M, 2003, PLANT J, V34, P107, DOI 10.1046/j.1365-313X.2003.01702.x; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Kosugi S, 2002, J BIOL CHEM, V277, P16553, DOI 10.1074/jbc.M200913200; Kosugi S, 2002, PLANT PHYSIOL, V128, P833, DOI 10.1104/pp.010642; Kwee HS, 2003, PLANT J, V36, P853, DOI 10.1046/j.1365-313X.2003.01925.x; Lafarge S, 2003, NUCLEIC ACIDS RES, V31, P1148, DOI 10.1093/nar/gkg202; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mariconti L, 2002, J BIOL CHEM, V277, P9911, DOI 10.1074/jbc.M110616200; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; Ormenese S, 2004, ANN BOT-LONDON, V93, P575, DOI 10.1093/aob/mch077; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Ramirez-Parra E, 2004, PLANT CELL, V16, P2350, DOI 10.1105/tpc.104.023978; Ramirez-Parra E, 2003, PLANT J, V33, P801, DOI 10.1046/j.1365-313X.2003.01662.x; Rider SD, 2003, PLANT J, V35, P33, DOI 10.1046/j.1365-313X.2003.01783.x; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Schnittger A, 2003, PLANT CELL, V15, P303, DOI 10.1105/tpc.008342; Schnittger A, 2002, CURR BIOL, V12, P415, DOI 10.1016/S0960-9822(02)00693-0; Schnittger A, 2002, P NATL ACAD SCI USA, V99, P6410, DOI 10.1073/pnas.092657299; Siddiqui NU, 2003, DEVELOPMENT, V130, P3283, DOI 10.1242/dev.00542; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85; Stevens R, 2004, PLANT CELL, V16, P99, DOI 10.1105/tpc.016865; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; Suzuki T, 2004, PLANT J, V38, P673, DOI 10.1111/j.1365-313X.2004.02074.x; Tantikanjana T, 2001, GENE DEV, V15, P1577, DOI 10.1101/gad.887301; Tong W, 2001, MOL CELL BIOL, V21, P1319, DOI 10.1128/MCB.21.4.1319-1328.2001; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Vlieghe K, 2005, CURR BIOL, V15, P59, DOI 10.1016/j.cub.2004.12.038; Vlieghe K, 2003, J CELL SCI, V116, P4249, DOI 10.1242/jcs.00715; Walker JD, 2000, DEVELOPMENT, V127, P3931; Wang GF, 2004, PLANT PHYSIOL, V135, P1084, DOI 10.1104/pp.104.040436; Wang H, 2000, PLANT J, V24, P613, DOI 10.1046/j.1365-313x.2000.00899.x; Wang WM, 2004, DEVELOPMENT, V131, P3147, DOI 10.1242/dev.01187; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; XIE Q, 1995, EMBO J, V14, P4073, DOI 10.1002/j.1460-2075.1995.tb00079.x; Xie Q, 1996, EMBO J, V15, P4900, DOI 10.1002/j.1460-2075.1996.tb00870.x; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yu Y, 2003, PLANT CELL, V15, P2763, DOI 10.1105/tpc.015990; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zhou YM, 2003, PLANTA, V216, P604, DOI 10.1007/s00425-002-0935-x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	93	105	115	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					535	541		10.1038/ncb0605-535	http://dx.doi.org/10.1038/ncb0605-535			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15928697				2022-12-27	WOS:000229562100002
J	Sato, M; Sato, K; Fonarev, P; Huang, CJ; Liou, W; Grant, BD				Sato, M; Sato, K; Fonarev, P; Huang, CJ; Liou, W; Grant, BD			Caenorhabditis elegans RME-6 is a novel regulator of RAB-5 at the clathrin-coated pit	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; J-DOMAIN PROTEIN; C-ELEGANS; EARLY ENDOSOMES; MEDIATED ENDOCYTOSIS; VULVAR INDUCTION; MEMBRANE-FUSION; EFFECTOR; ACTIVATION	Here we identify a new regulator of endocytosis called RME-6. RME-6 is evolutionarily conserved among metazoans and contains Ras-GAP (GTPase-activating protein)-like and Vps9 domains. Consistent with the known catalytic function of Vps9 domains in Rab5 GDP/GTP exchange, we found that RME-6 binds specifically to Caenorhabditis elegans RAB-5 in the GDP-bound conformation, and rme-6 mutants have phenotypes that indicate low RAB-5 activity. However, unlike other Rab5-associated proteins, a rescuing green fluorescent protein (GFP)-RME-6 fusion protein primarily localizes to clathrin-coated pits, physically interacts with alpha-adaptin, a clathrin adaptor protein, and requires clathrin to achieve its cortical localization. In rme-6 mutants, transport from the plasma membrane to endosomes is defective, and small 110-nm endocytic vesicles accumulate just below the plasma membrane. These results suggest a mechanism for the activation of Rab5 in clathrin-coated pits or clathrin-coated vesicles that is essential for the delivery of endocytic cargo to early endosomes.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Chang Gung Univ, Dept Anat, Taoyuan 333, Taiwan; RIKEN, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	Rutgers State University New Brunswick; Chang Gung University; RIKEN	Grant, BD (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	grant@biology.rutgers.edu	Sato, Miyuki/S-5112-2018	Sato, Miyuki/0000-0002-1944-4918; Huang, Chih-Jen/0000-0001-7791-6656; Grant, Barth/0000-0002-5943-8336; Liou, Willisa/0000-0002-3280-9635	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067237] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67237, R01 GM067237] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BRENNER S, 1974, GENETICS, V77, P71; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hayashizaki S, 1998, GENES CELLS, V3, P189, DOI 10.1046/j.1365-2443.1998.00179.x; HORIUCHI H, 1995, J BIOL CHEM, V270, P11257, DOI 10.1074/jbc.270.19.11257; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MISHRA SK, 2004, J BIOL CHEM; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Praitis V, 2001, GENETICS, V157, P1217; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Shiba Y, 2002, J BIOCHEM, V131, P327, DOI 10.1093/oxfordjournals.jbchem.a003107; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; WILLIAMS BD, 1992, GENETICS, V131, P609; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011	46	125	138	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					559	U7		10.1038/ncb1261	http://dx.doi.org/10.1038/ncb1261			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15895077	Green Accepted			2022-12-27	WOS:000229562100010
J	Bae, W; Lee, YJ; Kim, DH; Lee, J; Kim, S; Sohn, EJ; Hwang, I				Bae, Wonsil; Lee, Yong Jik; Kim, Dae Heon; Lee, Junho; Kim, Soojin; Sohn, Eun Ju; Hwang, Inhwan			AKr2A-mediated import of chloroplast outer membrane proteins is essential for chloroplast biogenesis	NATURE CELL BIOLOGY			English	Article							ENVELOPE MEMBRANE; RECEPTOR; DOMAIN; TRANSLOCATION; ATTOC159; SYSTEM; MUTANT; SIGNAL; PLAYS; OEP14	In plant cells, chloroplasts have essential roles in many biochemical reactions and physiological responses(1). Chloroplasts require numerous protein components, but only a fraction of these proteins are encoded by the chloroplast genome. Instead, most are encoded by the nuclear genome and imported into chloroplasts from the cytoplasm post-translationally(2-5). Membrane proteins located in the chloroplast outer envelope membrane (OEM) have a critical function in the import of proteins into the chloroplast. However, the biogenesis of chloroplast OEM proteins remains poorly understood. Here, we report that an Arabidopsis ankyrin repeat protein, AKR2A, plays an essential role in the biogenesis of the chloroplast OEM proteins. AKR2A binds to chloroplast OEM protein targeting signals, as well as to chloroplasts. It also displays chaperone activity towards chloroplast OEM proteins, and facilitates the targeting of OEP7 to chloroplasts in vitro. AKR2A RNAi in plants with an akr2b knockout background showed greatly reduced levels of chloroplast proteins, including OEM proteins, and chloroplast biogenesis was also defective. Thus, AKR2A functions as a cytosolic mediator for sorting and targeting of nascent chloroplast OEM proteins to the chloroplast.	[Bae, Wonsil; Lee, Yong Jik; Kim, Dae Heon; Lee, Junho; Kim, Soojin; Sohn, Eun Ju; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Hwang, I (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea.	ihhwang@postech.ac.kr						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hofmann NR, 2005, TRENDS PLANT SCI, V10, P450, DOI 10.1016/j.tplants.2005.07.009; Jarvis P, 2004, CURR BIOL, V14, pR317, DOI 10.1016/j.cub.2004.03.054; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Keegstra K, 1999, CURR OPIN PLANT BIOL, V2, P471, DOI 10.1016/S1369-5266(99)00021-7; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lee YJ, 2004, MOL CELLS, V17, P281; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; LI HM, 1991, PLANT CELL, V3, P709, DOI 10.1105/tpc.3.7.709; Li HM, 1996, PLANT CELL, V8, P2117, DOI 10.1105/tpc.8.11.2117; Schleiff E, 2000, PLANTA, V211, P449, DOI 10.1007/s004250000357; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Tu SL, 2000, PLANT CELL, V12, P1951, DOI 10.1105/tpc.12.10.1951; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WILSE RR, 2006, STRUCTURE FUNCTION P; Yan JQ, 2002, PLANT J, V29, P193, DOI 10.1046/j.0960-7412.2001.01205.x; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051	30	100	105	5	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					220	U101		10.1038/ncb1683	http://dx.doi.org/10.1038/ncb1683			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193034				2022-12-27	WOS:000252897800018
J	Corbit, KC; Shyer, AE; Dowdle, WE; Gaulden, J; Singla, V; Reiter, JF				Corbit, Kevin C.; Shyer, Amy E.; Dowdle, William E.; Gaulden, Julie; Singla, Veena; Reiter, Jeremy F.			Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; PRIMARY CILIUM; KINESIN-II; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MORPHOGENESIS; DROSOPHILA; TRANSPORT	Primary cilia are microtubule-based organelles involved in signal transduction and project from the surface of most vertebrate cells(1). Proteins that can localize to the cilium, for example, Inversin and Bardet-Biedl syndrome (BBS) proteins, are implicated in both beta-catenin-dependent and -independent Wnt signalling(2-4). Given that Inversin and BBS proteins are found both at the cilium and elsewhere in the cell, the role of the cilium itself in Wnt signalling is not clear. Using three separate mutations that disrupt ciliogenesis (affecting Kif3a, Ift88 and Ofd1)(5-7), we show in this study that the primary cilium restricts the activity of the canonical Wnt pathway in mouse embryos, primary fibroblasts, and embryonic stem cells. Interestingly, unciliated cells activate transcription only in response to Wnt stimulation, but do so much more robustly than ciliated cells. Loss of Kif3a, but not other ciliogenic genes, causes constitutive phosphorylation of Dishevelled (Dvl). Blocking the activity of casein kinase I (CKI) reverses this constitutive Dvl phosphorylation and abrogates pathway hyper-responsiveness. These results suggest that Kif3a restrains canonical Wnt signalling both by restricting the CKI-dependent phosphorylation of Dvl and through a separate ciliary mechanism. More generally, these findings reveal that, in contrast to its role in promoting Hedgehog (Hh) signalling, the cilium restrains canonical Wnt signalling.	[Corbit, Kevin C.; Shyer, Amy E.; Dowdle, William E.; Gaulden, Julie; Singla, Veena; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	jreiter@biochem.ucsf.edu	Dowdle, William/F-3424-2011	Singla, Veena/0000-0002-5107-0717	NIDDK NIH HHS [P30 DK063720] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Ulloa F, 2007, CURR BIOL, V17, P545, DOI 10.1016/j.cub.2007.01.062; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	31	378	394	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					70	U54		10.1038/ncb1670	http://dx.doi.org/10.1038/ncb1670			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084282				2022-12-27	WOS:000252116100014
J	Konno, D; Shioi, G; Shitamukai, A; Mori, A; Kiyonari, H; Miyata, T; Matsuzaki, F				Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Kiyonari, Hiroshi; Miyata, Takaki; Matsuzaki, Fumio			Neuroepithelial progenitors undergo LGN-dependent planar divisions to maintain self-renewability during mammalian neurogenesis	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; RADIAL GLIA; SPINDLE ORIENTATION; CORTICAL-NEURONS; MOUSE NEOCORTEX; PRECURSOR CELLS; G-PROTEIN; DROSOPHILA; FATE; DIFFERENTIATION	During mammalian development, neuroepithelial cells function as mitotic progenitors, which self-renew and generate neurons. Although spindle orientation is important for such polarized cells to undergo symmetric or asymmetric divisions(1,2), its role in mammalian neurogenesis remains unclear. Here we show that control of spindle orientation is essential in maintaining the population of neuroepithelial cells, but dispensable for the decision to either proliferate or differentiate. Knocking out LGN, (the G protein regulator)(3,4), randomized the orientation of normally planar neuroepithelial divisions. The resultant loss of the apical membrane from daughter cells frequently converted them into abnormally localized progenitors without affecting neuronal production rate. Furthermore, overexpression of Inscuteable(5) to induce vertical neuroepithelial divisions shifted the fate of daughter cells. Our results suggest that planar mitosis ensures the self-renewal of neuroepithelial progenitors by one daughter inheriting both apical and basal compartments during neurogenesis.	[Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Matsuzaki, Fumio] RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Konno, Daijiro; Shioi, Go; Shitamukai, Atsunori; Mori, Asako; Matsuzaki, Fumio] RIKEN, Japan Sci & Technol Corp, CREST, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Japan Sci & Technol Corp, Showa Ku,Dept Anat & Cell Biol, Aichi 4668550, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Japan Sci & Technol Corp, CREST,Showa Ku, Aichi 4668550, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN; RIKEN; Japan Science & Technology Agency (JST); Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Matsuzaki, F (corresponding author), RIKEN, Lab Cell Asymmetry, Ctr Dev Biol, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	fumio@cdb.riken.jp	Shitamukai, Atsunori/C-6817-2014; Kiyonari, Hiroshi/N-7936-2015; MIYATA, TAKAKI/I-7066-2014; Shitamukai, Atsunori/AAT-8802-2021	Shitamukai, Atsunori/0000-0003-4216-927X				Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2007, CURR BIOL, V17, P146, DOI 10.1016/j.cub.2006.11.023; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ochiai W, 2007, NEUROSCI RES, V57, P326, DOI 10.1016/j.neures.2006.10.015; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	38	368	373	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					93	U78		10.1038/ncb1673	http://dx.doi.org/10.1038/ncb1673			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084280				2022-12-27	WOS:000252116100017
J	Kanai, M; Hanashiro, K; Kim, SH; Hanai, S; Boulares, AH; Miwa, M; Fukasawa, K				Kanai, Masayuki; Hanashiro, Kazuhiko; Kim, Song-Hee; Hanai, Shuji; Boulares, A. Hamid; Miwa, Masanao; Fukasawa, Kenji			Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation	NATURE CELL BIOLOGY			English	Article							RING-FINGER DOMAIN; DNA-BINDING; PROTEIN; MDM2; POLYMERASE; ACTIVATION; CELLS; PARP; TRANSCRIPTION; LOCALIZATION	Poly( ADP- ribose) polymerase 1 (PARP- 1) and p53 are two key proteins in the DNA-damage response. Although PARP1 is known to poly( ADP- ribosyl) ate p53, the role of this modification remains elusive. Here, we identify the major poly( ADP- ribosyl) ated sites of p53 by PARP- 1 and find that PARP-1-mediated poly( ADP- ribosyl) ation blocks the interaction between p53 and the nuclear export receptor Crm1, resulting in nuclear accumulation of p53. These findings molecularly link PARP- 1 and p53 in the DNA-damage response, providing the mechanism for how p53 accumulates in the nucleus in response to DNA damage. PARP- 1 becomes super-activated by binding to damaged DNA, which in turn poly( ADP- ribosyl) ates p53. The nuclear export machinery is unable to target poly( ADP- ribosyl) ated p53, promoting accumulation of p53 in the nucleus where p53 exerts its transactivational function.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 305, Japan; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; Nagahama Inst Biosci & Technol, Fac Biosci, Shiga 526, Japan	H Lee Moffitt Cancer Center & Research Institute; University System of Ohio; University of Cincinnati; National Institute of Advanced Industrial Science & Technology (AIST); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fukasawa, K (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	kenji.fukasawa@uc.edu			NCI NIH HHS [CA90522, CA95925] Funding Source: Medline; NHLBI NIH HHS [HL072889] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090522, R01CA095925] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agarwal ML, 1997, ONCOGENE, V15, P1035, DOI 10.1038/sj.onc.1201274; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Burkle A, 2001, CANCER LETT, V163, P1, DOI 10.1016/S0304-3835(00)00694-7; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Kanai M, 2003, MOL CELL BIOL, V23, P2451, DOI 10.1128/MCB.23.7.2451-2462.2003; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Simbulan-Rosenthal CM, 1999, CANCER RES, V59, P2190; Simbulan-Rosenthal CM, 1998, BIOCHEM BIOPH RES CO, V253, P864, DOI 10.1006/bbrc.1998.9792; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wesierska-Gadek J, 2003, J CELL BIOCHEM, V89, P220, DOI 10.1002/jcb.10521; Wesierska-Gadek J, 2001, CELL MOL BIOL LETT, V6, P117; WesierskaGadek J, 1996, BIOCHEM BIOPH RES CO, V224, P96, DOI 10.1006/bbrc.1996.0990; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	34	158	161	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1175	1183		10.1038/ncb1638	http://dx.doi.org/10.1038/ncb1638			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891139				2022-12-27	WOS:000249882300013
J	Xie, ZP; Klionsky, DJ				Xie, Zhiping; Klionsky, Daniel J.			Autophagosome formation: Core machinery and adaptations	NATURE CELL BIOLOGY			English	Review							VACUOLE TARGETING PATHWAY; PROTEIN CONJUGATION SYSTEM; COILED-COIL PROTEIN; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; AMINOPEPTIDASE-I; PEROXISOME DEGRADATION; YEAST AUTOPHAGY; PICHIA-PASTORIS; MOLECULAR-MECHANISMS	Eukaryotic cells employ autophagy to degrade damaged or obsolete organelles and proteins. Central to this process is the formation of autophagosomes, double-membrane vesicles responsible for delivering cytoplasmic material to lysosomes. In the past decade many autophagy-related genes, ATG, have been identified that are required for selective and/or nonselective autophagic functions. In all types of autophagy, a core molecular machinery has a critical role in forming sequestering vesicles, the autophagosome, which is the hallmark morphological feature of this dynamic process. Additional components allow autophagy to adapt to the changing needs of the cell.	Univ Michigan, Inst Life Sci, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Xie, Zhiping/A-1306-2015	Xie, Zhiping/0000-0001-5816-6159	NIGMS NIH HHS [GM53396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ano Y, 2005, MOL BIOL CELL, V16, P446, DOI 10.1091/mbc.E04-09-0842; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cao Y, 2007, AUTOPHAGY, V3, P17, DOI 10.4161/auto.3371; Chang T, 2005, MOL BIOL CELL, V16, P4941, DOI 10.1091/mbc.E05-02-0143; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; DUNNER DL, 1983, PSYCHIAT DEV, V1, P75; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Hamasaki M, 2003, CELL STRUCT FUNCT, V28, P49; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Leao-Helder AN, 2004, FEBS LETT, V577, P491, DOI 10.1016/j.febslet.2004.10.055; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Monastyrska I, 2005, TRAFFIC, V6, P66, DOI 10.1111/j.1600-0854.2004.00252.x; Monastyrska I, 2005, AUTOPHAGY, V1, P92, DOI 10.4161/auto.1.2.1832; Mukaiyama H, 2004, MOL BIOL CELL, V15, P58, DOI 10.1091/mbc.e03-05-0340; Munz C, 2006, CELL MICROBIOL, V8, P891, DOI 10.1111/j.1462-5822.2006.00714.x; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nazarko TY, 2007, MOL BIOL CELL, V18, P106, DOI 10.1091/mbc.E06-06-0554; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Panaretou C, 1997, J BIOL CHEM, V272, P2477; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2006, J CELL SCI, V119, P2903, DOI 10.1242/jcs.03047; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stasyk OV, 2006, AUTOPHAGY, V2, P30, DOI 10.4161/auto.2226; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	100	1644	1721	14	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1102	1109		10.1038/ncb1007-1102	http://dx.doi.org/10.1038/ncb1007-1102			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17909521				2022-12-27	WOS:000249882300002
J	Denecker, G; Hoste, E; Gilbert, B; Hochepied, T; Ovaere, P; Lippens, S; Van den Broecke, C; Van Damme, P; D'Herde, K; Hachem, JP; Borgonie, G; Presland, RB; Schoonjans, L; Libert, C; Vandekerckhove, J; Gevaert, K; Vandenabeele, P; Declercq, W				Denecker, Geertrui; Hoste, Esther; Gilbert, Barbara; Hochepied, Tino; Ovaere, Petra; Lippens, Saskia; Van den Broecke, Caroline; Van Damme, Petra; D'Herde, Katharina; Hachem, Jean-Pierre; Borgonie, Gaetan; Presland, Richard B.; Schoonjans, Luc; Libert, Claude; Vandekerckhove, Joel; Gevaert, Kris; Vandenabeele, Peter; Declercq, Wim			Caspase-14 protects against epidermal UVB photodamage and water loss	NATURE CELL BIOLOGY			English	Article							STRATUM-CORNEUM; INDUCED APOPTOSIS; ICHTHYOSIS VULGARIS; MICE LACKING; CELL-DEATH; DIFFERENTIATION; SKIN; KERATINOCYTES; FILAGGRIN; PROFILAGGRIN	Caspase-14 belongs to a conserved family of aspartate-specific proteinases. Its expression is restricted almost exclusively to the suprabasal layers of the epidermis and the hair follicles(1-4). Moreover, the proteolytic activation of caspase-14 is associated with stratum corneum formation, implicating caspase-14 in terminal keratinocyte differentiation and cornification(5,6). Here, we show that the skin of caspase-14-deficient mice was shiny and lichenified, indicating an altered stratum-corneum composition. Caspase-14-deficient epidermis contained significantly more alveolar keratohyalin F-granules, the profilaggrin stores. Accordingly, caspase-14-deficient epidermis is characterized by an altered profilaggrin processing pattern and we show that recombinant caspase-14 can directly cleave profilaggrin in vitro. Caspase-14-deficient epidermis is characterized by reduced skin-hydration levels and increased water loss. In view of the important role of filaggrin in the structure and moisturization of the skin, the knockout phenotype could be explained by an aberrant processing of filaggrin. Importantly, the skin of caspase-14-deficient mice was highly sensitive to the formation of cyclobutane pyrimidine dimers after UVB irradiation, leading to increased levels of UVB-induced apoptosis. Removal of the stratum corneum indicate that caspase-14 controls the UVB scavenging capacity of the stratum corneum.	VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; Univ Ghent, Dept Pathol, B-9000 Ghent, Belgium; VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; Univ Ghent, Dept Anat Embryol Histol Med Phys, B-9000 Ghent, Belgium; Free Univ Brussels, Dept Dermatol, B-1090 Brussels, Belgium; Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; Univ Washington, Dept Oral Biol & Med Dermatol, Seattle, WA 98195 USA; Univ Leuven, Dept Mol & Cellular Med, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; University of Washington; University of Washington Seattle; KU Leuven	Vandenabeele, P (corresponding author), VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.ugent.be; wim.declercq@dmbr.ugent.be	Vandenabeele, Peter/C-8597-2009; Van Damme, Petra/C-7269-2008; Denecker, Geertrui/E-8134-2010; Gevaert, Kris/H-3637-2013; D'Herde, Katharina/AAM-4570-2020; Gevaert, Kris/D-6489-2017; Gevaert, Kris/AAE-4212-2019; Vandenabeele, Peter/AAD-5793-2022; Lippens, Saskia/C-1343-2009; Libert, Claude/A-6504-2010; Hoste, Esther/M-9926-2014	Van Damme, Petra/0000-0001-9090-027X; Gevaert, Kris/0000-0002-4237-0283; D'Herde, Katharina/0000-0001-6591-0476; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Vandenabeele, Peter/0000-0002-6669-8822; Lippens, Saskia/0000-0002-8261-3462; Presland, Richard/0000-0003-1440-7402; Denecker, Geertrui/0000-0002-2515-2911; Hoste, Esther/0000-0002-3181-431X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049183] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR49183] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alibardi L, 2004, J HISTOCHEM CYTOCHEM, V52, P1561, DOI 10.1369/jhc.4A6300.2004; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Chien AJ, 2002, BIOCHEM BIOPH RES CO, V296, P911, DOI 10.1016/S0006-291X(02)02015-6; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Fischer H, 2005, DIFFERENTIATION, V73, P406, DOI 10.1111/j.1432-0436.2005.00046.x; Fischer H, 2004, FEBS LETT, V577, P446, DOI 10.1016/j.febslet.2004.10.046; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lippens S, 2004, AM J PATHOL, V165, P833, DOI 10.1016/S0002-9440(10)63346-9; Lippens S, 2003, CELL DEATH DIFFER, V10, P257, DOI 10.1038/sj.cdd.4401141; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Lu YP, 2004, CANCER RES, V64, P5020, DOI 10.1158/0008-5472.CAN-04-0760; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mikolajczyk J, 2004, BIOCHEMISTRY-US, V43, P10560, DOI 10.1021/bi0498048; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings AV, 2005, J INVEST DERMATOL, V124, P1099, DOI 10.1111/j.1523-1747.2005.23726.x; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743	30	211	225	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					666	U101		10.1038/ncb1597	http://dx.doi.org/10.1038/ncb1597			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515931				2022-12-27	WOS:000246922700012
J	Masui, S; Nakatake, Y; Toyooka, Y; Shimosato, D; Yagi, R; Takahashi, K; Okochi, H; Okuda, A; Matoba, R; Sharov, AA; Ko, MSH; Niwa, H				Masui, Shinji; Nakatake, Yuhki; Toyooka, Yayoi; Shimosato, Daisuke; Yagi, Rika; Takahashi, Kazue; Okochi, Hitoshi; Okuda, Akihiko; Matoba, Ryo; Sharov, Alexei A.; Ko, Minoru S. H.; Niwa, Hitoshi			Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells	NATURE CELL BIOLOGY			English	Article							SELF-RENEWAL; ES CELLS; TRANSCRIPTIONAL REGULATION; GENE; OCT-3/4; NANOG; OCT4; DIFFERENTIATION; COMPLEX; IDENTIFICATION	The pluripotency of embryonic stem (ES) cells is thought to be maintained by a few key transcription factors, including Oct3/4 and Sox2. The function of Oct3/4 in ES cells has been extensively characterized, but that of Sox2 has yet to be determined. Sox2 can act synergistically with Oct3/4 in vitro to activate Oct-Sox enhancers, which regulate the expression of pluripotent stem cell-specific genes, including Nanog, Oct3/4 and Sox2 itself. These findings suggest that Sox2 is required by ES cells for its Oct-Sox enhancer activity. Using inducible Sox2-null mouse ES cells, we show that Sox2 is dispensable for the activation of these Oct-Sox enhancers. In contrast, we demonstrate that Sox2 is necessary for regulating multiple transcription factors that affect Oct3/4 expression and that the forced expression of Oct3/4 rescues the pluripotency of Sox2-null ES cells. These results indicate that the essential function of Sox2 is to stabilize ES cells in a pluripotent state by maintaining the requisite level of Oct3/4 expression.	RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Int Med Ctr Japan, Div Mol Biol & Cell Engn, Dept Regenerat Med, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; Kobe Univ, Lab Dev & Regenerat Med, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; Saitama Med Univ, Div Dev Biol, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; NIA, NIH, Dev Genom & Aging Sect, Genet Lab, Baltimore, MD 21224 USA	RIKEN; Japan Science & Technology Agency (JST); National Center for Global Health & Medicine - Japan; Kobe University; Saitama Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Masui, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Minatojima Minamimachi 2-2-3, Kobe, Hyogo 6500047, Japan.	masui@ri.imcj.go.jp; niwa@cdb.riken.jp	Nakatake, Yuhki/K-5405-2013; Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015; Masui, Shinji/0000-0001-7417-0019	NATIONAL INSTITUTE ON AGING [Z01AG000662, ZIAAG000656, Z01AG000656, ZIAAG000662] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; DEROBERTIS EM, 1995, NATURE, V374, P407, DOI 10.1038/374407a0; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Rathjen J, 1999, J CELL SCI, V112, P601; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Wiebe MS, 2003, J BIOL CHEM, V278, P17901, DOI 10.1074/jbc.M212211200; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	50	836	897	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					625	U26		10.1038/ncb1589	http://dx.doi.org/10.1038/ncb1589			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17515932				2022-12-27	WOS:000246922700007
J	Yang, ZF; Mott, S; Rosmarin, AG				Yang, Zhong-Fa; Mott, Stephanie; Rosmarin, Alan G.			The Ets transcription factor GABP is required for cell-cycle progression	NATURE CELL BIOLOGY			English	Article							MOUSE DNA-POLYMERASE; BINDING-PROTEIN; GENE-EXPRESSION; ALPHA; SKP2; E2F; ACTIVATION; SUBUNITS; PROMOTER; COMPLEX	The transition from cellular quiescence (G0) into S phase is regulated by the mitogenic-activation of D-type cyclins and cyclin-dependent kinases (Cdks), the sequestration of the Cdk inhibitors (CDKIs), p21 and p27, and the hyperphosphorylation of Rb with release of E2F transcription factors(1,2). However, fibroblasts that lack all D-type cyclins can still undergo serum-induced proliferation(3) and key E2F targets are expressed at stable levels despite cyclical Rb-E2F activity(1). Here, we show that serum induces expression of the Ets transcription factor, Gabp alpha, and that its ectopic expression induces quiescent cells to re-enter the cell cycle. Genetic disruption of Gabpa prevents entry into S phase, and selectively reduces expression of genes that are required for DNA synthesis and degradation of CDKIs, yet does not alter expression of D-type cyclins, Cdks, Rb or E2Fs. Thus, GABP is necessary and sufficient for re-entry into the cell cycle and it regulates a pathway that is distinct from that of D-type cyclins and CDKs.	Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; Brown Univ, Sch Med, Div Hematol Oncol, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Rosmarin, AG (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	Rosmarin@Brown.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757, P20RR017695, P20RR015578] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073945] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20RR018757, P20 RR15578, 1P20RR017695] Funding Source: Medline; NHLBI NIH HHS [1R01HL073945] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; CARTER RS, 1992, J BIOL CHEM, V267, P23418; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Genuario R. Robert, 1993, Gene Expression, V3, P279; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Imaki H, 2003, CANCER RES, V63, P4607; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Luo ML, 1999, GENE, V234, P119, DOI 10.1016/S0378-1119(99)00167-5; MIYAZAWA H, 1993, J BIOL CHEM, V268, P8111; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; Nishikawa NS, 2001, GENES CELLS, V6, P57, DOI 10.1046/j.1365-2443.2001.00395.x; Resendes KK, 2006, MOL CELL BIOL, V26, P3060, DOI 10.1128/MCB.26.8.3060-3070.2006; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rudge TL, 2002, EXP CELL RES, V274, P45, DOI 10.1006/excr.2001.5451; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sucharov C, 1995, GENE EXPRESSION, V5, P93; Villena JA, 1998, BIOCHEM J, V331, P121, DOI 10.1042/bj3310121; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	30	81	81	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					339	U164		10.1038/ncb1548	http://dx.doi.org/10.1038/ncb1548			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277770				2022-12-27	WOS:000244558600019
J	Takahashi, A; Ohtani, N; Yamakoshi, K; Iida, SI; Tahara, H; Nakayama, K; Nakayama, KI; Ide, T; Saya, H; Hara, E				Takahashi, Akiko; Ohtani, Naoko; Yamakoshi, Kimi; Iida, Shin-ichi; Tahara, Hidetoshi; Nakayama, Keiko; Nakayama, Keiichi I.; Ide, Toshinori; Saya, Hideyuki; Hara, Eiji			Mitogenic signalling and the p16(INK4a)-Rb pathway cooperate to enforce irreversible cellular senescence	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-C; HUMAN FIBROBLASTS; CANCER-CELLS; DELTA; P53; EXPRESSION; ARREST; PHOSPHORYLATION; SUPPRESSION; ACTIVATION	The p16(INK4a) cyclin-dependent kinase inhibitor has a key role in establishing stable G1 cell-cycle arrest through activating the retinoblastoma (Rb) tumour suppressor protein pRb(1-5) in cellular senescence. Here, we show that the p16(INK4a)/Rb-pathway also cooperates with mitogenic signals to induce elevated intracellular levels of reactive oxygen species (ROS), thereby activating protein kinase C delta (PKC delta) in human senescent cells. Importantly, once activated by ROS, PKC delta promotes further generation of ROS, thus establishing a positive feedback loop to sustain ROS-PKC delta signalling(6-8). Sustained activation of ROS-PKC delta signalling irreversibly blocks cytokinesis, at least partly through reducing the level of WARTS (also known as LATS1), a mitotic exit network (MEN) kinase required for cytokinesis(9--11), in human senescent cells. This irreversible cytokinetic block is likely to act as a second barrier to cellular immortalization ensuring stable cell-cycle arrest in human senescent cells. These results uncover an unexpected role for the p16(INK4a)-Rb pathway and provide a new insight into how senescent cell-cycle arrest is enforced in human cells.	Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; Kumamoto Univ, Grad Sch Med Sci, Kumamoto 8608556, Japan; Hiroshima Univ, Sch Med, Hiroshima 7348551, Japan; Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan; Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; Hiroshima Int Univ, Fac Pharmaceut Sci, Kure 7370112, Japan	Tokushima University; Kumamoto University; Hiroshima University; Tohoku University; Kyushu University	Hara, E (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	hara@genome.tokushima-u.ac.jp	Ohtani, Naoko/AAB-1891-2021; Saya, Hideyuki/J-4325-2013	Ohtani, Naoko/0000-0001-8934-0797; Takahashi, Akiko/0000-0003-1904-7645				Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Behrend L, 2005, MOL CELL BIOL, V25, P7758, DOI 10.1128/MCB.25.17.7758-7769.2005; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; ELIOR I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GORMAN SD, 1985, J CELL PHYSIOL, V125, P122, DOI 10.1002/jcp.1041250116; Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; TAHARA H, 1995, ONCOGENE, V10, P835; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Wheaton K, 2004, MOL CELL BIOL, V24, P7298, DOI 10.1128/MCB.24.16.7298-7311.2004; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140	31	361	381	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1291	U63		10.1038/ncb1491	http://dx.doi.org/10.1038/ncb1491			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17028578				2022-12-27	WOS:000241732400019
J	Huang, GN; Zeng, WZ; Kim, JY; Yuan, JP; Han, LH; Muallem, S; Worley, PF				Huang, Guo N.; Zeng, Weizhong; Kim, Joo Young; Yuan, Joseph P.; Han, Linhuang; Muallem, Shmuel; Worley, Paul F.			STIM1 carboxyl-terminus activates native SOC, I-crac and TRPC1 channels	NATURE CELL BIOLOGY			English	Article							PLASMA-MEMBRANE; CA2+ SENSOR; PROTEINS; STORE; FAMILY; CELLS; COMPONENTS; RECEPTORS	Receptor- evoked Ca2+ signalling involves Ca2+ release from the endoplasmic reticulum, followed by Ca2+ influx across the plasma membrane(1). Ca2+ influx is essential for many cellular functions, from secretion to transcription, and is mediated by Ca2+- release activated Ca2+ (I-crac) channels and store- operated calcium entry ( SOC) channels(2). Although the molecular identity and regulation of I-crac and SOC channels have not been precisely determined(1), notable recent findings are the identification of STIM1, which has been indicated to regulate SOC and I-crac channels by functioning as an endoplasmic reticulum Ca2+ sensor(3-6), and ORAI1 ( ref. 7) or CRACM1 ( ref. 8) - both of which may function as I-crac channels or as an I-crac subunit. How STIM1 activates the Ca2+ influx channels and whether STIM1 contributes to the channel pore remains unknown. Here, we identify the structural features that are essential for STIM1- dependent activation of SOC and I-crac channels, and demonstrate that they are identical to those involved in the binding and activation of TRPC1. Notably, the cytosolic carboxyl terminus of STIM1 is sufficient to activate SOC, I-crac and TRPC1 channels even when native STIM1 is depleted by small interfering RNA. Activity of STIM1 requires an ERM domain, which mediates the selective binding of STIM1 to TRPC1, 2 and 4, but not to TRPC3, 6 or 7, and a cationic lysine- rich region, which is essential for gating of TRPC1. Deletion of either region in the constitutively active STIM1(D76A) yields dominant- negative mutants that block native SOC channels, expressed TRPC1 in HEK293 cells and I-crac in Jurkat cells. These observations implicate STIM1 as a key regulator of activity rather than a channel component, and reveal similar regulation of SOC, I(cra)c and TRPC channel activation by STIM1.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Muallem, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	shumuel.muallem@utsouthwestern.edu; pworley@jhmi.edu	Kim, Joo Young/X-7562-2019	Kim, Joo Young/0000-0003-2623-1491; Huang, Guo/0000-0002-4335-9123	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00266, DA10309] Funding Source: Medline; NIMH NIH HHS [MH068830] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tsai RYL, 1997, BIOTECHNIQUES, V23, P794, DOI 10.2144/97235bm06; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	19	521	544	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1003	U96		10.1038/ncb1454	http://dx.doi.org/10.1038/ncb1454			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906149				2022-12-27	WOS:000240241700017
J	Friedmann, E; Hauben, E; Maylandt, K; Schleeger, S; Vreugde, S; Lichtenthaler, SF; Kuhn, PH; Stauffer, D; Rovelli, G; Martoglio, B				Friedmann, Elena; Hauben, Ehud; Maylandt, Kerstin; Schleeger, Simone; Vreugde, Sarah; Lichtenthaler, Stefan F.; Kuhn, Peer-Hendrik; Stauffer, Daniela; Rovelli, Giorgio; Martoglio, Bruno			SPPL2a and SPPL2b promote intramembrane proteolysis of TNF alpha in activated dendritic cells to trigger IL-12 production	NATURE CELL BIOLOGY			English	Article							SIGNAL PEPTIDE PEPTIDASE; TUMOR-NECROSIS-FACTOR; GAMMA-SECRETASE; ASPARTIC PROTEASES; TRANSMEMBRANE FORM; FACTOR RECEPTOR; IDENTIFICATION; PRESENILIN-1; SUPERFAMILY; MACROPHAGES	Homologues of signal peptide peptidase ( SPPLs) are putative aspartic proteases that may catalyse regulated intramembrane proteolysis of type II membrane-anchored signalling factors. Here, we show that four human SPPLs are each sorted to a different compartment of the secretory pathway. We demonstrate that SPPL2a and SPPL2b, which are sorted to endosomes and the plasma membrane, respectively, are functional proteases that catalyse intramembrane cleavage of tumour necrosis factor alpha ( TNF alpha). The two proteases promoted the release of the TNFa intracellular domain, which in turn triggers expression of the pro-inflammatory cytokine interleukin-12 by activated human dendritic cells. Our study reveals a critical function for SPPL2a and SPPL2b in the regulation of innate and adaptive immunity.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland; San Raffaele Telethon Inst Gene Therapy, HSR, TIGET, I-20132 Milan, Italy; Novartis Pharma AG, Expertise Platform Proteases, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; DIBIT, Mol Histol & Cell Growth Unit, I-20132 Milan, Italy; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Novartis; University of Munich	Martoglio, B (corresponding author), Novartis Pharma AG, Expertise Platform Proteases, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.	bruno.martoglio@novartis.com	Lichtenthaler, Stefan F/B-6587-2016; Hauben, Ehud/R-8692-2019	Lichtenthaler, Stefan F/0000-0003-2211-2575; Hauben, Ehud/0000-0002-6062-411X; Kuhn, Peer-Hendrik/0000-0001-7891-5102; Vreugde, Sarah/0000-0003-4719-9785				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; CARTSTEA ED, 2005, IDRUGS, V8, P642; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Domonkos A, 2001, EUR CYTOKINE NETW, V12, P411; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hauben E, 2005, TRENDS IMMUNOL, V26, P248, DOI 10.1016/j.it.2005.03.004; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; PECK R, 1989, CELL IMMUNOL, V122, P1, DOI 10.1016/0008-8749(89)90143-3; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2002, ESSAYS BIOCHEM, V38, P155, DOI 10.1042/bse0380155; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Watts AD, 1999, J LEUKOCYTE BIOL, V66, P1005, DOI 10.1002/jlb.66.6.1005; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	34	158	168	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					843	U95		10.1038/ncb1440	http://dx.doi.org/10.1038/ncb1440			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16829952				2022-12-27	WOS:000239423000014
J	Peinelt, C; Vig, M; Koomoa, DL; Beck, A; Nadler, MJS; Koblan-Huberson, M; Lis, A; Fleig, A; Penner, R; Kinet, JP				Peinelt, Christine; Vig, Monika; Koomoa, Dana L.; Beck, Andreas; Nadler, Monica J. S.; Koblan-Huberson, Murielle; Lis, Annette; Fleig, Andrea; Penner, Reinhold; Kinet, Jean-Pierre			Amplification of CRAC current by STIM1 and CRACM1 (Orai1)	NATURE CELL BIOLOGY			English	Article							OPERATED CALCIUM-CHANNELS; PLASMA-MEMBRANE; CA2+ CHANNELS; T-LYMPHOCYTES; MAST-CELLS; STORE; DEPLETION; POTENTIATION; INFLUX; SENSOR	Depletion of intracellular calcium stores activates store-operated calcium entry across the plasma membrane in many cells. STIM1, the putative calcium sensor in the endoplasmic reticulum, and the calcium release-activated calcium ( CRAC) modulator CRACM1 ( also known as Orai1) in the plasma membrane have recently been shown to be essential for controlling the store-operated CRAC current ( I-CRAC)(1-4). However, individual overexpression of either protein fails to significantly amplify I-CRAC. Here, we show that STIM1 and CRACM1 interact functionally. Overexpression of both proteins greatly potentiates I-CRAC, suggesting that STIM1 and CRACM1 mutually limit store-operated currents and that CRACM1 may be the long-sought CRAC channel.	Univ Hawaii, Ctr Biomed Res, Queens Med Ctr, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Penner, R (corresponding author), Univ Hawaii, Ctr Biomed Res, Queens Med Ctr, Honolulu, HI 96813 USA.	rpenner@hawaii.edu; jkinet@bidmc.harvard.edu	Peinelt, Christine/ABH-5292-2020	Fleig, Andrea/0000-0001-8396-7249; Peinelt, Christine/0000-0002-3474-6893; Vig, Monika/0000-0002-4770-8853; Penner, Reinhold/0000-0002-5366-1537	NIAID NIH HHS [R01-AI050200, R01 AI050200] Funding Source: Medline; NIGMS NIH HHS [R37 GM053950, R01 GM065360, R01-GM065360, 5-R37-GM053950] Funding Source: Medline; NINDS NIH HHS [R01-NS040927, R01 NS040927] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053950, R01GM065360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; HOTH M, 1995, PFLUG ARCH EUR J PHY, V430, P315, DOI 10.1007/BF00373905; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; VIG M, 2006, SCIENCE; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zweifach A, 1996, J GEN PHYSIOL, V107, P597, DOI 10.1085/jgp.107.5.597; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	15	464	496	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					771	U231		10.1038/ncb1435	http://dx.doi.org/10.1038/ncb1435			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16733527	Green Accepted			2022-12-27	WOS:000238837800021
J	Munoz, R; Moreno, M; Oliva, C; Orbenes, C; Larrain, J				Munoz, R; Moreno, M; Oliva, C; Orbenes, C; Larrain, J			Syndecan-4 regulates non-canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos	NATURE CELL BIOLOGY			English	Article							CONTROLS CELL POLARITY; GASTRULATION MOVEMENTS; FRIZZLED-7; ADHESION; INTEGRIN; REPAIR	Early shaping of Xenopus laevis embryos occurs through convergent and extension movements, a process that is driven by intercalation of polarized dorsal mesodermal cells and regulated by non-canonical Wnt signalling(1-3). Here, we have identified Xenopus syndecan-4 (xSyn4), a cell-surface transmembrane heparan sulphate proteoglycan. At the gastrula stage, xSyn4 is expressed in the involuting dorsal mesoderm and the anterior neuroectoderm. Later, it is found in the pronephros, branchial arches, brain and tailbud. Both gain- and loss-of-function of xSyn4 impaired convergent extension movements in Xenopus embryos and in activin-treated ectodermal explants. xSyn4 interacts functionally and biochemically with the Wnt receptor Frizzled7 (xFz7) and its signal transducer Dishevelled (xDsh). Furthermore, xSyn4 is necessary and sufficient for translocation of xDsh to the plasma membrane - a landmark in the activation of non-canonical Wnt signalling(1-3). Our results suggest that the ability of xSyn4 to translocate xDsh is regulated by fibronectin, a component of the extracellular matrix required for proper convergent extension movements(4-6). We propose a model where xSyn4 and fibronectin cooperate with xFz7 and Wnt in the specific activation of the non-canonical Wnt pathway.	Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cell & Mol Biol, Ctr Cell Regulat & Pathol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Larrain, J (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cell & Mol Biol, Ctr Cell Regulat & Pathol, Alameda 340, Santiago, Chile.	jlarrain@bio.puc.cl	Oliva, Carlos/AAS-1194-2020	Oliva, Carlos/0000-0002-9551-149X; Munoz Videla, Rosana/0000-0003-1957-4103				Djiane A, 2000, DEVELOPMENT, V127, P3091; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; Marsden M, 2001, DEVELOPMENT, V128, P3635; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Moreno M, 2005, EMBO J, V24, P1397, DOI 10.1038/sj.emboj.7600615; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Tada M, 2000, DEVELOPMENT, V127, P2227; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wilcox-Adelman SA, 2002, GLYCOCONJUGATE J, V19, P305, DOI 10.1023/A:1025304602057; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	27	114	123	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					492	U123		10.1038/ncb1399	http://dx.doi.org/10.1038/ncb1399			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16604063				2022-12-27	WOS:000237299400013
J	Huang, TT; Nijman, SMB; Mirchandani, KD; Galardy, PJ; Cohn, MA; Haas, W; Gygi, SP; Ploegh, HL; Bernards, R; D'Andrea, AD				Huang, TT; Nijman, SMB; Mirchandani, KD; Galardy, PJ; Cohn, MA; Haas, W; Gygi, SP; Ploegh, HL; Bernards, R; D'Andrea, AD			Regulation of monoubiquitinated PCNA by DUB autocleavage	NATURE CELL BIOLOGY			English	Article							DNA-POLYMERASE-ETA; FANCONI-ANEMIA PATHWAY; DEUBIQUITINATING ENZYMES; TRANSLESION SYNTHESIS; DAMAGE RESPONSE; KAPPA-B; UBIQUITIN; FIDELITY; FAMILY; FANCD2	Monoubiquitination is a reversible post-translational protein modification that has an important regulatory function in many biological processes, including DNA repair. Deubiquitinating enzymes (DUBs) are proteases that are negative regulators of monoubiquitination, but little is known about their regulation and contribution to the control of conjugated-substrate levels. Here, we show that the DUB ubiquitin specific protease 1 (USP1) deubiquitinates the DNA replication processivity factor, PCNA, as a safeguard against error-prone translesion synthesis (TLS) of DNA. Ultraviolet (UV) irradiation inactivates USP1 through an autocleavage event, thus enabling monoubiquitinated PCNA to accumulate and to activate TLS. Significantly, the site of USP1 cleavage is immediately after a conserved internal ubiquitin-like diglycine (Gly - Gly) motif. This mechanism is reminiscent of the processing of precursors of ubiquitin and ubiquitin-like modifiers by DUBs. Our results define a regulatory mechanism for protein ubiquitination that involves the signal-induced degradation of an inhibitory DUB.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Netherlands Cancer Institute; Netherlands Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Galardy, Paul/AAE-9297-2019	Cohn, Martin/0000-0002-2988-3009; Bernards, Rene/0000-0001-8677-3423				Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Choi JH, 2005, DNA REPAIR, V4, P211, DOI 10.1016/j.dnarep.2004.09.006; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PARRIS CN, 1994, J MOL BIOL, V236, P491, DOI 10.1006/jmbi.1994.1160; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Vugmeyster Y, 2002, MOL IMMUNOL, V39, P431, DOI 10.1016/S0161-5890(02)00123-2; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Zhu YA, 1997, J BIOL CHEM, V272, P51	39	418	432	6	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					339	U13		10.1038/ncb1378	http://dx.doi.org/10.1038/ncb1378			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16531995	Green Published			2022-12-27	WOS:000236560000012
J	Meusser, B; Hirsch, C; Jarosch, E; Sommer, T				Meusser, B; Hirsch, C; Jarosch, E; Sommer, T			ERAD: the long road to destruction	NATURE CELL BIOLOGY			English	Review							E3 UBIQUITIN LIGASE; ENDOPLASMIC-RETICULUM DEGRADATION; I MEMBRANE-PROTEIN; RECOGNIZES SUGAR CHAINS; TO-CYTOSOL DISLOCATION; CELL ANTIGEN RECEPTOR; VPU-PROTEIN; GLYCOPROTEIN DEGRADATION; RETRO-TRANSLOCATION; MISFOLDED PROTEINS	Endoplasmic reticulum (ER)-associated protein degradation (ERAD) eliminates misfolded or unassembled proteins from the ER. ERAD targets are selected by a quality control system within the ER lumen and are ultimately destroyed by the cytoplasmic ubiquitin-proteasome system (UPS). The spatial separation between substrate selection and degradation in ERAD requires substrate transport from the ER to the cytoplasm by a process termed dislocation. In this review, we will summarize advances in various aspects of ERAD and discuss new findings on how substrate dislocation is achieved.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Meusser, B (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	tsommer@mdc-berlin.de		Jarosch, Ernst/0000-0002-5897-3492				Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clemons WM, 2004, CURR OPIN STRUC BIOL, V14, P390, DOI 10.1016/j.sbi.2004.07.006; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gelman MS, 2002, J CLIN INVEST, V110, P1591, DOI 10.1172/JCI200216786; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jakob CA, 2001, EMBO REP, V2, P423; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lenk U, 2002, J CELL SCI, V115, P3007; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Pariyarath R, 2001, J BIOL CHEM, V276, P541, DOI 10.1074/jbc.M007944200; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang QQ, 2003, EMBO J, V22, P3792, DOI 10.1093/emboj/cdg378; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	98	942	978	4	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					766	772		10.1038/ncb0805-766	http://dx.doi.org/10.1038/ncb0805-766			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056268				2022-12-27	WOS:000230881500007
J	Qi, L; Strong, MA; Karim, BO; Huso, DL; Greider, CW				Qi, L; Strong, MA; Karim, BO; Huso, DL; Greider, CW			Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation	NATURE CELL BIOLOGY			English	Letter							ATAXIA-TELANGIECTASIA; SACCHAROMYCES-CEREVISIAE; DEFICIENT MICE; DNA BREAKS; DYSFUNCTION; ATM; LENGTH; INSTABILITY; CANCER; JOIN	Telomeres protect chromosome ends from fusion, degradation and recombination. Loss of telomere function has opposite effects on tumorigenesis: apoptosis, which inhibits tumour growth, and genomic instability, which accelerates tumour formation. Here we describe a new mechanism by which short telomeres inhibit tumorigenesis through interference with oncogenic translocations. In mice that are null for both ataxia-telangiectasia-mutated ( Atm) and telomerase RNA ( mTR), the first generation ( G1) Atm(-/-) mTR(-/-) mice have a lower rate of tumour formation than Atm(-/-) mTR(+/+) mice. These Atm(-/-) mTR(-/-) G1 tumours show no increase in either apoptosis or overall genomic instability. Strikingly, the tumours show a high fraction of translocations containing telomere signals at the translocation junctions. Translocations of the T- cell receptors on chromosome 14, which initiate tumorigenesis, were interrupted by fusion with telomeres. Telomere repeats were also detected at the translocation junctions in pre- malignant thymocytes. We propose that telomere fusion to DNA doublestrand breaks competes with the generation of oncogenic translocations and thus reduces tumour formation.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Qi, Ling/0000-0001-8229-0184; Greider, Carol/0000-0002-5494-8126; Strong, Margaret/0000-0002-0055-6573	NCI NIH HHS [CA16519] Funding Source: Medline; NCRR NIH HHS [RR07002, RR00171] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000171] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DuBois ML, 2002, GENETICS, V161, P995; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Latre L, 2003, EXP CELL RES, V287, P282, DOI 10.1016/S0014-4827(03)00134-4; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Qi L, 2003, CANCER RES, V63, P8188; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385	30	24	24	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					706	U99		10.1038/ncb1276	http://dx.doi.org/10.1038/ncb1276			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15965466				2022-12-27	WOS:000230190800015
J	Leidel, S; Delattre, M; Cerutti, L; Baumer, K; Gonczy, P				Leidel, S; Delattre, M; Cerutti, L; Baumer, K; Gonczy, P			SAS-6 defines a protein family required for centrosome duplication in C-elegans and in human cells	NATURE CELL BIOLOGY			English	Article							COILED-COIL PROTEIN; CENTRIOLE DUPLICATION; TUBULIN; SUBSTRATE; NEMATODE; ENCODES; GENE	The mechanisms that ensure centrosome duplication are poorly understood. In Caenorhabditis elegans, ZYG-1,SAS- 4, SAS- 5 and SPD-2 are required for centriole formation. However, it is unclear whether these proteins have functional homologues in other organisms. Here, we identify SAS- 6 as a component that is required for daughter centriole formation in C. elegans. SAS- 6 is a coiled-coil protein that is recruited to centrioles at the onset of the centrosome duplication cycle. Our analysis indicates that SAS-6 and SAS- 5 associate and that this interaction, as well as ZYG-1 function, is required for SAS- 6 centriolar recruitment. SAS- 6 is the founding member of an evolutionarily conserved protein family that contains the novel PISA motif. We investigated the function of the human homologue of SAS-6. GFP - HsSAS-6 localizes to centrosomes and its overexpression results in excess foci-bearing centriolar markers. Furthermore, siRNA-mediated inactivation of HsSAS-6 in U2OS cells abrogates centrosome overduplication following aphidicolin treatment and interferes with the normal centrosome duplication cycle. Therefore, HsSAS-6 is also required for centrosome duplication, indicating that the function of SAS-6-related proteins has been widely conserved during evolution.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	Pierre.Gonczy@isrec.unil.ch	Delattre, Marie/AAJ-1491-2020; Leidel, Sebastian/K-9507-2019; Delattre, Marie/CAG-5526-2022	Delattre, Marie/0000-0003-1640-0300; Leidel, Sebastian/0000-0002-0523-6325; Delattre, Marie/0000-0003-1640-0300; Gonczy, Pierre/0000-0002-6305-6883				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J., 2004, CENTROSOMES DEV DIS, P93; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; BRENNER S, 1974, GENETICS, V77, P71; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; de Loubresse NG, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-4; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Dutcher SK, 1998, MOL BIOL CELL, V9, P1293, DOI 10.1091/mbc.9.6.1293; Dutcher SK, 2002, MOL BIOL CELL, V13, P3859, DOI 10.1091/mbc.E02-04-0205; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Pihan GA, 2003, CANCER RES, V63, P1398; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Praitis V, 2001, GENETICS, V157, P1217; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SONNICHSEN B, IN PRESS NATURE; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5	36	284	294	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					115	U19		10.1038/ncb1220	http://dx.doi.org/10.1038/ncb1220			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15665853				2022-12-27	WOS:000226719500008
J	Torres, J; Watt, FM				Torres, Josema; Watt, Fiona M.			Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NF kappa B and cooperating with Stat3	NATURE CELL BIOLOGY			English	Article							IN-VITRO; TRANSCRIPTION; MAINTENANCE; EPIBLAST; GENE; DIFFERENTIATION; HOMEOPROTEIN; NETWORK; OCT4	Embryonic stem (ES) cells are pluripotent cells derived from the inner cell mass of blastocysts. Self-renewal of mouse ES cells depends on activation of Stat3 by leukaemia inhibitory factor (LIF) in collaboration with bone morphogenetic protein signalling(1-3). The transcription factor Nanog is essential in maintaining pluripotency(4,5) but the mechanisms involved are poorly understood. Here we examine the functional interactions of Nanog with the Stat3 and NF kappa B pathways. Nanog and Stat3 were found to bind to and synergistically activate Stat3-dependent promoters. We also found that Nanog binds to NF kappa B proteins; however, Nanog binding inhibited transcriptional activity of NF kappa B proteins. Endogenous NF kappa B activity and target-gene expression increased during differentiation of ES cells. Overexpression of NF kappa B proteins promoted differentiation, whereas inhibition of NF kappa B signalling, either by genetic ablation of the Ikbkg gene or overexpression of the I kappa B alpha super-repressor, increased expression of pluripotency markers. We conclude that Nanog represses the pro-differentiation activities of NF kappa B and cooperates with Stat3 to maintain pluripotency.	[Torres, Josema; Watt, Fiona M.] Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Watt, Fiona M.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Watt, FM (corresponding author), Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	Fiona.Watt@cancer.org.uk	Torres, Josema/F-7070-2013; Watt, Fiona/AHB-0226-2022	Torres, Josema/0000-0001-6906-7164; Watt, Fiona/0000-0001-9151-5154	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; EMRE N, CURR OPIN CHEM BIOL, V11, P252; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rasband W.S., 2006, IMAGEJ; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	34	110	120	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					194	U68		10.1038/ncb1680	http://dx.doi.org/10.1038/ncb1680			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18223644				2022-12-27	WOS:000252897800015
J	Bagnat, M; Cheung, ID; Mostov, KE; Stainier, DYR				Bagnat, Michel; Cheung, Isla D.; Mostov, Keith E.; Stainier, Didier Y. R.			Genetic control of single lumen formation in the zebrafish gut	NATURE CELL BIOLOGY			English	Article							TIGHT JUNCTIONS; TUBE MORPHOGENESIS; NAGIE-OKO; PROTEIN; DROSOPHILA; CLAUDINS; SYSTEM; FAMILY; CELL; SPECIFICATION	Most organs consist of networks of interconnected tubes that serve as conduits to transport fluid and cells and act as physiological barriers between compartments. Biological tubes are assembled through very diverse developmental processes that generate structures of different shapes and sizes. Nevertheless, all biological tubes invariably possess one single lumen. The mechanisms responsible for single lumen specification are not known. Here we show that zebrafish mutants for the MODY5 and familial GCKD gene tcf2 ( also known as vhnf1) fail to specify a single lumen in their gut tube and instead develop multiple lumens. We show that Tcf2 controls single lumen formation by regulating claudin15 and Na+/K+-ATPase expression. Our in vivo and in vitro results indicate that Claudin15 functions in paracellular ion transport to specify single lumen formation. This work shows that single lumen formation is genetically controlled and appears to be driven by the accumulation of fluid.	Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Genet & Human Genet, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94147 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bagnat, M (corresponding author), Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	michel.bagnat@ucsf.edu; dstainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026; mostov, keith/0000-0002-8123-6247; Bagnat, Michel/0000-0002-3829-0168				Barbacci E, 1999, DEVELOPMENT, V126, P4795; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GRANTHAM JJ, 1995, J CLIN INVEST, V95, P195, DOI 10.1172/JCI117638; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; Kubota K, 1999, CURR BIOL, V9, P1035, DOI 10.1016/S0960-9822(99)80452-7; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Van Itallie Christina M, 2004, Proc Am Thorac Soc, V1, P38, DOI 10.1513/pats.2306013; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134	31	189	193	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					954	U119		10.1038/ncb1621	http://dx.doi.org/10.1038/ncb1621			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17632505				2022-12-27	WOS:000248486700017
J	Mara, A; Schroeder, J; Chalouni, C; Holley, SA				Mara, Andrew; Schroeder, Joshua; Chalouni, Cecile; Holley, Scott A.			Priming, initiation and synchronization of the segmentation clock by deltaD and deltaC	NATURE CELL BIOLOGY			English	Article							ZEBRAFISH SOMITE-SEGMENTATION; GENE-EXPRESSION; LUNATIC-FRINGE; NOTCH; SOMITOGENESIS; HER1; CELL; OSCILLATOR; BOUNDARIES; ANTERIOR	Zebrafish somitogenesis is governed by a segmentation clock that generates oscillations in expression of several Notch pathway genes, including her1, her7 and deltaC(1-6). Using a combination of pharmacological inhibition and Mendelian genetics, we show that DeltaD and DeltaC, two Notch ligands, represent functionally distinct signals within the segmentation clock. Using high- resolution fluorescent in situ hybridization7, the oscillations were divided into phases based on eight distinct subcellular patterns of mRNA localization for 140,000 cells. her1, her7 and deltaC expression was examined in wild- type, deltaD(-/-) and deltaC(-/-) embryos. We identified areas within the tailbud where the clock is set up in the progenitor cells (priming), where the clock starts running (initiation), and where the clocks of neighbouring cells are entrained (synchronization). We find that the clocks of motile cells are primed by deltaD in a progenitor zone in the posterior tailbud and that deltaD is required for cells to initiate oscillations on exiting this zone. Oscillations of adjacent cells are synchronized and amplified by deltaC in the posterior presomitic mesoderm as cell movement subsides and cells maintain stable neighbour relationships.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Holley, SA (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	scott.holley@yale.edu			NICHD NIH HHS [R01 HD045738] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045738] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; COOKE I, 1981, PHILOS T R SOC B, V295, P509, DOI 10.1098/rstb.1981.0157; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Griffin KJP, 2002, NAT CELL BIOL, V4, P821, DOI 10.1038/ncb862; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Henry CA, 2002, DEVELOPMENT, V129, P3693; Henry CA, 2000, CURR BIOL, V10, P1063, DOI 10.1016/S0960-9822(00)00677-1; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kanki JP, 1997, DEVELOPMENT, V124, P881; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Nikaido M, 2002, NAT GENET, V31, P195, DOI 10.1038/ng899; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Takke C, 1999, DEVELOPMENT, V126, P3005; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153	38	76	77	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					523	U69		10.1038/ncb1578	http://dx.doi.org/10.1038/ncb1578			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17417625				2022-12-27	WOS:000246181500010
J	Li, JY; Brieher, WM; Scimone, ML; Kang, SJ; Zhu, H; Yin, H; von Andrian, UH; Mitchison, T; Yuan, JY				Li, Juying; Brieher, William M.; Scimone, M. Lucila; Kang, Shin Jung; Zhu, Hong; Yin, Helen; von Andrian, Ulrich H.; Mitchison, Timothy; Yuan, Junying			Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization	NATURE CELL BIOLOGY			English	Article							INTERACTING PROTEIN-1; FILAMENTS; COFILIN; FACTOR/COFILIN; IDENTIFICATION; REQUIREMENTS; ACTIVATION; DYNAMICS; EFFECTOR; MOTILITY	Coordinated regulation of cell migration, cytokine maturation and apoptosis is critical in inflammatory responses. Caspases, a family of cysteine proteases, are known to regulate cytokine maturation and apoptosis. Here, we show that caspase-11, a mammalian pro-inflammatory caspase, regulates cell migration during inflammation. Caspase-11-deficient lymphocytes exhibit a cell-autonomous migration defect in vitro and in vivo. We demonstrate that caspase-11 interacts physically and functionally with actin interacting protein 1 ( Aip1),an activator of cofilin-mediated actin depolymerization. The caspase-recruitment domain ( CARD) of caspase-11 interacts with the carboxy-terminal WD40 propeller domain of Aip1 to promote cofilin-mediated actin depolymerization. Cells with Aip1 or caspase-11 deficiency exhibit defects in actin dynamics. Using in vitro actin depolymerization assays, we found that caspase-11 and Aip1 work cooperatively to promote cofilin-mediated actin depolymerization. These data demonstrate a novel cell autonomous caspase-mediated mechanism that regulates actin dynamics and mammalian cell migration distinct from the receptor mediated Rho-Rac-Cdc42 pathway.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Li, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008	Brieher, William/0000-0002-3168-6688; Zhu, Hong/0000-0002-2575-4031	NIA NIH HHS [R37 AG12859] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Heyworth PG, 1997, HISTOCHEM CELL BIOL, V108, P221, DOI 10.1007/s004180050162; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Konzok A, 1999, J CELL BIOL, V146, P453, DOI 10.1083/jcb.146.2.453; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SOUTHWICK FS, 1989, J CELL BIOL, V109, P1561, DOI 10.1083/jcb.109.4.1561; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916	28	107	109	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					276	+		10.1038/ncb1541	http://dx.doi.org/10.1038/ncb1541			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17293856				2022-12-27	WOS:000244558600012
J	Vander Haar, E; Lee, S; Bandhakavi, S; Griffin, TJ; Kim, DH				Vander Haar, Emilie; Lee, Seong-il; Bandhakavi, Sricharan; Griffin, Timothy J.; Kim, Do-Hyung			Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40	NATURE CELL BIOLOGY			English	Article							RICH AKT-SUBSTRATE; MAMMALIAN TARGET; BINDING PARTNER; RAPAMYCIN; TOR; RAPTOR; PATHWAY; GROWTH; PHOSPHORYLATION; IDENTIFICATION	Insulin stimulates protein synthesis and cell growth by activation of the protein kinases Akt ( also known as protein kinase B, PKB) and mammalian target of rapamycin ( mTOR). It was reported that Akt activates mTOR by phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2)(1-4). However, in recent studies the physiological requirement of Akt phosphorylation of TSC2 for mTOR activation has been questioned(5,6). Here, we identify PRAS40 ( proline-rich Akt/PKB substrate 40 kDa) as a novel mTOR binding partner that mediates Akt signals to mTOR. PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition. Binding of PRAS40 inhibits mTOR activity and suppresses constitutive activation of mTOR in cells lacking TSC2. PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of mTOR to Akt signals. Furthermore, PRAS40 phosphorylation by Akt and association with 14-3-3, a cytosolic anchor protein, are crucial for insulin to stimulate mTOR. These findings identify PRAS40 as an important regulator of insulin sensitivity of the Akt-mTOR pathway and a potential target for the treatment of cancers, insulin resistance and hamartoma syndromes.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kim, DH (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	dhkim@umn.edu		Kim, Do-Hyung/0000-0002-2924-4370; Griffin, Timothy/0000-0001-6801-2559	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072004, R56DK072004] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK072004] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Singh A, 2005, GENETICS, V171, P169, DOI 10.1534/genetics.105.044180; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	878	898	1	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					316	U126		10.1038/ncb1547	http://dx.doi.org/10.1038/ncb1547			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277771				2022-12-27	WOS:000244558600016
J	Andrew, N; Insall, RH				Andrew, Natalie; Insall, Robert H.			Chemotaxis in shallow gradients is mediated independently of PtdIns 3-kinase by biased choices between random protrusions	NATURE CELL BIOLOGY			English	Article							DICTYOSTELIUM-DISCOIDEUM AMEBAS; EUKARYOTIC CHEMOTAXIS; CELL POLARITY; COMPASS; MOTILITY; PLAYS; MODEL; TRANSDUCTION; PSEUDOPODIA; MECHANISMS	Current models of eukaryotic chemotaxis propose that directional sensing causes localized generation of new pseudopods(1). However, quantitative analysis of pseudopod generation suggests a fundamentally different mechanism for chemotaxis in shallow gradients: first, pseudopods in multiple cell types are usually generated when existing ones bifurcate and are rarely made de novo; second, in Dictyostelium cells in shallow chemoattractant gradients, pseudopods are made at the same rate whether cells are moving up or down gradients. The location and direction of new pseudopods are random within the range allowed by bifurcation and are not oriented by chemoattractants. Thus, pseudopod generation is controlled independently of chemotactic signalling. Third, directional sensing is mediated by maintaining the most accurate existing pseudopod, rather than through the generation of new ones. Finally, the phosphatidylinositol 3-kinase (PI(3) K) inhibitor LY294002 affects the frequency of pseudopod generation, but not the accuracy of selection, suggesting that PI(3) K regulates the underlying mechanism of cell movement, rather than control of direction.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Insall, RH (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	r.h.insall@bham.ac.uk	Insall, Robert/G-5611-2011	Insall, Robert/0000-0003-4898-040X				Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; GERISCH G, 1981, J CELL SCI, V52, P1; Laevsky G, 2001, BIOTECHNIQUES, V31, P1140, DOI 10.2144/01315rr03; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Meinhardt H, 1999, J CELL SCI, V112, P2867; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Postma M, 2003, MOL BIOL CELL, V14, P5019, DOI 10.1091/mbc.E03-08-0566; Postma M, 2004, J CELL SCI, V117, P2925, DOI 10.1242/jcs.01143; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Sheikh S, 1996, BLOOD, V87, P5040, DOI 10.1182/blood.V87.12.5040.bloodjournal87125040; SHUTT DC, 1995, J CELL BIOL, V131, P1495, DOI 10.1083/jcb.131.6.1495; Stepanovic V, 2005, EUKARYOT CELL, V4, P775, DOI 10.1128/EC.4.4.775-786.2005; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; TRANQUILLO RT, 1988, J CELL BIOL, V106, P303, DOI 10.1083/jcb.106.2.303; Wang YQ, 2006, J CELL SCI, V119, P702, DOI 10.1242/jcs.02742; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	30	279	283	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					193	U91		10.1038/ncb1536	http://dx.doi.org/10.1038/ncb1536			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220879				2022-12-27	WOS:000243903000012
J	De la Fuente, R; Baumann, C; Fan, T; Schmidtmann, A; Dobrinski, I; Muegge, K				De La Fuente, Rabindranath; Baumann, Claudia; Fan, Tao; Schmidtmann, Anja; Dobrinski, Ina; Muegge, Kathrin			Lsh is required for meiotic chromosome synapsis and retrotransposon silencing in female germ cells	NATURE CELL BIOLOGY			English	Article							SNF2 FAMILY; MOUSE; HETEROCHROMATIN; OOCYTES; GENE; MICE; LOCALIZATION; METHYLATION; MEMBER	Lymphoid specific helicase (Lsh) is a major epigenetic regulator that is essential for DNA methylation and transcriptional silencing of parasitic elements in the mammalian genome(1,2). However, whether Lsh is involved in the regulation of chromatin-mediated processes during meiosis is not known. Here, we show that Lsh is essential for the completion of meiosis and transcriptional repression of repetitive elements in the female gonad. Oocytes from Lsh knockout mice exhibit demethylation of transposable elements and tandem repeats at pericentric heterochromatin, as well as incomplete chromosome synapsis associated with persistent RAD51 foci and gamma H2AX phosphorylation. Failure to load crossover-associated foci results in the generation of non-exchange chromosomes. The severe oocyte loss observed and lack of ovarian follicle formation, together with the patterns of Lsh nuclear compartmentalization in the germ line, demonstrate that Lsh has a critical and previously unidentified role in epigenetic gene silencing and maintenance of genomic stability during female meiosis.	Univ Penn, Sch Vet Med, Female Germ Cell Biol Grp, Dept Clin Studies,Ctr Anim Transgenesis & Germ Ce, Kennett Sq, PA 19348 USA; NCI, Mol Immunoregulat Lab, SAIC Basic Res Program, Frederick, MD 21701 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	De la Fuente, R (corresponding author), Univ Penn, Sch Vet Med, Female Germ Cell Biol Grp, Dept Clin Studies,Ctr Anim Transgenesis & Germ Ce, 382 W St Rd,Kennett Sq, Kennett Sq, PA 19348 USA.	rfuente@vet.upenn.edu	Dobrinski, Ina/A-1095-2007	Baumann, Claudia/0000-0002-4647-0839	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042740] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR017359] Funding Source: NIH RePORTER; NCRR NIH HHS [RR17359] Funding Source: Medline; NICHD NIH HHS [HD042740] Funding Source: Medline; PHS HHS [N01-C0-12400] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; De La Fuente R, 2004, DEV BIOL, V275, P447, DOI 10.1016/j.ydbio.2004.08.028; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Fan T, 2005, DEVELOPMENT, V132, P635, DOI 10.1242/dev.01612; Geiman TM, 1998, GENOMICS, V54, P477, DOI 10.1006/geno.1998.5557; Geiman TM, 2001, BBA-GEN SUBJECTS, V1526, P211, DOI 10.1016/S0304-4165(01)00129-5; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Jarvis CD, 1996, GENE, V169, P203, DOI 10.1016/0378-1119(95)00843-8; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kneitz B, 2000, GENE DEV, V14, P1085; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Libby BJ, 2002, DEV BIOL, V242, P174, DOI 10.1006/dbio.2001.0535; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	30	99	102	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1448	U85		10.1038/ncb1513	http://dx.doi.org/10.1038/ncb1513			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115026				2022-12-27	WOS:000242419800022
J	Swedlow, JR; Lewis, SE; Goldberg, IG				Swedlow, Jason R.; Lewis, Suzanna E.; Goldberg, Ilya G.			Modelling data across labs, genomes, space and time	NATURE CELL BIOLOGY			English	Review							QUANTITATIVE-ANALYSIS; CELLS; MICROSCOPY; INFORMATICS; DYNAMICS; ONTOLOGY; SCREEN; FILE	Logical models and physical specifications provide the foundation for storage, management and analysis of complex sets of data, and describe the relationships between measured data elements and metadata - the contextual descriptors that define the primary data. Here, we use imaging applications to illustrate the purpose of the various implementations of data specifications and the requirement for open, standardized, data formats to facilitate the sharing of critical digital data and metadata.	Univ Dundee, Fac Life Sci, Div Gene Regulat & Express, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94729 USA; NIA, Image Informat & Computat Biol Unit, Genet Lab, NIH, Baltimore, MD 21224 USA	University of Dundee; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Swedlow, JR (corresponding author), Univ Dundee, Fac Life Sci, Div Gene Regulat & Express, Wellcome Trust Bioctr, Dow St, Dundee DD1 5EH, Scotland.	jason@lifesci.dundee.ac.uk	Goldberg, Ilya/H-5307-2011	Goldberg, Ilya/0000-0001-8514-6110; Lewis, Suzanna/0000-0002-8343-612X; Swedlow, Jason/0000-0002-2198-1958	NATIONAL INSTITUTE ON AGING [Z01AG000671, ZICAG000671] Funding Source: NIH RePORTER; BBSRC [BB/D006589/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D006589/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews PD, 2002, TRAFFIC, V3, P29, DOI 10.1034/j.1600-0854.2002.30105.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Gerlich D, 2003, NAT CELL BIOL, pS14, DOI 10.1038/ncb1033; Goldberg IG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r47; Huang K, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P325, DOI 10.1109/ISBI.2002.1029259; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Johnston J, 2006, I S BIOMED IMAGING, P1380; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Roques EJS, 2002, TRAFFIC, V3, P61, DOI 10.1034/j.1600-0854.2002.30108.x; Seamer LC, 1997, CYTOMETRY, V28, P118, DOI 10.1002/(SICI)1097-0320(19970601)28:2<118::AID-CYTO3>3.0.CO;2-B; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	28	23	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1190	1194		10.1038/ncb1496	http://dx.doi.org/10.1038/ncb1496			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060903				2022-12-27	WOS:000241732400003
J	Vagnarelli, P; Hudson, DF; Ribeiro, SA; Trinkle-Mulcahy, L; Spence, JM; Lai, F; Farr, CJ; Lamond, AI; Earnshaw, WC				Vagnarelli, Paola; Hudson, Damien F.; Ribeiro, Susana A.; Trinkle-Mulcahy, Laura; Spence, Jennifer M.; Lai, Fan; Farr, Christine J.; Lamond, Angus I.; Earnshaw, William C.			Condensin and Repo-Man-PP1 co-operate in the regulation of chromosome architecture during mitosis	NATURE CELL BIOLOGY			English	Article							STRUCTURAL INTEGRITY; SISTER CHROMATIDS; TOPOISOMERASE-II; ESSENTIAL ROLES; AURORA-B; CENP-C; PROTEIN; SEGREGATION; RESOLUTION; FAMILY	The reversible condensation of chromosomes during cell division remains a classic problem in cell biology. Condensation requires the condensin complex(1) in certain experimental systems(2-8), but not in many others(9-15). Anaphase chromosome segregation almost always fails in condensin-depleted cells, leading to the formation of prominent chromatin bridges and cytokinesis failure(4,9-17). Here, live-cell analysis of chicken DT40 cells bearing a conditional knockout of condensin subunit SMC2 revealed that condensin-depleted chromosomes abruptly lose their compact architecture during anaphase and form massive chromatin bridges. The compact chromosome structure can be preserved and anaphase chromosome segregation rescued by preventing the targeting subunit Repo-Man from recruiting protein phosphatase 1 (PP1) to chromatin at anaphase onset. This study identifies an activity critical for mitotic chromosome structure that is inactivated by Repo-Man-PP1 during anaphase. This activity, provisionally termed 'regulator of chromosome architecture' (RCA), cooperates with condensin to preserve the characteristic chromosome architecture during mitosis.	Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; IPATIMUP, P-4050465 Oporto, Portugal; Univ Dundee, Dundee DD1 5EH, Scotland; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Edinburgh; University of Dundee; University of Cambridge	Earnshaw, WC (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	Bill.Earnshaw@ed.ac.uk	Fukagawa, Tatsuo/AAK-3922-2021; lai, fan/A-9732-2011; Earnshaw, William/AAY-7438-2020; Trinkle-Mulcahy, Laura/E-2197-2013; Lai, Fan/ABD-2862-2021; Vagnarelli, Paola/AAI-1996-2020	Vagnarelli, Paola/0000-0002-0000-2271; Earnshaw, William/0000-0002-7191-0621; Farr, Christine/0000-0002-5357-5962; Lamond, Angus/0000-0001-6204-6045; Lai, Fan/0000-0002-0568-2616	Wellcome Trust [073915, 073980] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Belmont AS, 1998, TRENDS CELL BIOL, V8, P121, DOI 10.1016/S0962-8924(97)01211-7; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Coelho PA, 2003, J CELL SCI, V116, P4763, DOI 10.1242/jcs.00799; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Savvidou E, 2005, J CELL SCI, V118, P2529, DOI 10.1242/jcs.02392; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154	30	174	179	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1133	U161		10.1038/ncb1475	http://dx.doi.org/10.1038/ncb1475			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998479	Green Accepted			2022-12-27	WOS:000241395300018
J	Ziv, Y; Bielopolski, D; Galanty, Y; Lukas, C; Taya, Y; Schultz, DC; Lukas, J; Bekker-Jensen, S; Bartek, J; Shiloh, Y				Ziv, Yael; Bielopolski, Dana; Galanty, Yaron; Lukas, Claudia; Taya, Yoichi; Schultz, David C.; Lukas, Jiri; Bekker-Jensen, Simon; Bartek, Jiri; Shiloh, Yosef			Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM and KAP-1 dependent pathway	NATURE CELL BIOLOGY			English	Article							ZINC-FINGER PROTEINS; CELLULAR-RESPONSE; REPRESSOR DOMAIN; IN-VIVO; DAMAGE; TRANSCRIPTION; COREPRESSOR; GENOME; REPAIR; CELLS	The cellular DNA-damage response is a signaling network that is vigorously activated by cytotoxic DNA lesions, such as double-strand breaks ( DSBs) 1. The DSB response is mobilized by the nuclear protein kinase ATM, which modulates this process by phosphorylating key players in these pathways(2). A long-standing question in this field is whether DSB formation affects chromatin condensation. Here, we show that DSB formation is followed by ATM-dependent chromatin relaxation. ATM's effector in this pathway is the protein KRAB-associated protein ( KAP-1, also known as TIF1 beta, KRIP-1 or TRIM28), previously known as a corepressor of gene transcription(3,4). In response to DSB induction, KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP- 1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.	Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Genet Res, Dept Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Tel Aviv University; Sackler Faculty of Medicine; Danish Cancer Society; National Cancer Center - Japan; Case Western Reserve University	Ziv, Y (corresponding author), Tel Aviv Univ, Sackler Sch Med, David & Inez Myers Lab Genet Res, Dept Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	yaelz@post.tau.ac.il; yossih@post.tau.ac.il	Bartek, Jiri/G-5870-2014	Lukas, Claudia/0000-0001-7169-6883; Bekker-Jensen, Simon/0000-0002-7308-4597; Bielopolski, Dana/0000-0001-9476-0032; Lukas, Jiri/0000-0001-9087-506X; Galanty, Yaron/0000-0001-7167-9004	NINDS NIH HHS [NS31763] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031763] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200; Cammas F, 2000, DEVELOPMENT, V127, P2955; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gontijo AMDC, 2003, BIOCHIMIE, V85, P1133, DOI 10.1016/j.biochi.2003.10.018; JABERABOANSARI A, 1989, RADIAT RES, V119, P57, DOI 10.2307/3577367; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; LE DB, 1996, EMBO J, V15, P6701; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lu Qianjin, 2004, Methods Mol Biol, V287, P77; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SHILOH Y, 2006, TRENDS BIOCH SCI; Shinozaki T, 2003, ONCOGENE, V22, P8870, DOI 10.1038/sj.onc.1207176; TAKAHASHI K, 1985, INT J RADIAT BIOL, V48, P389, DOI 10.1080/09553008514551391; TELFORD DJ, 1989, INT J BIOCHEM, V21, P127, DOI 10.1016/0020-711X(89)90100-6; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Verger A, 2004, CELL MOL LIFE SCI, V61, P2154, DOI 10.1007/s00018-004-4176-y; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	39	540	556	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					870	U142		10.1038/ncb1446	http://dx.doi.org/10.1038/ncb1446			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862143				2022-12-27	WOS:000239423000018
J	Wu, XY; Yoo, YD; Okuhama, NN; Tucker, PW; Liu, G; Guan, JL				Wu, Xiaoyang; Yoo, Youngdong; Okuhama, Nataly N.; Tucker, Philip W.; Liu, Gang; Guan, Jun-Lin			Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; ARP2/3 COMPLEX; BETA-ACTIN; PROTEINS; PSF; REARRANGEMENT; P54(NRB)/NONO; LOCALIZATION; HOMOLOG; SIGNALS	The presence of actin in the nucleus has been well established, and several studies have implicated nuclear actin in transcriptional regulation(1-3). Neuronal Wiskott-Aldrich syndrome protein ( N-WASP) is a member of the WASP family of proteins; these proteins function in the cytoplasm as key regulators of cortical actin filament(4-6). Interestingly, N-WASP has also been observed in the nucleus(7-11). However, a potential nuclear function for N-WASP has not been established. Here, we report the identification of nuclear N-WASP within a large nuclear-protein complex containing PSF-NonO ( polypyrimidine-tract-binding-protein-associated splicing factor-non-Pou-domain octamer-binding protein/p54nrb), nuclear actin and RNA polymerase II. The PSF-NonO complex is involved in the regulation of many cellular processes(12), such as transcription, RNA processing, DNA unwinding and repair. We demonstrate that the interaction of N-WASP with the PSF-NonO complex can couple N-WASP with RNA polymerase II to regulate transcription. We also provide evidence that the potential function of N-WASP in promoting polymerization of nuclear actins has an important role in this process. Based on these results, we propose a nuclear function for N-WASP in transcriptional regulation.	Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78705 USA	Cornell University; Albany Medical College; University of Texas System; University of Texas Austin	Guan, JL (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	jg19@cornell.edu			NHLBI NIH HHS [HL73394] Funding Source: Medline; NIGMS NIH HHS [GM48050] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048050] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bear JE, 2001, CURR OPIN CELL BIOL, V13, P158, DOI 10.1016/S0955-0674(00)00193-9; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Peng R, 2002, RNA, V8, P1334, DOI 10.1017/S1355838202022070; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; REDMOND T, 1994, J BIOL CHEM, V269, P21657; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Suetsugu S, 2003, J BIOL CHEM, V278, P42515, DOI 10.1074/jbc.M302177200; Takenawa T, 2001, J CELL SCI, V114, P1801; Vetterkind S, 2002, J BIOL CHEM, V277, P87, DOI 10.1074/jbc.M104555200; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; ZHANG WW, 1993, BIOCHEM J, V290, P267, DOI 10.1042/bj2900267	31	127	129	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					756	U215		10.1038/ncb1433	http://dx.doi.org/10.1038/ncb1433			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767080				2022-12-27	WOS:000238837800019
J	Abas, L; Benjamins, R; Malenica, N; Paciorek, T; Wirniewska, J; Moulinier-Anzola, JC; Sieberer, T; Friml, J; Luschnig, C				Abas, L; Benjamins, R; Malenica, N; Paciorek, T; Wirniewska, J; Moulinier-Anzola, JC; Sieberer, T; Friml, J; Luschnig, C			Intracellular trafficking and proteolysis of the Arabidopsis auxin-efflux facilitator PIN2 are involved in root gravitropism	NATURE CELL BIOLOGY			English	Article							INHIBITORS BLOCK; PLASMA-MEMBRANE; TRANSPORT; THALIANA; PROTEIN; LOCALIZATION; ENDOCYTOSIS; MUTANTS; ENCODES; CARRIER	Root gravitropism describes the orientation of root growth along the gravity vector and is mediated by differential cell elongation in the root meristem. This response requires the coordinated, asymmetric distribution of the phytohormone auxin within the root meristem, and depends on the concerted activities of PIN proteins and AUX1 - members of the auxin transport pathway. Here, we show that intracellular trafficking and proteasome activity combine to control PIN2 degradation during root gravitropism. Following gravi-stimulation, proteasome-dependent variations in PIN2 localization and degradation at the upper and lower sides of the root result in asymmetric distribution of PIN2. Ubiquitination of PIN2 occurs in a proteasome-dependent manner, indicating that the proteasome is involved in the control of PIN2 turnover. Stabilization of PIN2 affects its abundance and distribution, and leads to defects in auxin distribution and gravitropic responses. We describe the effects of auxin on PIN2 localization and protein levels, indicating that redistribution of auxin during the gravitropic response may be involved in the regulation of PIN2 protein.	Univ Nat Resources & Appl Life Sci BOKU, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria; Univ Tubingen, Ctr Mol Biol Plants, D-72076 Tubingen, Germany; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Masaryk Univ, Dept Funct Genom & Prote, Lab Mol Plant Physiol, CZ-62500 Brno, Czech Republic	University of Natural Resources & Life Sciences, Vienna; Eberhard Karls University of Tubingen; Nicolaus Copernicus University; Masaryk University Brno	Luschnig, C (corresponding author), Univ Nat Resources & Appl Life Sci BOKU, Inst Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	christian.luschnig@boku.ac.at	Malenica, Nenad/AAW-4495-2020; Friml, Jiri/D-9511-2012	Friml, Jiri/0000-0002-8302-7596; Luschnig, Christian/0000-0003-2099-9280; Moulinier-Anzola, Jeanette/0000-0001-8635-7227				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bechtold N, 1998, METH MOL B, V82, P259; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Kimbrough JM, 2004, PLANT PHYSIOL, V136, P2790, DOI 10.1104/pp.104.044594; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Pacher TB, 2004, ANAL BIOCHEM, V329, P148, DOI 10.1016/j.ab.2004.02.034; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; YOUNG LM, 1990, PLANT PHYSIOL, V92, P792, DOI 10.1104/pp.92.3.792	40	450	472	5	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					249	256		10.1038/ncb1369	http://dx.doi.org/10.1038/ncb1369			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16489343				2022-12-27	WOS:000235708000010
J	Hampoelz, B; Hoeller, O; Bowman, SK; Dunican, D; Knoblich, JA				Hampoelz, B; Hoeller, O; Bowman, SK; Dunican, D; Knoblich, JA			Drosophila Ric-8 is essential for plasma-membrane localization of heterotrimeric G proteins	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL DIVISIONS; CAENORHABDITIS-ELEGANS EMBRYOS; G-BETA-GAMMA; G-ALPHA; C-ELEGANS; SPINDLE POSITION; DISTINCT ROLES; DAUGHTER CELL; SYNEMBRYN; COMPLEX	Heterotrimeric G proteins act during signal transduction in response to extracellular ligands. They are also required for spindle orientation and cell polarity during asymmetric cell division. We show here that, in Drosophila, both functions require the G alpha interaction partner Ric-8. Drosophila Ric-8 is a cytoplasmic protein that binds both the GDP- and GTP-bound form of the G-protein alpha-subunit G alpha i. In ric-8 mutants, neither G alpha i nor its associated beta- subunit G beta 13F are localized at the plasma membrane, which leads to their degradation in the cytosol. During asymmetric cell division, this leads to various defects: apico-basal polarity is not maintained, mitotic spindles are misoriented and the size of the two daughter cells becomes nearly equal. ric-8 mutants also have defects in gastrulation that resemble mutants in the G alpha protein concertina or the extracellular ligand folded gastrulation. Our results indicate a model in which both receptor-dependent and receptor-independent G-protein functions are executed at the plasma membrane and require the Ric-8 protein.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Dunican, Dara/A-1208-2010	Knoblich, Juergen A/0000-0002-6751-3404; Dunican, Dara/0000-0001-6563-8089; Hampoelz, Bernhard/0000-0001-7491-0080				Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Ntwasa M, 2001, EXP CELL RES, V262, P134, DOI 10.1006/excr.2000.5086; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	32	90	92	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1099	1105		10.1038/ncb1318	http://dx.doi.org/10.1038/ncb1318			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16228011				2022-12-27	WOS:000232930400013
J	Wang, HY; Ng, KH; Qian, HL; Siderovski, DP; Chia, W; Yu, FW				Wang, HY; Ng, KH; Qian, HL; Siderovski, DP; Chia, W; Yu, FW			Ric-8 controls Drosophila neural progenitor asymmetric division by regulating heterotrimeric G proteins	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; G-BETA-GAMMA; CELL-DIVISION; G-ALPHA; C-ELEGANS; NERVOUS-SYSTEM/; DISTINCT ROLES; NEUROBLAST; COMPLEX; DETERMINANTS	Asymmetric division of Drosophila neuroblasts (NBs) and the Caenorhabditis elegans zygote uses polarity cues provided by the Par proteins, as well as heterotrimeric G-protein-signalling that is activated by a receptor-independent mechanism mediated by GoLoco/GPR motif proteins(1,2). Another key component of this non-canonical G-protein activation mechanism is a non-receptor guanine nucleotide-exchange factor (GEF) for G alpha, RIC-8, which has recently been characterized in C. elegans and in mammals(3-6). We show here that the Drosophila Ric-8 homologue is required for asymmetric division of both NBs and pI cells. Ric-8 is necessary for membrane targeting of G alpha i, Pins and G beta 13F, presumably by regulating multiple G alpha subunit( s). Ric-8 forms an in vivo complex with Gai and interacts preferentially with GDP - G alpha i, which is consistent with Ric-8 acting as a GEF for G alpha i. Comparisons of the phenotypes of G alpha i, Ric-8, G beta 13F single and Ric-8; G beta 13F double loss-of-function mutants indicate that, in NBs, Ric-8 positively regulates G alpha i activity. In addition, G beta gamma. acts to restrict G alpha i ( and GoLoco proteins) to the apical cortex, where Gai ( and Pins) can mediate asymmetric spindle geometry.	Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore	Chia, W (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	wchia@tll.org.sg; fengwei@tll.org.sg	Wang, Hongyan/AAB-3030-2019; Siderovski, David Peter/AAA-9603-2019	Wang, Hongyan/0000-0003-4623-1878; Siderovski, David Peter/0000-0002-0688-8210; Yu, Fengwei/0000-0003-0268-199X				Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Cismowski MJ, 2001, LIFE SCI, V68, P2301, DOI 10.1016/S0024-3205(01)01019-0; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Knust E, 2001, CELL, V107, P125, DOI 10.1016/S0092-8674(01)00534-7; Matsuzaki F, 2000, CURR OPIN NEUROBIOL, V10, P38, DOI 10.1016/S0959-4388(99)00052-5; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	29	96	98	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1091	1098		10.1038/ncb1317	http://dx.doi.org/10.1038/ncb1317			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16228012				2022-12-27	WOS:000232930400012
J	de Duve, C				de Duve, C			The lysosome turns fifty	NATURE CELL BIOLOGY			English	Article							RAT LIVER; TISSUE FRACTIONATION; PARTICLES	In the course of an investigation aimed at characterizing hepatic glucose 6- phosphatase, the unrelated acid phosphatase of rat liver was serendipitously observed to be latent and particle- bound in freshly prepared homogenates. Experiments designed to elucidate this intriguing finding led, 50 years ago, to the discovery of lysosomes. This could not have happened if strict adherence to a previously set programme had been mandatory.	Catholic Univ Louvain, B-3000 Louvain, Belgium; Rockefeller Univ, New York, NY 10021 USA	Universite Catholique Louvain; Rockefeller University	de Duve, C (corresponding author), Catholic Univ Louvain, B-3000 Louvain, Belgium.	deduve@icp.ucl.ac.be						APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; BAUDHUIN P, 1965, J CELL BIOL, V26, P219, DOI 10.1083/jcb.26.1.219; BAUDHUIN P, 1964, LAB INVEST, V13, P1139; BEAUFAY H, 1954, B SOC CHIM BIOL, V36, P1551; BERTHET J, 1951, BIOCHEM J, V50, P174, DOI 10.1042/bj0500174; BERTHET J, 1951, BIOCHEM J, V50, P182, DOI 10.1042/bj0500182; CLAUDE A, 1946, J EXP MED, V84, P51, DOI 10.1084/jem.84.1.51; CLAUDE A, 1946, J EXP MED, V84, P61, DOI 10.1084/jem.84.1.61; de Duve C, 2004, J BIOL CHEM, V279, P21679, DOI 10.1074/jbc.X400002200; De Duve C, 1965, Harvey Lect, V59, P49; DEDUVE C, 1951, NATURE, V167, P389, DOI 10.1038/167389a0; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; DEDUVE C, 1954, INT REV CYTOL, V3, P225, DOI 10.1016/S0074-7696(08)60440-4; DEDUVE C, 1959, PROG BIOPHYS MOL BIO, V9, P325; DEDUVE C, 1949, B SOC CHIM BIOL, V31, P1242; DEDUVE C, 1958, SUBCELLULAR PARTICLE, P128; DEDUVE C, 1969, LYSOSOMES BIOLOGY PA, V1, P3; DEREUCK AVS, 1963, CIBA FDN S LYSOSOMES; DINGLE JT, 1984, LYSOSOMES BIOL PATHO, V7; DINGLE JT, 1976, LYSOSOMES BIOL PATHO, V5; DINGLE JT, 1973, LYSOSOMES BIOL PATHO, V2; DINGLE JT, 1979, LYSOSOMES BIOL PATHO, V6; DINGLE JT, 1969, LYSOSOMES BIOL PATHO, V1; DINGLE JT, 1975, LYSOSOMES BIOL PATHO, V4; DINGLE JT, 1973, LYSOSOMES BIOL PATHO, V3; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375; Hers H. G., 1973, LYSOSOMES STORAGE DI; HERS HG, 1951, B SOC CHIM BIOL, V33, P21; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; LEJEUNE N, 1963, BIOCHEM J, V86, P16, DOI 10.1042/bj0860016; NOVIKOFF ALEX B., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179	33	244	244	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					847	849		10.1038/ncb0905-847	http://dx.doi.org/10.1038/ncb0905-847			3	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16136179				2022-12-27	WOS:000231601600003
J	Hausser, A; Storz, P; Martens, S; Link, G; Toker, A; Pfizenmaier, K				Hausser, A; Storz, P; Martens, S; Link, G; Toker, A; Pfizenmaier, K			Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase III beta at the Golgi complex	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; CELL-SURFACE; PLASMA-MEMBRANE; C-MU; 4-KINASE; RECRUITMENT; SUBSTRATE; NETWORK; LOCALIZATION; ORGANIZATION	Protein kinase D ( PKD) regulates the fission of vesicles originating from the trans- Golgi network(1,2). We show that phosphatidylinositol 4- kinase III beta ( PI4KIII beta) - a key player in the structure and function of the Golgi complex(3) - is a physiological substrate of PKD. Of the three PKD isoforms, only PKD1 and PKD2 phosphorylated PI4KIII beta at a motif that is highly conserved from yeast to humans. PKD- mediated phosphorylation stimulated lipid kinase activity of PI4KIII beta and enhanced vesicular stomatitis virus G- protein transport to the plasma membrane. The identification of PI4KIII beta as one of the PKD substrates should help to reveal the molecular events that enable transport- carrier formation.	Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	University of Stuttgart; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hausser, A (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	angelika.hausser@izi.uni-stuttgart.de; klaus.pfizenmaier@izi.uni-stuttgart.de	Hausser, Angelika/AAC-4531-2021		NCI NIH HHS [CA075134, R01 CA075134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Arnold R, 2005, MOL CELL BIOL, V25, P2364, DOI 10.1128/MCB.25.6.2364-2383.2005; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Suer S, 2001, EUR J BIOCHEM, V268, P2099, DOI 10.1046/j.1432-1327.2001.02089.x; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	26	268	274	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					880	U24		10.1038/ncb1289	http://dx.doi.org/10.1038/ncb1289			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16100512	Green Accepted			2022-12-27	WOS:000231601600011
J	Torres-Rosell, J; Machin, F; Farmer, S; Jarmuz, A; Eydmann, T; Dalgaard, JZ; Aragon, L				Torres-Rosell, J; Machin, F; Farmer, S; Jarmuz, A; Eydmann, T; Dalgaard, JZ; Aragon, L			SMC5 and SMC6 genes are required for the segregation of repetitive chromosome regions	NATURE CELL BIOLOGY			English	Article							REPLICATION FORK PROGRESSION; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; SMC5-SMC6 COMPLEX; HOLLIDAY JUNCTIONS; FISSION YEAST; CHECKPOINT; PROTEINS; MEIOSIS; CDC14	Structure chromosome (SMC) proteins organize the core of cohesin, condensin and Smc5-Smc6 complexes(1). The Smc5-Smc6 complex is required for DNA repair, as well as having another essential but enigmatic function(1). Here, we generated conditional mutants of SMC5 and SMC6 in budding yeast, in which the essential function was affected. We show that mutant smc5-6 and smc6-9 cells undergo an aberrant mitosis in which chromosome segregation of repetitive regions is impaired; this leads to DNA damage and RAD9-dependent activation of the Rad53 protein kinase. Consistent with a requirement for the segregation of repetitive regions, Smc5 and Smc6 proteins are enriched at ribosomal DNA (rDNA) and at some telomeres. We show that, following Smc5-Smc6 inactivation, metaphase-arrested cells show increased levels of X-shaped DNA (Holliday junctions) at the rDNA locus. Furthermore, deletion of RAD52 partially suppresses the temperature sensitivity of smc5-6 and smc6-9 mutants. We also present evidence showing that the rDNA segregation defects of smc5/smc6 mutants are mechanistically different from those previously observed for condensin mutants(2,3). These results point towards a role for the Smc5-Smc6 complex in preventing the formation of sister chromatid junctions, thereby ensuring the correct partitioning of chromosomes during anaphase.	Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, London W12 0NN, England; Marie Curie Res Inst, Surrey RH8 0TL, England	Imperial College London	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Torres-Rosell, Jordi/A-4213-2010; Machín, Félix/K-6569-2017	Torres-Rosell, Jordi/0000-0003-1308-6926; Machín, Félix/0000-0003-4559-7798; Dalgaard, Jacob/0000-0001-9545-7254	MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; COLLINS I, 1994, CELL, V76, P65, DOI 10.1016/0092-8674(94)90173-2; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Machin F, 2004, CURR BIOL, V14, P125, DOI 10.1016/j.cub.2004.01.001; McDonald WH, 2003, J BIOL CHEM, V278, P45460, DOI 10.1074/jbc.M308828200; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Melo JA, 2001, GENE DEV, V15, P2809; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Onoda F, 2004, DNA REPAIR, V3, P429, DOI 10.1016/j.dnarep.2003.12.007; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zhu Q, 2001, P NATL ACAD SCI USA, V98, P9766, DOI 10.1073/pnas.171579898; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	33	152	156	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					412	U48		10.1038/ncb1239	http://dx.doi.org/10.1038/ncb1239			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793567				2022-12-27	WOS:000228075500019
J	Ohanna, M; Sobering, AK; Lapointe, T; Lorenzo, L; Praud, C; Petroulakis, E; Sonenberg, N; Kelly, PA; Sotiropoulos, A; Pende, M				Ohanna, M; Sobering, AK; Lapointe, T; Lorenzo, L; Praud, C; Petroulakis, E; Sonenberg, N; Kelly, PA; Sotiropoulos, A; Pende, M			Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control	NATURE CELL BIOLOGY			English	Article							S6 KINASE; GROWTH; TRANSCRIPTION; TRANSLATION; PATHWAY; HYPERTROPHY; REGULATOR	The mammalian target of rapamycin ( mTOR) and Akt proteins regulate various steps of muscle development and growth, but the physiological relevance and the downstream effectors are under investigation(1-6). Here we show that S6 kinase 1 (S6K1), a protein kinase activated by nutrients and insulin- like growth factors (IGFs), is essential for the control of muscle cytoplasmic volume by Akt and mTOR. Deletion of S6K1 does not affect myoblast cell proliferation but reduces myoblast size to the same extent as that observed with mTOR inhibition by rapamycin. In the differentiated state, S6K1(-/-) myotubes have a normal number of nuclei but are smaller, and their hypertrophic response to IGF1, nutrients and membrane-targeted Akt is blunted. These growth defects reveal that mTOR requires distinct effectors for the control of muscle cell cycle and size, potentially opening new avenues of therapeutic intervention against neoplasia or muscle atrophy.	Univ Paris 05, INSERM, Avenir,U584, Fac Med Necker Enfants Malad, F-75730 Paris, France; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University	Sotiropoulos, A (corresponding author), Univ Paris 05, INSERM, Avenir,U584, Fac Med Necker Enfants Malad, 156 Rue Vaugirard, F-75730 Paris, France.	sotiropoulos@necker.fr; pende@necker.fr	Ohanna, Mickael/O-5784-2016; Sotiropoulos, Athanassia/P-4269-2017; Lorenzo, Lazaro/H-7902-2017; Pende, Mario/AFR-1348-2022; Praud, Christophe/AAT-9553-2020	Ohanna, Mickael/0000-0002-7751-9164; Lorenzo, Lazaro/0000-0001-6648-8684; Pende, Mario/0000-0002-7864-8937; Sotiropoulos, Athanassia/0000-0002-7265-1473				Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gingras AC, 2001, GENE DEV, V15, P2852; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pinset C, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P226; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	25	301	316	0	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					286	294		10.1038/ncb1231	http://dx.doi.org/10.1038/ncb1231			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15723049	Green Published			2022-12-27	WOS:000227329800017
J	Gotschlich, E; Gotschlich, K				Gotschlich, E; Gotschlich, K			Maclyn McCarty, 1911-2005	NATURE CELL BIOLOGY			English	Biographical-Item									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gotschlich, E (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.							MCCARTY M, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					111	111		10.1038/ncb0205-111	http://dx.doi.org/10.1038/ncb0205-111			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15689978	Bronze			2022-12-27	WOS:000226719500007
J	Takada, I; Mihara, M; Suzawa, M; Ohtake, F; Kobayashi, S; Igarashi, M; Youn, M; Takeyama, K; Nakamura, T; Mezaki, Y; Takezawa, S; Yogiashi, Y; Kitagawa, H; Yamada, G; Takada, S; Minami, Y; Shibuya, H; Matsumoto, K; Kato, S				Takada, Ichiro; Mihara, Masatomo; Suzawa, Miyuki; Ohtake, Fumiaki; Kobayashi, Shinji; Igarashi, Mamoru; Youn, Min-Young; Takeyama, Ken-ichi; Nakamura, Takashi; Mezaki, Yoshihiro; Takezawa, Shinichiro; Yogiashi, Yoshiko; Kitagawa, Hirochika; Yamada, Gen; Takada, Shinji; Minami, Yasuhiro; Shibuya, Hiroshi; Matsumoto, Kunihiro; Kato, Shigeaki			A histone lysine methyltransferase activated by non- canonical Wnt signalling suppresses PPAR-gamma transactivation	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; NUCLEAR RECEPTOR; INSULIN-RESISTANCE; WNT/BETA-CATENIN; GENE ACTIVATION; BONE MASS; PATHWAY; TRANSCRIPTION; DIFFERENTIATION; ADIPOGENESIS	Histone modifications induced by activated signalling cascades are crucial to cell-lineage decisions. Osteoblast and adipocyte differentiation from common mesenchymal stem cells is under transcriptional control by numerous factors. Although PPAR-gamma (peroxisome proliferator activated receptor-gamma) has been established as a prime inducer of adipogenesis, cellular signalling factors that determine cell lineage in bone marrow remain generally unknown. Here, we show that the non-canonical Wnt pathway through CaMKII-TAK1-TAB2-NLK transcriptionally represses PPAR-gamma transactivation and induces Runx2 expression, promoting osteoblastogenesis in preference to adipogenesis in bone marrow mesenchymal progenitors. Wnt-5a activates NLK ( Nemo-like kinase), which in turn phosphorylates a histone methyltransferase, SETDB1 ( SET domain bifurcated 1), leading to the formation of a co-repressor complex that inactivates PPAR-gamma function through histone H3-K9 methylation. These findings suggest that the non-canonical Wnt signalling pathway suppresses PPAR-gamma function through chromatin inactivation triggered by recruitment of a repressing histone methyltransferase, thus leading to an osteoblastic cell lineage from mesenchymal stem cells.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, ERATO, Kawaguchi, Saitama 3320012, Japan; Univ Tokushima, Inst Hlth Biosci, Dept Med & Bioregulatory Sci, Grad Sch, Tokushima 7708503, Japan; Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; Natl Inst Basic Biol, Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki 4448787, Japan; Kobe Univ, Grad Sch Med, Dept Genome Sci, Kobe, Hyogo 6500017, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Sch Biomed Sci, Chiyoda Ku, Tokyo 1010062, Japan; JST, CREST, Chiyoda Ku, Tokyo 1010062, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokushima University; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Kobe University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Nagoya University	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp		Nakamura, Takashi/0000-0002-6124-061X; Takada, Shinji/0000-0003-4125-6056				Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Asahina M, 2006, DEV CELL, V11, P203, DOI 10.1016/j.devcel.2006.06.003; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiwara M, 1999, BBA-GENE STRUCT EXPR, V1446, P265, DOI 10.1016/S0167-4781(99)00113-X; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2006, CURR OPIN GENET DEV, V16, P513, DOI 10.1016/j.gde.2006.08.013; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	50	337	364	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1273	U118		10.1038/ncb1647	http://dx.doi.org/10.1038/ncb1647			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17952062				2022-12-27	WOS:000250659600013
J	Wissmann, M; Yin, N; Muller, JM; Greschik, H; Fodor, BD; Jenuwein, T; Vogler, C; Schneider, R; Gunther, T; Buettner, R; Metzger, E; Schule, R				Wissmann, Melanie; Yin, Na; Mueller, Judith M.; Greschik, Holger; Fodor, Barna D.; Jenuwein, Thomas; Vogler, Christine; Schneider, Robert; Guenther, Thomas; Buettner, Reinhard; Metzger, Eric; Schuele, Roland			Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression	NATURE CELL BIOLOGY			English	Article							HISTONE; TRIMETHYLATION; COACTIVATOR; METHYLATION; LYSINE-9; SIGNALS; DOMAIN; FHL2	Posttranslational modifications of histones, such as methylation, regulate chromatin structure and gene expression(1). Recently, lysine-specific demethylase 1 (LSD1(2), the first histone demethylase, was identified. LSD1 interacts with the androgen receptor and promotes androgen-dependent transcription of target genes by ligand-induced demethylation of mono- and dimethylated histone H3 at Lys 9 (H3K9)(3) only. Here, we identify the Jumonji C ( JMJC)(4) domain-containing protein JMJD2C(5,6) as the first histone tridemethylase regulating androgen receptor function. JMJD2C interacts with androgen receptor in vitro and in vivo. Assembly of ligand-bound androgen receptor and JMJD2C on androgen receptor-target genes results in demethylation of trimethyl H3K9 and in stimulation of androgen receptor-dependent transcription. Conversely, knockdown of JMJD2C inhibits androgen-induced removal of trimethyl H3K9, transcriptional activation and tumour cell proliferation. Importantly, JMJD2C colocalizes with androgen receptor and LSD1 in normal prostate and in prostate carcinomas. JMJD2C and LSD1 interact and both demethylases cooperatively stimulate androgen receptor-dependent gene transcription. In addition, androgen receptor, JMJD2C and LSD1 assemble on chromatin to remove methyl groups from mono, di and trimethylated H3K9. Thus, our data suggest that specific gene regulation requires the assembly and coordinate action of demethylases with distinct substrate specificities.	Univ Freiburg Klinikum, Univ Frauenklin, D-79106 Freiburg, Germany; Univ Freiburg Klinikum, Zentrum Klin Forsch, D-79106 Freiburg, Germany; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Univ Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de		Gunther, Thomas/0000-0003-3903-9490; Fodor, Barna/0000-0003-1653-4376				Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	24	464	504	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					347	U176		10.1038/ncb1546	http://dx.doi.org/10.1038/ncb1546			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17277772				2022-12-27	WOS:000244558600020
J	Kumar, P; Bischof, O; Purbey, PK; Notani, D; Urlaub, H; Dejean, A; Galande, S				Kumar, Pavan P.; Bischof, Oliver; Purbey, Prabhat Kumar; Notani, Dimple; Urlaub, Henning; Dejean, Anne; Galande, Sanjeev			Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus	NATURE CELL BIOLOGY			English	Article							NUCLEAR-BODIES; SPATIAL-ORGANIZATION; BINDING PROTEIN; GENE; ATTACHMENT; EXPRESSION; REGIONS; PROTOONCOGENE; INTERFERON; ASSOCIATE	The function of the subnuclear structure the promyelocytic leukaemia (PML) body is unclear largely because of the functional heterogeneity of its constituents. Here, we provide the evidence for a direct link between PML, higher-order chromatin organization and gene regulation. We show that PML physically and functionally interacts with the matrix attachment region (MAR)-binding protein, special AT-rich sequence binding protein 1 (SATB1) to organize the major histocompatibility complex (MHC) class I locus into distinct higher-order chromatin-loop structures. Interferon gamma (IFN gamma) treatment and silencing of either SATB1 or PML dynamically alter chromatin architecture, thus affecting the expression profile of a subset of MHC class I genes. Our studies identify PML and SATB1 as a regulatory complex that governs transcription by orchestrating dynamic chromatin-loop architecture.	Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; Inst Pasteur, INSERM, U579, Unite Org Nucl & Oncogenese, F-75724 Paris 15, France; Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society	Galande, S (corresponding author), Natl Ctr Cell Sci, Ganeshkhind, Pune 411007, Maharashtra, India.	sanjeev@nccs.res.in	Dejean, Anne/L-5145-2018; Bischof, Oliver/K-1548-2019	Puvvula, Pavan Kumar/0000-0002-1326-6954; Notani, Dimple/0000-0002-9460-8070; Purbey, Prabhat/0000-0001-6373-6283	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Bloch DB, 1999, MOL CELL BIOL, V19, P4423; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CHANG KS, 1995, BLOOD, V85, P3646, DOI 10.1182/blood.V85.12.3646.bloodjournal85123646; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Grande MA, 1996, J CELL BIOCHEM, V63, P280, DOI 10.1002/(SICI)1097-4644(19961201)63:3<280::AID-JCB3>3.0.CO;2-T; Hawkins SM, 2001, J BIOL CHEM, V276, P44472, DOI 10.1074/jbc.M104193200; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kiesslich A, 2002, J STRUCT BIOL, V140, P167, DOI 10.1016/S1047-8477(02)00571-3; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Larghero J, 1999, LEUKEMIA, V13, P1295, DOI 10.1038/sj.leu.2401464; LAVAU C, 1995, ONCOGENE, V11, P871; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Platani M, 2004, PROG MOL SUBCELL BIO, V35, P1; Rampalli S, 2003, NUCLEIC ACIDS RES, V31, P3248, DOI 10.1093/nar/gkg410; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shiels C, 2001, J CELL SCI, V114, P3705; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Volpi EV, 2000, J CELL SCI, V113, P1565; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wiesmeijer K, 2002, J STRUCT BIOL, V140, P180, DOI 10.1016/S1047-8477(02)00529-4; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	45	181	190	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					45	U57		10.1038/ncb1516	http://dx.doi.org/10.1038/ncb1516			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173041	Green Published			2022-12-27	WOS:000243255100011
J	Woodbury, EL; Morgan, DO				Woodbury, Erika L.; Morgan, David O.			Cdk and APC activities limit the spindle-stabilizing function of Fin1 to anaphase	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC CYCLINS; BUDDING YEAST; DESTRUCTION; DYNAMICS; COMPLEX; CDC14; EXIT	The fidelity of chromosome segregation depends on proper regulation of mitotic spindle behaviour. In anaphase, spindle stability is promoted by the dephosphorylation of cyclin-dependent kinase (Cdk) substrates, which results from Cdk inactivation and phosphatase activation(1-4). Few of the critical Cdk targets have been identified(3,5,6). Here, we identify the budding-yeast protein Fin1 (ref. 7) as a spindle-stabilizing protein whose activity is strictly limited to anaphase by changes in its phosphorylation state and rate of degradation. Phosphorylation of Fin1 from S phase to metaphase, by the cyclin-dependent kinase Clb5-Cdk1, inhibits Fin1 association with the spindle. In anaphase, when Clb5-Cdk1 is inactivated, Fin1 is dephosphorylated by the phosphatase Cdc14. Fin1 dephosphorylation targets it to the poles and microtubules of the elongating spindle, where it contributes to spindle integrity. A non-phosphorylatable Fin1 mutant localizes to the spindle before anaphase and impairs efficient chromosome segregation. As cells complete mitosis and disassemble the spindle, the ubiqutin ligase APC(Cdh1) targets Fin1 for destruction. Our studies illustrate how phosphorylation-dependent changes in the behaviour of Cdk1 substrates influence complex mitotic processes.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2200,Genetech Hall Room N312B,600, San Francisco, CA 94158 USA.	David.Morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901, R01GM050684] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50684, R01 GM069901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P477; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	24	102	103	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					106	U138		10.1038/ncb1523	http://dx.doi.org/10.1038/ncb1523			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173039				2022-12-27	WOS:000243255100019
J	Lee, MH; Lee, SW; Lee, EJ; Choi, SJ; Chung, SS; Lee, JI; Cho, JM; Seol, JH; Baek, SH; Kim, KI; Chiba, T; Tanaka, K; Bang, OS; Chung, CH				Lee, Moon Hee; Lee, Sung Won; Lee, Eun Joo; Choi, Soo Joon; Chung, Sung Soo; Lee, Jae Il; Cho, Joong Myung; Seol, Jae Hong; Baek, Sung Hee; Kim, Keun Il; Chiba, Tomoki; Tanaka, Keiji; Bang, Ok Sun; Chung, Chin Ha			SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; E3 LIGASE; C-JUN; SUMOYLATION; TRANSCRIPTION; FAMILY; YEAST	The p53 tumour suppressor has a key role in the control of cell growth and differentiation, and in the maintenance of genome integrity(1,2). p53 is kept labile under normal conditions, but in response to stresses, such as DNA damage, it accumulates in the nucleus for induction of cell-cycle arrest, DNA repair or apoptosis. Mdm2 is an ubiquitin ligase that promotes p53 ubiquitination and degradation(3-5). Mdm2 is also self-ubiquitinated and degraded. Here, we identified a novel cascade for the increase in p53 level in response to DNA damage. A new SUMO-specific protease, SUSP4, removed SUMO-1 from Mdm2 and this desumoylation led to promotion of Mdm2 self-ubiquitination, resulting in p53 stabilization. Moreover, SUSP4 competed with p53 for binding to Mdm2, also resulting in p53 stabilization. Overexpression of SUSP4 inhibited cell growth, whereas knockdown of susp4 by RNA interference (RNAi) promoted of cell growth. UV damage induced SUSP4 expression, leading to an increase in p53 levels in parallel with a decrease in Mdm2 levels. These findings establish a new mechanism for the elevation of cellular p53 levels in response to UV damage.	Seoul Natl Univ, Sch Biol Sci, NRL Prot Biochem, Seoul 151742, South Korea; Crystalgenom Inc, Seoul 138736, South Korea; Sookmyung Womans Univ, Dept Biol Sci, Seoul 140742, South Korea; Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Seoul National University (SNU); Sookmyung Women's University; Tokyo Metropolitan Institute of Medical Science	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, NRL Prot Biochem, Seoul 151742, South Korea.	osbang@snu.ac.kr; chchung@snu.ac.kr	KIM, KEUN IL/D-2959-2011					Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	31	60	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1424	U72		10.1038/ncb1512	http://dx.doi.org/10.1038/ncb1512			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17086174				2022-12-27	WOS:000242419800019
J	Sacher, M; Pfander, B; Hoege, C; Jentsch, S				Sacher, Meik; Pfander, Boris; Hoege, Carsten; Jentsch, Stefan			Control of Rad52 recombination activity by double-strand break-induced SUMO modification	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; S-PHASE; MITOTIC RECOMBINATION; MEIOTIC RECOMBINATION; PACHYTENE CHECKPOINT; UBIQUITIN; SRS2; HELICASE; YEAST	Homologous recombination is essential for genetic exchange, meiosis and error-free repair of double-strand breaks(1). Central to this process is Rad52, a conserved homo-oligomeric ring-shaped protein, which mediates the exchange of the early recombination factor RPA by Rad51 and promotes strand annealing(2,3). Here, we report that Rad52 of Saccharomyces cerevisiae is modified by the ubiquitin-like protein SUMO, primarily at two sites that flank the conserved Rad52 domain. Sumoylation is induced on DNA damage and triggered by Mre11-Rad50-Xrs2 (MRX) complex-governed double-strand breaks (DSBs). Although sumoylation-defective Rad52 is largely recombination proficient, mutant analysis revealed that the SUMO modification sustains Rad52 activity and concomitantly shelters the protein from accelerated proteasomal degradation. Furthermore, our data indicate that sumoylation becomes particularly relevant for those Rad52 molecules that are engaged in recombination.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Pfander, Boris/A-8703-2013	Pfander, Boris/0000-0003-2180-5054				AGUILERA A, 1988, GENETICS, V119, P779; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hong EJE, 2002, GENE DEV, V16, P363, DOI 10.1101/gad.938102; Huang LS, 2005, P NATL ACAD SCI USA, V102, P12431, DOI 10.1073/pnas.0502324102; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Ramotar D, 2003, CURR GENET, V43, P213, DOI 10.1007/s00294-003-0396-1; RATTRAY AJ, 1994, GENETICS, V138, P587; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Sacher M, 2005, METHOD ENZYMOL, V399, P392, DOI 10.1016/S0076-6879(05)99027-7; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; SCHIESTL RH, 1990, GENETICS, V124, P817; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	38	149	152	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1284	U59		10.1038/ncb1488	http://dx.doi.org/10.1038/ncb1488			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17013376				2022-12-27	WOS:000241732400018
J	Petreaca, RC; Chiu, HC; Eckelhoefer, HA; Chuang, C; Xu, L; Nugent, CI				Petreaca, Ruben C.; Chiu, Huan-Chih; Eckelhoefer, Holly A.; Chuang, Charles; Xu, Ling; Nugent, Constance I.			Chromosome end protection plasticity revealed by Stn1p and Ten1p bypass of Cdc13p	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; DNA-POLYMERASE-ALPHA; BINDING PROTEIN; LENGTH REGULATION; YEAST; REPAIR; REPLICATION; MAINTENANCE; CHECKPOINT; SUBUNIT	Genome stability necessitates a mechanism to protect the termini of linear chromosomes from inappropriate degradation or recombination1,2. In many species this protection depends on 'capping' proteins that bind telomeric DNA(3,4). The budding yeast Cdc13p binds single-stranded telomeric sequences(5,6), prevents lethal degradation of chromosome ends(7,8) and regulates telomere extension by telomerase(5,9). Two Cdc13-interacting proteins, Stn1p and Ten1p, are also required for viability and telomere length regulation(10,11). It has been proposed that Cdc13p DNA binding directs a Cdc13p-Stn1p-Ten1p complex to telomeres to mediate end protection(12). However, the functional significance of these protein interactions, and their respective roles in maintaining telomere integrity, remain undefined. Here, we show that co-overexpressing TEN1 with a truncated form of STN1 efficiently bypasses the essential role of CDC13. We further show that this truncated Stn1p binds directly to Pol12p, a polymerase alpha-primase regulatory subunit, and that Pol12 activity is required for CDC13 bypass. Thus, Stn1p and Ten1p control a Cdc13p-independent telomere capping mechanism that is coupled to the conventional DNA replication machinery.	Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Nugent, CI (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 5429 Boyce Hall, Riverside, CA 92521 USA.	connie.nugent@ucr.edu						Bai C, 1996, METHOD ENZYMOL, V273, P331; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Evans SK, 2002, GENETICS, V162, P1101; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; James P, 1996, GENETICS, V144, P1425; Kaina B, 2004, CYTOGENET GENOME RES, V104, P77, DOI 10.1159/000077469; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Le S, 1999, GENETICS, V152, P143; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; McClintock B, 1941, GENETICS, V26, P234; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Muller H.J., 1938, COLLECTING NET, V13, P181; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Qi HY, 2000, GENE DEV, V14, P1777; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Theobald DL, 2003, STRUCTURE, V11, P1049, DOI 10.1016/S0969-2126(03)00183-7	33	58	58	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					748	U202		10.1038/ncb1430	http://dx.doi.org/10.1038/ncb1430			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767082				2022-12-27	WOS:000238837800018
J	Izumi, Y; Ohta, N; Hisata, K; Raabe, T; Matsuzaki, F				Izumi, Yasushi; Ohta, Nao; Hisata, Kanako; Raabe, Thomas; Matsuzaki, Fumio			Drosophila Pins-binding protein Mud regulates spindle-polarity coupling and centrosome organization	NATURE CELL BIOLOGY			English	Article							HETEROTRIMERIC G-PROTEINS; NEUROBLAST ASYMMETRIC DIVISIONS; CAENORHABDITIS-ELEGANS EMBRYOS; MUSHROOM-BODY-DEFECT; CELL-DIVISION; G-ALPHA; CYTOPLASMIC DYNEIN; DISTINCT ROLES; C-ELEGANS; COMPLEX	The orientation of the mitotic spindle relative to the cell axis determines whether polarized cells undergo symmetric or asymmetric divisions. Drosophila epithelial cells and neuroblasts provide an ideal pair of cells to study the regulatory mechanisms involved. Epithelial cells divide symmetrically, perpendicular to the apical-basal axis. In the asymmetric divisions of neuroblasts, by contrast, the spindle reorients parallel to that axis, leading to the unequal distribution of cell-fate determinants to one daughter cell(1). Receptor-independent G-protein signalling involving the GoLoco protein Pins is essential for spindle orientation in both cell types(2). Here, we identify Mushroom body defect ( Mud) 3 as a downstream effector in this pathway. Mud directly associates and colocalizes with Pins at the cell cortex overlying the spindle pole(s) in both neuroblasts and epithelial cells. The cortical Mud protein is essential for proper spindle orientation in the two different division modes. Moreover, Mud localizes to centrosomes during mitosis independently of Pins to regulate centrosomal organization. We propose that Drosophila Mud, vertebrate NuMA(4) and Caenorhabditis elegans Lin-5 (refs 5, 6) have conserved roles in the mechanism by which G-proteins regulate the mitotic spindle.	RIKEN, Ctr Dev Biol, Lab Cell Asymmetry, Chuo Ku, Kobe, Hyogo 6500047, Japan; Univ Wurzburg, Inst Med Res & Cell Res, D-97078 Wurzburg, Germany; Japan Sci & Technol Corp, CREST, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN; University of Wurzburg; Japan Science & Technology Agency (JST)	Izumi, Y (corresponding author), RIKEN, Ctr Dev Biol, Lab Cell Asymmetry, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	izumi@cdb.riken.jp; fumio@cdb.riken.jp						Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CHOU TB, 1992, GENETICS, V131, P643; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Guan ZH, 2000, P NATL ACAD SCI USA, V97, P8122, DOI 10.1073/pnas.97.14.8122; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	31	196	197	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					586	593		10.1038/ncb1409	http://dx.doi.org/10.1038/ncb1409			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16648846				2022-12-27	WOS:000238029000011
J	Hoshi, N; Langeberg, LK; Scott, JD				Hoshi, N; Langeberg, LK; Scott, JD			Distinct enzyme combinations in AKAP signalling complexes permit functional diversity	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; SYMPATHETIC NEURONS; CHANNEL SUBUNITS; PHOSPHORYLATION; SUPPRESSION; DOMAINS; GLUR1; INHIBITION; MODULATION; RECEPTORS	Specificity in cell signalling can be influenced by the targeting of different enzyme combinations to substrates. The A-kinase anchoring protein AKAP79/150 is a multivalent scaffolding protein that coordinates the subcellular localization of second-messenger-regulated enzymes, such as protein kinase A, protein kinase C and protein phosphatase 2B. We developed a new strategy that combines RNA interference of the endogenous protein with a protocol that selects cells that have been rescued with AKAP79/150 forms that are unable to anchor selected enzymes. Using this approach, we show that AKAP79/150 coordinates different enzyme combinations to modulate the activity of two distinct neuronal ion channels: AMPA-type glutamate receptors and M-type potassium channels. Utilization of distinct enzyme combinations in this manner provides a means to expand the repertoire of cellular events that the same AKAP modulates.	Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA	Howard Hughes Medical Institute; Oregon Health & Science University	Scott, JD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Howard Hughes Med Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	scott@ohsu.edu			NIGMS NIH HHS [R37 GM048231, R01 GM048231, GM48231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048231, R01GM048231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marrion NV, 1996, NEURON, V16, P163, DOI 10.1016/S0896-6273(00)80033-1; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	29	136	139	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1066	1073		10.1038/ncb1315	http://dx.doi.org/10.1038/ncb1315			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16228013	Green Accepted			2022-12-27	WOS:000232930400009
J	Elliott, JI; Surprenant, A; Marelli-Berg, FM; Cooper, JC; Cassady-Cain, RL; Wooding, C; Linton, K; Alexander, DR; Higgins, CF				Elliott, JI; Surprenant, A; Marelli-Berg, FM; Cooper, JC; Cassady-Cain, RL; Wooding, C; Linton, K; Alexander, DR; Higgins, CF			Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes	NATURE CELL BIOLOGY			English	Article							P2X(7) RECEPTOR; T-CELL; PLASMA-MEMBRANE; MULTIDRUG TRANSPORTER; ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; B-CELL; EXPOSURE; ANTIGEN; MITOCHONDRIAL	Phosphatidylserine (PS) exposure is normally associated with apoptosis and the removal of dying cells. We observed that PS is exposed constitutively at high levels on T lymphocytes that express low levels of the transmembrane tyrosine phosphatase CD45RB. CD45 was shown to be a negative regulator of PS translocation in response to various signals, including activation of the ATP receptor P2X(7). Changes in PS distribution were shown to modulate several membrane activities: Ca2+ and Na+ uptake through the P2X(7) cation channel itself; P2X(7)-stimulated shedding of the homing receptor CD62L; and reversal of activity of the multidrug transporter P-glycoprotein. The data identify a role for PS distribution changes in signal transduction, rapidly modulating the activities of several membrane proteins. This seems to be an all-or-none effect, coordinating the activity of most or all the molecules of a target protein in each cell. The data also suggest a new approach to circumventing multidrug resistance.	Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London W12 0NN, England; Univ Sheffield, Dept Biomed Sci, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England; Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Imperial College London; Imperial College London; University of Sheffield; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Elliott, JI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	james.elliott@csc.mrc.ac.uk						Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bucki R, 2001, BIOCHEMISTRY-US, V40, P15752, DOI 10.1021/bi010899c; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Castedo M, 1996, J IMMUNOL, V157, P512; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Elliott JI, 2004, BRIT J PHARMACOL, V143, P899, DOI 10.1038/sj.bjp.0705940; Elliott JI, 2004, DIABETES, V53, P2012, DOI 10.2337/diabetes.53.8.2012; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Faria RX, 2005, AM J PHYSIOL-CELL PH, V288, pC260, DOI 10.1152/ajpcell.00215.2004; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; James MJ, 2003, BLOOD, V102, P2173, DOI 10.1182/blood-2003-02-0637; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Marelli-Berg FM, 2000, J IMMUNOL, V165, P4182, DOI 10.4049/jimmunol.165.8.4182; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Marty V, 2005, GLIA, V49, P511, DOI 10.1002/glia.20138; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; Ralevic V, 1998, PHARMACOL REV, V50, P413; Schinkel AH, 2001, ADV EXP MED BIOL, V500, P365; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Schlegel RA, 2000, ANN NY ACAD SCI, V926, P217; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224	44	177	182	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					808	U76		10.1038/ncb1279	http://dx.doi.org/10.1038/ncb1279			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16025105				2022-12-27	WOS:000230881500015
J	Rajalingam, K; Wunder, C; Brinkmann, V; Churin, Y; Hekman, M; Sievers, C; Rapp, UR; Rudel, T				Rajalingam, K; Wunder, C; Brinkmann, V; Churin, Y; Hekman, M; Sievers, C; Rapp, UR; Rudel, T			Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration	NATURE CELL BIOLOGY			English	Letter							14-3-3 BINDING; C-RAF; KINASE; CHOLESTEROL; RECRUITMENT; MEMBRANE; CAVEOLAE; TARGETS; FAMILY	Ras proteins control the signalling pathways that are responsible for normal growth and malignant transformation(1). Raf protein kinases are direct Ras effector proteins that initiate the mitogen-activated protein kinase (MAPK) cascade(2), which mediates diverse biological functions such as cell growth, survival and differentiation(3). Here we show that prohibitin, a ubiquitously expressed and evolutionarily conserved protein(4) is indispensable for the activation of the Raf-MEK-ERK pathway by Ras. The membrane targeting and activation of C-Raf by Ras needs prohibitin in vivo. In addition, direct interaction with prohibitin is required for C-Raf activation. C-Raf kinase fails to interact with the active Ras induced by epidermal growth factor in the absence of prohibitin. Moreover, in prohibitin-deficient cells the adhesion complex proteins cadherin and beta-catenin relocalize to the plasma membrane and thereby stabilize adherens junctions. Our data show an unexpected role of prohibitin in the activation of the Ras-Raf signalling pathway and in modulating epithelial cell adhesion and migration.	Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; Microscopy Core Facil, D-10117 Berlin, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany	Max Planck Society; University of Wurzburg	Rudel, T (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Schumannstr 21-22, D-10117 Berlin, Germany.	rudel@mpiib-berlin.mpg.de	Brinkmann, Volker/A-6015-2009; Rajalingam, krishnaraj/D-3081-2011; Wunder, Christian/K-8542-2017	Wunder, Christian/0000-0001-9091-0080				ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Kerkhoff E, 2001, ADV ENZYME REGUL, V41, P261, DOI 10.1016/S0065-2571(00)00023-6; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Srisomsap C, 2002, PROTEOMICS, V2, P706, DOI 10.1002/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E; Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498	30	283	297	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					837	843		10.1038/ncb1283	http://dx.doi.org/10.1038/ncb1283			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16041367				2022-12-27	WOS:000230881500019
J	Irie, F; Okuno, M; Pasquale, EB; Yamaguchi, Y				Irie, F; Okuno, M; Pasquale, EB; Yamaguchi, Y			EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1	NATURE CELL BIOLOGY			English	Article							AMPA RECEPTOR ENDOCYTOSIS; VESICLE ENDOCYTOSIS; SYNAPTIC PLASTICITY; ENDOPHILIN; PROTEINS; GROWTH; REPULSION; DOMAIN; BRAIN; BIND	Recent studies show that Eph receptors act mainly through the regulation of actin reorganization(1). Here, we show a novel mode of action for EphB receptors. We identify synaptojanin 1 - a phosphatidylinositol 5'-phosphatase that is involved in clathrin-mediated endocytosis(2,3) - as a physiological substrate for EphB2. EphB2 causes tyrosine phosphorylation in the proline-rich domain of synaptojanin 1, and inhibits both the interaction with endophilin and the 5'-phosphatase activity of synaptojanin 1. Treatment with the EphB ligand, ephrinB2, elevates the cellular level of phosphatidylinositol 4,5-bisphosphate and promotes transferrin uptake. A kinase inactive mutant of EphB2 and a phosphorylation site mutant of synaptojanin 1 both neutralize the increase of transferrin uptake after ephrinB2 treatment. These mutants also inhibit AMPA glutamate receptor endocytosis in hippocampal neurons. Interestingly, incorporated transferrin does not reach endosomes, suggesting dual effects of EphB signalling on the early and late phases of clathrin-mediated endocytosis. Our results indicate that ephrinB-EphB signalling regulates clathrin-mediated endocytosis in various cellular contexts by influencing protein interactions and phosphoinositide turnover through tyrosine phosphorylation of synaptojanin 1.	Burnham Inst, Dev Neurobiol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Irie, F (corresponding author), Burnham Inst, Dev Neurobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	firie@burnham.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD025938, P01 HD25938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	32	88	90	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					501	U69		10.1038/ncb1252	http://dx.doi.org/10.1038/ncb1252			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15821731	Green Accepted			2022-12-27	WOS:000229123500017
J	Abell, K; Bilancio, A; Clarkson, RWE; Tiffen, PG; Altaparmakov, AI; Burdon, TG; Asano, T; Vanhaesebroeck, B; Watson, CJ				Abell, K; Bilancio, A; Clarkson, RWE; Tiffen, PG; Altaparmakov, AI; Burdon, TG; Asano, T; Vanhaesebroeck, B; Watson, CJ			Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition	NATURE CELL BIOLOGY			English	Article							MAMMARY-GLAND INVOLUTION; EMBRYONIC STEM-CELLS; P85 ALPHA-GENE; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; NEGATIVE REGULATION; ACTIVATION; P85-ALPHA; INSULIN; CANCER	Physiological apoptosis is induced by a switch from survival to death signalling. Dysregulation of this process is frequently associated with cancer(1). A powerful model for this apoptotic switch is mammary gland involution, during which redundant milk-producing epithelial cells undergo apoptosis(2). Signal transducer and activator of transcription 3 (Stat3) is an essential mediator of this switch but the mechanism has not yet been defined(3). Stat3-dependent cell death during involution can be blocked by activation of Akt/protein kinase B (PKB)(4), a downstream effector of the phosphoinositide-3-OH kinase (PI(3)K) pathway(5). Here we show that expression of the PI(3) K regulatory subunits p55 alpha and p50 alpha is induced by Stat3 during involution. In the absence of Stat3 in vivo, upregulation of p55 alpha and p50 alpha is abrogated, levels of activated Akt are sustained and apoptosis is prevented. Chromatin immunoprecipitation assays show that Stat3 binds directly to the p55 alpha and p50 alpha promoters in vivo. Overexpression of either p55 alpha or p50 alpha reduces levels of activated Akt. We propose a novel mechanism in which Stat3 regulates apoptosis by inducing expression of distinct PI(3) K regulatory subunits to downregulate PI(3)K-Akt-mediated survival signalling.	Univ Cambridge, Dept Pathol, Mammary Apoptosis & Dev Grp, Cambridge CB2 1QP, England; Ludwig Inst Canc Res, Cell Signalling Lab, London W1W 7BS, England; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Tokyo, Fac Med, Dept Internal Med 3, Tokyo 113, Japan; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of Cambridge; Ludwig Institute for Cancer Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Tokyo; University of London; University College London	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Mammary Apoptosis & Dev Grp, Tennis Court Rd, Cambridge CB2 1QP, England.	cjw53@mole.bio.cam.ac.uk	watson, Christine J/B-1431-2012; Clarkson, Richard/A-7505-2010	BILANCIO, Antonio/0000-0002-5118-3359; clarkson, richard/0000-0001-7389-8673	Biotechnology and Biological Sciences Research Council [BBS/E/R/00000664] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Davuluri RV, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459a; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Hallmann D, 2003, J BIOL CHEM, V278, P5099, DOI 10.1074/jbc.M208451200; Inukai I, 2001, FEBS LETT, V490, P32, DOI 10.1016/S0014-5793(01)02132-9; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Kumar R, 2000, ENDOCR-RELAT CANCER, V7, P257, DOI 10.1677/erc.0.0070257; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PONS S, 1995, MOL CELL BIOL, V15, P4453; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	31	88	91	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					392	398		10.1038/ncb1242	http://dx.doi.org/10.1038/ncb1242			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793565				2022-12-27	WOS:000228075500016
J	Li, Z; Dong, XM; Wang, ZL; Liu, WZ; Deng, N; Ding, Y; Tang, LY; Hla, T; Zeng, R; Li, L; Wu, DQ				Li, Z; Dong, XM; Wang, ZL; Liu, WZ; Deng, N; Ding, Y; Tang, LY; Hla, T; Zeng, R; Li, L; Wu, DQ			Regulation of PTEN by Rho small GTPases	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR PTEN; CELL-MIGRATION; FAMILY GTPASES; ACTIVATION; KINASE; 3-KINASE; CDC42; POLARIZATION; NEUTROPHILS; CHEMOTAXIS	PTEN ( phosphatase and tensin homologue) is a phosphatase that dephosphorylates both protein and phosphoinositide substrates. It is mutated in a variety of human tumours and has important roles in a diverse range of biological processes(1-4), including cell migration(5-7) and chemotaxis(8,9). PTEN's intracellular localization and presumably activity are regulated by chemoattractants in Dictyostelium(10,11) and mouse neutrophils(12). However, the mechanisms for its regulation remain elusive. Here we show that RhoA and Cdc42, members of the Rho family of small GTPases(13-16), regulate the intracellular localization of PTEN in leukocytes and human transfected embryonic kidney cells. In addition, active RhoA is able to stimulate the phospholipid phosphatase activity of PTEN in human embryonic kidney cells and leukocytes, and this regulation seems to require RhoA's downstream effector, RhoA-associated kinase (Rock). Furthermore, we have identified key residues on PTEN that are required for its regulation by the small GTPase, and show that small GTPase-mediated regulation of PTEN has a significant role in the regulation of chemotaxis.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Prote, Res Ctr Prote Anal, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China	University of Connecticut; University of Connecticut; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DQ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	lli@sibs.ac.cn; dwu@neuron.uchc.edu	Wang, Zhenglong/H-4237-2016; Deng, Ning/H-6561-2014; Hla, Timothy/G-5873-2012; Ding, Yu/A-2949-2013	Wang, Zhenglong/0000-0002-3016-8598; Hla, Timothy/0000-0001-8355-4065; DENG, NING/0000-0002-1321-5508				Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Parent CA, 2002, CELL, V109, P541, DOI 10.1016/S0092-8674(02)00765-1; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	30	382	397	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					399	U42		10.1038/ncb1236	http://dx.doi.org/10.1038/ncb1236			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793569				2022-12-27	WOS:000228075500017
J	Liu, L; Bailey, SM; Okuka, M; Munoz, P; Li, C; Zhou, LJ; Wu, C; Czerwiec, E; Sandler, L; Seyfang, A; Blasco, MA; Keefe, DL				Liu, Lin; Bailey, Susan M.; Okuka, Maja; Munoz, Purificacion; Li, Chao; Zhou, Lingjun; Wu, Chao; Czerwiec, Eva; Sandler, Laurel; Seyfang, Andreas; Blasco, Maria A.; Keefe, David L.			Telomere lengthening early in development	NATURE CELL BIOLOGY			English	Article							RECOMBINATION; CELLS; MOUSE; DNA; MICE; ALT; ASSOCIATION; INSTABILITY; DEFICIENT; PATHWAY	Stem cells and cancer cells maintain telomere length mostly through telomerase(1-3). Telomerase activity is high in male germ line and stem cells, but is low or absent in mature oocytes and cleavage stage embryos, and then high again in blastocysts(3). How early embryos reset telomere length remains poorly understood. Here, we show that oocytes actually have shorter telomeres than somatic cells, but their telomeres lengthen remarkably during early cleavage development. Moreover, parthenogenetically activated oocytes also lengthen their telomeres, thus the capacity to elongate telomeres must reside within oocytes themselves. Notably, telomeres also elongate in the early cleavage embryos of telomerase-null mice, demonstrating that telomerase is unlikely to be responsible for the abrupt lengthening of telomeres in these cells. Coincident with telomere lengthening, extensive telomere sister-chromatid exchange ( T-SCE) and colocalization of the DNA recombination proteins Rad50 and TRF1 were observed in early cleavage embryos. Both T-SCE and DNA recombination proteins decrease in blastocyst stage embryos, whereas telomerase activity increases and telomeres elongate only slowly. We suggest that telomeres lengthen during the early cleavage cycles following fertilization through a recombination-based mechanism, and that from the blastocyst stage onwards, telomerase only maintains the telomere length established by this alternative mechanism.	Univ S Florida, Coll Med, Dept Obstet & Gynecol, Lab Reprod Med, Tampa, FL 33612 USA; Colorado State Univ, Ft Collins, CO 80523 USA; Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510275, Peoples R China; Women & Infants Hosp Rhode Isl, Brown Med Sch, Providence, RI 02905 USA; Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Colorado State University; Centro Nacional de Investigaciones Oncologicas (CNIO); Sun Yat Sen University; Brown University; Women & Infants Hospital Rhode Island; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liu, L (corresponding author), Univ S Florida, Coll Med, Dept Obstet & Gynecol, Lab Reprod Med, Tampa, FL 33612 USA.	liutelom@yahoo.com; dkeefe@health.usf.edu	Seyfang, Andreas/H-2445-2012; Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Seyfang, Andreas/0000-0001-6231-9955				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Baird DM, 2006, HUM MOL GENET, V15, P45, DOI 10.1093/hmg/ddi424; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Keefe DL, 2007, CELL MOL LIFE SCI, V64, P139, DOI 10.1007/s00018-006-6466-z; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; McIlrath J, 2001, CANCER RES, V61, P912; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tanemura K, 2005, DEV BIOL, V281, P196, DOI 10.1016/j.ydbio.2005.02.025; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; WANG SS, 1990, NATURE, V345, P456, DOI 10.1038/345456a0; Wright WE, 1996, DEV GENET, V18, P173; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	36	276	284	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1436	U185		10.1038/ncb1664	http://dx.doi.org/10.1038/ncb1664			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17982445				2022-12-27	WOS:000251317300017
J	Soutoglou, E; Dorn, JF; Sengupta, K; Jasin, M; Nussenzweig, A; Ried, T; Danuser, G; Misteli, T				Soutoglou, Evi; Dorn, Jonas F.; Sengupta, Kundan; Jasin, Maria; Nussenzweig, Andre; Ried, Thomas; Danuser, Gaudenz; Misteli, Tom			Positional stability of single double-strand breaks in mammalian cells	NATURE CELL BIOLOGY			English	Article							LIVING CELLS; DNA BREAKS; HISTONE H2AX; TRANSLOCATIONS; REPAIR; VISUALIZATION; ORGANIZATION; CANCER; SITES; ENDONUCLEASE	Formation of cancerous translocations requires the illegitimate joining of chromosomes containing double-strand breaks (DSBs). It is unknown how broken chromosome ends find their translocation partners within the cell nucleus. Here, we have visualized and quantitatively analysed the dynamics of single DSBs in living mammalian cells. We demonstrate that broken ends are positionally stable and unable to roam the cell nucleus. Immobilization of broken chromosome ends requires the DNA-end binding protein Ku80, but is independent of DNA repair factors, H2AX, the MRN complex and the cohesion complex. DSBs preferentially undergo translocations with neighbouring chromosomes and loss of local positional constraint correlates with elevated genomic instability. These results support a contact-first model in which chromosome translocations predominantly form among spatially proximal DSBs.	NCI, NIH, Genet Branch, Bethesda, MD 20892 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Scripps Research Institute; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Genet Branch, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov		Soutoglou, Evi/0000-0002-3724-5613; Sengupta, Kundan/0000-0002-9936-2284; Dorn, Jonas/0000-0001-6696-0117; Danuser, Gaudenz/0000-0001-8583-2014	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NIGMS NIH HHS [GM68956, R01 GM068956] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010837, Z01BC010283, Z01BC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068956] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2004, CELL CYCLE, V3, P149; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bornfleth H, 1999, BIOPHYS J, V77, P2871, DOI 10.1016/S0006-3495(99)77119-5; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fugunaga K., 1990, INTRO STAT PATTERN R; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Martinez ED, 2005, J STEROID BIOCHEM, V97, P307, DOI 10.1016/j.jsbmb.2005.06.033; MCNEIL N, 2000, EXPERT REV MOL MED, P1; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Villalobos Michael J, 2006, Methods Mol Biol, V314, P109; Wyman C, 2002, CURR BIOL, V12, pR446, DOI 10.1016/S0960-9822(02)00941-7	41	387	398	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					675	U121		10.1038/ncb1591	http://dx.doi.org/10.1038/ncb1591			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486118	Green Accepted			2022-12-27	WOS:000246922700013
J	Thoma, CR; Frew, IJ; Hoerner, CR; Montani, M; Moch, H; Krek, W				Thoma, Claudio R.; Frew, Ian J.; Hoerner, Christian R.; Montani, Matteo; Moch, Holger; Krek, Wilhelm			pVHL and GSK3 beta are components of a primary cilium-maintenance signalling network	NATURE CELL BIOLOGY			English	Article							LINDAU TUMOR-SUPPRESSOR; GLYCOGEN-SYNTHASE KINASE-3; POLYCYSTIC KIDNEY-DISEASE; PROTEIN; INACTIVATION; GENE; CILIOGENESIS; ACTIVATION; STABILITY; LESIONS	Defects in the structure or function of the primary cilium, an antennae-like structure whose functional integrity has been linked to the suppression of uncontrolled kidney epithelial cell proliferation, are a common feature of genetic disorders characterized by kidney cysts(1,2). However, the mechanisms by which primary cilia are maintained remain poorly defined. von Hippel-Lindau (VHL) disease is characterized by the development of premalignant renal cysts and arises because of functional inactivation of the VHL tumour suppressor gene product, pVHL(3,4). Here, we show that pVHL and glycogen synthase kinase (GSK)3 beta are key components of an interlinked signalling pathway that maintains the primary cilium. Although inactivation of either pVHL or GSK3 beta alone did not affect cilia maintenance, their combined inactivation leads to loss of cilia. In VHL patients, GSK3 beta is subjected to inhibitory phosphorylation in renal cysts, but not in early VHL mutant lesions, and these cysts exhibit reduced frequencies of primary cilia. We propose that pVHL and GSK3 beta function together in a ciliary-maintenance signalling network, disruption of which enhances the vulnerability of cells to lose their cilia, thereby promoting cyst formation.	ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; Univ Zurich, PHD Programme Mol Life Sci, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Krek, W (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	wilhelm.krek@cell.biol.ethz.ch		Frew, Ian/0000-0003-2735-5509; Hoerner, Christian/0000-0002-8685-1126				Alieva I B, 1999, Membr Cell Biol, V12, P895; BRAUCH H, 1995, HUM GENET, V95, P551, DOI 10.1007/BF00223868; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; CHOYKE PL, 1992, AM J ROENTGENOL, V159, P1229, DOI 10.2214/ajr.159.6.1442389; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lolkema MP, 2004, EXP CELL RES, V301, P139, DOI 10.1016/j.yexcr.2004.07.016; Lutz MS, 2006, CANCER RES, V66, P6903, DOI 10.1158/0008-5472.CAN-06-0501; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2004, AM J PHYSIOL-RENAL, V287, pF969, DOI 10.1152/ajprenal.00096.2004; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; SOLOMON D, 1988, HUM PATHOL, V19, P1072, DOI 10.1016/S0046-8177(88)80089-3; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	34	178	180	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2007	9	5					588	U191		10.1038/ncb1579	http://dx.doi.org/10.1038/ncb1579			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	163RS	17450132				2022-12-27	WOS:000246181500018
J	Park, M; Yong, YY; Choi, SW; Kim, JH; Lee, JE; Kim, DW				Park, Minsun; Yong, Yeryoung; Choi, Seung-Won; Kim, Jae Hwan; Lee, Jong Eun; Kim, Dae-Won			Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; SOMITIC CHONDROGENESIS; TRANSCRIPTION FACTORS; SKELETAL DYSPLASIA; AXIAL SKELETON; BAPX1; BONE; GENE; DIFFERENTIATION; EXPRESSION	During endochondral ossification, a process that accounts for the majority of bone formation in vertebrates, hypertrophic chondrocytes display a greater susceptibility to apoptosis when compared to proliferating chondrocytes. However, the molecular mechanisms underlying this phenomenon remain unclear. Nkx3.2, a member of the NK class of homeoproteins, is initially expressed in chondrogenic precursor cells, and later, during cartilage maturation, its expression is restricted to proliferating chondrocytes. Here, we show that the nuclear factor kappa B (NF-kappa B) pathway is required for chondrocyte viability and that Nkx3.2 supports chondrocyte survival by constitutively activating RelA. Although signal-dependent NF-kappa B activation has been intensively studied, ligand-independent NF-kappa B activation is poorly understood. The data presented here support a novel ligand-independent mechanism of NF-kappa B activation, whereby Nkx3.2 recruits the ReIA-I kappa B alpha heteromeric complex into the nucleus by direct protein-protein interactions and activates RelA through proteasome-dependent I kappa B alpha degradation in the nucleus. Furthermore, we demonstrate that stage-specific NF-kappa B activation, mediated by Nkx3.2, regulates chondrocyte viability during cartilage maturation.	Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Dept Anat, Seoul 120752, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Kim, DW (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	kimdw@yonsei.ac.kr		Lee, Jong Eun/0000-0001-6203-7413				Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Church V, 2005, ANAT EMBRYOL, V209, P461, DOI 10.1007/s00429-005-0464-z; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tribioli C, 1997, GENE, V203, P225, DOI 10.1016/S0378-1119(97)00520-9; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Vortkamp A, 2001, OSTEOARTHR CARTILAGE, V9, pS109, DOI 10.1053/joca.2001.0452; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Yoshiura KI, 1997, GENOMICS, V45, P425, DOI 10.1006/geno.1997.4926; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002	32	39	43	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2007	9	3					287	U87		10.1038/ncb1538	http://dx.doi.org/10.1038/ncb1538			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	141DT	17310243				2022-12-27	WOS:000244558600013
J	Asselin-Labat, ML; Sutherland, KD; Barker, H; Thomas, R; Shackleton, M; Forrest, NC; Hartley, L; Robb, L; Grosveld, FG; van der Wees, J; Lindeman, GJ; Visvader, JE				Asselin-Labat, Marie-Liesse; Sutherland, Kate D.; Barker, Holly; Thomas, Richard; Shackleton, Mark; Forrest, Natasha C.; Hartley, Lynne; Robb, Lorraine; Grosveld, Frank G.; van der Wees, Jacqueline; Lindeman, Geoffrey J.; Visvader, Jane E.			Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; HUMAN BREAST-TUMORS; NERVOUS-SYSTEM; STEM-CELLS; GENE; EXPRESSION; CANCER; INITIATION; LINEAGE; THYMUS	The transcription factor Gata-3 is a defining marker of the 'luminal' subtypes of breast cancer(1-4). To gain insight into the role of Gata-3 in breast epithelial development and oncogenesis, we have explored its normal function within the mammary gland by conditionally deleting Gata-3 at different stages of development. We report that Gata-3 has essential roles in the morphogenesis of the mammary gland in both the embryo and adult. Through the discovery of a novel marker (beta(3)-integrin) of luminal progenitor cells and their purification, we demonstrate that Gata-3 deficiency leads to an expansion of luminal progenitors and a concomitant block in differentiation. Remarkably, introduction of Gata-3 into a stem cell-enriched population induced maturation along the alveolar luminal lineage. These studies provide evidence for the existence of an epithelial hierarchy within the mammary gland and establish Gata-3 as a critical regulator of luminal differentiation.	Walter & Eliza Hall Inst Med Res, BCRC Lab, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3050, Australia; Erasmus MC, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands; Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; Erasmus University Rotterdam; Erasmus MC; Royal Melbourne Hospital	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, BCRC Lab, Parkville, Vic 3050, Australia.	lindeman@wehi.edu.au; visvader@wehi.edu.au		Lindeman, Geoffrey/0000-0001-9386-2416; Barker, Holly/0000-0002-9350-5520; Sutherland, Kate/0000-0002-7453-3366				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sum EYM, 2005, ONCOGENE, V24, P4820, DOI 10.1038/sj.onc.1208638; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; van Doorninck J H, 1999, J Neurosci, V19, pRC12; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wilkinson DG, 1992, SITU HYBRIDIZATION P	33	612	632	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					201	U103		10.1038/ncb1530	http://dx.doi.org/10.1038/ncb1530			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17187062				2022-12-27	WOS:000243903000013
J	Yasuhara, N; Shibazaki, N; Tanaka, S; Nagai, M; Kamikawa, Y; Oe, S; Asally, M; Kamachi, Y; Kondoh, H; Yoneda, Y				Yasuhara, Noriko; Shibazaki, Noriko; Tanaka, Shinya; Nagai, Masahiro; Kamikawa, Yasunao; Oe, Souichi; Asally, Munehiro; Kamachi, Yusuke; Kondoh, Hisato; Yoneda, Yoshihiro			Triggering neural differentiation of ES cells by subtype switching of importin-alpha	NATURE CELL BIOLOGY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; TRANSCRIPTIONAL REGULATION; PROTEIN IMPORT; IDENTIFICATION; GENE; SOX2; EXPRESSION; REQUIRES; OCT-3/4; NANOG	Nuclear proteins are selectively imported into the nucleus by transport factors such as importin-alpha and importin-beta(1,2). Here, we show that the expression of importin-alpha subtypes is strictly regulated during neural differentiation of mouse embryonic stem (ES) cells, and that the switching of importin-alpha subtype expression is critical for neural differentiation. Moreover, reproducing the switching of importin-alpha subtype expression in undifferentiated ES cells induced neural differentiation in the presence of leukaemia inhibitory factor (LIF) and serum, coordinated with the regulated expression of Oct3/4, Brn2 and SOX2, which are involved in ES-neural identity determination. These transcription factors were selectively imported into the nucleus by specific subtypes of importin-alpha. Thus, importin-alpha subtype switching has a major impact on cell differentiation through the regulated nuclear import of a specific set of transcription factors. This is the first study to propose that transport factors should be considered as major players in cell-fate determination.	Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Dev Biol Grp, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Biomol Dynam Grp, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Yoneda, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp	Kamachi, Yusuke/C-9029-2009; Asally, Munehiro/AAZ-3693-2020; Kamachi, Yusuke/AAB-6710-2022	Asally, Munehiro/0000-0002-8273-7617; Kamachi, Yusuke/0000-0001-5018-1119				ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Baranek C, 2005, NUCLEIC ACIDS RES, V33, P6277, DOI 10.1093/nar/gki947; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Ilia M, 2003, EXP NEUROL, V181, P159, DOI 10.1016/S0014-4886(03)00047-5; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamikubo Y, 2004, HYBRIDOMA HYBRIDOM, V23, P301, DOI 10.1089/hyb.2004.23.301; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SAKAGUCHI T, 2003, HYBRIDOMA HYBRIDOM, V6, P397; Sock E, 1996, J BIOL CHEM, V271, P17512, DOI 10.1074/jbc.271.29.17512; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	27	180	184	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					72	U93		10.1038/ncb1521	http://dx.doi.org/10.1038/ncb1521			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17159997				2022-12-27	WOS:000243255100014
J	Aldridge, BB; Burke, JM; Lauffenburger, DA; Sorger, PK				Aldridge, Bree B.; Burke, John M.; Lauffenburger, Douglas A.; Sorger, Peter K.			Physicochemical modelling of cell signalling pathways	NATURE CELL BIOLOGY			English	Review							PARAMETER-ESTIMATION; METABOLIC PATHWAYS; DYNAMICS; NETWORK; REPRESENTATION; TRANSDUCTION	Physicochemical modelling of signal transduction links fundamental chemical and physical principles, prior knowledge about regulatory pathways, and experimental data of various types to create powerful tools for formalizing and extending traditional molecular and cellular biology.	MIT, Ctr Cell Decis Proc, Dept Biol Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Aldridge, BB (corresponding author), MIT, Ctr Cell Decis Proc, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	psorger@mit.edu		Sorger, Peter/0000-0002-3364-1838; Aldridge, Bree/0000-0003-2236-1424	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50-GM68762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Alves R, 2006, NAT BIOTECHNOL, V24, P667, DOI 10.1038/nbt0606-667; Balci O, 1997, PROCEEDINGS OF THE 1997 WINTER SIMULATION CONFERENCE, P135, DOI 10.1145/268437.268462; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; CONRAD E. D., 2006, SYSTEM MODELING CELL, P97; Conzelmann H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-34; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Dyson F, 2004, NATURE, V427, P297, DOI 10.1038/427297a; FARROW LA, 1974, INT J CHEM KINET, V1, P309; FREY D, 2004, ENG SYST 2004 S MIT; GARDINER CW, 2005, HDB STOCHASTIC PROCE; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HOPPENSTAEDT FC, 2000, ANAL SIMULATION CHAO; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; ODDE DJ, 1995, ANN BIOMED ENG, V23, P268, DOI 10.1007/BF02584428; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roussel MR, 2004, J CHEM PHYS, V121, P8716, DOI 10.1063/1.1802495; Sargent RG, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P130, DOI 10.1109/WSC.2005.1574246; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; Tolle D., 2006, CURR BIOINFORM, V1, P1; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van Riel NAW, 2006, IEE P SYST BIOL, V153, P263, DOI 10.1049/ip-syb:20050076; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; WIGGINS S, 2003, INTRO APPL NONLINEAR, P356	45	414	419	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1195	1203		10.1038/ncb1497	http://dx.doi.org/10.1038/ncb1497			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060902				2022-12-27	WOS:000241732400004
J	Morozova, N; Liang, YH; Tokarev, AA; Chen, SH; Cox, R; Andrejic, J; Lipatova, Z; Sciorra, VA; Emr, SD; Segev, N				Morozova, Nadya; Liang, Yongheng; Tokarev, Andrei A.; Chen, Shu H.; Cox, Randal; Andrejic, Jelena; Lipatova, Zhanna; Sciorra, Vicki A.; Emr, Scott D.; Segev, Nava			TRAPPII subunits are required for the specificity switch of a Ypt-Rab GEF	NATURE CELL BIOLOGY			English	Article							GENETIC INTERACTIONS; NUCLEOTIDE EXCHANGE; PROTEIN; YEAST; GTPASES; GOLGI; COMPLEX; IDENTIFICATION; LOCALIZATION; EFFECTOR	Ypt-Rab GTPases are key regulators of the various steps of intracellular trafficking. Guanine nucleotide-exchange factors (GEFs) regulate the conversion of Ypt-Rabs to the GTP-bound state, in which they interact with effectors that mediate all the known aspects of vesicular transport(1-3). An interesting possibility is that Ypt-Rabs coordinate separate steps of the transport pathways(4). The conserved modular complex TRAPP is a GEF for the Golgi gatekeepers Ypt1 and Ypt31/32 (refs 5-7). However, it is not known how Golgi entry and exit are coordinated. TRAPP comes in two configurations: the seven-subunit TRAPPI is required for endoplasmic reticulum-to-Golgi transport, whereas the ten-subunit TRAPPII functions in late Golgi(8-10). The two essential TRAPPII-specific subunits Trs120 and Trs130 have been identified as Ypt31/32 genetic interactors(11-13). Here, we show that they are required for switching the GEF specificity of TRAPP from Ypt1 to Ypt31. Moreover, a trs 130ts mutation confers opposite effects on the intracellular localization of these GTPases. We suggest that the Trs120-Trs130 subcomplex joins TRAPP in the late Golgi to switch its GEF activity from Ypt1 to Ypt31/32. Such a 'switchable' GEF could ensure sequential activation of these Ypts, thereby coordinating Golgi entry and exit.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego	Segev, N (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, Mol Biol Res Bldg,900 S Ashland Ave, Chicago, IL 60607 USA.	nava@uic.edu	Liang, Yongheng/B-2024-2009; Liang, Yongheng/F-9972-2011	Liang, Yongheng/0000-0002-5430-2042	NIGMS NIH HHS [GM-45444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045444] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bensen ES, 2001, MOL BIOL CELL, V12, P13, DOI 10.1091/mbc.12.1.13; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; James P, 1996, GENETICS, V144, P1425; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Jones S, 1998, MOL BIOL CELL, V9, P2819, DOI 10.1091/mbc.9.10.2819; JONES S, 1995, J CELL BIOL, V130, P1051, DOI 10.1083/jcb.130.5.1051; Jones S, 1999, GENETICS, V152, P1543; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Lafreniere RG, 1997, GENE, V198, P313, DOI 10.1016/S0378-1119(97)00333-8; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Nagamine K, 1997, BIOCHEM BIOPH RES CO, V235, P185, DOI 10.1006/bbrc.1997.6758; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; ROSE M, 1988, METHODS YEAST GENETI, P146; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Segev N, 2001, SCI STKE, pre11, DOI DOI 10.1126/STKE.2001.100.RE11; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CJ, 2002, YEAST, V19, P1075, DOI 10.1002/yea.903	34	117	124	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1263	U44		10.1038/ncb1489	http://dx.doi.org/10.1038/ncb1489			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17041589				2022-12-27	WOS:000241732400015
J	Gupta, ML; Carvalho, P; Roof, DM; Pellman, D				Gupta, Mohan L., Jr.; Carvalho, Pedro; Roof, David M.; Pellman, David			Plus end-specific depolymerase activity of Kip3, a kinesin-8 protein, explains its role in positioning the yeast mitotic spindle	NATURE CELL BIOLOGY			English	Article							REGULATE MICROTUBULE DYNAMICS; MOTOR PROTEINS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FISSION YEAST; NUCLEAR MIGRATION; CELL CORTEX; ANAPHASE; MICROSCOPY; MECHANISM	The budding yeast protein Kip3p is a member of the conserved kinesin-8 family of microtubule motors, which are required for microtubule -cortical interactions, normal spindle assembly and kinetochore dynamics. Here, we demonstrate that Kip3p is both a plus end-directed motor and a plus end-specific depolymerase - a unique combination of activities not found in other kinesins. The ATPase activity of Kip3p was activated by both microtubules and unpolymerized tubulin. Furthermore, Kip3p in the ATP-bound state formed a complex with unpolymerized tubulin. Thus, motile kinesin-8s may depolymerize microtubules by a mechanism that is similar to that used by non-motile kinesin-13 proteins. Fluorescent speckle analysis established that, in vivo, Kip3p moved toward and accumulated on the plus ends of growing microtubules, suggesting that motor activity brings Kip3p to its site of action. Globally, and more dramatically on cortical contact, Kip3p promoted catastrophes and pausing, and inhibited microtubule growth. These findings explain the role of Kip3p in positioning the mitotic spindle in budding yeast and potentially other processes controlled by kinesin-8 family members.	Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Penn, Dept Biol Anim, Program Cell & Mol Biol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania	Pellman, D (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Carvalho, Pedro/HHN-1424-2022	Carvalho, Pedro/0000-0002-9691-5277	NIGMS NIH HHS [R01 GM61345] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; ALGAIER J, 1988, BIOCHIM BIOPHYS ACTA, V954, P235, DOI 10.1016/0167-4838(88)90078-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Gatt MK, 2005, J CELL SCI, V118, P2671, DOI 10.1242/jcs.02410; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Komarova YA, 2002, J CELL SCI, V115, P3527; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; PASCHAL BM, 1993, METHOD CELL BIOL, V39, P65, DOI 10.1016/S0091-679X(08)60161-2; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Rischitor PE, 2004, EUKARYOT CELL, V3, P632, DOI 10.1128/EC.3.3.632-645.2004; Rose MD., 1990, METHODS YEAST GENETI; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sharp DJ, 2000, BBA-MOL CELL RES, V1496, P128, DOI 10.1016/S0167-4889(00)00014-8; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; TIWARI SC, 1993, ANAL BIOCHEM, V215, P96, DOI 10.1006/abio.1993.1560; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	54	239	241	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					913	U33		10.1038/ncb1457	http://dx.doi.org/10.1038/ncb1457			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906148				2022-12-27	WOS:000240241700007
J	von Kriegsheim, A; Pitt, A; Grindlay, GJ; Kolch, W; Dhillon, AS				von Kriegsheim, Alex; Pitt, Andrew; Grindlay, G. Joan; Kolch, Walter; Dhillon, Amardeep S.			Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; KINASE ACTIVATION; PHOSPHORYLATION; P21-ACTIVATED-KINASE-1; DEPHOSPHORYLATION; SPECIFICITY	The Raf-MEK-ERK pathway couples growth factor, mitogenic and extracellular matrix signals to cell fate decisions such as growth, proliferation, migration, differentiation and survival(1,2). Raf-1 is a direct effector of the Ras GTPase and is the initiating kinase in this signalling cascade. Although Raf-1 activation is well studied, little is known about how Raf-1 is inactivated. Here, we used a proteomic approach to identify molecules that may inactivate Raf-1 signalling. Protein phosphatase 5 (PP5) was identified as an inactivator that associates with Raf-1 on growth factor stimulation and selectively dephosphorylates an essential activating site, Ser 338. The PP5-mediated dephosphorylation of Ser 338 inhibited Raf-1 activity and downstream signalling to MEK, an effect that was prevented by phosphomimetic substitution of Ser 338, or by ablation of PP5 catalytic function. Furthermore, depletion of endogenous PP5 increased cellular phospho-Ser 338 levels. Our results suggest that PP5 is a physiological regulator of Raf-1 signalling pathways.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	Beatson Institute; University of Glasgow	Dhillon, AS (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	wkolch@beatson.gla.ac.uk; A.Dhillon@beatson.gla.ac.uk	Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022; Pitt, Andrew R/E-9083-2010; RASOR, Scotland/A-3274-2011; von Kriegsheim, Alex/C-2371-2016	von Kriegsheim, Alex/0000-0002-4952-8573; Pitt, Andrew R/0000-0003-3619-6503; Kolch, Walter/0000-0001-5777-5016; Dhillon, Amardeep/0000-0002-6065-663X	Biotechnology and Biological Sciences Research Council [BB/C511572/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496	25	101	106	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1011	U102		10.1038/ncb1465	http://dx.doi.org/10.1038/ncb1465			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16892053				2022-12-27	WOS:000240241700018
J	Alderton, GK; Galbiati, L; Griffith, E; Surinya, KH; Neitzel, H; Jackson, AP; Jeggo, PA; O'Driscoll, M				Alderton, Gemma K.; Galbiati, Laura; Griffith, Elen; Surinya, Katharina H.; Neitzel, Heidemarie; Jackson, Andrew P.; Jeggo, Penny A.; O'Driscoll, Mark			Regulation of mitotic entry by microcephalin and its overlap with ATR signalling	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; SECKEL-SYNDROME; CHECKPOINT; REPLICATION; CHK1; PATHWAY; PROTEIN; CDC25A; INACTIVATION; IRRADIATION	Ataxia-telangiectasia mutated and Rad3 related ( ATR)-Seckel syndrome and autosomal recessive primary microcephaly ( MCPH) syndrome share clinical features. RNA interference ( RNAi) of MCPH1 have implicated the protein it encodes as a DNA-damage response protein that regulates the transcription of Chk1 and BRCA1, two genes involved in the response to DNA damage(1,2). Here, we report that truncating mutations observed in MCPH-syndrome patients do not impact on Chk1 or BRCA1 expression or early ATR-dependent damage-induced phosphorylation events. However, like ATR-Seckel syndrome cells, MCPH1-mutant cell lines show defective G2-M checkpoint arrest and nuclear fragmentation after DNA damage, and contain supernumerary mitotic centrosomes. MCPH1-mutant and ATR-Seckel cells also show impaired degradation of Cdc25A and fail to inhibit Cdc45 loading onto chromatin after replication arrest. Additionally, microcephalin interacts with Chk1. We conclude that MCPH1 has a function downstream of Chk1 in the ATR-signalling pathway. In contrast with ATR-Seckel syndrome cells, MCPH1-mutant cells have low levels of Tyr 15-phosphorylated Cdk1 ( pY15-Cdk1) in S and G2 phases, which correlates with an elevated frequency of G2-like cells displaying premature chromosome condensation ( PCC)(3,4). Thus, MCPH1 also has an ATR-independent role in maintaining inhibitory Cdk1 phosphorylation, which prevents premature entry into mitosis.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Leeds, Mol Med Unit, Leeds LS2 9JT, W Yorkshire, England; Charite Univ Med, Inst Human Genet, Berlin, Germany; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Sussex; University of Leeds; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; M.O-Driscoll@sussex.ac.uk	Jackson, Andrew P/D-3442-2009	Jackson, Andrew P/0000-0002-8739-2646; Surinya, Kathy/0000-0003-0507-2962; O'Driscoll, Mark/0000-0003-2765-316X; Alderton, Gemma/0000-0003-3041-8451	Medical Research Council [G0300428, G108/461] Funding Source: Medline; MRC [G108/461, G0300428] Funding Source: UKRI; Medical Research Council [G0300662B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; FENECH M, 1986, MUTAT RES, V161, P193, DOI 10.1016/0027-5107(86)90010-2; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Sorensen CS, 2004, CELL CYCLE, V3, P941; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	133	141	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					725	U157		10.1038/ncb1431	http://dx.doi.org/10.1038/ncb1431			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16783362				2022-12-27	WOS:000238837800015
J	Liang, C; Feng, P; Ku, B; Dotan, I; Canaani, D; Oh, BH; Jung, JU				Liang, Chengyu; Feng, Pinghui; Ku, Bonsu; Dotan, Iris; Canaani, Dan; Oh, Byung-Ha; Jung, Jae U.			Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG	NATURE CELL BIOLOGY			English	Article							CELL-DEATH; IN-VIVO; INDUCED APOPTOSIS; COLON-CANCER; VIRAL BCL-2; GENE; BECLIN-1; INHIBITION; IDENTIFICATION; MACROAUTOPHAGY	Autophagy, the degradation of cytoplasmic components, is an evolutionarily conserved homeostatic process involved in environmental adaptation, lifespan determination and tumour development. The tumor suppressor Beclin1 is part of the PI( 3) kinase class III ( PI( 3) KC3) lipid-kinase complex that induces autophagy. The autophagic activity of the Beclin1-PI( 3) KC3 complex, however, is suppressed by Bcl-2. Here, we report the identification of a novel coiled-coil UV irradiation resistance-associated gene ( UVRAG) as a positive regulator of the Beclin1-PI( 3) KC3 complex. UVRAG, a tumour suppressor candidate that is monoallelically mutated at high frequency in human colon cancers, associates with the Beclin1-Bcl-2-PI( 3) KC3 multiprotein complex, where UVRAG and Beclin1 interdependently induce autophagy. UVRAG-mediated activation of the Beclin1-PI( 3) KC3 complex promotes autophagy and also suppresses the proliferation and tumorigenicity of human colon cancer cells. These results identify UVRAG as an essential component of the Beclin1-PI( 3) KC3 lipid kinase complex that is an important signalling checkpoint for autophagy and tumour-cell growth.	Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Tumor Virol, Southborough, MA 01772 USA; Pohang Univ Sci & Technol, Ctr Biomol Recognit, Dept Life Sci, Pohang 790784, South Korea; Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel	Harvard University; Harvard University; Pohang University of Science & Technology (POSTECH); Tel Aviv University	Jung, JU (corresponding author), Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, 1 Pine Hill Dr, Southborough, MA 01772 USA.	jae_jung@hms.harvard.edu	Oh, Byung-Ha/C-2061-2011	LIANG, CHENGYU/0000-0001-6082-2143; Ku, Bonsu/0000-0003-1784-8975	NATIONAL CANCER INSTITUTE [R01CA082057, R01CA106156, R01CA091819, R01CA031363] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NCI NIH HHS [CA31363, CA106156, CA91819, CA82057] Funding Source: Medline; NCRR NIH HHS [RR00168] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; de Lima BD, 2005, J GEN VIROL, V86, P31, DOI 10.1099/vir.0.80480-0; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Goi T, 2003, SURG TODAY, V33, P702, DOI 10.1007/s00595-002-2567-y; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Iida A, 2000, HUM GENET, V106, P277, DOI 10.1007/s004390051038; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Jia L, 1997, BRIT J HAEMATOL, V98, P673, DOI 10.1046/j.1365-2141.1997.2623081.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Loh J, 2005, PLOS PATHOG, V1, P80, DOI 10.1371/journal.ppat.0010010; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perelman B, 1997, GENOMICS, V41, P397, DOI 10.1006/geno.1997.4623; Polster BM, 2004, BBA-MOL CELL RES, V1644, P211, DOI 10.1016/j.bbamcr.2003.11.001; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Roy DJ, 2000, ARCH VIROL, V145, P2411, DOI 10.1007/s007050070030; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang GH, 1999, J GEN VIROL, V80, P2737, DOI 10.1099/0022-1317-80-10-2737; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	39	790	839	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					688	U94		10.1038/ncb1426	http://dx.doi.org/10.1038/ncb1426			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16799551				2022-12-27	WOS:000238837800011
J	Gambus, A; Jones, RC; Sanchez-Diaz, A; Kanemaki, M; van Deursen, F; Edmondson, RD; Labib, K				Gambus, A; Jones, RC; Sanchez-Diaz, A; Kanemaki, M; van Deursen, F; Edmondson, RD; Labib, K			GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks	NATURE CELL BIOLOGY			English	Article							CELL-FREE-EXTRACTS; YEAST SACCHAROMYCES-CEREVISIAE; SISTER-CHROMATID COHESION; POLYMERASE-ALPHA; S-PHASE; BUDDING YEAST; MULTIPROTEIN COMPLEX; FISSION YEAST; IN-VITRO; PROTEINS	The components of the replisome that preserve genomic stability by controlling the progression of eukaryotic DNA replication forks are poorly understood. Here, we show that the GINS ( go ichi ni san) complex allows the MCM ( minichromosome maintenance) helicase to interact with key regulatory proteins in large replisome progression complexes (RPCs) that are assembled during initiation and disassembled at the end of S phase. RPC components include the essential initiation and elongation factor, Cdc45, the checkpoint mediator Mrc1, the Tof1 - Csm3 complex that allows replication forks to pause at protein - DNA barriers, the histone chaperone FACT ( facilitates chromatin transcription) and Ctf4, which helps to establish sister chromatid cohesion. RPCs also interact with Mcm10 and topoisomerase I. During initiation, GINS is essential for a specific subset of RPC proteins to interact with MCM. GINS is also important for the normal progression of DNA replication forks, and we show that it is required after initiation to maintain the association between MCM and Cdc45 within RPCs.	Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England; US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; US Food & Drug Administration (FDA)	Labib, K (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	klabib@picr.man.ac.uk	Gambus, Aga/AAK-4687-2021; Sanchez-Diaz, Alberto/L-2320-2014; Kanemaki, Masato/Q-3246-2019	Gambus, Aga/0000-0002-4648-0332; Sanchez-Diaz, Alberto/0000-0002-3308-4824; Kanemaki, Masato/0000-0002-7657-1649				Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Jares P, 2000, GENE DEV, V14, P1528; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Obama K, 2005, ONCOL REP, V14, P701; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schlesinger MB, 2000, GENETICS, V155, P1593; Schultz MC, 1999, METHODS, V17, P161, DOI 10.1006/meth.1998.0727; Schultz MC, 1997, P NATL ACAD SCI USA, V94, P9034, DOI 10.1073/pnas.94.17.9034; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Simmons DT, 1996, VIROLOGY, V222, P365, DOI 10.1006/viro.1996.0433; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOLD MS, 1989, J BIOL CHEM, V264, P2801; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	60	561	569	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					358	U41		10.1038/ncb1382	http://dx.doi.org/10.1038/ncb1382			34	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16531994				2022-12-27	WOS:000236560000014
J	Liu, JD; Rivas, FV; Wohlschlegel, J; Yates, JR; Parker, R; Hannon, GJ				Liu, JD; Rivas, FV; Wohlschlegel, J; Yates, JR; Parker, R; Hannon, GJ			A role for the P-body component GW182 in microRNA function	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA DEGRADATION; PROCESSING BODIES; PROTEIN-SYNTHESIS; GW BODIES; C-ELEGANS; TRANSLATION; ARGONAUTE2; COMPLEX; MIRNAS; TARGET	In animals, the majority of microRNAs regulate gene expression through the RNA interference (RNAi) machinery without inducing small-interfering RNA (siRNA)-directed mRNA cleavage(1). Thus, the mechanisms by which microRNAs repress their targets have remained elusive. Recently, Argonaute proteins, which are key RNAi effector components, and their target mRNAs were shown to localize to cytoplasmic foci known as P-bodies or GW-bodies(2,3). Here, we show that the Argonaute proteins physically interact with a key P-/GW-body subunit, GW182. Silencing of GW182 delocalizes resident P-/GW-body proteins and impairs the silencing of microRNA reporters. Moreover, mutations that prevent Argonaute proteins from localizing in P-/GW-bodies prevent translational repression of mRNAs even when Argonaute is tethered to its target in a siRNA-independent fashion. Thus, our results support a functional link between cytoplasmic P-bodies and the ability of a microRNA to repress expression of a target mRNA.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Scripps Research Institute; University of Arizona; Howard Hughes Medical Institute; University of Arizona	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019		NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM045443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	30	501	534	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1261	1266		10.1038/ncb1333	http://dx.doi.org/10.1038/ncb1333			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16284623	Green Accepted			2022-12-27	WOS:000233748900021
J	Grimm, MOW; Grimm, HS; Patzold, AJ; Zinser, EG; Halonen, R; Duering, M; Tschape, JA; De Strooper, B; Muller, U; Shen, J; Hartmann, T				Grimm, MOW; Grimm, HS; Patzold, AJ; Zinser, EG; Halonen, R; Duering, M; Tschape, JA; De Strooper, B; Muller, U; Shen, J; Hartmann, T			Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin	NATURE CELL BIOLOGY			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; IN-VIVO; CELLS; EXPRESSION; PEPTIDES; STRESS; SIMVASTATIN	Amyloid beta peptide (A beta) has a key role in the pathological process of Alzheimer's disease ( AD), but the physiological function of A beta and of the amyloid precursor protein (APP) is unknown(1,2). Recently, it was shown that APP processing is sensitive to cholesterol and other lipids(3-10). Hydroxymethylglutaryl-CoA reductase (HMGR) and sphingomyelinases (SMases) are the main enzymes that regulate cholesterol biosynthesis and sphingomyelin (SM) levels, respectively. We show that control of cholesterol and SM metabolism involves APP processing. A beta 42 directly activates neutral SMase and downregulates SM levels, whereas A beta 40 reduces cholesterol de novo synthesis by inhibition of HMGR activity. This process strictly depends on gamma-secretase activity. In line with altered A beta 40/42 generation, pathological presenilin mutations result in increased cholesterol and decreased SM levels. Our results demonstrate a biological function for APP processing and also a functional basis for the link that has been observed between lipids and Alzheimer's disease (AD).	Ctr Mol Biol Heidelberg, D-69120 Heidelberg, Germany; Dept Human Genet, B-3000 Louvain, Belgium; Katholieke Univ Leuven, B-3000 Louvain, Belgium; Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Ruprecht Karls University Heidelberg; KU Leuven; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hartmann, T (corresponding author), Ctr Mol Biol Heidelberg, INF 282, D-69120 Heidelberg, Germany.	Tobias.Hartmann@zmbh.uni-heidelberg.de	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Duering, Marco/AAE-6949-2021; Hartmann, Tobias/AAB-8297-2022; Grimm, Marcus O. W./F-8134-2011	De Strooper, Bart/0000-0001-5455-5819; Duering, Marco/0000-0003-2302-3136; Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430				Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Burns M, 2003, J NEUROSCI, V23, P5645; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Qi XL, 2005, NEUROCHEM INT, V46, P613, DOI 10.1016/j.neuint.2005.02.007; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sawamura N, 2004, J BIOL CHEM, V279, P11984, DOI 10.1074/jbc.M309832200; Shoji M, 2001, NEUROBIOL AGING, V22, P209, DOI 10.1016/S0197-4580(00)00229-3; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200	30	337	345	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1118	1123		10.1038/ncb1313	http://dx.doi.org/10.1038/ncb1313			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16227967				2022-12-27	WOS:000232930400016
J	Pines, J; Lindon, C				Pines, J; Lindon, C			Proteolysis: anytime, any place, anywhere?	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE CONTROL; 26S PROTEASOME; MORPHOGENESIS CHECKPOINT; SACCHAROMYCES-CEREVISIAE; SPINDLE CHECKPOINT; SWE1P DEGRADATION; UBIQUITIN LIGASE; DNA-REPLICATION; NUCLEAR EXPORT	Proteolysis via the ubiquitin-proteasome system (UPS) is a rapid and effective method of degrading a specific protein at a specific time, and in many cases a protein is degraded only in response to a particular cellular signal or event. However, an added dimension to the control of protein degradation is possible because the ubiquitin system can be spatially regulated. Controlling where a protein is degraded can enhance the specificity and timing of proteolysis, generate asymmetry and maintain sub-compartments even in the mitotic cell. Here, we discuss this aspect of the UPS.	Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QN, England; Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK	Pines, J (corresponding author), Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Lindon, Catherine/0000-0003-3554-2574; Pines, Jonathon/0000-0002-5227-6004				Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; Bartholomew CR, 2001, MOL CELL BIOL, V21, P4949, DOI 10.1128/MCB.21.15.4949-4959.2001; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Ehlers MD, 2003, SCIENCE, V302, P800, DOI 10.1126/science.1092546; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang JY, 2002, J CELL SCI, V115, P2847; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Mathe E, 2004, CURR BIOL, V14, P1723, DOI 10.1016/j.cub.2004.09.023; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Rieder CL, 1997, P NATL ACAD SCI USA, V94, P5107, DOI 10.1073/pnas.94.10.5107; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wakefield JG, 2000, CURR BIOL, V10, P1367, DOI 10.1016/S0960-9822(00)00776-4; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	61	62	65	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					731	735		10.1038/ncb0805-731	http://dx.doi.org/10.1038/ncb0805-731			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056263				2022-12-27	WOS:000230881500002
J	Elshamy, WM; Livingston, DM				Elshamy, WM; Livingston, DM			Promoter usage of BRCA1-IRIS - Reply	NATURE CELL BIOLOGY			English	Letter									Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Elshamy, WM (corresponding author), Dana Farber Canc Inst, 44 Binney St,SM870, Boston, MA 02115 USA.	wael_elshamy@dfci.harvard.edu; david_livingston@dfci.harvard.edu	ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019					ElShamy WM, 2004, NAT CELL BIOL, V6, P954, DOI 10.1038/ncb1171	1	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					326	326		10.1038/ncb0405-326a	http://dx.doi.org/10.1038/ncb0405-326a			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15803127	Bronze			2022-12-27	WOS:000228075500003
J	Metzger, E; Yin, N; Wissmann, M; Kunowska, N; Fischer, K; Friedrichs, N; Patnaik, D; Higgins, JMG; Potier, N; Scheidtmann, KH; Buettner, R; Schule, R				Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Friedrichs, Nicolaus; Patnaik, Debasis; Higgins, Jonathan M. G.; Potier, Noelle; Scheidtmann, Karl-Heinz; Buettner, Reinhard; Schuele, Roland			Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulationx	NATURE CELL BIOLOGY			English	Article							ANDROGEN-RECEPTOR; PROSTATE-CANCER; RNA-POLYMERASE; COMPLEX; KINASE; H3; ACTIVATION; PROTEIN; DOMAIN; GENES	Posttranslational modifications of histones such as methylation, acetylation and phosphorylation regulate chromatin structure and gene expression. Here we show that protein-kinase-C-related kinase 1 (PRK1) phosphorylates histone H3 at threonine 11 (H3T11) upon ligand-dependent recruitment to androgen receptor target genes. PRK1 is pivotal to androgen receptor function because PRK1 knockdown or inhibition impedes androgen receptor-dependent transcription. Blocking PRK1 function abrogates androgen-induced H3T11 phosphorylation and inhibits androgen-induced demethylation of histone H3. Moreover, serine-5-phosphorylated RNA polymerase II is no longer observed at androgen receptor target promoters. Phosphorylation of H3T11 by PRK1 accelerates demethylation by the Jumonji C (JmjC)-domain-containing protein JMJD2C. Thus, phosphorylation of H3T11 by PRK1 establishes a novel chromatin mark for gene activation, identifying PRK1 as a gatekeeper of androgen receptor-dependent transcription. Importantly, levels of PRK1 and phosphorylated H3T11 correlate with Gleason scores of prostate carcinomas. Finally, inhibition of PRK1 blocks proliferation of androgen receptor-induced tumour cell proliferation, making PRK1 a promising therapeutic target.	[Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Schuele, Roland] Univ Freiburg Klinikum, Univ Frauenklin, D-79106 Freiburg, Germany; [Friedrichs, Nicolaus; Buettner, Reinhard] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany; [Patnaik, Debasis; Higgins, Jonathan M. G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Potier, Noelle] ISIS, CNRS UMR 7177, Inst Chim LC3, F-67083 Strasbourg, France; [Scheidtmann, Karl-Heinz] Univ Bonn, Inst Genet, D-53117 Bonn, Germany; [Metzger, Eric; Yin, Na; Wissmann, Melanie; Kunowska, Natalia; Fischer, Kristin; Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, D-79106 Freiburg, Germany	University of Freiburg; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Bonn; University of Freiburg	Schule, R (corresponding author), Univ Freiburg Klinikum, Univ Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de	Patnaik, Debasis/K-8779-2019; Patnaik, Debasis/A-9752-2016; Noelle, POTIER/AAX-7633-2021	Patnaik, Debasis/0000-0002-9829-3352; Patnaik, Debasis/0000-0002-9829-3352; Higgins, Jonathan/0000-0001-6622-8268	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074210] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074210, R01 GM074210-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; SCHRODER FH, 1992, PROSTATE, P129; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	22	165	175	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					53	U35		10.1038/ncb1668	http://dx.doi.org/10.1038/ncb1668			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066052	Green Accepted			2022-12-27	WOS:000252116100012
J	Sun, MG; Williams, J; Munoz-Pinedo, C; Perkins, GA; Brown, JM; Ellisman, MH; Green, DR; Frey, TG				Sun, Mei G.; Williams, James; Munoz-Pinedo, Cristina; Perkins, Guy A.; Brown, Joshua M.; Ellisman, Mark H.; Green, Douglas R.; Frey, Terrence G.			Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis	NATURE CELL BIOLOGY			English	Article							CYTOCHROME-C; FUSION; CRISTAE; TOMOGRAPHY; ORGANELLES; DYNAMICS; RELEASE; OPA1	In addition to their role in cellular bioenergetics, mitochondria also initiate common forms of programmed cell death ( apoptosis) through the release of proteins such as cytochrome c from the intermembrane and intracristal spaces(1,2). the release of these proteins is studied in populations of cells by western blotting mitochondrial and cytoplasmic fractions of cellular extracts, and in single cells by fluorescence microscopy using fluorescent indicators and fusion proteins(3,4). However, studying the changes in ultrastructure associated with release of proteins requires the higher resolution provided by transmission electron microscopy(5-7). Here, we have used fluorescence microscopy to characterize the state of apoptosis in Hela cells treated with etoposide followed by electron microscopy and three-dimensional electron microscope tomography of the identical cells to study the sequence of structural changes. We have identified a remodelling of the inner mitochondrial membrane into many separate vesicular matrix compartments that accompanies release of proteins; however, this remodelling is not required for efficient release of cytochrome c. swelling occurs only late in apoptosis after release of cytochrome c and loss of the mitochondrial membrane potential.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; St Jude Childrens Hosp, Memphis, TN 38105 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA	California State University System; San Diego State University; St Jude Children's Research Hospital; University of California System; University of California San Diego	Frey, TG (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tfrey@sunstroke.sdsu.edu	Green, Douglas R/N-8083-2018; Munoz-Pinedo, Cristina/B-6118-2008	Green, Douglas R/0000-0002-7332-1417; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Perkins, Guy/0000-0002-1834-6646	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072033] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NCRR NIH HHS [P41 RR004050] Funding Source: Medline; NIAID NIH HHS [AI52735, AI40646] Funding Source: Medline; NIGMS NIH HHS [GM72033] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; HEALTHENGEL HM, 2006, BIOCHIM BIOPHYS ACTA, V1763, P1277; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MANOR JC, 2006, INT C BIOINF COMP BI, P310; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003	23	186	191	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2007	9	9					1057	U21		10.1038/ncb1630	http://dx.doi.org/10.1038/ncb1630			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	207MZ	17721514				2022-12-27	WOS:000249256500013
J	Tian, TH; Harding, A; Inder, K; Plowman, S; Parton, RG; Hancock, JF				Tian, Tianhai; Harding, Angus; Inder, Kerry; Plowman, Sarah; Parton, Robert G.; Hancock, John F.			Plasma membrane nanoswitches generate high-fidelity Ras signal transduction	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; IMAGING MICROSCOPY DATA; H-RAS; K-RAS; LIPID RAFTS; SINGLE-MOLECULE; PHOSPHOINOSITIDE 3-KINASE; SCAFFOLD PROTEINS; CELL-MEMBRANES; LIVING CELLS	Ras proteins occupy dynamic plasma membrane nanodomains called nanoclusters. The significance of this spatial organization is unknown. Here we show, using in silico and in vivo analyses of mitogen-activated protein ( MAP) kinase signalling, that Ras nanoclusters operate as sensitive switches, converting graded ligand inputs into fixed outputs of activated extracellular signal-regulated kinase ( ERK). By generating Ras nanoclusters in direct proportion to ligand input, cells build an analogue-digital analogue circuit relay that transmits a signal across the plasma membrane with high fidelity. Signal transmission is completely dependent on Ras spatial organization and fails if nanoclustering is abrogated. A requirement for high-fidelity signalling may explain the non-random distribution of other plasma membrane signalling complexes.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Hancock, JF (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	j.hancock@imb.uq.edu.au	Parton, Robert G/C-5673-2009; Harding, Angus/B-4120-2012; Inder, Kerry/K-3769-2012; Tian, Tianhai/AAU-2335-2021	Parton, Robert G/0000-0002-7494-5248; Inder, Kerry/0000-0002-7648-2398; Hancock, John/0000-0003-0542-4710; Tian, Tianhai/0000-0001-6191-0209				Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Batada NN, 2004, P NATL ACAD SCI USA, V101, P6445, DOI 10.1073/pnas.0401314101; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Esposito A, 2005, BIOPHYS J, V89, P4286, DOI 10.1529/biophysj.104.053397; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harding A, 2003, J BIOL CHEM, V278, P45519, DOI 10.1074/jbc.M303106200; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kim Y, 2003, BIOCHEMISTRY-US, V42, P15197, DOI 10.1021/bi035346b; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2000, GENE DEV, V14, P895; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Roix J, 2002, HISTOCHEM CELL BIOL, V118, P105, DOI 10.1007/s00418-002-0446-7; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Roy S, 2002, MOL CELL BIOL, V22, P5128, DOI 10.1128/MCB.22.14.5128-5140.2002; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Verveer PJ, 2003, J MICROSC-OXFORD, V209, P1, DOI 10.1046/j.1365-2818.2003.01093.x; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	52	282	284	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					905	U60		10.1038/ncb1615	http://dx.doi.org/10.1038/ncb1615			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618274				2022-12-27	WOS:000248486700012
J	Wolf, K; Wu, YI; Liu, Y; Geiger, J; Tam, E; Overall, C; Stack, MS; Friedl, P				Wolf, Katarina; Wu, Yi I.; Liu, Yueying; Geiger, Joerg; Tam, Eric; Overall, Christopher; Stack, M. Sharon; Friedl, Peter			Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion	NATURE CELL BIOLOGY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; HEMOPEXIN-C DOMAIN; I COLLAGEN; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; TUMOR INVASION; MEMBRANE; MIGRATION; MT1-MMP	Invasive cell migration through tissue barriers requires pericellular remodelling of extracellular matrix (ECM) executed by cell-surface proteases, particularly membrane-type-1 matrix metalloproteinase (MT1-MMP/MMP-14). Using time-resolved multimodal microscopy, we show how invasive HT-1080 fibrosarcoma and MDA-MB-231 breast cancer cells coordinate mechanotransduction and fibrillar collagen remodelling by segregating the anterior force-generating leading edge containing beta(1) integrin, MT1-MMP and F-actin from a posterior proteolytic zone executing fibre breakdown. During forward movement, sterically impeding fibres are selectively realigned into microtracks of single-cell calibre. Microtracks become expanded by multiple following cells by means of the large-scale degradation of lateral ECM interfaces, ultimately prompting transition towards collective invasion similar to that in vivo. Both ECM track widening and transition to multicellular invasion are dependent on MT1-MMP-mediated collagenolysis, shown by broad-spectrum protease inhibition and RNA interference. Thus, invasive migration and proteolytic ECM remodelling are interdependent processes that control tissue micropatterning and macropatterning and, consequently, individual and collective cell migration.	Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; Northwestern Univ, Feinberg Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; Northwestern University; Feinberg School of Medicine; University of Wurzburg; University of British Columbia	Friedl, P (corresponding author), Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	peter.fr@mail.uni-wuerzburg.de	Friedl, Peter/A-8961-2010; Geiger, Joerg/I-6661-2013; Wolf, Katarina/A-7787-2010	Friedl, Peter/0000-0002-0119-4041; Geiger, Joerg/0000-0002-7689-531X; Wolf, Katarina/0000-0003-0616-2708	NCI NIH HHS [R01 CA86984] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086984] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BELL CD, 1986, INVAS METAST, V6, P11; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Deryugina EI, 1997, ANTICANCER RES, V17, P3201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Filla Michael B, 2004, Birth Defects Res C Embryo Today, V72, P267, DOI 10.1002/bdrc.20020; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; McNiff JM, 2005, J CUTAN PATHOL, V32, P413, DOI 10.1111/j.0303-6987.2005.00358.x; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Nabeshima K, 2000, CANCER RES, V60, P3364; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Petroll WM, 2004, SCANNING, V26, P1, DOI 10.1002/sca.4950260102; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434, DOI 10.1096/fasebj.7.15.8262328; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMADA KM, 1990, CANCER RES, V50, P4485; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	51	722	738	10	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					893	U39		10.1038/ncb1616	http://dx.doi.org/10.1038/ncb1616			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17618273				2022-12-27	WOS:000248486700011
J	Denoyelle, C; Abou-Rjaily, G; Bezrookove, V; Verhaegen, M; Johnson, TM; Fullen, DR; Pointer, JN; Gruber, SB; Su, LD; Nikiforov, MA; Kaufman, RJ; Bastian, BC; Soengas, MS				Denoyelle, Christophe; Abou-Rjaily, George; Bezrookove, Vladimir; Verhaegen, Monique; Johnson, Timothy M.; Fullen, Douglas R.; Pointer, Jenny N.; Gruber, Stephen B.; Su, Lyndon D.; Nikiforov, Mikhail A.; Kaufman, Randal J.; Bastian, Boris C.; Soengas, Maria S.			Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway	NATURE CELL BIOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-CYCLE ARREST; INDUCED SENESCENCE; TUMOR SUPPRESSION; MELANOCYTIC LESIONS; HUMAN FIBROBLASTS; STRESS INDUCTION; MAMMALIAN-CELLS; SPITZ NEVI; BRAF GENE	Dysfunction of the endoplasmic reticulum (ER) has been reported in a variety of human pathologies, including cancer. However, the contribution of the ER to the early stages of normal cell transformation is largely unknown. Using primary human melanocytes and biopsies of human naevi (moles), we show that the extent of ER stress induced by cellular oncogenes may define the mechanism of activation of premature senescence. Specifically, we found that oncogenic forms of HRAS (HRAS(G12V)) but not its downstream target BRAF (BRAF(V600E)), engaged a rapid cell-cycle arrest that was associated with massive vacuolization and expansion of the ER. However, neither p53, p16(INK4a) nor classical senescence markers - such as foci of heterochromatin or DNA damage - were able to account for the specific response of melanocytes to HRAS(G12V). Instead, HRAS(G12V)-driven senescence was mediated by the ER-associated unfolded protein response (UPR). The impact of HRAS on the UPR was selective, as it was poorly induced by activated NRAS (more frequently mutated in melanoma than HRAS). These results argue against premature senescence as a converging mechanism of response to activating oncogenes and support a direct role of the ER as a gatekeeper of tumour control.	Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet & Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Soengas, MS (corresponding author), Univ Michigan, Dept Dermatol, 1500E Med Ctr Dr,4217 CCGC, Ann Arbor, MI 48109 USA.	soengas@umich.edu	Soengas, Maria S/H-6455-2015; DENOYELLE, Christophe CD/K-6205-2015	Soengas, Maria S/0000-0003-0612-6299; DENOYELLE, Christophe CD/0000-0001-7153-8826; Poynter, Jenny/0000-0002-8460-3938; Bastian, Boris/0000-0003-1836-6062	NCI NIH HHS [CA107237, R33 CA95300, U01CA83180] Funding Source: Medline; NIAID NIH HHS [AI12243] Funding Source: Medline; NIDDK NIH HHS [DK42394] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA095300, U01CA083180, R01CA107237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Barnhill RL, 1999, HUM PATHOL, V30, P513, DOI 10.1016/S0046-8177(99)90193-4; Bastian BC, 2000, AM J PATHOL, V157, P967, DOI 10.1016/S0002-9440(10)64609-3; Bauer Jurgen, 2005, Adv Dermatol, V21, P81, DOI 10.1016/j.yadr.2005.04.002; Benanti JA, 2004, MOL CELL BIOL, V24, P2842, DOI 10.1128/MCB.24.7.2842-2852.2004; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Maldonado JL, 2004, AM J PATHOL, V164, P1783, DOI 10.1016/S0002-9440(10)63736-4; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Papp T, 1999, J MED GENET, V36, P610; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Strungs I, 2004, PATHOLOGY, V36, P396, DOI 10.1080/00313020412331283888; te Poele RH, 2002, CANCER RES, V62, P1876; Turner DJ, 2005, J CUTAN PATHOL, V32, P334, DOI 10.1111/j.0303-6987.2005.00338.x; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Wang Y, 2000, J BIOL CHEM, V275, P27013; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yazdi AS, 2003, J INVEST DERMATOL, V121, P1160, DOI 10.1046/j.1523-1747.2003.12559.x	56	258	264	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1053	U24		10.1038/ncb1471	http://dx.doi.org/10.1038/ncb1471			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16964246				2022-12-27	WOS:000241395300009
J	Yousefi, S; Perozzo, R; Schmid, I; Ziemiecki, A; Schaffner, T; Scapozza, L; Brunner, T; Simon, HU				Yousefi, Shida; Perozzo, Remo; Schmid, Ines; Ziemiecki, Andrew; Schaffner, Thomas; Scapozza, Leonardo; Brunner, Thomas; Simon, Hans-Uwe			Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis	NATURE CELL BIOLOGY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; EMBRYONIC-DEVELOPMENT; NEUTROPHIL APOPTOSIS; TUMOR-SUPPRESSOR; PROTEIN; GENE; P53; MITOCHONDRIA; DISRUPTION	Autophagy-related gene (Atg) 5 is a gene product required for the formation of autophagosomes. Here, we report that Atg5, in addition to the promotion of autophagy, enhances susceptibility towards apoptotic stimuli. Enforced expression of Atg5-sensitized tumour cells to anticancer drug treatment both in vitro and in vivo. In contrast, silencing the Atg5 gene with short interfering RNA (siRNA) resulted in partial resistance to chemotherapy. Apoptosis was associated with calpain-mediated Atg5 cleavage, resulting in an amino-terminal cleavage product with a relative molecular mass of 24,000 (M-r 24K). Atg5 cleavage was observed independent of the cell type and the apoptotic stimulus, suggesting that calpain activation and Atg5 cleavage are general phenomena in apoptotic cells. Truncated Atg5 translocated from the cytosol to mitochondria, associated with the anti-apoptotic molecule Bwcl-x(L) and triggered cytochrome c release and caspase activation. Taken together, calpain-mediated Atg5 cleavage provokes apoptotic cell death, therefore, represents a molecular link between autophagy and apoptosis - a finding with potential importance for clinical anticancer therapies.	Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland; Univ Geneva, Sch Pharmaceut Sci, EPGL, Pharmaceut Biochem Grp, CH-1211 Geneva 4, Switzerland; Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; Univ Bern, Dept Pathol, CH-3010 Bern, Switzerland	University of Bern; University of Geneva; University of Bern; University of Bern	Simon, HU (corresponding author), Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland.	hus@pki.unibe.ch	Yousefi, Shida/AAU-7986-2020; Simon, Hans-Uwe/AAU-5079-2020; Yousefi, Shida/L-9689-2016; Simon, Hans-Uwe/AAU-7410-2020	Yousefi, Shida/0000-0002-9855-4305; Yousefi, Shida/0000-0002-9855-4305; Simon, Hans-Uwe/0000-0002-9404-7736; Scapozza, Leonardo/0000-0003-1079-648X				Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Gao G, 2000, J CELL BIOCHEM, V80, P53; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simon HU, 2000, J IMMUNOL, V165, P4069, DOI 10.4049/jimmunol.165.7.4069; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; YOUSEFI S, 1994, P NATL ACAD SCI USA, V91, P10868, DOI 10.1073/pnas.91.23.10868; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	35	1010	1056	5	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1124	U146		10.1038/ncb1482	http://dx.doi.org/10.1038/ncb1482			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998475	Green Submitted			2022-12-27	WOS:000241395300017
J	Saleh, MC; van Rij, RP; Hekele, A; Gillis, A; Foley, E; O'Farrell, PH; Andino, R				Saleh, Maria-Carla; van Rij, Ronald P.; Hekele, Armin; Gillis, Amethyst; Foley, Edan; O'Farrell, Patrick H.; Andino, Raul			The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRANDED-RNA; SYSTEMIC RNAI; PROTEIN; INTERFERENCE; DROSOPHILA; TRANSPORT; MUSCLE	Many metazoan cells can take up exogenous double-stranded ( ds) RNA and use it to initiate an RNA silencing response, however, the mechanism for this uptake is ill-defined. Here, we identify the pathway for dsRNA uptake in Drosophila melanogaster S2 cells. Biochemical and cell biological analyses, and a genome-wide screen for components of the dsRNA-uptake machinery, indicated that dsRNA is taken up by an active process involving receptor-mediated endocytosis. Pharmacological inhibition of endocytic pathways disrupted exogenous dsRNA entry and the induction of gene silencing. This dsRNA uptake mechanism seems to be evolutionarily conserved, as knockdown of orthologues in Caenorhabditis elegans inactivated the RNA interference response in worms. Thus, this entry pathway is required for systemic RNA silencing in whole organisms. In Drosophila cells, pharmacological evidence suggests that dsRNA entry is mediated by pattern-recognition receptors. The possible role of these receptors in dsRNA entry may link RNA interference ( RNAi) silencing to other innate immune responses.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	Raul.Andino@UCSF.edu	Van Rij, Ronald/I-7073-2012; Saleh, Maria-Carla/ABC-2527-2021	Van Rij, Ronald/0000-0003-0221-4689; Saleh, Maria-Carla/0000-0001-8593-4117; O'Farrell, Patrick/0000-0003-0011-2734	NIAID NIH HHS [R01 AI060102, R01 AI060102-07, N01AI40085] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060102, R01AI040085, R21AI040085] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Castellino F, 1998, J IMMUNOL, V161, P4048; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Dzitoyeva S, 2003, P NATL ACAD SCI USA, V100, P5485, DOI 10.1073/pnas.0830111100; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lingor P, 2004, BIOCHEM BIOPH RES CO, V315, P1126, DOI 10.1016/j.bbrc.2004.01.170; Medzhitov R, 1998, P NATL ACAD SCI USA, V95, P429, DOI 10.1073/pnas.95.2.429; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525; Reed RC, 2000, INT J MOL MED, V6, P259; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; SUNWADA GH, 2004, BIOCHIM BIOPHYS ACTA, V1658, P1806; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614	43	375	422	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					793	U19		10.1038/ncb1439	http://dx.doi.org/10.1038/ncb1439			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862146	Green Accepted			2022-12-27	WOS:000239423000009
J	Kirkpatrick, DS; Hathaway, NA; Hanna, J; Elsasser, S; Rush, J; Finley, D; King, RW; Gygi, SP				Kirkpatrick, Donald S.; Hathaway, Nathaniel A.; Hanna, John; Elsasser, Suzanne; Rush, John; Finley, Daniel; King, Randall W.; Gygi, Steven P.			Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; DNA-REPAIR; CONJUGATING ENZYMES; MITOTIC CYCLIN; 26S PROTEASOME; PROTEIN; DEGRADATION; PROTEOLYSIS	Protein ubiquitination regulates many cellular processes, including protein degradation, signal transduction, DNA repair and cell division. In the classical model, a uniform polyubiquitin chain that is linked through Lys 48 is required for recognition and degradation by the 26S proteasome. Here, we used a reconstituted system and quantitative mass spectrometry to demonstrate that cyclin B1 is modified by ubiquitin chains of complex topology, rather than by homogeneous Lys 48-linked chains. The anaphase-promoting complex was found to attach monoubiquitin to multiple lysine residues on cyclin B1, followed by polyubiquitin chain extensions linked through multiple lysine residues of ubiquitin ( Lys 63, Lys 11 and Lys 48). These heterogeneous ubiquitin chains were sufficient for binding to ubiquitin receptors, as well as for degradation by the 26S proteasome, even when they were synthesized with mutant ubiquitin that lacked Lys 48. Together, our observations expand the context of what can be considered to be a sufficient degradation signal and provide unique insights into the mechanisms of substrate ubiquitination.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Cell Signaling Technol Inc, Beverly, MA 01915 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu; steven_gygi@hms.harvard.edu		Kirkpatrick, Donald/0000-0003-3091-2804; King, Randall/0000-0001-7882-8180	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R01GM065592, R01GM067945, R56GM066492] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG3456] Funding Source: Medline; NIGMS NIH HHS [GM66492, GM67945, GM065592] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Townsley FM, 1998, YEAST, V14, P747, DOI 10.1002/(SICI)1097-0061(19980615)14:8<747::AID-YEA271>3.0.CO;2-T; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	40	333	350	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					700	U121		10.1038/ncb1436	http://dx.doi.org/10.1038/ncb1436			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16799550				2022-12-27	WOS:000238837800012
J	Zubko, MK; Lydall, D				Zubko, Mikhajlo K.; Lydall, David			Linear chromosome maintenance in the absence of essential telomere-capping proteins	NATURE CELL BIOLOGY			English	Article							SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; END-PROTECTION; BUDDING YEAST; BINDING PROTEIN; CDC13; CHECKPOINT; MUTANTS; DAMAGE; EXO1	Telomeres were defined by their ability to cap chromosome ends(1,2). Proteins with high affinity for the structure at chromosome ends, binding the G-rich, 3' single-stranded overhang at telomeres include Pot1 in humans and fission yeast, TEBP in Oxytricha nova and Cdc13 in budding yeast(3-5). Cdc13 is considered essential for telomere capping because budding yeast that lack Cdc13 rapidly accumulate excessive single-stranded DNA ( ssDNA) at telomeres, arrest cell division and die(6-8). Cdc13 has a separate, critical role in telomerase recruitment to telomeres(9,10). Here, we show that neither Cdc13 nor its partner Stn1 are necessary for telomere capping if nuclease activities that are active at uncapped telomeres are attenuated. Recombination-dependent and -independent mechanisms permit maintenance of chromosomes without Cdc13. Our results indicate that the structure of the eukaryotic telomere cap is remarkably flexible and that changes in the DNA damage response allow alternative strategies for telomere capping to evolve.	Univ Newcastle Upon Tyne, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Integrated Syst Biol Ageing & Nutr, Henry Wellcome Lab Biogerontol Res, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lydall, D (corresponding author), Univ Newcastle Upon Tyne, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	d.a.lydall@ncl.ac.uk			Wellcome Trust [075294, 054371] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lin J, 2004, MOL BIOL CELL, V15, P1623, DOI 10.1091/mbc.E03-10-0740; Liti G, 2003, MOL CELL, V11, P1373, DOI 10.1016/S1097-2765(03)00177-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Maringele L, 2005, CELL CYCLE, V4, P747, DOI 10.4161/cc.4.6.1741; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; MARINGELE L, 2006, YEAST PROTOCOLS METH, P65; McClintock B, 1941, GENETICS, V26, P234; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; Muller H, 1938, COLLECTING NET, V13, P181; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Reddel RR, 2003, CANCER LETT, V194, P155, DOI 10.1016/S0304-3835(02)00702-4; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Theobald DL, 2003, STRUCTURE, V11, P1049, DOI 10.1016/S0969-2126(03)00183-7; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	30	35	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					734	740		10.1038/ncb1428	http://dx.doi.org/10.1038/ncb1428			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767084				2022-12-27	WOS:000238837800016
J	Wu, CJ; Conze, DB; Li, T; Srinivasula, SM; Ashwell, JD				Wu, CJ; Conze, DB; Li, T; Srinivasula, SM; Ashwell, JD			NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-kappa B activation	NATURE CELL BIOLOGY			English	Article							DEATH DOMAIN KINASE; GAMMA IKK-GAMMA; UBIQUITINATION; PROTEIN; COMPLEX; RIP; OLIGOMERIZATION; RECRUITMENT; PATHWAY; CHAINS	The transcription factor NF-kappa B is sequestered in the cytoplasm in a complex with I kappa B-1. Almost all NF-kappa B activation pathways converge on I kappa B kinase (IKK), which phosphorylates I kappa B resulting in Lys 48-linked polyubiquitination of I kappa B and its degradation. This allows migration of NF-kappa B to the nucleus where it regulates gene expression(2). IKK has two catalytic subunits, IKK alpha and IKK beta, and a regulatory subunit, IKK gamma or NEMO. NEMO is essential for NF-kappa B activation, and NEMO dysfunction in humans is the cause of incontinentia pigmenti and hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID)(3). The recruitment of IKK to occupied cytokine receptors, and its subsequent activation, are dependent on the attachment of Lys 63-linked polyubiquitin chains to signalling intermediates such as receptor-interacting protein ( RIP). Here, we show that NEMO binds to Lys 63-but not Lys 48-linked polyubiquitin, and that single point mutations in NEMO that prevent binding to Lys 63-linked polyubiquitin also abrogates the binding of NEMO to RIP in tumour necrosis factor ( TNF)alpha- stimulated cells, the recruitment of IKK to TNF receptor (TNF-R) 1, and the activation of IKK and NF-kappa B. RIP is also destabilized in the absence of NEMO binding and undergoes proteasomal degradation in TNF-alpha-treated cells. These results provide a mechanism for NEMO's critical role in IKK activation, and a key to understanding the link between cytokine-receptor proximal signalling and IKK and NF-kappa B activation.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov			Intramural NIH HHS Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010629, Z01BC010629] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Courtois G, 2001, TRENDS MOL MED, V7, P427, DOI 10.1016/S1471-4914(01)02154-2; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; LEE SY, 1985, COMPUT STAT DATA AN, V2, P279, DOI 10.1016/0167-9473(85)90002-7; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; TRAKSHEL GM, 1988, BIOCHEM J, V252, P127, DOI 10.1042/bj2520127; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	35	489	507	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					398	U58		10.1038/ncb1384	http://dx.doi.org/10.1038/ncb1384			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16547522				2022-12-27	WOS:000236560000019
J	Culver-Hanlon, TL; Lex, SA; Stephens, AD; Quintyne, NJ; King, SJ				Culver-Hanlon, TL; Lex, SA; Stephens, AD; Quintyne, NJ; King, SJ			A microtubule-binding domain in dynactin increases dynein processivity by skating along microtubules	NATURE CELL BIOLOGY			English	Article							ONE-DIMENSIONAL DIFFUSION; CYTOPLASMIC DYNEIN; IN-VITRO; MOTOR; PURIFICATION; TRANSPORT; DEGENERATION; PROTEINS; VIVO	Microtubule-associated proteins (MAPs) use particular microtubule-binding domains that allow them to interact with microtubules in a manner specific to their individual cellular functions. Here, we have identified a highly basic microtubule-binding domain in the p150 subunit of dynactin that is only present in the dynactin members of the CAP-Gly family of proteins. Using single-particle microtubule-binding assays, we found that the basic domain of dynactin moves progressively along microtubules in the absence of molecular motors - a process we term 'skating'. In contrast, the previously described CAP-Gly domain of dynactin remains firmly attached to a single point on microtubules. Further analyses showed that microtubule skating is a form of one-dimensional diffusion along the microtubule. To determine the cellular function of the skating phenomenon, dynein and the dynactin microtubule-binding domains were examined in single-molecule motility assays. We found that the basic domain increased dynein processivity fourfold whereas the CAP-Gly domain inhibited dynein motility. Our data show that the ability of the basic domain of dynactin to skate along microtubules is used by dynein to maintain longer interactions for each encounter with microtubules.	Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Missouri System; University of Missouri Kansas City; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	King, SJ (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	kingsj@umkc.edu		Stephens, Andrew/0000-0001-5474-7845; Quintyne, Nicholas/0000-0002-8817-2936	NINDS NIH HHS [R01 NS048501, NS48501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048501] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; SLOBODA RD, 1982, METHOD ENZYMOL, V85, P409; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373	18	156	160	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					264	270		10.1038/ncb1370	http://dx.doi.org/10.1038/ncb1370			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16474384				2022-12-27	WOS:000235708000012
J	Medeiros, NA; Burnette, DT; Forscher, P				Medeiros, NA; Burnette, DT; Forscher, P			Myosin II functions in actin-bundle turnover in neuronal growth cones	NATURE CELL BIOLOGY			English	Article							F-ACTIN; BLEBBISTATIN INHIBITION; RETROGRADE FLOW; 2 POPULATIONS; NERVE GROWTH; DYNAMICS; FILAMENTS; MECHANISM; MICROTUBULES; ORGANIZATION	Retrograde actin flow works in concert with cell adhesion to generate traction forces that are involved in axon guidance in neuronal growth cones. Myosins have been implicated in retrograde flow, but identification of the specific myosin subtype(s) involved has been controversial. Using fluorescent speckle microscopy (FSM) to assess actin dynamics, we report that inhibition of myosin II alone decreases retrograde flow by 51% and the remaining flow can be almost fully accounted for by the 'push' of plus-end actin assembly at the leading edge of the growth cone. Interestingly, actin bundles that are associated with filopodium roots elongated by approximately 83% after inhibition of myosin II. This unexpected result was due to decreased rates of actin-bundle severing near their proximal (minus or pointed) ends which are located in the transition zone of the growth cone. Our study reveals a mechanism for the regulation of actin-bundle length by myosin II that is dependent on actin-bundle severing, and demonstrate that retrograde flow is a steady state that depends on both myosin II contractility and actin-network treadmilling.	Yale Univ, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	Forscher, P (corresponding author), Yale Univ, Interdepartmental Neurosci Program, New Haven, CT 06520 USA.	paul.forscher@yale.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051786, R01-NS28695] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; Bridgman PC, 2001, J NEUROSCI, V21, P6159, DOI 10.1523/JNEUROSCI.21-16-06159.2001; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Henson JH, 2003, CELL MOTIL CYTOSKEL, V56, P252, DOI 10.1002/cm.10149; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nakhost A, 2002, J BIOL CHEM, V277, P40633, DOI 10.1074/jbc.M205099200; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Thompson C, 1996, J CELL SCI, V109, P2843; Torreano PJ, 2005, CELL MOTIL CYTOSKEL, V60, P166, DOI 10.1002/cm.20051; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Welnhofer EA, 1999, J NEUROSCI, V19, P7971; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	47	367	372	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					215	226		10.1038/ncb1367	http://dx.doi.org/10.1038/ncb1367			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16501565				2022-12-27	WOS:000235708000007
J	Zhang, HY; Macara, IG				Zhang, HY; Macara, IG			The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis	NATURE CELL BIOLOGY			English	Article							ASYMMETRIC CELL-DIVISION; C-ELEGANS; RAC; COMPLEX; INVOLVEMENT; ACTIVATION; PATHOLOGY; DYNAMICS; ZYGOTE	PAR-3 (partitioning-defective gene 3) is essential for cell polarization in many contexts, including axon specification. However, polarity proteins have not been implicated in later steps of neuronal differentiation, such as dendritic spine morphogenesis. Here, we show that PAR-3 is necessary for normal spine development in primary hippocampal neurons. Depletion of PAR-3 causes the formation of multiple filopodia- and lamellipodia-like dendritic protrusions - a phenotype similar to neurons expressing activated Rac. PAR-3 regulates spine formation by binding the Rac guanine nucleotide-exchange factor (GEF) TIAM1, and spatially restricting it to dendritic spines. Thus, a balance of PAR-3 and TIAM1 is essential to modulate Rac-GTP levels and to allow spine morphogenesis.	Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signalling, Charlottesville, VA 22908 USA	University of Virginia	Zhang, HY (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signalling, Charlottesville, VA 22908 USA.	hz5a@virginia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070902] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GOSLIN K, 1998, RAT HIPPOCAMPAL NEUR; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hirose T, 2002, J CELL SCI, V115, P2485; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	28	170	172	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					227	237		10.1038/ncb1368	http://dx.doi.org/10.1038/ncb1368			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16474385				2022-12-27	WOS:000235708000008
J	Feng, WY; Collingwood, D; Boeck, ME; Fox, LA; Alvino, GM; Fangman, WL; Raghuraman, MK; Brewer, BJ				Feng, WY; Collingwood, D; Boeck, ME; Fox, LA; Alvino, GM; Fangman, WL; Raghuraman, MK; Brewer, BJ			Genomic mapping of single-stranded DNA in hydroxyurea-challenged yeasts identifies origins of replication	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; FIRING ORIGINS; CELL-CYCLE; DAMAGE; FORK; PHOSPHORYLATION; TELOMERES; PROTEINS; PROFILE; KINASE	During DNA replication one or both strands transiently become single stranded: first at the sites where initiation of DNA synthesis occurs ( known as origins of replication) and subsequently on the lagging strands of replication forks as discontinuous Okazaki fragments are generated. We report a genome-wide analysis of single-stranded DNA (ssDNA) formation in the presence of hydroxyurea during DNA replication in wild-type and checkpoint-deficient rad53 Saccharomyces cerevisiae cells. In wild-type cells, ssDNA was first observed at a subset of replication origins and later 'migrated' bi-directionally, suggesting that ssDNA formation is associated with continuously moving replication forks. In rad53 cells, ssDNA was observed at virtually every known origin, but remained there over time, suggesting that replication forks stall. Telomeric regions seemed to be particularly sensitive to the loss of Rad53 checkpoint function. Replication origins in Schizosaccharomyces pombe were also mapped using our method.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Math, Seattle, WA 98195 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester	Brewer, BJ (corresponding author), Univ Washington, Dept Genome Sci, Box 357730, Seattle, WA 98195 USA.	bbrewer@gs.washington.edu		boeck, Max/0000-0001-9668-407X	NIGMS NIH HHS [R01 GM018926] Funding Source: Medline; PHS HHS [18926] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018926] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; HUTTER KJ, 1979, J GEN MICROBIOL, V113, P369, DOI 10.1099/00221287-113-2-369; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Longhese MP, 2000, GENETICS, V155, P1577; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Toueille M, 2004, CHROMOSOMA, V113, P113, DOI 10.1007/s00412-004-0303-7; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x	27	172	176	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					148	U39		10.1038/ncb1358	http://dx.doi.org/10.1038/ncb1358			37	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16429127	Green Accepted			2022-12-27	WOS:000235059800009
J	Millan, J; Hewlett, L; Glyn, M; Toomre, D; Clark, P; Ridley, AJ				Millan, J; Hewlett, L; Glyn, M; Toomre, D; Clark, P; Ridley, AJ			Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains	NATURE CELL BIOLOGY			English	Article							NEUTROPHIL TRANSENDOTHELIAL MIGRATION; EVANESCENT-WAVE MICROSCOPY; CELL-SURFACE; TIGHT JUNCTIONS; ADHESION; MEMBRANE; POLYMERIZATION; TRANSCYTOSIS; PERMEABILITY; POLARIZATION	During inflammation, leukocytes bind to the adhesion receptors ICAM-1 and VCAM-1 on the endothelial surface before undergoing transendothelial migration, also called diapedesis. ICAM-1 is also involved in transendothelial migration, independently of its role in adhesion, but the molecular basis of this function is poorly understood. Here we demonstrate that, following clustering, apical ICAM-1 translocated to caveolin-rich membrane domains close to the ends of actin stress fibres. In these F-actin- rich areas, ICAM-1 was internalized and transcytosed to the basal plasma membrane through caveolae. Human T-lymphocytes extended pseudopodia into endothelial cells in caveolin- and F-actin-enriched areas, induced local translocation of ICAM-1 and caveolin-1 to the endothelial basal membrane and transmigrated through transcellular passages formed by a ring of F-actin and caveolae. Reduction of caveolin-1 levels using RNA interference (RNAi) specifically decreased lymphocyte transcellular transmigration. We propose that the translocation of ICAM-1 to caveola- and F-actin-rich domains links the sequential steps of lymphocyte adhesion and transendothelial migration and facilitates lymphocyte migration through endothelial cells from capillaries into surrounding tissue.	Royal Free & Univ Coll Sch Med, Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London; Ludwig Institute for Cancer Research; Yale University	Ridley, AJ (corresponding author), Royal Free & Univ Coll Sch Med, Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	anne@ludwig.ucl.ac.uk		Ridley, Anne/0000-0001-8186-5708; Millan, Jaime/0000-0003-3107-147X				Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Burns AR, 2000, J CELL SCI, V113, P45; Burns AR, 1997, J IMMUNOL, V159, P2893; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Feng D, 2002, MICROSC RES TECHNIQ, V57, P289, DOI 10.1002/jemt.10087; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; FIELDING RG, 1987, J ADV NURS, V12, P281, DOI 10.1111/j.1365-2648.1987.tb01334.x; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kvietys PR, 2001, NEWS PHYSIOL SCI, V16, P15; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Millan J, 2002, BLOOD, V99, P978, DOI 10.1182/blood.V99.3.978; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; SIMIONESCU N, 1976, J CELL BIOL, V70, P608, DOI 10.1083/jcb.70.3.608; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Tilghman RW, 2002, FASEB J, V16, P1257, DOI 10.1096/fj.01-0969fje; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	42	301	310	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2006	8	2					113	U5		10.1038/ncb1356	http://dx.doi.org/10.1038/ncb1356			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	008SA	16429128				2022-12-27	WOS:000235059800006
J	Arias, EE; Walter, JC				Arias, EE; Walter, JC			PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; LICENSING FACTOR CDT1; DNA-REPLICATION; S-PHASE; INITIATION; GEMININ; COMPLEX; DEGRADATION; PROTEOLYSIS; INHIBITION	Ubiquitin- mediated proteolysis of the replication licensing factor Cdt1 ( Cdc10- dependent transcript 1) in S phase is a key mechanism that limits DNA replication to a single round per cell cycle in metazoans(1-6). In Xenopus egg extracts, Cdt1 is destroyed on chromatin during DNA replication(1). Here, we report that replication- dependent proteolysis of Cdt1 requires its interaction with proliferating cell nuclear antigen ( PCNA), a homotrimeric processivity factor for DNA polymerases(7). Cdt1 binds to PCNA through a consensus PCNA- interaction motif that is conserved in Cdt1 of all metazoans, and removal of PCNA from egg extracts inhibits replication- dependent Cdt1 destruction. Mutation of the PCNA- interaction motif yields a stabilized Cdt1 protein that induces re- replication. DDB1, a component of the Cul4 E3 ubiquitin ligase that mediates human Cdt1 proteolysis in response to DNA damage(8), is also required for replication- dependent Cdt1 destruction. Cdt1 and DDB1 interact in extracts, and DDB1 chromatin loading is dependent on the binding of Cdt1 to PCNA, which indicates that PCNA docking activates the pre- formed Cdt1 - Cul4(DDB1) ligase complex. Thus, PCNA functions as a platform for Cdt1 destruction, ensuring efficient and temporally restricted inactivation of a key cell- cycle regulator.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Walter, Johannes/0000-0002-4186-7570				Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Mattock H, 2001, EXP CELL RES, V265, P242, DOI 10.1006/excr.2001.5181; May NR, 2005, J CELL SCI, V118, P4207, DOI 10.1242/jcs.02534; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	33	239	245	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					84	U33		10.1038/ncb1346	http://dx.doi.org/10.1038/ncb1346			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16362051				2022-12-27	WOS:000234651500016
J	Chen, ZJJ				Chen, ZJJ			Ubiquitin signalling in the NF-kappa B pathway	NATURE CELL BIOLOGY			English	Review							NF-KAPPA-B1 PRECURSOR PROTEIN; SITE-SPECIFIC PHOSPHORYLATION; TUMOR-SUPPRESSOR CYLD; PROTEASOME PATHWAY; CELL-DEATH; BETA-TRCP; DEFECTIVE INTERLEUKIN-1; POLYUBIQUITIN CHAINS; IMMUNE-SYSTEM; ACTIVATION	The transcription factor NF-kappa B (nuclear factor kappa enhancer binding protein) controls many processes, including immunity, inflammation and apoptosis. Ubiquitination regulates at least three steps in the NF-kappa B pathway: degradation of I kappa B (inhibitor of NF-kappa B), processing of NF-kappa B precursors, and activation of the I kappa B kinase (IKK). Recent studies have revealed several enzymes involved in the ubiquitination and deubiquitination of signalling proteins that mediate IKK activation through a degradation-independent mechanism.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NIGMS NIH HHS [R01 GM063692, R01 GM 63692] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Amir RE, 2004, ONCOGENE, V23, P2540, DOI 10.1038/sj.onc.1207366; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; CHEN Z, 1998, ROLE UBIQUITIN PROTE, P303; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chung JY, 2002, J CELL SCI, V115, P679; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DENG L, 2003, ROLE UBIQUITIN NF KA, P139; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEE SY, 1985, COMPUT STAT DATA AN, V2, P279, DOI 10.1016/0167-9473(85)90002-7; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; van Oers NSC, 2005, SCIENCE, V308, P65, DOI 10.1126/science.1110902; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xia Z. P., 2005, SCI STKE, V2005, ppe7; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	84	961	1021	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					758	U19		10.1038/ncb0805-758	http://dx.doi.org/10.1038/ncb0805-758			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16056267	Green Accepted			2022-12-27	WOS:000230881500006
J	Nishiya, N; Kiosses, WB; Han, JW; Ginsberg, MH				Nishiya, N; Kiosses, WB; Han, JW; Ginsberg, MH			An alpha(4) integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells	NATURE CELL BIOLOGY			English	Article							ALPHA(4) CYTOPLASMIC DOMAIN; PAXILLIN KINASE LINKER; EXCHANGE FACTOR; LD4 MOTIF; INTEGRIN; PROTEIN; ARF6; ADHESION; PHOSPHORYLATION; BINDING	Formation of a stable lamellipodium at the front of migrating cells requires localization of Rac activation to the leading edge. Restriction of alpha(4) integrin phosphorylation to the leading edge limits the interaction of alpha(4) with paxillin to the sides and rear of a migrating cell. The alpha(4)-paxillin complex inhibits stable lamellipodia, thus confining lamellipod formation to the cell anterior. Here we report that binding of paxillin to the alpha(4) integrin subunit inhibits adhesion-dependent lamellipodium formation by blocking Rac activation. The paxillin LD4 domain mediates this reduction in Rac activity by recruiting an ADP-ribosylation factor GTPase-activating protein (Arf-GAP) that decreases Arf activity, thereby inhibiting Rac. Finally, the localized formation of the alpha(4)-paxillin-Arf-GAP complex mediates the polarization of Rac activity and promotes directional cell migration. These findings establish a mechanism for the spatial localization of Rac activity to enhance cell migration.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu		Nishiya, Naoyuki/0000-0003-1575-9944				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Han JW, 2003, J BIOL CHEM, V278, P34845, DOI 10.1074/jbc.M304691200; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Jongewaard IN, 1996, CELL ADHES COMMUN, V3, P487, DOI 10.3109/15419069609081025; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; LAM SCT, 1989, J BIOL CHEM, V264, P3742; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Sengbusch JK, 2002, J CELL BIOL, V157, P873, DOI 10.1083/jcb.200203075; Song J, 1998, J CELL SCI, V111, P2257; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2000, J CELL SCI, V113, P4139; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; YANG JT, 1995, DEVELOPMENT, V121, P549; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	57	176	184	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					343	U7		10.1038/ncb1234	http://dx.doi.org/10.1038/ncb1234			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793570				2022-12-27	WOS:000228075500010
J	Carr, AJF; Whitmore, D				Carr, AJF; Whitmore, D			Imaging of single light-responsive clock cells reveals fluctuating free-running periods	NATURE CELL BIOLOGY			English	Article							INDIVIDUAL FIBROBLASTS; CIRCADIAN-RHYTHMS; PERSISTENT; EXPRESSION; TIME	Zebrafish tissues and cell lines contain circadian clocks that respond directly to light(1,2). Using fluorescence-activated cell sorting, we have isolated clonal cell lines that contain the reporter construct, zfperiod4-luciferase(3). Bioluminescent assays show that oscillations within cell populations are dampened in constant darkness. However, single-cell imaging reveals that individual cells continue to oscillate, but with widely distributed phases and marked stochastic fluctuations in free-running period. Because these cells are directly light responsive, we can easily follow phase shifts to single light pulses. Here we show that light acts to reset desynchronous cellular oscillations to a common phase, as well as stabilize the subsequent free-running period.	UCL, Ctr Cell & Mol Dynam, Dept Anat & Dev Biol, London WC1E 6DE, England	University of London; University College London	Whitmore, D (corresponding author), UCL, Ctr Cell & Mol Dynam, Dept Anat & Dev Biol, Rockefeller Bldg,21 Univ St, London WC1E 6DE, England.	d.whitmore@ucl.ac.uk	Carr, Amanda/ABG-6282-2020; Zebrafish, UCL/A-3125-2009	Carr, Amanda/0000-0002-5469-0030; Whitmore, David/0000-0003-2420-8220				Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tamai TK, 2003, J NEUROENDOCRINOL, V15, P344; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	12	100	104	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2005	7	3					319	U127		10.1038/ncb1232	http://dx.doi.org/10.1038/ncb1232			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	902CU	15738976				2022-12-27	WOS:000227329800021
J	Wiggan, O; Bernstein, BW; Bamburg, JR				Wiggan, O; Bernstein, BW; Bamburg, JR			A phosphatase for cofilin to be HAD	NATURE CELL BIOLOGY			English	Editorial Material							ACTIN DYNAMICS; SLINGSHOT; ADF/COFILIN; FAMILY; REORGANIZATION; EXPRESSION	Regulating actin dynamics through cofilin dephosphorylation is the role of a newly identified phosphatase, chronophin, a member of the haloacid dehalogenase (HAD) superfamily. Chronophin, the second cofilin phosphatase to be identified, has high phosphoprotein specificity towards cofilin, but curiously it was also discovered independently as a pyridoxal phosphate (vitamin B6) phosphatase.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Wiggan, O (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	jbamburg@lamar.colostate.edu						Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; SOOSAIRAJAH J, IN PRESS EMBO J; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131	15	14	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					8	9		10.1038/ncb0105-8	http://dx.doi.org/10.1038/ncb0105-8			2	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632942				2022-12-27	WOS:000226113500005
J	Lee, J; Kitajima, TS; Tanno, Y; Yoshida, K; Morita, T; Miyano, T; Miyake, M; Watanabe, Y				Lee, Jibak; Kitajima, Tomoya S.; Tanno, Yuji; Yoshida, Kayo; Morita, Takashi; Miyano, Takashi; Miyake, Masashi; Watanabe, Yoshinori			Unified mode of centromeric protection by shugoshin in mammalian oocytes and somatic cells	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; PROTEIN PHOSPHATASE 2A; MEIOSIS-I; CHROMOSOME SEGREGATION; AURORA-B; INNER CENTROMERE; COHESIN; REC8; LOCALIZATION	Reductional chromosome segregation in germ cells, where sister chromatids are pulled to the same pole, accompanies the protection of cohesin at centromeres from separase cleavage. Here, we show that mammalian shugoshin Sgo2 is expressed in germ cells and is solely responsible for the centromeric localization of PP2A and the protection of cohesin Rec8 in oocytes, proving conservation of the mechanism from yeast to mammals. However, this role of Sgo2 contrasts with its mitotic role in protecting centromeric cohesin only from prophase dissociation, but never from anaphase cleavage. We demonstrate that, in somatic cells, shugoshin colocalizes with cohesin in prophase or prometaphase, but their localizations become separate when centromeres are pulled oppositely at metaphase. Remarkably, if tension is artificially removed from the centromeres at the metaphase-anaphase transition, cohesin at the centromeres can be protected from separase cleavage even in somatic cells, as in germ cells. These results argue for a unified view of centromeric protection by shugoshin in mitosis and meiosis.	[Kitajima, Tomoya S.; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Lee, Jibak; Miyano, Takashi; Miyake, Masashi] Kobe Univ, Lab Reprod Biol & Biotechnol, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Yoshida, Kayo; Morita, Takashi] Osaka City Univ, Dept Mol Genet, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	University of Tokyo; Kobe University; Osaka Metropolitan University	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016	Kitajima, Tomoya/0000-0002-6486-7143; Watanabe, Yoshinori/0000-0002-5488-4812				Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Gomez R, 2007, EMBO REP, V8, P173, DOI 10.1038/sj.embor.7400877; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; NAKAJIMA M, 2007, J CELL SCI; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pouwels J, 2007, CELL CYCLE, V6, P1579, DOI 10.4161/cc.6.13.4442; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yalon M, 2004, J CELL SCI, V117, P1961, DOI 10.1242/jcs.01032; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	48	194	203	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					42	U29		10.1038/ncb1667	http://dx.doi.org/10.1038/ncb1667			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084284				2022-12-27	WOS:000252116100011
J	Traer, CJ; Rutherford, AC; Palmer, KJ; Wassmer, T; Oakley, J; Attar, N; Carlton, JG; Kremerskothen, J; Stephens, DJ; Cullen, PJ				Traer, Colin J.; Rutherford, Anna C.; Palmer, Krysten J.; Wassmer, Thomas; Oakley, Jacqueline; Attar, Naomi; Carlton, Jez G.; Kremerskothen, Joachim; Stephens, David J.; Cullen, Peter J.			SNX4 coordinates endosomal sorting of TfnR with dynein-mediated transport into the endocytic recycling compartment	NATURE CELL BIOLOGY			English	Article							RETROGRADE TRANSPORT; MAMMALIAN-CELLS; YEAST ENDOSOMES; GOLGI NETWORK; MEMBRANE; RECEPTOR; PROTEIN; RETROMER; TRAFFICKING; KIBRA	SNX-BAR proteins are a sub-family of sorting nexins implicated in endosomal sorting. Here, we establish that through its phox homology (PX) and Bin-Amphiphysin-Rvs ( BAR) domains, sorting nexin-4 (SNX4) is associated with tubular and vesicular elements of a compartment that overlaps with peripheral early endosomes and the juxtanuclear endocytic recycling compartment ( ERC). Suppression of SNX4 perturbs transport between these compartments and causes lysosomal degradation of the transferrin receptor (TfnR). Through an interaction with KIBRA, a protein previously shown to bind dynein light chain 1, we establish that SNX4 associates with the minus end-directed microtubule motor dynein. Although suppression of KIBRA and dynein perturbs early endosome-to-ERC transport, TfnR sorting is maintained. We propose that by driving membrane tubulation, SNX4 coordinates iterative, geometric-based sorting of the TfnR with the long-range transport of carriers from early endosomes to the ERC. Finally, these data suggest that by associating with molecular motors, SNX-BAR proteins may coordinate sorting with carrier transport between donor and recipient membranes.	Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrat Signalling Labs, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Munster, Dept Expt Tumorbiol, D-4400 Munster, Germany; Guys Hosp, Univ London Kings Coll, London SE1 9RT, England	University of Bristol; University of Bristol; University of Munster; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Cullen, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Henry Wellcome Integrat Signalling Labs, Bristol BS8 1TD, Avon, England.	Pete.Cullen@bristol.ac.uk	Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014	Carlton, Jeremy/0000-0002-7255-1894; attar, naomi/0000-0002-6370-7885; Stephens, David/0000-0001-5297-3240; Cullen, Peter/0000-0002-9070-8349	MRC [G117/554] Funding Source: UKRI; Medical Research Council [G117/554, G117/554(71630)] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; DIA J, 2004, DEV CELL, V7, P771; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; EKENA K, 1995, MOL CELL BIOL, V15, P1671; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Krsmanovic T, 2005, MOL BIOL CELL, V16, P2809, DOI 10.1091/mbc.E04-10-0941; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Pelham HRB, 2002, CURR OPIN CELL BIOL, V14, P454, DOI 10.1016/S0955-0674(02)00352-6; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; VANDERGOOT G, 1956, TRENDS CELL BIOL, V16, P514; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999	41	195	203	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1370	U55		10.1038/ncb1656	http://dx.doi.org/10.1038/ncb1656			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	17994011				2022-12-27	WOS:000251317300010
J	Mor, A; Campi, G; Du, GW; Zheng, Y; Foster, DA; Dustin, ML; Philips, MR				Mor, Adam; Campi, Gabriele; Du, Guangwei; Zheng, Yang; Foster, David A.; Dustin, Michael L.; Philips, Mark R.			The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2	NATURE CELL BIOLOGY			English	Article							T-CELL-RECEPTOR; PHOSPHATIDIC-ACID; GOLGI-APPARATUS; ACTIVATION; LFA-1; PHAGOCYTOSIS; CYTOHESIN-1; MIGRATION; ADHESION; COMPLEX	Ras activation as a consequence of antigen receptor (T-cell receptor; TCR) engagement on T lymphocytes is required for T-cell development, selection and function. Lymphocyte function-associated antigen-1 (LFA-1) mediates lymphocyte adhesion, stabilization of the immune synapse and bidirectional signalling. Using a fluorescent biosensor we found that TCR activation with or without costimulation of CD28 led to activation of Ras only on the Golgi apparatus, whereas costimulation with LFA-1 induced Ras activation on both the Golgi and the plasma membrane. Ras activation on both compartments required RasGRP1, an exchange factor regulated by calcium and diacylglycerol (DAG), but phospholipase C ( PLC) activity was required only for activation on the Golgi. Engagement of LFA-1 increased DAG levels at the plasma membrane by stimulating phospholipase D (PLD). PLD2 and phosphatidic acid phosphatase (PAP) were required for Ras activation on the plasma membrane. Thus, LFA-1 acts through PLD2 to reshape the pattern of Ras activation downstream of the TCR.	NYU, Dept Med, Sch Med, New York, NY 10016 USA; NYU, Dept Pathol, Sch Med, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Philips, MR (corresponding author), NYU, Dept Med, Sch Med, 550 1St Ave, New York, NY 10016 USA.	philim01@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Du, Guangwei/0000-0003-4193-6975; Mark, Philips/0000-0002-1179-8156				Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bankaitis VA, 2002, SCIENCE, V295, P290, DOI 10.1126/science.1068446; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOER A, 1994, N-S ARCH PHARMACOL, V350, P653; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	30	109	112	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					713	U182		10.1038/ncb1592	http://dx.doi.org/10.1038/ncb1592			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486117				2022-12-27	WOS:000246922700018
J	Janiesch, PC; Kim, J; Mouysset, J; Barikbin, R; Lochmuller, H; Cassata, G; Krause, S; Hoppe, T				Janiesch, Philipp Christoph; Kim, Johnny; Mouysset, Julien; Barikbin, Roja; Lochmueller, Hanns; Cassata, Giuseppe; Krause, Sabine; Hoppe, Thorsten			The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; AAA-ATPASE; PROTEASOME PATHWAY; PROTEIN; UNC-45; ER; MUTATIONS; GENE; MULTIUBIQUITYLATION; POLYUBIQUITINATION	Protein degradation in eukaryotes often requires the ubiquitin-selective chaperone p97 for substrate recruitment and ubiquitin-chain assembly. However, the physiological relevance of p97, and its role in developmental processes, remain unclear. Here, we discover an unanticipated function for CDC-48/p97 in myosin assembly and myofibril organization, both in Caenorhabditis elegans and humans. The developmentally regulated assembly of a CDC-48 -UFD-2 -CHN-1 complex links turnover of the myosin-directed chaperone UNC-45 to functional muscle formation. Our data suggest a similarly conserved pathway regulating myosin assembly in humans. Remarkably, mutations in human p97, known to cause hereditary inclusion-body myopathy, abrogate UNC-45 degradation and result in severely disorganized myofibrils, detrimental towards sarcomeric function. These results identify a key role for CDC-48/p97 in the process of myofibre differentiation and maintenance, which is abolished during pathological conditions leading to protein aggregation and inclusion-body formation in human skeletal muscle.	Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; Univ Munich, Friedrich Baur Inst, D-81377 Munich, Germany; Univ Munich, Dept Neurol, D-81377 Munich, Germany; IFOM, FIRC, Inst Mol Oncol, I-20139 Milan, Italy	University of Hamburg; University of Munich; University of Munich; IFOM - FIRC Institute of Molecular Oncology	Hoppe, T (corresponding author), Univ Hamburg, ZMNH, Falkenried 94, D-20251 Hamburg, Germany.	thorsten.hoppe@zmnh.uni-hamburg.de	Krause, Sabine/AAJ-1163-2020; Hoppe, Thorsten/AAC-7880-2020; Kim, Johnny/AAY-2149-2020	Krause, Sabine/0000-0002-3141-886X; Lochmuller, Hanns/0000-0003-2324-8001; Hoppe, Thorsten/0000-0002-4734-9352; Kim, Johnny/0000-0002-5226-5460				Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; SLUSTON J, 1988, NEMATODE CAENORHABDI, P587; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tajsharghi H, 2005, EUR J HUM GENET, V13, P617, DOI 10.1038/sj.ejhg.5201375; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; VENOLIA L, 1990, GENETICS, V126, P345; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Yamanaka K, 2004, J STRUCT BIOL, V146, P242, DOI 10.1016/j.jsb.2003.11.017; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	44	115	128	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					379	U46		10.1038/ncb1554	http://dx.doi.org/10.1038/ncb1554			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369820				2022-12-27	WOS:000245359400009
J	Fulga, TA; Elson-Schwab, I; Khurana, V; Steinhilb, ML; Spires, TL; Hyman, BT; Feany, MB				Fulga, Tudor A.; Elson-Schwab, Ilan; Khurana, Vikram; Steinhilb, Michelle L.; Spires, Tara L.; Hyman, Bradley T.; Feany, Mel B.			Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo	NATURE CELL BIOLOGY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; HIRANO BODIES; MOUSE MODEL; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY PATHOLOGY; ALZHEIMERS-DISEASE; CELL-DEATH; DROSOPHILA; TAUOPATHY; FILAMENTS	Hyperphosphorylated forms of the microtubule-associated protein (MAP) tau accumulate in Alzheimer's disease and related tauopathies and are thought to have an important role in neurodegeneration. However, the mechanisms through which phosphorylated tau induces neurodegeneration have remained elusive. Here, we show that tau-induced neurodegeneration is associated with accumulation of filamentous actin (F-actin) and the formation of actin-rich rods in Drosophila and mouse models of tauopathy. Importantly, modulating F-actin levels genetically leads to dramatic modification of tau-induced neurodegeneration. The ability of tau to interact with F-actin in vivo and in vitro provides a molecular mechanism for the observed phenotypes. Finally, we show that the Alzheimer's disease-linked human beta-amyloid protein (A beta) synergistically enhances the ability of wild-type tau to promote alterations in the actin cytoskeleton and neurodegeneration. These findings raise the possibility that a direct interaction between tau and actin may be a critical mediator of tau-induced neurotoxicity in Alzheimer's disease and related disorders.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fulga, TA (corresponding author), Brigham & Womens Hosp, Dept Pathol, Harvard New Res Bldg Room 652,77 Loius Pasteur Av, Boston, MA 02115 USA.	Tudor_Fulga@hms.harvard.edu	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598; Khurana, Vikram/0000-0002-4018-5527; Fulga, Tudor/0000-0002-1056-0082; Feany, Mel/0000-0003-0315-7970	NATIONAL INSTITUTE ON AGING [R01AG019790] Funding Source: NIH RePORTER; NIA NIH HHS [AG19790, AG5134] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; CROSS D, 1993, J CELL SCI, V105, P51; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; DITELLA M, 1994, CELL MOTIL CYTOSKEL, V29, P117, DOI 10.1002/cm.970290204; Farias GA, 2002, J CELL BIOCHEM, V85, P315, DOI 10.1002/jcb.10133; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; GALLOWAY PG, 1987, BRAIN RES, V403, P337, DOI 10.1016/0006-8993(87)90071-0; GALLOWAY PG, 1987, J NEUROPATH EXP NEUR, V46, P185, DOI 10.1097/00005072-198703000-00006; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; GOLDMAN JE, 1983, J NEUROPATH EXP NEUR, V42, P146, DOI 10.1097/00005072-198303000-00004; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harms C, 2004, MOL CELL NEUROSCI, V25, P69, DOI 10.1016/j.mcn.2003.09.012; HENRIQUEZ JP, 1995, CELL BIOCHEM FUNCT, V13, P239, DOI 10.1002/cbf.290130404; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Kempf M, 1996, J NEUROSCI, V16, P5583; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; MACIVER SK, 1995, NEUROREPORT, V6, P1985, DOI 10.1097/00001756-199510010-00008; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MORAGA DM, 1993, J NEUROCHEM, V61, P979, DOI 10.1111/j.1471-4159.1993.tb03611.x; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHOCHET SS, 1968, ACTA NEUROPATHOL, V11, P330, DOI 10.1007/BF00686729; Shulman JM, 2003, GENETICS, V165, P1233; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Wagner CR, 2002, P NATL ACAD SCI USA, V99, P8037, DOI 10.1073/pnas.082235499; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zmuda JF, 2000, J CELL SCI, V113, P2797	49	327	342	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					139	U17		10.1038/ncb1528	http://dx.doi.org/10.1038/ncb1528			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17187063				2022-12-27	WOS:000243903000006
J	De Piccoli, G; Cortes-Ledesma, F; Ira, G; Torres-Rosell, J; Uhle, S; Farmer, S; Hwang, JY; Machin, F; Ceschia, A; McAleenan, A; Cordon-Preciado, V; Clemente-Blanco, A; Vilella-Mitjana, F; Ullal, P; Jarmuz, A; Leitao, B; Bressan, D; Dotiwala, F; Papusha, A; Zhao, XL; Myung, K; Haber, JE; Aguilera, A; Aragon, L				De Piccoli, Giacomo; Cortes-Ledesma, Felipe; Ira, Gregory; Torres-Rosell, Jordi; Uhle, Stefan; Farmer, Sarah; Hwang, Ji-Young; Machin, Felix; Ceschia, Audrey; McAleenan, Alexandra; Cordon-Preciado, Violeta; Clemente-Blanco, Andres; Vilella-Mitjana, Felip; Ullal, Pranav; Jarmuz, Adam; Leitao, Beatriz; Bressan, Debra; Dotiwala, Farokh; Papusha, Alma; Zhao, Xiaolan; Myung, Kyungjae; Haber, James E.; Aguilera, Andres; Aragon, Luis			Smc5-Smc6 mediate DNA double-strand-break repair by promoting sister-chromatid recombination	NATURE CELL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; COHESIN; REGIONS; GENES	DNA double-strand breaks (DSB) can arise during DNA replication, or after exposure to DNA-damaging agents, and their correct repair is fundamental for cell survival and genomic stability. Here, we show that the Smc5-Smc6 complex is recruited to DSBs de novo to support their repair by homologous recombination between sister chromatids. In addition, we demonstrate that Smc5-Smc6 is necessary to suppress gross chromosomal rearrangements. Our findings show that the Smc5-Smc6 complex is essential for genome stability as it promotes repair of DSBs by error-free sisterchromatid recombination (SCR), thereby suppressing inappropriate non-sister recombination events.	Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England; Univ Sevilla, Fac Biol, Dept Genet, E-41012 Seville, Spain; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Natl Human Genome Res Inst, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Imperial College London; University of Sevilla; Brandeis University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Memorial Sloan Kettering Cancer Center	Haber, JE (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	haber@brandeis.edu; aguilo@us.es; luis.aragon@csc.mrc.ac.uk	Dotiwala, Farokh/C-7068-2009; Blanco, Andrés Clemente/D-4255-2014; Hwang, Ji-Young/J-6460-2016; Dotiwala, Farokh/S-5367-2019; Ledesma, Felipe Cortés/F-4803-2014; Aguilera, Andres/L-1825-2014; Machín, Félix/K-6569-2017; Ira, Grzegorz/B-7912-2010; Torres-Rosell, Jordi/A-4213-2010; Vilella, Felipe/C-2970-2018	Blanco, Andrés Clemente/0000-0002-3674-0671; Hwang, Ji-Young/0000-0001-8044-1989; Dotiwala, Farokh/0000-0002-7387-2219; Ledesma, Felipe Cortés/0000-0002-0440-6783; Aguilera, Andres/0000-0003-4782-1714; Machín, Félix/0000-0003-4559-7798; Torres-Rosell, Jordi/0000-0003-1308-6926; Haber, James/0000-0002-1878-0610; Zhao, Xiaolan/0000-0002-8302-6905; Vilella, Felipe/0000-0002-0039-9846	MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [R01 GM020056, GM20056, R01 GM080600, R37 GM020056] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R01GM080600, R37GM020056] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; KADYK LC, 1992, GENETICS, V132, P387; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a	18	147	147	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					1032	U118		10.1038/ncb1466	http://dx.doi.org/10.1038/ncb1466			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16892052	Green Accepted			2022-12-27	WOS:000240241700021
J	Noren, NK; Foos, G; Hauser, CA; Pasquale, EB				Noren, Nicole K.; Foos, Gabriele; Hauser, Craig A.; Pasquale, Elena B.			The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway	NATURE CELL BIOLOGY			English	Article							TYROSINE KINASE; C-ABL; COLORECTAL-CANCER; FAMILY KINASES; GROWTH-FACTOR; BIOLOGICAL SIGNIFICANCE; EPITHELIAL-CELLS; UP-REGULATION; TUMOR-GROWTH; EXPRESSION	Recent evidence supports a role for EphB receptor tyrosine kinases as tumour suppressors in colorectal and prostate cancer. However, it is unclear how these receptors inhibit cancer cell tumorigenicity - an activity that is highly unusual for a family of receptor tyrosine kinases. Here, we report that the EphB4 receptor can behave as a tumour suppressor in a mouse xenograft model of breast cancer when stimulated by its ligand, ephrin-B2. In breast cancer cells, EphB4 activates an antioncogenic pathway involving Abl family tyrosine kinases and the Crk adaptor protein. This Abl - Crk pathway inhibits breast cancer cell viability and proliferation in addition to motility and invasion, and also downregulates the pro-invasive matrix metalloprotease, MMP-2. Consistent with these effects, EphB4 and the Abl - Crk pathway are constitutively active in non-transformed mammary epithelial cells. These findings identify a novel Eph receptor signalling pathway with tumour-suppressor activity and predict that therapeutic intervention to activate EphB4 signalling will inhibit tumour progression.	Burnham Inst Med Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92093 USA.	elenap@burnham.org	Noren Hooten, Nicole/J-5498-2019	Noren Hooten, Nicole/0000-0002-1683-3838				Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Berclaz G, 1996, BIOCHEM BIOPH RES CO, V226, P869, DOI 10.1006/bbrc.1996.1442; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Frasca F, 2001, ONCOGENE, V20, P3845, DOI 10.1038/sj.onc.1204531; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kain KH, 2003, ONCOGENE, V22, P6071, DOI 10.1038/sj.onc.1206930; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Liu W, 2004, BRIT J CANCER, V90, P1620, DOI 10.1038/sj.bjc.6601723; Liu WB, 2002, CANCER, V94, P934, DOI 10.1002/cncr.10122; Miao H, 2003, J CELL BIOL, V162, P1281, DOI 10.1083/jcb.200304018; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Nikolova Z, 1998, J CELL SCI, V111, P2741; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, CELL CYCLE, V2, P273, DOI 10.4161/cc.2.4.409; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Truong T, 2003, P NATL ACAD SCI USA, V100, P10281, DOI 10.1073/pnas.1635435100; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zelinski DP, 2001, CANCER RES, V61, P2301; Zou XM, 1999, J BIOL CHEM, V274, P18141, DOI 10.1074/jbc.274.26.18141; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	50	237	250	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					815	U53		10.1038/ncb1438	http://dx.doi.org/10.1038/ncb1438			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16862147				2022-12-27	WOS:000239423000011
J	Ching, YP; Chan, SF; Jeang, KT; Jin, DY				Ching, Yick-Pang; Chan, Shing-Fai; Jeang, Kuan-Teh; Jin, Dong-Yan			The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication	NATURE CELL BIOLOGY			English	Article							GENETIC INSTABILITY; TYPE-1 TAX; CELL-CYCLE; CENTRIOLE; DUPLICATION; SUPPRESSOR; AMPLIFICATION; ABERRATIONS; ACTIVATION; ROOTLETIN	Emerging evidence suggests that supernumerary centrosomes drive genome instability and oncogenesis(1-3). Human T-cell leukaemia virus type I ( HTLV-I) is etiologically associated with adult T-cell leukaemia ( ATL) 4. ATL cells are aneuploid, but the causes of aneuploidy are incompletely understood(5,6). Here, we show that centrosome amplification is frequent in HTLV-I-transformed cells and that this phenotype is caused by the viral Tax oncoprotein. We also show that the fraction of Tax protein that localizes to centrosomes interacts with TAX1BP2, a novel centrosomal protein composed almost entirely of coiled-coil domains. Overexpression of TAX1BP2 inhibited centrosome duplication, whereas depletion of TAX1BP2 by RNAi resulted in centrosome hyperamplification. Our findings suggest that the HTLV-I Tax oncoprotein targets TAX1BP2 causing genomic instability and aneuploidy.	Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; NIAID, Mol Microbiol Lab, Bethesda, MD 20892 USA	University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jin, DY (corresponding author), Univ Hong Kong, Dept Biochem, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	dyjin@hkucc.hku.hk	Jeang, Kuan-Teh/A-2424-2008; Ching, Yick Pang/C-4244-2009	CHING, Yick Pang/0000-0002-6461-8358	FIC NIH HHS [R01 TW06186-01] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW006186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001023, Z01AI000547] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Ching Yick-Pang, 2004, Retrovirology, V1, P18, DOI 10.1186/1742-4690-1-18; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Gatza ML, 2003, ONCOGENE, V22, P5141, DOI 10.1038/sj.onc.1206549; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Jeang KT, 2004, J BIOL CHEM, V279, P31991, DOI 10.1074/jbc.R400009200; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kramer A, 2005, LEUKEMIA, V19, P1142, DOI 10.1038/sj.leu.2403780; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsuoka M, 2005, CANCER RES, V65, P4467, DOI 10.1158/0008-5472.CAN-05-0559; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ou YY, 2002, J CELL SCI, V115, P1825; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Pihan GA, 1998, CANCER RES, V58, P3974; Semmes OJ, 1996, VIROLOGY, V217, P373, DOI 10.1006/viro.1996.0126; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Yang J, 2005, MOL CELL BIOL, V25, P4129, DOI 10.1128/MCB.25.10.4129-4137.2005; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	36	61	64	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2006	8	7					717	U143		10.1038/ncb1432	http://dx.doi.org/10.1038/ncb1432			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	060YJ	16767081				2022-12-27	WOS:000238837800014
J	Takegahara, N; Takamatsu, H; Toyofuku, T; Tsujimura, T; Okuno, T; Yukawa, K; Mizui, M; Yamamoto, M; Prasad, DVR; Suzuki, K; Ishii, M; Terai, K; Moriya, M; Nakatsuji, Y; Sakoda, S; Sato, S; Akira, S; Takeda, K; Inui, M; Takai, T; Ikawa, M; Okabe, M; Kumanogoh, A; Kikutani, H				Takegahara, Noriko; Takamatsu, Hyota; Toyofuku, Toshihiko; Tsujimura, Tohru; Okuno, Tatsusada; Yukawa, Kazunori; Mizui, Masayuki; Yamamoto, Midori; Prasad, Durbaka V. R.; Suzuki, Kazuhiro; Ishii, Masaru; Terai, Kenta; Moriya, Masayuki; Nakatsuji, Yuji; Sakoda, Saburo; Sato, Shintaro; Akira, Shizuo; Takeda, Kiyoshi; Inui, Masanori; Takai, Toshiyuki; Ikawa, Masahito; Okabe, Masaru; Kumanogoh, Atsushi; Kikutani, Hitoshi			Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis	NATURE CELL BIOLOGY			English	Article							IV SEMAPHORIN CD100; T-CELL ACTIVATION; DAP12-DEFICIENT MICE; NONREDUNDANT ROLES; B-CELL; RECEPTOR; GUIDANCE; SYSTEM; EXPRESSION; MUTATIONS	Semaphorins and their receptors have diverse functions in axon guidance, organogenesis, vascularization and/or angiogenesis, oncogenesis and regulation of immune responses(1-11). The primary receptors for semaphorins are members of the plexin family(2,12-14). In particular, plexin-A1, together with ligand-binding neuropilins, transduces repulsive axon guidance signals for soluble class III semaphorins(15), whereas plexin-A1 has multiple functions in chick cardiogenesis as a receptor for the transmembrane semaphorin, Sema6D, independent of neuropilins(16). Additionally, plexin-A1 has been implicated in dendritic cell function in the immune system(17). However, the role of plexin-A1 in vivo, and the mechanisms underlying its pleiotropic functions, remain unclear. Here, we generated plexin-A1-deficient (plexin-A1(-/-)) mice and identified its important roles, not only in immune responses, but also in bone homeostasis. Furthermore, we show that plexin-A1 associates with the triggering receptor expressed on myeloid cells-2 (Trem2), linking semaphorin-signalling to the immuno-receptor tyrosine-based activation motif (ITAM)-bearing adaptor protein, DAP12. These findings reveal an unexpected role for plexin-A1 and present a novel signalling mechanism for exerting the pleiotropic functions of semaphorins.	Osaka Univ, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Osaka Univ, CREST, Program JST, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Wakayama Med Coll, Dept Physiol 2, Wakayama 6410012, Japan; Natl Osaka Med Ctr, Dept Clin Res, Osaka 5868521, Japan; ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 8128582, Japan; Tohoku Univ, Int Dev Aging & Canc, Dept Expt Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; CREST, Program JST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Wakayama Medical University; Japan Science & Technology Agency (JST); Kyushu University; Tohoku University; Japan Science & Technology Agency (JST)	Kumanogoh, A (corresponding author), Osaka Univ, Dept Mol Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kumanogo@ragtime.biken.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Ishii, Masaru/D-2361-2009; Kumanogoh, Atsushi/C-7354-2009; Takegahara, Noriko/AAP-1694-2021; Akira, Shizuo/C-3134-2009; 寺井, 健太/AFQ-7663-2022; Mizui, Masayuki/AAD-1432-2019; Takeda, Kiyoshi/C-9331-2009; Kikutani, Hitoshi/C-9525-2009; Suzuki, Kazuhiro/B-3886-2012; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	寺井, 健太/0000-0001-7638-3720; Mizui, Masayuki/0000-0003-2543-8108; ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044; Suzuki, Kazuhiro/0000-0002-9081-538X; Takeda, Kiyoshi/0000-0002-1778-6332; Sato, Shintaro/0000-0001-5156-3354				Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Elhabazi A, 2003, CRIT REV IMMUNOL, V23, P65, DOI 10.1615/CritRevImmunol.v23.i12.40; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960	30	193	202	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					615	622		10.1038/ncb1416	http://dx.doi.org/10.1038/ncb1416			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16715077				2022-12-27	WOS:000238029000015
J	Funato, Y; Michiue, T; Asashima, M; Miki, H				Funato, Y; Michiue, T; Asashima, M; Miki, H			The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled	NATURE CELL BIOLOGY			English	Article							AXIS FORMATION; CYCLIN D1; KINASE; ACCUMULATION; DOWNSTREAM; CLONING; TARGET; GENE	Dishevelled (Dvl) transduces signals from the Wnt receptor, Frizzled, to downstream components, leading to the stabilization of beta-catenin and subsequent activation of the transcription factor T cell factor (TCF) and/or lymphoid enchancer factor (LEF)(1-3). However, the mechanism of Dvl action remains unclear. Here, we report that nucleoredoxin (NRX)(4), a thioredoxin (TRX) family protein, interacts with Dvl. Overexpression of NRX selectively suppresses the Wnt-beta-catenin pathway and ablation of NRX by RNA-interference (RNAi) results in activation of TCF, accelerated cell proliferation and enhancement of oncogenicity through cooperation with mitogen-activated extracellular signal regulated kinase kinase (MEK) or Ras. We find that cells respond to H2O2 stimulation by activating TCF. Redox-dependent activation of the Wnt-beta-catenin pathway occurs independently of extracellular Wnts and is impaired by RNAi of NRX. In addition, association between Dvl and NRX is inhibited by H2O2 treatment. These data suggest a relationship between the Wnt-beta-catenin pathway and redox signalling through redox-sensitive association of NRX with Dvl.	Univ Tokyo, Inst Med Sci, Div Canc Genom, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Biochem, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; JST, ICORP, Tokyo 1538902, Japan; PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Miki, H (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Genom, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	miki@ims.u-tokyo.ac.jp						Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BURDON RH, 1989, FREE RADICAL RES COM, V6, P345, DOI 10.3109/10715768909087918; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fujita M, 2001, CANCER RES, V61, P7722; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Miki H, 1999, J BIOL CHEM, V274, P27605, DOI 10.1074/jbc.274.39.27605; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SOKOL SY, 1995, DEVELOPMENT, V121, P1637; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8	30	285	298	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					501	U135		10.1038/ncb1405	http://dx.doi.org/10.1038/ncb1405			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16604061				2022-12-27	WOS:000237299400014
J	Hashimoto, M; Negi, J; Young, J; Israelsson, M; Schroeder, JI; Iba, K				Hashimoto, M; Negi, J; Young, J; Israelsson, M; Schroeder, JI; Iba, K			Arabidopsis HT1 kinase controls stomatal movements in response to CO2	NATURE CELL BIOLOGY			English	Article							ABSCISIC-ACID; GUARD-CELLS; ANION CHANNELS; SIGNAL-TRANSDUCTION; FAMILY; LIGHT; CONDUCTANCE; MUTANTS; CALCIUM; CLOSURE	Guard cells, which form stomata in leaf epidermes, sense a multitude of environmental signals and integrate this information to regulate stomatal movements(1,2). Compared with the advanced understanding of light and water stress responses in guard cells(2-4), the molecular mechanisms that underlie stomatal CO2 signalling have remained relatively obscure. With a high-throughput leaf thermal imaging CO2 screen, we report the isolation of two allelic Arabidopsis mutants ( high leaf temperature 1; ht1-1 and ht1-2) that are altered in their ability to control stomatal movements in response to CO2. The strong allele, ht1-2, exhibits a markedly impaired CO2 response but shows functional responses to blue light, fusicoccin and abscisic acid (ABA), indicating a role for HT1 in stomatal CO2 signalling. HT1 encodes a protein kinase that is expressed mainly in guard cells. Phosphorylation assays demonstrate that the activity of the HT1 protein carrying the ht1-1 or ht1-2 mutation is greatly impaired or abolished, respectively. Furthermore, dominant-negative HT1(K113W) transgenic plants, which lack HT1 kinase activity, show a disrupted CO2 response. These findings indicate that the HT1 kinase is important for regulation of stomatal movements and its function is more pronounced in response to CO2 than it is to ABA or light.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	Kyushu University; University of California System; University of California San Diego; University of California System; University of California San Diego	Iba, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	koibascb@mbox.nc.kyushu-u.ac.jp	Hashimoto-Sugimoto, Mimi/AAJ-6411-2021; Nordström, Maria/B-4561-2013	Schroeder, Julian/0000-0002-3283-5972	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM060396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assmann SM, 1999, PLANT CELL ENVIRON, V22, P629, DOI 10.1046/j.1365-3040.1999.00408.x; Brearley J, 1997, PLANTA, V203, P145, DOI 10.1007/s004250050176; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hanstein SM, 2002, PLANT PHYSIOL, V130, P940, DOI 10.1104/pp.004283; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kinoshita T, 2001, PLANT CELL PHYSIOL, V42, P424, DOI 10.1093/pcp/pce055; Leggett J., 1992, CLIMATE CHANGE 1992, P69; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Morison J. I. L., 1987, Stomatal function, P229; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Olsen RL, 2002, NEW PHYTOL, V153, P497, DOI 10.1046/j.0028-646X.2001.00337.x; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Raschke K, 2003, PLANTA, V217, P639, DOI 10.1007/s00425-003-1033-4; Roelfsema MRG, 2002, PLANT J, V32, P65, DOI 10.1046/j.1365-313X.2002.01403.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHWARTZ A, 1988, PLANT PHYSIOL, V87, P583, DOI 10.1104/pp.87.3.583; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Webb AAR, 1996, PLANT J, V9, P297, DOI 10.1046/j.1365-313X.1996.09030297.x; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8	33	185	197	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					391	U52		10.1038/ncb1387	http://dx.doi.org/10.1038/ncb1387			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16518390				2022-12-27	WOS:000236560000018
J	Sans, N; Wang, PY; Due, QS; Petralia, RS; Wang, YX; Nakka, S; Blumer, JB; Macara, IG; Wenthold, RJ				Sans, N; Wang, PY; Due, QS; Petralia, RS; Wang, YX; Nakka, S; Blumer, JB; Macara, IG; Wenthold, RJ			Mpins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression	NATURE CELL BIOLOGY			English	Article							G-PROTEINS; TETRATRICOPEPTIDE REPEAT; MOTIF; AGS3; PHOSPHORYLATION; IDENTIFICATION; DOMAIN; INTERACTS; POLARITY; PARTNER	Appropriate trafficking and targeting of glutamate receptors (GIuRs) to the postsynaptic density is crucial for synaptic function. We show that mPins (mammalian homologue of Drosophila melanogaster partner of inscuteable) interacts with SAP102 and PSD-95 (two PDZ proteins present in neurons), and functions in the formation of the NMDAR-MAGUK (N-methyl-D-aspartate receptor-membrane-associated guanylate kinase) complex. mPins enhances trafficking of SAP102 and NMDARs to the plasma membrane in neurons. Expression of dominant-negative constructs and short-interfering RNA (siRNA)-mediated knockdown of mPins decreases SAP102 in dendrites and modifies surface expression of NMDARs. mPins changes the number and morphology of dendritic spines and these effects depend on its G alpha i interaction domain, thus implicating G-protein signalling in the regulation of postsynaptic structure and trafficking of GluRs.	NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Virginia; University of Virginia; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sans, N (corresponding author), INSERM, Inst Neurosci F Magendie, Equipe AVENIR, IFR8, F-33077 Bordeaux, France.	nathalie.sans@bordeaux.inserm.fr	Sans, Nathalie/N-7008-2017	Sans, Nathalie/0000-0001-7658-2471; Du, Quansheng/0000-0003-4079-8662; Blumer, Joe/0000-0002-0020-3815	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH065092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM070902] Funding Source: Medline; NIMH NIH HHS [F32 MH065092, F32MH65092] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Guo W, 2004, J NEUROSCI, V24, P9161, DOI 10.1523/JNEUROSCI.3422-04.2004; Imamura Y, 2003, NEUROREPORT, V14, P1203, DOI 10.1097/00001756-200307010-00003; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Marty C, 2003, MOL CELL BIOL, V23, P3847, DOI 10.1128/MCB.23.11.3847-3858.2003; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	38	100	103	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1179	1190		10.1038/ncb1325	http://dx.doi.org/10.1038/ncb1325			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16299499				2022-12-27	WOS:000233748900011
J	Ross, ED; Minton, A; Wickner, RB				Ross, ED; Minton, A; Wickner, RB			Prion domains: sequences, structures and interactions	NATURE CELL BIOLOGY			English	Review							SOLID-STATE NMR; CREUTZFELDT-JAKOB-DISEASE; CHAPERONE PROTEIN HSP104; BETA-AMYLOID FIBRILS; YEAST SUP35 PROTEIN; PRP KNOCKOUT MICE; SACCHAROMYCES-CEREVISIAE; PSI(+) PRION; IN-VITRO; PODOSPORA-ANSERINA	Mammalian and most fungal infectious proteins ( also known as prions) are self-propagating amyloid, a filamentous beta- sheet structure. A prion domain determines the infectious properties of a protein by forming the core of the amyloid. We compare the properties of known prion domains and their interactions with the remainder of the protein and with chaperones. Ure2p and Sup35p, two yeast prion proteins, can still form prions when the prion domains are shuffled, indicating a parallel in-register beta- sheet structure.	NIDDKD, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ross, ED (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	wickner@helix.nih.gov		Ross, Eric/0000-0002-6473-9977; Minton, Allen/0000-0001-8459-1247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024943] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1999, CURR GENET, V35, P59, DOI 10.1007/s002940050433; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; DOEL SM, 1994, GENETICS, V137, P659; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Fernandez-Bellot E, 2000, EMBO J, V19, P3215, DOI 10.1093/emboj/19.13.3215; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Inou Y, 2004, J BIOL CHEM, V279, P52319, DOI 10.1074/jbc.M408159200; Inoue Y, 2001, J BIOL CHEM, V276, P35227, DOI 10.1074/jbc.C100304200; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jung G, 2000, GENETICS, V156, P559; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Kicka S, 2004, GENETICS, V166, P1241, DOI 10.1534/genetics.166.3.1241; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Kochneva-Pervukhova NV, 1998, CURR GENET, V34, P146, DOI 10.1007/s002940050379; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; OWEN F, 1989, LANCET, V1, P51; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Tuite MF, 2004, MOL CELL, V14, P541, DOI 10.1016/j.molcel.2004.05.012; Tycko R, 2003, BIOCHEMISTRY-US, V42, P3151, DOI 10.1021/bi027378p; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104	100	106	108	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1039	1044		10.1038/ncb1105-1039	http://dx.doi.org/10.1038/ncb1105-1039			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16385730				2022-12-27	WOS:000232930400001
J	Saude, L; Lourenco, R; Goncalves, A; Palmeirim, I				Saude, L; Lourenco, R; Goncalves, A; Palmeirim, I			terra is a left-right asymmetry gene required for left-right synchronization of the segmentation clock	NATURE CELL BIOLOGY			English	Article							DOUBLESEX-RELATED GENE; ZEBRAFISH; SOMITOGENESIS; EXPRESSION; VERTEBRATES; OSCILLATOR; EMBRYO	To establish the vertebrate body plan, it is fundamental to create left - right asymmetry in the lateral- plate mesoderm to correctly position the organs. However, it is also crucial to maintain symmetry between the left and the right sides of the presomitic mesoderm, ensuring the allocation of symmetrical body structures, such as the axial skeleton and skeletal muscles. Here, we show that terra is an early left- sided expressed gene that links left - right patterning with bilateral synchronization of the segmentation clock.	Gulbenkian Inst Sci, Ctr Biol Desenvolvimento, P-2780156 Oeiras, Portugal; Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal	Universidade do Minho	Saude, L (corresponding author), Gulbenkian Inst Sci, Ctr Biol Desenvolvimento, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mlsaude@igc.gulbenkian.pt	Saúde, Leonor/D-2720-2012; Palmeirim, Isabel/F-4522-2012	Saúde, Leonor/0000-0001-5933-8872; Lourenco, Raquel/0000-0002-6176-3066; Palmeirim, Isabel/0000-0003-2282-7829				Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Brunner B, 2001, GENOMICS, V77, P8, DOI 10.1006/geno.2001.6615; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holley SA, 2000, GENE DEV, V14, P1678; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Meng AM, 1999, DEVELOPMENT, V126, P1259; Oates AC, 2002, DEVELOPMENT, V129, P2929; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Thisse C., 1998, ZEBRAFISH SCI MON, V5, P8; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488	20	52	57	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					918	U82		10.1038/ncb1294	http://dx.doi.org/10.1038/ncb1294			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16136187				2022-12-27	WOS:000231601600017
J	Hara, MR; Agrawal, N; Kim, SF; Cascio, MB; Fujimuro, M; Ozeki, Y; Takahashi, M; Cheah, JH; Tankou, SK; Hester, LD; Ferris, CD; Hayward, SD; Snyder, SH; Sawa, A				Hara, MR; Agrawal, N; Kim, SF; Cascio, MB; Fujimuro, M; Ozeki, Y; Takahashi, M; Cheah, JH; Tankou, SK; Hester, LD; Ferris, CD; Hayward, SD; Snyder, SH; Sawa, A			S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding	NATURE CELL BIOLOGY			English	Article							SHORT-INTERFERING RNAS; NEURONAL NITRIC-OXIDE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; OXIDATIVE-STRESS; CEREBRAL-ISCHEMIA; MAMMALIAN-CELLS; HISTONE H2B; PROTEIN; GENE; ACTIVATION	Glyceraldehyde- 3- phosphate dehydrogenase ( GAPDH) influences cytotoxicity, translocating to the nucleus during apoptosis. Here we report a signalling pathway in which nitric oxide ( NO) generation that follows apoptotic stimulation elicits S- nitrosylation of GAPDH, which triggers binding to Siah1 ( an E3 ubiquitin ligase), nuclear translocation and apoptosis. S- nitrosylation of GAPDH augments its binding to Siah1, whose nuclear localization signal mediates translocation of GAPDH. GAPDH stabilizes Siah1, facilitating its degradation of nuclear proteins. Activation of macrophages by endotoxin and of neurons by glutamate elicits GAPDH - Siah1 binding, nuclear translocation and apoptosis, which are prevented by NO deletion. The NO - S- nitrosylation GAPDH - Siah1 cascade may represent an important molecular mechanism of cytotoxicity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu; asawa1@jhmi.edu	Fujimuro, Masahiro/AAC-4727-2020	Fujimuro, Masahiro/0000-0002-5165-0789	NIDA NIH HHS [DA-00074, DA-00266] Funding Source: Medline; NIMH NIH HHS [MH-069853] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BURKE JR, 1996, NAT MED, V347, P350; Bustamante J, 2002, NITRIC OXIDE-BIOL CH, V6, P333, DOI 10.1006/niox.2001.0420; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Dastoor Z, 2001, J CELL SCI, V114, P1643; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1999, MOL CELL BIOL, V19, P724; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Koshy B, 1996, HUM MOL GENET, V5, P1311, DOI 10.1093/hmg/5.9.1311; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Li HG, 2000, MOL PHARMACOL, V57, P427, DOI 10.1124/mol.57.3.427; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; MCDONALD LJ, 1993, P NATL ACAD SCI USA, V90, P6238, DOI 10.1073/pnas.90.13.6238; Mohr S, 1996, J BIOL CHEM, V271, P4209; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Stefanelli C, 1997, BIOCHEM J, V322, P909, DOI 10.1042/bj3220909; STEIN GS, 1972, J CELL BIOL, V52, P292, DOI 10.1083/jcb.52.2.292; Tatton WG, 1996, NEUROLOGY, V47, pS171, DOI 10.1212/WNL.47.6_Suppl_3.171S; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	52	833	869	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					665	U40		10.1038/ncb1268	http://dx.doi.org/10.1038/ncb1268			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15951807				2022-12-27	WOS:000230190800010
J	Bonazzi, M; Spano, S; Turacchio, G; Cericola, C; Valente, C; Colanzi, A; Kweon, HS; Hsu, VW; Polishchuck, EV; Polishchuck, RS; Sallese, M; Pulvirenti, T; Corda, D; Luini, A				Bonazzi, M; Spano, S; Turacchio, G; Cericola, C; Valente, C; Colanzi, A; Kweon, HS; Hsu, VW; Polishchuck, EV; Polishchuck, RS; Sallese, M; Pulvirenti, T; Corda, D; Luini, A			CtBP3/BARS drives membrane fission in dynamin-independent transport pathways	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATED SUBSTRATE; COATED VESICLE FORMATION; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; GOLGI NETWORK; COREPRESSOR CTBP; MAMMALIAN-CELLS; MUTANT DYNAMIN; YEAST; EXIT	Membrane fission is a fundamental step in membrane transport. So far, the only fission protein machinery that has been implicated in in vivo transport involves dynamin, and functions in several, but not all, transport pathways. Thus, other fission machineries may exist. Here, we report that carboxy-terminal binding protein 3/brefeldin A-ribosylated substrate (CtBP3/BARS) controls fission in basolateral transport from the Golgi to the plasma membrane and in fluid-phase endocytosis, whereas dynamin is not involved in these steps. Conversely, CtBP3/BARS protein is inactive in apical transport to the plasma membrane and in receptor-mediated endocytosis, both steps being controlled by dynamin. This indicates that CtBP3/BARS controls membrane fission in endocytic and exocytic transport pathways, distinct from those that require dynamin.	Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Lab Membrane Traff, I-66030 Santa Maria Imbaro, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Lab Cell Regulat, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luini, A (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Lab Membrane Traff, I-66030 Santa Maria Imbaro, Italy.	luini@dcbo.negrisud.it	Bonazzi, Matteo/G-1623-2011; Sallese, Michele/J-5347-2016; Corda, Daniela/K-6385-2016; Valente, Carmen/AAH-5261-2019; Bonazzi, Matteo/AAT-2653-2020; Colanzi, Antonino/D-6821-2012; Spanò, Stefania/F-4951-2011; Pulvirenti, Teodoro/AAJ-7661-2020; Luini, Alberto/L-1372-2013	Bonazzi, Matteo/0000-0001-5499-8759; Sallese, Michele/0000-0002-2555-3571; Corda, Daniela/0000-0002-3614-751X; Valente, Carmen/0000-0002-6244-9108; Bonazzi, Matteo/0000-0001-5499-8759; Colanzi, Antonino/0000-0002-5643-0216; Spanò, Stefania/0000-0001-9154-7463; Pulvirenti, Teodoro/0000-0001-9342-6614; Luini, Alberto/0000-0002-8729-2549	Telethon [GGP04235] Funding Source: Medline	Telethon(Fondazione Telethon)		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; BOULAN ER, 1980, CELL, V20, P45, DOI 10.1016/0092-8674(80)90233-0; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cao H, 2000, J CELL SCI, V113, P1993; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Mironov A, 1997, J CELL BIOL, V139, P1109, DOI 10.1083/jcb.139.5.1109; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nardini M, 2002, ACTA CRYSTALLOGR D, V58, P1068, DOI 10.1107/S0907444902006984; Pagano M, 2004, CELL, V118, P535, DOI 10.1016/j.cell.2004.08.013; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SCHALK EM, 1992, BIOCHEM BIOPH RES CO, V188, P780, DOI 10.1016/0006-291X(92)91124-9; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhang QH, 2002, SCIENCE, V295, P1895	51	140	142	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					570	U11		10.1038/ncb1260	http://dx.doi.org/10.1038/ncb1260			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15880102				2022-12-27	WOS:000229562100011
J	Franch-Marro, X; Wendler, F; Guidato, S; Griffith, J; Baena-Lopez, A; Itasaki, N; Maurice, MM; Vincent, JP				Franch-Marro, Xavier; Wendler, Franz; Guidato, Sonia; Griffith, Janice; Baena-Lopez, Alberto; Itasaki, Nobue; Maurice, Madelon M.; Vincent, Jean-Paul			Wingless secretion requires endosome-to-Golgi retrieval of Wntless/Evi/Sprinter by the retromer complex	NATURE CELL BIOLOGY			English	Article							WNT PROTEINS; TRANSMEMBRANE PROTEIN; GRADIENT FORMATION; DROSOPHILA; HEDGEHOG; SIGNALS; RECEPTION; POLARITY; LIGANDS; CELLS	The glycolipoproteins of the Wnt family raise interesting trafficking issues, especially with respect to spreading within tissues. Recently, the retromer complex has been suggested to participate in packaging Wnts into long-range transport vehicles(1,2). Our analysis of a Drosophila mutant in Vps35 show that, instead, the retromer complex is required for efficient progression of Wingless ( a Drosophila Wnt) through the secretory pathway. Indeed expression of senseless, a short-range target gene(3), is lost in Vps35-deficient imaginal discs. In contrast, Vps35 is not required for Hedgehog secretion, suggesting specificity. Overexpression of Wntless, a transmembrane protein known to be specifically required for Wingless secretion(4-6) overcomes the secretion block of Vps35-mutant cells. Furthermore, biochemical evidence confirms that Wntless engages with the retromer complex. We propose that Wntless accompanies Wingless to the plasma membrane where the two proteins dissociate. Following dissociation from Wingless, Wntless is internalized and returns to the Golgi apparatus in a retromer-dependent manner. Without the retromer-dependent recycling route, Wingless secretion is impaired and, as electron microscopy suggests, Wntless is diverted to a degradative compartment.	[Franch-Marro, Xavier; Wendler, Franz; Guidato, Sonia; Baena-Lopez, Alberto; Itasaki, Nobue; Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England; [Griffith, Janice; Maurice, Madelon M.] UMCU, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	MRC National Institute for Medical Research; Unilever; Utrecht University; Utrecht University Medical Center	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk	Baena, Luis Alberto/GLR-1590-2022; Franch-Marro, Xavier/E-4457-2017	Baena, Luis Alberto/0000-0002-8663-3794; Franch-Marro, Xavier/0000-0002-7465-6729; Maurice, Madelon/0000-0001-6885-5361; Itasaki, Nobue/0000-0003-0587-9141	European Research Council [294523] Funding Source: Medline; Medical Research Council [MC_U117560543, MC_U117584268] Funding Source: Medline; MRC [MC_U117560543, MC_U117584268] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandre C, 1999, DEVELOPMENT, V126, P5689; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; LIOU W, 1996, CELL BIOL, V106, P41; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	24	197	205	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					170	U40		10.1038/ncb1678	http://dx.doi.org/10.1038/ncb1678			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193037	Green Accepted			2022-12-27	WOS:000252897800012
J	Zhao, C; Du, GW; Skowronek, K; Frohman, MA; Bar-Sagi, D				Zhao, Chen; Du, Guangwei; Skowronek, Karl; Frohman, Michael A.; Bar-Sagi, Dafna			Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos	NATURE CELL BIOLOGY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; EXCHANGE FACTOR SON; PLASMA-MEMBRANE; BINDING DOMAIN; D ISOFORM; RECEPTOR; TRANSLOCATION; ASSOCIATION; EXPRESSION; ROLES	The activation of Ras by the guanine nucleotide-exchange factor Son of sevenless (Sos) constitutes the rate-limiting step in the transduction process that links receptor tyrosine kinases to Ras-triggered intracellular signalling pathways. A prerequisite for the function of Sos in this context is its ligand-dependent membrane recruitment, and the prevailing model implicates both the Sos carboxy-terminal proline-rich motifs and amino-terminal pleckstrin homology (PH) domain in this process. Here, we describe a previously unrecognized pathway for the PH domain-dependent membrane recruitment of Sos that is initiated by the growth factor-induced generation of phosphatidic acid via the signalling enzyme phospholipase D2 (PLD2). Phosphatidic acid interacts with a defined site in the Sos PH domain with high affinity and specificity. This interaction is essential for epidermal growth factor (EGF)-induced Sos membrane recruitment and Ras activation. Our findings establish a crucial role for PLD2 in the coupling of extracellular signals to Sos-mediated Ras activation, and provide new insights into the spatial coordination of this activation event.	SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	Dafna.Bar-Sagi@med.nyu.edu	zhao, chen/C-7358-2011	Du, Guangwei/0000-0003-4193-6975; Bar-Sagi, Dafna/0000-0003-2597-8948	NCI NIH HHS [CA55360, CA28146] Funding Source: Medline; NIDDK NIH HHS [DK64166] Funding Source: Medline; NIGMS NIH HHS [GM71520, GM071475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146, R37CA055360, R01CA055360, R56CA055360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071520, R01GM071475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Byrne JL, 1996, ONCOGENE, V13, P2055; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fiucci G, 2000, INT J CANCER, V85, P882, DOI 10.1002/(SICI)1097-0215(20000315)85:6<882::AID-IJC24>3.0.CO;2-E; Foster DA, 2003, MOL CANCER RES, V1, P789; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; Kubiseski TJ, 1997, J BIOL CHEM, V272, P1799, DOI 10.1074/jbc.272.3.1799; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MCCOLLAM L, 1995, J BIOL CHEM, V270, P15954, DOI 10.1074/jbc.270.27.15954; Park JW, 1996, BIOCHEM BIOPH RES CO, V229, P758, DOI 10.1006/bbrc.1996.1877; Qian XL, 1998, MOL CELL BIOL, V18, P771, DOI 10.1128/MCB.18.2.771; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12748, DOI 10.1021/bi00166a006; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WELSH CJ, 1994, BIOCHEM BIOPH RES CO, V202, P211, DOI 10.1006/bbrc.1994.1914; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719; Zheng J, 1997, J BIOL CHEM, V272, P30340, DOI 10.1074/jbc.272.48.30340	33	251	260	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					706	U171		10.1038/ncb1594	http://dx.doi.org/10.1038/ncb1594			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486115				2022-12-27	WOS:000246922700017
J	Neef, R; Gruneberg, U; Kopajtich, R; Li, XL; Nigg, EA; Sillje, H; Barr, FA				Neef, Ruediger; Gruneberg, Ulrike; Kopajtich, Robert; Li, Xiuling; Nigg, Erich A.; Sillje, Herman; Barr, Francis A.			Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1	NATURE CELL BIOLOGY			English	Article							POLO-LIKE KINASE; CENTRAL-SPINDLE; CELL-CYCLE; MITOTIC SPINDLE; MIDZONE FORMATION; BOX DOMAIN; PRC1; BINDING; PLX1; PHOSPHORYLATION	Spatial and temporal coordination of polo-like kinase 1 (Plk1) activity is necessary for mitosis and cytokinesis, and this is achieved through binding to phosphorylated docking proteins with distinct subcellular localizations(1-4). Although cyclin-dependent kinase 1 (Cdk1) creates these phosphorylated docking sites in metaphase(1,2), a general principle that explains how Plk1 activity is controlled in anaphase after Cdk1 inactivation is lacking. Here, we show that the microtubule-associated protein regulating cytokinesis (PRC1) is an anaphase-specific binding partner for Plk1, and that this interaction is required for cytokinesis. In anaphase, Plk1 creates its own docking site on PRC1, whereas in metaphase Cdk1 phosphorylates PRC1 adjacent to this docking site and thereby prevents binding of Plk1. Mutation of these Cdk1-sites results in a form of PRC1 that prematurely recruits Plk1 to the spindle during prometaphase and blocks mitotic progression. The activation state of Cdk1, therefore, controls the switch of Plk1 localization from centrosomes and kinetochores during metaphase, to the central spindle during anaphase.	Max Planck Inst Biochem, Independent Jr Res Grp, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Kiadis Pharma, NL-9747 AN Groningen, Netherlands; Univ Liverpool, Canc Studies Ctr, Liverpool L3 9TA, Merseyside, England	Max Planck Society; Max Planck Society; University of Liverpool	Barr, FA (corresponding author), Max Planck Inst Biochem, Independent Jr Res Grp, D-82152 Martinsried, Germany.	barr@biochem.mpg.de	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Barr, Francis/0000-0001-7518-253X; nigg, erich/0000-0003-4835-5719				Abrieu A, 1998, J CELL SCI, V111, P1751; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Doree M, 2002, J CELL SCI, V115, P2461; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Lowery DM, 2004, CELL CYCLE, V3, P128; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mollinari C, 2005, MOL BIOL CELL, V16, P1043, DOI 10.1091/mbc.E04-04-0346; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PINES J, 1999, NATL CELL BIOL, V1, P73; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; ZIEVE G, 1982, CELL, V28, P233, DOI 10.1016/0092-8674(82)90341-5	34	188	194	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					436	U132		10.1038/ncb1557	http://dx.doi.org/10.1038/ncb1557			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351640				2022-12-27	WOS:000245359400015
J	Chan, J; Calder, G; Fox, S; Lloyd, C				Chan, Jordi; Calder, Grant; Fox, Samantha; Lloyd, Clive			Cortical microtubule arrays undergo rotary movements in Arabidopsis hypocotyl epidermal cells	NATURE CELL BIOLOGY			English	Article							CYCLIC REORIENTATION; MAIZE COLEOPTILES; LIVING CELLS; GROWTH-RATE; ORIENTATION; WALL; REVEALS; VISUALIZATION; ESTABLISHMENT; GIBBERELLIN	Plant-cell expansion is controlled by cellulose microfibrils in the wall(1) with microtubules providing tracks for cellulose synthesizing enzymes(2). Microtubules can be reoriented experimentally(3-11) and are hypothesized to reorient cyclically in aerial organs(12-14), but the mechanism is unclear. Here, Arabidopsis hypocotyl microtubules were labelled with AtEB1a-GFP (Arabidopsis microtubule end-binding protein 1a) or GFP-TUA6 (Arabidopsis alpha-tubulin 6) to record long cycles of reorientation. This revealed microtubules undergoing previously unseen clockwise or counter-clockwise rotations. Existing models emphasize selective shrinkage and regrowth(15) or the outcome of individual microtubule encounters to explain realignment(16). Our higher-order view emphasizes microtubule group behaviour over time. Successive microtubules move in the same direction along self-sustaining tracks. Significantly, the tracks themselves migrate, always in the direction of the individual fast-growing ends, but twentyfold slower. Spontaneous sorting of tracks into groups with common polarities generates a mosaic of domains. Domains slowly migrate around the cell in skewed paths, generating rotations whose progressive nature is interrupted when one domain is displaced by collision with another. Rotary movements could explain how the angle of cellulose microfibrils can change from layer to layer in the polylamellate cell wall.	John Innes Ctr, Dept Dev & Cell Biol, Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Chan, J (corresponding author), John Innes Ctr, Dept Dev & Cell Biol, Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	jordi.chan@bbsrc.ac.uk		Fox, Samantha/0000-0003-1271-6412				Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Chan J, 2005, PLANT CELL, V17, P1737, DOI 10.1105/tpc.105.032615; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Costa MMR, 2005, DEVELOPMENT, V132, P5093, DOI 10.1242/dev.02085; Dhonukshe P, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-11; Dixit R, 2006, MOL BIOL CELL, V17, P1298, DOI 10.1091/mbc.E05-09-0864; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GIDDINGS TH, 1991, MICROTUBULE MEDIATED; Hejnowicz Z, 2005, PROTOPLASMA, V225, P243, DOI 10.1007/s00709-005-0091-9; HUSH JM, 1994, J CELL SCI, V107, P775; IGDDINGS TH, 1991, MICROTUBULE MEDIATED; ISHIDA K, 1992, INT J PLANT SCI, V153, P155, DOI 10.1086/297017; ISHIDA K, 1991, PLANT CELL PHYSIOL, V32, P409, DOI 10.1093/oxfordjournals.pcp.a078095; IWATA K, 1989, PLANT CELL PHYSIOL, V30, P1011; LASKOWSKI MJ, 1990, PLANTA, V181, P44, DOI 10.1007/BF00202323; Le J, 2005, J PLANT GROWTH REGUL, V24, P166, DOI 10.1007/s00344-005-0044-8; Lloyd CW, 1996, J MICROSC-OXFORD, V181, P140, DOI 10.1046/j.1365-2818.1996.100380.x; Mayumi K, 1996, PROTOPLASMA, V195, P112, DOI 10.1007/BF01279190; Nakajima K, 2006, PLANT CELL PHYSIOL, V47, P513, DOI 10.1093/pcp/pcj020; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Penfold R, 2006, LANGMUIR, V22, P2005, DOI 10.1021/la052719w; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Takesue K, 1998, PLANTA, V205, P539, DOI 10.1007/s004250050353; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; YUAN M, 1995, PLANT J, V7, P17, DOI 10.1046/j.1365-313X.1995.07010017.x; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	32	122	125	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2007	9	2					171	U57		10.1038/ncb1533	http://dx.doi.org/10.1038/ncb1533			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	131WR	17220881				2022-12-27	WOS:000243903000009
J	Fergus, GJ; Milne, L; Kulkarni, S; Sasaki, T; Walker, S; Andrews, S; Crabbe, T; Finan, P; Jones, G; Jackson, S; Camps, M; Rommel, C; Wymann, M; Hirsch, E; Hawkins, P; Stephens, L				Fergus, G. John; Milne, Laura; Kulkarni, Suhasini; Sasaki, Takehiko; Walker, Simon; Andrews, Simon; Crabbe, Tom; Finan, Peter; Jones, Gareth; Jackson, Shaun; Camps, Montserrat; Rommel, Christian; Wymann, Matthias; Hirsch, Emilio; Hawkins, Phillip; Stephens, Len			PI(3)K gamma has an important context-dependent role in neutrophil chemokinesis	NATURE CELL BIOLOGY			English	Article							3-KINASE; ACTIVATION; PI3K-GAMMA; DICTYOSTELIUM; CHEMOTAXIS; KINASE; ACTIN; GAMMA	The directional movement of cells in a gradient of external stimulus is termed chemotaxis and is important in many aspects of development and differentiated cell function. Phophoinositide 3-kinases (PI(3)Ks) are thought to have critical roles within the gradient-sensing machinery of a variety of highly motile cells(1,2), such as mammalian phagocytes(3), allowing these cells to respond quickly and efficiently to shallow gradients of soluble stimuli. Our analysis of mammalian neutrophil migration towards ligands such as fMLP shows that, although PtdIns(3,4)P-2 and PtdIns(3,4,5)P-3 accumulate in a PI(3)K gamma-dependent fashion at the up-gradient leading-edge, this signal is not required for efficient gradient-sensing and gradient-biased movement. PI(3)K gamma activity is however, a critical determinant of the proportion of cells that can move, that is, respond chemokinetically, in reaction to fMLP. Furthermore, this dependence of chemokinesis on PI(3)K gamma activity is context dependent, both with respect to the state of priming of the neutrophils and the type of surface on which they are migrating. We propose this effect of PI(3)K gamma is through roles in the regulation of some aspects of neutrophil polarization that are relevant to movement, such as integrin-based adhesion and the accumulation of polymerized (F)-actin at the leading-edge.	Babraham Inst, Cambridge CB22 3AT, England; Akita Univ, Akita 010, Japan; UCB, Slough SL1 4EN, Berks, England; Novartis, Cambridge, MA USA; Kings Coll London, London SE1 1UL, England; Monash Univ, Melbourne, Vic 3004, Australia; Serono Res Inst, CH-1211 Geneva, Switzerland; DKBW Univ, CH-4508 Basel, Switzerland; Univ Turin, I-10126 Turin, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Akita University; UCB Pharma SA; Novartis; University of London; King's College London; Monash University; University of Turin	Stephens, L (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.	len.stephens@bbsrc.ac.uk	Jones, Gareth E/H-2282-2012; Wymann, Matthias P/C-3227-2008; Hirsch, Emilio/F-4848-2013	Jones, Gareth E/0000-0001-5879-3048; Wymann, Matthias P/0000-0003-3349-4281; Hirsch, Emilio/0000-0002-9073-6024; Sasaki, Takehiko/0000-0003-1837-3748; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; Camps, Montserrat/0000-0002-9849-8657; Jackson, Shaun/0000-0002-4750-1991; Walker, Simon/0000-0001-9185-4922				Coffer PJ, 1998, BIOCHEM J, V329, P121; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; HASLETT C, 1985, AM J PATHOL, V119, P101; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; KELLER H, 1995, EUR J CELL BIOL, V66, P157; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; NISHIO M, 2006, NATURE CELL BIOL, V8, DOI DOI 10.1028/NCB1515; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sasaki Atsuo T, 2005, Novartis Found Symp, V269, P73; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SENGELOV H, 1993, J CLIN INVEST, V92, P1467, DOI 10.1172/JCI116724; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SMITH DF, 2006, J LEUKOCYTE BIOL, DOI DOI 10.1189/JIB.0306227; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Wells Claire M., 2004, V294, P31; Zicha D, 1997, Methods Mol Biol, V75, P449	29	202	208	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					86	U109		10.1038/ncb1517	http://dx.doi.org/10.1038/ncb1517			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17173040				2022-12-27	WOS:000243255100016
J	Suire, S; Condliffe, AM; Ferguson, GJ; Ellson, CD; Guillou, H; Davidson, K; Welch, H; Coadwell, J; Turner, M; Chilvers, ER; Hawkins, PT; Stephens, L				Suire, Sabine; Condliffe, Alison M.; Ferguson, G. John; Ellson, Chris D.; Guillou, Herve; Davidson, Keith; Welch, Heidi; Coadwell, John; Turner, Martin; Chilvers, Edwin R.; Hawkins, Phillip T.; Stephens, Len			G beta gamma s and the Ras binding domain of p110 gamma are both important regulators of PI(3)K gamma signalling in neutrophils	NATURE CELL BIOLOGY			English	Article							PHOSPHOINOSITIDE 3-KINASE; CELL POLARITY; ACTIVATION; PI3K-GAMMA; ROLES; PI3K; IB; RECRUITMENT; KINASE	Through their ability to regulate production of the key lipid messenger PtdIns(3,4,5)P-3, the class I phosphatidylinositol-3-OH kinases (PI(3)Ks) support many critical cell responses(1,2). They, in turn, can be regulated by cell-surface receptors through signals acting on either their adaptor subunits (for example, through phosphotyrosine or G beta gamma s) or their catalytic subunits (for example, through GTP-Ras). The relative significance of these controlling inputs is undefined in vivo. Here, we have studied the roles of G beta gamma s, the adaptor p101, Ras and the Ras binding domain (RBD) in the control of the class I PI(3)K, PI(3)K gamma, in mouse neutrophils. Loss of p101 leads to major reductions in the accumulation of PtdIns(3,4,5)P-3, activation of protein kinase B (PKB) and in migration towards G-protein activating ligands in vitro, and to an aseptically inflamed peritoneum in vivo. Loss of sensitivity of PI(3)K gamma to Ras unexpectedly caused similar reductions, but additionally caused a substantial loss in production of reactive oxygen species (ROS). We conclude that G beta gamma s, p101 and the Ras-RBD interaction all have important roles in the regulation of PI(3)K gamma in vivo and that they can simultaneously, but differentially, control distinct PI(3)K gamma effectors.	Babraham Inst, Babraham CB22 3AT, Cambs, England; Univ Cambridge, Addenbrookes Hosp, Resp Med Div, Sch Clin Med, Cambridge CB2 2QQ, England; Univ Cambridge, Sch Clin Med, Resp Med Div, Papworth Hosp, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge	Stephens, L (corresponding author), Babraham Inst, Babraham CB22 3AT, Cambs, England.	len.stephens@bbsrc.ac.uk	Turner, Martin/N-9976-2014; Guillou, Herve/AAG-2826-2020; Guillou, Hervé/AGL-0750-2022	Turner, Martin/0000-0002-3801-9896; Guillou, Herve/0000-0002-5363-9081; Guillou, Hervé/0000-0002-5363-9081; Welch, Heidi/0000-0001-7865-7000; Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487; suire, sabine/0000-0002-2773-2215; condliffe, alison/0000-0002-6697-8648; Chilvers, Edwin/0000-0002-4230-9677	BBSRC [BB/D013593/1] Funding Source: UKRI; MRC [G120/825, G117/424] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M090, BB/D013593/1, C20177, C19943] Funding Source: Medline; Medical Research Council [G120/825, G117/424] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Coffer PJ, 1998, BIOCHEM J, V329, P121; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Krugmann S, 2002, BIOCHEM J, V362, P725, DOI 10.1042/0264-6021:3620725; Krugmann S, 1997, BIOCHEM SOC T, V25, pS604, DOI 10.1042/bst025s604; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.bioeng.7.060804.100423; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Zheng LM, 1997, J BIOL CHEM, V272, P23448, DOI 10.1074/jbc.272.37.23448	32	134	138	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1303	1309		10.1038/ncb1494	http://dx.doi.org/10.1038/ncb1494			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17041586				2022-12-27	WOS:000241732400021
J	Ancelin, K; Lange, UC; Hajkova, P; Schneider, R; Bannister, AJ; Kouzarides, T; Surani, MA				Ancelin, Katia; Lange, Ulrike C.; Hajkova, Petra; Schneider, Robert; Bannister, Andrew J.; Kouzarides, Tony; Surani, M. Azim			Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells	NATURE CELL BIOLOGY			English	Article							SPECIFICATION; H3; EXPRESSION; REPRESSION; PRDI-BF1; PROGRAM; GENE; G9A; H4	Blimp1, a transcriptional repressor, has a crucial role in the specification of primordial germ cells (PGCs) in mice at embryonic day 7.5 (E7.5)(1,2). This SET-PR domain protein can form complexes with various chromatin modifiers in a context-dependent manner(3,4). Here, we show that Blimp1 has a novel interaction with Prmt5, an arginine-specific histone methyltransferase, which mediates symmetrical dimethylation of arginine 3 on histone H2A and/or H4 tails (H2A/H4R3me2s). Prmt5 has been shown to associate with Tudor, a component of germ plasm in Drosophila melanogaster5. Blimp1-Prmt5 colocalization results in high levels of H2A/H4 R3 methylation in PGCs at E8.5. However, at E11.5, Blimp1-Prmt5 translocates from the nucleus to the cytoplasm, resulting in the loss of H2A/H4 R3 methylation at the time of extensive epigenetic reprogramming of germ cells(6). Subsequently, Dhx38, a putative target of the Blimp1-Prmt5 complex, is upregulated. Interestingly, expression of Dhx38 is also seen in pluripotent embryonic germ cells that are derived from PGCs when Blimp1 expression is lost. Our study demonstrates that Blimp1 is involved in a novel transcriptional regulatory complex in the mouse germ-cell lineage.	Univ Cambridge, Gurdon Inst Canc & Dev Biol, Wellcome Trust Canc Res UK, Cambridge CB2 1QN, England; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	Cancer Research UK; University of Cambridge; Max Planck Society	Surani, MA (corresponding author), Univ Cambridge, Gurdon Inst Canc & Dev Biol, Wellcome Trust Canc Res UK, Tennis Court Rd, Cambridge CB2 1QN, England.	as10021@mole.bio.cam.ac.uk	Ancelin, Katia/R-1719-2019	Ancelin, Katia/0000-0002-2117-9754; Bannister, Andrew/0000-0002-6312-4436; Surani, Azim/0000-0002-8640-4318; Kouzarides, Tony/0000-0002-8918-4162; Hajkova, Petra/0000-0003-4145-1468	Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; COTE J, 2005, J BIOL CHEM, V13, P13; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GRAHAM PL, 1993, GENETICS, V133, P919; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Oberley MJ, 2003, J BIOL CHEM, V278, P42466, DOI 10.1074/jbc.M307733200; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	30	354	397	0	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					623	630		10.1038/ncb1413	http://dx.doi.org/10.1038/ncb1413			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16699504				2022-12-27	WOS:000238029000016
J	Flick, K; Raasi, S; Zhang, HW; Yen, JL; Kaiser, P				Flick, K; Raasi, S; Zhang, HW; Yen, JL; Kaiser, P			A ubiquitin-interacting motif protects polyubiquitinated Met4 from degradation by the 26S proteasome	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTIONAL ACTIVATOR MET4; SACCHAROMYCES-CEREVISIAE; BINDING PROTEINS; CELL-CYCLE; PROTEOLYSIS; INHIBITION; DOMAINS; METABOLISM; COMPLEX; LYSINE	Covalent attachment of ubiquitin to proteins regulates a host of cellular events by proteolysis dependent and independent mechanisms. A variety of protein domains that bind noncovalently to ubiquitin have been described and functionally linked to diverse cellular processes(1). Overall, however, the understanding and knowledge of the mechanisms by which ubiquitin-binding domains (UBDs) regulate these processes is limited. Here, we describe identification of a UBD in the yeast transcription factor Met4. Met4 activity, but not its stability, is regulated by polyubiquitination(2-4). We found that the UBD restricts the length of the polyubiquitin chain that is assembled on Met4, and prevents proteasomal recognition and degradation of polyubiquitinated Met4. Inactivation of the UBD allowed synthesis of longer ubiquitin chains on Met4 and transformed the normally stable polyubiquitinated Met4 into a short-lived protein. Our results demonstrate a function for UBDs in ubiquitin-chain synthesis and regulation of protein degradation.	Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University of California System; University of California Irvine; Johns Hopkins University	Kaiser, P (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 240D Med Sci I, Irvine, CA 92697 USA.	pkaiser@uci.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066164, R56GM066164] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46984] Funding Source: Medline; NIGMS NIH HHS [GM66164] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Su NY, 2005, MOL CELL BIOL, V25, P3875, DOI 10.1128/MCB.25.10.3875-3885.2005; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Yen JL, 2005, MOL BIOL CELL, V16, P1872, DOI 10.1091/mbc.E04-12-1130; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	29	70	73	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					509	U144		10.1038/ncb1402	http://dx.doi.org/10.1038/ncb1402			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16604062				2022-12-27	WOS:000237299400015
J	Mziaut, H; Trajkovski, M; Kersting, S; Ehninger, A; Altkruger, A; Lemaitre, RP; Schmidt, D; Saeger, HD; Lee, MS; Drechsel, DN; Muller, S; Solimena, M				Mziaut, H; Trajkovski, M; Kersting, S; Ehninger, A; Altkruger, A; Lemaitre, RP; Schmidt, D; Saeger, HD; Lee, MS; Drechsel, DN; Muller, S; Solimena, M			Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5	NATURE CELL BIOLOGY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PANCREATIC BETA-CELLS; INSULIN GENE-TRANSCRIPTION; PROINSULIN BIOSYNTHESIS; SUMO-1 CONJUGATION; IA-2; IDENTIFICATION; ACTIVATION; EXOCYTOSIS; EXPRESSION	Nutrients and growth hormones promote insulin production and the proliferation of pancreatic beta-cells. An imbalance between ever-increasing metabolic demands and insulin output causes diabetes. Recent evidence indicates that beta-cells enhance insulin gene expression depending on their secretory activity. This signalling pathway involves a catalytically inactive receptor tyrosine phosphatase, ICA512, whose cytoplasmic tail is cleaved on glucose-stimulated exocytosis of insulin secretory granules and then moves into the nucleus, where it upregulates insulin transcription. Here, we show that the cleaved cytosolic fragment of ICA512 enhances the transcription of secretory granule genes ( including its own gene) by binding to tyrosine phosphorylated signal transducers and activators of transcription ( STAT) 5 and preventing its dephosphorylation. Sumoylation of ICA512 by the E3 SUMO ligase PIASy, in turn, may reverse this process by decreasing the binding of ICA512 to STAT5. These findings illustrate how the exocytosis of secretory granules, through a retrograde pathway that sustains STAT activity, converges with growth hormone signalling to induce adaptive changes in beta-cells in response to metabolic demands.	Dresden Univ Technol, Sch Med, Dept Surg, D-01307 Dresden, Germany; Dresden Univ Technol, Sch Med, Med Clin 3, D-01307 Dresden, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Max Planck Society; Sungkyunkwan University (SKKU); Samsung Medical Center	Solimena, M (corresponding author), Dresden Univ Technol, Sch Med, Dept Surg, D-01307 Dresden, Germany.	michele.solimena@mailbox.tu-dresden.de	Kersting, Stephan/ABG-2973-2020; Solimena, Michele/E-1275-2011; Lee, Myung Shik/C-9606-2011; Kersting, Stephan/C-5137-2009; Kersting, Stephan/AAQ-1889-2020; Solimena, Michele/GVS-5990-2022	Kersting, Stephan/0000-0002-2124-3103; Trajkovski, Mirko/0000-0002-3152-9551; Muller, Stefan/0000-0002-8792-7700				Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Felberg J, 2004, J BIOL CHEM, V279, P3455, DOI 10.1074/jbc.M309537200; Friedrichsen BN, 2003, MOL ENDOCRINOL, V17, P945, DOI 10.1210/me.2002-0356; Galsgaard ED, 1996, MOL ENDOCRINOL, V10, P652, DOI 10.1210/me.10.6.652; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Harashima S, 2005, P NATL ACAD SCI USA, V102, P8704, DOI 10.1073/pnas.0408887102; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kennedy HJ, 1999, BIOCHEM J, V342, P275, DOI 10.1042/0264-6021:3420275; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Matsuoka T, 2001, J BIOL CHEM, V276, P22071, DOI 10.1074/jbc.M010321200; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; SOLIMENA M, 1996, EMBO J, V15, P21002; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ungureanu D, 2003, BLOOD, V102, P3311, DOI 10.1182/blood-2002-12-3816; Weinhaus AJ, 1996, ENDOCRINOLOGY, V137, P1640, DOI 10.1210/en.137.5.1640; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zhou YP, 2003, METABOLISM, V52, P528, DOI 10.1053/meta.2003.50091	50	66	69	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2006	8	5					435	U20		10.1038/ncb1395	http://dx.doi.org/10.1038/ncb1395			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	039IO	16622421				2022-12-27	WOS:000237299400007
J	Bohnsack, MT; Stuven, T; Kuhn, C; Cordes, VC; Gorlich, D				Bohnsack, MT; Stuven, T; Kuhn, C; Cordes, VC; Gorlich, D			A selective block of nuclear actin export stabilizes the giant nuclei of Xenopus oocytes	NATURE CELL BIOLOGY			English	Article							PORE COMPLEXES; NUCLEOCYTOPLASMIC TRANSPORT; CYTOPLASMIC ACTIN; TRANSFER-RNA; DIMETHYLSULFOXIDE; TRANSCRIPTION; PROTEINS; INDUCTION; MIGRATION; MEDIATOR	Actin is a major cytoskeletal element and is normally kept cytoplasmic by exportin 6 (Exp6)-driven nuclear export. Here, we show that Exp6 recognizes actin features that are conserved from yeast to human. Surprisingly however, microinjected actin was not exported from Xenopus laevis oocyte nuclei, unless Exp6 was co-injected, indicating that the pathway is inactive in this cell type. Indeed, Exp6 is undetectable in oocytes, but is synthesized from meiotic maturation onwards, which explains how actin export resumes later in embryogenesis. Exp6 thus represents the first example of a strictly developmentally regulated nuclear transport pathway. We asked why Xenopus oocytes lack Exp6 and observed that ectopic application of Exp6 renders the giant oocyte nuclei extremely fragile. This effect correlates with the selective disappearance of a sponge-like intranuclear scaffold of F-actin. These nuclei have a normal G2-phase DNA content in a volume 100,000 times larger than nuclei of somatic cells. Apparently, their mechanical integrity cannot be maintained by chromatin and the associated nuclear matrix, but instead requires an intranuclear actin-scaffold.	Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Gorlich, D (corresponding author), Heidelberg Univ, Zentrum Mol Biol, INF 282, D-69120 Heidelberg, Germany.	dg@zmbh.uni-heidelberg.de	Bohnsack, Markus T./D-3076-2011; Görlich, Dirk/B-8296-2017	Bohnsack, Markus T./0000-0001-7063-5456; Görlich, Dirk/0000-0002-4343-5210				AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Boal D. H., 2002, MECH CELL; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0; Cordes VC, 1997, EXP CELL RES, V237, P419, DOI 10.1006/excr.1997.3806; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; DEROBERTIS EM, 1978, NATURE, V272, P254, DOI 10.1038/272254a0; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; FUKUI Y, 1979, EXP CELL RES, V120, P451, DOI 10.1016/0014-4827(79)90412-9; Gard DL, 1999, MICROSC RES TECHNIQ, V44, P388; Gonsior SM, 1999, J CELL SCI, V112, P797; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Handwerger KE, 2005, MOL BIOL CELL, V16, P202, DOI 10.1091/mbc.E04-08-0742; Hausen P., 1991, EARLY DEV XENOPUS LA; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; IIDA K, 1986, EXP CELL RES, V165, P207, DOI 10.1016/0014-4827(86)90545-8; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Kwak IH, 2004, CANCER RES, V64, P572, DOI 10.1158/0008-5472.CAN-03-1856; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; OSBORN M, 1980, EXP CELL RES, V129, P103, DOI 10.1016/0014-4827(80)90335-3; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Pollard TD, 2002, CELL BIOL; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Roeder Amy D., 1994, Zygote, V2, P111; SANGER JW, 1980, J EXP ZOOL, V213, P227, DOI 10.1002/jez.1402130210; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; THIEBAUD CH, 1977, CHROMOSOMA, V59, P253, DOI 10.1007/BF00292781; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X	43	123	132	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2006	8	3					257	263		10.1038/ncb1357	http://dx.doi.org/10.1038/ncb1357			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	017QL	16489345	Green Published			2022-12-27	WOS:000235708000011
J	Jakymiw, A; Lian, SL; Eystathioy, T; Li, SQ; Satoh, M; Hamel, JC; Fritzler, MJ; Chan, EKL				Jakymiw, A; Lian, SL; Eystathioy, T; Li, SQ; Satoh, M; Hamel, JC; Fritzler, MJ; Chan, EKL			Disruption of GW bodies impairs mammalian RNA interference	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; CYTOPLASMIC AUTOANTIGEN; HUMAN-CELLS; P-BODIES; GW182; COMPLEX; LOCALIZATION; PROTEINS; SIRNAS; DECAY	The GW182 RNA-binding protein was initially shown to associate with a specific subset of mRNAs and to reside within discrete cytoplasmic foci named GW bodies (GWBs)(1). GWBs are enriched in proteins that are involved in mRNA degradation(2). Recent reports have shown that exogenously introduced human Argonaute-2 (Ago2) is also enriched in GWBs, indicating that RNA interference function may be somehow linked to these structures(3,4). In this report, we demonstrate that endogenous Agog and transfected small interfering RNAs (siRNAs) are also present within these same cytoplasmic bodies and that the GW182 protein interacts with Agog. Disruption of these cytoplasmic foci in HeLa cells interferes with the silencing capability of a siRNA that is specific to lamin-A/C. Our data support a model in which GW182 and/or the microenvironment of the cytoplasmic GWBs contribute to the RNA-induced silencing complex and to RNA silencing.	Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Florida, Dept Med, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Calgary; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chan, EKL (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	echan@ufl.edu	Chan, Edward K. L./B-5671-2009; Satoh, Minoru/E-2421-2011	Chan, Edward K. L./0000-0003-3938-9503; Jakymiw, Andrew/0000-0001-6431-8753; Satoh, Minoru/0000-0001-8769-5105	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047859, R01AI039645, R21AI047859] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47859, AI39645] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eystathioy T, 2003, J MOL MED, V81, P811, DOI 10.1007/s00109-003-0495-y; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2003, HYBRIDOMA HYBRIDOM, V22, P79, DOI 10.1089/153685903321947996; Eystathioy T, 2002, ARTHRITIS RHEUM, V46, P726, DOI 10.1002/art.10220; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Ou Y, 2004, CLIN EXP IMMUNOL, V136, P379, DOI 10.1111/j.1365-2249.2004.02432.x; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Tahbaz N, 2001, J BIOL CHEM, V276, P43294, DOI 10.1074/jbc.M107808200; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	30	314	335	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1267	1274		10.1038/ncb1334	http://dx.doi.org/10.1038/ncb1334			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16284622				2022-12-27	WOS:000233748900022
J	Lu, H; Bilder, D				Lu, H; Bilder, D			Endocytic control of epithelial polarity and proliferation in Drosophila	NATURE CELL BIOLOGY			English	Article							CELL POLARITY; MEMBRANE TRAFFICKING; SYNTAXIN 7; NOTCH; GROWTH; RAB5; EYE; ORGANIZATION; JUNCTIONS; HOMOLOG	Intracellular protein transport is a key factor in epithelial cell polarity. Here we report that mutations in two core components of the vesicle trafficking machinery - a syntaxin and a Rab protein - cause an expansion of the apical membrane domain of Drosophila melanogaster epithelia; this polarity defect is coupled with overproliferation to form neoplastic tumours. Surprisingly, these proteins are associated with the endocytic, and not the exocytic, pathway. The syntaxin Avalanche (Avl) localizes to early endosomes, and loss of avl results in the cellular accumulation of specific membrane proteins, including the Notch signalling receptor and the polarity determinant Crumbs (Crb). Protein accumulation results from a failure in endosomal entry and progression towards lysosomal degradation; these and other avl phenotypes are also detected in Rab5 null mutant cells. Overexpression of Crb alone is sufficient to induce overproliferation of wild-type imaginal tissue, suggesting that polarity alterations in avl and Rab5 mutants directly contribute to tumour formation. Our findings reveal a critical and specific role for endocytic traffic in the control of both apico-basal polarity and cell proliferation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 142 LSA 3200, Berkeley, CA 94720 USA.	bilder@berkeley.edu		Bilder, David/0000-0002-1842-4966	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675, R01GM090150] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM090150, GM 068675-01, R01 GM068675] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelilah-Seyfried S, 2003, DEVELOPMENT, V130, P1927, DOI 10.1242/dev.00420; Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Dollar G, 2002, DEVELOPMENT, V129, P517; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Newsome TP, 2000, DEVELOPMENT, V127, P851; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	34	260	261	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1232	1239		10.1038/ncb1324	http://dx.doi.org/10.1038/ncb1324			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16258546				2022-12-27	WOS:000233748900017
J	David, NB; Martin, CA; Segalen, M; Rosenfeld, F; Schweisguth, F; Bellaiche, Y				David, NB; Martin, CA; Segalen, M; Rosenfeld, F; Schweisguth, F; Bellaiche, Y			Drosophila Ric-8 regulates G alpha i cortical localization to promote G alpha i-dependent planar orientation of the mitotic spindle during asymmetric cell division	NATURE CELL BIOLOGY			English	Article							HETEROTRIMERIC G-PROTEINS; C-ELEGANS; MICROCHAETE LINEAGE; POLARITY; PINS; DETERMINANTS; ACTIVATION; SYNEMBRYN; ROTATION; BAZOOKA	Localization and activation of heterotrimeric G proteins have a crucial role during asymmetric cell division. The asymmetric division of the Drosophila sensory precursor cell (pI) is polarized along the antero-posterior axis by Frizzled signalling and, during this division, activation of G alpha i depends on Partner of Inscuteable ( Pins). We establish here that Ric-8, which belongs to a family of guanine nucleotide-exchange factors for G alpha i, regulates cortical localization of the subunits Gai and G beta 13F. Ric-8, G alpha i and Pins are not necessary for the control of the anteroposterior orientation of the mitotic spindle during pI cell division downstream of Frizzled signalling, but they are required for maintainance of the spindle within the plane of the epithelium. On the contrary, Frizzled signalling orients the spindle along the antero-posterior axis but also tilts it along the apico-basal axis. Thus, Frizzled and heterotrimeric G-protein signalling act in opposition to ensure that the spindle aligns both in the plane of the epithelium and along the tissue polarity axis.	Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	David, NB (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris, France.	nicolas.david@curie.fr; yohanns.bellaiche@curie.fr	David, Nicolas/A-1699-2008	David, Nicolas/0000-0003-1166-6732; Manil-Segalen, Marion/0000-0002-3922-3194; bellaiche, yohanns/0000-0003-1686-2943				Adams RJ, 1996, J NEUROSCI, V16, P7610; Adler PN, 2001, CURR BIOL, V11, pR233, DOI 10.1016/S0960-9822(01)00113-0; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fichelson P, 2003, DEVELOPMENT, V130, P123, DOI 10.1242/dev.00198; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Roegiers F, 2001, P NATL ACAD SCI USA, V98, P14469, DOI 10.1073/pnas.261555598; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Sausedo RA, 1997, J COMP NEUROL, V381, P473; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505	35	99	101	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1083	1090		10.1038/ncb1319	http://dx.doi.org/10.1038/ncb1319			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16228010	Green Submitted			2022-12-27	WOS:000232930400011
J	Schirenbeck, A; Bretschneider, T; Arasada, R; Schleicher, M; Faix, J				Schirenbeck, A; Bretschneider, T; Arasada, R; Schleicher, M; Faix, J			The Diaphanous-related formin dDia2 is required for the formation and maintenance of filopodia	NATURE CELL BIOLOGY			English	Article							DICTYOSTELIUM-DISCOIDEUM; CAPPING PROTEIN; ACTIN-BINDING; CELL MOTILITY; CLEAVAGE FURROW; CYTOKINESIS; DOMAIN; PROFILIN; FAMILY; YEAST	Formins have important roles in the nucleation of actin and the formation of linear actin filaments, but their role in filopodium formation has remained elusive. Dictyostelium discoideum Diaphanous-related formin dDia2 is enriched at the tips of filopodia and interacts with profilin II and Rac1. An FH1FH2 fragment of dDia2 nucleated actin polymerization and removed capping protein from capped filament ends. Genetic studies showed that dDia2 is important for cell migration as well as the formation, elongation and maintenance of filopodia. Here we provide evidence that dDia2 specifically controls filopodial dynamics by regulating actin turnover at the barbed ends of actin filaments.	Univ Munich, A Butenandt Inst Zellbiol, D-80336 Munich, Germany; Max Planck Inst Biochem, AG Zelldynamik, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Faix, J (corresponding author), Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany.	faix@bpc.mh-hannover.de	Bretschneider, Till/D-4667-2011	Bretschneider, Till/0000-0002-5317-603X				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dumontier M, 2000, J CELL SCI, V113, P2253; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Faix J, 1996, FEBS LETT, V394, P251, DOI 10.1016/0014-5793(96)00963-5; Faix J, 1998, J CELL SCI, V111, P3059; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; HARTMANN H, 1989, J BIOL CHEM, V264, P12639; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	35	195	201	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					619	U24		10.1038/ncb1266	http://dx.doi.org/10.1038/ncb1266			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15908944				2022-12-27	WOS:000229562100016
J	Tseng, YH; Butte, AJ; Kokkotou, E; Yechoor, VK; Taniguchi, CM; Kriauciunas, KM; Cypess, AM; Niinobe, M; Yoshikawa, K; Patti, ME; Kahn, CR				Tseng, YH; Butte, AJ; Kokkotou, E; Yechoor, VK; Taniguchi, CM; Kriauciunas, KM; Cypess, AM; Niinobe, M; Yoshikawa, K; Patti, ME; Kahn, CR			Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin	NATURE CELL BIOLOGY			English	Article							PRADER-WILLI-SYNDROME; ADIPOCYTE DIFFERENTIATION; MATRIX METALLOPROTEINASES; ADIPOSE-TISSUE; ADIPOGENESIS; ACTIVATION; INHIBITION; PROTEIN; RESISTANCE; INTERACTS	The insulin/IGF-1 (insulin-like growth factor 1) signalling pathway promotes adipocyte differentiation via complex signalling networks. Here, using microarray analysis of brown preadipocytes that are derived from wild-type and insulin receptor substrate (Irs) knockout animals that exhibit progressively impaired differentiation, we define 374 genes/expressed-sequence tags whose expression in preadipocytes correlates with the ultimate ability of the cells to differentiate. Many of these genes, including preadipocyte factor-1 (Pref-1) and multiple members of the Wnt signalling pathway, are related to early adipogenic events. Necdin is also markedly increased in Irs knockout cells that cannot differentiate, and knockdown of necdin restores brown adipogenesis with downregulation of Pref-1 and Wnt10a expression. Insulin receptor substrate proteins regulate a necdin-E2F4 interaction that represses peroxisome-proliferator-activated receptor gamma (PPAR gamma) transcription via a cyclic AMP response element binding protein (CREB)-dependent pathway. Together these define a key signalling network that is involved in brown preadipocyte determination.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Informat Program, Childrens Hosp, Boston, MA 02215 USA; Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Suita, Osaka 5650871, Japan	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Harvard Medical School; Osaka University	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Yechoor, Vijay/AAX-3244-2021; Tseng, Yu-Hua/AAE-6471-2021; Kahn, Ronald/AAY-2435-2021	Tseng, Yu-Hua/0000-0003-2053-9559; Kahn, Ronald/0000-0002-7583-9228; Taniguchi, Cullen/0000-0002-8052-3316	NIDDK NIH HHS [DK63696, DK07260, DK101183, DK33201, R01 DK033201, DK60837, P30 DK036836] Funding Source: Medline; NLM NIH HHS [K22 LM008261-01A1, K22 LM008261] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033201, R01DK060837, F32DK101183, P30DK036836, T32DK007260] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008261] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; BARTHOLOMEW DJ, 1959, BIOMETRIKA, V46, P36; Boeuf S, 2001, PHYSIOL GENOMICS, V7, P15, DOI 10.1152/physiolgenomics.00048.2001; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Landsberg RL, 2003, P NATL ACAD SCI USA, V100, P2456, DOI 10.1073/pnas.0138064100; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Martelli F, 1999, P NATL ACAD SCI USA, V96, P2858, DOI 10.1073/pnas.96.6.2858; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Pan W., 2002, GENOME BIOL, V3; Press W., 1992, NUMERICAL RECIPES, V2nd; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schiller PC, 2001, J BIOL CHEM, V276, P14133, DOI 10.1074/jbc.M011055200; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WEINER FR, 1989, BIOCHEMISTRY-US, V28, P4094, DOI 10.1021/bi00435a070; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yi TG, 2001, EXP MOL MED, V33, P269, DOI 10.1038/emm.2001.44	50	172	182	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					601	U22		10.1038/ncb1259	http://dx.doi.org/10.1038/ncb1259			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15895078				2022-12-27	WOS:000229562100014
J	Dubois, T; Paleotti, O; Mironov, AA; Fraisier, V; Stradal, TEB; De Matteis, MA; Franco, M; Chavrier, P				Dubois, T; Paleotti, O; Mironov, AA; Fraisier, V; Stradal, TEB; De Matteis, MA; Franco, M; Chavrier, P			Golgi-localized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; BREFELDIN-A; PROTEINS; RHO; TRANSPORT; CYTOSKELETON; RECRUITMENT; RESIDUES; GTPASES	The small GTP-binding ADP-ribosylation factor 1 (ARF1) acts as a master regulator of Golgi structure and function through the recruitment and activation of various downstream effectors. It has been proposed that members of the Rho family of small GTPases also control Golgi function in coordination with ARF1, possibly through the regulation of Arp2/3 complex and actin polymerization on Golgi membranes. Here, we identify ARHGAP10 - a novel Rho GTPase-activating protein (Rho-GAP) that is recruited to Golgi membranes through binding to GTP-ARF1. We show that ARHGAP10 functions preferentially as a GAP for Cdc42 and regulates the Arp2/3 complex and F-actin dynamics at the Golgi through the control of Cdc42 activity. Our results establish a role for ARHGAP10 in Golgi structure and function at the crossroads between ARF1 and Cdc42 signalling pathways.	Inst Curie, CNRS, UMR144, Membrane & Cytoskeleton Dynam Grp, F-75248 Paris, France; CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, CH, Italy; Inst Curie, CNRS, UMR144, F-75248 Paris, France; German Res Ctr Biotechnol GBF, Dept Cell Biol, D-38124 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Helmholtz Association; Helmholtz-Center for Infection Research	Chavrier, P (corresponding author), Inst Curie, CNRS, UMR144, Membrane & Cytoskeleton Dynam Grp, F-75248 Paris, France.	philippe.chavrier@curie.fr	De Matteis, Maria Antonietta/AHE-5161-2022; CHAVRIER, Philippe/AAG-2645-2020; CHAVRIER, Philippe/B-4707-2010; FRANCO, michel/AAA-9735-2021; Franco, Michel/ABH-4993-2020; Dubois, Thierry/D-2852-2017	De Matteis, Maria Antonietta/0000-0003-0053-3061; CHAVRIER, Philippe/0000-0002-7351-733X; CHAVRIER, Philippe/0000-0002-7351-733X; Franco, Michel/0000-0003-1853-8661; Stradal, Theresia/0000-0002-0352-9474; Mironov, Aleksandr/0000-0002-1497-328X; Dubois, Thierry/0000-0003-4739-6164	Telethon [GP0203Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Basseres DS, 2002, BIOCHEM BIOPH RES CO, V294, P579; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Camera P, 2003, NAT CELL BIOL, V5, P1071, DOI 10.1038/ncb1064; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chen JL, 2004, FEBS LETT, V566, P281, DOI 10.1016/j.febslet.2004.04.061; DASCHER C, 1994, J BIOL CHEM, V269, P1437; De Matteis MA, 2000, J CELL SCI, V113, P2331; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; Kikuno R, 2004, NUCLEIC ACIDS RES, V32, pD502, DOI 10.1093/nar/gkh035; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Niebuhr K, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P398; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Schafer DA, 2000, TRAFFIC, V1, P892; Sibarita JB, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P769; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	33	135	139	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					353	U9		10.1038/ncb1244	http://dx.doi.org/10.1038/ncb1244			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793564				2022-12-27	WOS:000228075500011
J	Belyantseva, IA; Boger, ET; Naz, S; Frolenkov, GI; Sellers, JR; Ahmed, ZM; Griffith, AJ; Friedman, TB				Belyantseva, IA; Boger, ET; Naz, S; Frolenkov, GI; Sellers, JR; Ahmed, ZM; Griffith, AJ; Friedman, TB			Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; UNCONVENTIONAL MYOSIN; MOLECULAR TREADMILL; DEAFNESS DFNB3; BIRD COCHLEA; BUNDLES; MOUSE; ORGANIZATION; CYTOSKELETON; MICROVILLI	Stereocilia are microvilli-derived mechanosensory organelles that are arranged in rows of graded heights on the apical surface of inner-ear hair cells(1). The 'staircase'-like architecture of stereocilia bundles is necessary to detect sound and head movement, and is achieved through differential elongation of the actin core of each stereocilium to a predetermined length(2,3). Abnormally short stereocilia bundles that have a diminished staircase are characteristic of the shaker 2 (Myo15a(sh2)) and whirler (Whrn(wi)) strains of deaf mice(4-6). We show that myosin-XVa is a motor protein that, in vivo, interacts with the third PDZ domain of whirlin through its carboxy-terminal PDZ-ligand. Myosin-XVa then delivers whirlin to the tips of stereocilia. Moreover, if green fluorescent protein (GFP)-Myo15a is transfected into hair cells of Myo15a(sh2) mice, the wild-type pattern of hair bundles is restored by recruitment of endogenous whirlin to the tips of stereocilia. The interaction of myosin-XVa and whirlin is therefore a key event in hair-bundle morphogenesis.	Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, NIH, Rockville, MD 20850 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, NIH, Rockville, MD 20850 USA; NHLBI, Lab Mol Physiol, Bethesda, MD 20890 USA; Natl Inst Deafness & Other Commun Disorders, Hearing Sect, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, NIH, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Naz, Sadaf/C-3911-2019	Naz, Sadaf/0000-0002-1912-0235; Frolenkov, Gregory/0000-0002-9810-5024	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, Z01HL004232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000048, ZIADC000060, ZIADC000039, Z01DC000039, Z01DC000048, Z01DC000060] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anderson DW, 2000, HUM MOL GENET, V9, P1729, DOI 10.1093/hmg/9.12.1729; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; DeRosier DJ, 2000, J CELL BIOL, V148, P1; EDDS KT, 1977, J CELL BIOL, V73, P479, DOI 10.1083/jcb.73.2.479; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holme RH, 2002, J COMP NEUROL, V450, P94, DOI 10.1002/cne.10301; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Kambara T, 1999, J BIOL CHEM, V274, P16400, DOI 10.1074/jbc.274.23.16400; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; SELVE N, 1986, J MOL BIOL, V187, P627, DOI 10.1016/0022-2836(86)90341-4; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; TILNEY LG, 1981, J CELL BIOL, V90, P485, DOI 10.1083/jcb.90.2.485; TILNEY LG, 1986, HEARING RES, V22, P55, DOI 10.1016/0378-5955(86)90077-8; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3	30	250	262	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2005	7	2					148	U60		10.1038/ncb1219	http://dx.doi.org/10.1038/ncb1219			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	893LC	15654330				2022-12-27	WOS:000226719500011
J	Bruzzone, R; Cohen-Salmon, M				Bruzzone, R; Cohen-Salmon, M			Hearing the messenger: Ins(1,4,5)P-3 and deafness	NATURE CELL BIOLOGY			English	Editorial Material							GAP-JUNCTION CHANNELS; CONNEXIN CHANNELS; HELA-CELLS; INNER-EAR; PERMEABILITY	Genetic studies have conclusively linked connexin channels to human diseases, but the nature of the signals that are disrupted by channel mutations has remained elusive. A recent study has taken advantage of a deafness-causing mutation to suggest that permeability to inositol trisphosphate, the Ca2+-mobilizing messenger, is crucial for normal hearing.	Inst Pasteur, Dept Neurosci, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bruzzone, R (corresponding author), Inst Pasteur, Dept Neurosci, F-75015 Paris, France.	bruzzone@pasteur.fr	Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Cohen-Salmon, Martine/0000-0002-5312-8476				Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Niessen H, 2000, J CELL SCI, V113, P1365; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Valiunas V, 1999, J PHYSIOL-LONDON, V519, P631, DOI 10.1111/j.1469-7793.1999.0631n.x	15	10	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					14	16		10.1038/ncb0105-14	http://dx.doi.org/10.1038/ncb0105-14			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632945				2022-12-27	WOS:000226113500008
J	Zhang, XD; Matunis, MJ				Zhang, XD; Matunis, MJ			Ub in charge: Regulating E2 enzyme nuclear import	NATURE CELL BIOLOGY			English	Editorial Material							LOCALIZATION SIGNALS; BINDING PROTEINS; CELL-CYCLE; RNA	The activation and targeted localization of ubiquitin E2 conjugating enzymes could provide a point for regulating ubiquitin-dependent cell functions. Supporting this view, the ubiquitin charging and activation of a class of E2 enzymes has been directly linked to their nuclear import.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, XD (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	matunis@jhsph.edu		Zhang, Xiang-Dong/0000-0001-5097-3191; Matunis, Michael/0000-0002-9350-6611	NIGMS NIH HHS [R01 GM060980, R01 GM060980-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Stephen AG, 1996, J BIOL CHEM, V271, P15608, DOI 10.1074/jbc.271.26.15608; Stephen AG, 1997, J BIOL CHEM, V272, P10895; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	11	10	12	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2005	7	1					12	14		10.1038/ncb0105-12	http://dx.doi.org/10.1038/ncb0105-12			4	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	884UZ	15632944				2022-12-27	WOS:000226113500007
J	Cox, LJ; Hengst, U; Gurskaya, NG; Lukyanov, KA; Jaffrey, SR				Cox, Llewellyn J.; Hengst, Ulrich; Gurskaya, Nadya G.; Lukyanov, Konstantin A.; Jaffrey, Samie R.			Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival	NATURE CELL BIOLOGY			English	Article							NERVE GROWTH-FACTOR; ACTIN MESSENGER-RNA; SYMPATHETIC NEURONS; PROTEIN-SYNTHESIS; SENSORY NEURONS; TRANSPORT; RECEPTOR; EXPRESSION; LOCALIZATION; APOPTOSIS	During development of the nervous system, axons and growth cones contain mRNAs such as beta-actin, cofilin and RhoA, which are locally translated in response to guidance cues. Intra-axonal translation of these mRNAs results in local morphological responses; however, other functions of intra-axonal mRNA translation remain unknown. Here, we show that axons of developing mammalian neurons contain mRNA encoding the cAMP-responsive element (CRE)-binding protein ( CREB). CREB is translated within axons in response to nerve growth factor (NGF) and is retrogradely trafficked to the cell body. In neurons that are selectively deficient in axonal CREB transcripts, increases in nuclear pCREB, CRE-mediated transcription and neuronal survival elicited by axonal application of NGF are abolished, indicating a signalling function for axonally synthesized CREB. These studies identify a signalling role for axonally derived CREB, and indicate that signal-dependent synthesis and retrograde trafficking of transcription factors enables specific transcriptional responses to signalling events at distal axons.	[Cox, Llewellyn J.; Hengst, Ulrich; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Gurskaya, Nadya G.; Lukyanov, Konstantin A.] Russian Acad Sci, Inst Bioorgan Chem, Moscow 117997, Russia	Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	srj2003@med.cornell.edu	Lukyanov, Konstantin A/D-4030-2013; Gurskaya, Nadya G/Q-1750-2016; Hengst, Ulrich/L-1413-2014	Lukyanov, Konstantin A/0000-0001-9845-2088; Gurskaya, Nadya G/0000-0002-8028-8176; Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958	NIMH NIH HHS [R01 MH080420-01, R01 MH080420] Funding Source: Medline; NINDS NIH HHS [R01 NS056306, R01 NS056306-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BRIMIJOIN S, 1976, BRAIN RES, V102, P217, DOI 10.1016/0006-8993(76)90878-7; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Crino P, 1998, P NATL ACAD SCI USA, V95, P2313, DOI 10.1073/pnas.95.5.2313; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jeromin A, 2003, J NEUROPHYSIOL, V90, P2741, DOI 10.1152/jn.00464.2003; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; MARTENSON CH, 1995, TOXICOL APPL PHARM, V133, P73, DOI 10.1006/taap.1995.1128; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tong JX, 1997, J NEUROCYTOL, V26, P771, DOI 10.1023/A:1018566431912; Ure DR, 1997, J NEUROSCI, V17, P1282; WAEBER G, 1991, MOL ENDOCRINOL, V5, P1418, DOI 10.1210/mend-5-10-1418; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	49	214	218	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					149	U30		10.1038/ncb1677	http://dx.doi.org/10.1038/ncb1677			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193038	Green Accepted			2022-12-27	WOS:000252897800010
J	Guillaud, L; Wong, R; Hirokawa, N				Guillaud, Laurent; Wong, Richard; Hirokawa, Nobutaka			Disruption of KIF17-Mint1 interaction by CaMKII-dependent phosphorylation: a molecular model of kinesin-cargo release	NATURE CELL BIOLOGY			English	Article							MOTOR PROTEIN KIF17; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; AXONAL-TRANSPORT; LIGHT-CHAINS; MYOSIN-V; TRAFFICKING; SUPERFAMILY; SPECIFICITY; MECHANISMS	Establishment and maintenance of cell structures and functions are highly dependent on the efficient regulation of intracellular transport in which proteins of the kinesin superfamily ( KIFs) are very important. In this regard, how KIFs regulate the release of their cargo is a critical process that remains to be elucidated. To address this specific question, we have investigated the mechanism behind the regulation of the KIF17-Mint1 interaction. Here we report that the tail region of the molecular motor KIF17 is regulated by phosphorylation. Using direct visualization of protein-protein interaction by FRET and various in vitro and in vivo approaches we have demonstrated that CaMKII-dependent phosphorylation of KIF17 on Ser 1029 disrupts the KIF17-Mint1 association and results in the release of the transported cargo from its microtubule-based transport.	[Guillaud, Laurent; Wong, Richard; Hirokawa, Nobutaka] Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Wong, Richard W./E-9155-2011; Guillaud, Laurent/Q-4214-2016	Guillaud, Laurent/0000-0002-9688-0991				ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frank R, 1996, Methods Mol Biol, V66, P149; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Guillaud L, 2003, J NEUROSCI, V23, P131; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mok H, 2002, J NEUROSCI, V22, P5253; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sparks AB, 1998, METH MOL B, V84, P87; SPIEGEL RM, 2000, SCI STKE, V38, pI1; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WASHBOURNE P, 2004, J NEUROSCI, V90, P3950; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099	39	141	144	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					19	U8		10.1038/ncb1665	http://dx.doi.org/10.1038/ncb1665			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18066053				2022-12-27	WOS:000252116100009
J	Kumari, S; Mayor, S				Kumari, Sudha; Mayor, Satyajit			ARF1 is directly involved in dynamin-independent endocytosis	NATURE CELL BIOLOGY			English	Article							ADP-RIBOSYLATION FACTOR-1; GPI-ANCHORED PROTEINS; BREFELDIN-A; GUANINE-NUCLEOTIDE; RECYCLING ENDOSOMES; EXCHANGE FACTOR; GOLGI; CLATHRIN; TRANSPORT; COMPLEX	Endocytosis of glycosylphosphatidyl inositol (GPI)-anchored proteins (GPI-APs) and the fluid phase takes place primarily through a dynamin- and clathrin-independent, Cdc42-regulated pinocytic mechanism. This mechanism is mediated by primary carriers called clathrin-independent carriers (CLICs), which fuse to form tubular early endocytic compartments called GPI-AP enriched endosomal compartments (GEECs). Here, we show that reduction in activity or levels of ARF1 specifically inhibits GPI-AP and fluid-phase endocytosis without affecting other clathrin-dependent or independent endocytic pathways. ARF1 is activated at distinct sites on the plasma membrane, and by the recruitment of RhoGAP domain-containing protein, ARHGAP10, to the plasma membrane, modulates cell-surface Cdc42 dynamics. This results in the coupling of ARF1 and Cdc42 activity to regulate endocytosis at the plasma membrane. These findings provide a molecular basis for a crosstalk of endocytosis with secretion by the sharing of a key regulator of secretory traffic, ARF1.	[Kumari, Sudha; Mayor, Satyajit] Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in		Kumari, Sudha/0000-0001-7082-2825				Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Deretic D, 2004, MOL BIOL CELL, V15, P359, DOI 10.1091/mbc.E03-04-0203; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Ellis MA, 2004, J BIOL CHEM, V279, P52735, DOI 10.1074/jbc.M410533200; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Vasudevan C, 1998, J CELL SCI, V111, P1277; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	49	158	159	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2008	10	1					30	U22		10.1038/ncb1666	http://dx.doi.org/10.1038/ncb1666			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	247XO	18084285				2022-12-27	WOS:000252116100010
J	Zhang, X; Zhu, J; Yang, GY; Wang, QJ; Qian, L; Chen, YM; Chen, F; Tao, Y; Hu, HS; Wang, T; Luo, ZG				Zhang, Xian; Zhu, Ji; Yang, Guo-Ying; Wang, Qing-Jie; Qian, Lei; Chen, Yan-Min; Chen, Fei; Tao, Yu; Hu, Han-Song; Wang, Tong; Luo, Zhen-Ge			Dishevelled promotes axon differentiation by regulating atypical protein kinase C	NATURE CELL BIOLOGY			English	Article							HIPPOCAMPAL NEURONAL POLARITY; WNT SIGNALING PATHWAY; CELL-POLARITY; ESTABLISHMENT; GSK-3-BETA; PAR-1; GUIDANCE; ELEGANS; COMPLEX; CDC42	The atypical protein kinase C (aPKC) in complex with PAR3 and PAR6 is required for axon-dendrite differentiation, but the upstream factors responsible for regulating its activity are largely unknown. Here, we report that in cultured hippocampal neurons aPKC is directly regulated by Dishevelled (Dvl), an immediate downstream effector of Wnt. We found that downregulation of Dvl abrogated axon differentiation, whereas Dvl overexpression resulted in multiple axon formation. Interestingly, Dvl was associated with aPKC and this interaction resulted in aPKC stabilization and activation. Furthermore, the multiple axon formation resulting from Dvl overexpression was attenuated by expressing a dominant-negative aPKC in these neurons and overexpression of aPKC prevented the loss of axon caused by Dvl downregulation. Finally, Wnt5a, a noncanonical Wnt, activated aPKC and promoted axon differentiation. The Wnt5a effect on axon differentiation was attenuated by downregulating Dvl or inhibiting aPKC. Thus, Dvl-aPKC interaction can promote axon differentiation mediated by the PAR3-PAR6-aPKC complex.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Qian, Lei/H-1977-2013; CHEN, YANMIN/H-6124-2011; Wang, Tong/AAJ-9949-2020; Qian, Lei/N-1796-2019; Luo, Zhen-Ge/GNM-7635-2022	Qian, Lei/0000-0002-3480-4248; Wang, Tong/0000-0002-3680-8189; Qian, Lei/0000-0002-3480-4248; Luo, Zhen-Ge/0000-0001-5037-0542				Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lucas FR, 1998, J CELL SCI, V111, P1351; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salinas PC, 2003, CURR BIOL, V13, pR60, DOI 10.1016/S0960-9822(02)01429-X; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	43	168	175	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					743	U27		10.1038/ncb1603	http://dx.doi.org/10.1038/ncb1603			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17558396				2022-12-27	WOS:000247760700010
J	Valadi, H; Ekstrom, K; Bossios, A; Sjostrand, M; Lee, JJ; Lotvall, JO				Valadi, Hadi; Ekstrom, Karin; Bossios, Apostolos; Sjostrand, Margareta; Lee, James J.; Lotvall, Jan O.			Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells	NATURE CELL BIOLOGY			English	Article							MAST-CELL; PROTEOMIC ANALYSIS; DENDRITIC CELLS; ANIMAL DEVELOPMENT; MICROVESICLES; VESICLES; ACCUMULATION; ACTIVATION; COMPLEX; SURFACE	Exosomes are vesicles of endocytic origin released by many cells. These vesicles can mediate communication between cells, facilitating processes such as antigen presentation. Here, we show that exosomes from a mouse and a human mast cell line (MC/9 and HMC-1, respectively), as well as primary bone marrow-derived mouse mast cells, contain RNA. Microarray assessments revealed the presence of mRNA from approximately 1300 genes, many of which are not present in the cytoplasm of the donor cell. In vitro translation proved that the exosome mRNAs were functional. Quality control RNA analysis of total RNA derived from exosomes also revealed presence of small RNAs, including microRNAs. The RNA from mast cell exosomes is transferable to other mouse and human mast cells. After transfer of mouse exosomal RNA to human mast cells, new mouse proteins were found in the recipient cells, indicating that transferred exosomal mRNA can be translated after entering another cell. In summary, we show that exosomes contain both mRNA and microRNA, which can be delivered to another cell, and can be functional in this new location. We propose that this RNA is called "exosomal shuttle RNA" (esRNA).	Univ Gothenburg, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden; Univ Gothenburg, Dept Resp Med & Allergol, Sahlgrenska Acad, Gothenburg, Sweden; Mayo Clin, Scottsdale, AZ 85259 USA	University of Gothenburg; University of Gothenburg; Mayo Clinic; Mayo Clinic Phoenix	Lotvall, JO (corresponding author), Univ Gothenburg, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden.	jan.lotvall@gu.se	Bossios, Apostolos/A-1720-2008; Ekström, Karin/M-7501-2013; Valadi, Hadi/ABH-9766-2020; Bossios, Apostolos/ABH-8262-2020	Ekström, Karin/0000-0001-7808-4572; Valadi, Hadi/0000-0003-3482-2451; Bossios, Apostolos/0000-0002-0494-2690; Lotvall, Jan/0000-0001-9195-9249				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bess JW, 1997, VIROLOGY, V230, P134, DOI 10.1006/viro.1997.8499; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; RAZIN E, 1984, J IMMUNOL, V132, P1479; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	28	8332	8810	69	1806	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2007	9	6					654	U72		10.1038/ncb1596	http://dx.doi.org/10.1038/ncb1596			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	174DY	17486113				2022-12-27	WOS:000246922700010
J	Lim, CJ; Han, J; Yousefi, N; Ma, YL; Amieux, PS; McKnight, GS; Taylor, SS; Ginsberg, MH				Lim, Chinten James; Han, Jaewon; Yousefi, Nima; Ma, Yuliang; Amieux, Paul S.; McKnight, G. Stanley; Taylor, Susan S.; Ginsberg, Mark H.			alpha 4 integrins are Type I cAMP-dependent protein kinase-anchoring proteins	NATURE CELL BIOLOGY			English	Article							REGULATORY SUBUNIT; RI-ALPHA; ACTIVATION; BINDING; PAXILLIN; PHOSPHORYLATION; CONSEQUENCES; MUTATIONS; STABILITY; COMPLEX	A-kinase anchoring proteins (AKAPs) control the localization and substrate specificity of cAMP-dependent protein kinase (PKA), tetramers of regulatory (PKA-R) and catalytic (PKA-C) subunits, by binding to PKA-R subunits(1). Most mammalian AKAPs bind Type II PKA through PKA-RII (ref. 2), whereas dual specificity AKAPs bind both PKA-RI and PKA-RII (ref. 3). Inhibition of PKA-AKAP interactions modulates PKA signalling(2). Localized PKA activation in pseudopodia of migrating cells(4) phosphorylates alpha 4 integrins to provide spatial cues governing cell motility(5). Here, we report that the alpha 4 cytoplasmic domain is a Type I PKA-specific AKAP that is distinct from canonical AKAPs in two ways: the a4 interaction requires the PKA holoenzyme, and is insensitive to amphipathic peptides that disrupt most PKA-AKAP interactions. We exploited type-specific PKA anchoring peptides to create genetically encoded baits that sequester specific PKA isoforms to the mitochondria and found that mislocalization of Type I, but not Type II, PKA disrupts alpha 4 phosphorylation and markedly inhibits the velocity and directional persistence of cell migration.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Lim, Chinten James/G-3777-2013; Amieux, Paul/AAG-4102-2021	Lim, Chinten James/0000-0001-6381-7585; 				Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Carlson CR, 2003, J MOL BIOL, V327, P609, DOI 10.1016/S0022-2836(03)00093-7; CARR DW, 1991, J BIOL CHEM, V266, P14188; Carrasco YR, 2006, EMBO J, V25, P889, DOI 10.1038/sj.emboj.7600944; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; MANDEVILLE JTH, 1995, BIOPHYS J, V68, P1207, DOI 10.1016/S0006-3495(95)80336-X; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	29	69	70	6	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					415	U96		10.1038/ncb1561	http://dx.doi.org/10.1038/ncb1561			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17369818				2022-12-27	WOS:000245359400012
J	Li, JH; Li, WX				Li, Jinghong; Li, Willis X.			A novel function of Drosophila eIF4A as a negative regulator of Dpp/BMP signalling that mediates SMAD degradation	NATURE CELL BIOLOGY			English	Article							WINGLESS; MUTATION; DOMINANT; HEDGEHOG	Signalling by the TGF-beta superfamily member and BMP orthologue Decapentaplegic (Dpp) is crucial for multiple developmental programmes and has to be tightly regulated. Here, we demonstrate that the Drosophila Dpp pathway is negatively regulated by eukaryotic translation initiation factor 4A (elF4A), which mediates activation-dependent degradation of the Dpp signalling components Mad and Medea. elF4A mutants exhibit increased Dpp signalling and accumulation of Mad and phospho-Mad. Overexpression of elF4A decreases Dpp signalling and causes loss of Mad and phospho-Mad. Furthermore, elF4A physically associates with Mad and Medea, and promotes their degradation following activation of Dpp signalling in a translation-independent manner. Finally, we show that elF4A acts synergistically with, but independently of, the ubiquitin ligase DSmurf, indicating that a dual system controls SMAD degradation. Thus, in addition to being an obligatory component of the cap-dependent translation initiation complex, elF4A has a novel function as a specific inhibitor of Dpp signalling that mediates the degradation of SMAD homologues.	Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis X/AAL-7212-2020; Li, Willis/ABC-5695-2020	Li, Willis X/0000-0001-9041-7341; Li, Willis/0000-0001-9041-7341; Li, Jinghong/0000-0003-2497-9295	NIGMS NIH HHS [R01GM077046, R01 GM077046-04, R01 GM077046, R01 GM065774, R01GM65774, R01 GM065774-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077046, R01GM065774] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Kopp A, 1997, DEVELOPMENT, V124, P3703; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Neumann CJ, 1996, GENETICS, V142, P1147	4	24	26	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1407	U62		10.1038/ncb1506	http://dx.doi.org/10.1038/ncb1506			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17115029	Green Accepted			2022-12-27	WOS:000242419800017
J	Higa, LA; Wu, M; Ye, T; Kobayashi, R; Sun, H; Zhang, H				Higa, Leigh Ann; Wu, Min; Ye, Tao; Kobayashi, Ryuji; Sun, Hong; Zhang, Hui			CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation	NATURE CELL BIOLOGY			English	Article							DNA-BINDING-PROTEIN; WD-REPEAT PROTEINS; MOLECULAR RECOGNITION; H3; COMPLEXES; CDT1; METHYLTRANSFERASE; CHROMATIN; DAMAGE; HETEROCHROMATIN	The CUL4-DDB1-ROC1 ubiquitin E3 ligase regulates cell-cycle progression, replication and DNA damage response(1-4). However, the substrate-specific adaptors of this ligase remain uncharacterized. Here, we show that CUL4-DDB1 complexes interact with multiple WD40-repeat proteins (WDRs) including TLE1-3, WDR5, L2DTL (also known as CDT2) and the Polycomb-group protein EED (also known as ESC). WDR5 and EED are core components of histone methylation complexes that are essential for histone H3 methylation and epigenetic control at K4 or K9 and K27, respectively(5-7), whereas L2DTL regulates CDT1 proteolysis after DNA damage through CUL4-DDB1 (ref. 8). We found that CUL4A-DDB1 interacts with H3 methylated mononucleosomes and peptides. Inactivation of either CUL4 or DDB1 impairs these histone modifications. However, loss of WDR5 specifically affects histone H3 methylation at K4 but not CDT1 degradation, whereas inactivation of L2DTL prevents CDT1 degradation but not histone methylation. Our studies suggest that CUL4-DDB1 ligases use WDR proteins as molecular adaptors for substrate recognition, and modulate multiple biological processes through ubiquitin-dependent proteolysis.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Peking Univ, Lab Chem Genom, Grad Sch, Shenzhen 518055, Peoples R China; Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Yale University; Peking University; Hong Kong Polytechnic University; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	hui.zhang@yale.edu	Wu, Min/AAE-5066-2021; Ye，PhD，FRSC, Tao/ABB-8698-2020	Wu, Min/0000-0003-1372-4764; Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Higa, Leigh Ann/0000-0003-0117-0397	NCI NIH HHS [CA72878, CA98955, CA77695] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098955, R01CA072878, R01CA077695] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	32	329	363	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1277	U48		10.1038/ncb1490	http://dx.doi.org/10.1038/ncb1490			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17041588				2022-12-27	WOS:000241732400017
J	Kersey, P; Apweiler, R				Kersey, Paul; Apweiler, Rolf			Linking publication, gene and protein data	NATURE CELL BIOLOGY			English	Review							SEQUENCE DATABASE; RESOURCE; INFORMATION; GENOMES; SYSTEM; TOOLS; NCBI; SRS		EMBL European Bioinformat Inst, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL)	Kersey, P (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Campus, Cambridge CB10 1SD, England.	pkersey@ebi.ac.uk		Kersey, Paul/0000-0002-7054-800X; Apweiler, Rolf/0000-0001-7078-200X				Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blake JA, 2006, NUCLEIC ACIDS RES, V34, pD562, DOI 10.1093/nar/gkj085; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Cochrane G, 2006, NUCLEIC ACIDS RES, V34, pD10, DOI 10.1093/nar/gkj130; Davidson SB, 2001, IBM SYST J, V40, P512, DOI 10.1147/sj.402.0512; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Etzold T, 1996, METHOD ENZYMOL, V266, P114; Garavelli JS, 2004, PROTEOMICS, V4, P1527, DOI 10.1002/pmic.200300777; Geer Renata C., 2003, Briefings in Bioinformatics, V4, P179, DOI 10.1093/bib/4.2.179; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Jenuth J P, 2000, Methods Mol Biol, V132, P301; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Lopez Rodrigo, 2003, Briefings in Bioinformatics, V4, P332, DOI 10.1093/bib/4.4.332; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; NELSON SJ, 2004, MEDINFO 1, V11, P67; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Okubo K, 2006, NUCLEIC ACIDS RES, V34, pD6, DOI 10.1093/nar/gkj111; Orchard Sandra, 2006, Proteomics, V6, P738, DOI 10.1002/pmic.200500868; Pearson W R, 1994, Methods Mol Biol, V24, P307; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Sequeira E, 2001, NATURE, V410, P740, DOI 10.1038/35071270; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stevens RD, 2003, BIOINFORMATICS, V19, pi302, DOI 10.1093/bioinformatics/btg1041; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zdobnov EM, 2002, BIOINFORMATICS, V18, P1149, DOI 10.1093/bioinformatics/18.8.1149	44	24	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2006	8	11					1183	U10		10.1038/ncb1495	http://dx.doi.org/10.1038/ncb1495			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101HR	17060904				2022-12-27	WOS:000241732400002
J	Kawauchi, T; Chihama, K; Nabeshima, Y; Hoshino, M				Kawauchi, T; Chihama, K; Nabeshima, Y; Hoshino, M			Cdk5 phosphorylates and stabilizes p27(kip1) contributing to actin organization and cortical neuronal migration	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; CELL-MIGRATION; MICE LACKING; CEREBRAL-CORTEX; NERVOUS-SYSTEM; NUCLEAR EXPORT; P27; GROWTH; MOUSE; EXPRESSION	p(27kip1), a cyclin- dependent kinase ( CDK) inhibitor ( CKI), generally suppresses CDK activity in proliferating cells. Although another role of p27 in cell migration has been recently suggested in vitro, the physiological importance of p27 in cell migration remains elusive, as p27- deficient mice have not shown any obvious migration- defect- related phenotypes. Here, we show that Cdk5, an unconventional neuronal CDK, phosphorylates and stabilizes p27 as an upstream regulator, maintaining the amount of p27 in post- mitotic neurons. In vivo RNA interference ( RNAi) experiments showed that reduced amounts of p27 caused inhibition of cortical neuronal migration and decreased the amount of F- actin in the processes of migrating neurons. The Cdk5 p27 pathway activates an actin- binding protein, cofilin, which is also shown to be involved in cortical neuronal migration in vivo. Our findings shed light on a previously unknown new relationship between CDK and CKI in GO- arrested cells that regulates cytoskeletal reorganization and neuronal migration during corticogenesis.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Hoshino, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan.	mikio@lmls.med.kyoto-u.ac.jp	Kawauchi, Takeshi/L-4770-2013	Kawauchi, Takeshi/0000-0002-8650-4474				Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Corbo JC, 2002, J NEUROSCI, V22, P7548; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Goto T, 2004, DEV NEUROSCI-BASEL, V26, P208, DOI 10.1159/000082138; Gotz M, 2003, NAT NEUROSCI, V6, P1245, DOI 10.1038/nn1203-1245; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Izawa I, 1998, ONCOGENE, V17, P2863, DOI 10.1038/sj.onc.1202213; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Morisaki H, 1997, BIOCHEM BIOPH RES CO, V240, P386, DOI 10.1006/bbrc.1997.7590; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tabata H, 2003, J NEUROSCI, V23, P9996; Tarui T, 2005, CEREB CORTEX, V15, P1343, DOI 10.1093/cercor/bhi017; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	49	221	229	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2006	8	1					17	U6		10.1038/ncb1338	http://dx.doi.org/10.1038/ncb1338			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	002ZN	16341208				2022-12-27	WOS:000234651500008
J	Mukherjee, A; Veraksa, A; Bauer, A; Rosse, C; Camonis, J; Artavanis-Tsakonas, S				Mukherjee, A; Veraksa, A; Bauer, A; Rosse, C; Camonis, J; Artavanis-Tsakonas, S			Regulation of notch signalling by non-visual beta-arrestin	NATURE CELL BIOLOGY			English	Article							FACTOR-I RECEPTOR; DROSOPHILA-MELANOGASTER; ANKYRIN REPEATS; DOWN-REGULATION; PROTEIN; DELTEX; PATHWAY; ENDOCYTOSIS; BETA-ARRESTIN-2; UBIQUITINATION	Signalling activity of the Notch receptor, which plays a fundamental role in metazoan cell fate determination, is controlled at multiple levels. We uncovered a Notch signal-controlling mechanism that depends on the ability of the non-visual P-arrestin, Kurtz (Krz), to influence the degradation and, consequently, the function of the Notch receptor. We identified Krz as a binding partner of a known Notch-pathway modulator, Deltex (Dx), and demonstrated the existence of a trimeric Notch-Dx-Krz protein complex. This complex mediates the degradation of the Notch receptor through a ubiquitination-dependent pathway. Our results establish a novel mode of regulation of Notch signalling and define a new function for non-visual beta-arrestins.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA; Inst Curie, F-75248 Paris, France; Cellzome AG, D-69117 Heidelberg, Germany; Coll France, F-75231 Paris, France	Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; GlaxoSmithKline; Cellzome GmbH; UDICE-French Research Universities; PSL Research University Paris; College de France	Artavanis-Tsakonas, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA.	tsakonas@helix.mgh.harvard.edu	Rosse, Carine/L-4775-2017	Veraksa, Alexey/0000-0003-2920-080X	NCI NIH HHS [CA098402] Funding Source: Medline; NIGMS NIH HHS [GM62931] Funding Source: Medline; NINDS NIH HHS [NS26084] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026084, R37NS026084] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BUSSEAU I, 1994, GENETICS, V136, P585; Chen B, 2003, ATHEROSCLEROSIS SUPP, V4, P301, DOI 10.1016/S1567-5688(03)91288-8; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cornell M, 1999, GENETICS, V152, P567; deCelis JF, 1996, DEVELOPMENT, V122, P359; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Luttrell LM, 2002, J CELL SCI, V115, P455; Matsuno K, 2002, DEVELOPMENT, V129, P1049; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; RAMOS RGP, 1989, GENETICS, V123, P337; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Roman G, 2000, GENETICS, V155, P1281; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu JH, 2003, J BIOL CHEM, V278, P44238, DOI 10.1074/jbc.M309450200; XU T, 1993, DEVELOPMENT, V117, P1223; XU T, 1990, GENETICS, V126, P665; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200	50	166	169	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2005	7	12					1191	1201		10.1038/ncb1327	http://dx.doi.org/10.1038/ncb1327			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	990MW	16284625				2022-12-27	WOS:000233748900012
J	Ishitani, T; Matsumoto, K; Chitnis, AB; Itoh, M				Ishitani, T; Matsumoto, K; Chitnis, AB; Itoh, M			Nrarp functions to modulate neural-crest-cell differentiation by regulating LEF1 protein stability	NATURE CELL BIOLOGY			English	Article							ANKYRIN-REPEAT PROTEIN; SIGNALING PATHWAY; ZEBRAFISH; EXPRESSION; HOMOLOG; FATE; DOMAIN; NOTCH1; DELTA	Nrarp (Notch-regulated ankyrin repeat protein) is a small protein that has two ankyrin repeats(1-5). Although Nrarp is known to be an inhibitory component of the Notch signalling pathway that operates in different developmental processes(1,2,4,5), the in vivo roles of Nrarp have not been fully characterized. Here, we show that Nrarp is a positive regulator in the Wnt signalling pathway. In zebrafish, knockdown of Nrarp-a expression by an antisense morpholino oligonucleotide (MO) results in altered Wnt-signalling-dependent neural-crest-cell development. Nrarp stabilizes LEF1 protein, a pivotal transcription factor in the Wnt signalling cascade, by blocking LEF1 ubiquitination. In accordance with this, the knockdown phenotype of lef1 is similar to that of nrarp-a, at least in part, in its effect on the development of multiple tissues in zebrafish. Furthermore, activation of LEF1 does not affect Notch activity or vice versa. These findings reveal that Nrarp independently regulates canonical Wnt and Notch signalling by modulating LEF1 and Notch protein turnover, respectively.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Lab Cell Regulat,Unit Nervous Syst Dev, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Lab Cell Regulat,Grp Signal Transduct,Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; NICHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Itoh, M (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Lab Cell Regulat,Unit Nervous Syst Dev, Nagoya, Aichi 4648602, Japan.	mito@bunshi3.bio.nagoya-u.ac.jp	, Tohru/AAH-8979-2020; Ishitani, Tohru/E-9781-2014	, Tohru/0000-0002-6200-7043; 				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dorsky RI, 2000, GENE DEV, V14, P158; Dorsky RI, 1999, MECH DEVELOP, V86, P147, DOI 10.1016/S0925-4773(99)00101-X; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Holley SA, 2000, GENE DEV, V14, P1678; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kato H, 1997, DEVELOPMENT, V124, P4133; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; MOURY JD, 1990, DEV BIOL, V141, P243, DOI 10.1016/0012-1606(90)90380-2; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Takke C, 1999, DEVELOPMENT, V126, P1811; Topczewska JM, 2003, GENE EXPR PATTERNS, V3, P169, DOI 10.1016/S1567-133X(03)00009-7; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834	26	63	68	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1106	1112		10.1038/ncb1311	http://dx.doi.org/10.1038/ncb1311			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16228014				2022-12-27	WOS:000232930400014
J	Liu, JD; Valencia-Sanchez, MA; Hannon, GJ; Parker, R				Liu, JD; Valencia-Sanchez, MA; Hannon, GJ; Parker, R			MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies	NATURE CELL BIOLOGY			English	Letter							C-ELEGANS; PROCESSING BODIES; CYTOPLASMIC FOCI; INTERFERENCE; DECAY; PROTEINS; ARABIDOPSIS; COMPLEX; LIN-14; CELLS	Small RNAs, including small interfering RNAs ( siRNAs) and microRNAs ( miRNAs) can silence target genes through several different effector mechanisms(1). Whereas siRNA- directed mRNA cleavage is increasingly understood, the mechanisms by which miRNAs repress protein synthesis are obscure. Recent studies have revealed the existence of specific cytoplasmic foci, referred to herein as processing bodies ( P- bodies), which contain untranslated mRNAs and can serve as sites of mRNA degradation(2-7). Here we demonstrate that Argonaute proteins - the signature components of the RNA interference ( RNAi) effector complex, RISC - localize to mammalian P- bodies. Moreover, reporter mRNAs that are targeted for translational repression by endogenous or exogenous miRNAs become concentrated in P- bodies in a miRNA- dependent manner. These results provide a link between miRNA function and mammalian P- bodies and suggest that translation repression by RISC delivers mRNAs to P- bodies, either as a cause or as a consequence of inhibiting protein synthesis.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Cold Spring Harbor Laboratory; University of Arizona; Howard Hughes Medical Institute; University of Arizona	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.org; rrparker@u.arizona.edu	Hannon, Gregory/AAB-3568-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM045443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Newbury S, 2004, RNA, V10, P59, DOI 10.1261/rna.2195504; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; SEN GL, NATURE CELL BIOL, V7, P633; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	30	898	961	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2005	7	7					719	U118		10.1038/ncb1274	http://dx.doi.org/10.1038/ncb1274			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	941BX	15937477	Green Accepted			2022-12-27	WOS:000230190800017
J	Wulf, G; Finn, G; Suizu, F; Lu, KP				Wulf, G; Finn, G; Suizu, F; Lu, KP			Phosphorylation-specific prolyl isomerization: is there an underlying theme?	NATURE CELL BIOLOGY			English	Editorial Material							PROLINE-DIRECTED PHOSPHORYLATION; NF-KAPPA-B; ISOMERASE PIN1; STRUCTURAL BASIS; BETA-CATENIN; TERMINAL DOMAIN; BREAST-CANCER; SUBSTRATE; PHOSPHOSERINE; PROTEIN	The prolyl isomerase Pin1 is a conserved enzyme that is intimately involved in diverse biological processes and pathological conditions such as cancer and Alzheimer's disease. By catalysing cis-trans interconversion of certain motifs containing phosphorylated serine or threonine residues followed by a proline residue (pSer/Thr-Pro), Pin1 can have profound effects on phosphorylation signalling. The structural and functional differences that result from cis-trans isomerization of specific pSer/Thr-Pro motifs probably underlie most, if not all, Pin1-dependent actions. Phosphorylation-dependent prolyl isomerization by Pin1 remains a unique mode for the modulation of signal transduction. Here, we provide an overview of the plethora of regulatory events that involve this unique enzyme, with a particular focus on oncogenic signalling and neurodegeneration.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wulf, G (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, 77 Ave Louis Pasteur,NRB 1030, Boston, MA 02115 USA.	gwulf@bidmc.harvard.edu	Suizu, Futoshi/G-3530-2019; Wulf, Gerburg/AAS-6713-2021	Suizu, Futoshi/0000-0003-0206-4289; 	NATIONAL CANCER INSTITUTE [K08CA093655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056230, R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022082, R01AG017870] Funding Source: NIH RePORTER; NCI NIH HHS [CA093655] Funding Source: Medline; NIA NIH HHS [AG22082, AG17870] Funding Source: Medline; NIGMS NIH HHS [GM58556, GM56230] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Thorpe JR, 2004, NEUROBIOL DIS, V17, P237, DOI 10.1016/j.nbd.2004.07.008; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Weiwad M, 2000, FEBS LETT, V478, P39, DOI 10.1016/S0014-5793(00)01794-4; Wilcox CB, 2004, GENETICS, V167, P93, DOI 10.1534/genetics.167.1.93; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012	60	216	226	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					435	441		10.1038/ncb0505-435	http://dx.doi.org/10.1038/ncb0505-435			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15867923				2022-12-27	WOS:000229123500003
J	Bostrom, P; Andersson, L; Rutberg, M; Perman, J; Lidberg, U; Johansson, BR; Fernandez-Rodriguez, J; Ericson, J; Nilsson, T; Boren, J; Olofsson, SO				Bostrom, Pontus; Andersson, Linda; Rutberg, Mikael; Perman, Jeanna; Lidberg, Ulf; Johansson, Bengt R.; Fernandez-Rodriguez, Julia; Ericson, Johanna; Nilsson, Tommy; Boren, Jan; Olofsson, Sven-Olof			SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity	NATURE CELL BIOLOGY			English	Article							MEMBRANE-FUSION; CELL-LINE; MECHANISMS; TRANSPORT; HL-1; PLD1	The accumulation of cytosolic lipid droplets in muscle and liver cells has been linked to the development of insulin resistance and type 2 diabetes(1). such droplets are formed as small structures(2) that increase in size through fusion(3), a process that is dependent on intact microtubules and the motor protein dynein(3,4). Approximately 15% of all droplets are involved in fusion processes at a given time(3). Here, we show that lipid droplets are associated with proteins involved in fusion processes in the cell: NSF (N-ethylmaleimide-sensitive-factor), alpha-SNAP ( soluble NSF attachment protein) and the SNAREs (SNAP receptors), SNAP23 (synaptosomal-associated protein of 23 kDa), syntaxin-5 and VAMP4 ( vesicle-associated membrane protein 4). Knockdown of the genes for SNAP23, syntaxin-5 or VAMP4, or microinjection of a dominant-negative mutant of alpha-SNAP, decreases the rate of fusion and the size of the lipid droplets. thus, the SNARE system seems to have an important role in lipid droplet fusion. We also show that oleic acid treatment decreases the insulin sensitivity of heart muscle cells, and this sensitivity is completely restored by transfection with SNAP23. thus, SNAP23 might be a link between insulin sensitivity and the inflow of fatty acids to the cell.	Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, SE-41345 Gothenburg, Sweden; Univ Gothenburg, Dept Biomed, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Olofsson, SO (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, SE-41345 Gothenburg, Sweden.	Sven-Olof.Olofsson@wlab.gu.se	Adiels, Martin/C-9278-2011	Fernandez-Rodriguez, Julia/0000-0003-4522-0966; Andersson, Linda/0000-0003-3230-5397				Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Asp L, 2005, ARTERIOSCL THROM VAS, V25, P566, DOI 10.1161/01.ATV.0000154135.21689.47; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; FOSTER J, 1999, AM J PHYSIOL, V276, pC1108; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang XH, 2001, PANCREAS, V23, P125, DOI 10.1097/00006676-200108000-00002; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Short B, 2004, CURR BIOL, V14, pR187, DOI 10.1016/j.cub.2004.02.017; Shuralyova I, 2004, AM J PHYSIOL-HEART C, V286, pH627, DOI 10.1152/ajpheart.00639.2003; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y	30	263	264	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2007	9	11					1286	U139		10.1038/ncb1648	http://dx.doi.org/10.1038/ncb1648			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	227MA	17922004				2022-12-27	WOS:000250659600014
J	Reis, A; Madgwick, S; Chang, HY; Nabti, I; Levasseur, M; Jones, KT				Reis, Alexandra; Madgwick, Suzanne; Chang, Heng-Yu; Nabti, Ibtissem; Levasseur, Mark; Jones, Keith T.			Prometaphase APC(cdh1) activity prevents non-disjunction in mammalian oocytes	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; 1ST MEIOTIC DIVISION; METAPHASE-I ARREST; MOUSE OOCYTES; MEIOSIS-I; SPINDLE CHECKPOINT; XENOPUS-OOCYTES; CYCLIN-B; DEGRADATION; SECURIN	The first female meiotic division ( meiosis I, MI) is uniquely prone to chromosome segregation errors through nondisjunction, resulting in trisomies and early pregnancy loss(1). Here, we show a fundamental difference in the control of mammalian meiosis that may underlie such susceptibility. It involves a reversal in the well-established timing of activation of the anaphase-promoting complex (APC) (2,3) by its co-activators cdc20 and cdh1. APC(cdh1) was active first, during prometaphase I, and was needed in order to allow homologue congression, as loss of cdh1 speeded up MI, leading to premature chromosome segregation and a non-disjunction phenotype. APCcdh1 targeted cdc20 for degradation, but did not target securin or cyclin B1. These were degraded later in MI through APC(cdc20), making cdc20 re-synthesis essential for successful meiotic progression. The switch from APCcdh1 to APCcdc20 activity was controlled by increasing CDK1 and cdh1 loss. These findings demonstrate a fundamentally different mechanism of control for the first meiotic division in mammalian oocytes that is not observed in meioses of other species.	Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Jones, KT (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	k.t.jones@ncl.ac.uk	Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851	Wellcome Trust [075744] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HAMPL A, 1995, DEVELOPMENT, V121, P925; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Listovsky T, 2000, EXP CELL RES, V255, P184, DOI 10.1006/excr.1999.4788; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	31	80	82	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2007	9	10					1192	1198		10.1038/ncb1640	http://dx.doi.org/10.1038/ncb1640			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	216MO	17891138	Green Accepted			2022-12-27	WOS:000249882300015
J	Zaidel-Bar, R; Itzkovitz, S; Ma'ayan, A; Iyengar, R; Geiger, B				Zaidel-Bar, Ronen; Itzkovitz, Shalev; Ma'ayan, Avi; Iyengar, Ravi; Geiger, Benjamin			Functional atlas of the integrin adhesome	NATURE CELL BIOLOGY			English	Article							EXTRACELLULAR-MATRIX; INTERACTION NETWORK; CELL; ADHESIONS; DATABASE; MODELS; MOTIFS		Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai	Zaidel-Bar, R (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017; Zaidel-Bar, Ronen/0000-0002-1374-5007	NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, U54GM064346, P50GM071558] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY016586, PN2 EY016586-05] Funding Source: Medline; NIGMS NIH HHS [U54 GM64346, P50 GM071558-01A20007, P50 GM071558-030007, P50 GM071558-020007, GM-54508, U54 GM064346, P50 GM071558, R01 GM054508, R01 GM054508-20] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Caldarelli G, 2004, EUR PHYS J B, V38, P183, DOI 10.1140/epjb/e2004-00020-6; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; GOUGH NR, 2002, SCI STKE, V135, pEG8; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; Iragne F, 2005, BIOINFORMATICS, V21, P272, DOI 10.1093/bioinformatics/bth494; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	38	813	825	2	100	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2007	9	8					858	868		10.1038/ncb0807-858	http://dx.doi.org/10.1038/ncb0807-858			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	196MM	17671451	Green Accepted			2022-12-27	WOS:000248486700003
J	Kim, DY; Carey, BW; Wang, HB; Ingano, LAM; Binshtok, AM; Wertz, MH; Pettingell, WH; He, P; Lee, VMY; Woolf, CJ; Kovacs, DM				Kim, Doo Yeon; Carey, Bryce W.; Wang, Haibin; Ingano, Laura A. M.; Binshtok, Alexander M.; Wertz, Mary H.; Pettingell, Warren H.; He, Ping; Lee, Virginia M. -Y.; Woolf, Clifford J.; Kovacs, Dora M.			BACE1 regulates voltage-gated sodium channels and neuronal activity	NATURE CELL BIOLOGY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; ALZHEIMERS-DISEASE; ALPHA-SUBUNIT; CELL-ADHESION; MOLECULAR-MECHANISMS; MESSENGER-RNAS; RAT-BRAIN; IN-VIVO; SEIZURES	BACE1 activity is significantly increased in the brains of Alzheimer's disease patients, potentially contributing to neurodegeneration. The voltage-gated sodium channel ( Na(v)1) beta 2-subunit (beta 2), a type I membrane protein that covalently binds to Nav1 alpha-subunits, is a substrate for BACE1 and gamma-secretase. Here, we find that BACE1-gamma-secretase cleavages release the intracellular domain of beta 2, which increases mRNA and protein levels of the pore-forming Na v 1.1 a-subunit in neuroblastoma cells. Similarly, endogenous beta 2 processing and Na(v) 1.1 protein levels are elevated in brains of BACE1-transgenic mice and Alzheimer's disease patients with high BACE1 levels. However, Na(v) 1.1 is retained inside the cells and cell surface expression of the Na(v) 1 alpha-subunits and sodium current densities are markedly reduced in both neuroblastoma cells and adult hippocampal neurons from BACE1-transgenic mice. BACE1, by cleaving beta 2, thus regulates Na(v)1 alpha-subunit levels and controls cell-surface sodium current densities. BACE1 inhibitors may normalize membrane excitability in Alzheimer's disease patients with elevated BACE1 activity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat Dis,Neurobiol Dis Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Anaesthesia & Crit Care, Neural Plastic Res Grp, Boston, MA 02129 USA; Sun Hlth Res Inst, Haldeman Lab Mol & Cellular Neurobiol, Sun City, AZ 85351 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Banner Research; Banner Health; Banner Sun Health Research Institute; University of Pennsylvania; Pennsylvania Medicine	Kovacs, DM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MassGen Inst Neurodegenerat Dis,Neurobiol Dis Lab, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Binshtok, Alexander/0000-0002-3620-8116	NIA NIH HHS [P01 AG015379, P01 AG015379-100006, R01 AG014713, R01 AG014713-11] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG014713] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chang WP, 2004, J NEUROCHEM, V89, P1409, DOI 10.1111/j.1471-4159.2004.02452.x; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; DibHajj SD, 1996, FEBS LETT, V384, P78, DOI 10.1016/0014-5793(96)00273-6; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 1999, J COMP NEUROL, V412, P342; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhou JS, 2000, CIRC RES, V87, P33, DOI 10.1161/01.RES.87.1.33; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703	44	236	253	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUL	2007	9	7					755	U43		10.1038/ncb1602	http://dx.doi.org/10.1038/ncb1602			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	186EA	17576410	Green Accepted			2022-12-27	WOS:000247760700011
J	Carazo-Salas, RE; Nurse, P				Carazo-Salas, Rafael E.; Nurse, Paul			Self-organization of interphase microtubule arrays in fission yeast	NATURE CELL BIOLOGY			English	Article							SPINDLE POLE BODY; ORGANIZING CENTERS; NUCLEAR-ENVELOPE; CELL-DIVISION; DYNAMICS; MITOSIS; ROLES	Microtubule organization is key to eukaryotic cell structure and function. In most animal cells, interphase microtubules organize around the centrosome, the major microtubule organizing centre (MTOC). Interphase microtubules can also become organized independently of a centrosome, but how acentrosomal microtubules arrays form and whether they are functionally equivalent to centrosomal arrays remains poorly understood 1,2. Here, we show that the interphase microtubule arrays of fission yeast cells can persist independently of nuclear-associated MTOCs, including the spindle pole body (SPB) - the centrosomal equivalent. By artificially enucleating cells, we show that arrays can form de novo (self-organize) without nuclear-associated MTOCs, but require the microtubule nucleator mod20-mbo1-mto1 (refs 3 - 5), the bundling factor ase1 (refs 6,7), and the kinesin klp2 (refs 8,9). Microtubule arrays in enucleated and nucleated cells are morphologically indistinguishable and similarly locate to the cellular axis and centre. By simultaneously tracking nuclear-independent and SPB-associated microtubule arrays within individual nucleated cells, we show that both define the cell centre with comparable precision. We propose that in fission yeast, nuclear-independent, self- organized, acentrosomal microtubule arrays are structurally and functionally equivalent to centrosomal arrays.	London Res Inst, Canc Res UK, Cell Cycle Lab, London WC2A 1PX, England; Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10021 USA	Cancer Research UK; Rockefeller University	Carazo-Salas, RE (corresponding author), London Res Inst, Canc Res UK, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 1PX, England.	rafael.carazo-salas@cancer.org.uk		Carazo-Salas, Rafael E/0000-0002-5943-3981				Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Malikov V, 2005, NAT CELL BIOL, V7, P1213, DOI 10.1038/ncb1332; Reilein A, 2005, J CELL BIOL, V171, P845, DOI 10.1083/jcb.200505071; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Samejima I, 2005, MOL BIOL CELL, V16, P3040, DOI 10.1091/mbc.e04-11-1003; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zheng LF, 2006, MOL BIOL CELL, V17, P2212, DOI 10.1091/mbc.E05-08-0811	24	57	57	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2006	8	10					1102	U94		10.1038/ncb1479	http://dx.doi.org/10.1038/ncb1479			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	096RU	16998477				2022-12-27	WOS:000241395300014
J	Choudhury, A; Marks, DL; Proctor, KM; Gould, GW; Pagano, RE				Choudhury, A; Marks, DL; Proctor, KM; Gould, GW; Pagano, RE			Regulation of caveolar endocytosis by syntaxin 6-dependent delivery of membrane components to the cell surface	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; LIPID RAFTS; 3T3-L1 ADIPOCYTES; TRAFFICKING; TRANSPORT; GLUT4; INTERNALIZATION; INVOLVEMENT; PROTEINS; INSULIN	Caveolar endocytosis has an important function in the cellular uptake of some bacterial toxins, viruses and circulating proteins. However, the molecular machinery involved in regulating caveolar uptake is poorly defined. Here, we demonstrate that caveolar endocytosis is regulated by syntaxin 6, a target membrane soluble N-ethylmaleimide attachment protein receptor (t-SNARE) involved in membrane fusion events along the secretory pathway. When syntaxin 6 function was inhibited, internalization through caveolae was dramatically reduced, whereas other endocytic mechanisms were unaffected. Syntaxin 6 inhibition also reduced the presence of caveolin-1 and caveolae at the plasma membrane. In addition, syntaxin 6 inhibition decreased the delivery of GM1 ganglioside ( GM1) and glycosylphosphatidylinositol (GPI)- GFP ( but not vesicular stomatitis virus-glycoprotein G; VSV-G) protein from the Golgi complex to the plasma membrane. Addition of GM1 to syntaxin 6-inhibited cells resulted in the reappearance of caveolin-1 and caveolae at the plasma membrane, and restored caveolar uptake. These results suggest that syntaxin 6 regulates the delivery of microdomain-associated lipids and proteins to the cell surface, which are required for caveolar endocytosis.	Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Henry Wellcome Lab Cell Biol, Glasgow G12 8QQ, Lanark, Scotland	Mayo Clinic; University of Glasgow	Pagano, RE (corresponding author), Mayo Clin Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	pagano.richard@mayo.edu	Gould, Gwyn/AAF-6721-2019	Gould, Gwyn/0000-0001-6571-2875	NIGMS NIH HHS [GM-22942] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022942, R01GM022942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Duncan MJ, 2002, CELL MICROBIOL, V4, P783, DOI 10.1046/j.1462-5822.2002.00230.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Kim YN, 2002, ENDOCRINOLOGY, V143, P1726, DOI 10.1210/en.143.5.1726; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; MARJOMAKI VS, 1990, J HISTOCHEM CYTOCHEM, V38, P1155, DOI 10.1177/38.8.2164059; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Martin-Martin B, 2000, BLOOD, V96, P2574; McIntosh DP, 1999, AM J PHYSIOL-HEART C, V277, pH2222, DOI 10.1152/ajpheart.1999.277.6.H2222; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Norkin LC, 2001, ADV DRUG DELIVER REV, V49, P301, DOI 10.1016/S0169-409X(01)00143-0; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; PREDESCU D, 1994, P NATL ACAD SCI USA, V91, P3014, DOI 10.1073/pnas.91.8.3014; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x	48	75	75	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					317	U6		10.1038/ncb1380	http://dx.doi.org/10.1038/ncb1380			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16565709				2022-12-27	WOS:000236560000010
J	Veigel, C; Schmitz, S; Wang, F; Sellers, JR				Veigel, C; Schmitz, S; Wang, F; Sellers, JR			Load-dependent kinetics of myosin-V can explain its high processivity	NATURE CELL BIOLOGY			English	Article							SMOOTH-MUSCLE MYOSIN; STEPPING KINETICS; WORKING STROKE; MOTOR; FORCE; MOVEMENT; BINDING; HEADS; MODEL; ADP	Recent studies provide strong evidence that single myosin class V molecules transport vesicles and organelles processively along F- actin, taking several 36- nm steps, ' hand over hand', for each diffusional encounter. The mechanisms regulating myosin- V's processivity remain unknown. Here, we have used an optical- tweezers- based transducer to measure the effect of load on the mechanical interactions between rabbit skeletal F- actin and a single head of mouse brain myosin- V, which produces its working stroke in two phases. We found that the lifetimes of the first phase of the working stroke changed exponentially and about 10-fold over a range of pushing and pulling forces of +/- 1.5 pN. Stiffness measurements suggest that intramolecular forces could approach 3.6 pN when both heads are bound to F- actin, in which case extrapolation would predict the detachment kinetics of the front head to slow down 50- fold and the kinetics of the rear head to accelerate respectively. This synchronizing effect on the chemo- mechanical cycles of the heads increases the probability of the trail head detaching first and causes a strong increase in the number of forward steps per diffusional encounter over a system with no strain dependence.	Natl Inst Med Res, London NW7 1AA, England; NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Veigel, C (corresponding author), Natl Inst Med Res, Ridgeway,Mill Hill, London NW7 1AA, England.	cveigel@nimr.mrc.ac.uk			Medical Research Council [MC_U117570593] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004229, ZIAHL004229] Funding Source: NIH RePORTER; MRC [MC_U117570593] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Berger CEM, 2001, J BIOL CHEM, V276, P23240, DOI 10.1074/jbc.M100524200; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Kolomeisky AB, 2003, BIOPHYS J, V84, P1642, DOI 10.1016/S0006-3495(03)74973-X; Lan GH, 2005, BIOPHYS J, V88, P4107, DOI 10.1529/biophysj.104.056846; LOMBARDI V, 1995, NATURE, V374, P553, DOI 10.1038/374553a0; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mehta AD, 1997, P NATL ACAD SCI USA, V94, P7927, DOI 10.1073/pnas.94.15.7927; Miller KE, 2000, J BIOL CHEM, V275, P2598, DOI 10.1074/jbc.275.4.2598; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Sellers J. R., 1999, MYOSINS; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	41	206	207	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2005	7	9					861	869		10.1038/ncb1287	http://dx.doi.org/10.1038/ncb1287			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	960NY	16100513				2022-12-27	WOS:000231601600009
J	Cote, JF; Motoyama, AB; Bush, JA; Vuori, K				Cote, JF; Motoyama, AB; Bush, JA; Vuori, K			A novel and evolutionarily conserved PtdIns(3,4,5)P-3-binding domain is necessary for DOCK180 signalling	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESION KINASE; CELL-MIGRATION; MYOBLAST CITY; C2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; CRKII/DOCK180/RAC PATHWAY; MEMBRANE ASSOCIATION; LIVING CELLS; PROTEIN; BINDING	The evolutionarily conserved DOCK180 protein has an indispensable role in cell migration by functioning as an exchange factor for Rac GTPase via its DOCK homology region (DHR)-2 domain. We report here that the conserved DHR-1 domain also has an important signalling role. A form of DOCK180 that lacks DHR-1 fails to promote cell migration, although it is capable of inducing Rac GTP-loading. The DHR-1 domain interacts with PtdIns(3,4,5)P-3 in vitro and in vivo, and mediates the DOCK180 signalling complex localization at sites of PtdIns(3,4,5)P-3 accumulation in the cell's leading edge. A form of DOCK180 in which the DHR-1 domain has been replaced by a canonical PtdIns(3,4,5)P-3-binding pleckstrin homology domain is fully functional at inducing cell elongation and migration, suggesting that the main function of DHR-1 is to bind PtdIns(3,4,5)P-3. These results demonstrate that DOCK180, via its DHR-1 and DHR-2 domains, couples PtdIns(3,4,5)P-3 signalling to Rac GTP-loading, which is essential for directional cell movement.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Vuori, K (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kvuori@burnham.org	Motoyama, Andrea/AAB-9362-2019		NATIONAL CANCER INSTITUTE [P01CA102583] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA102583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Catz SD, 2002, P NATL ACAD SCI USA, V99, P11652, DOI 10.1073/pnas.172382799; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Takenawa T, 2001, J CELL SCI, V114, P1801; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	43	179	184	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	AUG	2005	7	8					797	U63		10.1038/ncb1280	http://dx.doi.org/10.1038/ncb1280			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	950TU	16025104	Green Accepted			2022-12-27	WOS:000230881500014
J	Becam, IE; Tanentzapf, G; Lepesant, JA; Brown, NH; Huynh, JR				Becam, IE; Tanentzapf, G; Lepesant, JA; Brown, NH; Huynh, JR			Integrin-independent repression of cadherin transcription by talin during axis formation in Drosophila	NATURE CELL BIOLOGY			English	Article							ADHESION; PROTEIN; MORPHOGENESIS; POLARITY; SITE	The Drosophila melanogaster anterior - posterior axis becomes polarized early during oogenesis by the posterior localization of the oocyte within the egg chamber. The invariant position of the oocyte is thought to be driven by an upregulation of the adhesion molecule DE-cadherin in the oocyte and the posterior somatic follicle cells, providing the first in vivo example of cell sorting that is specified by quantitative differences in cell - cell adhesion(1,2). However, it has remained unclear how DE-cadherin levels are regulated. Here, we show that talin, known for its role in linking integrins to the actin cytoskeleton, has the unexpected function of specifically inhibiting DE-cadherin transcription. Follicle cells that are mutant for talin show a strikingly high level of DE-cadherin, due to elevated transcription of DE-cadherin. We demonstrate that this deregulation of DE-cadherin is sufficient to attract the oocyte to lateral and anterior positions. Surprisingly, this function of talin is independent of integrins. These results uncover a new role for talin in regulating cadherin-mediated cell adhesion.	Univ Paris 06, CNRS, Inst Jacques Monod, F-75251 Paris, France; Univ Paris 07, CNRS, Inst Jacques Monod, F-75251 Paris, France; Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Anat, Cambridge CB2 1QR, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; University of Cambridge	Huynh, JR (corresponding author), Univ Paris 06, CNRS, Inst Jacques Monod, 2 Pl Jussieu, F-75251 Paris, France.	huynh@ijm.jussieu.fr	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; HUYNH, Jean-Rene/0000-0002-4078-399X; Brown, Nicholas/0000-0002-8958-7017				Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Balda MS, 2003, TRENDS CELL BIOL, V13, P310, DOI 10.1016/S0962-8924(03)00105-3; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; BUNCH TA, 1992, GENETICS, V132, P519; CHOU TB, 1992, GENETICS, V131, P643; Cram EJ, 2004, TRENDS CELL BIOL, V14, P55, DOI 10.1016/j.tcb.2003.12.009; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; GONZALEZREYES A, 1994, SCIENCE, V266, P639, DOI 10.1126/science.7939717; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Oda H, 2001, J CELL SCI, V114, P493; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pignoni F, 1997, DEVELOPMENT, V124, P271; Prout M, 1997, GENETICS, V146, P275; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361	33	55	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2005	7	5					510	516		10.1038/ncb1253	http://dx.doi.org/10.1038/ncb1253			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	926LA	15852002	Green Submitted			2022-12-27	WOS:000229123500018
J	Port, F; Kuster, M; Herr, P; Furger, E; Banziger, C; Hausmann, G; Basler, K				Port, Fillip; Kuster, Marco; Herr, Patrick; Furger, Edy; Baenziger, Carla; Hausmann, George; Basler, Konrad			Wingless secretion promotes and requires retromer-dependent cycling of Wntless	NATURE CELL BIOLOGY			English	Article							SEGMENT POLARITY GENE; GRADIENT FORMATION; WNT PROTEINS; DROSOPHILA; PATHWAY; COMPLEX	Wnt ligands are lipid-modified, secreted glycoproteins that control multiple steps during embryogenesis and adult-tissue homeostasis. Little is known about the mechanisms underlying Wnt secretion. Recently, Wntless (Wls/Evi/Srt) was identified as a conserved multi-pass transmembrane protein whose function seems to be dedicated to promoting the release of Wnts(1-3). Here, we describe Wls accumulation in the Golgi apparatus of Wnt/Wingless (Wg)-producing cells in Drosophila, and show that this localization is essential for Wg secretion. Moreover, Wls localization and levels critically depend on retromer, a conserved protein complex that mediates endosome-to-Golgi protein trafficking in yeast(4). In the absence of the retromer components Dvps35 or Dvps26, but in presence of Wg, Wls is degraded and Wg secretion impaired. Our results indicate that Wg, clathrin-mediated endocytosis and retromer sustain a Wls traffic loop from the Golgi to the plasma membrane and back to the Golgi, thereby enabling Wls to direct Wnt secretion.	[Port, Fillip; Kuster, Marco; Herr, Patrick; Furger, Edy; Baenziger, Carla; Hausmann, George; Basler, Konrad] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.uzh.ch	Herr, Patrick/ABA-6092-2021	Herr, Patrick/0000-0003-2945-966X; Basler, Konrad/0000-0003-3534-1529; Port, Fillip/0000-0002-5157-4835				BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Llimargas M, 2001, P NATL ACAD SCI USA, V98, P14487, DOI 10.1073/pnas.251304398; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; THEISEN H, 1994, DEVELOPMENT, V120, P347; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	36	195	200	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2008	10	2					178	U48		10.1038/ncb1687	http://dx.doi.org/10.1038/ncb1687			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	258VO	18193032				2022-12-27	WOS:000252897800013
J	Burnette, DT; Schaefer, AW; Ji, L; Danuser, G; Forscher, P				Burnette, Dylan T.; Schaefer, Andrew W.; Ji, Lin; Danuser, Gaudenz; Forscher, Paul			Filopodial actin bundles are not necessary for microtubule advance into the peripheral domain of Aplysia neuronal growth cones	NATURE CELL BIOLOGY			English	Article							FLUORESCENT SPECKLE MICROSCOPY; DYNAMIC INSTABILITY; ENA/VASP PROTEINS; 2 POPULATIONS; FILAMENTS; ORGANIZATION; CYTOSKELETON; TRANSPORT; GUIDANCE; FLOW	Filopodial actin bundles guide microtubule assembly in the growth cone peripheral ( P) domain and retrograde actin-network flow simultaneously transports microtubules rearward. Therefore, microtubule-end position is determined by the sum of microtubule assembly and retrograde transport rates. However, how filopodia actually affect microtubule assembly dynamics is unknown. To address this issue we quantitatively assessed microtubule and actin dynamics before and after selective removal of filopodia. Filopodium removal had surprisingly little effect on retrograde actin-flow rates or underlying network structures, but resulted in an approximate doubling of peripheral microtubule density and deeper penetration of microtubules into the P domain. The latter stemmed from less efficient coupling of microtubules to remaining actin networks and not from a change in microtubule polymer dynamics. Loss of filopodia also resulted in increased lateral microtubule movements and a more randomized microtubule distribution in the P domain. In summary, filopodia do not seem to be formally required for microtubule advance; however, their presence ensures radial distribution of microtubules in the P domain and facilitates microtubule transport by retrograde flow. The resulting dynamic steady state has interesting implications for rapid microtubule-positioning responses in the P domain.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Yale University; Scripps Research Institute	Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	paul.forscher@yale.edu		Danuser, Gaudenz/0000-0001-8583-2014	NIGMS NIH HHS [U54-GM64346, R01-GM67230] Funding Source: Medline; NINDS NIH HHS [R01 NS051786, R01-NS28695, R01-NS051786] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM067230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Buck KB, 2002, J NEUROSCI, V22, P9358; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Koleske Anthony J, 2003, Sci STKE, V2003, ppe20; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Torreano PJ, 2005, CELL MOTIL CYTOSKEL, V60, P166, DOI 10.1002/cm.20051; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	30	69	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1360	U39		10.1038/ncb1655	http://dx.doi.org/10.1038/ncb1655			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18026092				2022-12-27	WOS:000251317300009
J	Stock, JK; Giadrossi, S; Casanova, M; Brookes, E; Vidal, M; Koseki, H; Brockdorff, N; Fisher, AG; Pombo, A				Stock, Julie K.; Giadrossi, Sara; Casanova, Miguel; Brookes, Emily; Vidal, Miguel; Koseki, Haruhiko; Brockdorff, Neil; Fisher, Amanda G.; Pombo, Ana			Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells	NATURE CELL BIOLOGY			English	Article							DEVELOPMENTAL REGULATORS; TRANSCRIPTION FACTOR; HISTONE H2A; POLYCOMB; EXPRESSION; UBIQUITYLATION; ASSOCIATION; RECRUITMENT; SIGNATURES; BLOCKS	Changes in phosphorylation of the carboxy-terminal domain ( CTD) of RNA polymerase II ( RNAP) are associated with transcription initiation, elongation and termination(1-3). Sites of active transcription are generally characterized by hyperphosphorylated RNAP, particularly at Ser 2 residues, whereas inactive or poised genes may lack RNAP or may bind Ser 5-phosphorylated RNAP at promoter proximal regions. Recent studies have demonstrated that silent developmental regulator genes have an unusual histone modification profile in ES cells, being simultaneously marked with Polycomb repressor-mediated histone H3K27 methylation, and marks normally associated with gene activity(4,5). Contrary to the prevailing view, we show here that this important subset of developmental regulator genes, termed bivalent genes, assemble RNAP complexes phosphorylated on Ser 5 and are transcribed at low levels. We provide evidence that this poised RNAP configuration is enforced by Polycomb Repressor Complex ( PRC)-mediated ubiquitination of H2A, as conditional deletion of Ring1A and Ring1B leads to the sequential loss of ubiquitination of H2A, release of poised RNAP, and subsequent gene de-repression. These observations provide an insight into the molecular mechanisms that allow ES cells to self-renew and yet retain the ability to generate multiple lineage outcomes.	Hammersmith Hosp, Nucl Org, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr,Dev Epigenet Grp, London W12 0NN, England; CSIC, Ctr Invest Biol, Dept Dev & Cell Biol, Madrid, Spain; Yokohama Inst, RIKEN, Res Ctr Allergy & Immunol, Dept Dev Genet, Yokohama, Kanagawa, Japan	Imperial College London; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); RIKEN	Pombo, A (corresponding author), Hammersmith Hosp, Nucl Org, Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk; ana.pombo@csc.mrc.ac.uk	Koseki, Haruhiko/I-3825-2014; Pombo, Ana/A-1045-2010; Vidal, Miguel/M-8861-2016	Koseki, Haruhiko/0000-0001-8424-5854; Pombo, Ana/0000-0002-7493-6288; Vidal, Miguel/0000-0003-4374-6761; Brookes, Emily/0000-0003-2175-4349; Brockdorff, Neil/0000-0003-4838-2653; Casanova, Miguel/0000-0001-8622-6550	Medical Research Council [MC_U120061476, MC_U120027516, MC_U120031757] Funding Source: Medline; MRC [MC_U120027516, MC_U120031757, MC_U120061476] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Billon N, 2002, J CELL SCI, V115, P3657, DOI 10.1242/jcs.00049; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lam LT, 2001, GENOME BIOL, V2; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726	39	474	493	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2007	9	12					1428	U174		10.1038/ncb1663	http://dx.doi.org/10.1038/ncb1663			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236QA	18037880	Green Submitted			2022-12-27	WOS:000251317300016
J	Trenker, M; Malli, R; Fertschai, I; Levak-Frank, S; Graier, WF				Trenker, Michael; Malli, Roland; Fertschai, Ismene; Levak-Frank, Sanja; Graier, Wolfgang F.			Uncoupling proteins 2 and 3 are fundamental for mitochondrial Ca2+ uniport	NATURE CELL BIOLOGY			English	Article							ENDOPLASMIC-RETICULUM; YEAST MITOCHONDRIA; PROTEIN HOMOLOGS; SKELETAL-MUSCLE; CALCIUM; ACTIVATION; CELLS; SUPEROXIDE; EXPRESSION; CHANNEL	Mitochondrial Ca2+ uptake is crucial for the regulation of the rate of oxidative phosphorylation(1), the modulation of spatiotemporal cytosolic Ca2+ signals(2,3,4) and apoptosis(5). Although the phenomenon of mitochondrial Ca2+ sequestration, its characteristics and physiological consequences have been convincingly reported(6,7), the actual protein(s) involved in this process are unknown. Here, we show that the uncoupling proteins 2 and 3 (UCP2 and UCP3) are essential for mitochondrial Ca2+ uptake. Using overexpression, knockdown (small interfering RNA) and mutagenesis experiments, we demonstrate that UCP2 and UCP3 are elementary for mitochondrial Ca2+ sequestration in response to cell stimulation under physiological conditions - observations supported by isolated liver mitochondria of Ucp2(-/)-mice lacking ruthenium red-sensitive Ca2+ uptake. Our results reveal a novel molecular function for UCP2 and UCP3, and may provide the molecular mechanism for their reported effects(8-10). Moreover, the identification of proteins fundemental for mitochondrial Ca2+ uptake expands our knowledge of the physiological role for mitochondrial Ca2+ sequestration.	Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria	Medical University of Graz	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Harrachgasse 21-11, A-8010 Graz, Austria.	wolfgang.graier@meduni-graz.at	Graier, Wolfgang F./B-7052-2008; Malli, Roland/B-7369-2008	Graier, Wolfgang F./0000-0003-1871-3298; Malli, Roland/0000-0001-6327-8729	Austrian Science Fund FWF [F 3010, P 16860] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dejean L, 2004, J CELL PHYSIOL, V201, P294, DOI 10.1002/jcp.20048; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Harper JA, 2002, BIOCHEM J, V361, P49, DOI 10.1042/0264-6021:3610049; Harper ME, 2002, DIABETES, V51, P2459, DOI 10.2337/diabetes.51.8.2459; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jezek P, 2004, PHYSIOL RES, V53, pS199; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Osibow K, 2006, J BIOL CHEM, V281, P5017, DOI 10.1074/jbc.M508583200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Schaeffer G, 2003, DIABETOLOGIA, V46, P773, DOI 10.1007/s00125-003-1091-y; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Szilagyi G, 2006, NEUROSCI LETT, V399, P206, DOI 10.1016/j.neulet.2006.01.071; Vergun O, 2004, BIOPHYS J, V87, P3585, DOI 10.1529/biophysj.104.042671; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Yoshitomi H, 1998, GENE, V215, P77, DOI 10.1016/S0378-1119(98)00279-0; Zoratti C, 2003, BRIT J PHARMACOL, V140, P1351, DOI 10.1038/sj.bjp.0705529	35	272	278	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2007	9	4					445	U156		10.1038/ncb1556	http://dx.doi.org/10.1038/ncb1556			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	152JX	17351641	Green Accepted			2022-12-27	WOS:000245359400016
J	Manjon, C; Sanchez-Herrero, E; Suzanne, M				Manjon, Cristina; Sanchez-Herrero, Ernesto; Suzanne, Magali			Sharp boundaries of Dpp signalling trigger local cell death required for Drosophila leg morphogenesis	NATURE CELL BIOLOGY			English	Article							GRADIENT FORMATION; GENETIC-CONTROL; EXPRESSION; SEGMENTATION; APOPTOSIS; NOTCH; PATHWAY; GROWTH; FATES	Morphogens are secreted signalling molecules that govern many developmental processes(1). In the Drosophila wing disc, the transforming growth factor beta (TGF beta) homologue Decapentaplegic (Dpp) forms a smooth gradient and specifies cell fate by conferring a defined value of morphogen activity. Thus, neighbouring cells have similar amounts of Dpp protein, and if a sharp discontinuity in Dpp activity is generated between these cells, Jun kinase (JNK)-dependent apoptosis is triggered to restore graded positional information(2,3). To date, it has been assumed that this apoptotic process is only activated when normal signalling is distorted. However, we now show that a similar process occurs during normal development: rupture in Dpp activity occurs during normal segmentation of the distal legs of Drosophila. This sharp boundary of Dpp signalling, independently of the absolute level of Dpp activity, induces a JNK-reaper-dependent apoptosis required for the morphogenesis of a particular structure of the leg, the joint. Our results show that Dpp could induce a developmental programme not only in a concentration dependent manner, but also by the creation of a sharp boundary of Dpp activity. Furthermore, the same process could be used either to restore a normal pattern in response to artificial disturbance or to direct a morphogenetic process.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Suzanne, M (corresponding author), Univ Nice, CNRS, UMR 6543, Inst Signalling Dev Biol & Canc, Parc Valrose, F-06108 Nice, France.	suzanne@unice.fr	Sánchez-Herrero, Ernesto/ABE-3595-2020					Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bishop SA, 1999, DEVELOPMENT, V126, P2993; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell G, 2002, NATURE, V418, P781, DOI 10.1038/nature00971; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Cashio P, 2005, SEMIN CELL DEV BIOL, V16, P225, DOI 10.1016/j.semcdb.2005.01.002; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Edwards CJ, 2001, SEMIN ARTHRITIS RHEU, V31, P33, DOI 10.1053/sarh.2001.24875; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Galindo MI, 2002, SCIENCE, V297, P256, DOI 10.1126/science.1072311; Haerry TE, 1998, DEVELOPMENT, V125, P3977; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Jockusch EL, 2000, DEVELOPMENT, V127, P1617; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Niwa N, 2000, DEVELOPMENT, V127, P4373; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Rauskolb C, 2001, DEVELOPMENT, V128, P4511; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Yu SY, 2002, DEVELOPMENT, V129, P3269	33	85	87	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2007	9	1					57	U66		10.1038/ncb1518	http://dx.doi.org/10.1038/ncb1518			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	122VL	17143268	Green Submitted			2022-12-27	WOS:000243255100012
J	Lee, J; Mo, JH; Katakura, K; Alkalay, I; Rucker, AN; Liu, YT; Lee, HK; Shen, C; Cojocaru, G; Shenouda, S; Kagnoff, M; Eckmann, L; Ben-Neriah, Y; Raz, E				Lee, Jongdae; Mo, Ji-Hun; Katakura, Kyoko; Alkalay, Irit; Rucker, Adam N.; Liu, Yu-Tsueng; Lee, Hyun-Ku; Shen, Carol; Cojocaru, Gady; Shenouda, Steve; Kagnoff, Martin; Eckmann, Lars; Ben-Neriah, Yinon; Raz, Eyal			Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells	NATURE CELL BIOLOGY			English	Article						g	TOLL-LIKE RECEPTOR-9; NF-KAPPA-B; MURINE COLITIS; BACTERIAL FLAGELLIN; MOLECULAR-PATTERNS; NF-KAPPA-B1 P105; GENE-EXPRESSION; KINASE; DNA; LIPOPOLYSACCHARIDE	The mechanisms by which commensal bacteria suppress inflammatory signalling in the gut are still unclear. Here, we present a cellular mechanism whereby the polarity of intestinal epithelial cells (IECs) has a major role in colonic homeostasis. TLR9 activation through apical and basolateral surface domains have distinct transcriptional responses, evident by NF-kappa B activation and cDNA microarray analysis. Whereas basolateral TLR9 signals I kappa B alpha degradation and activation of the NF-kappa B pathway, apical TLR9 stimulation invokes a unique response in which ubiquitinated I kappa Ba accumulates in the cytoplasm preventing NF-kappa B activation. Furthermore, apical TLR9 stimulation confers intracellular tolerance to subsequent TLR challenges. IECs in TLR9-deficient mice, when compared with wild-type and TLR2-deficient mice, display a lower NF-kappa B activation threshold and these mice are highly susceptible to experimental colitis. Our data provide a case for organ-specific innate immunity in which TLR expression in polarized IECs has uniquely evolved to maintain colonic homeostasis and regulate tolerance and inflammation.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Hebrew University of Jerusalem; Scripps Research Institute	Raz, E (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	j142133@ucsd.edu; yinon@cc.huji.ac.il; eraz@ucsd.edu	Ben-Neriah, Yinon/L-6285-2019; Mo, Ji-Hun/E-5586-2011	Mo, Ji-Hun/0000-0003-1331-364X; Lee, Jongdae/0000-0002-6270-4658	NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056075, R01AI057709, P01AI040682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NCRR NIH HHS [RR17030] Funding Source: Medline; NIAID NIH HHS [AI57709, AI56075, AI40682] Funding Source: Medline; NIDDK NIH HHS [DK35108] Funding Source: Medline; NINDS NIH HHS [P30 NS047101] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akhtar M, 2003, FASEB J, V17, P1319, DOI 10.1096/fj.02-0950fje; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; BONEV MN, 1990, INT J RADIAT BIOL, V57, P993, DOI 10.1080/09553009014551111; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; CAMPBELL A, 1994, ANNU REV MICROBIOL, V48, P193, DOI 10.1146/annurev.micro.48.1.193; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; COOPER HS, 1993, LAB INVEST, V69, P238; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Kazmierczak BI, 2001, ANNU REV MICROBIOL, V55, P407, DOI 10.1146/annurev.micro.55.1.407; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Marrero JA, 2000, AM J PHYSIOL-GASTR L, V278, pG797, DOI 10.1152/ajpgi.2000.278.5.G797; Naidu AS, 1999, CRIT REV FOOD SCI, V39, P13, DOI 10.1080/10408699991279187; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; PARMA DH, 1992, GENE DEV, V6, P497, DOI 10.1101/gad.6.3.497; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VAN ISC, 2000, J CELL PHYSL, V184, P151; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4	46	453	475	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1327	U7		10.1038/ncb1500	http://dx.doi.org/10.1038/ncb1500			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17128265				2022-12-27	WOS:000242419800008
J	Yook, JI; Li, XY; Ota, I; Hu, C; Kim, HS; Kim, NH; Cha, SY; Ryu, JK; Choi, YJ; Kim, J; Fearon, ER; Weiss, SJ				Yook, Jong In; Li, Xiao-Yan; Ota, Ichiro; Hu, Casey; Kim, Hyun Sil; Kim, Nam Hee; Cha, So Young; Ryu, Joo Kyung; Choi, Yoon Jung; Kim, Jin; Fearon, Eric R.; Weiss, Stephen J.			A Wnt-Axin2-GSK3 beta cascade regulates Snail1 activity in breast cancer cells	NATURE CELL BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOGEN-SYNTHASE KINASE-3-BETA; BETA-CATENIN; MAMMARY DEVELOPMENT; PROGENITOR CELLS; REPRESSOR SNAIL; AXIN; PATHWAY; PHOSPHORYLATION; MORPHOGENESIS	Accumulating evidence indicates that hyperactive Wnt signalling occurs in association with the development and progression of human breast cancer. As a consequence of engaging the canonical Wnt pathway, a beta-catenin-T-cell factor (TCF) transcriptional complex is generated, which has been postulated to trigger the epithelial - mesenchymal transition (EMT) that characterizes the tissue-invasive phenotype. However, the molecular mechanisms by which the beta-catenin-TCF complex induces EMT-like programmes remain undefined. Here, we demonstrate that canonical Wnt signalling engages tumour cell dedifferentiation and tissue-invasive activity through an Axin2-dependent pathway that stabilizes the Snail1 zinc-transcription factor, a key regulator of normal and neoplastic EMT programmes. Axin2 regulates EMT by acting as a nucleocytoplasmic chaperone for GSK3 beta, the dominant kinase responsible for controlling Snail1 protein turnover and activity. As dysregulated Wnt signalling marks a diverse array of cancerous tissue types, the identification of a beta-catenin-TCF-regulated Axin2 -GSK3 beta-Snail1 axis provides new mechanistic insights into cancer-associated EMT programmes.	Univ Michigan, Ctr Comprehens Canc, Div Med & Mol Genet, Dept Internal Med,Life Sci Inst, Ann Arbor, MI 48109 USA; Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol, Seoul 120752, South Korea; Ilsan Hosp, Natl Hlth Insurance Corp, Dept Pathol, Kyungki 419719, South Korea; Univ Michigan, Dept Internal Med Human Genet & Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Yonsei University; Yonsei University Health System; NHIS Ilsan Hospital; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Ctr Comprehens Canc, Div Med & Mol Genet, Dept Internal Med,Life Sci Inst, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu		Ota, Ichiro/0000-0003-3815-8877; Kim, Hyun Sil/0000-0003-3614-1764; Yook, Jong In/0000-0002-7318-6112; Kim, Nam Hee/0000-0002-3087-5276	NATIONAL CANCER INSTITUTE [R01CA071699] Funding Source: NIH RePORTER; NCI NIH HHS [5 R01 CA71699] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rowlands TM, 2003, P NATL ACAD SCI USA, V100, P11400, DOI 10.1073/pnas.1534601100; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Stoothof WH, 2002, J NEUROCHEM, V83, P904, DOI 10.1046/j.1471-4159.2002.01197.x; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	30	501	517	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2006	8	12					1398	U57		10.1038/ncb1508	http://dx.doi.org/10.1038/ncb1508			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	110ZJ	17072303				2022-12-27	WOS:000242419800016
J	Yao, TT; Song, L; Xu, W; DeMartino, GN; Florens, L; Swanson, SK; Washburn, MP; Conaway, RC; Conaway, JW; Cohen, RE				Yao, Tingting; Song, Ling; Xu, Wei; DeMartino, George N.; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan Weliky; Cohen, Robert E.			Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1	NATURE CELL BIOLOGY			English	Article							GASTRIC-CARCINOMA CELLS; UBIQUITIN HYDROLASE; REGULATORY COMPLEX; STRUCTURAL BASIS; IDENTIFICATION; PROTEIN; SPECIFICITY; ISOPEPTIDASE; ASSOCIATION; CLONING	Uch37 is one of the three principal deubiquitinating enzymes (DUBs), and the only ubiquitin carboxy-terminal hydrolase (UCH)-family protease, that is associated with mammalian proteasomes. We show that Uch37 is responsible for the ubiquitin isopeptidase activity in the PA700 (19S) proteasome regulatory complex(1). PA700 isopeptidase disassembles Lys 48-linked polyubiquitin specifically from the distal end of the chain, a property that may be used to clear poorly ubiquitinated or unproductively bound substrates from the proteasome. To better understand Uch37 function and the mechanism responsible for its specificity, we investigated how Uch37 is recruited to proteasomes. Uch37 binds through Adrm1, a previously unrecognized orthologue of Saccharomyces cerevisiae Rpn13p, which in turn is bound to the S1 (also known as Rpn2) subunit of the 19S complex. Adrm1 (human Rpn13, hRpn13) binds the carboxy-terminal tail of Uch37, a region that is distinct from the UCH catalytic domain, which we show inhibits Uch37 activity. Following binding, Adrm1 relieves Uch37 autoinhibition, accelerating the hydrolysis of ubiquitin-7-amido-4-methylcoumarin (ubiquitin-AMC). However, neither Uch37 alone nor the Uch37-Adrm1 or Uch37-Adrm1-S1 complexes can hydrolyse di-ubiquitin efficiently; rather, incorporation into the 19S complex is required to enable processing of polyubiquitin chains.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Iowa; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Kansas; University of Kansas Medical Center	Cohen, RE (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	rcohen@jhsph.edu	Song, Ling/HGA-5011-2022	Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM037666] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM37666, R37 GM41628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; James P, 1996, GENETICS, V144, P1425; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lamerant N, 2005, FEBS J, V272, P1833, DOI 10.1111/j.1742-4658.2005.04613.x; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; Li TW, 2001, FEBS LETT, V488, P201, DOI 10.1016/S0014-5793(00)02436-4; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; SHIMADA S, 1994, CANCER RES, V54, P3831; SHIMADA S, 1991, CANCER RES, V51, P5694; Simins AB, 1999, CLIN EXP METASTAS, V17, P641, DOI 10.1023/A:1006790912877; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	30	253	267	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2006	8	9					994	U92		10.1038/ncb1460	http://dx.doi.org/10.1038/ncb1460			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	080IS	16906146				2022-12-27	WOS:000240241700016
J	Magidson, V; Chang, F; Khodjakov, A				Magidson, Valentin; Chang, Fred; Khodjakov, Alexey			Regulation of cytokinesis by spindle-pole bodies	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; PROTEIN; KINASE; CELL; SIN; SEGREGATION; ANAPHASE	In the fission yeast Schizosaccharomyces pombe, cytokinesis is thought to be controlled by the daughter spindle-pole body ( SPB) through a regulatory pathway named the septation initiation network ( SIN). Here, we demonstrate that laser ablation of both, but not a single SPB, results in failure of cytokinesis. Ablation of only the daughter SPB often leads to activation of the SIN on the mother SPB and successful cytokinesis. Thus, either SPB can drive cytokinesis.	Wadsworth Ctr, Albany, NY 12201 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Wadsworth Center; Columbia University; Marine Biological Laboratory - Woods Hole	Khodjakov, A (corresponding author), Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org		Magidson, Valentin/0000-0002-0780-9123	NIGMS NIH HHS [R01 GM059363-08, R01 GM059363] Funding Source: Medline; PHS HHS [GMS 69670, GMS 59363] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cerutti L, 1999, J CELL SCI, V112, P2313; Daga RR, 2005, EMBO J, V24, P2436, DOI 10.1038/sj.emboj.7600705; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Le Goff X, 2000, J CELL SCI, V113, P4157; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; Morrell JL, 2004, CURR BIOL, V14, P579, DOI 10.1016/j.cub.2004.03.036; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Sparks CA, 1999, J CELL BIOL, V146, P777, DOI 10.1083/jcb.146.4.777; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	14	25	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	AUG	2006	8	8					891	U169		10.1038/ncb1449	http://dx.doi.org/10.1038/ncb1449			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	069CO	16845379	Green Submitted			2022-12-27	WOS:000239423000021
J	Joglekar, AP; Bouck, DC; Molk, JN; Bloom, KS; Salmon, ED				Joglekar, Ajit P.; Bouck, David C.; Molk, Jeffrey N.; Bloom, Kerry S.; Salmon, Edward D.			Molecular architecture of a kinetochore-microtubule attachment site	NATURE CELL BIOLOGY			English	Article							BUDDING YEAST KINETOCHORE; SACCHAROMYCES-CEREVISIAE; PROTEIN INTERACTIONS; VERTEBRATE CELLS; CENTROMERE; COMPLEX; CORE; COMPONENT; DYNAMICS; CSE4P	Kinetochore attachment to spindle microtubule plus-ends is necessary for accurate chromosome segregation during cell division in all eukaryotes. The centromeric DNA of each chromosome is linked to microtubule plus-ends by eight structural-protein complexes(1-9). Knowing the copy number of each of these complexes at one kinetochore-microtubule attachment site is necessary to understand the molecular architecture of the complex, and to elucidate the mechanisms underlying kinetochore function. We have counted, with molecular accuracy, the number of structural protein complexes in a single kinetochore-microtubule attachment using quantitative fluorescence microscopy of GFP-tagged kinetochore proteins in the budding yeast Saccharomyces cerevisiae. We find that relative to the two Cse4p molecules in the centromeric histone(1), the copy number ranges from one or two for inner kinetochore proteins such as Mif2p(2), to 16 for the DAM DASH complex(8.9) at the kinetochore-microtubule interface. These counts allow us to visualize the overall arrangement of a kinetochore-microtubule attachment. As most of the budding yeast kinetochore proteins have homologues in higher eukaryotes, including humans, this molecular arrangement is likely to be replicated in more complex kinetochores that have multiple microtubule attachments.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, 607 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA.	tsalmon@email.unc.edu		Joglekar, Ajit/0000-0002-0607-5332; Bloom, Kerry/0000-0002-3457-004X; Bouck, David/0000-0002-6281-2544	NIGMS NIH HHS [GM60678, R37 GM032238, R37 GM024364, R01 GM032238-18, GM32238, R01 GM060678, R01 GM032238, GM24364, R01 GM024364] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060678, R37GM024364, R37GM032238, R01GM032238, R01GM024364] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Espelin CW, 2003, MOL BIOL CELL, V14, P4557, DOI 10.1091/mbc.E02-08-0533; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yang SS, 1997, J CELL BIOL, V136, P345, DOI 10.1083/jcb.136.2.345; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	30	217	235	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JUN	2006	8	6					581	585		10.1038/ncb1414	http://dx.doi.org/10.1038/ncb1414			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	049PR	16715078	Green Accepted, Green Published			2022-12-27	WOS:000238029000010
J	Dyce, PW; Wen, LH; Li, JL				Dyce, PW; Wen, LH; Li, JL			In vitro germline potential of stem cells derived from fetal porcine skin	NATURE CELL BIOLOGY			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; ZONA-PELLUCIDA; MOUSE; EXPRESSION; OOCYTES; GENE; PRODUCT; FAMILY; PROLIFERATION; DERIVATION	Two of the unanswered questions in mammalian developmental biology are when and where the fate of the germ cell is specified. Here, we report that stem cells isolated from the skin of porcine fetuses have the intrinsic ability to differentiate into oocyte-like cells. When differentiation was induced, a subpopulation of these cells expressed markers such as Oct4, Growth differentiation factor 9b (GDF9b), the Deleted in Azoospermia-like (DAZL) gene and Vasa - all consistent with germ-cell formation. On further differentiation, these cells formed follicle-like aggregates that secreted oestradiol and progesterone and responded to gonadotropin stimulation. Some of these aggregates extruded large oocyte-like cells that expressed oocyte markers, such as zona pellucida, and the meiosis marker, synaptonemal complex protein 3 (SCP3). Some of these oocyte-like cells spontaneously developed into parthenogenetic embryo-like structures. The ability to generate oocyte-like cells from skin-derived cells may offer new possibilities for tissue therapy and provide a new in vitro model to study germ-cell formation and oogenesis.	Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Li, JL (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	jli@uoguelph.ca		Dyce, Paul/0000-0002-4574-3321				Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; DUNBAR BS, 1994, REPROD FERT DEVELOP, V6, P331, DOI 10.1071/RD9940331; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Miyano T, 2005, J REPROD DEVELOP, V51, P169, DOI 10.1262/jrd.16014; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; Pesce M, 1997, MECH DEVELOP, V68, P37, DOI 10.1016/S0925-4773(97)00120-2; RICHARDS JS, 1988, ANNU REV PHYSIOL, V50, P441; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Shim H, 1998, THERIOGENOLOGY, V49, P521, DOI 10.1016/S0093-691X(98)00003-X; Spargo SC, 2003, BIOL REPROD, V68, P358, DOI 10.1095/biolreprod.102.008086; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; TAYA T, 1995, BIOCHEM BIOPH RES CO, V207, P790, DOI 10.1006/bbrc.1995.1256; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Webb R, 2003, REPRODUCTION, P71; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x	30	198	223	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					384	U50		10.1038/ncb1388	http://dx.doi.org/10.1038/ncb1388			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16565707				2022-12-27	WOS:000236560000017
J	Franke, WW				Franke, WW			Shoichiro Tsukita - 1953-2005	NATURE CELL BIOLOGY			English	Biographical-Item									German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Franke, WW (corresponding author), German Canc Res Ctr, Div Cell Biol, A010,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	w.franke@dkfz.de		Franke, Werner W./0000-0002-4873-8448					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2006	8	4					302	302		10.1038/ncb0406-302	http://dx.doi.org/10.1038/ncb0406-302			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	029KA	16607264	Bronze			2022-12-27	WOS:000236560000002
J	Chang, P; Coughlin, M; Mitchison, TJ				Chang, P; Coughlin, M; Mitchison, TJ			Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function	NATURE CELL BIOLOGY			English	Article							COMPONENT; PHOSPHORYLATION; GLYCOHYDROLASE; ORGANIZATION; ASSOCIATION; INHIBITORS; MITOSIS; IRAP; PARP; NUMA	Poly(ADP-ribose) (PAR) is a large, negatively charged posttranslational modification that is produced by polymerization of NAD+ by PAR polymerases (PARPs)(1). There are at least 18 PARPs in the human genome, several of which have functions that are unknown(1). PAR modifications are dynamic; PAR structure depends on the balance between synthesis and hydrolysis by PAR glycohydrolase(2). We previously found that PAR is enriched in vertebrate somatic-cell mitotic spindles and demonstrated a requirement for PAR in the assembly of Xenopus egg extract spindles(3). Here, we knockdown all characterized PARPs using RNA interference (RNAi), and identify tankyrase-1 as the PARP that is required for mitosis. Tankyrase-1 localizes to mitotic spindle poles, to telomeres(4) and to the Golgi apparatus(5). Tankyrase-1 RNAi was recently shown to result in mitotic arrest, with abnormal chromosome distributions and spindle morphology observed - data that is interpreted as evidence of post-anaphase arrest induced by failure of telomere separation(6). We show that tankyrase-1 RNAi results in pre-anaphase arrest, with intact sister-chromatid cohesion. We also demonstrate a requirement for tankyrase-1 in the assembly of bipolar spindles, and identify the spindle-pole protein NuMA(7) as a substrate for covalent modification by tankyrase-1.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chang, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	paul_chang2@hms.harvard.edu			NIGMS NIH HHS [F32 GM070090, GM39565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070090, R37GM039565, R01GM039565] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; BOYLES J, 1985, J HISTOCHEM CYTOCHEM, V33, P1116, DOI 10.1177/33.11.3902963; Bryant HE, 2004, BIOCHEM SOC T, V32, P959, DOI 10.1042/BST0320959; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Mitchison TJ, 2004, MOL BIOL CELL, V15, P5603, DOI 10.1091/mbc.E04-05-0440; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Smith S, 1999, J CELL SCI, V112, P3649; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	26	210	222	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1133	1139		10.1038/ncb1322	http://dx.doi.org/10.1038/ncb1322			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16244666				2022-12-27	WOS:000232930400018
J	Wynder, C; Hakimi, MA; Epstein, JA; Shilatifard, A; Shiekhattar, R				Wynder, C; Hakimi, MA; Epstein, JA; Shilatifard, A; Shiekhattar, R			Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation	NATURE CELL BIOLOGY			English	Article							CELLS IN-VITRO; CHROMATIN-STRUCTURE; TARGET GENES; COMPLEX; METHYLTRANSFERASE; TRANSCRIPTION; REPRESSION; NEURONS	Differentiation of progenitor cells into post-mitotic neurons requires the engagement of mechanisms by which the repressive effects of the neuronal silencer, RE-1 silencing transcription factor (REST), can be overcome(1,2). Previously, we described a high-mobility group (HMG)-containing protein, BRAF35, which is a component of a co-repressor complex that is required for the repression of REST-responsive genes(3). Here, we show that the BRAF35 family member inhibitor of BRAF35 (iBRAF) activates REST-responsive genes through the modulation of histone methylation. In contrast to BRAF35, iBRAF expression leads to the abrogation of REST-mediated transcriptional repression and the resultant activation of neuronal-specific genes. Analysis of P19 cells during neuronal differentiation revealed an increased concentration of iBRAF at the promoter of neuronal-specific genes coincident with augmented expression of synapsin, recruitment of the methyltransferase MLL and enhanced trimethylation of histone H3 lysine 4 (H3K4). Importantly, ectopic expression of iBRAF is sufficient to induce neuronal differentiation through recruitment of MLL, resulting in increased histone H3K4 trimethylation and activation of neuronal-specific genes. Moreover, depletion of iBRAF abrogates recruitment of MLL and enhancement of histone H3K4 trimethylation. Together, these results indicate that the HMG-domain protein iBRAF has a key role in the initiation of neuronal differentiation.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Grenoble 1, CNRS, UMR5163, F-38700 La Tronche, France; Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63108 USA	The Wistar Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Pennsylvania; Saint Louis University	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	HAKIMI, Mohamed-ali/GYJ-0879-2022; HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/Q-6475-2019	HAKIMI, Mohamed-Ali/0000-0002-2547-8233; HAKIMI, Mohamed-ali/0000-0002-2547-8233	NIGMS NIH HHS [GM 61204] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061204] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Caslini C, 2000, P NATL ACAD SCI USA, V97, P2797, DOI 10.1073/pnas.040574897; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Kanda S, 2004, INT J DEV NEUROSCI, V22, P149, DOI 10.1016/j.ijdevneu.2004.01.002; Lichota J, 2003, BIOL CHEM, V384, P1019, DOI 10.1515/BC.2003.114; MacPherson Paul A., 1995, Methods (Orlando), V7, P238, DOI 10.1006/meth.1995.1029; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; MORASSUTTI DJ, 1994, NEUROSCIENCE, V58, P753, DOI 10.1016/0306-4522(94)90452-9; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nishimura E, 1996, NEUROSCI LETT, V211, P101, DOI 10.1016/0304-3940(96)12722-1; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tagoh H, 2004, BLOOD, V103, P2950, DOI 10.1182/blood-2003-09-3323; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741	19	66	68	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1113	1117		10.1038/ncb1312	http://dx.doi.org/10.1038/ncb1312			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16227968				2022-12-27	WOS:000232930400015
J	Xie, Y; Ding, YQ; Hong, Y; Feng, Z; Navarre, S; Xi, CX; Zhu, XJ; Wang, CL; Ackerman, SL; Kozlowski, D; Mei, L; Xiong, WC				Xie, Y; Ding, YQ; Hong, Y; Feng, Z; Navarre, S; Xi, CX; Zhu, XJ; Wang, CL; Ackerman, SL; Kozlowski, D; Mei, L; Xiong, WC			Phosphatidylinositol transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth	NATURE CELL BIOLOGY			English	Article							COLORECTAL-CANCER; NETRIN RECEPTOR; AXON GUIDANCE; PITP-ALPHA; DCC; GROWTH; ZEBRAFISH; KINASE; SLIT; ACTIVATION	Neurite extension is essential for wiring the nervous system during development. Although several factors are known to regulate neurite outgrowth, the underlying mechanisms remain unclear. Here, we provide evidence for a role of phosphatidylinositol transfer protein-alpha ( PITP alpha) in neurite extension in response to netrin-1, an extracellular guidance cue. PITP alpha interacts with the netrin receptor DCC ( deleted in colorectal cancer) and neogenin. Netrin-1 stimulates PITP alpha binding to DCC and to phosphatidylinositol ( 5) phosphate [ PI( 5) P], increases its lipid-transfer activity and elevates hydrolysis of phosphatidylinositol bisphosphate (PIP2). In addition, the stimulated PIP2 hydrolysis requires PITP alpha. Furthermore, cortical explants of PITP alpha mutant mice are defective in extending neurites in response to netrin-1. Commissural neurons from chicken embryos expressing a dominant-negative PITP alpha mutant show reduced axon outgrowth. Morpholino-mediated knockdown of PITP alpha expression in zebrafish embryos leads to dose-dependent defects in motor-neuron axons and reduced numbers of spinal-cord neurons. Taken together, these results identify a crucial role for PITP alpha in netrin-1-induced neurite outgrowth, revealing a signalling mechanism for DCC/neogenin and PITP alpha regulation.	Med Coll Georgia, Inst Mol Med & Genom, Augusta, GA 30912 USA; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Howard Hughes Medical Institute; Jackson Laboratory	Xiong, WC (corresponding author), Med Coll Georgia, Inst Mol Med & Genom, Augusta, GA 30912 USA.	wxiong@mcg.edu	Wang, Chunlei/G-7652-2014; Mei, Lin/G-8755-2012	Ding, Yu-Qiang/0000-0003-1202-4635	NIAMS NIH HHS [AR48120] Funding Source: Medline; NIDCD NIH HHS [DC006140] Funding Source: Medline; NIGMS NIH HHS [GM63861] Funding Source: Medline; NINDS NIH HHS [NS40480, NS045710, NS44521] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044521, R01NS045710, R01NS040480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006140] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Finger JH, 2002, J NEUROSCI, V22, P10346; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hara S, 1997, J BIOL CHEM, V272, P14908, DOI 10.1074/jbc.272.23.14908; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kennedy TE, 2000, BIOCHEM CELL BIOL, V78, P569, DOI 10.1139/bcb-78-5-569; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Morgan CP, 2004, J BIOL CHEM, V279, P47159, DOI 10.1074/jbc.M405827200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richards LJ, 1997, J NEUROSCI, V17, P2445; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; VANPARIDON PA, 1988, BIOCHIM BIOPHYS ACTA, V943, P76, DOI 10.1016/0005-2736(88)90348-3; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	35	78	82	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2005	7	11					1124	1132		10.1038/ncb1321	http://dx.doi.org/10.1038/ncb1321			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	979GM	16244667				2022-12-27	WOS:000232930400017
J	Ezratty, EJ; Partridge, MA; Gundersen, GG				Ezratty, EJ; Partridge, MA; Gundersen, GG			Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase	NATURE CELL BIOLOGY			English	Article							BINDING PROTEIN RHO; CELL-MIGRATION; LYSOPHOSPHATIDIC ACID; SIGNAL-TRANSDUCTION; REGULATES RHO; INTEGRIN; FIBROBLASTS; FAK; PHOSPHORYLATION; STABILIZATION	Imaging studies implicate microtubule targeting of focal adhesions in focal adhesion disassembly, although the molecular mechanism is unknown. Here, we develop a model system of focal adhesion disassembly based on the finding that microtubule regrowth after nocodazole washout induces disassembly of focal adhesions, and that this disassembly occurs independently of Rho and Rac, but depends on focal adhesion kinase (FAK) and dynamin. During disassembly, dynamin interacts with FAK and colocalizes with focal adhesions. Inhibition of dynamin prevents migration of cells with a focal adhesion phenotype. Our results show that focal adhesion disassembly involves microtubules, dynamin and FAK, and is not simply the reversal of focal adhesion formation.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, 630 W 168th St,BB 1217, New York, NY 10032 USA.	ggg1@columbia.edu			NIGMS NIH HHS [GM68595] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068595] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KHARBANDA S, 1995, P NATL ACAD SCI USA, V92, P6132, DOI 10.1073/pnas.92.13.6132; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kranenburg O, 1999, BIOCHEM J, V339, P11, DOI 10.1042/0264-6021:3390011; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mikhailov A, 1998, CELL MOTIL CYTOSKEL, V41, P325, DOI 10.1002/(SICI)1097-0169(1998)41:4<325::AID-CM5>3.0.CO;2-D; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Ory S, 2002, EUR J CELL BIOL, V81, P351, DOI 10.1078/0171-9335-00255; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pierini LM, 2000, BLOOD, V95, P2471; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Sieg DJ, 1999, J CELL SCI, V112, P2677; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094	50	458	468	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2005	7	6					581	U15		10.1038/ncb1262	http://dx.doi.org/10.1038/ncb1262			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	932OD	15895076				2022-12-27	WOS:000229562100012
J	Ingouff, M; Gerald, JNF; Guerin, C; Robert, H; Sorensen, MB; Van Damme, D; Geelen, D; Blanchoin, L; Berger, F				Ingouff, M; Gerald, JNF; Guerin, C; Robert, H; Sorensen, MB; Van Damme, D; Geelen, D; Blanchoin, L; Berger, F			Plant formin AtFH5 is an evolutionarily conserved actin nucleator involved in cytokinesis	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS-THALIANA; CELL PLATE; SEED DEVELOPMENT; ENDOSPERM; PROTEIN; TRANSFORMATION; ORGANIZATION; CYTOSKELETON; INTERPHASE; FILAMENTS	Formins are actin-organizing proteins that are involved in cytokinesis and cell polarity(1). In the plant Arabidopsis thaliana, there are more than 20 formin homologues, all of which have unknown roles(2). In this study, we characterize specific cellular and molecular functions of the Arabidopsis formin AtFH5. Despite the low identity of AtFH5 to yeast and mammalian formins, the AtFH5 protein interacts with the barbed end of actin filaments and nucleates actin-filament polymerization in vitro, as is the case in yeast and mammals. In vivo, the AtFH5-GFP fusion protein localizes to the cell plate, a plant-specific membranous component that is assembled at the plane of cell division. Consistent with these data, loss of function of atfh5 compromises cytokinesis in the seed endosperm. Furthermore, endogenous AtFH5 transcripts accumulate in the posterior pole of the endosperm and loss of function of atfh5 perturbs proper morphogenesis of the endosperm posterior pole. Although cytokinesis in animals, yeast and plants occurs through morphologically distinct mechanisms, our study finds that formin recruitment to sites of actin assembly is a common feature of cell division among eukaryotes.	Ecole Normale Super Lyon, Inst Federat Rech 128, UMR 5667, EMBO YIP Team, F-69364 Lyon, France; Univ Grenoble 1, CNRS, CEA, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France; Ghent Univ VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Flanders Institute for Biotechnology (VIB); Ghent University	Berger, F (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, 1 Res Link, Singapore 117604, Singapore.	laurent.blanchoin@cea.fr; fred@tll.org.sg	Berger, Frédéric/B-6947-2009; Ingouff, Mathieu/F-7373-2016; van damme, daniel/ABA-1397-2020; Sørensen, Mikael Blom/B-4183-2012; van damme, daniel/F-6139-2014; robert, helene/I-3130-2012	van damme, daniel/0000-0002-9385-4851; van damme, daniel/0000-0002-9385-4851; robert, helene/0000-0002-6610-836X; INGOUFF, Mathieu/0000-0002-6106-4564; Berger, Frederic/0000-0002-3609-8260				Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Brown RC, 1999, SEX PLANT REPROD, V12, P32, DOI 10.1007/s004970050169; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deeks MJ, 2003, CURR OPIN PLANT BIOL, V6, P561, DOI 10.1016/j.pbi.2003.09.013; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Endle MC, 1998, EUR J CELL BIOL, V77, P10, DOI 10.1016/S0171-9335(98)80097-6; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Huang SR, 1997, PLANT MOL BIOL, V33, P125, DOI 10.1023/A:1005741514764; JACKSON D, 1992, MOL PLANT PATHOL, V1, P163; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Ketelaar T, 2004, PLANT PHYSIOL, V136, P3990, DOI 10.1104/pp.104.050799; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Nguyen H, 2001, INT J PLANT SCI, V162, P1, DOI 10.1086/317898; PALEVITZ BA, 1974, CHROMOSOMA, V46, P327, DOI 10.1007/BF00284885; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; SCHMIT AC, 1987, J CELL BIOL, V105, P2157, DOI 10.1083/jcb.105.5.2157; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Sorensen MB, 2002, DEVELOPMENT, V129, P5567, DOI 10.1242/dev.00152; Sorensen MB, 2001, CURR BIOL, V11, P277, DOI 10.1016/S0960-9822(01)00072-0; Staehlin LA, 1996, CELL, V84, P821, DOI 10.1016/S0092-8674(00)81060-0; Valster AH, 1997, PLANT CELL, V9, P1815; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; ZIGMOND SH, 2004, CURR OPIN CELL BIOL, V16, P1	34	130	140	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					374	U34		10.1038/ncb1238	http://dx.doi.org/10.1038/ncb1238			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15765105				2022-12-27	WOS:000228075500013
J	Sasagawa, S; Ozaki, Y; Fujita, K; Kuroda, S				Sasagawa, S; Ozaki, Y; Fujita, K; Kuroda, S			Prediction and validation of the distinct dynamics of transient and sustained ERK activation	NATURE CELL BIOLOGY			English	Review							NERVE GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; MAP KINASE CASCADE; SIGNAL-TRANSDUCTION PATHWAYS; FACTOR RECEPTOR TRAFFICKING; PC12 CELL-DIFFERENTIATION; GTP-BINDING PROTEIN; EGF-RECEPTOR; TYROSINE PHOSPHORYLATION; B-RAF	To elucidate the hidden dynamics of extracellular-signal-regulated kinase (ERK) signalling networks, we developed a simulation model of ERK signalling networks by constraining in silico dynamics based on in vivo dynamics in PC12 cells. We predicted and validated that transient ERK activation depends on rapid increases of epidermal growth factor and nerve growth factor (NGF) but not on their final concentrations, whereas sustained ERK activation depends on the final concentration of NGF but not on the temporal rate of increase. These ERK dynamics depend on Ras and Rap1 dynamics, the inactivation processes of which are growth-factor-dependent and -independent, respectively. Therefore, the Ras and Rap1 systems capture the temporal rate and concentration of growth factors, and encode these distinct physical properties into transient and sustained ERK activation, respectively.	Univ Tokyo, Grad Sch Informat Sci & Technol, Undergrad Program Bioinformat & Syst Biol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2778583, Japan; Japan Sci & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Undergrad Program Bioinformat & Syst Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	skuroda@is.s.u-tokyo.ac.jp	KURODA, SHINYA/G-4961-2014	Sasagawa, Satoru/0000-0001-5769-8700				Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Chang JH, 2003, J BIOL CHEM, V278, P42877, DOI 10.1074/jbc.M308155200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Choi DY, 2001, MOL CELL BIOL, V21, P2695, DOI 10.1128/MCB.21.8.2695-2705.2001; Chook YM, 1996, J BIOL CHEM, V271, P30472, DOI 10.1074/jbc.271.48.30472; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DeWitt A, 2002, DEV BIOL, V250, P305, DOI 10.1006/dbio.2002.0807; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Farooq A, 1999, J BIOL CHEM, V274, P6114, DOI 10.1074/jbc.274.10.6114; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Gatti A, 2003, NEUROREPORT, V14, P1031, DOI 10.1097/00001756-200305230-00025; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Holt KH, 1996, J BIOL CHEM, V271, P8300, DOI 10.1074/jbc.271.14.8300; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAWATA M, 1988, J BIOL CHEM, V263, P18965; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Marshall CJ, 1998, NATURE, V392, P553, DOI 10.1038/33293; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; MOODIE SA, 1994, MOL CELL BIOL, V14, P7153, DOI 10.1128/MCB.14.11.7153; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SASAOKA T, 1994, J BIOL CHEM, V269, P32621; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SEGER R, 1992, J BIOL CHEM, V267, P14373; SHIRAKABE K, 1992, J BIOL CHEM, V267, P16685; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; SOLER C, 1993, J BIOL CHEM, V268, P22010; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Waters SB, 1996, J BIOL CHEM, V271, P18224, DOI 10.1074/jbc.271.30.18224; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; YAMAMORI B, 1995, J BIOL CHEM, V270, P11723, DOI 10.1074/jbc.270.20.11723; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	105	335	337	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2005	7	4					365	U31		10.1038/ncb1233	http://dx.doi.org/10.1038/ncb1233			31	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	912KA	15793571				2022-12-27	WOS:000228075500012
